,GeneID,GO_ID,gene-symbol,GO_term,gene-score
0,18,GO:0001666,ABAT,response to hypoxia,3.0
1,18,GO:0003867,ABAT,4-aminobutyrate transaminase activity,3.0
2,18,GO:0005739,ABAT,mitochondrion,3.0
5,18,GO:0005759,ABAT,mitochondrial matrix,3.0
6,18,GO:0007568,ABAT,aging,3.0
7,18,GO:0007620,ABAT,copulation,3.0
8,18,GO:0007626,ABAT,locomotory behavior,3.0
9,18,GO:0009448,ABAT,gamma-aminobutyric acid metabolic process,3.0
10,18,GO:0009449,ABAT,gamma-aminobutyric acid biosynthetic process,3.0
11,18,GO:0009450,ABAT,gamma-aminobutyric acid catabolic process,3.0
12,18,GO:0010039,ABAT,response to iron ion,3.0
13,18,GO:0014053,ABAT,negative regulation of gamma-aminobutyric acid secretion,3.0
14,18,GO:0021549,ABAT,cerebellum development,3.0
15,18,GO:0030170,ABAT,pyridoxal phosphate binding,3.0
17,18,GO:0031652,ABAT,positive regulation of heat generation,3.0
18,18,GO:0032024,ABAT,positive regulation of insulin secretion,3.0
19,18,GO:0032144,ABAT,4-aminobutyrate transaminase complex,3.0
20,18,GO:0032145,ABAT,succinate-semialdehyde dehydrogenase binding,3.0
21,18,GO:0033602,ABAT,negative regulation of dopamine secretion,3.0
22,18,GO:0034386,ABAT,4-aminobutyrate:2-oxoglutarate transaminase activity,3.0
23,18,GO:0035094,ABAT,response to nicotine,3.0
24,18,GO:0035640,ABAT,exploration behavior,3.0
25,18,GO:0042135,ABAT,neurotransmitter catabolic process,3.0
26,18,GO:0042493,ABAT,response to drug,3.0
27,18,GO:0042802,ABAT,identical protein binding,3.0
28,18,GO:0043005,ABAT,neuron projection,3.0
29,18,GO:0045471,ABAT,response to ethanol,3.0
30,18,GO:0045776,ABAT,negative regulation of blood pressure,3.0
31,18,GO:0045964,ABAT,positive regulation of dopamine metabolic process,3.0
32,18,GO:0046872,ABAT,metal ion binding,3.0
33,18,GO:0047298,ABAT,(S)-3-amino-2-methylpropionate transaminase activity,3.0
34,18,GO:0048148,ABAT,behavioral response to cocaine,3.0
35,18,GO:0051536,ABAT,iron-sulfur cluster binding,3.0
36,18,GO:0070474,ABAT,positive regulation of uterine smooth muscle contraction,3.0
37,18,GO:0090331,ABAT,negative regulation of platelet aggregation,3.0
38,18,GO:0097151,ABAT,positive regulation of inhibitory postsynaptic potential,3.0
39,18,GO:1902722,ABAT,positive regulation of prolactin secretion,3.0
40,18,GO:1904450,ABAT,positive regulation of aspartate secretion,3.0
41,10349,GO:0005319,ABCA10,lipid transporter activity,3.0
42,10349,GO:0005524,ABCA10,ATP binding,3.0
43,10349,GO:0006869,ABCA10,lipid transport,3.0
44,10349,GO:0016021,ABCA10,integral component of membrane,3.0
45,10349,GO:0016887,ABCA10,ATPase activity,3.0
46,10349,GO:0042626,ABCA10,ATPase-coupled transmembrane transporter activity,3.0
47,10349,GO:0043231,ABCA10,intracellular membrane-bounded organelle,3.0
48,10349,GO:0055085,ABCA10,transmembrane transport,3.0
49,154664,GO:0005319,ABCA13,lipid transporter activity,3.0
50,154664,GO:0005524,ABCA13,ATP binding,3.0
51,154664,GO:0005886,ABCA13,plasma membrane,3.0
52,154664,GO:0006869,ABCA13,lipid transport,3.0
53,154664,GO:0016021,ABCA13,integral component of membrane,3.0
54,154664,GO:0030667,ABCA13,secretory granule membrane,3.0
55,154664,GO:0035577,ABCA13,azurophil granule membrane,3.0
56,154664,GO:0042626,ABCA13,ATPase-coupled transmembrane transporter activity,3.0
57,154664,GO:0043231,ABCA13,intracellular membrane-bounded organelle,3.0
58,154664,GO:0043312,ABCA13,neutrophil degranulation,3.0
59,154664,GO:0055085,ABCA13,transmembrane transport,3.0
60,10347,GO:0000139,ABCA7,Golgi membrane,3.0
61,10347,GO:0001891,ABCA7,phagocytic cup,3.0
62,10347,GO:0005319,ABCA7,lipid transporter activity,3.0
63,10347,GO:0005524,ABCA7,ATP binding,3.0
64,10347,GO:0005548,ABCA7,phospholipid transporter activity,3.0
65,10347,GO:0005783,ABCA7,endoplasmic reticulum,3.0
66,10347,GO:0005794,ABCA7,Golgi apparatus,3.0
67,10347,GO:0005886,ABCA7,plasma membrane,3.0
69,10347,GO:0006869,ABCA7,lipid transport,3.0
70,10347,GO:0006909,ABCA7,phagocytosis,3.0
71,10347,GO:0007613,ABCA7,memory,3.0
72,10347,GO:0008542,ABCA7,visual learning,3.0
73,10347,GO:0009986,ABCA7,cell surface,3.0
74,10347,GO:0010875,ABCA7,positive regulation of cholesterol efflux,3.0
75,10347,GO:0016021,ABCA7,integral component of membrane,3.0
76,10347,GO:0016887,ABCA7,ATPase activity,3.0
77,10347,GO:0018149,ABCA7,peptide cross-linking,3.0
78,10347,GO:0019216,ABCA7,regulation of lipid metabolic process,3.0
79,10347,GO:0030054,ABCA7,cell junction,3.0
80,10347,GO:0031901,ABCA7,early endosome membrane,3.0
81,10347,GO:0032587,ABCA7,ruffle membrane,3.0
82,10347,GO:0033344,ABCA7,cholesterol efflux,3.0
84,10347,GO:0033700,ABCA7,phospholipid efflux,3.0
87,10347,GO:0034188,ABCA7,apolipoprotein A-I receptor activity,3.0
89,10347,GO:0034205,ABCA7,amyloid-beta formation,3.0
90,10347,GO:0034380,ABCA7,high-density lipoprotein particle assembly,3.0
91,10347,GO:0034504,ABCA7,protein localization to nucleus,3.0
92,10347,GO:0038027,ABCA7,apolipoprotein A-I-mediated signaling pathway,3.0
93,10347,GO:0042626,ABCA7,ATPase-coupled transmembrane transporter activity,3.0
94,10347,GO:0042985,ABCA7,negative regulation of amyloid precursor protein biosynthetic process,3.0
95,10347,GO:0043231,ABCA7,intracellular membrane-bounded organelle,3.0
96,10347,GO:0043409,ABCA7,negative regulation of MAPK cascade,3.0
97,10347,GO:0044857,ABCA7,plasma membrane raft organization,3.0
98,10347,GO:0045332,ABCA7,phospholipid translocation,3.0
99,10347,GO:0045806,ABCA7,negative regulation of endocytosis,3.0
100,10347,GO:0050766,ABCA7,positive regulation of phagocytosis,3.0
101,10347,GO:0055085,ABCA7,transmembrane transport,3.0
102,10347,GO:0070374,ABCA7,positive regulation of ERK1 and ERK2 cascade,3.0
103,10347,GO:0090554,ABCA7,phosphatidylcholine floppase activity,3.0
105,10347,GO:0090556,ABCA7,phosphatidylserine floppase activity,3.0
107,10347,GO:0097386,ABCA7,glial cell projection,3.0
108,10347,GO:0140328,ABCA7,floppase activity,3.0
109,10347,GO:0150094,ABCA7,amyloid-beta clearance by cellular catabolic process,3.0
110,10347,GO:1900223,ABCA7,positive regulation of amyloid-beta clearance,3.0
111,10347,GO:1901076,ABCA7,positive regulation of engulfment of apoptotic cell,3.0
112,10347,GO:1902430,ABCA7,negative regulation of amyloid-beta formation,3.0
113,10347,GO:1902991,ABCA7,regulation of amyloid precursor protein catabolic process,3.0
114,10347,GO:1902995,ABCA7,positive regulation of phospholipid efflux,3.0
115,10347,GO:1903898,ABCA7,negative regulation of PERK-mediated unfolded protein response,3.0
116,10347,GO:2000010,ABCA7,positive regulation of protein localization to cell surface,3.0
117,1636,GO:0001822,ACE,kidney development,3.0
118,1636,GO:0001974,ACE,blood vessel remodeling,3.0
119,1636,GO:0002003,ACE,angiotensin maturation,3.0
121,1636,GO:0002019,ACE,regulation of renal output by angiotensin,3.0
122,1636,GO:0002446,ACE,neutrophil mediated immunity,3.0
123,1636,GO:0002474,ACE,antigen processing and presentation of peptide antigen via MHC class I,3.0
124,1636,GO:0003081,ACE,regulation of systemic arterial blood pressure by renin-angiotensin,3.0
127,1636,GO:0003084,ACE,positive regulation of systemic arterial blood pressure,3.0
128,1636,GO:0004175,ACE,endopeptidase activity,3.0
129,1636,GO:0004180,ACE,carboxypeptidase activity,3.0
130,1636,GO:0005576,ACE,extracellular region,3.0
131,1636,GO:0005615,ACE,extracellular space,3.0
133,1636,GO:0005764,ACE,lysosome,3.0
134,1636,GO:0005768,ACE,endosome,3.0
135,1636,GO:0005886,ACE,plasma membrane,3.0
138,1636,GO:0006508,ACE,proteolysis,3.0
139,1636,GO:0007283,ACE,spermatogenesis,3.0
140,1636,GO:0008144,ACE,drug binding,3.0
141,1636,GO:0008217,ACE,regulation of blood pressure,3.0
142,1636,GO:0008237,ACE,metallopeptidase activity,3.0
146,1636,GO:0008238,ACE,exopeptidase activity,3.0
147,1636,GO:0008240,ACE,tripeptidyl-peptidase activity,3.0
148,1636,GO:0008241,ACE,peptidyl-dipeptidase activity,3.0
152,1636,GO:0008270,ACE,zinc ion binding,3.0
153,1636,GO:0009897,ACE,external side of plasma membrane,3.0
154,1636,GO:0010608,ACE,posttranscriptional regulation of gene expression,3.0
155,1636,GO:0010629,ACE,negative regulation of gene expression,3.0
156,1636,GO:0014910,ACE,regulation of smooth muscle cell migration,3.0
157,1636,GO:0016021,ACE,integral component of membrane,3.0
158,1636,GO:0019229,ACE,regulation of vasoconstriction,3.0
159,1636,GO:0031404,ACE,chloride ion binding,3.0
160,1636,GO:0031434,ACE,mitogen-activated protein kinase kinase binding,3.0
161,1636,GO:0031711,ACE,bradykinin receptor binding,3.0
162,1636,GO:0032091,ACE,negative regulation of protein binding,3.0
163,1636,GO:0032092,ACE,positive regulation of protein binding,3.0
164,1636,GO:0032943,ACE,mononuclear cell proliferation,3.0
165,1636,GO:0042447,ACE,hormone catabolic process,3.0
167,1636,GO:0043171,ACE,peptide catabolic process,3.0
168,1636,GO:0050435,ACE,amyloid-beta metabolic process,3.0
169,1636,GO:0050482,ACE,arachidonic acid secretion,3.0
170,1636,GO:0051019,ACE,mitogen-activated protein kinase binding,3.0
171,1636,GO:0060047,ACE,heart contraction,3.0
172,1636,GO:0060177,ACE,regulation of angiotensin metabolic process,3.0
173,1636,GO:0060218,ACE,hematopoietic stem cell differentiation,3.0
174,1636,GO:0061098,ACE,positive regulation of protein tyrosine kinase activity,3.0
175,1636,GO:0070062,ACE,extracellular exosome,3.0
177,1636,GO:0070573,ACE,metallodipeptidase activity,3.0
178,1636,GO:0071838,ACE,cell proliferation in bone marrow,3.0
179,1636,GO:0097746,ACE,blood vessel diameter maintenance,3.0
180,1636,GO:1900086,ACE,positive regulation of peptidyl-tyrosine autophosphorylation,3.0
181,1636,GO:1902033,ACE,regulation of hematopoietic stem cell proliferation,3.0
183,1636,GO:1903597,ACE,negative regulation of gap junction assembly,3.0
184,1636,GO:2000170,ACE,positive regulation of peptidyl-cysteine S-nitrosylation,3.0
335,81,GO:0000977,ACTN4,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
336,81,GO:0001666,ACTN4,response to hypoxia,3.0
337,81,GO:0001725,ACTN4,stress fiber,3.0
338,81,GO:0001882,ACTN4,nucleoside binding,3.0
339,81,GO:0002576,ACTN4,platelet degranulation,3.0
340,81,GO:0003713,ACTN4,transcription coactivator activity,3.0
341,81,GO:0003723,ACTN4,RNA binding,3.0
342,81,GO:0003779,ACTN4,actin binding,3.0
343,81,GO:0005178,ACTN4,integrin binding,3.0
344,81,GO:0005509,ACTN4,calcium ion binding,3.0
345,81,GO:0005515,ACTN4,protein binding,3.0
346,81,GO:0005576,ACTN4,extracellular region,3.0
347,81,GO:0005615,ACTN4,extracellular space,3.0
348,81,GO:0005634,ACTN4,nucleus,3.0
349,81,GO:0005737,ACTN4,cytoplasm,3.0
351,81,GO:0005829,ACTN4,cytosol,3.0
352,81,GO:0005903,ACTN4,brush border,3.0
353,81,GO:0005911,ACTN4,cell-cell junction,3.0
354,81,GO:0005925,ACTN4,focal adhesion,3.0
355,81,GO:0015031,ACTN4,protein transport,3.0
356,81,GO:0015629,ACTN4,actin cytoskeleton,3.0
357,81,GO:0016604,ACTN4,nuclear body,3.0
358,81,GO:0030018,ACTN4,Z disc,3.0
359,81,GO:0030050,ACTN4,vesicle transport along actin filament,3.0
360,81,GO:0030335,ACTN4,positive regulation of cell migration,3.0
361,81,GO:0030374,ACTN4,nuclear receptor coactivator activity,3.0
362,81,GO:0030863,ACTN4,cortical cytoskeleton,3.0
363,81,GO:0031093,ACTN4,platelet alpha granule lumen,3.0
364,81,GO:0031143,ACTN4,pseudopodium,3.0
365,81,GO:0031490,ACTN4,chromatin DNA binding,3.0
366,81,GO:0032417,ACTN4,positive regulation of sodium:proton antiporter activity,3.0
367,81,GO:0032991,ACTN4,protein-containing complex,3.0
368,81,GO:0033209,ACTN4,tumor necrosis factor-mediated signaling pathway,3.0
369,81,GO:0035257,ACTN4,nuclear hormone receptor binding,3.0
370,81,GO:0035357,ACTN4,peroxisome proliferator activated receptor signaling pathway,3.0
371,81,GO:0042803,ACTN4,protein homodimerization activity,3.0
372,81,GO:0042974,ACTN4,retinoic acid receptor binding,3.0
373,81,GO:0042981,ACTN4,regulation of apoptotic process,3.0
374,81,GO:0043005,ACTN4,neuron projection,3.0
375,81,GO:0044325,ACTN4,ion channel binding,3.0
376,81,GO:0047485,ACTN4,protein N-terminus binding,3.0
377,81,GO:0048384,ACTN4,retinoic acid receptor signaling pathway,3.0
378,81,GO:0048471,ACTN4,perinuclear region of cytoplasm,3.0
379,81,GO:0048549,ACTN4,positive regulation of pinocytosis,3.0
380,81,GO:0051015,ACTN4,actin filament binding,3.0
382,81,GO:0051017,ACTN4,actin filament bundle assembly,3.0
383,81,GO:0051271,ACTN4,negative regulation of cellular component movement,3.0
384,81,GO:0051272,ACTN4,positive regulation of cellular component movement,3.0
386,81,GO:0070062,ACTN4,extracellular exosome,3.0
387,81,GO:0070830,ACTN4,bicellular tight junction assembly,3.0
388,81,GO:1900025,ACTN4,negative regulation of substrate adhesion-dependent cell spreading,3.0
389,81,GO:1901224,ACTN4,positive regulation of NIK/NF-kappaB signaling,3.0
390,81,GO:1902396,ACTN4,protein localization to bicellular tight junction,3.0
391,81,GO:1903506,ACTN4,regulation of nucleic acid-templated transcription,3.0
392,81,GO:1903508,ACTN4,positive regulation of nucleic acid-templated transcription,3.0
393,81,GO:1990904,ACTN4,ribonucleoprotein complex,3.0
504,111,GO:0001973,ADCY5,G protein-coupled adenosine receptor signaling pathway,3.0
505,111,GO:0003091,ADCY5,renal water homeostasis,3.0
506,111,GO:0004016,ADCY5,adenylate cyclase activity,3.0
509,111,GO:0005524,ADCY5,ATP binding,3.0
510,111,GO:0005886,ADCY5,plasma membrane,3.0
512,111,GO:0005887,ADCY5,integral component of plasma membrane,3.0
513,111,GO:0005929,ADCY5,cilium,3.0
514,111,GO:0006171,ADCY5,cAMP biosynthetic process,3.0
517,111,GO:0007186,ADCY5,G protein-coupled receptor signaling pathway,3.0
518,111,GO:0007189,ADCY5,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
521,111,GO:0007190,ADCY5,activation of adenylate cyclase activity,3.0
522,111,GO:0007191,ADCY5,adenylate cyclase-activating dopamine receptor signaling pathway,3.0
523,111,GO:0007193,ADCY5,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,3.0
525,111,GO:0007195,ADCY5,adenylate cyclase-inhibiting dopamine receptor signaling pathway,3.0
526,111,GO:0007204,ADCY5,positive regulation of cytosolic calcium ion concentration,3.0
527,111,GO:0007626,ADCY5,locomotory behavior,3.0
528,111,GO:0008179,ADCY5,adenylate cyclase binding,3.0
529,111,GO:0016021,ADCY5,integral component of membrane,3.0
530,111,GO:0034199,ADCY5,activation of protein kinase A activity,3.0
531,111,GO:0045111,ADCY5,intermediate filament cytoskeleton,3.0
532,111,GO:0046872,ADCY5,metal ion binding,3.0
533,111,GO:0050885,ADCY5,neuromuscular process controlling balance,3.0
534,111,GO:0061178,ADCY5,regulation of insulin secretion involved in cellular response to glucose stimulus,3.0
535,111,GO:0071377,ADCY5,cellular response to glucagon stimulus,3.0
536,111,GO:0097110,ADCY5,scaffold protein binding,3.0
537,111,GO:1904322,ADCY5,cellular response to forskolin,3.0
538,132,GO:0003723,ADK,RNA binding,3.0
539,132,GO:0004001,ADK,adenosine kinase activity,3.0
540,132,GO:0005524,ADK,ATP binding,3.0
541,132,GO:0005634,ADK,nucleus,3.0
542,132,GO:0005654,ADK,nucleoplasm,3.0
543,132,GO:0005829,ADK,cytosol,3.0
546,132,GO:0006166,ADK,purine ribonucleoside salvage,3.0
547,132,GO:0006175,ADK,dATP biosynthetic process,3.0
548,132,GO:0009156,ADK,ribonucleoside monophosphate biosynthetic process,3.0
549,132,GO:0016310,ADK,phosphorylation,3.0
550,132,GO:0043101,ADK,purine-containing compound salvage,3.0
551,132,GO:0044209,ADK,AMP salvage,3.0
552,132,GO:0046872,ADK,metal ion binding,3.0
585,140,GO:0001609,ADORA3,G protein-coupled adenosine receptor activity,3.0
586,140,GO:0001973,ADORA3,G protein-coupled adenosine receptor signaling pathway,3.0
587,140,GO:0005886,ADORA3,plasma membrane,3.0
588,140,GO:0005887,ADORA3,integral component of plasma membrane,3.0
589,140,GO:0006954,ADORA3,inflammatory response,3.0
590,140,GO:0007165,ADORA3,signal transduction,3.0
591,140,GO:0007186,ADORA3,G protein-coupled receptor signaling pathway,3.0
592,140,GO:0007190,ADORA3,activation of adenylate cyclase activity,3.0
593,140,GO:0008016,ADORA3,regulation of heart contraction,3.0
594,140,GO:0008285,ADORA3,negative regulation of cell population proliferation,3.0
595,140,GO:0009611,ADORA3,response to wounding,3.0
596,140,GO:0030336,ADORA3,negative regulation of cell migration,3.0
597,140,GO:0032088,ADORA3,negative regulation of NF-kappaB transcription factor activity,3.0
632,116987,GO:0003924,AGAP1,GTPase activity,3.0
633,116987,GO:0005096,AGAP1,GTPase activator activity,3.0
634,116987,GO:0005515,AGAP1,protein binding,3.0
635,116987,GO:0005525,AGAP1,GTP binding,3.0
636,116987,GO:0005543,AGAP1,phospholipid binding,3.0
637,116987,GO:0005634,AGAP1,nucleus,3.0
638,116987,GO:0005737,AGAP1,cytoplasm,3.0
639,116987,GO:0015031,AGAP1,protein transport,3.0
640,116987,GO:0043547,AGAP1,positive regulation of GTPase activity,3.0
641,116987,GO:0046872,AGAP1,metal ion binding,3.0
673,159,GO:0000287,ADSS2,magnesium ion binding,3.0
674,159,GO:0002376,ADSS2,immune system process,3.0
675,159,GO:0004019,ADSS2,adenylosuccinate synthase activity,3.0
678,159,GO:0005515,ADSS2,protein binding,3.0
679,159,GO:0005525,ADSS2,GTP binding,3.0
680,159,GO:0005737,ADSS2,cytoplasm,3.0
681,159,GO:0005739,ADSS2,mitochondrion,3.0
682,159,GO:0005829,ADSS2,cytosol,3.0
684,159,GO:0005886,ADSS2,plasma membrane,3.0
685,159,GO:0006167,ADSS2,AMP biosynthetic process,3.0
687,159,GO:0006531,ADSS2,aspartate metabolic process,3.0
688,159,GO:0009168,ADSS2,purine ribonucleoside monophosphate biosynthetic process,3.0
689,159,GO:0014074,ADSS2,response to purine-containing compound,3.0
690,159,GO:0042301,ADSS2,phosphate ion binding,3.0
691,159,GO:0044208,ADSS2,'de novo' AMP biosynthetic process,3.0
693,159,GO:0046040,ADSS2,IMP metabolic process,3.0
694,159,GO:0060359,ADSS2,response to ammonium ion,3.0
695,159,GO:0070062,ADSS2,extracellular exosome,3.0
696,159,GO:0071257,ADSS2,cellular response to electrical stimulus,3.0
697,84871,GO:0004181,AGBL4,metallocarboxypeptidase activity,3.0
698,84871,GO:0005794,AGBL4,Golgi apparatus,3.0
699,84871,GO:0005814,AGBL4,centriole,3.0
700,84871,GO:0005829,AGBL4,cytosol,3.0
701,84871,GO:0006508,AGBL4,proteolysis,3.0
702,84871,GO:0008270,AGBL4,zinc ion binding,3.0
703,84871,GO:0008285,AGBL4,negative regulation of cell population proliferation,3.0
704,84871,GO:0015631,AGBL4,tubulin binding,3.0
705,84871,GO:0021954,AGBL4,central nervous system neuron development,3.0
706,84871,GO:0035608,AGBL4,protein deglutamylation,3.0
707,84871,GO:0035609,AGBL4,C-terminal protein deglutamylation,3.0
708,84871,GO:0035610,AGBL4,protein side chain deglutamylation,3.0
709,84871,GO:0036064,AGBL4,ciliary basal body,3.0
710,84871,GO:0051607,AGBL4,defense response to virus,3.0
711,84871,GO:0098957,AGBL4,anterograde axonal transport of mitochondrion,3.0
712,84871,GO:0098958,AGBL4,retrograde axonal transport of mitochondrion,3.0
713,84871,GO:0120222,AGBL4,regulation of blastocyst development,3.0
714,84871,GO:1904115,AGBL4,axon cytoplasm,3.0
715,84871,GO:2000060,AGBL4,positive regulation of ubiquitin-dependent protein catabolic process,3.0
716,392636,GO:0005506,AGMO,iron ion binding,3.0
717,392636,GO:0005515,AGMO,protein binding,3.0
718,392636,GO:0005783,AGMO,endoplasmic reticulum,3.0
720,392636,GO:0005789,AGMO,endoplasmic reticulum membrane,3.0
721,392636,GO:0006643,AGMO,membrane lipid metabolic process,3.0
723,392636,GO:0016021,AGMO,integral component of membrane,3.0
724,392636,GO:0019432,AGMO,triglyceride biosynthetic process,3.0
725,392636,GO:0046485,AGMO,ether lipid metabolic process,3.0
726,392636,GO:0050479,AGMO,glyceryl-ether monooxygenase activity,3.0
729,392636,GO:0055114,AGMO,oxidation-reduction process,3.0
769,192669,GO:0000794,AGO3,condensed nuclear chromosome,3.0
770,192669,GO:0000932,AGO3,P-body,3.0
771,192669,GO:0003723,AGO3,RNA binding,3.0
772,192669,GO:0003725,AGO3,double-stranded RNA binding,3.0
773,192669,GO:0003727,AGO3,single-stranded RNA binding,3.0
774,192669,GO:0004521,AGO3,endoribonuclease activity,3.0
775,192669,GO:0005515,AGO3,protein binding,3.0
776,192669,GO:0005654,AGO3,nucleoplasm,3.0
777,192669,GO:0005737,AGO3,cytoplasm,3.0
778,192669,GO:0005829,AGO3,cytosol,3.0
779,192669,GO:0006402,AGO3,mRNA catabolic process,3.0
780,192669,GO:0007223,AGO3,"Wnt signaling pathway, calcium modulating pathway",3.0
781,192669,GO:0010501,AGO3,RNA secondary structure unwinding,3.0
783,192669,GO:0010628,AGO3,positive regulation of gene expression,3.0
784,192669,GO:0010629,AGO3,negative regulation of gene expression,3.0
785,192669,GO:0016020,AGO3,membrane,3.0
786,192669,GO:0016442,AGO3,RISC complex,3.0
787,192669,GO:0031054,AGO3,pre-miRNA processing,3.0
788,192669,GO:0035194,AGO3,post-transcriptional gene silencing by RNA,3.0
789,192669,GO:0035196,AGO3,production of miRNAs involved in gene silencing by miRNA,3.0
790,192669,GO:0035198,AGO3,miRNA binding,3.0
791,192669,GO:0035278,AGO3,miRNA mediated inhibition of translation,3.0
792,192669,GO:0035279,AGO3,mRNA cleavage involved in gene silencing by miRNA,3.0
793,192669,GO:0035280,AGO3,miRNA loading onto RISC involved in gene silencing by miRNA,3.0
794,192669,GO:0036464,AGO3,cytoplasmic ribonucleoprotein granule,3.0
795,192669,GO:0045652,AGO3,regulation of megakaryocyte differentiation,3.0
796,192669,GO:0046872,AGO3,metal ion binding,3.0
797,192669,GO:0070578,AGO3,RISC-loading complex,3.0
798,192669,GO:0072091,AGO3,regulation of stem cell proliferation,3.0
799,192669,GO:0090502,AGO3,"RNA phosphodiester bond hydrolysis, endonucleolytic",3.0
800,192669,GO:0090624,AGO3,"endoribonuclease activity, cleaving miRNA-paired mRNA",3.0
801,192669,GO:0090625,AGO3,mRNA cleavage involved in gene silencing by siRNA,3.0
802,192669,GO:1901224,AGO3,positive regulation of NIK/NF-kappaB signaling,3.0
834,186,GO:0001819,AGTR2,positive regulation of cytokine production,3.0
835,186,GO:0001974,AGTR2,blood vessel remodeling,3.0
836,186,GO:0001991,AGTR2,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,3.0
837,186,GO:0002018,AGTR2,renin-angiotensin regulation of aldosterone production,3.0
838,186,GO:0002033,AGTR2,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,3.0
839,186,GO:0002035,AGTR2,brain renin-angiotensin system,3.0
840,186,GO:0004930,AGTR2,G protein-coupled receptor activity,3.0
841,186,GO:0004945,AGTR2,angiotensin type II receptor activity,3.0
843,186,GO:0005515,AGTR2,protein binding,3.0
844,186,GO:0005886,AGTR2,plasma membrane,3.0
846,186,GO:0005887,AGTR2,integral component of plasma membrane,3.0
847,186,GO:0006883,AGTR2,cellular sodium ion homeostasis,3.0
848,186,GO:0006954,AGTR2,inflammatory response,3.0
849,186,GO:0007166,AGTR2,cell surface receptor signaling pathway,3.0
850,186,GO:0007186,AGTR2,G protein-coupled receptor signaling pathway,3.0
853,186,GO:0007199,AGTR2,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,3.0
854,186,GO:0007263,AGTR2,nitric oxide mediated signal transduction,3.0
856,186,GO:0007420,AGTR2,brain development,3.0
857,186,GO:0008134,AGTR2,transcription factor binding,3.0
858,186,GO:0008217,AGTR2,regulation of blood pressure,3.0
859,186,GO:0008284,AGTR2,positive regulation of cell population proliferation,3.0
860,186,GO:0010459,AGTR2,negative regulation of heart rate,3.0
861,186,GO:0010700,AGTR2,negative regulation of norepinephrine secretion,3.0
862,186,GO:0021695,AGTR2,cerebellar cortex development,3.0
863,186,GO:0030308,AGTR2,negative regulation of cell growth,3.0
864,186,GO:0032304,AGTR2,negative regulation of icosanoid secretion,3.0
865,186,GO:0032516,AGTR2,positive regulation of phosphoprotein phosphatase activity,3.0
866,186,GO:0035556,AGTR2,intracellular signal transduction,3.0
867,186,GO:0035566,AGTR2,regulation of metanephros size,3.0
868,186,GO:0035640,AGTR2,exploration behavior,3.0
869,186,GO:0035815,AGTR2,positive regulation of renal sodium excretion,3.0
870,186,GO:0035932,AGTR2,aldosterone secretion,3.0
871,186,GO:0038166,AGTR2,angiotensin-activated signaling pathway,3.0
872,186,GO:0042306,AGTR2,regulation of protein import into nucleus,3.0
873,186,GO:0042311,AGTR2,vasodilation,3.0
874,186,GO:0042416,AGTR2,dopamine biosynthetic process,3.0
875,186,GO:0043537,AGTR2,negative regulation of blood vessel endothelial cell migration,3.0
876,186,GO:0045429,AGTR2,positive regulation of nitric oxide biosynthetic process,3.0
877,186,GO:0045893,AGTR2,"positive regulation of transcription, DNA-templated",3.0
878,186,GO:0048019,AGTR2,receptor antagonist activity,3.0
879,186,GO:0048147,AGTR2,negative regulation of fibroblast proliferation,3.0
880,186,GO:0048471,AGTR2,perinuclear region of cytoplasm,3.0
881,186,GO:0051000,AGTR2,positive regulation of nitric-oxide synthase activity,3.0
882,186,GO:0051387,AGTR2,negative regulation of neurotrophin TRK receptor signaling pathway,3.0
883,186,GO:0061049,AGTR2,cell growth involved in cardiac muscle cell development,3.0
884,186,GO:0071549,AGTR2,cellular response to dexamethasone stimulus,3.0
885,186,GO:0072300,AGTR2,positive regulation of metanephric glomerulus development,3.0
886,186,GO:0090190,AGTR2,positive regulation of branching involved in ureteric bud morphogenesis,3.0
887,186,GO:0097755,AGTR2,positive regulation of blood vessel diameter,3.0
888,186,GO:2000272,AGTR2,negative regulation of signaling receptor activity,3.0
889,186,GO:2001238,AGTR2,positive regulation of extrinsic apoptotic signaling pathway,3.0
1191,729092,GO:0005096,AGAP5,GTPase activator activity,3.0
1192,729092,GO:0005634,AGAP5,nucleus,3.0
1193,729092,GO:0043547,AGAP5,positive regulation of GTPase activity,3.0
1194,729092,GO:0046872,AGAP5,metal ion binding,3.0
1208,56899,GO:0005829,ANKS1B,cytosol,3.0
1210,56899,GO:0005886,ANKS1B,plasma membrane,3.0
1211,56899,GO:0014069,ANKS1B,postsynaptic density,3.0
1212,56899,GO:0015030,ANKS1B,Cajal body,3.0
1213,56899,GO:0043197,ANKS1B,dendritic spine,3.0
1214,56899,GO:0043231,ANKS1B,intracellular membrane-bounded organelle,3.0
1215,56899,GO:0046875,ANKS1B,ephrin receptor binding,3.0
1217,56899,GO:0048013,ANKS1B,ephrin receptor signaling pathway,3.0
1218,56899,GO:1900383,ANKS1B,regulation of synaptic plasticity by receptor localization to synapse,3.0
1365,321,GO:0001540,APBA2,amyloid-beta binding,3.0
1366,321,GO:0001701,APBA2,in utero embryonic development,3.0
1367,321,GO:0005515,APBA2,protein binding,3.0
1368,321,GO:0005737,APBA2,cytoplasm,3.0
1369,321,GO:0005886,APBA2,plasma membrane,3.0
1370,321,GO:0007268,APBA2,chemical synaptic transmission,3.0
1371,321,GO:0007399,APBA2,nervous system development,3.0
1372,321,GO:0007626,APBA2,locomotory behavior,3.0
1373,321,GO:0008021,APBA2,synaptic vesicle,3.0
1374,321,GO:0010468,APBA2,regulation of gene expression,3.0
1375,321,GO:0015031,APBA2,protein transport,3.0
1376,321,GO:0035264,APBA2,multicellular organism growth,3.0
1377,321,GO:0042802,APBA2,identical protein binding,3.0
1378,321,GO:0043197,APBA2,dendritic spine,3.0
1464,89839,GO:0005096,ARHGAP11B,GTPase activator activity,3.0
1465,89839,GO:0005829,ARHGAP11B,cytosol,3.0
1466,89839,GO:0007165,ARHGAP11B,signal transduction,3.0
1467,89839,GO:0021987,ARHGAP11B,cerebral cortex development,3.0
1468,89839,GO:0043547,ARHGAP11B,positive regulation of GTPase activity,3.0
1469,89839,GO:0051056,ARHGAP11B,regulation of small GTPase mediated signal transduction,3.0
1470,9743,GO:0000139,ARHGAP32,Golgi membrane,3.0
1471,9743,GO:0001650,ARHGAP32,fibrillar center,3.0
1473,9743,GO:0005096,ARHGAP32,GTPase activator activity,3.0
1474,9743,GO:0005515,ARHGAP32,protein binding,3.0
1475,9743,GO:0005654,ARHGAP32,nucleoplasm,3.0
1477,9743,GO:0005789,ARHGAP32,endoplasmic reticulum membrane,3.0
1478,9743,GO:0005794,ARHGAP32,Golgi apparatus,3.0
1480,9743,GO:0005829,ARHGAP32,cytosol,3.0
1481,9743,GO:0005938,ARHGAP32,cell cortex,3.0
1482,9743,GO:0007264,ARHGAP32,small GTPase mediated signal transduction,3.0
1483,9743,GO:0010008,ARHGAP32,endosome membrane,3.0
1484,9743,GO:0014069,ARHGAP32,postsynaptic density,3.0
1485,9743,GO:0015629,ARHGAP32,actin cytoskeleton,3.0
1486,9743,GO:0043197,ARHGAP32,dendritic spine,3.0
1487,9743,GO:0043547,ARHGAP32,positive regulation of GTPase activity,3.0
1488,9743,GO:0051056,ARHGAP32,regulation of small GTPase mediated signal transduction,3.0
1489,9743,GO:1901981,ARHGAP32,phosphatidylinositol phosphate binding,3.0
1490,394,GO:0003924,ARHGAP5,GTPase activity,3.0
1491,394,GO:0005096,ARHGAP5,GTPase activator activity,3.0
1492,394,GO:0005515,ARHGAP5,protein binding,3.0
1493,394,GO:0005525,ARHGAP5,GTP binding,3.0
1494,394,GO:0005737,ARHGAP5,cytoplasm,3.0
1495,394,GO:0005783,ARHGAP5,endoplasmic reticulum,3.0
1497,394,GO:0005829,ARHGAP5,cytosol,3.0
1500,394,GO:0005886,ARHGAP5,plasma membrane,3.0
1501,394,GO:0007155,ARHGAP5,cell adhesion,3.0
1502,394,GO:0007266,ARHGAP5,Rho protein signal transduction,3.0
1503,394,GO:0042169,ARHGAP5,SH2 domain binding,3.0
1505,394,GO:0043547,ARHGAP5,positive regulation of GTPase activity,3.0
1506,394,GO:0051056,ARHGAP5,regulation of small GTPase mediated signal transduction,3.0
1507,9639,GO:0005085,ARHGEF10,guanyl-nucleotide exchange factor activity,3.0
1509,9639,GO:0005515,ARHGEF10,protein binding,3.0
1510,9639,GO:0005813,ARHGEF10,centrosome,3.0
1512,9639,GO:0005829,ARHGEF10,cytosol,3.0
1513,9639,GO:0019894,ARHGEF10,kinesin binding,3.0
1514,9639,GO:0022011,ARHGEF10,myelination in peripheral nervous system,3.0
1515,9639,GO:0030036,ARHGEF10,actin cytoskeleton organization,3.0
1516,9639,GO:0035023,ARHGEF10,regulation of Rho protein signal transduction,3.0
1517,9639,GO:0051298,ARHGEF10,centrosome duplication,3.0
1518,9639,GO:0051496,ARHGEF10,positive regulation of stress fiber assembly,3.0
1520,9639,GO:0090307,ARHGEF10,mitotic spindle assembly,3.0
1522,9639,GO:0090630,ARHGEF10,activation of GTPase activity,3.0
1553,196528,GO:0003007,ARID2,heart morphogenesis,3.0
1554,196528,GO:0003677,ARID2,DNA binding,3.0
1555,196528,GO:0005515,ARID2,protein binding,3.0
1556,196528,GO:0005654,ARID2,nucleoplasm,3.0
1557,196528,GO:0005886,ARID2,plasma membrane,3.0
1558,196528,GO:0006337,ARID2,nucleosome disassembly,3.0
1559,196528,GO:0006355,ARID2,"regulation of transcription, DNA-templated",3.0
1560,196528,GO:0008285,ARID2,negative regulation of cell population proliferation,3.0
1561,196528,GO:0030336,ARID2,negative regulation of cell migration,3.0
1562,196528,GO:0042592,ARID2,homeostatic process,3.0
1563,196528,GO:0046872,ARID2,metal ion binding,3.0
1564,196528,GO:0048568,ARID2,embryonic organ development,3.0
1565,196528,GO:0060038,ARID2,cardiac muscle cell proliferation,3.0
1566,196528,GO:0060982,ARID2,coronary artery morphogenesis,3.0
1567,196528,GO:1905168,ARID2,positive regulation of double-strand break repair via homologous recombination,3.0
1568,9915,GO:0000785,ARNT2,chromatin,3.0
1569,9915,GO:0000978,ARNT2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
1571,9915,GO:0000981,ARNT2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
1574,9915,GO:0001228,ARNT2,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
1575,9915,GO:0001666,ARNT2,response to hypoxia,3.0
1576,9915,GO:0001701,ARNT2,in utero embryonic development,3.0
1577,9915,GO:0003700,ARNT2,DNA-binding transcription factor activity,3.0
1578,9915,GO:0005515,ARNT2,protein binding,3.0
1579,9915,GO:0005634,ARNT2,nucleus,3.0
1581,9915,GO:0005654,ARNT2,nucleoplasm,3.0
1583,9915,GO:0005667,ARNT2,transcription regulator complex,3.0
1584,9915,GO:0005737,ARNT2,cytoplasm,3.0
1585,9915,GO:0006355,ARNT2,"regulation of transcription, DNA-templated",3.0
1586,9915,GO:0006357,ARNT2,regulation of transcription by RNA polymerase II,3.0
1587,9915,GO:0006805,ARNT2,xenobiotic metabolic process,3.0
1588,9915,GO:0007417,ARNT2,central nervous system development,3.0
1589,9915,GO:0007420,ARNT2,brain development,3.0
1590,9915,GO:0008284,ARNT2,positive regulation of cell population proliferation,3.0
1591,9915,GO:0017162,ARNT2,aryl hydrocarbon receptor binding,3.0
1592,9915,GO:0032355,ARNT2,response to estradiol,3.0
1593,9915,GO:0034751,ARNT2,aryl hydrocarbon receptor complex,3.0
1594,9915,GO:0043066,ARNT2,negative regulation of apoptotic process,3.0
1595,9915,GO:0044877,ARNT2,protein-containing complex binding,3.0
1596,9915,GO:0045893,ARNT2,"positive regulation of transcription, DNA-templated",3.0
1597,9915,GO:0045944,ARNT2,positive regulation of transcription by RNA polymerase II,3.0
1598,9915,GO:0046982,ARNT2,protein heterodimerization activity,3.0
1601,9915,GO:1990837,ARNT2,sequence-specific double-stranded DNA binding,3.0
1632,142686,GO:0005829,ASB14,cytosol,3.0
1633,142686,GO:0016567,ASB14,protein ubiquitination,3.0
1634,142686,GO:0035556,ASB14,intracellular signal transduction,3.0
1635,142686,GO:0043687,ASB14,post-translational protein modification,3.0
1664,438,GO:0005829,ASMT,cytosol,3.0
1665,438,GO:0006412,ASMT,translation,3.0
1666,438,GO:0008171,ASMT,O-methyltransferase activity,3.0
1667,438,GO:0008172,ASMT,S-methyltransferase activity,3.0
1668,438,GO:0008757,ASMT,S-adenosylmethionine-dependent methyltransferase activity,3.0
1669,438,GO:0017096,ASMT,acetylserotonin O-methyltransferase activity,3.0
1671,438,GO:0019438,ASMT,aromatic compound biosynthetic process,3.0
1672,438,GO:0030187,ASMT,melatonin biosynthetic process,3.0
1675,438,GO:0032259,ASMT,methylation,3.0
1676,438,GO:0042802,ASMT,identical protein binding,3.0
1677,438,GO:0042803,ASMT,protein homodimerization activity,3.0
1678,438,GO:0046219,ASMT,indolalkylamine biosynthetic process,3.0
1721,135,GO:0000139,ADORA2A,Golgi membrane,3.0
1722,135,GO:0001609,ADORA2A,G protein-coupled adenosine receptor activity,3.0
1723,135,GO:0001963,ADORA2A,"synaptic transmission, dopaminergic",3.0
1724,135,GO:0001973,ADORA2A,G protein-coupled adenosine receptor signaling pathway,3.0
1725,135,GO:0001975,ADORA2A,response to amphetamine,3.0
1726,135,GO:0005515,ADORA2A,protein binding,3.0
1727,135,GO:0005882,ADORA2A,intermediate filament,3.0
1728,135,GO:0005886,ADORA2A,plasma membrane,3.0
1730,135,GO:0005887,ADORA2A,integral component of plasma membrane,3.0
1731,135,GO:0006355,ADORA2A,"regulation of transcription, DNA-templated",3.0
1732,135,GO:0006469,ADORA2A,negative regulation of protein kinase activity,3.0
1733,135,GO:0006909,ADORA2A,phagocytosis,3.0
1734,135,GO:0006915,ADORA2A,apoptotic process,3.0
1735,135,GO:0006954,ADORA2A,inflammatory response,3.0
1736,135,GO:0006968,ADORA2A,cellular defense response,3.0
1737,135,GO:0007186,ADORA2A,G protein-coupled receptor signaling pathway,3.0
1738,135,GO:0007188,ADORA2A,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,3.0
1739,135,GO:0007189,ADORA2A,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
1740,135,GO:0007205,ADORA2A,protein kinase C-activating G protein-coupled receptor signaling pathway,3.0
1741,135,GO:0007267,ADORA2A,cell-cell signaling,3.0
1742,135,GO:0007271,ADORA2A,"synaptic transmission, cholinergic",3.0
1743,135,GO:0007417,ADORA2A,central nervous system development,3.0
1744,135,GO:0007596,ADORA2A,blood coagulation,3.0
1745,135,GO:0007600,ADORA2A,sensory perception,3.0
1746,135,GO:0007626,ADORA2A,locomotory behavior,3.0
1747,135,GO:0008015,ADORA2A,blood circulation,3.0
1748,135,GO:0008285,ADORA2A,negative regulation of cell population proliferation,3.0
1749,135,GO:0014049,ADORA2A,positive regulation of glutamate secretion,3.0
1750,135,GO:0014057,ADORA2A,"positive regulation of acetylcholine secretion, neurotransmission",3.0
1751,135,GO:0014061,ADORA2A,regulation of norepinephrine secretion,3.0
1752,135,GO:0014069,ADORA2A,postsynaptic density,3.0
1753,135,GO:0016020,ADORA2A,membrane,3.0
1754,135,GO:0019899,ADORA2A,enzyme binding,3.0
1755,135,GO:0030425,ADORA2A,dendrite,3.0
1756,135,GO:0030673,ADORA2A,axolemma,3.0
1757,135,GO:0031000,ADORA2A,response to caffeine,3.0
1758,135,GO:0031802,ADORA2A,type 5 metabotropic glutamate receptor binding,3.0
1759,135,GO:0032230,ADORA2A,"positive regulation of synaptic transmission, GABAergic",3.0
1760,135,GO:0035249,ADORA2A,"synaptic transmission, glutamatergic",3.0
1761,135,GO:0035810,ADORA2A,positive regulation of urine volume,3.0
1762,135,GO:0035815,ADORA2A,positive regulation of renal sodium excretion,3.0
1763,135,GO:0040013,ADORA2A,negative regulation of locomotion,3.0
1764,135,GO:0042311,ADORA2A,vasodilation,3.0
1765,135,GO:0042493,ADORA2A,response to drug,3.0
1766,135,GO:0042755,ADORA2A,eating behavior,3.0
1767,135,GO:0042802,ADORA2A,identical protein binding,3.0
1768,135,GO:0043025,ADORA2A,neuronal cell body,3.0
1769,135,GO:0043116,ADORA2A,negative regulation of vascular permeability,3.0
1770,135,GO:0043154,ADORA2A,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
1771,135,GO:0043524,ADORA2A,negative regulation of neuron apoptotic process,3.0
1772,135,GO:0044267,ADORA2A,cellular protein metabolic process,3.0
1773,135,GO:0044877,ADORA2A,protein-containing complex binding,3.0
1774,135,GO:0045938,ADORA2A,"positive regulation of circadian sleep/wake cycle, sleep",3.0
1775,135,GO:0046636,ADORA2A,negative regulation of alpha-beta T cell activation,3.0
1776,135,GO:0048143,ADORA2A,astrocyte activation,3.0
1777,135,GO:0048786,ADORA2A,presynaptic active zone,3.0
1778,135,GO:0048812,ADORA2A,neuron projection morphogenesis,3.0
1779,135,GO:0050714,ADORA2A,positive regulation of protein secretion,3.0
1780,135,GO:0050728,ADORA2A,negative regulation of inflammatory response,3.0
1781,135,GO:0051393,ADORA2A,alpha-actinin binding,3.0
1782,135,GO:0051881,ADORA2A,regulation of mitochondrial membrane potential,3.0
1783,135,GO:0051899,ADORA2A,membrane depolarization,3.0
1784,135,GO:0051924,ADORA2A,regulation of calcium ion transport,3.0
1785,135,GO:0051968,ADORA2A,"positive regulation of synaptic transmission, glutamatergic",3.0
1786,135,GO:0060079,ADORA2A,excitatory postsynaptic potential,3.0
1787,135,GO:0060080,ADORA2A,inhibitory postsynaptic potential,3.0
1788,135,GO:0060134,ADORA2A,prepulse inhibition,3.0
1789,135,GO:0099055,ADORA2A,integral component of postsynaptic membrane,3.0
1790,135,GO:0099056,ADORA2A,integral component of presynaptic membrane,3.0
1791,135,GO:1900273,ADORA2A,positive regulation of long-term synaptic potentiation,3.0
1792,135,GO:2001235,ADORA2A,positive regulation of apoptotic signaling pathway,3.0
1793,154,GO:0001540,ADRB2,amyloid-beta binding,3.0
1794,154,GO:0002024,ADRB2,diet induced thermogenesis,3.0
1795,154,GO:0002025,ADRB2,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,3.0
1796,154,GO:0002028,ADRB2,regulation of sodium ion transport,3.0
1797,154,GO:0002032,ADRB2,desensitization of G protein-coupled receptor signaling pathway by arrestin,3.0
1798,154,GO:0004930,ADRB2,G protein-coupled receptor activity,3.0
1799,154,GO:0004941,ADRB2,beta2-adrenergic receptor activity,3.0
1802,154,GO:0005515,ADRB2,protein binding,3.0
1803,154,GO:0005634,ADRB2,nucleus,3.0
1804,154,GO:0005764,ADRB2,lysosome,3.0
1805,154,GO:0005768,ADRB2,endosome,3.0
1806,154,GO:0005769,ADRB2,early endosome,3.0
1807,154,GO:0005794,ADRB2,Golgi apparatus,3.0
1808,154,GO:0005886,ADRB2,plasma membrane,3.0
1810,154,GO:0005887,ADRB2,integral component of plasma membrane,3.0
1812,154,GO:0006898,ADRB2,receptor-mediated endocytosis,3.0
1813,154,GO:0007166,ADRB2,cell surface receptor signaling pathway,3.0
1814,154,GO:0007171,ADRB2,activation of transmembrane receptor protein tyrosine kinase activity,3.0
1815,154,GO:0007186,ADRB2,G protein-coupled receptor signaling pathway,3.0
1816,154,GO:0007188,ADRB2,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,3.0
1817,154,GO:0007190,ADRB2,activation of adenylate cyclase activity,3.0
1818,154,GO:0008179,ADRB2,adenylate cyclase binding,3.0
1819,154,GO:0008333,ADRB2,endosome to lysosome transport,3.0
1820,154,GO:0009409,ADRB2,response to cold,3.0
1821,154,GO:0010008,ADRB2,endosome membrane,3.0
1822,154,GO:0010739,ADRB2,positive regulation of protein kinase A signaling,3.0
1823,154,GO:0015459,ADRB2,potassium channel regulator activity,3.0
1824,154,GO:0016020,ADRB2,membrane,3.0
1825,154,GO:0016324,ADRB2,apical plasma membrane,3.0
1826,154,GO:0016579,ADRB2,protein deubiquitination,3.0
1827,154,GO:0030501,ADRB2,positive regulation of bone mineralization,3.0
1828,154,GO:0030665,ADRB2,clathrin-coated vesicle membrane,3.0
1829,154,GO:0031398,ADRB2,positive regulation of protein ubiquitination,3.0
1830,154,GO:0031649,ADRB2,heat generation,3.0
1831,154,GO:0040015,ADRB2,negative regulation of multicellular organism growth,3.0
1832,154,GO:0042802,ADRB2,identical protein binding,3.0
1833,154,GO:0042803,ADRB2,protein homodimerization activity,3.0
1834,154,GO:0043235,ADRB2,receptor complex,3.0
1835,154,GO:0043410,ADRB2,positive regulation of MAPK cascade,3.0
1836,154,GO:0044877,ADRB2,protein-containing complex binding,3.0
1837,154,GO:0045453,ADRB2,bone resorption,3.0
1838,154,GO:0045944,ADRB2,positive regulation of transcription by RNA polymerase II,3.0
1839,154,GO:0045986,ADRB2,negative regulation of smooth muscle contraction,3.0
1840,154,GO:0050873,ADRB2,brown fat cell differentiation,3.0
1841,154,GO:0051380,ADRB2,norepinephrine binding,3.0
1843,154,GO:0061024,ADRB2,membrane organization,3.0
1844,154,GO:0061885,ADRB2,positive regulation of mini excitatory postsynaptic potential,3.0
1845,154,GO:0071875,ADRB2,adrenergic receptor signaling pathway,3.0
1846,154,GO:0071880,ADRB2,adenylate cyclase-activating adrenergic receptor signaling pathway,3.0
1847,154,GO:0071902,ADRB2,positive regulation of protein serine/threonine kinase activity,3.0
1848,154,GO:0120162,ADRB2,positive regulation of cold-induced thermogenesis,3.0
1849,154,GO:1901098,ADRB2,positive regulation of autophagosome maturation,3.0
1850,154,GO:1904504,ADRB2,positive regulation of lipophagy,3.0
1851,154,GO:1904646,ADRB2,cellular response to amyloid-beta,3.0
1852,154,GO:1990911,ADRB2,response to psychosocial stress,3.0
1853,154,GO:2000481,ADRB2,positive regulation of cAMP-dependent protein kinase activity,3.0
1854,154,GO:2000969,ADRB2,positive regulation of AMPA receptor activity,3.0
1900,476,GO:0002026,ATP1A1,regulation of the force of heart contraction,3.0
1901,476,GO:0002028,ATP1A1,regulation of sodium ion transport,3.0
1902,476,GO:0005391,ATP1A1,sodium:potassium-exchanging ATPase activity,3.0
1907,476,GO:0005515,ATP1A1,protein binding,3.0
1908,476,GO:0005524,ATP1A1,ATP binding,3.0
1909,476,GO:0005768,ATP1A1,endosome,3.0
1910,476,GO:0005783,ATP1A1,endoplasmic reticulum,3.0
1911,476,GO:0005794,ATP1A1,Golgi apparatus,3.0
1912,476,GO:0005886,ATP1A1,plasma membrane,3.0
1916,476,GO:0005890,ATP1A1,sodium:potassium-exchanging ATPase complex,3.0
1919,476,GO:0005901,ATP1A1,caveola,3.0
1920,476,GO:0006883,ATP1A1,cellular sodium ion homeostasis,3.0
1922,476,GO:0008217,ATP1A1,regulation of blood pressure,3.0
1923,476,GO:0010248,ATP1A1,establishment or maintenance of transmembrane electrochemical gradient,3.0
1924,476,GO:0014069,ATP1A1,postsynaptic density,3.0
1925,476,GO:0014704,ATP1A1,intercalated disc,3.0
1926,476,GO:0016020,ATP1A1,membrane,3.0
1927,476,GO:0016021,ATP1A1,integral component of membrane,3.0
1928,476,GO:0016311,ATP1A1,dephosphorylation,3.0
1929,476,GO:0016323,ATP1A1,basolateral plasma membrane,3.0
1930,476,GO:0016324,ATP1A1,apical plasma membrane,3.0
1931,476,GO:0016328,ATP1A1,lateral plasma membrane,3.0
1932,476,GO:0016791,ATP1A1,phosphatase activity,3.0
1933,476,GO:0019901,ATP1A1,protein kinase binding,3.0
1934,476,GO:0019904,ATP1A1,protein domain specific binding,3.0
1935,476,GO:0030007,ATP1A1,cellular potassium ion homeostasis,3.0
1937,476,GO:0030315,ATP1A1,T-tubule,3.0
1938,476,GO:0030506,ATP1A1,ankyrin binding,3.0
1939,476,GO:0030955,ATP1A1,potassium ion binding,3.0
1940,476,GO:0031090,ATP1A1,organelle membrane,3.0
1941,476,GO:0031402,ATP1A1,sodium ion binding,3.0
1942,476,GO:0031947,ATP1A1,negative regulation of glucocorticoid biosynthetic process,3.0
1943,476,GO:0032991,ATP1A1,protein-containing complex,3.0
1944,476,GO:0034220,ATP1A1,ion transmembrane transport,3.0
1945,476,GO:0036126,ATP1A1,sperm flagellum,3.0
1946,476,GO:0036376,ATP1A1,sodium ion export across plasma membrane,3.0
1949,476,GO:0042383,ATP1A1,sarcolemma,3.0
1950,476,GO:0042470,ATP1A1,melanosome,3.0
1951,476,GO:0042493,ATP1A1,response to drug,3.0
1952,476,GO:0043531,ATP1A1,ADP binding,3.0
1953,476,GO:0043548,ATP1A1,phosphatidylinositol 3-kinase binding,3.0
1954,476,GO:0045121,ATP1A1,membrane raft,3.0
1955,476,GO:0045822,ATP1A1,negative regulation of heart contraction,3.0
1956,476,GO:0045823,ATP1A1,positive regulation of heart contraction,3.0
1957,476,GO:0045989,ATP1A1,positive regulation of striated muscle contraction,3.0
1958,476,GO:0046982,ATP1A1,protein heterodimerization activity,3.0
1959,476,GO:0051087,ATP1A1,chaperone binding,3.0
1960,476,GO:0055119,ATP1A1,relaxation of cardiac muscle,3.0
1961,476,GO:0060081,ATP1A1,membrane hyperpolarization,3.0
1962,476,GO:0060342,ATP1A1,photoreceptor inner segment membrane,3.0
1963,476,GO:0070062,ATP1A1,extracellular exosome,3.0
1964,476,GO:0071260,ATP1A1,cellular response to mechanical stimulus,3.0
1965,476,GO:0071383,ATP1A1,cellular response to steroid hormone stimulus,3.0
1966,476,GO:0086002,ATP1A1,cardiac muscle cell action potential involved in contraction,3.0
1967,476,GO:0086004,ATP1A1,regulation of cardiac muscle cell contraction,3.0
1968,476,GO:0086009,ATP1A1,membrane repolarization,3.0
1969,476,GO:0086013,ATP1A1,membrane repolarization during cardiac muscle cell action potential,3.0
1970,476,GO:0086064,ATP1A1,cell communication by electrical coupling involved in cardiac conduction,3.0
1971,476,GO:1902600,ATP1A1,proton transmembrane transport,3.0
1972,476,GO:1903416,ATP1A1,response to glycoside,3.0
1973,476,GO:1903561,ATP1A1,extracellular vesicle,3.0
1974,476,GO:1903779,ATP1A1,regulation of cardiac conduction,3.0
1975,476,GO:1990239,ATP1A1,steroid hormone binding,3.0
1976,476,GO:1990573,ATP1A1,potassium ion import across plasma membrane,3.0
1990,367,GO:0000122,AR,negative regulation of transcription by RNA polymerase II,3.0
1991,367,GO:0000785,AR,chromatin,3.0
1994,367,GO:0000976,AR,transcription regulatory region sequence-specific DNA binding,3.0
1995,367,GO:0000978,AR,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
1997,367,GO:0000981,AR,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
1998,367,GO:0001085,AR,RNA polymerase II transcription factor binding,3.0
1999,367,GO:0001091,AR,RNA polymerase II general transcription initiation factor binding,3.0
2000,367,GO:0001225,AR,RNA polymerase II transcription coactivator binding,3.0
2002,367,GO:0001228,AR,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
2003,367,GO:0001701,AR,in utero embryonic development,3.0
2004,367,GO:0003073,AR,regulation of systemic arterial blood pressure,3.0
2005,367,GO:0003382,AR,epithelial cell morphogenesis,3.0
2006,367,GO:0003682,AR,chromatin binding,3.0
2007,367,GO:0003700,AR,DNA-binding transcription factor activity,3.0
2008,367,GO:0004879,AR,nuclear receptor activity,3.0
2012,367,GO:0005102,AR,signaling receptor binding,3.0
2013,367,GO:0005496,AR,steroid binding,3.0
2014,367,GO:0005497,AR,androgen binding,3.0
2015,367,GO:0005515,AR,protein binding,3.0
2016,367,GO:0005634,AR,nucleus,3.0
2017,367,GO:0005654,AR,nucleoplasm,3.0
2018,367,GO:0005737,AR,cytoplasm,3.0
2019,367,GO:0005829,AR,cytosol,3.0
2020,367,GO:0005886,AR,plasma membrane,3.0
2021,367,GO:0006357,AR,regulation of transcription by RNA polymerase II,3.0
2022,367,GO:0006367,AR,transcription initiation from RNA polymerase II promoter,3.0
2023,367,GO:0007165,AR,signal transduction,3.0
2024,367,GO:0007267,AR,cell-cell signaling,3.0
2025,367,GO:0007283,AR,spermatogenesis,3.0
2026,367,GO:0007338,AR,single fertilization,3.0
2027,367,GO:0008013,AR,beta-catenin binding,3.0
2030,367,GO:0008134,AR,transcription factor binding,3.0
2031,367,GO:0008270,AR,zinc ion binding,3.0
2032,367,GO:0008284,AR,positive regulation of cell population proliferation,3.0
2033,367,GO:0008285,AR,negative regulation of cell population proliferation,3.0
2034,367,GO:0008584,AR,male gonad development,3.0
2035,367,GO:0010628,AR,positive regulation of gene expression,3.0
2037,367,GO:0016579,AR,protein deubiquitination,3.0
2038,367,GO:0016607,AR,nuclear speck,3.0
2039,367,GO:0019102,AR,male somatic sex determination,3.0
2040,367,GO:0019899,AR,enzyme binding,3.0
2041,367,GO:0030518,AR,intracellular steroid hormone receptor signaling pathway,3.0
2042,367,GO:0030520,AR,intracellular estrogen receptor signaling pathway,3.0
2043,367,GO:0030521,AR,androgen receptor signaling pathway,3.0
2044,367,GO:0030522,AR,intracellular receptor signaling pathway,3.0
2045,367,GO:0032991,AR,protein-containing complex,3.0
2046,367,GO:0033148,AR,positive regulation of intracellular estrogen receptor signaling pathway,3.0
2047,367,GO:0033327,AR,Leydig cell differentiation,3.0
2048,367,GO:0035264,AR,multicellular organism growth,3.0
2049,367,GO:0042327,AR,positive regulation of phosphorylation,3.0
2050,367,GO:0043410,AR,positive regulation of MAPK cascade,3.0
2051,367,GO:0043568,AR,positive regulation of insulin-like growth factor receptor signaling pathway,3.0
2052,367,GO:0045597,AR,positive regulation of cell differentiation,3.0
2053,367,GO:0045720,AR,negative regulation of integrin biosynthetic process,3.0
2054,367,GO:0045726,AR,positive regulation of integrin biosynthetic process,3.0
2055,367,GO:0045893,AR,"positive regulation of transcription, DNA-templated",3.0
2056,367,GO:0045944,AR,positive regulation of transcription by RNA polymerase II,3.0
2058,367,GO:0045945,AR,positive regulation of transcription by RNA polymerase III,3.0
2059,367,GO:0048638,AR,regulation of developmental growth,3.0
2060,367,GO:0048645,AR,animal organ formation,3.0
2061,367,GO:0048808,AR,male genitalia morphogenesis,3.0
2062,367,GO:0050680,AR,negative regulation of epithelial cell proliferation,3.0
2063,367,GO:0051092,AR,positive regulation of NF-kappaB transcription factor activity,3.0
2064,367,GO:0051117,AR,ATPase binding,3.0
2065,367,GO:0060520,AR,activation of prostate induction by androgen receptor signaling pathway,3.0
2066,367,GO:0060571,AR,morphogenesis of an epithelial fold,3.0
2067,367,GO:0060599,AR,lateral sprouting involved in mammary gland duct morphogenesis,3.0
2068,367,GO:0060736,AR,prostate gland growth,3.0
2069,367,GO:0060740,AR,prostate gland epithelium morphogenesis,3.0
2070,367,GO:0060742,AR,epithelial cell differentiation involved in prostate gland development,3.0
2071,367,GO:0060748,AR,tertiary branching involved in mammary gland duct morphogenesis,3.0
2072,367,GO:0060749,AR,mammary gland alveolus development,3.0
2073,367,GO:0060769,AR,positive regulation of epithelial cell proliferation involved in prostate gland development,3.0
2074,367,GO:0070974,AR,POU domain binding,3.0
2075,367,GO:0071383,AR,cellular response to steroid hormone stimulus,3.0
2076,367,GO:0071391,AR,cellular response to estrogen stimulus,3.0
2077,367,GO:0071394,AR,cellular response to testosterone stimulus,3.0
2078,367,GO:0072520,AR,seminiferous tubule development,3.0
2079,367,GO:1903076,AR,regulation of protein localization to plasma membrane,3.0
2080,367,GO:2001237,AR,negative regulation of extrinsic apoptotic signaling pathway,3.0
2081,478,GO:0001540,ATP1A3,amyloid-beta binding,3.0
2083,478,GO:0001917,ATP1A3,photoreceptor inner segment,3.0
2084,478,GO:0005391,ATP1A3,sodium:potassium-exchanging ATPase activity,3.0
2088,478,GO:0005515,ATP1A3,protein binding,3.0
2089,478,GO:0005524,ATP1A3,ATP binding,3.0
2090,478,GO:0005783,ATP1A3,endoplasmic reticulum,3.0
2091,478,GO:0005794,ATP1A3,Golgi apparatus,3.0
2092,478,GO:0005886,ATP1A3,plasma membrane,3.0
2095,478,GO:0005890,ATP1A3,sodium:potassium-exchanging ATPase complex,3.0
2098,478,GO:0006883,ATP1A3,cellular sodium ion homeostasis,3.0
2100,478,GO:0010248,ATP1A3,establishment or maintenance of transmembrane electrochemical gradient,3.0
2101,478,GO:0016020,ATP1A3,membrane,3.0
2102,478,GO:0016021,ATP1A3,integral component of membrane,3.0
2103,478,GO:0030007,ATP1A3,cellular potassium ion homeostasis,3.0
2105,478,GO:0030424,ATP1A3,axon,3.0
2106,478,GO:0031090,ATP1A3,organelle membrane,3.0
2107,478,GO:0032809,ATP1A3,neuronal cell body membrane,3.0
2108,478,GO:0034220,ATP1A3,ion transmembrane transport,3.0
2109,478,GO:0036376,ATP1A3,sodium ion export across plasma membrane,3.0
2111,478,GO:0043025,ATP1A3,neuronal cell body,3.0
2112,478,GO:0045202,ATP1A3,synapse,3.0
2113,478,GO:0046872,ATP1A3,metal ion binding,3.0
2114,478,GO:0051087,ATP1A3,chaperone binding,3.0
2115,478,GO:0060075,ATP1A3,regulation of resting membrane potential,3.0
2116,478,GO:0060342,ATP1A3,photoreceptor inner segment membrane,3.0
2117,478,GO:0071383,ATP1A3,cellular response to steroid hormone stimulus,3.0
2118,478,GO:0086064,ATP1A3,cell communication by electrical coupling involved in cardiac conduction,3.0
2119,478,GO:0098984,ATP1A3,neuron to neuron synapse,3.0
2120,478,GO:0099520,ATP1A3,ion antiporter activity involved in regulation of presynaptic membrane potential,3.0
2121,478,GO:1902600,ATP1A3,proton transmembrane transport,3.0
2122,478,GO:1903416,ATP1A3,response to glycoside,3.0
2123,478,GO:1903561,ATP1A3,extracellular vesicle,3.0
2124,478,GO:1903779,ATP1A3,regulation of cardiac conduction,3.0
2125,478,GO:1904646,ATP1A3,cellular response to amyloid-beta,3.0
2126,478,GO:1990239,ATP1A3,steroid hormone binding,3.0
2127,478,GO:1990535,ATP1A3,neuron projection maintenance,3.0
2128,478,GO:1990573,ATP1A3,potassium ion import across plasma membrane,3.0
2166,23545,GO:0000220,ATP6V0A2,"vacuolar proton-transporting V-type ATPase, V0 domain",3.0
2167,23545,GO:0001669,ATP6V0A2,acrosomal vesicle,3.0
2168,23545,GO:0005515,ATP6V0A2,protein binding,3.0
2169,23545,GO:0005765,ATP6V0A2,lysosomal membrane,3.0
2170,23545,GO:0005886,ATP6V0A2,plasma membrane,3.0
2171,23545,GO:0006879,ATP6V0A2,cellular iron ion homeostasis,3.0
2172,23545,GO:0006955,ATP6V0A2,immune response,3.0
2173,23545,GO:0007035,ATP6V0A2,vacuolar acidification,3.0
2174,23545,GO:0008286,ATP6V0A2,insulin receptor signaling pathway,3.0
2175,23545,GO:0010008,ATP6V0A2,endosome membrane,3.0
2176,23545,GO:0016021,ATP6V0A2,integral component of membrane,3.0
2177,23545,GO:0016241,ATP6V0A2,regulation of macroautophagy,3.0
2178,23545,GO:0016471,ATP6V0A2,vacuolar proton-transporting V-type ATPase complex,3.0
2179,23545,GO:0030670,ATP6V0A2,phagocytic vesicle membrane,3.0
2180,23545,GO:0033572,ATP6V0A2,transferrin transport,3.0
2181,23545,GO:0034220,ATP6V0A2,ion transmembrane transport,3.0
2182,23545,GO:0036295,ATP6V0A2,cellular response to increased oxygen levels,3.0
2183,23545,GO:0046961,ATP6V0A2,"proton-transporting ATPase activity, rotational mechanism",3.0
2184,23545,GO:0048471,ATP6V0A2,perinuclear region of cytoplasm,3.0
2185,23545,GO:0051117,ATP6V0A2,ATPase binding,3.0
2186,23545,GO:0090383,ATP6V0A2,phagosome acidification,3.0
2187,23545,GO:1902600,ATP6V0A2,proton transmembrane transport,3.0
2294,563,GO:0001580,AZGP1,detection of chemical stimulus involved in sensory perception of bitter taste,3.0
2295,563,GO:0001895,AZGP1,retina homeostasis,3.0
2296,563,GO:0001916,AZGP1,positive regulation of T cell mediated cytotoxicity,3.0
2297,563,GO:0002476,AZGP1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,3.0
2298,563,GO:0002486,AZGP1,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.0
2299,563,GO:0004540,AZGP1,ribonuclease activity,3.0
2300,563,GO:0005515,AZGP1,protein binding,3.0
2301,563,GO:0005576,AZGP1,extracellular region,3.0
2304,563,GO:0005615,AZGP1,extracellular space,3.0
2307,563,GO:0005634,AZGP1,nucleus,3.0
2308,563,GO:0006955,AZGP1,immune response,3.0
2309,563,GO:0007155,AZGP1,cell adhesion,3.0
2310,563,GO:0008285,AZGP1,negative regulation of cell population proliferation,3.0
2311,563,GO:0008320,AZGP1,protein transmembrane transporter activity,3.0
2312,563,GO:0009897,AZGP1,external side of plasma membrane,3.0
2313,563,GO:0055085,AZGP1,transmembrane transport,3.0
2314,563,GO:0062023,AZGP1,collagen-containing extracellular matrix,3.0
2315,563,GO:0070062,AZGP1,extracellular exosome,3.0
2316,563,GO:0071806,AZGP1,protein transmembrane transport,3.0
2317,563,GO:0090501,AZGP1,RNA phosphodiester bond hydrolysis,3.0
2325,585,GO:0000226,BBS4,microtubule cytoskeleton organization,3.0
2326,585,GO:0000242,BBS4,pericentriolar material,3.0
2327,585,GO:0000281,BBS4,mitotic cytokinesis,3.0
2328,585,GO:0001103,BBS4,RNA polymerase II repressing transcription factor binding,3.0
2329,585,GO:0001750,BBS4,photoreceptor outer segment,3.0
2330,585,GO:0001764,BBS4,neuron migration,3.0
2331,585,GO:0001843,BBS4,neural tube closure,3.0
2332,585,GO:0001895,BBS4,retina homeostasis,3.0
2333,585,GO:0001917,BBS4,photoreceptor inner segment,3.0
2334,585,GO:0001947,BBS4,heart looping,3.0
2335,585,GO:0003085,BBS4,negative regulation of systemic arterial blood pressure,3.0
2336,585,GO:0005515,BBS4,protein binding,3.0
2337,585,GO:0005634,BBS4,nucleus,3.0
2338,585,GO:0005813,BBS4,centrosome,3.0
2339,585,GO:0005814,BBS4,centriole,3.0
2340,585,GO:0005829,BBS4,cytosol,3.0
2342,585,GO:0005929,BBS4,cilium,3.0
2343,585,GO:0007098,BBS4,centrosome cycle,3.0
2344,585,GO:0007286,BBS4,spermatid development,3.0
2345,585,GO:0007601,BBS4,visual perception,3.0
2346,585,GO:0007608,BBS4,sensory perception of smell,3.0
2347,585,GO:0010629,BBS4,negative regulation of gene expression,3.0
2348,585,GO:0015031,BBS4,protein transport,3.0
2349,585,GO:0016358,BBS4,dendrite development,3.0
2350,585,GO:0019216,BBS4,regulation of lipid metabolic process,3.0
2351,585,GO:0021591,BBS4,ventricular system development,3.0
2352,585,GO:0021756,BBS4,striatum development,3.0
2353,585,GO:0021766,BBS4,hippocampus development,3.0
2354,585,GO:0021987,BBS4,cerebral cortex development,3.0
2355,585,GO:0030534,BBS4,adult behavior,3.0
2356,585,GO:0030674,BBS4,protein-macromolecule adaptor activity,3.0
2357,585,GO:0030837,BBS4,negative regulation of actin filament polymerization,3.0
2358,585,GO:0031514,BBS4,motile cilium,3.0
2359,585,GO:0032391,BBS4,photoreceptor connecting cilium,3.0
2360,585,GO:0032402,BBS4,melanosome transport,3.0
2361,585,GO:0032465,BBS4,regulation of cytokinesis,3.0
2362,585,GO:0033365,BBS4,protein localization to organelle,3.0
2363,585,GO:0034260,BBS4,negative regulation of GTPase activity,3.0
2364,585,GO:0034451,BBS4,centriolar satellite,3.0
2365,585,GO:0034452,BBS4,dynactin binding,3.0
2366,585,GO:0034454,BBS4,microtubule anchoring at centrosome,3.0
2367,585,GO:0034464,BBS4,BBSome,3.0
2368,585,GO:0035176,BBS4,social behavior,3.0
2369,585,GO:0035845,BBS4,photoreceptor cell outer segment organization,3.0
2370,585,GO:0035869,BBS4,ciliary transition zone,3.0
2371,585,GO:0036064,BBS4,ciliary basal body,3.0
2372,585,GO:0038108,BBS4,negative regulation of appetite by leptin-mediated signaling pathway,3.0
2373,585,GO:0040018,BBS4,positive regulation of multicellular organism growth,3.0
2374,585,GO:0043014,BBS4,alpha-tubulin binding,3.0
2375,585,GO:0045444,BBS4,fat cell differentiation,3.0
2376,585,GO:0045494,BBS4,photoreceptor cell maintenance,3.0
2377,585,GO:0045724,BBS4,positive regulation of cilium assembly,3.0
2378,585,GO:0046548,BBS4,retinal rod cell development,3.0
2379,585,GO:0046907,BBS4,intracellular transport,3.0
2380,585,GO:0048487,BBS4,beta-tubulin binding,3.0
2381,585,GO:0048854,BBS4,brain morphogenesis,3.0
2382,585,GO:0050893,BBS4,sensory processing,3.0
2383,585,GO:0051457,BBS4,maintenance of protein location in nucleus,3.0
2384,585,GO:0051492,BBS4,regulation of stress fiber assembly,3.0
2385,585,GO:0060170,BBS4,ciliary membrane,3.0
2386,585,GO:0060271,BBS4,cilium assembly,3.0
2387,585,GO:0060296,BBS4,regulation of cilium beat frequency involved in ciliary motility,3.0
2388,585,GO:0060324,BBS4,face development,3.0
2389,585,GO:0060613,BBS4,fat pad development,3.0
2390,585,GO:0061512,BBS4,protein localization to cilium,3.0
2391,585,GO:0071539,BBS4,protein localization to centrosome,3.0
2392,585,GO:0097730,BBS4,non-motile cilium,3.0
2393,585,GO:1902855,BBS4,regulation of non-motile cilium assembly,3.0
2394,585,GO:1903546,BBS4,protein localization to photoreceptor outer segment,3.0
2395,585,GO:1905515,BBS4,non-motile cilium assembly,3.0
2396,8537,GO:0005737,BCAS1,cytoplasm,3.0
2397,8537,GO:0014069,BCAS1,postsynaptic density,3.0
2398,8537,GO:0042552,BCAS1,myelination,3.0
2400,8537,GO:0070062,BCAS1,extracellular exosome,3.0
2444,57448,GO:0000922,BIRC6,spindle pole,3.0
2445,57448,GO:0004842,BIRC6,ubiquitin-protein transferase activity,3.0
2446,57448,GO:0004869,BIRC6,cysteine-type endopeptidase inhibitor activity,3.0
2448,57448,GO:0005515,BIRC6,protein binding,3.0
2449,57448,GO:0005634,BIRC6,nucleus,3.0
2450,57448,GO:0005768,BIRC6,endosome,3.0
2451,57448,GO:0005802,BIRC6,trans-Golgi network,3.0
2452,57448,GO:0005815,BIRC6,microtubule organizing center,3.0
2453,57448,GO:0006468,BIRC6,protein phosphorylation,3.0
2454,57448,GO:0006511,BIRC6,ubiquitin-dependent protein catabolic process,3.0
2455,57448,GO:0006915,BIRC6,apoptotic process,3.0
2456,57448,GO:0007049,BIRC6,cell cycle,3.0
2457,57448,GO:0008284,BIRC6,positive regulation of cell population proliferation,3.0
2458,57448,GO:0010951,BIRC6,negative regulation of endopeptidase activity,3.0
2459,57448,GO:0016020,BIRC6,membrane,3.0
2460,57448,GO:0016567,BIRC6,protein ubiquitination,3.0
2461,57448,GO:0030496,BIRC6,midbody,3.0
2462,57448,GO:0032465,BIRC6,regulation of cytokinesis,3.0
2463,57448,GO:0042127,BIRC6,regulation of cell population proliferation,3.0
2464,57448,GO:0043066,BIRC6,negative regulation of apoptotic process,3.0
2467,57448,GO:0051301,BIRC6,cell division,3.0
2468,57448,GO:0060711,BIRC6,labyrinthine layer development,3.0
2469,57448,GO:0061631,BIRC6,ubiquitin conjugating enzyme activity,3.0
2470,57448,GO:0090543,BIRC6,Flemming body,3.0
2471,57448,GO:2001237,BIRC6,negative regulation of extrinsic apoptotic signaling pathway,3.0
2504,675,GO:0000722,BRCA2,telomere maintenance via recombination,3.0
2505,675,GO:0000724,BRCA2,double-strand break repair via homologous recombination,3.0
2508,675,GO:0000781,BRCA2,"chromosome, telomeric region",3.0
2509,675,GO:0000800,BRCA2,lateral element,3.0
2510,675,GO:0001556,BRCA2,oocyte maturation,3.0
2511,675,GO:0001833,BRCA2,inner cell mass cell proliferation,3.0
2512,675,GO:0002020,BRCA2,protease binding,3.0
2513,675,GO:0003697,BRCA2,single-stranded DNA binding,3.0
2514,675,GO:0004402,BRCA2,histone acetyltransferase activity,3.0
2515,675,GO:0005515,BRCA2,protein binding,3.0
2516,675,GO:0005634,BRCA2,nucleus,3.0
2518,675,GO:0005654,BRCA2,nucleoplasm,3.0
2520,675,GO:0005813,BRCA2,centrosome,3.0
2521,675,GO:0005829,BRCA2,cytosol,3.0
2522,675,GO:0006289,BRCA2,nucleotide-excision repair,3.0
2523,675,GO:0006302,BRCA2,double-strand break repair,3.0
2524,675,GO:0006355,BRCA2,"regulation of transcription, DNA-templated",3.0
2525,675,GO:0006978,BRCA2,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",3.0
2526,675,GO:0007141,BRCA2,male meiosis I,3.0
2527,675,GO:0007283,BRCA2,spermatogenesis,3.0
2528,675,GO:0007420,BRCA2,brain development,3.0
2529,675,GO:0007569,BRCA2,cell aging,3.0
2530,675,GO:0008022,BRCA2,protein C-terminus binding,3.0
2531,675,GO:0008585,BRCA2,female gonad development,3.0
2532,675,GO:0010165,BRCA2,response to X-ray,3.0
2533,675,GO:0010225,BRCA2,response to UV-C,3.0
2534,675,GO:0010332,BRCA2,response to gamma radiation,3.0
2535,675,GO:0010484,BRCA2,H3 histone acetyltransferase activity,3.0
2536,675,GO:0010485,BRCA2,H4 histone acetyltransferase activity,3.0
2537,675,GO:0030097,BRCA2,hemopoiesis,3.0
2538,675,GO:0030141,BRCA2,secretory granule,3.0
2539,675,GO:0032465,BRCA2,regulation of cytokinesis,3.0
2540,675,GO:0032991,BRCA2,protein-containing complex,3.0
2541,675,GO:0033593,BRCA2,BRCA2-MAGE-D1 complex,3.0
2542,675,GO:0033600,BRCA2,negative regulation of mammary gland epithelial cell proliferation,3.0
2543,675,GO:0042771,BRCA2,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3.0
2544,675,GO:0042802,BRCA2,identical protein binding,3.0
2545,675,GO:0043015,BRCA2,gamma-tubulin binding,3.0
2546,675,GO:0043966,BRCA2,histone H3 acetylation,3.0
2547,675,GO:0043967,BRCA2,histone H4 acetylation,3.0
2548,675,GO:0045893,BRCA2,"positive regulation of transcription, DNA-templated",3.0
2549,675,GO:0045931,BRCA2,positive regulation of mitotic cell cycle,3.0
2550,675,GO:0048478,BRCA2,replication fork protection,3.0
2551,675,GO:0051298,BRCA2,centrosome duplication,3.0
2552,675,GO:0070200,BRCA2,establishment of protein localization to telomere,3.0
2553,675,GO:1990426,BRCA2,mitotic recombination-dependent replication fork processing,3.0
2554,23476,GO:0000083,BRD4,regulation of transcription involved in G1/S transition of mitotic cell cycle,3.0
2555,23476,GO:0000794,BRD4,condensed nuclear chromosome,3.0
2556,23476,GO:0002039,BRD4,p53 binding,3.0
2557,23476,GO:0003682,BRD4,chromatin binding,3.0
2558,23476,GO:0003712,BRD4,transcription coregulator activity,3.0
2559,23476,GO:0005515,BRD4,protein binding,3.0
2560,23476,GO:0005634,BRD4,nucleus,3.0
2561,23476,GO:0005654,BRD4,nucleoplasm,3.0
2562,23476,GO:0006325,BRD4,chromatin organization,3.0
2563,23476,GO:0006468,BRD4,protein phosphorylation,3.0
2564,23476,GO:0006974,BRD4,cellular response to DNA damage stimulus,3.0
2565,23476,GO:0008353,BRD4,RNA polymerase II CTD heptapeptide repeat kinase activity,3.0
2566,23476,GO:0010971,BRD4,positive regulation of G2/M transition of mitotic cell cycle,3.0
2567,23476,GO:0016032,BRD4,viral process,3.0
2568,23476,GO:0019899,BRD4,enzyme binding,3.0
2569,23476,GO:0032968,BRD4,positive regulation of transcription elongation from RNA polymerase II promoter,3.0
2571,23476,GO:0043123,BRD4,positive regulation of I-kappaB kinase/NF-kappaB signaling,3.0
2572,23476,GO:0045893,BRD4,"positive regulation of transcription, DNA-templated",3.0
2573,23476,GO:0045944,BRD4,positive regulation of transcription by RNA polymerase II,3.0
2574,23476,GO:0050727,BRD4,regulation of inflammatory response,3.0
2575,23476,GO:0070577,BRD4,lysine-acetylated histone binding,3.0
2576,23476,GO:0099122,BRD4,RNA polymerase II C-terminal domain binding,3.0
2577,23476,GO:0106140,BRD4,P-TEFb complex binding,3.0
2578,23476,GO:1901407,BRD4,regulation of phosphorylation of RNA polymerase II C-terminal domain,3.0
2579,23476,GO:2001255,BRD4,positive regulation of histone H3-K36 trimethylation,3.0
2634,683,GO:0001931,BST1,uropod,3.0
2635,683,GO:0001952,BST1,regulation of cell-matrix adhesion,3.0
2636,683,GO:0002691,BST1,regulation of cellular extravasation,3.0
2637,683,GO:0003953,BST1,NAD+ nucleosidase activity,3.0
2638,683,GO:0005576,BST1,extracellular region,3.0
2639,683,GO:0005886,BST1,plasma membrane,3.0
2641,683,GO:0006959,BST1,humoral immune response,3.0
2642,683,GO:0007165,BST1,signal transduction,3.0
2643,683,GO:0008284,BST1,positive regulation of cell population proliferation,3.0
2644,683,GO:0016740,BST1,transferase activity,3.0
2645,683,GO:0016849,BST1,phosphorus-oxygen lyase activity,3.0
2646,683,GO:0019674,BST1,NAD metabolic process,3.0
2647,683,GO:0019898,BST1,extrinsic component of membrane,3.0
2648,683,GO:0030890,BST1,positive regulation of B cell proliferation,3.0
2649,683,GO:0031225,BST1,anchored component of membrane,3.0
2650,683,GO:0032956,BST1,regulation of actin cytoskeleton organization,3.0
2651,683,GO:0035579,BST1,specific granule membrane,3.0
2652,683,GO:0043312,BST1,neutrophil degranulation,3.0
2653,683,GO:0050135,BST1,NAD(P)+ nucleosidase activity,3.0
2654,683,GO:0050727,BST1,regulation of inflammatory response,3.0
2655,683,GO:0050730,BST1,regulation of peptidyl-tyrosine phosphorylation,3.0
2656,683,GO:0050848,BST1,regulation of calcium-mediated signaling,3.0
2658,683,GO:0061809,BST1,"NAD+ nucleotidase, cyclic ADP-ribose generating",3.0
2659,683,GO:0061811,BST1,ADP-ribosyl cyclase activity,3.0
2660,683,GO:0061812,BST1,cyclic ADP-ribose hydrolase,3.0
2661,683,GO:0070062,BST1,extracellular exosome,3.0
2662,683,GO:0090022,BST1,regulation of neutrophil chemotaxis,3.0
2663,683,GO:0090322,BST1,regulation of superoxide metabolic process,3.0
2664,683,GO:2001044,BST1,regulation of integrin-mediated signaling pathway,3.0
2674,8945,GO:0000086,BTRC,G2/M transition of mitotic cell cycle,3.0
2675,8945,GO:0000209,BTRC,protein polyubiquitination,3.0
2678,8945,GO:0002223,BTRC,stimulatory C-type lectin receptor signaling pathway,3.0
2679,8945,GO:0004842,BTRC,ubiquitin-protein transferase activity,3.0
2680,8945,GO:0005515,BTRC,protein binding,3.0
2681,8945,GO:0005654,BTRC,nucleoplasm,3.0
2682,8945,GO:0005829,BTRC,cytosol,3.0
2683,8945,GO:0006470,BTRC,protein dephosphorylation,3.0
2684,8945,GO:0006511,BTRC,ubiquitin-dependent protein catabolic process,3.0
2685,8945,GO:0007165,BTRC,signal transduction,3.0
2686,8945,GO:0008013,BTRC,beta-catenin binding,3.0
2687,8945,GO:0016032,BTRC,viral process,3.0
2688,8945,GO:0016055,BTRC,Wnt signaling pathway,3.0
2689,8945,GO:0016567,BTRC,protein ubiquitination,3.0
2692,8945,GO:0016874,BTRC,ligase activity,3.0
2693,8945,GO:0019005,BTRC,SCF ubiquitin ligase complex,3.0
2695,8945,GO:0031146,BTRC,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,3.0
2696,8945,GO:0031648,BTRC,protein destabilization,3.0
2697,8945,GO:0033598,BTRC,mammary gland epithelial cell proliferation,3.0
2698,8945,GO:0038061,BTRC,NIK/NF-kappaB signaling,3.0
2699,8945,GO:0038095,BTRC,Fc-epsilon receptor signaling pathway,3.0
2700,8945,GO:0042752,BTRC,regulation of circadian rhythm,3.0
2701,8945,GO:0042753,BTRC,positive regulation of circadian rhythm,3.0
2702,8945,GO:0043122,BTRC,regulation of I-kappaB kinase/NF-kappaB signaling,3.0
2703,8945,GO:0043161,BTRC,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
2704,8945,GO:0043433,BTRC,negative regulation of DNA-binding transcription factor activity,3.0
2705,8945,GO:0043687,BTRC,post-translational protein modification,3.0
2706,8945,GO:0045309,BTRC,protein phosphorylated amino acid binding,3.0
2707,8945,GO:0045862,BTRC,positive regulation of proteolysis,3.0
2708,8945,GO:0045879,BTRC,negative regulation of smoothened signaling pathway,3.0
2709,8945,GO:0045892,BTRC,"negative regulation of transcription, DNA-templated",3.0
2710,8945,GO:0045893,BTRC,"positive regulation of transcription, DNA-templated",3.0
2711,8945,GO:0046983,BTRC,protein dimerization activity,3.0
2712,8945,GO:0048511,BTRC,rhythmic process,3.0
2713,8945,GO:0050852,BTRC,T cell receptor signaling pathway,3.0
2714,8945,GO:0051403,BTRC,stress-activated MAPK cascade,3.0
2715,8945,GO:0060444,BTRC,branching involved in mammary gland duct morphogenesis,3.0
2716,8945,GO:0060828,BTRC,regulation of canonical Wnt signaling pathway,3.0
2717,8945,GO:0061136,BTRC,regulation of proteasomal protein catabolic process,3.0
2718,8945,GO:0061630,BTRC,ubiquitin protein ligase activity,3.0
2719,8945,GO:0070498,BTRC,interleukin-1-mediated signaling pathway,3.0
2720,8945,GO:0070936,BTRC,protein K48-linked ubiquitination,3.0
2721,8945,GO:0071407,BTRC,cellular response to organic cyclic compound,3.0
2722,8945,GO:1901990,BTRC,regulation of mitotic cell cycle phase transition,3.0
2723,8945,GO:1904668,BTRC,positive regulation of ubiquitin protein ligase activity,3.0
2724,8945,GO:1990756,BTRC,ubiquitin ligase-substrate adaptor activity,3.0
2725,8945,GO:1990757,BTRC,ubiquitin ligase activator activity,3.0
2738,643338,GO:0005737,C15orf62,cytoplasm,3.0
2739,643338,GO:0005739,C15orf62,mitochondrion,3.0
2740,643338,GO:0005856,C15orf62,cytoskeleton,3.0
2741,643338,GO:0005886,C15orf62,plasma membrane,3.0
2742,643338,GO:0007266,C15orf62,Rho protein signal transduction,3.0
2743,643338,GO:0008360,C15orf62,regulation of cell shape,3.0
2744,643338,GO:0030838,C15orf62,positive regulation of actin filament polymerization,3.0
2745,643338,GO:0031267,C15orf62,small GTPase binding,3.0
2746,643338,GO:0031274,C15orf62,positive regulation of pseudopodium assembly,3.0
2747,721,GO:0001848,C4B,complement binding,3.0
2748,721,GO:0004866,C4B,endopeptidase inhibitor activity,3.0
2749,721,GO:0005576,C4B,extracellular region,3.0
2750,721,GO:0005615,C4B,extracellular space,3.0
2753,721,GO:0005886,C4B,plasma membrane,3.0
2754,721,GO:0006954,C4B,inflammatory response,3.0
2755,721,GO:0006956,C4B,complement activation,3.0
2758,721,GO:0006958,C4B,"complement activation, classical pathway",3.0
2759,721,GO:0008228,C4B,opsonization,3.0
2760,721,GO:0010951,C4B,negative regulation of endopeptidase activity,3.0
2761,721,GO:0030246,C4B,carbohydrate binding,3.0
2762,721,GO:0030424,C4B,axon,3.0
2763,721,GO:0030425,C4B,dendrite,3.0
2764,721,GO:0030449,C4B,regulation of complement activation,3.0
2765,721,GO:0032490,C4B,detection of molecule of bacterial origin,3.0
2766,721,GO:0044216,C4B,other organism cell,3.0
2767,721,GO:0045087,C4B,innate immune response,3.0
2768,721,GO:0045202,C4B,synapse,3.0
2769,721,GO:0070062,C4B,extracellular exosome,3.0
2770,721,GO:0072562,C4B,blood microparticle,3.0
2771,721,GO:2000427,C4B,positive regulation of apoptotic cell clearance,3.0
2772,765,GO:0001580,CA6,detection of chemical stimulus involved in sensory perception of bitter taste,3.0
2773,765,GO:0004089,CA6,carbonate dehydratase activity,3.0
2774,765,GO:0005576,CA6,extracellular region,3.0
2775,765,GO:0005615,CA6,extracellular space,3.0
2778,765,GO:0006730,CA6,one-carbon metabolic process,3.0
2779,765,GO:0008270,CA6,zinc ion binding,3.0
2780,765,GO:0015701,CA6,bicarbonate transport,3.0
2781,765,GO:0016836,CA6,hydro-lyase activity,3.0
2782,765,GO:0070062,CA6,extracellular exosome,3.0
2815,774,GO:0001540,CACNA1B,amyloid-beta binding,3.0
2816,774,GO:0005245,CACNA1B,voltage-gated calcium channel activity,3.0
2817,774,GO:0005509,CACNA1B,calcium ion binding,3.0
2818,774,GO:0005515,CACNA1B,protein binding,3.0
2819,774,GO:0005524,CACNA1B,ATP binding,3.0
2820,774,GO:0005886,CACNA1B,plasma membrane,3.0
2821,774,GO:0005891,CACNA1B,voltage-gated calcium channel complex,3.0
2822,774,GO:0006816,CACNA1B,calcium ion transport,3.0
2823,774,GO:0007268,CACNA1B,chemical synaptic transmission,3.0
2824,774,GO:0007269,CACNA1B,neurotransmitter secretion,3.0
2825,774,GO:0007626,CACNA1B,locomotory behavior,3.0
2826,774,GO:0008016,CACNA1B,regulation of heart contraction,3.0
2827,774,GO:0008022,CACNA1B,protein C-terminus binding,3.0
2828,774,GO:0008217,CACNA1B,regulation of blood pressure,3.0
2829,774,GO:0008331,CACNA1B,high voltage-gated calcium channel activity,3.0
2830,774,GO:0030425,CACNA1B,dendrite,3.0
2831,774,GO:0034765,CACNA1B,regulation of ion transmembrane transport,3.0
2832,774,GO:0043025,CACNA1B,neuronal cell body,3.0
2833,774,GO:0048265,CACNA1B,response to pain,3.0
2834,774,GO:0050804,CACNA1B,modulation of chemical synaptic transmission,3.0
2835,774,GO:0051899,CACNA1B,membrane depolarization,3.0
2836,774,GO:0051924,CACNA1B,regulation of calcium ion transport,3.0
2837,774,GO:0070509,CACNA1B,calcium ion import,3.0
2838,774,GO:0070588,CACNA1B,calcium ion transmembrane transport,3.0
2839,774,GO:0098793,CACNA1B,presynapse,3.0
2840,774,GO:1904645,CACNA1B,response to amyloid-beta,3.0
2944,778,GO:0001750,CACNA1F,photoreceptor outer segment,3.0
2945,778,GO:0005245,CACNA1F,voltage-gated calcium channel activity,3.0
2947,778,GO:0005886,CACNA1F,plasma membrane,3.0
2948,778,GO:0005891,CACNA1F,voltage-gated calcium channel complex,3.0
2949,778,GO:0006816,CACNA1F,calcium ion transport,3.0
2950,778,GO:0007601,CACNA1F,visual perception,3.0
2951,778,GO:0008331,CACNA1F,high voltage-gated calcium channel activity,3.0
2952,778,GO:0016021,CACNA1F,integral component of membrane,3.0
2953,778,GO:0034765,CACNA1F,regulation of ion transmembrane transport,3.0
2954,778,GO:0043029,CACNA1F,T cell homeostasis,3.0
2955,778,GO:0043204,CACNA1F,perikaryon,3.0
2956,778,GO:0046872,CACNA1F,metal ion binding,3.0
2957,778,GO:0050856,CACNA1F,regulation of T cell receptor signaling pathway,3.0
2958,778,GO:0050908,CACNA1F,detection of light stimulus involved in visual perception,3.0
2959,778,GO:0061337,CACNA1F,cardiac conduction,3.0
2960,778,GO:0070509,CACNA1F,calcium ion import,3.0
2961,778,GO:0070588,CACNA1F,calcium ion transmembrane transport,3.0
2962,8913,GO:0001518,CACNA1G,voltage-gated sodium channel complex,3.0
2963,8913,GO:0005248,CACNA1G,voltage-gated sodium channel activity,3.0
2964,8913,GO:0005737,CACNA1G,cytoplasm,3.0
2965,8913,GO:0005886,CACNA1G,plasma membrane,3.0
2966,8913,GO:0005891,CACNA1G,voltage-gated calcium channel complex,3.0
2967,8913,GO:0007268,CACNA1G,chemical synaptic transmission,3.0
2968,8913,GO:0008332,CACNA1G,low voltage-gated calcium channel activity,3.0
2970,8913,GO:0010045,CACNA1G,response to nickel cation,3.0
2971,8913,GO:0019228,CACNA1G,neuronal action potential,3.0
2972,8913,GO:0034765,CACNA1G,regulation of ion transmembrane transport,3.0
2973,8913,GO:0035725,CACNA1G,sodium ion transmembrane transport,3.0
2974,8913,GO:0042391,CACNA1G,regulation of membrane potential,3.0
2975,8913,GO:0043005,CACNA1G,neuron projection,3.0
2976,8913,GO:0045202,CACNA1G,synapse,3.0
2977,8913,GO:0045956,CACNA1G,positive regulation of calcium ion-dependent exocytosis,3.0
2978,8913,GO:0060371,CACNA1G,regulation of atrial cardiac muscle cell membrane depolarization,3.0
2979,8913,GO:0070509,CACNA1G,calcium ion import,3.0
2981,8913,GO:0070588,CACNA1G,calcium ion transmembrane transport,3.0
2982,8913,GO:0086002,CACNA1G,cardiac muscle cell action potential involved in contraction,3.0
2983,8913,GO:0086010,CACNA1G,membrane depolarization during action potential,3.0
2984,8913,GO:0086015,CACNA1G,SA node cell action potential,3.0
2985,8913,GO:0086016,CACNA1G,AV node cell action potential,3.0
2986,8913,GO:0086018,CACNA1G,SA node cell to atrial cardiac muscle cell signaling,3.0
2987,8913,GO:0086027,CACNA1G,AV node cell to bundle of His cell signaling,3.0
2988,8913,GO:0086045,CACNA1G,membrane depolarization during AV node cell action potential,3.0
2989,8913,GO:0086046,CACNA1G,membrane depolarization during SA node cell action potential,3.0
2990,8913,GO:0086056,CACNA1G,voltage-gated calcium channel activity involved in AV node cell action potential,3.0
2991,8913,GO:0086059,CACNA1G,voltage-gated calcium channel activity involved SA node cell action potential,3.0
2992,8913,GO:0086091,CACNA1G,regulation of heart rate by cardiac conduction,3.0
2993,8913,GO:0097110,CACNA1G,scaffold protein binding,3.0
2994,553,GO:0001992,AVPR1B,regulation of systemic arterial blood pressure by vasopressin,3.0
2995,553,GO:0004930,AVPR1B,G protein-coupled receptor activity,3.0
2996,553,GO:0005000,AVPR1B,vasopressin receptor activity,3.0
2998,553,GO:0005080,AVPR1B,protein kinase C binding,3.0
2999,553,GO:0005768,AVPR1B,endosome,3.0
3000,553,GO:0005794,AVPR1B,Golgi apparatus,3.0
3001,553,GO:0005886,AVPR1B,plasma membrane,3.0
3003,553,GO:0005887,AVPR1B,integral component of plasma membrane,3.0
3004,553,GO:0007186,AVPR1B,G protein-coupled receptor signaling pathway,3.0
3007,553,GO:0007202,AVPR1B,activation of phospholipase C activity,3.0
3008,553,GO:0007204,AVPR1B,positive regulation of cytosolic calcium ion concentration,3.0
3009,553,GO:0032430,AVPR1B,positive regulation of phospholipase A2 activity,3.0
3010,553,GO:0042127,AVPR1B,regulation of cell population proliferation,3.0
3011,553,GO:0042277,AVPR1B,peptide binding,3.0
3012,553,GO:0043410,AVPR1B,positive regulation of MAPK cascade,3.0
3013,553,GO:0045907,AVPR1B,positive regulation of vasoconstriction,3.0
3014,553,GO:0060732,AVPR1B,positive regulation of inositol phosphate biosynthetic process,3.0
3015,553,GO:0090238,AVPR1B,positive regulation of arachidonic acid secretion,3.0
3016,553,GO:0150104,AVPR1B,transport across blood-brain barrier,3.0
3017,339479,GO:0005576,BRINP3,extracellular region,3.0
3018,339479,GO:0005739,BRINP3,mitochondrion,3.0
3019,339479,GO:0005783,BRINP3,endoplasmic reticulum,3.0
3020,339479,GO:0007050,BRINP3,cell cycle arrest,3.0
3021,339479,GO:0030425,BRINP3,dendrite,3.0
3022,339479,GO:0043025,BRINP3,neuronal cell body,3.0
3023,339479,GO:0045666,BRINP3,positive regulation of neuron differentiation,3.0
3025,339479,GO:0045930,BRINP3,negative regulation of mitotic cell cycle,3.0
3027,339479,GO:0071300,BRINP3,cellular response to retinoic acid,3.0
3060,8911,GO:0001518,CACNA1I,voltage-gated sodium channel complex,3.0
3061,8911,GO:0005245,CACNA1I,voltage-gated calcium channel activity,3.0
3062,8911,GO:0005248,CACNA1I,voltage-gated sodium channel activity,3.0
3063,8911,GO:0005515,CACNA1I,protein binding,3.0
3064,8911,GO:0005891,CACNA1I,voltage-gated calcium channel complex,3.0
3065,8911,GO:0007165,CACNA1I,signal transduction,3.0
3066,8911,GO:0008332,CACNA1I,low voltage-gated calcium channel activity,3.0
3067,8911,GO:0019228,CACNA1I,neuronal action potential,3.0
3068,8911,GO:0030317,CACNA1I,flagellated sperm motility,3.0
3069,8911,GO:0030431,CACNA1I,sleep,3.0
3070,8911,GO:0034765,CACNA1I,regulation of ion transmembrane transport,3.0
3071,8911,GO:0035725,CACNA1I,sodium ion transmembrane transport,3.0
3072,8911,GO:0043005,CACNA1I,neuron projection,3.0
3073,8911,GO:0045956,CACNA1I,positive regulation of calcium ion-dependent exocytosis,3.0
3074,8911,GO:0070509,CACNA1I,calcium ion import,3.0
3075,8911,GO:0070588,CACNA1I,calcium ion transmembrane transport,3.0
3076,8911,GO:0086010,CACNA1I,membrane depolarization during action potential,3.0
3077,781,GO:0005245,CACNA2D1,voltage-gated calcium channel activity,3.0
3081,781,GO:0005886,CACNA2D1,plasma membrane,3.0
3082,781,GO:0005891,CACNA2D1,voltage-gated calcium channel complex,3.0
3084,781,GO:0006816,CACNA2D1,calcium ion transport,3.0
3085,781,GO:0016529,CACNA2D1,sarcoplasmic reticulum,3.0
3086,781,GO:0046872,CACNA2D1,metal ion binding,3.0
3087,781,GO:0051924,CACNA2D1,regulation of calcium ion transport,3.0
3088,781,GO:0060307,CACNA2D1,regulation of ventricular cardiac muscle cell membrane repolarization,3.0
3089,781,GO:0060402,CACNA2D1,calcium ion transport into cytosol,3.0
3090,781,GO:0061337,CACNA2D1,cardiac conduction,3.0
3091,781,GO:0061577,CACNA2D1,calcium ion transmembrane transport via high voltage-gated calcium channel,3.0
3092,781,GO:0070062,CACNA2D1,extracellular exosome,3.0
3093,781,GO:0086002,CACNA2D1,cardiac muscle cell action potential involved in contraction,3.0
3094,781,GO:0086007,CACNA2D1,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,3.0
3095,781,GO:0086048,CACNA2D1,membrane depolarization during bundle of His cell action potential,3.0
3096,781,GO:0086057,CACNA2D1,voltage-gated calcium channel activity involved in bundle of His cell action potential,3.0
3097,781,GO:0086091,CACNA2D1,regulation of heart rate by cardiac conduction,3.0
3098,781,GO:0098703,CACNA2D1,calcium ion import across plasma membrane,3.0
3099,781,GO:0098903,CACNA2D1,regulation of membrane repolarization during action potential,3.0
3100,781,GO:1901843,CACNA2D1,positive regulation of high voltage-gated calcium channel activity,3.0
3101,781,GO:1902514,CACNA2D1,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,3.0
3102,781,GO:1904646,CACNA2D1,cellular response to amyloid-beta,3.0
3103,781,GO:1990454,CACNA2D1,L-type voltage-gated calcium channel complex,3.0
3142,23705,GO:0001819,CADM1,positive regulation of cytokine production,3.0
3143,23705,GO:0001913,CADM1,T cell mediated cytotoxicity,3.0
3144,23705,GO:0005102,CADM1,signaling receptor binding,3.0
3146,23705,GO:0005515,CADM1,protein binding,3.0
3147,23705,GO:0005886,CADM1,plasma membrane,3.0
3149,23705,GO:0005911,CADM1,cell-cell junction,3.0
3150,23705,GO:0006915,CADM1,apoptotic process,3.0
3151,23705,GO:0007156,CADM1,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3152,23705,GO:0007157,CADM1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3153,23705,GO:0007275,CADM1,multicellular organism development,3.0
3154,23705,GO:0007283,CADM1,spermatogenesis,3.0
3155,23705,GO:0008037,CADM1,cell recognition,3.0
3157,23705,GO:0016021,CADM1,integral component of membrane,3.0
3158,23705,GO:0016032,CADM1,viral process,3.0
3159,23705,GO:0016323,CADM1,basolateral plasma membrane,3.0
3160,23705,GO:0030154,CADM1,cell differentiation,3.0
3161,23705,GO:0030165,CADM1,PDZ domain binding,3.0
3162,23705,GO:0034332,CADM1,adherens junction organization,3.0
3163,23705,GO:0042271,CADM1,susceptibility to natural killer cell mediated cytotoxicity,3.0
3166,23705,GO:0042803,CADM1,protein homodimerization activity,3.0
3167,23705,GO:0045202,CADM1,synapse,3.0
3168,23705,GO:0045954,CADM1,positive regulation of natural killer cell mediated cytotoxicity,3.0
3170,23705,GO:0050798,CADM1,activated T cell proliferation,3.0
3171,23705,GO:0051606,CADM1,detection of stimulus,3.0
3173,253559,GO:0005886,CADM2,plasma membrane,3.0
3174,253559,GO:0007155,CADM2,cell adhesion,3.0
3175,253559,GO:0016021,CADM2,integral component of membrane,3.0
3176,253559,GO:0030424,CADM2,axon,3.0
3177,253559,GO:0034332,CADM2,adherens junction organization,3.0
3178,253559,GO:0045202,CADM2,synapse,3.0
3179,8618,GO:0005515,CADPS,protein binding,3.0
3180,8618,GO:0005829,CADPS,cytosol,3.0
3181,8618,GO:0006887,CADPS,exocytosis,3.0
3182,8618,GO:0008289,CADPS,lipid binding,3.0
3183,8618,GO:0015031,CADPS,protein transport,3.0
3184,8618,GO:0016079,CADPS,synaptic vesicle exocytosis,3.0
3185,8618,GO:0019901,CADPS,protein kinase binding,3.0
3186,8618,GO:0045921,CADPS,positive regulation of exocytosis,3.0
3187,8618,GO:0046872,CADPS,metal ion binding,3.0
3188,8618,GO:0098793,CADPS,presynapse,3.0
3189,8618,GO:0098978,CADPS,glutamatergic synapse,3.0
3190,8618,GO:0099012,CADPS,neuronal dense core vesicle membrane,3.0
3191,8618,GO:1990504,CADPS,dense core granule exocytosis,3.0
3192,93664,GO:0005654,CADPS2,nucleoplasm,3.0
3193,93664,GO:0006887,CADPS2,exocytosis,3.0
3194,93664,GO:0008289,CADPS2,lipid binding,3.0
3195,93664,GO:0009267,CADPS2,cellular response to starvation,3.0
3196,93664,GO:0015031,CADPS2,protein transport,3.0
3197,93664,GO:0016082,CADPS2,synaptic vesicle priming,3.0
3198,93664,GO:0030659,CADPS2,cytoplasmic vesicle membrane,3.0
3199,93664,GO:0042734,CADPS2,presynaptic membrane,3.0
3200,93664,GO:0043231,CADPS2,intracellular membrane-bounded organelle,3.0
3201,93664,GO:0045211,CADPS2,postsynaptic membrane,3.0
3202,93664,GO:0045921,CADPS2,positive regulation of exocytosis,3.0
3203,93664,GO:0046872,CADPS2,metal ion binding,3.0
3204,93664,GO:0098688,CADPS2,parallel fiber to Purkinje cell synapse,3.0
3205,93664,GO:0098978,CADPS2,glutamatergic synapse,3.0
3206,93664,GO:1990504,CADPS2,dense core granule exocytosis,3.0
3207,92558,GO:0005737,BICDL1,cytoplasm,3.0
3208,92558,GO:0005813,BICDL1,centrosome,3.0
3209,92558,GO:0031175,BICDL1,neuron projection development,3.0
3210,92558,GO:0031267,BICDL1,small GTPase binding,3.0
3212,92558,GO:0034452,BICDL1,dynactin binding,3.0
3213,92558,GO:0047496,BICDL1,vesicle transport along microtubule,3.0
3214,92558,GO:0055107,BICDL1,Golgi to secretory granule transport,3.0
3216,815,GO:0000082,CAMK2A,G1/S transition of mitotic cell cycle,3.0
3217,815,GO:0002931,CAMK2A,response to ischemia,3.0
3218,815,GO:0004674,CAMK2A,protein serine/threonine kinase activity,3.0
3220,815,GO:0004683,CAMK2A,calmodulin-dependent protein kinase activity,3.0
3222,815,GO:0005515,CAMK2A,protein binding,3.0
3223,815,GO:0005516,CAMK2A,calmodulin binding,3.0
3225,815,GO:0005524,CAMK2A,ATP binding,3.0
3226,815,GO:0005634,CAMK2A,nucleus,3.0
3227,815,GO:0005654,CAMK2A,nucleoplasm,3.0
3228,815,GO:0005737,CAMK2A,cytoplasm,3.0
3229,815,GO:0005739,CAMK2A,mitochondrion,3.0
3230,815,GO:0005829,CAMK2A,cytosol,3.0
3231,815,GO:0005954,CAMK2A,calcium- and calmodulin-dependent protein kinase complex,3.0
3232,815,GO:0006468,CAMK2A,protein phosphorylation,3.0
3234,815,GO:0006816,CAMK2A,calcium ion transport,3.0
3235,815,GO:0007223,CAMK2A,"Wnt signaling pathway, calcium modulating pathway",3.0
3236,815,GO:0009931,CAMK2A,calcium-dependent protein serine/threonine kinase activity,3.0
3237,815,GO:0010666,CAMK2A,positive regulation of cardiac muscle cell apoptotic process,3.0
3238,815,GO:0014069,CAMK2A,postsynaptic density,3.0
3239,815,GO:0016301,CAMK2A,kinase activity,3.0
3240,815,GO:0018105,CAMK2A,peptidyl-serine phosphorylation,3.0
3241,815,GO:0030666,CAMK2A,endocytic vesicle membrane,3.0
3242,815,GO:0035254,CAMK2A,glutamate receptor binding,3.0
3243,815,GO:0038166,CAMK2A,angiotensin-activated signaling pathway,3.0
3244,815,GO:0042802,CAMK2A,identical protein binding,3.0
3245,815,GO:0042803,CAMK2A,protein homodimerization activity,3.0
3246,815,GO:0043005,CAMK2A,neuron projection,3.0
3247,815,GO:0043197,CAMK2A,dendritic spine,3.0
3248,815,GO:0046777,CAMK2A,protein autophosphorylation,3.0
3249,815,GO:0046872,CAMK2A,metal ion binding,3.0
3250,815,GO:0046928,CAMK2A,regulation of neurotransmitter secretion,3.0
3251,815,GO:0048168,CAMK2A,regulation of neuronal synaptic plasticity,3.0
3252,815,GO:0048813,CAMK2A,dendrite morphogenesis,3.0
3253,815,GO:0051092,CAMK2A,positive regulation of NF-kappaB transcription factor activity,3.0
3254,815,GO:0051346,CAMK2A,negative regulation of hydrolase activity,3.0
3255,815,GO:0051928,CAMK2A,positive regulation of calcium ion transport,3.0
3256,815,GO:0060333,CAMK2A,interferon-gamma-mediated signaling pathway,3.0
3257,815,GO:0060996,CAMK2A,dendritic spine development,3.0
3258,815,GO:0098685,CAMK2A,Schaffer collateral - CA1 synapse,3.0
3259,815,GO:0099148,CAMK2A,regulation of synaptic vesicle docking,3.0
3260,815,GO:1900034,CAMK2A,regulation of cellular response to heat,3.0
3261,815,GO:1902108,CAMK2A,regulation of mitochondrial membrane permeability involved in apoptotic process,3.0
3262,815,GO:1990443,CAMK2A,peptidyl-threonine autophosphorylation,3.0
3263,815,GO:2000124,CAMK2A,regulation of endocannabinoid signaling pathway,3.0
3264,815,GO:2001222,CAMK2A,regulation of neuron migration,3.0
3295,814,GO:0001650,CAMK4,fibrillar center,3.0
3296,814,GO:0002250,CAMK4,adaptive immune response,3.0
3297,814,GO:0002372,CAMK4,myeloid dendritic cell cytokine production,3.0
3298,814,GO:0004683,CAMK4,calmodulin-dependent protein kinase activity,3.0
3300,814,GO:0005516,CAMK4,calmodulin binding,3.0
3301,814,GO:0005524,CAMK4,ATP binding,3.0
3302,814,GO:0005634,CAMK4,nucleus,3.0
3303,814,GO:0005654,CAMK4,nucleoplasm,3.0
3305,814,GO:0005737,CAMK4,cytoplasm,3.0
3306,814,GO:0006468,CAMK4,protein phosphorylation,3.0
3307,814,GO:0006954,CAMK4,inflammatory response,3.0
3308,814,GO:0007165,CAMK4,signal transduction,3.0
3309,814,GO:0007616,CAMK4,long-term memory,3.0
3310,814,GO:0009931,CAMK4,calcium-dependent protein serine/threonine kinase activity,3.0
3311,814,GO:0018105,CAMK4,peptidyl-serine phosphorylation,3.0
3312,814,GO:0033081,CAMK4,regulation of T cell differentiation in thymus,3.0
3313,814,GO:0035556,CAMK4,intracellular signal transduction,3.0
3314,814,GO:0043011,CAMK4,myeloid dendritic cell differentiation,3.0
3315,814,GO:0045670,CAMK4,regulation of osteoclast differentiation,3.0
3316,814,GO:0045893,CAMK4,"positive regulation of transcription, DNA-templated",3.0
3317,814,GO:0046777,CAMK4,protein autophosphorylation,3.0
3318,814,GO:0070062,CAMK4,extracellular exosome,3.0
3319,147968,GO:0004198,CAPN12,calcium-dependent cysteine-type endopeptidase activity,3.0
3320,147968,GO:0005509,CAPN12,calcium ion binding,3.0
3321,147968,GO:0005737,CAPN12,cytoplasm,3.0
3322,147968,GO:0006508,CAPN12,proteolysis,3.0
3337,84433,GO:0001772,CARD11,immunological synapse,3.0
3338,84433,GO:0002223,CARD11,stimulatory C-type lectin receptor signaling pathway,3.0
3339,84433,GO:0002377,CARD11,immunoglobulin production,3.0
3340,84433,GO:0004385,CARD11,guanylate kinase activity,3.0
3341,84433,GO:0005515,CARD11,protein binding,3.0
3342,84433,GO:0005737,CARD11,cytoplasm,3.0
3344,84433,GO:0005829,CARD11,cytosol,3.0
3345,84433,GO:0005886,CARD11,plasma membrane,3.0
3347,84433,GO:0007249,CARD11,I-kappaB kinase/NF-kappaB signaling,3.0
3348,84433,GO:0030183,CARD11,B cell differentiation,3.0
3349,84433,GO:0030890,CARD11,positive regulation of B cell proliferation,3.0
3350,84433,GO:0031295,CARD11,T cell costimulation,3.0
3351,84433,GO:0032449,CARD11,CBM complex,3.0
3352,84433,GO:0032623,CARD11,interleukin-2 production,3.0
3353,84433,GO:0032743,CARD11,positive regulation of interleukin-2 production,3.0
3354,84433,GO:0038095,CARD11,Fc-epsilon receptor signaling pathway,3.0
3355,84433,GO:0038202,CARD11,TORC1 signaling,3.0
3356,84433,GO:0042100,CARD11,B cell proliferation,3.0
3357,84433,GO:0042102,CARD11,positive regulation of T cell proliferation,3.0
3358,84433,GO:0042981,CARD11,regulation of apoptotic process,3.0
3359,84433,GO:0043123,CARD11,positive regulation of I-kappaB kinase/NF-kappaB signaling,3.0
3361,84433,GO:0045061,CARD11,thymic T cell selection,3.0
3362,84433,GO:0045121,CARD11,membrane raft,3.0
3363,84433,GO:0045577,CARD11,regulation of B cell differentiation,3.0
3364,84433,GO:0045580,CARD11,regulation of T cell differentiation,3.0
3365,84433,GO:0046037,CARD11,GMP metabolic process,3.0
3366,84433,GO:0046710,CARD11,GDP metabolic process,3.0
3367,84433,GO:0048872,CARD11,homeostasis of number of cells,3.0
3368,84433,GO:0050700,CARD11,CARD domain binding,3.0
3370,84433,GO:0050852,CARD11,T cell receptor signaling pathway,3.0
3371,84433,GO:0050862,CARD11,positive regulation of T cell receptor signaling pathway,3.0
3372,84433,GO:0051092,CARD11,positive regulation of NF-kappaB transcription factor activity,3.0
3373,84433,GO:0070062,CARD11,extracellular exosome,3.0
3440,440193,GO:0001932,CCDC88C,regulation of protein phosphorylation,3.0
3441,440193,GO:0001965,CCDC88C,G-protein alpha-subunit binding,3.0
3442,440193,GO:0003383,CCDC88C,apical constriction,3.0
3443,440193,GO:0005085,CCDC88C,guanyl-nucleotide exchange factor activity,3.0
3444,440193,GO:0005109,CCDC88C,frizzled binding,3.0
3445,440193,GO:0005515,CCDC88C,protein binding,3.0
3446,440193,GO:0005737,CCDC88C,cytoplasm,3.0
3448,440193,GO:0005813,CCDC88C,centrosome,3.0
3449,440193,GO:0007264,CCDC88C,small GTPase mediated signal transduction,3.0
3450,440193,GO:0008017,CCDC88C,microtubule binding,3.0
3451,440193,GO:0030054,CCDC88C,cell junction,3.0
3452,440193,GO:0030165,CCDC88C,PDZ domain binding,3.0
3453,440193,GO:0030705,CCDC88C,cytoskeleton-dependent intracellular transport,3.0
3454,440193,GO:0031098,CCDC88C,stress-activated protein kinase signaling cascade,3.0
3455,440193,GO:0031122,CCDC88C,cytoplasmic microtubule organization,3.0
3456,440193,GO:0031648,CCDC88C,protein destabilization,3.0
3457,440193,GO:0035567,CCDC88C,non-canonical Wnt signaling pathway,3.0
3458,440193,GO:0042802,CCDC88C,identical protein binding,3.0
3459,440193,GO:0043621,CCDC88C,protein self-association,3.0
3460,440193,GO:0051959,CCDC88C,dynein light intermediate chain binding,3.0
3461,440193,GO:0090090,CCDC88C,negative regulation of canonical Wnt signaling pathway,3.0
3462,55297,GO:0005654,CCDC91,nucleoplasm,3.0
3463,55297,GO:0005794,CCDC91,Golgi apparatus,3.0
3464,55297,GO:0005802,CCDC91,trans-Golgi network,3.0
3466,55297,GO:0005829,CCDC91,cytosol,3.0
3467,55297,GO:0015031,CCDC91,protein transport,3.0
3468,55297,GO:0016020,CCDC91,membrane,3.0
3469,55297,GO:0042802,CCDC91,identical protein binding,3.0
3470,55297,GO:0090160,CCDC91,Golgi to lysosome transport,3.0
3472,881,GO:0005515,CCIN,protein binding,3.0
3473,881,GO:0005634,CCIN,nucleus,3.0
3474,881,GO:0007283,CCIN,spermatogenesis,3.0
3475,881,GO:0007420,CCIN,brain development,3.0
3476,881,GO:0015629,CCIN,actin cytoskeleton,3.0
3477,881,GO:0030036,CCIN,actin cytoskeleton organization,3.0
3478,881,GO:0030154,CCIN,cell differentiation,3.0
3479,881,GO:0032839,CCIN,dendrite cytoplasm,3.0
3480,881,GO:0033150,CCIN,cytoskeletal calyx,3.0
3481,881,GO:0051015,CCIN,actin filament binding,3.0
3546,80381,GO:0001817,CD276,regulation of cytokine production,3.0
3547,80381,GO:0005102,CD276,signaling receptor binding,3.0
3549,80381,GO:0005515,CD276,protein binding,3.0
3550,80381,GO:0009897,CD276,external side of plasma membrane,3.0
3552,80381,GO:0016021,CD276,integral component of membrane,3.0
3553,80381,GO:0032729,CD276,positive regulation of interferon-gamma production,3.0
3554,80381,GO:0042102,CD276,positive regulation of T cell proliferation,3.0
3555,80381,GO:0042110,CD276,T cell activation,3.0
3556,80381,GO:0050776,CD276,regulation of immune response,3.0
3557,80381,GO:0050852,CD276,T cell receptor signaling pathway,3.0
3558,952,GO:0001666,CD38,response to hypoxia,3.0
3559,952,GO:0003953,CD38,NAD+ nucleosidase activity,3.0
3561,952,GO:0005634,CD38,nucleus,3.0
3562,952,GO:0005886,CD38,plasma membrane,3.0
3564,952,GO:0007165,CD38,signal transduction,3.0
3565,952,GO:0007204,CD38,positive regulation of cytosolic calcium ion concentration,3.0
3566,952,GO:0007565,CD38,female pregnancy,3.0
3567,952,GO:0009986,CD38,cell surface,3.0
3568,952,GO:0010977,CD38,negative regulation of neuron projection development,3.0
3569,952,GO:0014824,CD38,artery smooth muscle contraction,3.0
3570,952,GO:0016020,CD38,membrane,3.0
3571,952,GO:0016021,CD38,integral component of membrane,3.0
3572,952,GO:0016323,CD38,basolateral plasma membrane,3.0
3573,952,GO:0016740,CD38,transferase activity,3.0
3574,952,GO:0016849,CD38,phosphorus-oxygen lyase activity,3.0
3575,952,GO:0019674,CD38,NAD metabolic process,3.0
3576,952,GO:0030307,CD38,positive regulation of cell growth,3.0
3577,952,GO:0030667,CD38,secretory granule membrane,3.0
3578,952,GO:0030890,CD38,positive regulation of B cell proliferation,3.0
3580,952,GO:0032024,CD38,positive regulation of insulin secretion,3.0
3581,952,GO:0032355,CD38,response to estradiol,3.0
3582,952,GO:0032526,CD38,response to retinoic acid,3.0
3583,952,GO:0032570,CD38,response to progesterone,3.0
3584,952,GO:0033194,CD38,response to hydroperoxide,3.0
3585,952,GO:0042493,CD38,response to drug,3.0
3586,952,GO:0042802,CD38,identical protein binding,3.0
3587,952,GO:0043066,CD38,negative regulation of apoptotic process,3.0
3588,952,GO:0045779,CD38,negative regulation of bone resorption,3.0
3589,952,GO:0045892,CD38,"negative regulation of transcription, DNA-templated",3.0
3590,952,GO:0045893,CD38,"positive regulation of transcription, DNA-templated",3.0
3591,952,GO:0045907,CD38,positive regulation of vasoconstriction,3.0
3592,952,GO:0050135,CD38,NAD(P)+ nucleosidase activity,3.0
3593,952,GO:0050853,CD38,B cell receptor signaling pathway,3.0
3594,952,GO:0060292,CD38,long-term synaptic depression,3.0
3595,952,GO:0061809,CD38,"NAD+ nucleotidase, cyclic ADP-ribose generating",3.0
3596,952,GO:0070062,CD38,extracellular exosome,3.0
3597,952,GO:0070555,CD38,response to interleukin-1,3.0
3598,952,GO:0097190,CD38,apoptotic signaling pathway,3.0
3599,83692,GO:0005515,CD99L2,protein binding,3.0
3600,83692,GO:0005886,CD99L2,plasma membrane,3.0
3601,83692,GO:0005912,CD99L2,adherens junction,3.0
3602,83692,GO:0005925,CD99L2,focal adhesion,3.0
3603,83692,GO:0007155,CD99L2,cell adhesion,3.0
3604,83692,GO:0009986,CD99L2,cell surface,3.0
3605,83692,GO:0016021,CD99L2,integral component of membrane,3.0
3606,83692,GO:0050904,CD99L2,diapedesis,3.0
3607,83692,GO:2000391,CD99L2,positive regulation of neutrophil extravasation,3.0
3608,83692,GO:2000409,CD99L2,positive regulation of T cell extravasation,3.0
3638,1008,GO:0000902,CDH10,cell morphogenesis,3.0
3639,1008,GO:0005509,CDH10,calcium ion binding,3.0
3640,1008,GO:0005886,CDH10,plasma membrane,3.0
3641,1008,GO:0005912,CDH10,adherens junction,3.0
3642,1008,GO:0007043,CDH10,cell-cell junction assembly,3.0
3643,1008,GO:0007156,CDH10,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3644,1008,GO:0007275,CDH10,multicellular organism development,3.0
3645,1008,GO:0016021,CDH10,integral component of membrane,3.0
3646,1008,GO:0016339,CDH10,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3647,1008,GO:0016342,CDH10,catenin complex,3.0
3648,1008,GO:0034332,CDH10,adherens junction organization,3.0
3650,1008,GO:0045296,CDH10,cadherin binding,3.0
3651,1008,GO:0098609,CDH10,cell-cell adhesion,3.0
3652,1008,GO:0098742,CDH10,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
3653,1009,GO:0000902,CDH11,cell morphogenesis,3.0
3654,1009,GO:0001501,CDH11,skeletal system development,3.0
3655,1009,GO:0001503,CDH11,ossification,3.0
3656,1009,GO:0005509,CDH11,calcium ion binding,3.0
3657,1009,GO:0005737,CDH11,cytoplasm,3.0
3658,1009,GO:0005886,CDH11,plasma membrane,3.0
3659,1009,GO:0005912,CDH11,adherens junction,3.0
3660,1009,GO:0007043,CDH11,cell-cell junction assembly,3.0
3661,1009,GO:0007155,CDH11,cell adhesion,3.0
3662,1009,GO:0007156,CDH11,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3663,1009,GO:0007275,CDH11,multicellular organism development,3.0
3664,1009,GO:0016021,CDH11,integral component of membrane,3.0
3665,1009,GO:0016339,CDH11,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3666,1009,GO:0016342,CDH11,catenin complex,3.0
3667,1009,GO:0021957,CDH11,corticospinal tract morphogenesis,3.0
3668,1009,GO:0034332,CDH11,adherens junction organization,3.0
3670,1009,GO:0045296,CDH11,cadherin binding,3.0
3671,1009,GO:0050804,CDH11,modulation of chemical synaptic transmission,3.0
3672,1009,GO:0070062,CDH11,extracellular exosome,3.0
3673,1009,GO:0098685,CDH11,Schaffer collateral - CA1 synapse,3.0
3674,1009,GO:0098742,CDH11,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
3675,1009,GO:0098978,CDH11,glutamatergic synapse,3.0
3724,64405,GO:0000902,CDH22,cell morphogenesis,3.0
3725,64405,GO:0005509,CDH22,calcium ion binding,3.0
3726,64405,GO:0005912,CDH22,adherens junction,3.0
3727,64405,GO:0007043,CDH22,cell-cell junction assembly,3.0
3728,64405,GO:0007156,CDH22,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3729,64405,GO:0007275,CDH22,multicellular organism development,3.0
3730,64405,GO:0007420,CDH22,brain development,3.0
3731,64405,GO:0016021,CDH22,integral component of membrane,3.0
3732,64405,GO:0016339,CDH22,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3733,64405,GO:0016342,CDH22,catenin complex,3.0
3734,64405,GO:0034332,CDH22,adherens junction organization,3.0
3735,64405,GO:0045296,CDH22,cadherin binding,3.0
3736,64405,GO:0098742,CDH22,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
3737,1006,GO:0000902,CDH8,cell morphogenesis,3.0
3738,1006,GO:0005509,CDH8,calcium ion binding,3.0
3739,1006,GO:0005886,CDH8,plasma membrane,3.0
3741,1006,GO:0005912,CDH8,adherens junction,3.0
3742,1006,GO:0007043,CDH8,cell-cell junction assembly,3.0
3743,1006,GO:0007155,CDH8,cell adhesion,3.0
3744,1006,GO:0007156,CDH8,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3745,1006,GO:0007275,CDH8,multicellular organism development,3.0
3746,1006,GO:0009409,CDH8,response to cold,3.0
3747,1006,GO:0016021,CDH8,integral component of membrane,3.0
3748,1006,GO:0016339,CDH8,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3749,1006,GO:0016342,CDH8,catenin complex,3.0
3750,1006,GO:0034332,CDH8,adherens junction organization,3.0
3752,1006,GO:0035249,CDH8,"synaptic transmission, glutamatergic",3.0
3753,1006,GO:0042802,CDH8,identical protein binding,3.0
3754,1006,GO:0043083,CDH8,synaptic cleft,3.0
3755,1006,GO:0043679,CDH8,axon terminus,3.0
3756,1006,GO:0045296,CDH8,cadherin binding,3.0
3757,1006,GO:0050807,CDH8,regulation of synapse organization,3.0
3758,1006,GO:0098742,CDH8,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
3759,1007,GO:0000902,CDH9,cell morphogenesis,3.0
3760,1007,GO:0003674,CDH9,molecular_function,3.0
3761,1007,GO:0005509,CDH9,calcium ion binding,3.0
3762,1007,GO:0005886,CDH9,plasma membrane,3.0
3763,1007,GO:0005912,CDH9,adherens junction,3.0
3764,1007,GO:0007043,CDH9,cell-cell junction assembly,3.0
3765,1007,GO:0007156,CDH9,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
3766,1007,GO:0007275,CDH9,multicellular organism development,3.0
3767,1007,GO:0007416,CDH9,synapse assembly,3.0
3768,1007,GO:0016339,CDH9,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
3769,1007,GO:0016342,CDH9,catenin complex,3.0
3770,1007,GO:0034332,CDH9,adherens junction organization,3.0
3772,1007,GO:0045296,CDH9,cadherin binding,3.0
3773,1007,GO:0098609,CDH9,cell-cell adhesion,3.0
3774,1007,GO:0098742,CDH9,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
3775,1007,GO:0099055,CDH9,integral component of postsynaptic membrane,3.0
3776,1007,GO:0099056,CDH9,integral component of presynaptic membrane,3.0
3777,1007,GO:0099560,CDH9,synaptic membrane adhesion,3.0
3832,782,GO:0005245,CACNB1,voltage-gated calcium channel activity,3.0
3833,782,GO:0005515,CACNB1,protein binding,3.0
3834,782,GO:0005886,CACNB1,plasma membrane,3.0
3835,782,GO:0005891,CACNB1,voltage-gated calcium channel complex,3.0
3836,782,GO:0007268,CACNB1,chemical synaptic transmission,3.0
3837,782,GO:0007528,CACNB1,neuromuscular junction development,3.0
3838,782,GO:0008331,CACNB1,high voltage-gated calcium channel activity,3.0
3839,782,GO:0042383,CACNB1,sarcolemma,3.0
3840,782,GO:0045202,CACNB1,synapse,3.0
3841,782,GO:0061337,CACNB1,cardiac conduction,3.0
3842,782,GO:0070588,CACNB1,calcium ion transmembrane transport,3.0
3843,782,GO:1901385,CACNB1,regulation of voltage-gated calcium channel activity,3.0
3844,782,GO:1902514,CACNB1,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,3.0
3845,782,GO:1904646,CACNB1,cellular response to amyloid-beta,3.0
3879,50937,GO:0001708,CDON,cell fate specification,3.0
3880,50937,GO:0002088,CDON,lens development in camera-type eye,3.0
3881,50937,GO:0005515,CDON,protein binding,3.0
3882,50937,GO:0005886,CDON,plasma membrane,3.0
3883,50937,GO:0005887,CDON,integral component of plasma membrane,3.0
3884,50937,GO:0007155,CDON,cell adhesion,3.0
3885,50937,GO:0007224,CDON,smoothened signaling pathway,3.0
3886,50937,GO:0007520,CDON,myoblast fusion,3.0
3887,50937,GO:0009952,CDON,anterior/posterior pattern specification,3.0
3888,50937,GO:0010172,CDON,embryonic body morphogenesis,3.0
3889,50937,GO:0014816,CDON,skeletal muscle satellite cell differentiation,3.0
3890,50937,GO:0021987,CDON,cerebral cortex development,3.0
3891,50937,GO:0043393,CDON,regulation of protein binding,3.0
3892,50937,GO:0043410,CDON,positive regulation of MAPK cascade,3.0
3893,50937,GO:0045663,CDON,positive regulation of myoblast differentiation,3.0
3894,50937,GO:0045666,CDON,positive regulation of neuron differentiation,3.0
3895,50937,GO:0045944,CDON,positive regulation of transcription by RNA polymerase II,3.0
3896,50937,GO:0048643,CDON,positive regulation of skeletal muscle tissue development,3.0
3897,50937,GO:0051057,CDON,positive regulation of small GTPase mediated signal transduction,3.0
3898,50937,GO:0051149,CDON,positive regulation of muscle cell differentiation,3.0
3899,50937,GO:0060059,CDON,embryonic retina morphogenesis in camera-type eye,3.0
3900,50937,GO:0062023,CDON,collagen-containing extracellular matrix,3.0
3901,50937,GO:2000179,CDON,positive regulation of neural precursor cell proliferation,3.0
3902,27443,GO:0000791,CECR2,euchromatin,3.0
3903,27443,GO:0005634,CECR2,nucleus,3.0
3904,27443,GO:0006309,CECR2,apoptotic DNA fragmentation,3.0
3905,27443,GO:0007010,CECR2,cytoskeleton organization,3.0
3906,27443,GO:0007338,CECR2,single fertilization,3.0
3907,27443,GO:0016192,CECR2,vesicle-mediated transport,3.0
3908,27443,GO:0043044,CECR2,ATP-dependent chromatin remodeling,3.0
3910,27443,GO:0061640,CECR2,cytoskeleton-dependent cytokinesis,3.0
3911,27443,GO:0090537,CECR2,CERF complex,3.0
3913,27443,GO:0097194,CECR2,execution phase of apoptosis,3.0
3935,60677,GO:0000381,CELF6,"regulation of alternative mRNA splicing, via spliceosome",3.0
3937,60677,GO:0003723,CELF6,RNA binding,3.0
3939,60677,GO:0003729,CELF6,mRNA binding,3.0
3940,60677,GO:0005634,CELF6,nucleus,3.0
3942,60677,GO:0005737,CELF6,cytoplasm,3.0
3944,60677,GO:0006376,CELF6,mRNA splice site selection,3.0
3945,60677,GO:1990904,CELF6,ribonucleoprotein complex,3.0
3958,80184,GO:0000086,CEP290,G2/M transition of mitotic cell cycle,3.0
3959,80184,GO:0000930,CEP290,gamma-tubulin complex,3.0
3960,80184,GO:0005515,CEP290,protein binding,3.0
3961,80184,GO:0005576,CEP290,extracellular region,3.0
3962,80184,GO:0005634,CEP290,nucleus,3.0
3963,80184,GO:0005737,CEP290,cytoplasm,3.0
3964,80184,GO:0005813,CEP290,centrosome,3.0
3966,80184,GO:0005814,CEP290,centriole,3.0
3967,80184,GO:0005829,CEP290,cytosol,3.0
3969,80184,GO:0010389,CEP290,regulation of G2/M transition of mitotic cell cycle,3.0
3970,80184,GO:0015031,CEP290,protein transport,3.0
3971,80184,GO:0016020,CEP290,membrane,3.0
3972,80184,GO:0030902,CEP290,hindbrain development,3.0
3973,80184,GO:0030916,CEP290,otic vesicle formation,3.0
3974,80184,GO:0032391,CEP290,photoreceptor connecting cilium,3.0
3975,80184,GO:0032991,CEP290,protein-containing complex,3.0
3976,80184,GO:0034451,CEP290,centriolar satellite,3.0
3977,80184,GO:0035580,CEP290,specific granule lumen,3.0
3978,80184,GO:0035869,CEP290,ciliary transition zone,3.0
3979,80184,GO:0036038,CEP290,MKS complex,3.0
3980,80184,GO:0042462,CEP290,eye photoreceptor cell development,3.0
3981,80184,GO:0042802,CEP290,identical protein binding,3.0
3982,80184,GO:0043312,CEP290,neutrophil degranulation,3.0
3983,80184,GO:0045893,CEP290,"positive regulation of transcription, DNA-templated",3.0
3984,80184,GO:0048793,CEP290,pronephros development,3.0
3985,80184,GO:0051011,CEP290,microtubule minus-end binding,3.0
3986,80184,GO:0060271,CEP290,cilium assembly,3.0
3988,80184,GO:0070201,CEP290,regulation of establishment of protein localization,3.0
3989,80184,GO:0090316,CEP290,positive regulation of intracellular protein transport,3.0
3990,80184,GO:0097711,CEP290,ciliary basal body-plasma membrane docking,3.0
4034,1105,GO:0003677,CHD1,DNA binding,3.0
4035,1105,GO:0003678,CHD1,DNA helicase activity,3.0
4036,1105,GO:0005515,CHD1,protein binding,3.0
4037,1105,GO:0005524,CHD1,ATP binding,3.0
4038,1105,GO:0005634,CHD1,nucleus,3.0
4039,1105,GO:0005654,CHD1,nucleoplasm,3.0
4040,1105,GO:0005737,CHD1,cytoplasm,3.0
4041,1105,GO:0006338,CHD1,chromatin remodeling,3.0
4042,1105,GO:0006357,CHD1,regulation of transcription by RNA polymerase II,3.0
4043,1105,GO:0016569,CHD1,covalent chromatin modification,3.0
4044,1105,GO:0032508,CHD1,DNA duplex unwinding,3.0
4045,1105,GO:0035064,CHD1,methylated histone binding,3.0
4047,1105,GO:0043923,CHD1,positive regulation by host of viral transcription,3.0
4188,1121,GO:0004663,CHM,Rab geranylgeranyltransferase activity,3.0
4189,1121,GO:0005092,CHM,GDP-dissociation inhibitor activity,3.0
4190,1121,GO:0005096,CHM,GTPase activator activity,3.0
4191,1121,GO:0005515,CHM,protein binding,3.0
4192,1121,GO:0005634,CHM,nucleus,3.0
4193,1121,GO:0005737,CHM,cytoplasm,3.0
4194,1121,GO:0005829,CHM,cytosol,3.0
4197,1121,GO:0005968,CHM,Rab-protein geranylgeranyltransferase complex,3.0
4199,1121,GO:0006612,CHM,protein targeting to membrane,3.0
4200,1121,GO:0007264,CHM,small GTPase mediated signal transduction,3.0
4201,1121,GO:0007601,CHM,visual perception,3.0
4202,1121,GO:0016192,CHM,vesicle-mediated transport,3.0
4203,1121,GO:0018344,CHM,protein geranylgeranylation,3.0
4205,1121,GO:0031267,CHM,small GTPase binding,3.0
4208,1121,GO:0042981,CHM,regulation of apoptotic process,3.0
4209,1121,GO:0043547,CHM,positive regulation of GTPase activity,3.0
4210,1121,GO:0043687,CHM,post-translational protein modification,3.0
4243,1131,GO:0003056,CHRM3,regulation of vascular associated smooth muscle contraction,3.0
4244,1131,GO:0004435,CHRM3,phosphatidylinositol phospholipase C activity,3.0
4245,1131,GO:0004993,CHRM3,G protein-coupled serotonin receptor activity,3.0
4246,1131,GO:0005515,CHRM3,protein binding,3.0
4247,1131,GO:0005789,CHRM3,endoplasmic reticulum membrane,3.0
4248,1131,GO:0005886,CHRM3,plasma membrane,3.0
4250,1131,GO:0005887,CHRM3,integral component of plasma membrane,3.0
4252,1131,GO:0006464,CHRM3,cellular protein modification process,3.0
4253,1131,GO:0007165,CHRM3,signal transduction,3.0
4254,1131,GO:0007186,CHRM3,G protein-coupled receptor signaling pathway,3.0
4255,1131,GO:0007187,CHRM3,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",3.0
4256,1131,GO:0007197,CHRM3,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,3.0
4257,1131,GO:0007213,CHRM3,G protein-coupled acetylcholine receptor signaling pathway,3.0
4258,1131,GO:0007268,CHRM3,chemical synaptic transmission,3.0
4259,1131,GO:0007399,CHRM3,nervous system development,3.0
4260,1131,GO:0009925,CHRM3,basal plasma membrane,3.0
4261,1131,GO:0016907,CHRM3,G protein-coupled acetylcholine receptor activity,3.0
4263,1131,GO:0019722,CHRM3,calcium-mediated signaling,3.0
4264,1131,GO:0030425,CHRM3,dendrite,3.0
4265,1131,GO:0030594,CHRM3,neurotransmitter receptor activity,3.0
4266,1131,GO:0032412,CHRM3,regulation of ion transmembrane transporter activity,3.0
4267,1131,GO:0038023,CHRM3,signaling receptor activity,3.0
4268,1131,GO:0042166,CHRM3,acetylcholine binding,3.0
4269,1131,GO:0045202,CHRM3,synapse,3.0
4270,1131,GO:0045211,CHRM3,postsynaptic membrane,3.0
4271,1131,GO:0045987,CHRM3,positive regulation of smooth muscle contraction,3.0
4272,1131,GO:0046541,CHRM3,saliva secretion,3.0
4273,1131,GO:0095500,CHRM3,acetylcholine receptor signaling pathway,3.0
4274,1131,GO:0098664,CHRM3,G protein-coupled serotonin receptor signaling pathway,3.0
4369,1142,GO:0005886,CHRNB3,plasma membrane,3.0
4370,1142,GO:0005887,CHRNB3,integral component of plasma membrane,3.0
4371,1142,GO:0005892,CHRNB3,acetylcholine-gated channel complex,3.0
4372,1142,GO:0007165,CHRNB3,signal transduction,3.0
4373,1142,GO:0007268,CHRNB3,chemical synaptic transmission,3.0
4374,1142,GO:0007271,CHRNB3,"synaptic transmission, cholinergic",3.0
4375,1142,GO:0008144,CHRNB3,drug binding,3.0
4376,1142,GO:0015267,CHRNB3,channel activity,3.0
4377,1142,GO:0015464,CHRNB3,acetylcholine receptor activity,3.0
4378,1142,GO:0016021,CHRNB3,integral component of membrane,3.0
4379,1142,GO:0022848,CHRNB3,acetylcholine-gated cation-selective channel activity,3.0
4380,1142,GO:0030594,CHRNB3,neurotransmitter receptor activity,3.0
4381,1142,GO:0034220,CHRNB3,ion transmembrane transport,3.0
4382,1142,GO:0035094,CHRNB3,response to nicotine,3.0
4383,1142,GO:0042166,CHRNB3,acetylcholine binding,3.0
4384,1142,GO:0042391,CHRNB3,regulation of membrane potential,3.0
4385,1142,GO:0043005,CHRNB3,neuron projection,3.0
4386,1142,GO:0044877,CHRNB3,protein-containing complex binding,3.0
4387,1142,GO:0045202,CHRNB3,synapse,3.0
4388,1142,GO:0045211,CHRNB3,postsynaptic membrane,3.0
4389,1142,GO:0050877,CHRNB3,nervous system process,3.0
4390,1142,GO:0060079,CHRNB3,excitatory postsynaptic potential,3.0
4494,1183,GO:0005247,CLCN4,voltage-gated chloride channel activity,3.0
4495,1183,GO:0005254,CLCN4,chloride channel activity,3.0
4496,1183,GO:0005515,CLCN4,protein binding,3.0
4497,1183,GO:0005524,CLCN4,ATP binding,3.0
4498,1183,GO:0005765,CLCN4,lysosomal membrane,3.0
4499,1183,GO:0005769,CLCN4,early endosome,3.0
4500,1183,GO:0005789,CLCN4,endoplasmic reticulum membrane,3.0
4501,1183,GO:0005794,CLCN4,Golgi apparatus,3.0
4502,1183,GO:0005887,CLCN4,integral component of plasma membrane,3.0
4503,1183,GO:0006821,CLCN4,chloride transport,3.0
4505,1183,GO:0008021,CLCN4,synaptic vesicle,3.0
4506,1183,GO:0010008,CLCN4,endosome membrane,3.0
4508,1183,GO:0015297,CLCN4,antiporter activity,3.0
4510,1183,GO:0015299,CLCN4,solute:proton antiporter activity,3.0
4511,1183,GO:0031901,CLCN4,early endosome membrane,3.0
4512,1183,GO:0031902,CLCN4,late endosome membrane,3.0
4513,1183,GO:0034220,CLCN4,ion transmembrane transport,3.0
4514,1183,GO:0055037,CLCN4,recycling endosome,3.0
4515,1183,GO:0055038,CLCN4,recycling endosome membrane,3.0
4516,1183,GO:1902476,CLCN4,chloride transmembrane transport,3.0
4517,1183,GO:1902600,CLCN4,proton transmembrane transport,3.0
4518,2055,GO:0001306,CLN8,age-dependent response to oxidative stress,3.0
4519,2055,GO:0005515,CLN8,protein binding,3.0
4520,2055,GO:0005739,CLN8,mitochondrion,3.0
4521,2055,GO:0005783,CLN8,endoplasmic reticulum,3.0
4523,2055,GO:0005789,CLN8,endoplasmic reticulum membrane,3.0
4524,2055,GO:0005793,CLN8,endoplasmic reticulum-Golgi intermediate compartment,3.0
4525,2055,GO:0006644,CLN8,phospholipid metabolic process,3.0
4527,2055,GO:0006672,CLN8,ceramide metabolic process,3.0
4528,2055,GO:0006869,CLN8,lipid transport,3.0
4529,2055,GO:0007006,CLN8,mitochondrial membrane organization,3.0
4530,2055,GO:0007040,CLN8,lysosome organization,3.0
4531,2055,GO:0007399,CLN8,nervous system development,3.0
4533,2055,GO:0007601,CLN8,visual perception,3.0
4534,2055,GO:0007628,CLN8,adult walking behavior,3.0
4535,2055,GO:0008203,CLN8,cholesterol metabolic process,3.0
4536,2055,GO:0008306,CLN8,associative learning,3.0
4537,2055,GO:0008361,CLN8,regulation of cell size,3.0
4538,2055,GO:0008610,CLN8,lipid biosynthetic process,3.0
4539,2055,GO:0016021,CLN8,integral component of membrane,3.0
4540,2055,GO:0021523,CLN8,somatic motor neuron differentiation,3.0
4541,2055,GO:0030163,CLN8,protein catabolic process,3.0
4542,2055,GO:0033116,CLN8,endoplasmic reticulum-Golgi intermediate compartment membrane,3.0
4543,2055,GO:0035176,CLN8,social behavior,3.0
4544,2055,GO:0043066,CLN8,negative regulation of apoptotic process,3.0
4545,2055,GO:0044257,CLN8,cellular protein catabolic process,3.0
4546,2055,GO:0045494,CLN8,photoreceptor cell maintenance,3.0
4547,2055,GO:0045861,CLN8,negative regulation of proteolysis,3.0
4548,2055,GO:0046513,CLN8,ceramide biosynthetic process,3.0
4549,2055,GO:0050881,CLN8,musculoskeletal movement,3.0
4550,2055,GO:0050884,CLN8,neuromuscular process controlling posture,3.0
4551,2055,GO:0050885,CLN8,neuromuscular process controlling balance,3.0
4552,2055,GO:0051935,CLN8,glutamate reuptake,3.0
4553,2055,GO:0055088,CLN8,lipid homeostasis,3.0
4554,2055,GO:0060041,CLN8,retina development in camera-type eye,3.0
4555,2055,GO:0060052,CLN8,neurofilament cytoskeleton organization,3.0
4556,2055,GO:0097001,CLN8,ceramide binding,3.0
4558,2055,GO:0098793,CLN8,presynapse,3.0
4559,8218,GO:0000278,CLTCL1,mitotic cell cycle,3.0
4561,8218,GO:0005198,CLTCL1,structural molecule activity,3.0
4562,8218,GO:0005515,CLTCL1,protein binding,3.0
4563,8218,GO:0005769,CLTCL1,early endosome,3.0
4564,8218,GO:0005770,CLTCL1,late endosome,3.0
4565,8218,GO:0005802,CLTCL1,trans-Golgi network,3.0
4566,8218,GO:0005819,CLTCL1,spindle,3.0
4567,8218,GO:0005829,CLTCL1,cytosol,3.0
4568,8218,GO:0005886,CLTCL1,plasma membrane,3.0
4569,8218,GO:0005905,CLTCL1,clathrin-coated pit,3.0
4570,8218,GO:0006886,CLTCL1,intracellular protein transport,3.0
4571,8218,GO:0006898,CLTCL1,receptor-mediated endocytosis,3.0
4573,8218,GO:0009653,CLTCL1,anatomical structure morphogenesis,3.0
4574,8218,GO:0016020,CLTCL1,membrane,3.0
4575,8218,GO:0030130,CLTCL1,clathrin coat of trans-Golgi network vesicle,3.0
4576,8218,GO:0030135,CLTCL1,coated vesicle,3.0
4577,8218,GO:0030136,CLTCL1,clathrin-coated vesicle,3.0
4578,8218,GO:0032051,CLTCL1,clathrin light chain binding,3.0
4579,8218,GO:0042147,CLTCL1,"retrograde transport, endosome to Golgi",3.0
4580,8218,GO:0045334,CLTCL1,clathrin-coated endocytic vesicle,3.0
4582,8218,GO:0046326,CLTCL1,positive regulation of glucose import,3.0
4583,8218,GO:0055037,CLTCL1,recycling endosome,3.0
4584,8218,GO:0061024,CLTCL1,membrane organization,3.0
4585,8218,GO:0070062,CLTCL1,extracellular exosome,3.0
4586,8218,GO:0071439,CLTCL1,clathrin complex,3.0
4587,8218,GO:0097443,CLTCL1,sorting endosome,3.0
4588,80790,GO:0005515,CMIP,protein binding,3.0
4589,80790,GO:0005654,CMIP,nucleoplasm,3.0
4591,80790,GO:0005829,CMIP,cytosol,3.0
4593,129607,GO:0004127,CMPK2,cytidylate kinase activity,3.0
4595,129607,GO:0004550,CMPK2,nucleoside diphosphate kinase activity,3.0
4597,129607,GO:0004798,CMPK2,thymidylate kinase activity,3.0
4598,129607,GO:0005524,CMPK2,ATP binding,3.0
4599,129607,GO:0005737,CMPK2,cytoplasm,3.0
4600,129607,GO:0005739,CMPK2,mitochondrion,3.0
4602,129607,GO:0006165,CMPK2,nucleoside diphosphate phosphorylation,3.0
4603,129607,GO:0006227,CMPK2,dUDP biosynthetic process,3.0
4604,129607,GO:0006233,CMPK2,dTDP biosynthetic process,3.0
4605,129607,GO:0006235,CMPK2,dTTP biosynthetic process,3.0
4606,129607,GO:0009041,CMPK2,uridylate kinase activity,3.0
4607,129607,GO:0009142,CMPK2,nucleoside triphosphate biosynthetic process,3.0
4608,129607,GO:0033862,CMPK2,UMP kinase activity,3.0
4609,129607,GO:0046940,CMPK2,nucleoside monophosphate phosphorylation,3.0
4610,129607,GO:0071222,CMPK2,cellular response to lipopolysaccharide,3.0
4611,54714,GO:0001750,CNGB3,photoreceptor outer segment,3.0
4612,54714,GO:0005222,CNGB3,intracellular cAMP-activated cation channel activity,3.0
4613,54714,GO:0005223,CNGB3,intracellular cGMP-activated cation channel activity,3.0
4615,54714,GO:0006812,CNGB3,cation transport,3.0
4616,54714,GO:0007165,CNGB3,signal transduction,3.0
4617,54714,GO:0007601,CNGB3,visual perception,3.0
4618,54714,GO:0030553,CNGB3,cGMP binding,3.0
4620,54714,GO:0098655,CNGB3,cation transmembrane transport,3.0
4621,54714,GO:1902495,CNGB3,transmembrane transporter complex,3.0
4701,5067,GO:0005576,CNTN3,extracellular region,3.0
4702,5067,GO:0005886,CNTN3,plasma membrane,3.0
4703,5067,GO:0007155,CNTN3,cell adhesion,3.0
4704,5067,GO:0007399,CNTN3,nervous system development,3.0
4705,5067,GO:0031225,CNTN3,anchored component of membrane,3.0
4706,5067,GO:0043005,CNTN3,neuron projection,3.0
4792,129684,GO:0007155,CNTNAP5,cell adhesion,3.0
4793,129684,GO:0016021,CNTNAP5,integral component of membrane,3.0
4794,340267,GO:0004867,COL28A1,serine-type endopeptidase inhibitor activity,3.0
4795,340267,GO:0005201,COL28A1,extracellular matrix structural constituent,3.0
4796,340267,GO:0005576,COL28A1,extracellular region,3.0
4797,340267,GO:0005581,COL28A1,collagen trimer,3.0
4798,340267,GO:0005604,COL28A1,basement membrane,3.0
4799,340267,GO:0005615,COL28A1,extracellular space,3.0
4800,340267,GO:0005788,COL28A1,endoplasmic reticulum lumen,3.0
4801,340267,GO:0007155,COL28A1,cell adhesion,3.0
4802,340267,GO:0010951,COL28A1,negative regulation of endopeptidase activity,3.0
4803,340267,GO:0030020,COL28A1,extracellular matrix structural constituent conferring tensile strength,3.0
4804,340267,GO:0030198,COL28A1,extracellular matrix organization,3.0
4805,340267,GO:0031012,COL28A1,extracellular matrix,3.0
4806,340267,GO:0062023,COL28A1,collagen-containing extracellular matrix,3.0
4807,1376,GO:0001676,CPT2,long-chain fatty acid metabolic process,3.0
4808,1376,GO:0004095,CPT2,carnitine O-palmitoyltransferase activity,3.0
4812,1376,GO:0005515,CPT2,protein binding,3.0
4813,1376,GO:0005654,CPT2,nucleoplasm,3.0
4814,1376,GO:0005730,CPT2,nucleolus,3.0
4815,1376,GO:0005739,CPT2,mitochondrion,3.0
4817,1376,GO:0005743,CPT2,mitochondrial inner membrane,3.0
4819,1376,GO:0006635,CPT2,fatty acid beta-oxidation,3.0
4822,1376,GO:0006853,CPT2,carnitine shuttle,3.0
4823,1376,GO:0009437,CPT2,carnitine metabolic process,3.0
4824,1376,GO:0016746,CPT2,"transferase activity, transferring acyl groups",3.0
4825,1376,GO:0019216,CPT2,regulation of lipid metabolic process,3.0
4826,1376,GO:0120162,CPT2,positive regulation of cold-induced thermogenesis,3.0
4827,8532,GO:0004181,CPZ,metallocarboxypeptidase activity,3.0
4828,8532,GO:0005615,CPZ,extracellular space,3.0
4829,8532,GO:0006508,CPZ,proteolysis,3.0
4830,8532,GO:0006518,CPZ,peptide metabolic process,3.0
4831,8532,GO:0008270,CPZ,zinc ion binding,3.0
4832,8532,GO:0016055,CPZ,Wnt signaling pathway,3.0
4833,8532,GO:0016485,CPZ,protein processing,3.0
5000,64478,GO:0001964,CSMD1,startle response,3.0
5001,64478,GO:0007613,CSMD1,memory,3.0
5002,64478,GO:0016021,CSMD1,integral component of membrane,3.0
5003,64478,GO:0042593,CSMD1,glucose homeostasis,3.0
5004,64478,GO:1990708,CSMD1,conditioned place preference,3.0
5005,1454,GO:0000086,CSNK1E,G2/M transition of mitotic cell cycle,3.0
5006,1454,GO:0003723,CSNK1E,RNA binding,3.0
5007,1454,GO:0004672,CSNK1E,protein kinase activity,3.0
5009,1454,GO:0004674,CSNK1E,protein serine/threonine kinase activity,3.0
5012,1454,GO:0005515,CSNK1E,protein binding,3.0
5013,1454,GO:0005524,CSNK1E,ATP binding,3.0
5014,1454,GO:0005634,CSNK1E,nucleus,3.0
5016,1454,GO:0005654,CSNK1E,nucleoplasm,3.0
5017,1454,GO:0005737,CSNK1E,cytoplasm,3.0
5019,1454,GO:0005829,CSNK1E,cytosol,3.0
5020,1454,GO:0006281,CSNK1E,DNA repair,3.0
5021,1454,GO:0006468,CSNK1E,protein phosphorylation,3.0
5023,1454,GO:0006897,CSNK1E,endocytosis,3.0
5024,1454,GO:0007165,CSNK1E,signal transduction,3.0
5025,1454,GO:0010389,CSNK1E,regulation of G2/M transition of mitotic cell cycle,3.0
5026,1454,GO:0016055,CSNK1E,Wnt signaling pathway,3.0
5027,1454,GO:0018105,CSNK1E,peptidyl-serine phosphorylation,3.0
5029,1454,GO:0032091,CSNK1E,negative regulation of protein binding,3.0
5030,1454,GO:0032436,CSNK1E,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3.0
5032,1454,GO:0032922,CSNK1E,circadian regulation of gene expression,3.0
5033,1454,GO:0042752,CSNK1E,regulation of circadian rhythm,3.0
5034,1454,GO:0060070,CSNK1E,canonical Wnt signaling pathway,3.0
5037,1454,GO:0090263,CSNK1E,positive regulation of canonical Wnt signaling pathway,3.0
5038,1454,GO:0097711,CSNK1E,ciliary basal body-plasma membrane docking,3.0
5039,1454,GO:0106310,CSNK1E,protein serine kinase activity,3.0
5040,1454,GO:0106311,CSNK1E,protein threonine kinase activity,3.0
5041,1454,GO:1903827,CSNK1E,regulation of cellular protein localization,3.0
5042,1454,GO:1905426,CSNK1E,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,3.0
5043,1454,GO:2000052,CSNK1E,positive regulation of non-canonical Wnt signaling pathway,3.0
5044,1457,GO:0004674,CSNK2A1,protein serine/threonine kinase activity,3.0
5049,1457,GO:0005515,CSNK2A1,protein binding,3.0
5050,1457,GO:0005524,CSNK2A1,ATP binding,3.0
5051,1457,GO:0005634,CSNK2A1,nucleus,3.0
5054,1457,GO:0005654,CSNK2A1,nucleoplasm,3.0
5056,1457,GO:0005829,CSNK2A1,cytosol,3.0
5058,1457,GO:0005886,CSNK2A1,plasma membrane,3.0
5059,1457,GO:0005956,CSNK2A1,protein kinase CK2 complex,3.0
5061,1457,GO:0006457,CSNK2A1,protein folding,3.0
5062,1457,GO:0006468,CSNK2A1,protein phosphorylation,3.0
5063,1457,GO:0006656,CSNK2A1,phosphatidylcholine biosynthetic process,3.0
5064,1457,GO:0006915,CSNK2A1,apoptotic process,3.0
5065,1457,GO:0007049,CSNK2A1,cell cycle,3.0
5066,1457,GO:0007165,CSNK2A1,signal transduction,3.0
5067,1457,GO:0008284,CSNK2A1,positive regulation of cell population proliferation,3.0
5068,1457,GO:0016055,CSNK2A1,Wnt signaling pathway,3.0
5069,1457,GO:0016236,CSNK2A1,macroautophagy,3.0
5070,1457,GO:0016301,CSNK2A1,kinase activity,3.0
5071,1457,GO:0016580,CSNK2A1,Sin3 complex,3.0
5072,1457,GO:0016581,CSNK2A1,NuRD complex,3.0
5073,1457,GO:0018105,CSNK2A1,peptidyl-serine phosphorylation,3.0
5075,1457,GO:0018107,CSNK2A1,peptidyl-threonine phosphorylation,3.0
5077,1457,GO:0030177,CSNK2A1,positive regulation of Wnt signaling pathway,3.0
5078,1457,GO:0030307,CSNK2A1,positive regulation of cell growth,3.0
5079,1457,GO:0031519,CSNK2A1,PcG protein complex,3.0
5080,1457,GO:0042802,CSNK2A1,identical protein binding,3.0
5081,1457,GO:0043154,CSNK2A1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
5082,1457,GO:0045732,CSNK2A1,positive regulation of protein catabolic process,3.0
5083,1457,GO:0047485,CSNK2A1,protein N-terminus binding,3.0
5084,1457,GO:0048511,CSNK2A1,rhythmic process,3.0
5085,1457,GO:0051726,CSNK2A1,regulation of cell cycle,3.0
5086,1457,GO:0051879,CSNK2A1,Hsp90 protein binding,3.0
5087,1457,GO:0061077,CSNK2A1,chaperone-mediated protein folding,3.0
5088,1457,GO:0106310,CSNK2A1,protein serine kinase activity,3.0
5089,1457,GO:0106311,CSNK2A1,protein threonine kinase activity,3.0
5090,1457,GO:1901796,CSNK2A1,regulation of signal transduction by p53 class mediator,3.0
5091,1457,GO:1905818,CSNK2A1,regulation of chromosome separation,3.0
5092,1457,GO:2000059,CSNK2A1,negative regulation of ubiquitin-dependent protein catabolic process,3.0
5093,1457,GO:2001234,CSNK2A1,negative regulation of apoptotic signaling pathway,3.0
5194,29119,GO:0005515,CTNNA3,protein binding,3.0
5195,29119,GO:0005737,CTNNA3,cytoplasm,3.0
5196,29119,GO:0005856,CTNNA3,cytoskeleton,3.0
5197,29119,GO:0005912,CTNNA3,adherens junction,3.0
5198,29119,GO:0005916,CTNNA3,fascia adherens,3.0
5199,29119,GO:0008013,CTNNA3,beta-catenin binding,3.0
5200,29119,GO:0030027,CTNNA3,lamellipodium,3.0
5201,29119,GO:0045296,CTNNA3,cadherin binding,3.0
5202,29119,GO:0051015,CTNNA3,actin filament binding,3.0
5203,29119,GO:0086073,CTNNA3,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,3.0
5204,29119,GO:0086091,CTNNA3,regulation of heart rate by cardiac conduction,3.0
5205,29119,GO:0098609,CTNNA3,cell-cell adhesion,3.0
5206,29119,GO:0098911,CTNNA3,regulation of ventricular cardiac muscle cell action potential,3.0
5523,7461,GO:0005634,CLIP2,nucleus,3.0
5524,7461,GO:0005737,CLIP2,cytoplasm,3.0
5525,7461,GO:0005875,CLIP2,microtubule associated complex,3.0
5526,7461,GO:0005881,CLIP2,cytoplasmic microtubule,3.0
5527,7461,GO:0008017,CLIP2,microtubule binding,3.0
5528,7461,GO:0031122,CLIP2,cytoplasmic microtubule organization,3.0
5529,7461,GO:0035371,CLIP2,microtubule plus-end,3.0
5531,7461,GO:0051010,CLIP2,microtubule plus-end binding,3.0
5581,23316,GO:0000122,CUX2,negative regulation of transcription by RNA polymerase II,3.0
5582,23316,GO:0000785,CUX2,chromatin,3.0
5583,23316,GO:0000977,CUX2,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
5585,23316,GO:0000978,CUX2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
5586,23316,GO:0000981,CUX2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
5588,23316,GO:0001227,CUX2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
5589,23316,GO:0005634,CUX2,nucleus,3.0
5591,23316,GO:0006357,CUX2,regulation of transcription by RNA polymerase II,3.0
5592,23316,GO:0007614,CUX2,short-term memory,3.0
5593,23316,GO:0010628,CUX2,positive regulation of gene expression,3.0
5594,23316,GO:0043565,CUX2,sequence-specific DNA binding,3.0
5595,23316,GO:0050775,CUX2,positive regulation of dendrite morphogenesis,3.0
5596,23316,GO:0050890,CUX2,cognition,3.0
5597,23316,GO:0051965,CUX2,positive regulation of synapse assembly,3.0
5598,23316,GO:0061003,CUX2,positive regulation of dendritic spine morphogenesis,3.0
5599,23316,GO:0070062,CUX2,extracellular exosome,3.0
5600,23316,GO:0071310,CUX2,cellular response to organic substance,3.0
5601,23316,GO:1990837,CUX2,sequence-specific double-stranded DNA binding,3.0
5602,23316,GO:2000463,CUX2,positive regulation of excitatory postsynaptic potential,3.0
5603,1524,GO:0002052,CX3CR1,positive regulation of neuroblast proliferation,3.0
5604,1524,GO:0002931,CX3CR1,response to ischemia,3.0
5605,1524,GO:0004930,CX3CR1,G protein-coupled receptor activity,3.0
5606,1524,GO:0004950,CX3CR1,chemokine receptor activity,3.0
5607,1524,GO:0005515,CX3CR1,protein binding,3.0
5608,1524,GO:0005886,CX3CR1,plasma membrane,3.0
5609,1524,GO:0005887,CX3CR1,integral component of plasma membrane,3.0
5610,1524,GO:0006935,CX3CR1,chemotaxis,3.0
5611,1524,GO:0006955,CX3CR1,immune response,3.0
5612,1524,GO:0006968,CX3CR1,cellular defense response,3.0
5613,1524,GO:0007155,CX3CR1,cell adhesion,3.0
5614,1524,GO:0007186,CX3CR1,G protein-coupled receptor signaling pathway,3.0
5615,1524,GO:0007200,CX3CR1,phospholipase C-activating G protein-coupled receptor signaling pathway,3.0
5616,1524,GO:0007204,CX3CR1,positive regulation of cytosolic calcium ion concentration,3.0
5617,1524,GO:0007267,CX3CR1,cell-cell signaling,3.0
5618,1524,GO:0007613,CX3CR1,memory,3.0
5619,1524,GO:0008528,CX3CR1,G protein-coupled peptide receptor activity,3.0
5620,1524,GO:0009611,CX3CR1,response to wounding,3.0
5621,1524,GO:0009897,CX3CR1,external side of plasma membrane,3.0
5622,1524,GO:0009986,CX3CR1,cell surface,3.0
5625,1524,GO:0016032,CX3CR1,viral process,3.0
5626,1524,GO:0016493,CX3CR1,C-C chemokine receptor activity,3.0
5627,1524,GO:0016495,CX3CR1,C-X3-C chemokine receptor activity,3.0
5628,1524,GO:0016525,CX3CR1,negative regulation of angiogenesis,3.0
5629,1524,GO:0019722,CX3CR1,calcium-mediated signaling,3.0
5630,1524,GO:0019957,CX3CR1,C-C chemokine binding,3.0
5631,1524,GO:0019960,CX3CR1,C-X3-C chemokine binding,3.0
5633,1524,GO:0021626,CX3CR1,central nervous system maturation,3.0
5634,1524,GO:0030336,CX3CR1,negative regulation of cell migration,3.0
5635,1524,GO:0032680,CX3CR1,regulation of tumor necrosis factor production,3.0
5636,1524,GO:0032691,CX3CR1,negative regulation of interleukin-1 beta production,3.0
5637,1524,GO:0032809,CX3CR1,neuronal cell body membrane,3.0
5638,1524,GO:0035176,CX3CR1,social behavior,3.0
5639,1524,GO:0035425,CX3CR1,autocrine signaling,3.0
5640,1524,GO:0043005,CX3CR1,neuron projection,3.0
5641,1524,GO:0045087,CX3CR1,innate immune response,3.0
5642,1524,GO:0045428,CX3CR1,regulation of nitric oxide biosynthetic process,3.0
5643,1524,GO:0045766,CX3CR1,positive regulation of angiogenesis,3.0
5644,1524,GO:0048167,CX3CR1,regulation of synaptic plasticity,3.0
5645,1524,GO:0048471,CX3CR1,perinuclear region of cytoplasm,3.0
5646,1524,GO:0050767,CX3CR1,regulation of neurogenesis,3.0
5647,1524,GO:0050769,CX3CR1,positive regulation of neurogenesis,3.0
5648,1524,GO:0050804,CX3CR1,modulation of chemical synaptic transmission,3.0
5649,1524,GO:0050901,CX3CR1,leukocyte tethering or rolling,3.0
5650,1524,GO:0051092,CX3CR1,positive regulation of NF-kappaB transcription factor activity,3.0
5651,1524,GO:0051897,CX3CR1,positive regulation of protein kinase B signaling,3.0
5652,1524,GO:0060074,CX3CR1,synapse maturation,3.0
5653,1524,GO:0060326,CX3CR1,cell chemotaxis,3.0
5654,1524,GO:0070098,CX3CR1,chemokine-mediated signaling pathway,3.0
5655,1524,GO:0071222,CX3CR1,cellular response to lipopolysaccharide,3.0
5656,1524,GO:0071560,CX3CR1,cellular response to transforming growth factor beta stimulus,3.0
5657,1524,GO:0097447,CX3CR1,dendritic tree,3.0
5658,1524,GO:0098883,CX3CR1,synapse pruning,3.0
5659,1524,GO:0110091,CX3CR1,negative regulation of hippocampal neuron apoptotic process,3.0
5660,1524,GO:0150090,CX3CR1,"multiple spine synapse organization, single dendrite",3.0
5661,1524,GO:1900272,CX3CR1,negative regulation of long-term synaptic potentiation,3.0
5662,1524,GO:1903721,CX3CR1,positive regulation of I-kappaB phosphorylation,3.0
5663,1524,GO:1904139,CX3CR1,regulation of microglial cell migration,3.0
5664,1524,GO:1904141,CX3CR1,positive regulation of microglial cell migration,3.0
5665,1524,GO:2001234,CX3CR1,negative regulation of apoptotic signaling pathway,3.0
5722,1539,GO:0005200,CYLC2,structural constituent of cytoskeleton,3.0
5723,1539,GO:0005634,CYLC2,nucleus,3.0
5724,1539,GO:0007010,CYLC2,cytoskeleton organization,3.0
5725,1539,GO:0007275,CYLC2,multicellular organism development,3.0
5726,1539,GO:0007283,CYLC2,spermatogenesis,3.0
5727,1539,GO:0030154,CYLC2,cell differentiation,3.0
5728,1539,GO:0033150,CYLC2,cytoskeletal calyx,3.0
5729,1584,GO:0004507,CYP11B1,steroid 11-beta-monooxygenase activity,3.0
5732,1584,GO:0005506,CYP11B1,iron ion binding,3.0
5733,1584,GO:0005739,CYP11B1,mitochondrion,3.0
5734,1584,GO:0005743,CYP11B1,mitochondrial inner membrane,3.0
5737,1584,GO:0006700,CYP11B1,C21-steroid hormone biosynthetic process,3.0
5739,1584,GO:0006704,CYP11B1,glucocorticoid biosynthetic process,3.0
5741,1584,GO:0006955,CYP11B1,immune response,3.0
5742,1584,GO:0008203,CYP11B1,cholesterol metabolic process,3.0
5743,1584,GO:0008217,CYP11B1,regulation of blood pressure,3.0
5744,1584,GO:0016125,CYP11B1,sterol metabolic process,3.0
5745,1584,GO:0020037,CYP11B1,heme binding,3.0
5746,1584,GO:0032342,CYP11B1,aldosterone biosynthetic process,3.0
5749,1584,GO:0032870,CYP11B1,cellular response to hormone stimulus,3.0
5750,1584,GO:0034650,CYP11B1,cortisol metabolic process,3.0
5751,1584,GO:0034651,CYP11B1,cortisol biosynthetic process,3.0
5753,1584,GO:0035865,CYP11B1,cellular response to potassium ion,3.0
5754,1584,GO:0042593,CYP11B1,glucose homeostasis,3.0
5755,1584,GO:0047783,CYP11B1,corticosterone 18-monooxygenase activity,3.0
5756,1584,GO:0055114,CYP11B1,oxidation-reduction process,3.0
5757,1584,GO:0071375,CYP11B1,cellular response to peptide hormone stimulus,3.0
5780,747,GO:0005515,DAGLA,protein binding,3.0
5781,747,GO:0005886,DAGLA,plasma membrane,3.0
5782,747,GO:0007216,DAGLA,G protein-coupled glutamate receptor signaling pathway,3.0
5783,747,GO:0007405,DAGLA,neuroblast proliferation,3.0
5784,747,GO:0016787,DAGLA,hydrolase activity,3.0
5785,747,GO:0019369,DAGLA,arachidonic acid metabolic process,3.0
5786,747,GO:0022008,DAGLA,neurogenesis,3.0
5787,747,GO:0031901,DAGLA,early endosome membrane,3.0
5788,747,GO:0032590,DAGLA,dendrite membrane,3.0
5789,747,GO:0032591,DAGLA,dendritic spine membrane,3.0
5790,747,GO:0042136,DAGLA,neurotransmitter biosynthetic process,3.0
5792,747,GO:0043196,DAGLA,varicosity,3.0
5793,747,GO:0045211,DAGLA,postsynaptic membrane,3.0
5794,747,GO:0046340,DAGLA,diacylglycerol catabolic process,3.0
5796,747,GO:0046872,DAGLA,metal ion binding,3.0
5797,747,GO:0071926,DAGLA,endocannabinoid signaling pathway,3.0
5798,747,GO:0098839,DAGLA,postsynaptic density membrane,3.0
5799,747,GO:0098921,DAGLA,retrograde trans-synaptic signaling by endocannabinoid,3.0
5802,747,GO:0099055,DAGLA,integral component of postsynaptic membrane,3.0
5803,747,GO:0150077,DAGLA,regulation of neuroinflammatory response,3.0
5911,168400,GO:0003723,DDX53,RNA binding,3.0
5912,168400,GO:0003724,DDX53,RNA helicase activity,3.0
5913,168400,GO:0005524,DDX53,ATP binding,3.0
5914,168400,GO:0005654,DDX53,nucleoplasm,3.0
5915,168400,GO:0005730,DDX53,nucleolus,3.0
5916,168400,GO:0005829,DDX53,cytosol,3.0
5917,168400,GO:0043231,DDX53,intracellular membrane-bounded organelle,3.0
6068,205428,GO:0000139,DIPK2A,Golgi membrane,3.0
6069,205428,GO:0005615,DIPK2A,extracellular space,3.0
6071,205428,GO:0014066,DIPK2A,regulation of phosphatidylinositol 3-kinase signaling,3.0
6073,205428,GO:0030126,DIPK2A,COPI vesicle coat,3.0
6075,205428,GO:0034392,DIPK2A,negative regulation of smooth muscle cell apoptotic process,3.0
6076,205428,GO:0060038,DIPK2A,cardiac muscle cell proliferation,3.0
6078,205428,GO:1900020,DIPK2A,positive regulation of protein kinase C activity,3.0
6096,85458,GO:0003779,DIXDC1,actin binding,3.0
6097,85458,GO:0005515,DIXDC1,protein binding,3.0
6098,85458,GO:0005829,DIXDC1,cytosol,3.0
6100,85458,GO:0005856,DIXDC1,cytoskeleton,3.0
6101,85458,GO:0005925,DIXDC1,focal adhesion,3.0
6102,85458,GO:0019904,DIXDC1,protein domain specific binding,3.0
6103,85458,GO:0021799,DIXDC1,cerebral cortex radially oriented cell migration,3.0
6104,85458,GO:0021869,DIXDC1,forebrain ventricular zone progenitor cell division,3.0
6105,85458,GO:0030177,DIXDC1,positive regulation of Wnt signaling pathway,3.0
6106,85458,GO:0032956,DIXDC1,regulation of actin cytoskeleton organization,3.0
6107,85458,GO:0043015,DIXDC1,gamma-tubulin binding,3.0
6108,85458,GO:0045665,DIXDC1,negative regulation of neuron differentiation,3.0
6109,85458,GO:0060070,DIXDC1,canonical Wnt signaling pathway,3.0
6111,85458,GO:0070507,DIXDC1,regulation of microtubule cytoskeleton organization,3.0
6112,1739,GO:0000122,DLG1,negative regulation of transcription by RNA polymerase II,3.0
6113,1739,GO:0000165,DLG1,MAPK cascade,3.0
6114,1739,GO:0001658,DLG1,branching involved in ureteric bud morphogenesis,3.0
6115,1739,GO:0001771,DLG1,immunological synapse formation,3.0
6116,1739,GO:0001772,DLG1,immunological synapse,3.0
6118,1739,GO:0001935,DLG1,endothelial cell proliferation,3.0
6119,1739,GO:0002088,DLG1,lens development in camera-type eye,3.0
6120,1739,GO:0002369,DLG1,T cell cytokine production,3.0
6121,1739,GO:0004385,DLG1,guanylate kinase activity,3.0
6122,1739,GO:0004721,DLG1,phosphoprotein phosphatase activity,3.0
6123,1739,GO:0005515,DLG1,protein binding,3.0
6124,1739,GO:0005604,DLG1,basement membrane,3.0
6125,1739,GO:0005634,DLG1,nucleus,3.0
6126,1739,GO:0005737,DLG1,cytoplasm,3.0
6127,1739,GO:0005783,DLG1,endoplasmic reticulum,3.0
6128,1739,GO:0005789,DLG1,endoplasmic reticulum membrane,3.0
6129,1739,GO:0005794,DLG1,Golgi apparatus,3.0
6130,1739,GO:0005829,DLG1,cytosol,3.0
6131,1739,GO:0005874,DLG1,microtubule,3.0
6132,1739,GO:0005886,DLG1,plasma membrane,3.0
6133,1739,GO:0005911,DLG1,cell-cell junction,3.0
6134,1739,GO:0005923,DLG1,bicellular tight junction,3.0
6135,1739,GO:0006470,DLG1,protein dephosphorylation,3.0
6136,1739,GO:0007015,DLG1,actin filament organization,3.0
6137,1739,GO:0007093,DLG1,mitotic cell cycle checkpoint,3.0
6138,1739,GO:0007163,DLG1,establishment or maintenance of cell polarity,3.0
6139,1739,GO:0007268,DLG1,chemical synaptic transmission,3.0
6140,1739,GO:0008022,DLG1,protein C-terminus binding,3.0
6141,1739,GO:0008092,DLG1,cytoskeletal protein binding,3.0
6142,1739,GO:0008284,DLG1,positive regulation of cell population proliferation,3.0
6143,1739,GO:0008328,DLG1,ionotropic glutamate receptor complex,3.0
6144,1739,GO:0008360,DLG1,regulation of cell shape,3.0
6145,1739,GO:0009790,DLG1,embryo development,3.0
6146,1739,GO:0009898,DLG1,cytoplasmic side of plasma membrane,3.0
6147,1739,GO:0014704,DLG1,intercalated disc,3.0
6148,1739,GO:0015459,DLG1,potassium channel regulator activity,3.0
6151,1739,GO:0016032,DLG1,viral process,3.0
6152,1739,GO:0016323,DLG1,basolateral plasma membrane,3.0
6154,1739,GO:0016324,DLG1,apical plasma membrane,3.0
6155,1739,GO:0016328,DLG1,lateral plasma membrane,3.0
6156,1739,GO:0019901,DLG1,protein kinase binding,3.0
6157,1739,GO:0019902,DLG1,phosphatase binding,3.0
6158,1739,GO:0030054,DLG1,cell junction,3.0
6160,1739,GO:0030432,DLG1,peristalsis,3.0
6161,1739,GO:0030838,DLG1,positive regulation of actin filament polymerization,3.0
6162,1739,GO:0030866,DLG1,cortical actin cytoskeleton organization,3.0
6163,1739,GO:0030953,DLG1,astral microtubule organization,3.0
6164,1739,GO:0031253,DLG1,cell projection membrane,3.0
6165,1739,GO:0031434,DLG1,mitogen-activated protein kinase kinase binding,3.0
6166,1739,GO:0031579,DLG1,membrane raft organization,3.0
6167,1739,GO:0031594,DLG1,neuromuscular junction,3.0
6168,1739,GO:0031641,DLG1,regulation of myelination,3.0
6169,1739,GO:0032147,DLG1,activation of protein kinase activity,3.0
6170,1739,GO:0033268,DLG1,node of Ranvier,3.0
6171,1739,GO:0034629,DLG1,cellular protein-containing complex localization,3.0
6172,1739,GO:0035748,DLG1,myelin sheath abaxonal region,3.0
6173,1739,GO:0042110,DLG1,T cell activation,3.0
6174,1739,GO:0042130,DLG1,negative regulation of T cell proliferation,3.0
6175,1739,GO:0042383,DLG1,sarcolemma,3.0
6176,1739,GO:0042391,DLG1,regulation of membrane potential,3.0
6177,1739,GO:0042982,DLG1,amyloid precursor protein metabolic process,3.0
6178,1739,GO:0043005,DLG1,neuron projection,3.0
6179,1739,GO:0043113,DLG1,receptor clustering,3.0
6180,1739,GO:0043219,DLG1,lateral loop,3.0
6181,1739,GO:0043268,DLG1,positive regulation of potassium ion transport,3.0
6182,1739,GO:0043622,DLG1,cortical microtubule organization,3.0
6183,1739,GO:0044325,DLG1,ion channel binding,3.0
6184,1739,GO:0045121,DLG1,membrane raft,3.0
6185,1739,GO:0045197,DLG1,establishment or maintenance of epithelial cell apical/basal polarity,3.0
6186,1739,GO:0045296,DLG1,cadherin binding,3.0
6187,1739,GO:0045930,DLG1,negative regulation of mitotic cell cycle,3.0
6188,1739,GO:0046037,DLG1,GMP metabolic process,3.0
6189,1739,GO:0046710,DLG1,GDP metabolic process,3.0
6190,1739,GO:0048471,DLG1,perinuclear region of cytoplasm,3.0
6191,1739,GO:0048608,DLG1,reproductive structure development,3.0
6192,1739,GO:0048704,DLG1,embryonic skeletal system morphogenesis,3.0
6193,1739,GO:0048745,DLG1,smooth muscle tissue development,3.0
6194,1739,GO:0050680,DLG1,negative regulation of epithelial cell proliferation,3.0
6195,1739,GO:0051660,DLG1,establishment of centrosome localization,3.0
6196,1739,GO:0051898,DLG1,negative regulation of protein kinase B signaling,3.0
6197,1739,GO:0060022,DLG1,hard palate development,3.0
6198,1739,GO:0060090,DLG1,molecular adaptor activity,3.0
6199,1739,GO:0070062,DLG1,extracellular exosome,3.0
6200,1739,GO:0070373,DLG1,negative regulation of ERK1 and ERK2 cascade,3.0
6201,1739,GO:0070830,DLG1,bicellular tight junction assembly,3.0
6202,1739,GO:0072659,DLG1,protein localization to plasma membrane,3.0
6204,1739,GO:0097016,DLG1,L27 domain binding,3.0
6205,1739,GO:0097025,DLG1,MPP7-DLG1-LIN7 complex,3.0
6206,1739,GO:0097060,DLG1,synaptic membrane,3.0
6207,1739,GO:0097120,DLG1,receptor localization to synapse,3.0
6208,1739,GO:0098609,DLG1,cell-cell adhesion,3.0
6210,1739,GO:0098839,DLG1,postsynaptic density membrane,3.0
6211,1739,GO:0098911,DLG1,regulation of ventricular cardiac muscle cell action potential,3.0
6212,1739,GO:0098919,DLG1,structural constituent of postsynaptic density,3.0
6213,1739,GO:0098978,DLG1,glutamatergic synapse,3.0
6214,1739,GO:0099562,DLG1,maintenance of postsynaptic density structure,3.0
6215,1739,GO:0099645,DLG1,neurotransmitter receptor localization to postsynaptic specialization membrane,3.0
6216,1739,GO:1901222,DLG1,regulation of NIK/NF-kappaB signaling,3.0
6217,1739,GO:1902305,DLG1,regulation of sodium ion transmembrane transport,3.0
6218,1739,GO:1902473,DLG1,regulation of protein localization to synapse,3.0
6219,1739,GO:1903078,DLG1,positive regulation of protein localization to plasma membrane,3.0
6220,1739,GO:1903286,DLG1,regulation of potassium ion import,3.0
6221,1739,GO:1903753,DLG1,negative regulation of p38MAPK cascade,3.0
6222,1739,GO:1903760,DLG1,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,3.0
6223,1739,GO:1903764,DLG1,regulation of potassium ion export across plasma membrane,3.0
6224,1739,GO:2000310,DLG1,regulation of NMDA receptor activity,3.0
6348,9228,GO:0005515,DLGAP2,protein binding,3.0
6349,9228,GO:0005883,DLGAP2,neurofilament,3.0
6350,9228,GO:0005886,DLGAP2,plasma membrane,3.0
6351,9228,GO:0007270,DLGAP2,neuron-neuron synaptic transmission,3.0
6352,9228,GO:0014069,DLGAP2,postsynaptic density,3.0
6353,9228,GO:0060090,DLGAP2,molecular adaptor activity,3.0
6354,9228,GO:0098962,DLGAP2,regulation of postsynaptic neurotransmitter receptor activity,3.0
6355,9228,GO:0098978,DLGAP2,glutamatergic synapse,3.0
6356,9228,GO:0099572,DLGAP2,postsynaptic specialization,3.0
6357,58512,GO:0001540,DLGAP3,amyloid-beta binding,3.0
6358,58512,GO:0005515,DLGAP3,protein binding,3.0
6359,58512,GO:0005886,DLGAP3,plasma membrane,3.0
6360,58512,GO:0014069,DLGAP3,postsynaptic density,3.0
6361,58512,GO:0023052,DLGAP3,signaling,3.0
6362,58512,GO:0031594,DLGAP3,neuromuscular junction,3.0
6363,58512,GO:0060090,DLGAP3,molecular adaptor activity,3.0
6364,58512,GO:0098962,DLGAP3,regulation of postsynaptic neurotransmitter receptor activity,3.0
6365,58512,GO:0098978,DLGAP3,glutamatergic synapse,3.0
6366,58512,GO:0098981,DLGAP3,cholinergic synapse,3.0
6367,58512,GO:0099572,DLGAP3,postsynaptic specialization,3.0
6368,28514,GO:0001709,DLL1,cell fate determination,3.0
6369,28514,GO:0001756,DLL1,somitogenesis,3.0
6370,28514,GO:0001757,DLL1,somite specification,3.0
6371,28514,GO:0001947,DLL1,heart looping,3.0
6372,28514,GO:0002315,DLL1,marginal zone B cell differentiation,3.0
6373,28514,GO:0003323,DLL1,type B pancreatic cell development,3.0
6374,28514,GO:0005112,DLL1,Notch binding,3.0
6376,28514,GO:0005509,DLL1,calcium ion binding,3.0
6377,28514,GO:0005515,DLL1,protein binding,3.0
6378,28514,GO:0005576,DLL1,extracellular region,3.0
6379,28514,GO:0005886,DLL1,plasma membrane,3.0
6381,28514,GO:0005887,DLL1,integral component of plasma membrane,3.0
6382,28514,GO:0005912,DLL1,adherens junction,3.0
6383,28514,GO:0007219,DLL1,Notch signaling pathway,3.0
6387,28514,GO:0007368,DLL1,determination of left/right symmetry,3.0
6388,28514,GO:0007386,DLL1,compartment pattern specification,3.0
6389,28514,GO:0008217,DLL1,regulation of blood pressure,3.0
6390,28514,GO:0008284,DLL1,positive regulation of cell population proliferation,3.0
6391,28514,GO:0008285,DLL1,negative regulation of cell population proliferation,3.0
6392,28514,GO:0009954,DLL1,proximal/distal pattern formation,3.0
6393,28514,GO:0014002,DLL1,astrocyte development,3.0
6394,28514,GO:0014807,DLL1,regulation of somitogenesis,3.0
6395,28514,GO:0016324,DLL1,apical plasma membrane,3.0
6396,28514,GO:0021510,DLL1,spinal cord development,3.0
6397,28514,GO:0021688,DLL1,cerebellar molecular layer formation,3.0
6398,28514,GO:0021693,DLL1,cerebellar Purkinje cell layer structural organization,3.0
6399,28514,GO:0030097,DLL1,hemopoiesis,3.0
6400,28514,GO:0030154,DLL1,cell differentiation,3.0
6401,28514,GO:0030155,DLL1,regulation of cell adhesion,3.0
6402,28514,GO:0030857,DLL1,negative regulation of epithelial cell differentiation,3.0
6403,28514,GO:0030957,DLL1,Tat protein binding,3.0
6404,28514,GO:0031410,DLL1,cytoplasmic vesicle,3.0
6405,28514,GO:0032693,DLL1,negative regulation of interleukin-10 production,3.0
6406,28514,GO:0034351,DLL1,negative regulation of glial cell apoptotic process,3.0
6407,28514,GO:0035265,DLL1,organ growth,3.0
6408,28514,GO:0040008,DLL1,regulation of growth,3.0
6409,28514,GO:0045121,DLL1,membrane raft,3.0
6410,28514,GO:0045596,DLL1,negative regulation of cell differentiation,3.0
6411,28514,GO:0045605,DLL1,negative regulation of epidermal cell differentiation,3.0
6412,28514,GO:0045608,DLL1,negative regulation of inner ear auditory receptor cell differentiation,3.0
6413,28514,GO:0045638,DLL1,negative regulation of myeloid cell differentiation,3.0
6414,28514,GO:0045662,DLL1,negative regulation of myoblast differentiation,3.0
6415,28514,GO:0045665,DLL1,negative regulation of neuron differentiation,3.0
6416,28514,GO:0045746,DLL1,negative regulation of Notch signaling pathway,3.0
6417,28514,GO:0045747,DLL1,positive regulation of Notch signaling pathway,3.0
6418,28514,GO:0045807,DLL1,positive regulation of endocytosis,3.0
6419,28514,GO:0045944,DLL1,positive regulation of transcription by RNA polymerase II,3.0
6420,28514,GO:0046331,DLL1,lateral inhibition,3.0
6421,28514,GO:0048630,DLL1,skeletal muscle tissue growth,3.0
6422,28514,GO:0048631,DLL1,regulation of skeletal muscle tissue growth,3.0
6423,28514,GO:0048633,DLL1,positive regulation of skeletal muscle tissue growth,3.0
6424,28514,GO:0048665,DLL1,neuron fate specification,3.0
6425,28514,GO:0048839,DLL1,inner ear development,3.0
6426,28514,GO:0050767,DLL1,regulation of neurogenesis,3.0
6427,28514,GO:0051302,DLL1,regulation of cell division,3.0
6428,28514,GO:0060041,DLL1,retina development in camera-type eye,3.0
6429,28514,GO:0060042,DLL1,retina morphogenesis in camera-type eye,3.0
6430,28514,GO:0060853,DLL1,Notch signaling pathway involved in arterial endothelial cell fate commitment,3.0
6431,28514,GO:0070986,DLL1,left/right axis specification,3.0
6432,28514,GO:0072006,DLL1,nephron development,3.0
6433,28514,GO:0072014,DLL1,proximal tubule development,3.0
6434,28514,GO:0072070,DLL1,loop of Henle development,3.0
6435,28514,GO:0072583,DLL1,clathrin-dependent endocytosis,3.0
6436,28514,GO:0097009,DLL1,energy homeostasis,3.0
6437,28514,GO:0097102,DLL1,endothelial tip cell fate specification,3.0
6438,28514,GO:0097110,DLL1,scaffold protein binding,3.0
6439,28514,GO:0097150,DLL1,neuronal stem cell population maintenance,3.0
6441,28514,GO:0098773,DLL1,skin epidermis development,3.0
6442,28514,GO:1900746,DLL1,regulation of vascular endothelial growth factor signaling pathway,3.0
6443,28514,GO:1903672,DLL1,positive regulation of sprouting angiogenesis,3.0
6444,28514,GO:2000726,DLL1,negative regulation of cardiac muscle cell differentiation,3.0
6464,1750,GO:0000785,DLX6,chromatin,3.0
6466,1750,GO:0000978,DLX6,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
6467,1750,GO:0000981,DLX6,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
6469,1750,GO:0001501,DLX6,skeletal system development,3.0
6470,1750,GO:0003700,DLX6,DNA-binding transcription factor activity,3.0
6471,1750,GO:0006357,DLX6,regulation of transcription by RNA polymerase II,3.0
6472,1750,GO:0007399,DLX6,nervous system development,3.0
6473,1750,GO:0009790,DLX6,embryo development,3.0
6474,1750,GO:0030154,DLX6,cell differentiation,3.0
6475,1750,GO:0030326,DLX6,embryonic limb morphogenesis,3.0
6476,1750,GO:0030855,DLX6,epithelial cell differentiation,3.0
6477,1750,GO:0042472,DLX6,inner ear morphogenesis,3.0
6478,1750,GO:0048646,DLX6,anatomical structure formation involved in morphogenesis,3.0
6479,1750,GO:0050679,DLX6,positive regulation of epithelial cell proliferation,3.0
6480,1750,GO:0060021,DLX6,roof of mouth development,3.0
6481,1750,GO:0060322,DLX6,head development,3.0
6482,1750,GO:1990837,DLX6,sequence-specific double-stranded DNA binding,3.0
6568,1762,GO:0003674,DMWD,molecular_function,3.0
6569,1762,GO:0005575,DMWD,cellular_component,3.0
6570,1762,GO:0005634,DMWD,nucleus,3.0
6571,1762,GO:0030425,DMWD,dendrite,3.0
6572,1762,GO:0043204,DMWD,perikaryon,3.0
6573,23312,GO:0005615,DMXL2,extracellular space,3.0
6574,23312,GO:0007035,DMXL2,vacuolar acidification,3.0
6575,23312,GO:0008021,DMXL2,synaptic vesicle,3.0
6576,23312,GO:0030672,DMXL2,synaptic vesicle membrane,3.0
6577,23312,GO:0031267,DMXL2,small GTPase binding,3.0
6578,23312,GO:0043291,DMXL2,RAVE complex,3.0
6579,23312,GO:0098992,DMXL2,neuronal dense core vesicle,3.0
6580,196385,GO:0005524,DNAH10,ATP binding,3.0
6581,196385,GO:0005874,DNAH10,microtubule,3.0
6582,196385,GO:0005930,DNAH10,axoneme,3.0
6583,196385,GO:0007018,DNAH10,microtubule-based movement,3.0
6584,196385,GO:0008569,DNAH10,"ATP-dependent microtubule motor activity, minus-end-directed",3.0
6585,196385,GO:0030286,DNAH10,dynein complex,3.0
6586,196385,GO:0045505,DNAH10,dynein intermediate chain binding,3.0
6587,196385,GO:0051959,DNAH10,dynein light intermediate chain binding,3.0
6588,8632,GO:0003341,DNAH17,cilium movement,3.0
6589,8632,GO:0003777,DNAH17,microtubule motor activity,3.0
6590,8632,GO:0005524,DNAH17,ATP binding,3.0
6591,8632,GO:0005858,DNAH17,axonemal dynein complex,3.0
6592,8632,GO:0005874,DNAH17,microtubule,3.0
6593,8632,GO:0005930,DNAH17,axoneme,3.0
6595,8632,GO:0007018,DNAH17,microtubule-based movement,3.0
6596,8632,GO:0008569,DNAH17,"ATP-dependent microtubule motor activity, minus-end-directed",3.0
6597,8632,GO:0030286,DNAH17,dynein complex,3.0
6598,8632,GO:0031514,DNAH17,motile cilium,3.0
6599,8632,GO:0036126,DNAH17,sperm flagellum,3.0
6600,8632,GO:0036157,DNAH17,outer dynein arm,3.0
6601,8632,GO:0036158,DNAH17,outer dynein arm assembly,3.0
6602,8632,GO:0045505,DNAH17,dynein intermediate chain binding,3.0
6603,8632,GO:0051959,DNAH17,dynein light intermediate chain binding,3.0
6604,8632,GO:0060285,DNAH17,cilium-dependent cell motility,3.0
6605,55567,GO:0003777,DNAH3,microtubule motor activity,3.0
6606,55567,GO:0005524,DNAH3,ATP binding,3.0
6607,55567,GO:0005858,DNAH3,axonemal dynein complex,3.0
6608,55567,GO:0005874,DNAH3,microtubule,3.0
6609,55567,GO:0007018,DNAH3,microtubule-based movement,3.0
6610,55567,GO:0008569,DNAH3,"ATP-dependent microtubule motor activity, minus-end-directed",3.0
6611,55567,GO:0030286,DNAH3,dynein complex,3.0
6612,55567,GO:0045505,DNAH3,dynein intermediate chain binding,3.0
6613,55567,GO:0051959,DNAH3,dynein light intermediate chain binding,3.0
6614,55567,GO:0060285,DNAH3,cilium-dependent cell motility,3.0
6615,92737,GO:0001764,DNER,neuron migration,3.0
6616,92737,GO:0004888,DNER,transmembrane signaling receptor activity,3.0
6617,92737,GO:0005112,DNER,Notch binding,3.0
6618,92737,GO:0005509,DNER,calcium ion binding,3.0
6619,92737,GO:0005515,DNER,protein binding,3.0
6620,92737,GO:0005769,DNER,early endosome,3.0
6621,92737,GO:0005886,DNER,plasma membrane,3.0
6622,92737,GO:0006897,DNER,endocytosis,3.0
6623,92737,GO:0007219,DNER,Notch signaling pathway,3.0
6624,92737,GO:0007220,DNER,Notch receptor processing,3.0
6625,92737,GO:0007416,DNER,synapse assembly,3.0
6626,92737,GO:0007417,DNER,central nervous system development,3.0
6627,92737,GO:0010001,DNER,glial cell differentiation,3.0
6628,92737,GO:0016021,DNER,integral component of membrane,3.0
6629,92737,GO:0030276,DNER,clathrin binding,3.0
6630,92737,GO:0030425,DNER,dendrite,3.0
6631,92737,GO:0043025,DNER,neuronal cell body,3.0
6632,92737,GO:0048741,DNER,skeletal muscle fiber development,3.0
6678,1793,GO:0005085,DOCK1,guanyl-nucleotide exchange factor activity,3.0
6680,1793,GO:0005096,DOCK1,GTPase activator activity,3.0
6681,1793,GO:0005515,DOCK1,protein binding,3.0
6682,1793,GO:0005654,DOCK1,nucleoplasm,3.0
6683,1793,GO:0005737,DOCK1,cytoplasm,3.0
6684,1793,GO:0005829,DOCK1,cytosol,3.0
6686,1793,GO:0006911,DOCK1,"phagocytosis, engulfment",3.0
6687,1793,GO:0006915,DOCK1,apoptotic process,3.0
6688,1793,GO:0007165,DOCK1,signal transduction,3.0
6689,1793,GO:0007229,DOCK1,integrin-mediated signaling pathway,3.0
6690,1793,GO:0007264,DOCK1,small GTPase mediated signal transduction,3.0
6691,1793,GO:0007596,DOCK1,blood coagulation,3.0
6692,1793,GO:0010634,DOCK1,positive regulation of epithelial cell migration,3.0
6693,1793,GO:0016020,DOCK1,membrane,3.0
6694,1793,GO:0016477,DOCK1,cell migration,3.0
6695,1793,GO:0016607,DOCK1,nuclear speck,3.0
6696,1793,GO:0017124,DOCK1,SH3 domain binding,3.0
6697,1793,GO:0032045,DOCK1,guanyl-nucleotide exchange factor complex,3.0
6698,1793,GO:0038096,DOCK1,Fc-gamma receptor signaling pathway involved in phagocytosis,3.0
6699,1793,GO:0043547,DOCK1,positive regulation of GTPase activity,3.0
6700,1793,GO:0048010,DOCK1,vascular endothelial growth factor receptor signaling pathway,3.0
6701,1793,GO:1900026,DOCK1,positive regulation of substrate adhesion-dependent cell spreading,3.0
6702,9732,GO:0005085,DOCK4,guanyl-nucleotide exchange factor activity,3.0
6703,9732,GO:0005096,DOCK4,GTPase activator activity,3.0
6704,9732,GO:0005515,DOCK4,protein binding,3.0
6705,9732,GO:0005730,DOCK4,nucleolus,3.0
6706,9732,GO:0005794,DOCK4,Golgi apparatus,3.0
6707,9732,GO:0005829,DOCK4,cytosol,3.0
6708,9732,GO:0005886,DOCK4,plasma membrane,3.0
6709,9732,GO:0007264,DOCK4,small GTPase mediated signal transduction,3.0
6710,9732,GO:0016020,DOCK4,membrane,3.0
6711,9732,GO:0017124,DOCK4,SH3 domain binding,3.0
6712,9732,GO:0030165,DOCK4,PDZ domain binding,3.0
6713,9732,GO:0030971,DOCK4,receptor tyrosine kinase binding,3.0
6714,9732,GO:0031267,DOCK4,small GTPase binding,3.0
6715,9732,GO:0032420,DOCK4,stereocilium,3.0
6716,9732,GO:0032421,DOCK4,stereocilium bundle,3.0
6717,9732,GO:0043547,DOCK4,positive regulation of GTPase activity,3.0
6718,9732,GO:0060326,DOCK4,cell chemotaxis,3.0
6719,9732,GO:1904694,DOCK4,negative regulation of vascular associated smooth muscle contraction,3.0
6720,9732,GO:1904754,DOCK4,positive regulation of vascular associated smooth muscle cell migration,3.0
6760,10072,GO:0005515,DPP3,protein binding,3.0
6761,10072,GO:0005737,DPP3,cytoplasm,3.0
6762,10072,GO:0005829,DPP3,cytosol,3.0
6763,10072,GO:0006508,DPP3,proteolysis,3.0
6764,10072,GO:0008239,DPP3,dipeptidyl-peptidase activity,3.0
6766,10072,GO:0008270,DPP3,zinc ion binding,3.0
6767,10072,GO:0070006,DPP3,metalloaminopeptidase activity,3.0
6768,10072,GO:0070062,DPP3,extracellular exosome,3.0
6769,1803,GO:0001618,DPP4,virus receptor activity,3.0
6770,1803,GO:0001662,DPP4,behavioral fear response,3.0
6771,1803,GO:0001666,DPP4,response to hypoxia,3.0
6772,1803,GO:0002020,DPP4,protease binding,3.0
6773,1803,GO:0004252,DPP4,serine-type endopeptidase activity,3.0
6774,1803,GO:0005102,DPP4,signaling receptor binding,3.0
6775,1803,GO:0005515,DPP4,protein binding,3.0
6776,1803,GO:0005576,DPP4,extracellular region,3.0
6777,1803,GO:0005765,DPP4,lysosomal membrane,3.0
6778,1803,GO:0005886,DPP4,plasma membrane,3.0
6780,1803,GO:0005925,DPP4,focal adhesion,3.0
6781,1803,GO:0006508,DPP4,proteolysis,3.0
6782,1803,GO:0007155,DPP4,cell adhesion,3.0
6783,1803,GO:0008236,DPP4,serine-type peptidase activity,3.0
6784,1803,GO:0008239,DPP4,dipeptidyl-peptidase activity,3.0
6785,1803,GO:0008284,DPP4,positive regulation of cell population proliferation,3.0
6786,1803,GO:0009986,DPP4,cell surface,3.0
6787,1803,GO:0010716,DPP4,negative regulation of extracellular matrix disassembly,3.0
6788,1803,GO:0016020,DPP4,membrane,3.0
6789,1803,GO:0016021,DPP4,integral component of membrane,3.0
6790,1803,GO:0016324,DPP4,apical plasma membrane,3.0
6791,1803,GO:0030027,DPP4,lamellipodium,3.0
6792,1803,GO:0030139,DPP4,endocytic vesicle,3.0
6793,1803,GO:0031258,DPP4,lamellipodium membrane,3.0
6794,1803,GO:0031295,DPP4,T cell costimulation,3.0
6795,1803,GO:0033632,DPP4,regulation of cell-cell adhesion mediated by integrin,3.0
6796,1803,GO:0035641,DPP4,locomotory exploration behavior,3.0
6797,1803,GO:0036343,DPP4,psychomotor behavior,3.0
6798,1803,GO:0042110,DPP4,T cell activation,3.0
6799,1803,GO:0042802,DPP4,identical protein binding,3.0
6800,1803,GO:0042803,DPP4,protein homodimerization activity,3.0
6801,1803,GO:0043542,DPP4,endothelial cell migration,3.0
6802,1803,GO:0045121,DPP4,membrane raft,3.0
6803,1803,GO:0045499,DPP4,chemorepellent activity,3.0
6805,1803,GO:0046581,DPP4,intercellular canaliculus,3.0
6806,1803,GO:0046718,DPP4,viral entry into host cell,3.0
6807,1803,GO:0050796,DPP4,regulation of insulin secretion,3.0
6808,1803,GO:0050919,DPP4,negative chemotaxis,3.0
6809,1803,GO:0070062,DPP4,extracellular exosome,3.0
6810,1803,GO:0071438,DPP4,invadopodium membrane,3.0
6811,1803,GO:0090024,DPP4,negative regulation of neutrophil chemotaxis,3.0
6812,1804,GO:0005886,DPP6,plasma membrane,3.0
6813,1804,GO:0006508,DPP6,proteolysis,3.0
6814,1804,GO:0008076,DPP6,voltage-gated potassium channel complex,3.0
6815,1804,GO:0008236,DPP6,serine-type peptidase activity,3.0
6816,1804,GO:0008239,DPP6,dipeptidyl-peptidase activity,3.0
6817,1804,GO:0015459,DPP6,potassium channel regulator activity,3.0
6819,1804,GO:0016021,DPP6,integral component of membrane,3.0
6820,1804,GO:0072659,DPP6,protein localization to plasma membrane,3.0
6821,1804,GO:1901379,DPP6,regulation of potassium ion transmembrane transport,3.0
6823,1806,GO:0002058,DPYD,uracil binding,3.0
6824,1806,GO:0005515,DPYD,protein binding,3.0
6825,1806,GO:0005737,DPYD,cytoplasm,3.0
6826,1806,GO:0005829,DPYD,cytosol,3.0
6829,1806,GO:0006145,DPYD,purine nucleobase catabolic process,3.0
6830,1806,GO:0006208,DPYD,pyrimidine nucleobase catabolic process,3.0
6832,1806,GO:0006210,DPYD,thymine catabolic process,3.0
6834,1806,GO:0006212,DPYD,uracil catabolic process,3.0
6836,1806,GO:0006214,DPYD,thymidine catabolic process,3.0
6837,1806,GO:0017113,DPYD,dihydropyrimidine dehydrogenase (NADP+) activity,3.0
6841,1806,GO:0019483,DPYD,beta-alanine biosynthetic process,3.0
6842,1806,GO:0042803,DPYD,protein homodimerization activity,3.0
6844,1806,GO:0046135,DPYD,pyrimidine nucleoside catabolic process,3.0
6845,1806,GO:0046872,DPYD,metal ion binding,3.0
6846,1806,GO:0050660,DPYD,flavin adenine dinucleotide binding,3.0
6847,1806,GO:0050661,DPYD,NADP binding,3.0
6849,1806,GO:0051536,DPYD,iron-sulfur cluster binding,3.0
6850,1806,GO:0051539,DPYD,"4 iron, 4 sulfur cluster binding",3.0
6851,1806,GO:0055114,DPYD,oxidation-reduction process,3.0
6871,1809,GO:0004157,DPYSL3,dihydropyrimidinase activity,3.0
6872,1809,GO:0005515,DPYSL3,protein binding,3.0
6873,1809,GO:0005615,DPYSL3,extracellular space,3.0
6874,1809,GO:0005829,DPYSL3,cytosol,3.0
6876,1809,GO:0006208,DPYSL3,pyrimidine nucleobase catabolic process,3.0
6877,1809,GO:0010976,DPYSL3,positive regulation of neuron projection development,3.0
6878,1809,GO:0010977,DPYSL3,negative regulation of neuron projection development,3.0
6879,1809,GO:0017124,DPYSL3,SH3 domain binding,3.0
6880,1809,GO:0030027,DPYSL3,lamellipodium,3.0
6881,1809,GO:0030336,DPYSL3,negative regulation of cell migration,3.0
6882,1809,GO:0030426,DPYSL3,growth cone,3.0
6883,1809,GO:0031005,DPYSL3,filamin binding,3.0
6884,1809,GO:0031941,DPYSL3,filamentous actin,3.0
6885,1809,GO:0035374,DPYSL3,chondroitin sulfate binding,3.0
6886,1809,GO:0042802,DPYSL3,identical protein binding,3.0
6887,1809,GO:0044297,DPYSL3,cell body,3.0
6888,1809,GO:0048666,DPYSL3,neuron development,3.0
6889,1809,GO:0048678,DPYSL3,response to axon injury,3.0
6890,1809,GO:0051017,DPYSL3,actin filament bundle assembly,3.0
6891,1809,GO:0051491,DPYSL3,positive regulation of filopodium assembly,3.0
6892,1809,GO:0051764,DPYSL3,actin crosslink formation,3.0
6894,1809,GO:0070382,DPYSL3,exocytic vesicle,3.0
6895,1809,GO:0071345,DPYSL3,cellular response to cytokine stimulus,3.0
6896,1813,GO:0000139,DRD2,Golgi membrane,3.0
6897,1813,GO:0001591,DRD2,"dopamine neurotransmitter receptor activity, coupled via Gi/Go",3.0
6899,1813,GO:0001659,DRD2,temperature homeostasis,3.0
6900,1813,GO:0001666,DRD2,response to hypoxia,3.0
6901,1813,GO:0001669,DRD2,acrosomal vesicle,3.0
6902,1813,GO:0001933,DRD2,negative regulation of protein phosphorylation,3.0
6903,1813,GO:0001975,DRD2,response to amphetamine,3.0
6904,1813,GO:0001976,DRD2,nervous system process involved in regulation of systemic arterial blood pressure,3.0
6905,1813,GO:0002027,DRD2,regulation of heart rate,3.0
6906,1813,GO:0002028,DRD2,regulation of sodium ion transport,3.0
6907,1813,GO:0002031,DRD2,G protein-coupled receptor internalization,3.0
6908,1813,GO:0002052,DRD2,positive regulation of neuroblast proliferation,3.0
6909,1813,GO:0002092,DRD2,positive regulation of receptor internalization,3.0
6910,1813,GO:0004930,DRD2,G protein-coupled receptor activity,3.0
6911,1813,GO:0005515,DRD2,protein binding,3.0
6912,1813,GO:0005886,DRD2,plasma membrane,3.0
6914,1813,GO:0005887,DRD2,integral component of plasma membrane,3.0
6916,1813,GO:0005929,DRD2,cilium,3.0
6917,1813,GO:0006914,DRD2,autophagy,3.0
6918,1813,GO:0007186,DRD2,G protein-coupled receptor signaling pathway,3.0
6919,1813,GO:0007194,DRD2,negative regulation of adenylate cyclase activity,3.0
6920,1813,GO:0007195,DRD2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,3.0
6922,1813,GO:0007270,DRD2,neuron-neuron synaptic transmission,3.0
6923,1813,GO:0007409,DRD2,axonogenesis,3.0
6924,1813,GO:0007416,DRD2,synapse assembly,3.0
6925,1813,GO:0007608,DRD2,sensory perception of smell,3.0
6926,1813,GO:0007616,DRD2,long-term memory,3.0
6927,1813,GO:0007625,DRD2,grooming behavior,3.0
6928,1813,GO:0007626,DRD2,locomotory behavior,3.0
6929,1813,GO:0007628,DRD2,adult walking behavior,3.0
6930,1813,GO:0008104,DRD2,protein localization,3.0
6931,1813,GO:0008144,DRD2,drug binding,3.0
6932,1813,GO:0008285,DRD2,negative regulation of cell population proliferation,3.0
6933,1813,GO:0008306,DRD2,associative learning,3.0
6934,1813,GO:0008542,DRD2,visual learning,3.0
6935,1813,GO:0009416,DRD2,response to light stimulus,3.0
6936,1813,GO:0009636,DRD2,response to toxic substance,3.0
6937,1813,GO:0010039,DRD2,response to iron ion,3.0
6938,1813,GO:0014059,DRD2,regulation of dopamine secretion,3.0
6939,1813,GO:0014069,DRD2,postsynaptic density,3.0
6940,1813,GO:0014854,DRD2,response to inactivity,3.0
6941,1813,GO:0016055,DRD2,Wnt signaling pathway,3.0
6942,1813,GO:0016328,DRD2,lateral plasma membrane,3.0
6943,1813,GO:0021756,DRD2,striatum development,3.0
6944,1813,GO:0021769,DRD2,orbitofrontal cortex development,3.0
6945,1813,GO:0021853,DRD2,cerebral cortex GABAergic interneuron migration,3.0
6946,1813,GO:0021984,DRD2,adenohypophysis development,3.0
6947,1813,GO:0030139,DRD2,endocytic vesicle,3.0
6948,1813,GO:0030336,DRD2,negative regulation of cell migration,3.0
6949,1813,GO:0030424,DRD2,axon,3.0
6950,1813,GO:0030425,DRD2,dendrite,3.0
6951,1813,GO:0030432,DRD2,peristalsis,3.0
6952,1813,GO:0030672,DRD2,synaptic vesicle membrane,3.0
6953,1813,GO:0031223,DRD2,auditory behavior,3.0
6954,1813,GO:0032147,DRD2,activation of protein kinase activity,3.0
6955,1813,GO:0032228,DRD2,"regulation of synaptic transmission, GABAergic",3.0
6956,1813,GO:0032467,DRD2,positive regulation of cytokinesis,3.0
6957,1813,GO:0032922,DRD2,circadian regulation of gene expression,3.0
6958,1813,GO:0033602,DRD2,negative regulation of dopamine secretion,3.0
6959,1813,GO:0034776,DRD2,response to histamine,3.0
6960,1813,GO:0035094,DRD2,response to nicotine,3.0
6961,1813,GO:0035240,DRD2,dopamine binding,3.0
6962,1813,GO:0035255,DRD2,ionotropic glutamate receptor binding,3.0
6963,1813,GO:0035810,DRD2,positive regulation of urine volume,3.0
6964,1813,GO:0035815,DRD2,positive regulation of renal sodium excretion,3.0
6965,1813,GO:0036126,DRD2,sperm flagellum,3.0
6966,1813,GO:0040018,DRD2,positive regulation of multicellular organism growth,3.0
6967,1813,GO:0042220,DRD2,response to cocaine,3.0
6968,1813,GO:0042321,DRD2,"negative regulation of circadian sleep/wake cycle, sleep",3.0
6969,1813,GO:0042417,DRD2,dopamine metabolic process,3.0
6970,1813,GO:0042493,DRD2,response to drug,3.0
6971,1813,GO:0042756,DRD2,drinking behavior,3.0
6972,1813,GO:0042802,DRD2,identical protein binding,3.0
6973,1813,GO:0043197,DRD2,dendritic spine,3.0
6974,1813,GO:0043204,DRD2,perikaryon,3.0
6975,1813,GO:0043266,DRD2,regulation of potassium ion transport,3.0
6977,1813,GO:0043278,DRD2,response to morphine,3.0
6978,1813,GO:0043473,DRD2,pigmentation,3.0
6979,1813,GO:0043666,DRD2,regulation of phosphoprotein phosphatase activity,3.0
6980,1813,GO:0043679,DRD2,axon terminus,3.0
6981,1813,GO:0044877,DRD2,protein-containing complex binding,3.0
6982,1813,GO:0045745,DRD2,positive regulation of G protein-coupled receptor signaling pathway,3.0
6983,1813,GO:0045776,DRD2,negative regulation of blood pressure,3.0
6984,1813,GO:0045824,DRD2,negative regulation of innate immune response,3.0
6985,1813,GO:0045944,DRD2,positive regulation of transcription by RNA polymerase II,3.0
6986,1813,GO:0046676,DRD2,negative regulation of insulin secretion,3.0
6987,1813,GO:0046717,DRD2,acid secretion,3.0
6988,1813,GO:0048148,DRD2,behavioral response to cocaine,3.0
6989,1813,GO:0048149,DRD2,behavioral response to ethanol,3.0
6990,1813,GO:0048169,DRD2,regulation of long-term neuronal synaptic plasticity,3.0
6991,1813,GO:0048678,DRD2,response to axon injury,3.0
6992,1813,GO:0048755,DRD2,branching morphogenesis of a nerve,3.0
6993,1813,GO:0050482,DRD2,arachidonic acid secretion,3.0
6994,1813,GO:0050709,DRD2,negative regulation of protein secretion,3.0
6995,1813,GO:0051209,DRD2,release of sequestered calcium ion into cytosol,3.0
6996,1813,GO:0051481,DRD2,negative regulation of cytosolic calcium ion concentration,3.0
6997,1813,GO:0051482,DRD2,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,3.0
6998,1813,GO:0051584,DRD2,regulation of dopamine uptake involved in synaptic transmission,3.0
6999,1813,GO:0051586,DRD2,positive regulation of dopamine uptake involved in synaptic transmission,3.0
7000,1813,GO:0051823,DRD2,regulation of synapse structural plasticity,3.0
7001,1813,GO:0051898,DRD2,negative regulation of protein kinase B signaling,3.0
7003,1813,GO:0051967,DRD2,"negative regulation of synaptic transmission, glutamatergic",3.0
7005,1813,GO:0060079,DRD2,excitatory postsynaptic potential,3.0
7006,1813,GO:0060124,DRD2,positive regulation of growth hormone secretion,3.0
7007,1813,GO:0060134,DRD2,prepulse inhibition,3.0
7008,1813,GO:0060158,DRD2,phospholipase C-activating dopamine receptor signaling pathway,3.0
7010,1813,GO:0060160,DRD2,negative regulation of dopamine receptor signaling pathway,3.0
7011,1813,GO:0060170,DRD2,ciliary membrane,3.0
7012,1813,GO:0060548,DRD2,negative regulation of cell death,3.0
7013,1813,GO:0070374,DRD2,positive regulation of ERK1 and ERK2 cascade,3.0
7014,1813,GO:0071880,DRD2,adenylate cyclase-activating adrenergic receptor signaling pathway,3.0
7015,1813,GO:0090325,DRD2,regulation of locomotion involved in locomotory behavior,3.0
7016,1813,GO:0097730,DRD2,non-motile cilium,3.0
7017,1813,GO:0098691,DRD2,dopaminergic synapse,3.0
7018,1813,GO:0098978,DRD2,glutamatergic synapse,3.0
7019,1813,GO:0099056,DRD2,integral component of presynaptic membrane,3.0
7020,1813,GO:0099170,DRD2,postsynaptic modulation of chemical synaptic transmission,3.0
7021,1813,GO:1900168,DRD2,positive regulation of glial cell-derived neurotrophic factor production,3.0
7022,1813,GO:1900273,DRD2,positive regulation of long-term synaptic potentiation,3.0
7023,1813,GO:1901386,DRD2,negative regulation of voltage-gated calcium channel activity,3.0
7024,1813,GO:1990384,DRD2,hyaloid vascular plexus regression,3.0
7025,1813,GO:2000300,DRD2,regulation of synaptic vesicle exocytosis,3.0
7026,1814,GO:0000122,DRD3,negative regulation of transcription by RNA polymerase II,3.0
7027,1814,GO:0001591,DRD3,"dopamine neurotransmitter receptor activity, coupled via Gi/Go",3.0
7030,1814,GO:0001975,DRD3,response to amphetamine,3.0
7031,1814,GO:0002016,DRD3,regulation of blood volume by renin-angiotensin,3.0
7032,1814,GO:0002031,DRD3,G protein-coupled receptor internalization,3.0
7033,1814,GO:0004930,DRD3,G protein-coupled receptor activity,3.0
7034,1814,GO:0005515,DRD3,protein binding,3.0
7035,1814,GO:0005886,DRD3,plasma membrane,3.0
7037,1814,GO:0005887,DRD3,integral component of plasma membrane,3.0
7040,1814,GO:0006874,DRD3,cellular calcium ion homeostasis,3.0
7041,1814,GO:0006914,DRD3,autophagy,3.0
7042,1814,GO:0007186,DRD3,G protein-coupled receptor signaling pathway,3.0
7044,1814,GO:0007191,DRD3,adenylate cyclase-activating dopamine receptor signaling pathway,3.0
7045,1814,GO:0007194,DRD3,negative regulation of adenylate cyclase activity,3.0
7046,1814,GO:0007195,DRD3,adenylate cyclase-inhibiting dopamine receptor signaling pathway,3.0
7048,1814,GO:0007611,DRD3,learning or memory,3.0
7049,1814,GO:0007612,DRD3,learning,3.0
7050,1814,GO:0007626,DRD3,locomotory behavior,3.0
7051,1814,GO:0008144,DRD3,drug binding,3.0
7052,1814,GO:0008284,DRD3,positive regulation of cell population proliferation,3.0
7053,1814,GO:0008542,DRD3,visual learning,3.0
7054,1814,GO:0014059,DRD3,regulation of dopamine secretion,3.0
7056,1814,GO:0019216,DRD3,regulation of lipid metabolic process,3.0
7057,1814,GO:0019904,DRD3,protein domain specific binding,3.0
7058,1814,GO:0030139,DRD3,endocytic vesicle,3.0
7059,1814,GO:0031748,DRD3,D1 dopamine receptor binding,3.0
7060,1814,GO:0032416,DRD3,negative regulation of sodium:proton antiporter activity,3.0
7061,1814,GO:0032467,DRD3,positive regulation of cytokinesis,3.0
7062,1814,GO:0032922,DRD3,circadian regulation of gene expression,3.0
7063,1814,GO:0034776,DRD3,response to histamine,3.0
7064,1814,GO:0035176,DRD3,social behavior,3.0
7065,1814,GO:0035240,DRD3,dopamine binding,3.0
7066,1814,GO:0035483,DRD3,gastric emptying,3.0
7067,1814,GO:0035815,DRD3,positive regulation of renal sodium excretion,3.0
7068,1814,GO:0040014,DRD3,regulation of multicellular organism growth,3.0
7069,1814,GO:0042220,DRD3,response to cocaine,3.0
7070,1814,GO:0042417,DRD3,dopamine metabolic process,3.0
7071,1814,GO:0042493,DRD3,response to drug,3.0
7072,1814,GO:0042995,DRD3,cell projection,3.0
7073,1814,GO:0043066,DRD3,negative regulation of apoptotic process,3.0
7074,1814,GO:0043266,DRD3,regulation of potassium ion transport,3.0
7075,1814,GO:0043278,DRD3,response to morphine,3.0
7076,1814,GO:0045177,DRD3,apical part of cell,3.0
7077,1814,GO:0045187,DRD3,"regulation of circadian sleep/wake cycle, sleep",3.0
7078,1814,GO:0045471,DRD3,response to ethanol,3.0
7079,1814,GO:0045776,DRD3,negative regulation of blood pressure,3.0
7080,1814,GO:0045840,DRD3,positive regulation of mitotic nuclear division,3.0
7081,1814,GO:0045944,DRD3,positive regulation of transcription by RNA polymerase II,3.0
7082,1814,GO:0046717,DRD3,acid secretion,3.0
7083,1814,GO:0048148,DRD3,behavioral response to cocaine,3.0
7085,1814,GO:0048715,DRD3,negative regulation of oligodendrocyte differentiation,3.0
7086,1814,GO:0050482,DRD3,arachidonic acid secretion,3.0
7087,1814,GO:0050709,DRD3,negative regulation of protein secretion,3.0
7088,1814,GO:0050883,DRD3,"musculoskeletal movement, spinal reflex action",3.0
7089,1814,GO:0051481,DRD3,negative regulation of cytosolic calcium ion concentration,3.0
7090,1814,GO:0051482,DRD3,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,3.0
7091,1814,GO:0051584,DRD3,regulation of dopamine uptake involved in synaptic transmission,3.0
7092,1814,GO:0051898,DRD3,negative regulation of protein kinase B signaling,3.0
7093,1814,GO:0051967,DRD3,"negative regulation of synaptic transmission, glutamatergic",3.0
7094,1814,GO:0060134,DRD3,prepulse inhibition,3.0
7095,1814,GO:0060158,DRD3,phospholipase C-activating dopamine receptor signaling pathway,3.0
7096,1814,GO:0060160,DRD3,negative regulation of dopamine receptor signaling pathway,3.0
7097,1814,GO:0060161,DRD3,positive regulation of dopamine receptor signaling pathway,3.0
7098,1814,GO:0071880,DRD3,adenylate cyclase-activating adrenergic receptor signaling pathway,3.0
7099,1814,GO:0090325,DRD3,regulation of locomotion involved in locomotory behavior,3.0
7100,1814,GO:0098691,DRD3,dopaminergic synapse,3.0
7101,1814,GO:1901386,DRD3,negative regulation of voltage-gated calcium channel activity,3.0
7136,667,GO:0003779,DST,actin binding,3.0
7137,667,GO:0005178,DST,integrin binding,3.0
7138,667,GO:0005198,DST,structural molecule activity,3.0
7139,667,GO:0005509,DST,calcium ion binding,3.0
7140,667,GO:0005515,DST,protein binding,3.0
7141,667,GO:0005604,DST,basement membrane,3.0
7142,667,GO:0005634,DST,nucleus,3.0
7143,667,GO:0005635,DST,nuclear envelope,3.0
7144,667,GO:0005654,DST,nucleoplasm,3.0
7145,667,GO:0005737,DST,cytoplasm,3.0
7147,667,GO:0005789,DST,endoplasmic reticulum membrane,3.0
7148,667,GO:0005829,DST,cytosol,3.0
7150,667,GO:0005882,DST,intermediate filament,3.0
7151,667,GO:0005925,DST,focal adhesion,3.0
7153,667,GO:0005938,DST,cell cortex,3.0
7154,667,GO:0007010,DST,cytoskeleton organization,3.0
7155,667,GO:0007155,DST,cell adhesion,3.0
7156,667,GO:0007229,DST,integrin-mediated signaling pathway,3.0
7157,667,GO:0008017,DST,microtubule binding,3.0
7158,667,GO:0008022,DST,protein C-terminus binding,3.0
7159,667,GO:0008090,DST,retrograde axonal transport,3.0
7160,667,GO:0009611,DST,response to wounding,3.0
7161,667,GO:0009925,DST,basal plasma membrane,3.0
7162,667,GO:0015630,DST,microtubule cytoskeleton,3.0
7163,667,GO:0016020,DST,membrane,3.0
7164,667,GO:0016021,DST,integral component of membrane,3.0
7165,667,GO:0030011,DST,maintenance of cell polarity,3.0
7166,667,GO:0030018,DST,Z disc,3.0
7167,667,GO:0030056,DST,hemidesmosome,3.0
7169,667,GO:0031122,DST,cytoplasmic microtubule organization,3.0
7170,667,GO:0031252,DST,cell leading edge,3.0
7171,667,GO:0031410,DST,cytoplasmic vesicle,3.0
7172,667,GO:0031581,DST,hemidesmosome assembly,3.0
7173,667,GO:0031673,DST,H zone,3.0
7174,667,GO:0035371,DST,microtubule plus-end,3.0
7175,667,GO:0042060,DST,wound healing,3.0
7176,667,GO:0045104,DST,intermediate filament cytoskeleton organization,3.0
7179,667,GO:0048870,DST,cell motility,3.0
7180,667,GO:0051010,DST,microtubule plus-end binding,3.0
7181,667,GO:1904115,DST,axon cytoplasm,3.0
7182,128853,GO:0004725,DUSP15,protein tyrosine phosphatase activity,3.0
7183,128853,GO:0005515,DUSP15,protein binding,3.0
7184,128853,GO:0005829,DUSP15,cytosol,3.0
7186,128853,GO:0005886,DUSP15,plasma membrane,3.0
7187,128853,GO:0007179,DUSP15,transforming growth factor beta receptor signaling pathway,3.0
7188,128853,GO:0008138,DUSP15,protein tyrosine/serine/threonine phosphatase activity,3.0
7189,128853,GO:0016311,DUSP15,dephosphorylation,3.0
7190,128853,GO:0016791,DUSP15,phosphatase activity,3.0
7191,128853,GO:0035335,DUSP15,peptidyl-tyrosine dephosphorylation,3.0
7192,128853,GO:0042127,DUSP15,regulation of cell population proliferation,3.0
7193,128853,GO:0046330,DUSP15,positive regulation of JNK cascade,3.0
7194,128853,GO:0106306,DUSP15,protein serine phosphatase activity,3.0
7195,128853,GO:0106307,DUSP15,protein threonine phosphatase activity,3.0
7196,1857,GO:0000785,DVL3,chromatin,3.0
7197,1857,GO:0001934,DVL3,positive regulation of protein phosphorylation,3.0
7198,1857,GO:0002020,DVL3,protease binding,3.0
7199,1857,GO:0005102,DVL3,signaling receptor binding,3.0
7200,1857,GO:0005109,DVL3,frizzled binding,3.0
7203,1857,GO:0005515,DVL3,protein binding,3.0
7204,1857,GO:0005829,DVL3,cytosol,3.0
7207,1857,GO:0008013,DVL3,beta-catenin binding,3.0
7208,1857,GO:0031267,DVL3,small GTPase binding,3.0
7209,1857,GO:0035556,DVL3,intracellular signal transduction,3.0
7210,1857,GO:0035567,DVL3,non-canonical Wnt signaling pathway,3.0
7212,1857,GO:0038031,DVL3,non-canonical Wnt signaling pathway via JNK cascade,3.0
7213,1857,GO:0042493,DVL3,response to drug,3.0
7214,1857,GO:0043507,DVL3,positive regulation of JUN kinase activity,3.0
7215,1857,GO:0043547,DVL3,positive regulation of GTPase activity,3.0
7216,1857,GO:0045893,DVL3,"positive regulation of transcription, DNA-templated",3.0
7217,1857,GO:0045944,DVL3,positive regulation of transcription by RNA polymerase II,3.0
7218,1857,GO:0050821,DVL3,protein stabilization,3.0
7219,1857,GO:0060070,DVL3,canonical Wnt signaling pathway,3.0
7224,1857,GO:0060071,DVL3,"Wnt signaling pathway, planar cell polarity pathway",3.0
7226,1857,GO:0090090,DVL3,negative regulation of canonical Wnt signaling pathway,3.0
7227,1857,GO:0090179,DVL3,planar cell polarity pathway involved in neural tube closure,3.0
7228,1857,GO:0150012,DVL3,positive regulation of neuron projection arborization,3.0
7229,1857,GO:1903827,DVL3,regulation of cellular protein localization,3.0
7230,1857,GO:1904886,DVL3,beta-catenin destruction complex disassembly,3.0
7231,143241,GO:0000781,DYDC1,"chromosome, telomeric region",3.0
7232,143241,GO:0005515,DYDC1,protein binding,3.0
7233,143241,GO:0006348,DYDC1,chromatin silencing at telomere,3.0
7234,143241,GO:0044666,DYDC1,MLL3/4 complex,3.0
7235,143241,GO:0048188,DYDC1,Set1C/COMPASS complex,3.0
7236,143241,GO:0051568,DYDC1,histone H3-K4 methylation,3.0
7237,84332,GO:0000781,DYDC2,"chromosome, telomeric region",3.0
7238,84332,GO:0005515,DYDC2,protein binding,3.0
7239,84332,GO:0006348,DYDC2,chromatin silencing at telomere,3.0
7240,84332,GO:0044666,DYDC2,MLL3/4 complex,3.0
7241,84332,GO:0048188,DYDC2,Set1C/COMPASS complex,3.0
7242,84332,GO:0051568,DYDC2,histone H3-K4 methylation,3.0
7341,1644,GO:0004058,DDC,aromatic-L-amino-acid decarboxylase activity,3.0
7343,1644,GO:0005515,DDC,protein binding,3.0
7344,1644,GO:0005737,DDC,cytoplasm,3.0
7345,1644,GO:0005829,DDC,cytosol,3.0
7346,1644,GO:0006520,DDC,cellular amino acid metabolic process,3.0
7347,1644,GO:0006584,DDC,catecholamine metabolic process,3.0
7348,1644,GO:0007623,DDC,circadian rhythm,3.0
7349,1644,GO:0008021,DDC,synaptic vesicle,3.0
7350,1644,GO:0010259,DDC,multicellular organism aging,3.0
7351,1644,GO:0015842,DDC,aminergic neurotransmitter loading into synaptic vesicle,3.0
7352,1644,GO:0016597,DDC,amino acid binding,3.0
7353,1644,GO:0016831,DDC,carboxy-lyase activity,3.0
7354,1644,GO:0019899,DDC,enzyme binding,3.0
7355,1644,GO:0019904,DDC,protein domain specific binding,3.0
7356,1644,GO:0030170,DDC,pyridoxal phosphate binding,3.0
7357,1644,GO:0030424,DDC,axon,3.0
7358,1644,GO:0033076,DDC,isoquinoline alkaloid metabolic process,3.0
7359,1644,GO:0035690,DDC,cellular response to drug,3.0
7360,1644,GO:0036468,DDC,L-dopa decarboxylase activity,3.0
7361,1644,GO:0042416,DDC,dopamine biosynthetic process,3.0
7362,1644,GO:0042423,DDC,catecholamine biosynthetic process,3.0
7363,1644,GO:0042427,DDC,serotonin biosynthetic process,3.0
7364,1644,GO:0043025,DDC,neuronal cell body,3.0
7365,1644,GO:0046219,DDC,indolalkylamine biosynthetic process,3.0
7366,1644,GO:0046684,DDC,response to pyrethroid,3.0
7367,1644,GO:0052314,DDC,phytoalexin metabolic process,3.0
7368,1644,GO:0070062,DDC,extracellular exosome,3.0
7369,1644,GO:0071312,DDC,cellular response to alkaloid,3.0
7370,1644,GO:0071363,DDC,cellular response to growth factor stimulus,3.0
7371,1746,GO:0000122,DLX2,negative regulation of transcription by RNA polymerase II,3.0
7372,1746,GO:0000785,DLX2,chromatin,3.0
7374,1746,GO:0000978,DLX2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
7375,1746,GO:0000981,DLX2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
7377,1746,GO:0001228,DLX2,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
7378,1746,GO:0003682,DLX2,chromatin binding,3.0
7379,1746,GO:0003700,DLX2,DNA-binding transcription factor activity,3.0
7380,1746,GO:0003727,DLX2,single-stranded RNA binding,3.0
7381,1746,GO:0005515,DLX2,protein binding,3.0
7382,1746,GO:0006357,DLX2,regulation of transcription by RNA polymerase II,3.0
7383,1746,GO:0007420,DLX2,brain development,3.0
7384,1746,GO:0009790,DLX2,embryo development,3.0
7385,1746,GO:0009954,DLX2,proximal/distal pattern formation,3.0
7386,1746,GO:0021544,DLX2,subpallium development,3.0
7387,1746,GO:0021766,DLX2,hippocampus development,3.0
7388,1746,GO:0021772,DLX2,olfactory bulb development,3.0
7389,1746,GO:0021893,DLX2,cerebral cortex GABAergic interneuron fate commitment,3.0
7390,1746,GO:0030154,DLX2,cell differentiation,3.0
7391,1746,GO:0042475,DLX2,odontogenesis of dentin-containing tooth,3.0
7392,1746,GO:0045597,DLX2,positive regulation of cell differentiation,3.0
7393,1746,GO:0045746,DLX2,negative regulation of Notch signaling pathway,3.0
7394,1746,GO:0045944,DLX2,positive regulation of transcription by RNA polymerase II,3.0
7395,1746,GO:0046533,DLX2,negative regulation of photoreceptor cell differentiation,3.0
7396,1746,GO:0048701,DLX2,embryonic cranial skeleton morphogenesis,3.0
7397,1746,GO:0048715,DLX2,negative regulation of oligodendrocyte differentiation,3.0
7398,1746,GO:0048755,DLX2,branching morphogenesis of a nerve,3.0
7399,1746,GO:0051216,DLX2,cartilage development,3.0
7400,1746,GO:1902871,DLX2,positive regulation of amacrine cell differentiation,3.0
7401,1746,GO:1990837,DLX2,sequence-specific double-stranded DNA binding,3.0
7402,1812,GO:0001588,DRD1,"dopamine neurotransmitter receptor activity, coupled via Gs",3.0
7405,1812,GO:0001659,DRD1,temperature homeostasis,3.0
7406,1812,GO:0001661,DRD1,conditioned taste aversion,3.0
7407,1812,GO:0001662,DRD1,behavioral fear response,3.0
7408,1812,GO:0001932,DRD1,regulation of protein phosphorylation,3.0
7409,1812,GO:0001963,DRD1,"synaptic transmission, dopaminergic",3.0
7410,1812,GO:0001975,DRD1,response to amphetamine,3.0
7411,1812,GO:0004930,DRD1,G protein-coupled receptor activity,3.0
7412,1812,GO:0004952,DRD1,dopamine neurotransmitter receptor activity,3.0
7413,1812,GO:0005515,DRD1,protein binding,3.0
7414,1812,GO:0005634,DRD1,nucleus,3.0
7415,1812,GO:0005789,DRD1,endoplasmic reticulum membrane,3.0
7416,1812,GO:0005886,DRD1,plasma membrane,3.0
7418,1812,GO:0005887,DRD1,integral component of plasma membrane,3.0
7420,1812,GO:0005929,DRD1,cilium,3.0
7421,1812,GO:0006606,DRD1,protein import into nucleus,3.0
7422,1812,GO:0007186,DRD1,G protein-coupled receptor signaling pathway,3.0
7423,1812,GO:0007187,DRD1,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",3.0
7424,1812,GO:0007189,DRD1,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
7425,1812,GO:0007190,DRD1,activation of adenylate cyclase activity,3.0
7426,1812,GO:0007191,DRD1,adenylate cyclase-activating dopamine receptor signaling pathway,3.0
7427,1812,GO:0007212,DRD1,dopamine receptor signaling pathway,3.0
7428,1812,GO:0007416,DRD1,synapse assembly,3.0
7429,1812,GO:0007613,DRD1,memory,3.0
7430,1812,GO:0007617,DRD1,mating behavior,3.0
7431,1812,GO:0007625,DRD1,grooming behavior,3.0
7432,1812,GO:0007628,DRD1,adult walking behavior,3.0
7433,1812,GO:0008542,DRD1,visual learning,3.0
7434,1812,GO:0010628,DRD1,positive regulation of gene expression,3.0
7435,1812,GO:0014002,DRD1,astrocyte development,3.0
7436,1812,GO:0015872,DRD1,dopamine transport,3.0
7437,1812,GO:0019226,DRD1,transmission of nerve impulse,3.0
7438,1812,GO:0019228,DRD1,neuronal action potential,3.0
7439,1812,GO:0021542,DRD1,dentate gyrus development,3.0
7440,1812,GO:0021756,DRD1,striatum development,3.0
7441,1812,GO:0021853,DRD1,cerebral cortex GABAergic interneuron migration,3.0
7442,1812,GO:0030335,DRD1,positive regulation of cell migration,3.0
7443,1812,GO:0030432,DRD1,peristalsis,3.0
7444,1812,GO:0035106,DRD1,operant conditioning,3.0
7445,1812,GO:0035240,DRD1,dopamine binding,3.0
7446,1812,GO:0042053,DRD1,regulation of dopamine metabolic process,3.0
7447,1812,GO:0042311,DRD1,vasodilation,3.0
7448,1812,GO:0042417,DRD1,dopamine metabolic process,3.0
7449,1812,GO:0042493,DRD1,response to drug,3.0
7450,1812,GO:0042711,DRD1,maternal behavior,3.0
7451,1812,GO:0043197,DRD1,dendritic spine,3.0
7452,1812,GO:0043268,DRD1,positive regulation of potassium ion transport,3.0
7453,1812,GO:0043987,DRD1,histone H3-S10 phosphorylation,3.0
7454,1812,GO:0046323,DRD1,glucose import,3.0
7455,1812,GO:0046959,DRD1,habituation,3.0
7456,1812,GO:0046960,DRD1,sensitization,3.0
7457,1812,GO:0048148,DRD1,behavioral response to cocaine,3.0
7458,1812,GO:0051281,DRD1,positive regulation of release of sequestered calcium ion into cytosol,3.0
7459,1812,GO:0051482,DRD1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,3.0
7460,1812,GO:0051584,DRD1,regulation of dopamine uptake involved in synaptic transmission,3.0
7461,1812,GO:0051968,DRD1,"positive regulation of synaptic transmission, glutamatergic",3.0
7462,1812,GO:0060134,DRD1,prepulse inhibition,3.0
7463,1812,GO:0060158,DRD1,phospholipase C-activating dopamine receptor signaling pathway,3.0
7465,1812,GO:0060170,DRD1,ciliary membrane,3.0
7466,1812,GO:0060291,DRD1,long-term synaptic potentiation,3.0
7467,1812,GO:0060292,DRD1,long-term synaptic depression,3.0
7468,1812,GO:0071870,DRD1,cellular response to catecholamine stimulus,3.0
7469,1812,GO:0071880,DRD1,adenylate cyclase-activating adrenergic receptor signaling pathway,3.0
7470,1812,GO:0097730,DRD1,non-motile cilium,3.0
7471,1812,GO:1903351,DRD1,cellular response to dopamine,3.0
7472,1812,GO:2000300,DRD1,regulation of synaptic vesicle exocytosis,3.0
7510,1960,GO:0000785,EGR3,chromatin,3.0
7512,1960,GO:0000978,EGR3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
7513,1960,GO:0000981,EGR3,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
7515,1960,GO:0001228,EGR3,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
7516,1960,GO:0001938,EGR3,positive regulation of endothelial cell proliferation,3.0
7517,1960,GO:0002042,EGR3,cell migration involved in sprouting angiogenesis,3.0
7518,1960,GO:0003700,EGR3,DNA-binding transcription factor activity,3.0
7519,1960,GO:0006357,EGR3,regulation of transcription by RNA polymerase II,3.0
7520,1960,GO:0007274,EGR3,neuromuscular synaptic transmission,3.0
7521,1960,GO:0007422,EGR3,peripheral nervous system development,3.0
7522,1960,GO:0007517,EGR3,muscle organ development,3.0
7523,1960,GO:0007623,EGR3,circadian rhythm,3.0
7524,1960,GO:0033089,EGR3,positive regulation of T cell differentiation in thymus,3.0
7525,1960,GO:0035767,EGR3,endothelial cell chemotaxis,3.0
7526,1960,GO:0035924,EGR3,cellular response to vascular endothelial growth factor stimulus,3.0
7527,1960,GO:0043066,EGR3,negative regulation of apoptotic process,3.0
7528,1960,GO:0044344,EGR3,cellular response to fibroblast growth factor stimulus,3.0
7529,1960,GO:0045202,EGR3,synapse,3.0
7530,1960,GO:0045586,EGR3,regulation of gamma-delta T cell differentiation,3.0
7531,1960,GO:0045944,EGR3,positive regulation of transcription by RNA polymerase II,3.0
7532,1960,GO:0046872,EGR3,metal ion binding,3.0
7533,1960,GO:1990837,EGR3,sequence-specific double-stranded DNA binding,3.0
7605,1977,GO:0000082,EIF4E,G1/S transition of mitotic cell cycle,3.0
7606,1977,GO:0000339,EIF4E,RNA cap binding,3.0
7607,1977,GO:0000340,EIF4E,RNA 7-methylguanosine cap binding,3.0
7609,1977,GO:0000932,EIF4E,P-body,3.0
7610,1977,GO:0001662,EIF4E,behavioral fear response,3.0
7611,1977,GO:0003723,EIF4E,RNA binding,3.0
7612,1977,GO:0003743,EIF4E,translation initiation factor activity,3.0
7615,1977,GO:0005515,EIF4E,protein binding,3.0
7616,1977,GO:0005634,EIF4E,nucleus,3.0
7617,1977,GO:0005737,EIF4E,cytoplasm,3.0
7618,1977,GO:0005829,EIF4E,cytosol,3.0
7620,1977,GO:0005845,EIF4E,mRNA cap binding complex,3.0
7621,1977,GO:0006405,EIF4E,RNA export from nucleus,3.0
7622,1977,GO:0006406,EIF4E,mRNA export from nucleus,3.0
7623,1977,GO:0006413,EIF4E,translational initiation,3.0
7624,1977,GO:0006417,EIF4E,regulation of translation,3.0
7625,1977,GO:0010494,EIF4E,cytoplasmic stress granule,3.0
7626,1977,GO:0010507,EIF4E,negative regulation of autophagy,3.0
7627,1977,GO:0016032,EIF4E,viral process,3.0
7628,1977,GO:0016281,EIF4E,eukaryotic translation initiation factor 4F complex,3.0
7630,1977,GO:0016442,EIF4E,RISC complex,3.0
7631,1977,GO:0017148,EIF4E,negative regulation of translation,3.0
7632,1977,GO:0019827,EIF4E,stem cell population maintenance,3.0
7633,1977,GO:0019899,EIF4E,enzyme binding,3.0
7634,1977,GO:0030324,EIF4E,lung development,3.0
7635,1977,GO:0031370,EIF4E,eukaryotic initiation factor 4G binding,3.0
7636,1977,GO:0033391,EIF4E,chromatoid body,3.0
7637,1977,GO:0036464,EIF4E,cytoplasmic ribonucleoprotein granule,3.0
7638,1977,GO:0045665,EIF4E,negative regulation of neuron differentiation,3.0
7639,1977,GO:0045931,EIF4E,positive regulation of mitotic cell cycle,3.0
7640,1977,GO:0048471,EIF4E,perinuclear region of cytoplasm,3.0
7641,1977,GO:0070062,EIF4E,extracellular exosome,3.0
7642,1977,GO:0070491,EIF4E,repressing transcription factor binding,3.0
7643,1977,GO:0071549,EIF4E,cellular response to dexamethasone stimulus,3.0
7644,1977,GO:0098978,EIF4E,glutamatergic synapse,3.0
7645,1977,GO:0099524,EIF4E,postsynaptic cytosol,3.0
7646,1981,GO:0000184,EIF4G1,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.0
7647,1981,GO:0001662,EIF4G1,behavioral fear response,3.0
7648,1981,GO:0002191,EIF4G1,cap-dependent translational initiation,3.0
7649,1981,GO:0003723,EIF4G1,RNA binding,3.0
7651,1981,GO:0003729,EIF4G1,mRNA binding,3.0
7653,1981,GO:0003743,EIF4G1,translation initiation factor activity,3.0
7655,1981,GO:0005515,EIF4G1,protein binding,3.0
7656,1981,GO:0005524,EIF4G1,ATP binding,3.0
7657,1981,GO:0005634,EIF4G1,nucleus,3.0
7658,1981,GO:0005737,EIF4G1,cytoplasm,3.0
7660,1981,GO:0005829,EIF4G1,cytosol,3.0
7662,1981,GO:0005844,EIF4G1,polysome,3.0
7663,1981,GO:0006412,EIF4G1,translation,3.0
7665,1981,GO:0006413,EIF4G1,translational initiation,3.0
7667,1981,GO:0006446,EIF4G1,regulation of translational initiation,3.0
7669,1981,GO:0008135,EIF4G1,"translation factor activity, RNA binding",3.0
7670,1981,GO:0008190,EIF4G1,eukaryotic initiation factor 4E binding,3.0
7672,1981,GO:0010494,EIF4G1,cytoplasmic stress granule,3.0
7673,1981,GO:0010507,EIF4G1,negative regulation of autophagy,3.0
7674,1981,GO:0010801,EIF4G1,negative regulation of peptidyl-threonine phosphorylation,3.0
7675,1981,GO:0010942,EIF4G1,positive regulation of cell death,3.0
7676,1981,GO:0016020,EIF4G1,membrane,3.0
7677,1981,GO:0016032,EIF4G1,viral process,3.0
7678,1981,GO:0016281,EIF4G1,eukaryotic translation initiation factor 4F complex,3.0
7680,1981,GO:0030307,EIF4G1,positive regulation of cell growth,3.0
7681,1981,GO:0031369,EIF4G1,translation initiation factor binding,3.0
7682,1981,GO:0031669,EIF4G1,cellular response to nutrient levels,3.0
7683,1981,GO:0032270,EIF4G1,positive regulation of cellular protein metabolic process,3.0
7684,1981,GO:0032502,EIF4G1,developmental process,3.0
7685,1981,GO:0033138,EIF4G1,positive regulation of peptidyl-serine phosphorylation,3.0
7686,1981,GO:0034645,EIF4G1,cellular macromolecule biosynthetic process,3.0
7687,1981,GO:0036493,EIF4G1,positive regulation of translation in response to endoplasmic reticulum stress,3.0
7688,1981,GO:0042802,EIF4G1,identical protein binding,3.0
7689,1981,GO:0043488,EIF4G1,regulation of mRNA stability,3.0
7690,1981,GO:0045666,EIF4G1,positive regulation of neuron differentiation,3.0
7691,1981,GO:0060090,EIF4G1,molecular adaptor activity,3.0
7692,1981,GO:0060964,EIF4G1,regulation of gene silencing by miRNA,3.0
7693,1981,GO:0080135,EIF4G1,regulation of cellular response to stress,3.0
7694,1981,GO:0097009,EIF4G1,energy homeostasis,3.0
7695,1981,GO:1900087,EIF4G1,positive regulation of G1/S transition of mitotic cell cycle,3.0
7696,1981,GO:1901215,EIF4G1,negative regulation of neuron death,3.0
7697,1981,GO:1905537,EIF4G1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,3.0
7698,1981,GO:1905606,EIF4G1,regulation of presynapse assembly,3.0
7699,1981,GO:1905612,EIF4G1,positive regulation of mRNA cap binding,3.0
7700,1981,GO:1905618,EIF4G1,positive regulation of miRNA mediated inhibition of translation,3.0
7701,1981,GO:1905696,EIF4G1,regulation of polysome binding,3.0
7702,1993,GO:0000398,ELAVL2,"mRNA splicing, via spliceosome",3.0
7703,1993,GO:0003723,ELAVL2,RNA binding,3.0
7704,1993,GO:0003730,ELAVL2,mRNA 3'-UTR binding,3.0
7705,1993,GO:0005515,ELAVL2,protein binding,3.0
7706,1993,GO:0005654,ELAVL2,nucleoplasm,3.0
7707,1993,GO:0006355,ELAVL2,"regulation of transcription, DNA-templated",3.0
7708,1993,GO:1990904,ELAVL2,ribonucleoprotein complex,3.0
7729,2020,GO:0000785,EN2,chromatin,3.0
7730,2020,GO:0000978,EN2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
7731,2020,GO:0000981,EN2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
7733,2020,GO:0001650,EN2,fibrillar center,3.0
7734,2020,GO:0005634,EN2,nucleus,3.0
7735,2020,GO:0005654,EN2,nucleoplasm,3.0
7736,2020,GO:0005730,EN2,nucleolus,3.0
7737,2020,GO:0006357,EN2,regulation of transcription by RNA polymerase II,3.0
7738,2020,GO:0007275,EN2,multicellular organism development,3.0
7739,2020,GO:0016020,EN2,membrane,3.0
7740,2020,GO:0030182,EN2,neuron differentiation,3.0
7741,2020,GO:0030901,EN2,midbrain development,3.0
7742,2020,GO:0030902,EN2,hindbrain development,3.0
7743,2020,GO:0043524,EN2,negative regulation of neuron apoptotic process,3.0
7744,2020,GO:0045944,EN2,positive regulation of transcription by RNA polymerase II,3.0
7745,2020,GO:0048666,EN2,neuron development,3.0
7746,2020,GO:1990403,EN2,embryonic brain development,3.0
7747,2020,GO:1990837,EN2,sequence-specific double-stranded DNA binding,3.0
7890,26122,GO:0004402,EPC2,histone acetyltransferase activity,3.0
7891,26122,GO:0006281,EPC2,DNA repair,3.0
7892,26122,GO:0006357,EPC2,regulation of transcription by RNA polymerase II,3.0
7893,26122,GO:0016573,EPC2,histone acetylation,3.0
7894,26122,GO:0032777,EPC2,Piccolo NuA4 histone acetyltransferase complex,3.0
7895,2048,GO:0001525,EPHB2,angiogenesis,3.0
7896,2048,GO:0001540,EPHB2,amyloid-beta binding,3.0
7898,2048,GO:0001655,EPHB2,urogenital system development,3.0
7899,2048,GO:0001933,EPHB2,negative regulation of protein phosphorylation,3.0
7900,2048,GO:0004713,EPHB2,protein tyrosine kinase activity,3.0
7901,2048,GO:0004714,EPHB2,transmembrane receptor protein tyrosine kinase activity,3.0
7902,2048,GO:0005005,EPHB2,transmembrane-ephrin receptor activity,3.0
7905,2048,GO:0005102,EPHB2,signaling receptor binding,3.0
7906,2048,GO:0005515,EPHB2,protein binding,3.0
7907,2048,GO:0005524,EPHB2,ATP binding,3.0
7908,2048,GO:0005576,EPHB2,extracellular region,3.0
7909,2048,GO:0005654,EPHB2,nucleoplasm,3.0
7910,2048,GO:0005829,EPHB2,cytosol,3.0
7911,2048,GO:0005886,EPHB2,plasma membrane,3.0
7913,2048,GO:0005887,EPHB2,integral component of plasma membrane,3.0
7915,2048,GO:0007169,EPHB2,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
7916,2048,GO:0007275,EPHB2,multicellular organism development,3.0
7917,2048,GO:0007399,EPHB2,nervous system development,3.0
7918,2048,GO:0007411,EPHB2,axon guidance,3.0
7920,2048,GO:0007413,EPHB2,axonal fasciculation,3.0
7921,2048,GO:0007611,EPHB2,learning or memory,3.0
7922,2048,GO:0007612,EPHB2,learning,3.0
7923,2048,GO:0008046,EPHB2,axon guidance receptor activity,3.0
7924,2048,GO:0010628,EPHB2,positive regulation of gene expression,3.0
7925,2048,GO:0016310,EPHB2,phosphorylation,3.0
7926,2048,GO:0018108,EPHB2,peptidyl-tyrosine phosphorylation,3.0
7927,2048,GO:0021631,EPHB2,optic nerve morphogenesis,3.0
7928,2048,GO:0021952,EPHB2,central nervous system projection neuron axonogenesis,3.0
7929,2048,GO:0022038,EPHB2,corpus callosum development,3.0
7930,2048,GO:0030193,EPHB2,regulation of blood coagulation,3.0
7931,2048,GO:0030424,EPHB2,axon,3.0
7932,2048,GO:0030425,EPHB2,dendrite,3.0
7933,2048,GO:0031290,EPHB2,retinal ganglion cell axon guidance,3.0
7934,2048,GO:0031915,EPHB2,positive regulation of synaptic plasticity,3.0
7935,2048,GO:0033674,EPHB2,positive regulation of kinase activity,3.0
7936,2048,GO:0042472,EPHB2,inner ear morphogenesis,3.0
7937,2048,GO:0042802,EPHB2,identical protein binding,3.0
7938,2048,GO:0043005,EPHB2,neuron projection,3.0
7939,2048,GO:0043025,EPHB2,neuronal cell body,3.0
7940,2048,GO:0043235,EPHB2,receptor complex,3.0
7941,2048,GO:0044877,EPHB2,protein-containing complex binding,3.0
7942,2048,GO:0046580,EPHB2,negative regulation of Ras protein signal transduction,3.0
7943,2048,GO:0048013,EPHB2,ephrin receptor signaling pathway,3.0
7945,2048,GO:0048168,EPHB2,regulation of neuronal synaptic plasticity,3.0
7946,2048,GO:0048170,EPHB2,positive regulation of long-term neuronal synaptic plasticity,3.0
7947,2048,GO:0048593,EPHB2,camera-type eye morphogenesis,3.0
7948,2048,GO:0050771,EPHB2,negative regulation of axonogenesis,3.0
7949,2048,GO:0050878,EPHB2,regulation of body fluid levels,3.0
7950,2048,GO:0051389,EPHB2,inactivation of MAPKK activity,3.0
7951,2048,GO:0051965,EPHB2,positive regulation of synapse assembly,3.0
7952,2048,GO:0060021,EPHB2,roof of mouth development,3.0
7953,2048,GO:0060996,EPHB2,dendritic spine development,3.0
7954,2048,GO:0060997,EPHB2,dendritic spine morphogenesis,3.0
7955,2048,GO:0070373,EPHB2,negative regulation of ERK1 and ERK2 cascade,3.0
7956,2048,GO:0071679,EPHB2,commissural neuron axon guidance,3.0
7957,2048,GO:0098794,EPHB2,postsynapse,3.0
7958,2048,GO:0099557,EPHB2,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission",3.0
7959,2048,GO:0106028,EPHB2,neuron projection retraction,3.0
7960,2048,GO:1900273,EPHB2,positive regulation of long-term synaptic potentiation,3.0
7961,2048,GO:1903078,EPHB2,positive regulation of protein localization to plasma membrane,3.0
7962,2048,GO:1904782,EPHB2,negative regulation of NMDA glutamate receptor activity,3.0
7963,2048,GO:1904783,EPHB2,positive regulation of NMDA glutamate receptor activity,3.0
7964,83481,GO:0003723,EPPK1,RNA binding,3.0
7965,83481,GO:0005198,EPPK1,structural molecule activity,3.0
7966,83481,GO:0005737,EPPK1,cytoplasm,3.0
7967,83481,GO:0005856,EPPK1,cytoskeleton,3.0
7968,83481,GO:0005882,EPPK1,intermediate filament,3.0
7969,83481,GO:0005923,EPPK1,bicellular tight junction,3.0
7970,83481,GO:0010839,EPPK1,negative regulation of keratinocyte proliferation,3.0
7971,83481,GO:0016020,EPPK1,membrane,3.0
7972,83481,GO:0016323,EPPK1,basolateral plasma membrane,3.0
7973,83481,GO:0016327,EPPK1,apicolateral plasma membrane,3.0
7974,83481,GO:0019215,EPPK1,intermediate filament binding,3.0
7975,83481,GO:0030054,EPPK1,cell junction,3.0
7976,83481,GO:0030056,EPPK1,hemidesmosome,3.0
7977,83481,GO:0030336,EPPK1,negative regulation of cell migration,3.0
7978,83481,GO:0042060,EPPK1,wound healing,3.0
7980,83481,GO:0042995,EPPK1,cell projection,3.0
7981,83481,GO:0045095,EPPK1,keratin filament,3.0
7983,83481,GO:0045104,EPPK1,intermediate filament cytoskeleton organization,3.0
7984,83481,GO:0045109,EPPK1,intermediate filament organization,3.0
7987,83481,GO:0045110,EPPK1,intermediate filament bundle assembly,3.0
7988,83481,GO:0050680,EPPK1,negative regulation of epithelial cell proliferation,3.0
7989,83481,GO:0051548,EPPK1,negative regulation of keratinocyte migration,3.0
7990,83481,GO:0061045,EPPK1,negative regulation of wound healing,3.0
7991,83481,GO:0071944,EPPK1,cell periphery,3.0
7992,83481,GO:0097356,EPPK1,perinucleolar compartment,3.0
7993,83481,GO:1905041,EPPK1,regulation of epithelium regeneration,3.0
7994,83481,GO:1990254,EPPK1,keratin filament binding,3.0
7995,57471,GO:0001763,ERMN,morphogenesis of a branching structure,3.0
7996,57471,GO:0005515,ERMN,protein binding,3.0
7997,57471,GO:0005737,ERMN,cytoplasm,3.0
7998,57471,GO:0005856,ERMN,cytoskeleton,3.0
7999,57471,GO:0005938,ERMN,cell cortex,3.0
8001,57471,GO:0007015,ERMN,actin filament organization,3.0
8003,57471,GO:0008360,ERMN,regulation of cell shape,3.0
8005,57471,GO:0030175,ERMN,filopodium,3.0
8006,57471,GO:0031344,ERMN,regulation of cell projection organization,3.0
8008,57471,GO:0033269,ERMN,internode region of axon,3.0
8010,57471,GO:0033270,ERMN,paranode region of axon,3.0
8012,57471,GO:0043025,ERMN,neuronal cell body,3.0
8013,57471,GO:0043209,ERMN,myelin sheath,3.0
8014,57471,GO:0051015,ERMN,actin filament binding,3.0
8015,57471,GO:0070062,ERMN,extracellular exosome,3.0
8016,2100,GO:0000122,ESR2,negative regulation of transcription by RNA polymerase II,3.0
8017,2100,GO:0000785,ESR2,chromatin,3.0
8019,2100,GO:0000978,ESR2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
8021,2100,GO:0000981,ESR2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
8022,2100,GO:0003677,ESR2,DNA binding,3.0
8023,2100,GO:0003707,ESR2,steroid hormone receptor activity,3.0
8024,2100,GO:0004879,ESR2,nuclear receptor activity,3.0
8027,2100,GO:0005496,ESR2,steroid binding,3.0
8029,2100,GO:0005515,ESR2,protein binding,3.0
8030,2100,GO:0005634,ESR2,nucleus,3.0
8032,2100,GO:0005654,ESR2,nucleoplasm,3.0
8033,2100,GO:0005739,ESR2,mitochondrion,3.0
8034,2100,GO:0006355,ESR2,"regulation of transcription, DNA-templated",3.0
8035,2100,GO:0006357,ESR2,regulation of transcription by RNA polymerase II,3.0
8036,2100,GO:0006367,ESR2,transcription initiation from RNA polymerase II promoter,3.0
8037,2100,GO:0007165,ESR2,signal transduction,3.0
8038,2100,GO:0007267,ESR2,cell-cell signaling,3.0
8039,2100,GO:0008270,ESR2,zinc ion binding,3.0
8040,2100,GO:0019899,ESR2,enzyme binding,3.0
8041,2100,GO:0030284,ESR2,estrogen receptor activity,3.0
8044,2100,GO:0030308,ESR2,negative regulation of cell growth,3.0
8045,2100,GO:0030518,ESR2,intracellular steroid hormone receptor signaling pathway,3.0
8046,2100,GO:0030520,ESR2,intracellular estrogen receptor signaling pathway,3.0
8047,2100,GO:0034056,ESR2,estrogen response element binding,3.0
8048,2100,GO:0042802,ESR2,identical protein binding,3.0
8049,2100,GO:0045893,ESR2,"positive regulation of transcription, DNA-templated",3.0
8050,2100,GO:0048019,ESR2,receptor antagonist activity,3.0
8051,2100,GO:0051091,ESR2,positive regulation of DNA-binding transcription factor activity,3.0
8052,2100,GO:0071392,ESR2,cellular response to estradiol stimulus,3.0
8053,2100,GO:2000272,ESR2,negative regulation of signaling receptor activity,3.0
8054,2103,GO:0000785,ESRRB,chromatin,3.0
8056,2103,GO:0000793,ESRRB,condensed chromosome,3.0
8057,2103,GO:0000978,ESRRB,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
8059,2103,GO:0000981,ESRRB,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
8061,2103,GO:0000987,ESRRB,cis-regulatory region sequence-specific DNA binding,3.0
8062,2103,GO:0000993,ESRRB,RNA polymerase II complex binding,3.0
8063,2103,GO:0001228,ESRRB,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
8064,2103,GO:0001892,ESRRB,embryonic placenta development,3.0
8065,2103,GO:0003700,ESRRB,DNA-binding transcription factor activity,3.0
8066,2103,GO:0003707,ESRRB,steroid hormone receptor activity,3.0
8067,2103,GO:0004879,ESRRB,nuclear receptor activity,3.0
8068,2103,GO:0005496,ESRRB,steroid binding,3.0
8069,2103,GO:0005634,ESRRB,nucleus,3.0
8070,2103,GO:0005654,ESRRB,nucleoplasm,3.0
8071,2103,GO:0005737,ESRRB,cytoplasm,3.0
8072,2103,GO:0006355,ESRRB,"regulation of transcription, DNA-templated",3.0
8073,2103,GO:0006357,ESRRB,regulation of transcription by RNA polymerase II,3.0
8074,2103,GO:0006367,ESRRB,transcription initiation from RNA polymerase II promoter,3.0
8075,2103,GO:0008134,ESRRB,transcription factor binding,3.0
8076,2103,GO:0008270,ESRRB,zinc ion binding,3.0
8077,2103,GO:0017145,ESRRB,stem cell division,3.0
8078,2103,GO:0019827,ESRRB,stem cell population maintenance,3.0
8079,2103,GO:0030522,ESRRB,intracellular receptor signaling pathway,3.0
8080,2103,GO:0032039,ESRRB,integrator complex,3.0
8081,2103,GO:0043401,ESRRB,steroid hormone mediated signaling pathway,3.0
8082,2103,GO:0043565,ESRRB,sequence-specific DNA binding,3.0
8083,2103,GO:0043697,ESRRB,cell dedifferentiation,3.0
8084,2103,GO:0045494,ESRRB,photoreceptor cell maintenance,3.0
8085,2103,GO:0045725,ESRRB,positive regulation of glycogen biosynthetic process,3.0
8086,2103,GO:0045821,ESRRB,positive regulation of glycolytic process,3.0
8087,2103,GO:0045893,ESRRB,"positive regulation of transcription, DNA-templated",3.0
8088,2103,GO:0045944,ESRRB,positive regulation of transcription by RNA polymerase II,3.0
8089,2103,GO:0048839,ESRRB,inner ear development,3.0
8090,2103,GO:0071931,ESRRB,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,3.0
8091,2103,GO:0090282,ESRRB,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,3.0
8092,2103,GO:1902459,ESRRB,positive regulation of stem cell population maintenance,3.0
8093,2103,GO:1990837,ESRRB,sequence-specific double-stranded DNA binding,3.0
8094,2103,GO:2000035,ESRRB,regulation of stem cell division,3.0
8095,2103,GO:2000737,ESRRB,negative regulation of stem cell differentiation,3.0
8104,11336,GO:0000145,EXOC3,exocyst,3.0
8105,11336,GO:0000149,EXOC3,SNARE binding,3.0
8106,11336,GO:0005515,EXOC3,protein binding,3.0
8107,11336,GO:0005794,EXOC3,Golgi apparatus,3.0
8108,11336,GO:0005829,EXOC3,cytosol,3.0
8109,11336,GO:0006887,EXOC3,exocytosis,3.0
8110,11336,GO:0015031,EXOC3,protein transport,3.0
8111,11336,GO:0030426,EXOC3,growth cone,3.0
8112,11336,GO:0030496,EXOC3,midbody,3.0
8113,11336,GO:0030667,EXOC3,secretory granule membrane,3.0
8114,11336,GO:0042734,EXOC3,presynaptic membrane,3.0
8115,11336,GO:0045296,EXOC3,cadherin binding,3.0
8116,11336,GO:0048471,EXOC3,perinuclear region of cytoplasm,3.0
8117,11336,GO:0051601,EXOC3,exocyst localization,3.0
8118,10640,GO:0000145,EXOC5,exocyst,3.0
8119,10640,GO:0005515,EXOC5,protein binding,3.0
8120,10640,GO:0005737,EXOC5,cytoplasm,3.0
8121,10640,GO:0005829,EXOC5,cytosol,3.0
8122,10640,GO:0006887,EXOC5,exocytosis,3.0
8123,10640,GO:0006892,EXOC5,post-Golgi vesicle-mediated transport,3.0
8124,10640,GO:0006893,EXOC5,Golgi to plasma membrane transport,3.0
8125,10640,GO:0015031,EXOC5,protein transport,3.0
8126,10640,GO:0030496,EXOC5,midbody,3.0
8127,10640,GO:0031267,EXOC5,small GTPase binding,3.0
8128,10640,GO:0047485,EXOC5,protein N-terminus binding,3.0
8129,10640,GO:0072659,EXOC5,protein localization to plasma membrane,3.0
8130,54536,GO:0000145,EXOC6,exocyst,3.0
8131,54536,GO:0005515,EXOC6,protein binding,3.0
8132,54536,GO:0005829,EXOC6,cytosol,3.0
8133,54536,GO:0005886,EXOC6,plasma membrane,3.0
8134,54536,GO:0006887,EXOC6,exocytosis,3.0
8135,54536,GO:0006893,EXOC6,Golgi to plasma membrane transport,3.0
8136,54536,GO:0006904,EXOC6,vesicle docking involved in exocytosis,3.0
8137,54536,GO:0015031,EXOC6,protein transport,3.0
8138,54536,GO:0016020,EXOC6,membrane,3.0
8139,54536,GO:0030426,EXOC6,growth cone,3.0
8140,54536,GO:0048471,EXOC6,perinuclear region of cytoplasm,3.0
8141,54536,GO:0090543,EXOC6,Flemming body,3.0
8142,23233,GO:0000145,EXOC6B,exocyst,3.0
8143,23233,GO:0005515,EXOC6B,protein binding,3.0
8144,23233,GO:0006887,EXOC6B,exocytosis,3.0
8145,23233,GO:0006893,EXOC6B,Golgi to plasma membrane transport,3.0
8146,23233,GO:0006904,EXOC6B,vesicle docking involved in exocytosis,3.0
8147,23233,GO:0015031,EXOC6B,protein transport,3.0
8148,23233,GO:0016020,EXOC6B,membrane,3.0
8149,2131,GO:0000139,EXT1,Golgi membrane,3.0
8150,2131,GO:0001501,EXT1,skeletal system development,3.0
8151,2131,GO:0001503,EXT1,ossification,3.0
8152,2131,GO:0002062,EXT1,chondrocyte differentiation,3.0
8153,2131,GO:0003416,EXT1,endochondral bone growth,3.0
8154,2131,GO:0005783,EXT1,endoplasmic reticulum,3.0
8155,2131,GO:0005789,EXT1,endoplasmic reticulum membrane,3.0
8156,2131,GO:0005794,EXT1,Golgi apparatus,3.0
8158,2131,GO:0006024,EXT1,glycosaminoglycan biosynthetic process,3.0
8160,2131,GO:0006486,EXT1,protein glycosylation,3.0
8161,2131,GO:0007033,EXT1,vacuole organization,3.0
8162,2131,GO:0007155,EXT1,cell adhesion,3.0
8163,2131,GO:0007165,EXT1,signal transduction,3.0
8164,2131,GO:0007224,EXT1,smoothened signaling pathway,3.0
8165,2131,GO:0007369,EXT1,gastrulation,3.0
8166,2131,GO:0007411,EXT1,axon guidance,3.0
8167,2131,GO:0007492,EXT1,endoderm development,3.0
8168,2131,GO:0007498,EXT1,mesoderm development,3.0
8169,2131,GO:0008217,EXT1,regulation of blood pressure,3.0
8170,2131,GO:0008283,EXT1,cell population proliferation,3.0
8171,2131,GO:0008375,EXT1,acetylglucosaminyltransferase activity,3.0
8173,2131,GO:0008543,EXT1,fibroblast growth factor receptor signaling pathway,3.0
8174,2131,GO:0009615,EXT1,response to virus,3.0
8175,2131,GO:0009642,EXT1,response to light intensity,3.0
8176,2131,GO:0010467,EXT1,gene expression,3.0
8177,2131,GO:0015012,EXT1,heparan sulfate proteoglycan biosynthetic process,3.0
8179,2131,GO:0015014,EXT1,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",3.0
8180,2131,GO:0015020,EXT1,glucuronosyltransferase activity,3.0
8182,2131,GO:0016021,EXT1,integral component of membrane,3.0
8183,2131,GO:0016757,EXT1,"transferase activity, transferring glycosyl groups",3.0
8185,2131,GO:0017145,EXT1,stem cell division,3.0
8186,2131,GO:0021772,EXT1,olfactory bulb development,3.0
8187,2131,GO:0030176,EXT1,integral component of endoplasmic reticulum membrane,3.0
8188,2131,GO:0030199,EXT1,collagen fibril organization,3.0
8189,2131,GO:0030210,EXT1,heparin biosynthetic process,3.0
8190,2131,GO:0032836,EXT1,glomerular basement membrane development,3.0
8191,2131,GO:0033692,EXT1,cellular polysaccharide biosynthetic process,3.0
8192,2131,GO:0035176,EXT1,social behavior,3.0
8193,2131,GO:0035249,EXT1,"synaptic transmission, glutamatergic",3.0
8194,2131,GO:0042044,EXT1,fluid transport,3.0
8195,2131,GO:0042060,EXT1,wound healing,3.0
8196,2131,GO:0042311,EXT1,vasodilation,3.0
8197,2131,GO:0042328,EXT1,heparan sulfate N-acetylglucosaminyltransferase activity,3.0
8198,2131,GO:0042596,EXT1,fear response,3.0
8199,2131,GO:0042803,EXT1,protein homodimerization activity,3.0
8200,2131,GO:0045165,EXT1,cell fate commitment,3.0
8201,2131,GO:0045202,EXT1,synapse,3.0
8202,2131,GO:0046872,EXT1,metal ion binding,3.0
8203,2131,GO:0046982,EXT1,protein heterodimerization activity,3.0
8204,2131,GO:0050508,EXT1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,3.0
8206,2131,GO:0050509,EXT1,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,3.0
8208,2131,GO:0050891,EXT1,multicellular organismal water homeostasis,3.0
8209,2131,GO:0055078,EXT1,sodium ion homeostasis,3.0
8210,2131,GO:0060047,EXT1,heart contraction,3.0
8211,2131,GO:0060070,EXT1,canonical Wnt signaling pathway,3.0
8212,2131,GO:0060560,EXT1,developmental growth involved in morphogenesis,3.0
8213,2131,GO:0061744,EXT1,motor behavior,3.0
8214,2131,GO:0061974,EXT1,perichondral bone morphogenesis,3.0
8215,2131,GO:0071625,EXT1,vocalization behavior,3.0
8216,2131,GO:0071711,EXT1,basement membrane organization,3.0
8217,2131,GO:0072112,EXT1,glomerular visceral epithelial cell differentiation,3.0
8218,2131,GO:0072498,EXT1,embryonic skeletal joint development,3.0
8219,2131,GO:0120193,EXT1,tight junction organization,3.0
8220,2131,GO:1990823,EXT1,response to leukemia inhibitory factor,3.0
8221,2171,GO:0001972,FABP5,retinoic acid binding,3.0
8222,2171,GO:0005324,FABP5,long-chain fatty acid transporter activity,3.0
8223,2171,GO:0005504,FABP5,fatty acid binding,3.0
8224,2171,GO:0005515,FABP5,protein binding,3.0
8225,2171,GO:0005576,FABP5,extracellular region,3.0
8226,2171,GO:0005634,FABP5,nucleus,3.0
8227,2171,GO:0005654,FABP5,nucleoplasm,3.0
8228,2171,GO:0005737,FABP5,cytoplasm,3.0
8230,2171,GO:0005829,FABP5,cytosol,3.0
8231,2171,GO:0005886,FABP5,plasma membrane,3.0
8232,2171,GO:0006006,FABP5,glucose metabolic process,3.0
8233,2171,GO:0006629,FABP5,lipid metabolic process,3.0
8234,2171,GO:0006656,FABP5,phosphatidylcholine biosynthetic process,3.0
8235,2171,GO:0008289,FABP5,lipid binding,3.0
8236,2171,GO:0008544,FABP5,epidermis development,3.0
8237,2171,GO:0010829,FABP5,negative regulation of glucose transmembrane transport,3.0
8238,2171,GO:0014069,FABP5,postsynaptic density,3.0
8239,2171,GO:0015909,FABP5,long-chain fatty acid transport,3.0
8240,2171,GO:0019433,FABP5,triglyceride catabolic process,3.0
8241,2171,GO:0030667,FABP5,secretory granule membrane,3.0
8242,2171,GO:0031392,FABP5,regulation of prostaglandin biosynthetic process,3.0
8243,2171,GO:0035360,FABP5,positive regulation of peroxisome proliferator activated receptor signaling pathway,3.0
8244,2171,GO:0035578,FABP5,azurophil granule lumen,3.0
8245,2171,GO:0042593,FABP5,glucose homeostasis,3.0
8246,2171,GO:0042802,FABP5,identical protein binding,3.0
8247,2171,GO:0043312,FABP5,neutrophil degranulation,3.0
8248,2171,GO:0045202,FABP5,synapse,3.0
8249,2171,GO:0051930,FABP5,regulation of sensory perception of pain,3.0
8250,2171,GO:0070062,FABP5,extracellular exosome,3.0
8251,2171,GO:0099178,FABP5,regulation of retrograde trans-synaptic signaling by endocanabinoid,3.0
8252,2171,GO:0120162,FABP5,positive regulation of cold-induced thermogenesis,3.0
8253,2171,GO:1990379,FABP5,lipid transport across blood-brain barrier,3.0
8291,147965,GO:0005515,FAM98C,protein binding,3.0
8292,147965,GO:0072669,FAM98C,tRNA-splicing ligase complex,3.0
8293,22909,GO:0000287,FAN1,magnesium ion binding,3.0
8294,22909,GO:0000724,FAN1,double-strand break repair via homologous recombination,3.0
8295,22909,GO:0004528,FAN1,phosphodiesterase I activity,3.0
8296,22909,GO:0005515,FAN1,protein binding,3.0
8297,22909,GO:0005634,FAN1,nucleus,3.0
8299,22909,GO:0005654,FAN1,nucleoplasm,3.0
8301,22909,GO:0005829,FAN1,cytosol,3.0
8302,22909,GO:0006281,FAN1,DNA repair,3.0
8303,22909,GO:0006289,FAN1,nucleotide-excision repair,3.0
8304,22909,GO:0008409,FAN1,5'-3' exonuclease activity,3.0
8306,22909,GO:0017108,FAN1,5'-flap endonuclease activity,3.0
8308,22909,GO:0033683,FAN1,"nucleotide-excision repair, DNA incision",3.0
8310,22909,GO:0036297,FAN1,interstrand cross-link repair,3.0
8313,22909,GO:0045171,FAN1,intercellular bridge,3.0
8314,22909,GO:0070336,FAN1,flap-structured DNA binding,3.0
8316,22909,GO:0140036,FAN1,ubiquitin-dependent protein binding,3.0
8317,2195,GO:0002088,FAT1,lens development in camera-type eye,3.0
8318,2195,GO:0003382,FAT1,epithelial cell morphogenesis,3.0
8319,2195,GO:0003412,FAT1,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis,3.0
8320,2195,GO:0005509,FAT1,calcium ion binding,3.0
8321,2195,GO:0005515,FAT1,protein binding,3.0
8322,2195,GO:0005634,FAT1,nucleus,3.0
8323,2195,GO:0005886,FAT1,plasma membrane,3.0
8324,2195,GO:0005887,FAT1,integral component of plasma membrane,3.0
8325,2195,GO:0005911,FAT1,cell-cell junction,3.0
8326,2195,GO:0005925,FAT1,focal adhesion,3.0
8327,2195,GO:0007015,FAT1,actin filament organization,3.0
8328,2195,GO:0007155,FAT1,cell adhesion,3.0
8329,2195,GO:0007156,FAT1,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
8330,2195,GO:0007163,FAT1,establishment or maintenance of cell polarity,3.0
8331,2195,GO:0007267,FAT1,cell-cell signaling,3.0
8332,2195,GO:0009653,FAT1,anatomical structure morphogenesis,3.0
8333,2195,GO:0016324,FAT1,apical plasma membrane,3.0
8334,2195,GO:0016477,FAT1,cell migration,3.0
8335,2195,GO:0030027,FAT1,lamellipodium,3.0
8336,2195,GO:0030175,FAT1,filopodium,3.0
8337,2195,GO:0048471,FAT1,perinuclear region of cytoplasm,3.0
8338,2195,GO:0070062,FAT1,extracellular exosome,3.0
8339,2195,GO:0098609,FAT1,cell-cell adhesion,3.0
8382,80204,GO:0000151,FBXO11,ubiquitin ligase complex,3.0
8383,80204,GO:0000209,FBXO11,protein polyubiquitination,3.0
8384,80204,GO:0004842,FBXO11,ubiquitin-protein transferase activity,3.0
8385,80204,GO:0005515,FBXO11,protein binding,3.0
8386,80204,GO:0005634,FBXO11,nucleus,3.0
8387,80204,GO:0005654,FBXO11,nucleoplasm,3.0
8388,80204,GO:0005694,FBXO11,chromosome,3.0
8389,80204,GO:0005730,FBXO11,nucleolus,3.0
8390,80204,GO:0005737,FBXO11,cytoplasm,3.0
8391,80204,GO:0005829,FBXO11,cytosol,3.0
8393,80204,GO:0006464,FBXO11,cellular protein modification process,3.0
8394,80204,GO:0006511,FBXO11,ubiquitin-dependent protein catabolic process,3.0
8396,80204,GO:0007605,FBXO11,sensory perception of sound,3.0
8397,80204,GO:0008270,FBXO11,zinc ion binding,3.0
8398,80204,GO:0016274,FBXO11,protein-arginine N-methyltransferase activity,3.0
8399,80204,GO:0016567,FBXO11,protein ubiquitination,3.0
8401,80204,GO:0035246,FBXO11,peptidyl-arginine N-methylation,3.0
8402,80204,GO:0042981,FBXO11,regulation of apoptotic process,3.0
8403,80204,GO:0043687,FBXO11,post-translational protein modification,3.0
8404,51725,GO:0000209,FBXO40,protein polyubiquitination,3.0
8405,51725,GO:0005737,FBXO40,cytoplasm,3.0
8406,51725,GO:0005829,FBXO40,cytosol,3.0
8407,51725,GO:0008270,FBXO40,zinc ion binding,3.0
8408,51725,GO:0042692,FBXO40,muscle cell differentiation,3.0
8409,51725,GO:0043687,FBXO40,post-translational protein modification,3.0
8410,51725,GO:0061630,FBXO40,ubiquitin protein ligase activity,3.0
8411,343413,GO:0004888,FCRL6,transmembrane signaling receptor activity,3.0
8412,343413,GO:0005515,FCRL6,protein binding,3.0
8413,343413,GO:0005886,FCRL6,plasma membrane,3.0
8414,343413,GO:0005887,FCRL6,integral component of plasma membrane,3.0
8415,343413,GO:0007166,FCRL6,cell surface receptor signaling pathway,3.0
8416,343413,GO:0009897,FCRL6,external side of plasma membrane,3.0
8417,343413,GO:0019902,FCRL6,phosphatase binding,3.0
8418,343413,GO:0019903,FCRL6,protein phosphatase binding,3.0
8419,343413,GO:0042289,FCRL6,MHC class II protein binding,3.0
8420,55079,GO:0000122,FEZF2,negative regulation of transcription by RNA polymerase II,3.0
8421,55079,GO:0000978,FEZF2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
8422,55079,GO:0001227,FEZF2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
8423,55079,GO:0001228,FEZF2,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
8424,55079,GO:0003682,FEZF2,chromatin binding,3.0
8425,55079,GO:0005634,FEZF2,nucleus,3.0
8426,55079,GO:0007413,FEZF2,axonal fasciculation,3.0
8427,55079,GO:0007626,FEZF2,locomotory behavior,3.0
8428,55079,GO:0008285,FEZF2,negative regulation of cell population proliferation,3.0
8429,55079,GO:0010468,FEZF2,regulation of gene expression,3.0
8430,55079,GO:0016358,FEZF2,dendrite development,3.0
8431,55079,GO:0016571,FEZF2,histone methylation,3.0
8432,55079,GO:0021542,FEZF2,dentate gyrus development,3.0
8433,55079,GO:0021797,FEZF2,forebrain anterior/posterior pattern specification,3.0
8434,55079,GO:0021853,FEZF2,cerebral cortex GABAergic interneuron migration,3.0
8435,55079,GO:0021902,FEZF2,commitment of neuronal cell to specific neuron type in forebrain,3.0
8436,55079,GO:0043697,FEZF2,cell dedifferentiation,3.0
8437,55079,GO:0045665,FEZF2,negative regulation of neuron differentiation,3.0
8438,55079,GO:0045666,FEZF2,positive regulation of neuron differentiation,3.0
8439,55079,GO:0045944,FEZF2,positive regulation of transcription by RNA polymerase II,3.0
8440,55079,GO:0046872,FEZF2,metal ion binding,3.0
8441,55079,GO:0048664,FEZF2,neuron fate determination,3.0
8442,55079,GO:1902667,FEZF2,regulation of axon guidance,3.0
8443,2243,GO:0002224,FGA,toll-like receptor signaling pathway,3.0
8444,2243,GO:0002250,FGA,adaptive immune response,3.0
8445,2243,GO:0002576,FGA,platelet degranulation,3.0
8446,2243,GO:0005102,FGA,signaling receptor binding,3.0
8447,2243,GO:0005198,FGA,structural molecule activity,3.0
8449,2243,GO:0005201,FGA,extracellular matrix structural constituent,3.0
8451,2243,GO:0005515,FGA,protein binding,3.0
8452,2243,GO:0005576,FGA,extracellular region,3.0
8454,2243,GO:0005577,FGA,fibrinogen complex,3.0
8456,2243,GO:0005615,FGA,extracellular space,3.0
8457,2243,GO:0005788,FGA,endoplasmic reticulum lumen,3.0
8458,2243,GO:0005886,FGA,plasma membrane,3.0
8459,2243,GO:0005938,FGA,cell cortex,3.0
8460,2243,GO:0007160,FGA,cell-matrix adhesion,3.0
8461,2243,GO:0007596,FGA,blood coagulation,3.0
8462,2243,GO:0009897,FGA,external side of plasma membrane,3.0
8463,2243,GO:0009986,FGA,cell surface,3.0
8464,2243,GO:0030198,FGA,extracellular matrix organization,3.0
8465,2243,GO:0031091,FGA,platelet alpha granule,3.0
8466,2243,GO:0031093,FGA,platelet alpha granule lumen,3.0
8467,2243,GO:0031639,FGA,plasminogen activation,3.0
8468,2243,GO:0034116,FGA,positive regulation of heterotypic cell-cell adhesion,3.0
8470,2243,GO:0034622,FGA,cellular protein-containing complex assembly,3.0
8471,2243,GO:0042730,FGA,fibrinolysis,3.0
8473,2243,GO:0043152,FGA,induction of bacterial agglutination,3.0
8474,2243,GO:0043687,FGA,post-translational protein modification,3.0
8475,2243,GO:0044267,FGA,cellular protein metabolic process,3.0
8476,2243,GO:0045087,FGA,innate immune response,3.0
8477,2243,GO:0045202,FGA,synapse,3.0
8478,2243,GO:0045907,FGA,positive regulation of vasoconstriction,3.0
8479,2243,GO:0045921,FGA,positive regulation of exocytosis,3.0
8480,2243,GO:0046872,FGA,metal ion binding,3.0
8481,2243,GO:0050714,FGA,positive regulation of protein secretion,3.0
8482,2243,GO:0050839,FGA,cell adhesion molecule binding,3.0
8483,2243,GO:0051258,FGA,protein polymerization,3.0
8485,2243,GO:0051592,FGA,response to calcium ion,3.0
8486,2243,GO:0062023,FGA,collagen-containing extracellular matrix,3.0
8487,2243,GO:0065003,FGA,protein-containing complex assembly,3.0
8488,2243,GO:0070062,FGA,extracellular exosome,3.0
8489,2243,GO:0070374,FGA,positive regulation of ERK1 and ERK2 cascade,3.0
8491,2243,GO:0070527,FGA,platelet aggregation,3.0
8494,2243,GO:0072377,FGA,"blood coagulation, common pathway",3.0
8496,2243,GO:0072378,FGA,"blood coagulation, fibrin clot formation",3.0
8497,2243,GO:0072562,FGA,blood microparticle,3.0
8498,2243,GO:0090277,FGA,positive regulation of peptide hormone secretion,3.0
8500,2243,GO:1900026,FGA,positive regulation of substrate adhesion-dependent cell spreading,3.0
8501,2243,GO:1902042,FGA,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,3.0
8503,2243,GO:1903561,FGA,extracellular vesicle,3.0
8504,2243,GO:2000352,FGA,negative regulation of endothelial cell apoptotic process,3.0
8506,2272,GO:0000166,FHIT,nucleotide binding,3.0
8507,2272,GO:0001650,FHIT,fibrillar center,3.0
8508,2272,GO:0003824,FHIT,catalytic activity,3.0
8509,2272,GO:0005515,FHIT,protein binding,3.0
8510,2272,GO:0005634,FHIT,nucleus,3.0
8511,2272,GO:0005737,FHIT,cytoplasm,3.0
8513,2272,GO:0005739,FHIT,mitochondrion,3.0
8514,2272,GO:0005829,FHIT,cytosol,3.0
8515,2272,GO:0005886,FHIT,plasma membrane,3.0
8517,2272,GO:0006163,FHIT,purine nucleotide metabolic process,3.0
8519,2272,GO:0009117,FHIT,nucleotide metabolic process,3.0
8520,2272,GO:0015964,FHIT,diadenosine triphosphate catabolic process,3.0
8521,2272,GO:0016787,FHIT,hydrolase activity,3.0
8522,2272,GO:0031625,FHIT,ubiquitin protein ligase binding,3.0
8524,2272,GO:0032435,FHIT,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,3.0
8526,2272,GO:0042802,FHIT,identical protein binding,3.0
8527,2272,GO:0047710,FHIT,bis(5'-adenosyl)-triphosphatase activity,3.0
8529,2272,GO:0072332,FHIT,intrinsic apoptotic signaling pathway by p53 class mediator,3.0
8727,54898,GO:0005515,ELOVL2,protein binding,3.0
8728,54898,GO:0005783,ELOVL2,endoplasmic reticulum,3.0
8729,54898,GO:0005789,ELOVL2,endoplasmic reticulum membrane,3.0
8730,54898,GO:0006636,ELOVL2,unsaturated fatty acid biosynthetic process,3.0
8731,54898,GO:0009922,ELOVL2,fatty acid elongase activity,3.0
8734,54898,GO:0019367,ELOVL2,"fatty acid elongation, saturated fatty acid",3.0
8735,54898,GO:0030148,ELOVL2,sphingolipid biosynthetic process,3.0
8736,54898,GO:0030176,ELOVL2,integral component of endoplasmic reticulum membrane,3.0
8737,54898,GO:0034625,ELOVL2,"fatty acid elongation, monounsaturated fatty acid",3.0
8738,54898,GO:0034626,ELOVL2,"fatty acid elongation, polyunsaturated fatty acid",3.0
8740,54898,GO:0035338,ELOVL2,long-chain fatty-acyl-CoA biosynthetic process,3.0
8741,54898,GO:0036109,ELOVL2,alpha-linolenic acid metabolic process,3.0
8742,54898,GO:0042761,ELOVL2,very long-chain fatty acid biosynthetic process,3.0
8744,54898,GO:0043651,ELOVL2,linoleic acid metabolic process,3.0
8745,54898,GO:0102336,ELOVL2,3-oxo-arachidoyl-CoA synthase activity,3.0
8746,54898,GO:0102337,ELOVL2,3-oxo-cerotoyl-CoA synthase activity,3.0
8747,54898,GO:0102338,ELOVL2,3-oxo-lignoceronyl-CoA synthase activity,3.0
8748,54898,GO:0102756,ELOVL2,very-long-chain 3-ketoacyl-CoA synthase activity,3.0
8749,5167,GO:0003676,ENPP1,nucleic acid binding,3.0
8750,5167,GO:0004527,ENPP1,exonuclease activity,3.0
8751,5167,GO:0004528,ENPP1,phosphodiesterase I activity,3.0
8754,5167,GO:0004551,ENPP1,nucleotide diphosphatase activity,3.0
8756,5167,GO:0005044,ENPP1,scavenger receptor activity,3.0
8757,5167,GO:0005158,ENPP1,insulin receptor binding,3.0
8758,5167,GO:0005509,ENPP1,calcium ion binding,3.0
8759,5167,GO:0005515,ENPP1,protein binding,3.0
8760,5167,GO:0005524,ENPP1,ATP binding,3.0
8761,5167,GO:0005615,ENPP1,extracellular space,3.0
8762,5167,GO:0005765,ENPP1,lysosomal membrane,3.0
8763,5167,GO:0005886,ENPP1,plasma membrane,3.0
8765,5167,GO:0005887,ENPP1,integral component of plasma membrane,3.0
8766,5167,GO:0006091,ENPP1,generation of precursor metabolites and energy,3.0
8767,5167,GO:0006771,ENPP1,riboflavin metabolic process,3.0
8768,5167,GO:0006796,ENPP1,phosphate-containing compound metabolic process,3.0
8769,5167,GO:0006897,ENPP1,endocytosis,3.0
8770,5167,GO:0006955,ENPP1,immune response,3.0
8771,5167,GO:0008270,ENPP1,zinc ion binding,3.0
8772,5167,GO:0009143,ENPP1,nucleoside triphosphate catabolic process,3.0
8774,5167,GO:0009986,ENPP1,cell surface,3.0
8776,5167,GO:0016021,ENPP1,integral component of membrane,3.0
8777,5167,GO:0016323,ENPP1,basolateral plasma membrane,3.0
8778,5167,GO:0030247,ENPP1,polysaccharide binding,3.0
8779,5167,GO:0030308,ENPP1,negative regulation of cell growth,3.0
8780,5167,GO:0030318,ENPP1,melanocyte differentiation,3.0
8781,5167,GO:0030500,ENPP1,regulation of bone mineralization,3.0
8783,5167,GO:0030502,ENPP1,negative regulation of bone mineralization,3.0
8784,5167,GO:0030505,ENPP1,inorganic diphosphate transport,3.0
8786,5167,GO:0030643,ENPP1,cellular phosphate ion homeostasis,3.0
8787,5167,GO:0030730,ENPP1,sequestering of triglyceride,3.0
8788,5167,GO:0031214,ENPP1,biomineral tissue development,3.0
8789,5167,GO:0031953,ENPP1,negative regulation of protein autophosphorylation,3.0
8790,5167,GO:0032869,ENPP1,cellular response to insulin stimulus,3.0
8791,5167,GO:0035529,ENPP1,NADH pyrophosphatase activity,3.0
8792,5167,GO:0036218,ENPP1,dTTP diphosphatase activity,3.0
8793,5167,GO:0042803,ENPP1,protein homodimerization activity,3.0
8794,5167,GO:0045599,ENPP1,negative regulation of fat cell differentiation,3.0
8796,5167,GO:0045719,ENPP1,negative regulation of glycogen biosynthetic process,3.0
8797,5167,GO:0046034,ENPP1,ATP metabolic process,3.0
8799,5167,GO:0046325,ENPP1,negative regulation of glucose import,3.0
8800,5167,GO:0046627,ENPP1,negative regulation of insulin receptor signaling pathway,3.0
8801,5167,GO:0047429,ENPP1,nucleoside-triphosphate diphosphatase activity,3.0
8802,5167,GO:0050427,ENPP1,3'-phosphoadenosine 5'-phosphosulfate metabolic process,3.0
8803,5167,GO:0050656,ENPP1,3'-phosphoadenosine 5'-phosphosulfate binding,3.0
8804,5167,GO:0090305,ENPP1,nucleic acid phosphodiester bond hydrolysis,3.0
8805,5167,GO:0106177,ENPP1,cyclic-GMP-AMP hydrolase activity,3.0
8806,5167,GO:1990787,ENPP1,negative regulation of hh target transcription factor activity,3.0
8807,2078,GO:0000785,ERG,chromatin,3.0
8808,2078,GO:0000978,ERG,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
8809,2078,GO:0000981,ERG,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
8811,2078,GO:0001228,ERG,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
8812,2078,GO:0003677,ERG,DNA binding,3.0
8813,2078,GO:0003682,ERG,chromatin binding,3.0
8814,2078,GO:0005515,ERG,protein binding,3.0
8815,2078,GO:0005634,ERG,nucleus,3.0
8816,2078,GO:0005737,ERG,cytoplasm,3.0
8817,2078,GO:0006357,ERG,regulation of transcription by RNA polymerase II,3.0
8818,2078,GO:0006468,ERG,protein phosphorylation,3.0
8819,2078,GO:0007165,ERG,signal transduction,3.0
8820,2078,GO:0007275,ERG,multicellular organism development,3.0
8821,2078,GO:0030154,ERG,cell differentiation,3.0
8822,2078,GO:0045944,ERG,positive regulation of transcription by RNA polymerase II,3.0
8824,2078,GO:1990837,ERG,sequence-specific double-stranded DNA binding,3.0
8825,2078,GO:1990904,ERG,ribonucleoprotein complex,3.0
8827,254170,GO:0005515,FBXO33,protein binding,3.0
8828,254170,GO:0016567,FBXO33,protein ubiquitination,3.0
8829,254170,GO:0019005,FBXO33,SCF ubiquitin ligase complex,3.0
8830,254170,GO:0031146,FBXO33,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,3.0
8831,2259,GO:0005515,FGF14,protein binding,3.0
8832,2259,GO:0005576,FGF14,extracellular region,3.0
8833,2259,GO:0005634,FGF14,nucleus,3.0
8834,2259,GO:0005737,FGF14,cytoplasm,3.0
8835,2259,GO:0007165,FGF14,signal transduction,3.0
8836,2259,GO:0007267,FGF14,cell-cell signaling,3.0
8837,2259,GO:0007399,FGF14,nervous system development,3.0
8838,2259,GO:0008083,FGF14,growth factor activity,3.0
8839,2259,GO:0017080,FGF14,sodium channel regulator activity,3.0
8840,2259,GO:0048167,FGF14,regulation of synaptic plasticity,3.0
8841,2259,GO:0060078,FGF14,regulation of postsynaptic membrane potential,3.0
8842,2259,GO:1901843,FGF14,positive regulation of high voltage-gated calcium channel activity,3.0
8843,2259,GO:1903421,FGF14,regulation of synaptic vesicle recycling,3.0
8844,2259,GO:1905150,FGF14,regulation of voltage-gated sodium channel activity,3.0
8879,2444,GO:0000122,FRK,negative regulation of transcription by RNA polymerase II,3.0
8880,2444,GO:0004713,FRK,protein tyrosine kinase activity,3.0
8881,2444,GO:0004715,FRK,non-membrane spanning protein tyrosine kinase activity,3.0
8882,2444,GO:0005102,FRK,signaling receptor binding,3.0
8883,2444,GO:0005515,FRK,protein binding,3.0
8884,2444,GO:0005524,FRK,ATP binding,3.0
8885,2444,GO:0005576,FRK,extracellular region,3.0
8886,2444,GO:0005622,FRK,intracellular anatomical structure,3.0
8887,2444,GO:0005634,FRK,nucleus,3.0
8888,2444,GO:0005654,FRK,nucleoplasm,3.0
8889,2444,GO:0005829,FRK,cytosol,3.0
8891,2444,GO:0006468,FRK,protein phosphorylation,3.0
8892,2444,GO:0007169,FRK,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
8893,2444,GO:0008285,FRK,negative regulation of cell population proliferation,3.0
8894,2444,GO:0030154,FRK,cell differentiation,3.0
8895,2444,GO:0031234,FRK,extrinsic component of cytoplasmic side of plasma membrane,3.0
8896,2444,GO:0035578,FRK,azurophil granule lumen,3.0
8897,2444,GO:0035580,FRK,specific granule lumen,3.0
8898,2444,GO:0038083,FRK,peptidyl-tyrosine autophosphorylation,3.0
8899,2444,GO:0042127,FRK,regulation of cell population proliferation,3.0
8900,2444,GO:0043312,FRK,neutrophil degranulation,3.0
8901,2444,GO:0045087,FRK,innate immune response,3.0
8902,2444,GO:0070062,FRK,extracellular exosome,3.0
8911,9568,GO:0004888,GABBR2,transmembrane signaling receptor activity,3.0
8912,9568,GO:0004965,GABBR2,G protein-coupled GABA receptor activity,3.0
8913,9568,GO:0005515,GABBR2,protein binding,3.0
8914,9568,GO:0005737,GABBR2,cytoplasm,3.0
8915,9568,GO:0005886,GABBR2,plasma membrane,3.0
8916,9568,GO:0005887,GABBR2,integral component of plasma membrane,3.0
8917,9568,GO:0007186,GABBR2,G protein-coupled receptor signaling pathway,3.0
8918,9568,GO:0007194,GABBR2,negative regulation of adenylate cyclase activity,3.0
8919,9568,GO:0007214,GABBR2,gamma-aminobutyric acid signaling pathway,3.0
8921,9568,GO:0007268,GABBR2,chemical synaptic transmission,3.0
8922,9568,GO:0038039,GABBR2,G protein-coupled receptor heterodimeric complex,3.0
8924,9568,GO:0043005,GABBR2,neuron projection,3.0
8925,9568,GO:0045211,GABBR2,postsynaptic membrane,3.0
8926,9568,GO:0046982,GABBR2,protein heterodimerization activity,3.0
8927,9568,GO:0150099,GABBR2,neuron-glial cell signaling,3.0
8928,9568,GO:1902710,GABBR2,GABA receptor complex,3.0
8956,2557,GO:0004890,GABRA4,GABA-A receptor activity,3.0
8957,2557,GO:0005237,GABRA4,inhibitory extracellular ligand-gated ion channel activity,3.0
8958,2557,GO:0005254,GABRA4,chloride channel activity,3.0
8959,2557,GO:0005886,GABRA4,plasma membrane,3.0
8960,2557,GO:0005887,GABRA4,integral component of plasma membrane,3.0
8961,2557,GO:0007165,GABRA4,signal transduction,3.0
8962,2557,GO:0007214,GABRA4,gamma-aminobutyric acid signaling pathway,3.0
8963,2557,GO:0007268,GABRA4,chemical synaptic transmission,3.0
8964,2557,GO:0007417,GABRA4,central nervous system development,3.0
8965,2557,GO:0008503,GABRA4,benzodiazepine receptor activity,3.0
8966,2557,GO:0022851,GABRA4,GABA-gated chloride ion channel activity,3.0
8967,2557,GO:0030594,GABRA4,neurotransmitter receptor activity,3.0
8968,2557,GO:0032590,GABRA4,dendrite membrane,3.0
8969,2557,GO:0034220,GABRA4,ion transmembrane transport,3.0
8970,2557,GO:0034707,GABRA4,chloride channel complex,3.0
8971,2557,GO:0042391,GABRA4,regulation of membrane potential,3.0
8972,2557,GO:0043005,GABRA4,neuron projection,3.0
8973,2557,GO:0045202,GABRA4,synapse,3.0
8974,2557,GO:0050877,GABRA4,nervous system process,3.0
8975,2557,GO:0051932,GABRA4,"synaptic transmission, GABAergic",3.0
8976,2557,GO:0060078,GABRA4,regulation of postsynaptic membrane potential,3.0
8977,2557,GO:0098794,GABRA4,postsynapse,3.0
8978,2557,GO:0098982,GABRA4,GABA-ergic synapse,3.0
8979,2557,GO:0099060,GABRA4,integral component of postsynaptic specialization membrane,3.0
8980,2557,GO:1902476,GABRA4,chloride transmembrane transport,3.0
8981,2557,GO:1902711,GABRA4,GABA-A receptor complex,3.0
8982,2557,GO:1904315,GABRA4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,3.0
9052,114805,GO:0000139,GALNT13,Golgi membrane,3.0
9053,114805,GO:0004653,GALNT13,polypeptide N-acetylgalactosaminyltransferase activity,3.0
9054,114805,GO:0005794,GALNT13,Golgi apparatus,3.0
9055,114805,GO:0016021,GALNT13,integral component of membrane,3.0
9056,114805,GO:0016266,GALNT13,O-glycan processing,3.0
9057,114805,GO:0018242,GALNT13,protein O-linked glycosylation via serine,3.0
9058,114805,GO:0018243,GALNT13,protein O-linked glycosylation via threonine,3.0
9059,114805,GO:0030246,GALNT13,carbohydrate binding,3.0
9060,114805,GO:0046872,GALNT13,metal ion binding,3.0
9061,79623,GO:0000139,GALNT14,Golgi membrane,3.0
9062,79623,GO:0004653,GALNT14,polypeptide N-acetylgalactosaminyltransferase activity,3.0
9063,79623,GO:0005794,GALNT14,Golgi apparatus,3.0
9064,79623,GO:0016021,GALNT14,integral component of membrane,3.0
9065,79623,GO:0016266,GALNT14,O-glycan processing,3.0
9066,79623,GO:0030246,GALNT14,carbohydrate binding,3.0
9067,79623,GO:0046872,GALNT14,metal ion binding,3.0
9075,2620,GO:0000226,GAS2,microtubule cytoskeleton organization,3.0
9076,2620,GO:0001544,GAS2,initiation of primordial ovarian follicle growth,3.0
9077,2620,GO:0001547,GAS2,antral ovarian follicle growth,3.0
9078,2620,GO:0005829,GAS2,cytosol,3.0
9079,2620,GO:0005874,GAS2,microtubule,3.0
9080,2620,GO:0005884,GAS2,actin filament,3.0
9081,2620,GO:0006915,GAS2,apoptotic process,3.0
9082,2620,GO:0007050,GAS2,cell cycle arrest,3.0
9083,2620,GO:0008017,GAS2,microtubule binding,3.0
9084,2620,GO:0008093,GAS2,cytoskeletal anchor activity,3.0
9085,2620,GO:0008360,GAS2,regulation of cell shape,3.0
9086,2620,GO:0008593,GAS2,regulation of Notch signaling pathway,3.0
9087,2620,GO:0016020,GAS2,membrane,3.0
9088,2620,GO:0030728,GAS2,ovulation,3.0
9089,2620,GO:0051015,GAS2,actin filament binding,3.0
9090,2620,GO:0051764,GAS2,actin crosslink formation,3.0
9091,2620,GO:0071711,GAS2,basement membrane organization,3.0
9110,9615,GO:0005622,GDA,intracellular anatomical structure,3.0
9111,9615,GO:0005829,GDA,cytosol,3.0
9112,9615,GO:0006139,GDA,nucleobase-containing compound metabolic process,3.0
9113,9615,GO:0006147,GDA,guanine catabolic process,3.0
9114,9615,GO:0006195,GDA,purine nucleotide catabolic process,3.0
9115,9615,GO:0007399,GDA,nervous system development,3.0
9116,9615,GO:0008270,GDA,zinc ion binding,3.0
9117,9615,GO:0008892,GDA,guanine deaminase activity,3.0
9118,9615,GO:0019239,GDA,deaminase activity,3.0
9119,9615,GO:0046098,GDA,guanine metabolic process,3.0
9163,148979,GO:0000122,GLIS1,negative regulation of transcription by RNA polymerase II,3.0
9164,148979,GO:0000978,GLIS1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
9165,148979,GO:0000981,GLIS1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
9166,148979,GO:0001227,GLIS1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
9167,148979,GO:0001228,GLIS1,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
9168,148979,GO:0001649,GLIS1,osteoblast differentiation,3.0
9169,148979,GO:0005515,GLIS1,protein binding,3.0
9170,148979,GO:0005634,GLIS1,nucleus,3.0
9172,148979,GO:0006357,GLIS1,regulation of transcription by RNA polymerase II,3.0
9173,148979,GO:0010454,GLIS1,negative regulation of cell fate commitment,3.0
9174,148979,GO:0045444,GLIS1,fat cell differentiation,3.0
9175,148979,GO:0045944,GLIS1,positive regulation of transcription by RNA polymerase II,3.0
9176,148979,GO:0046872,GLIS1,metal ion binding,3.0
9177,148979,GO:1990837,GLIS1,sequence-specific double-stranded DNA binding,3.0
9178,2739,GO:0004462,GLO1,lactoylglutathione lyase activity,3.0
9179,2739,GO:0005515,GLO1,protein binding,3.0
9180,2739,GO:0005654,GLO1,nucleoplasm,3.0
9181,2739,GO:0005737,GLO1,cytoplasm,3.0
9182,2739,GO:0005829,GLO1,cytosol,3.0
9184,2739,GO:0005886,GLO1,plasma membrane,3.0
9185,2739,GO:0005975,GLO1,carbohydrate metabolic process,3.0
9186,2739,GO:0006090,GLO1,pyruvate metabolic process,3.0
9187,2739,GO:0006357,GLO1,regulation of transcription by RNA polymerase II,3.0
9188,2739,GO:0006749,GLO1,glutathione metabolic process,3.0
9189,2739,GO:0008270,GLO1,zinc ion binding,3.0
9190,2739,GO:0009438,GLO1,methylglyoxal metabolic process,3.0
9191,2739,GO:0030316,GLO1,osteoclast differentiation,3.0
9192,2739,GO:0043066,GLO1,negative regulation of apoptotic process,3.0
9195,2739,GO:0070062,GLO1,extracellular exosome,3.0
9196,2742,GO:0004888,GLRA2,transmembrane signaling receptor activity,3.0
9197,2742,GO:0005254,GLRA2,chloride channel activity,3.0
9198,2742,GO:0005886,GLRA2,plasma membrane,3.0
9199,2742,GO:0005887,GLRA2,integral component of plasma membrane,3.0
9201,2742,GO:0007165,GLRA2,signal transduction,3.0
9202,2742,GO:0007218,GLRA2,neuropeptide signaling pathway,3.0
9204,2742,GO:0007268,GLRA2,chemical synaptic transmission,3.0
9206,2742,GO:0016594,GLRA2,glycine binding,3.0
9207,2742,GO:0016934,GLRA2,extracellularly glycine-gated chloride channel activity,3.0
9208,2742,GO:0022852,GLRA2,glycine-gated chloride ion channel activity,3.0
9209,2742,GO:0030594,GLRA2,neurotransmitter receptor activity,3.0
9210,2742,GO:0034220,GLRA2,ion transmembrane transport,3.0
9212,2742,GO:0034707,GLRA2,chloride channel complex,3.0
9213,2742,GO:0042391,GLRA2,regulation of membrane potential,3.0
9214,2742,GO:0043005,GLRA2,neuron projection,3.0
9215,2742,GO:0043200,GLRA2,response to amino acid,3.0
9216,2742,GO:0045202,GLRA2,synapse,3.0
9217,2742,GO:0045211,GLRA2,postsynaptic membrane,3.0
9218,2742,GO:0046872,GLRA2,metal ion binding,3.0
9219,2742,GO:0050877,GLRA2,nervous system process,3.0
9220,2742,GO:0060012,GLRA2,"synaptic transmission, glycinergic",3.0
9221,2742,GO:0060079,GLRA2,excitatory postsynaptic potential,3.0
9222,2742,GO:0071230,GLRA2,cellular response to amino acid stimulus,3.0
9223,2742,GO:0071294,GLRA2,cellular response to zinc ion,3.0
9224,2742,GO:0071361,GLRA2,cellular response to ethanol,3.0
9225,2742,GO:1902476,GLRA2,chloride transmembrane transport,3.0
9227,2778,GO:0001664,GNAS,G protein-coupled receptor binding,3.0
9228,2778,GO:0001894,GNAS,tissue homeostasis,3.0
9229,2778,GO:0001958,GNAS,endochondral ossification,3.0
9230,2778,GO:0003924,GNAS,GTPase activity,3.0
9231,2778,GO:0005159,GNAS,insulin-like growth factor receptor binding,3.0
9232,2778,GO:0005515,GNAS,protein binding,3.0
9233,2778,GO:0005525,GNAS,GTP binding,3.0
9234,2778,GO:0005829,GNAS,cytosol,3.0
9236,2778,GO:0005834,GNAS,heterotrimeric G-protein complex,3.0
9237,2778,GO:0006112,GNAS,energy reserve metabolic process,3.0
9238,2778,GO:0006306,GNAS,DNA methylation,3.0
9239,2778,GO:0007188,GNAS,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,3.0
9240,2778,GO:0007189,GNAS,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
9241,2778,GO:0007191,GNAS,adenylate cyclase-activating dopamine receptor signaling pathway,3.0
9242,2778,GO:0007606,GNAS,sensory perception of chemical stimulus,3.0
9243,2778,GO:0010856,GNAS,adenylate cyclase activator activity,3.0
9244,2778,GO:0016020,GNAS,membrane,3.0
9247,2778,GO:0016324,GNAS,apical plasma membrane,3.0
9248,2778,GO:0030425,GNAS,dendrite,3.0
9249,2778,GO:0031683,GNAS,G-protein beta/gamma-subunit complex binding,3.0
9250,2778,GO:0031698,GNAS,beta-2 adrenergic receptor binding,3.0
9251,2778,GO:0031748,GNAS,D1 dopamine receptor binding,3.0
9252,2778,GO:0031852,GNAS,mu-type opioid receptor binding,3.0
9253,2778,GO:0035116,GNAS,embryonic hindlimb morphogenesis,3.0
9254,2778,GO:0035255,GNAS,ionotropic glutamate receptor binding,3.0
9255,2778,GO:0035264,GNAS,multicellular organism growth,3.0
9256,2778,GO:0040032,GNAS,post-embryonic body morphogenesis,3.0
9257,2778,GO:0042493,GNAS,response to drug,3.0
9258,2778,GO:0043085,GNAS,positive regulation of catalytic activity,3.0
9259,2778,GO:0043588,GNAS,skin development,3.0
9260,2778,GO:0045669,GNAS,positive regulation of osteoblast differentiation,3.0
9261,2778,GO:0045672,GNAS,positive regulation of osteoclast differentiation,3.0
9262,2778,GO:0046872,GNAS,metal ion binding,3.0
9263,2778,GO:0048589,GNAS,developmental growth,3.0
9264,2778,GO:0048701,GNAS,embryonic cranial skeleton morphogenesis,3.0
9265,2778,GO:0051216,GNAS,cartilage development,3.0
9266,2778,GO:0051430,GNAS,corticotropin-releasing hormone receptor 1 binding,3.0
9267,2778,GO:0060348,GNAS,bone development,3.0
9268,2778,GO:0070062,GNAS,extracellular exosome,3.0
9269,2778,GO:0070527,GNAS,platelet aggregation,3.0
9270,2778,GO:0071514,GNAS,genetic imprinting,3.0
9271,2778,GO:0120162,GNAS,positive regulation of cold-induced thermogenesis,3.0
9272,2778,GO:2000828,GNAS,regulation of parathyroid hormone secretion,3.0
9273,54584,GO:0003674,GNB1L,molecular_function,3.0
9274,54584,GO:0005737,GNB1L,cytoplasm,3.0
9275,54584,GO:0007186,GNB1L,G protein-coupled receptor signaling pathway,3.0
9276,54584,GO:0009898,GNB1L,cytoplasmic side of plasma membrane,3.0
9277,54584,GO:0035176,GNB1L,social behavior,3.0
9278,54584,GO:0035556,GNB1L,intracellular signal transduction,3.0
9304,10082,GO:0001523,GPC6,retinoid metabolic process,3.0
9305,10082,GO:0005515,GPC6,protein binding,3.0
9306,10082,GO:0005576,GPC6,extracellular region,3.0
9307,10082,GO:0005615,GPC6,extracellular space,3.0
9308,10082,GO:0005634,GPC6,nucleus,3.0
9309,10082,GO:0005796,GPC6,Golgi lumen,3.0
9310,10082,GO:0005886,GPC6,plasma membrane,3.0
9311,10082,GO:0006024,GPC6,glycosaminoglycan biosynthetic process,3.0
9312,10082,GO:0006027,GPC6,glycosaminoglycan catabolic process,3.0
9313,10082,GO:0009966,GPC6,regulation of signal transduction,3.0
9314,10082,GO:0009986,GPC6,cell surface,3.0
9315,10082,GO:0016477,GPC6,cell migration,3.0
9317,10082,GO:0043202,GPC6,lysosomal lumen,3.0
9318,10082,GO:0045202,GPC6,synapse,3.0
9319,10082,GO:0046658,GPC6,anchored component of plasma membrane,3.0
9320,10082,GO:0060071,GPC6,"Wnt signaling pathway, planar cell polarity pathway",3.0
9321,10082,GO:0062023,GPC6,collagen-containing extracellular matrix,3.0
9322,10082,GO:0098696,GPC6,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,3.0
9323,10082,GO:0099560,GPC6,synaptic membrane adhesion,3.0
9324,10082,GO:1904929,GPC6,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway",3.0
9325,10082,GO:1905475,GPC6,regulation of protein localization to membrane,3.0
9326,10082,GO:1905606,GPC6,regulation of presynapse assembly,3.0
9327,2820,GO:0004368,GPD2,glycerol-3-phosphate dehydrogenase (quinone) activity,3.0
9328,2820,GO:0005509,GPD2,calcium ion binding,3.0
9329,2820,GO:0005739,GPD2,mitochondrion,3.0
9330,2820,GO:0005743,GPD2,mitochondrial inner membrane,3.0
9331,2820,GO:0006072,GPD2,glycerol-3-phosphate metabolic process,3.0
9332,2820,GO:0006094,GPD2,gluconeogenesis,3.0
9333,2820,GO:0006127,GPD2,glycerophosphate shuttle,3.0
9334,2820,GO:0009331,GPD2,glycerol-3-phosphate dehydrogenase complex,3.0
9335,2820,GO:0019563,GPD2,glycerol catabolic process,3.0
9336,2820,GO:0035264,GPD2,multicellular organism growth,3.0
9337,2820,GO:0043010,GPD2,camera-type eye development,3.0
9338,2820,GO:0052591,GPD2,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,3.0
9375,2861,GO:0000151,GPR37,ubiquitin ligase complex,3.0
9376,2861,GO:0004930,GPR37,G protein-coupled receptor activity,3.0
9377,2861,GO:0005515,GPR37,protein binding,3.0
9378,2861,GO:0005737,GPR37,cytoplasm,3.0
9379,2861,GO:0005783,GPR37,endoplasmic reticulum,3.0
9380,2861,GO:0005789,GPR37,endoplasmic reticulum membrane,3.0
9381,2861,GO:0005886,GPR37,plasma membrane,3.0
9384,2861,GO:0005887,GPR37,integral component of plasma membrane,3.0
9385,2861,GO:0007186,GPR37,G protein-coupled receptor signaling pathway,3.0
9386,2861,GO:0007193,GPR37,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,3.0
9388,2861,GO:0007218,GPR37,neuropeptide signaling pathway,3.0
9389,2861,GO:0008188,GPR37,neuropeptide receptor activity,3.0
9390,2861,GO:0008528,GPR37,G protein-coupled peptide receptor activity,3.0
9392,2861,GO:0009986,GPR37,cell surface,3.0
9393,2861,GO:0030544,GPR37,Hsp70 protein binding,3.0
9394,2861,GO:0031072,GPR37,heat shock protein binding,3.0
9395,2861,GO:0031625,GPR37,ubiquitin protein ligase binding,3.0
9396,2861,GO:0031987,GPR37,locomotion involved in locomotory behavior,3.0
9397,2861,GO:0036505,GPR37,prosaposin receptor activity,3.0
9399,2861,GO:0042277,GPR37,peptide binding,3.0
9400,2861,GO:0042416,GPR37,dopamine biosynthetic process,3.0
9401,2861,GO:0042923,GPR37,neuropeptide binding,3.0
9402,2861,GO:0043235,GPR37,receptor complex,3.0
9404,2861,GO:0043410,GPR37,positive regulation of MAPK cascade,3.0
9406,2861,GO:0045964,GPR37,positive regulation of dopamine metabolic process,3.0
9407,2861,GO:1903206,GPR37,negative regulation of hydrogen peroxide-induced cell death,3.0
9408,54329,GO:0004930,GPR85,G protein-coupled receptor activity,3.0
9410,54329,GO:0005515,GPR85,protein binding,3.0
9411,54329,GO:0005783,GPR85,endoplasmic reticulum,3.0
9412,54329,GO:0005886,GPR85,plasma membrane,3.0
9414,54329,GO:0007165,GPR85,signal transduction,3.0
9415,54329,GO:0007186,GPR85,G protein-coupled receptor signaling pathway,3.0
9416,54329,GO:0016021,GPR85,integral component of membrane,3.0
9417,2876,GO:0001659,GPX1,temperature homeostasis,3.0
9418,2876,GO:0001885,GPX1,endothelial cell development,3.0
9419,2876,GO:0002862,GPX1,negative regulation of inflammatory response to antigenic stimulus,3.0
9420,2876,GO:0004601,GPX1,peroxidase activity,3.0
9421,2876,GO:0004602,GPX1,glutathione peroxidase activity,3.0
9423,2876,GO:0005737,GPX1,cytoplasm,3.0
9424,2876,GO:0005739,GPX1,mitochondrion,3.0
9426,2876,GO:0005759,GPX1,mitochondrial matrix,3.0
9427,2876,GO:0005829,GPX1,cytosol,3.0
9429,2876,GO:0006195,GPX1,purine nucleotide catabolic process,3.0
9430,2876,GO:0006641,GPX1,triglyceride metabolic process,3.0
9431,2876,GO:0006749,GPX1,glutathione metabolic process,3.0
9433,2876,GO:0007605,GPX1,sensory perception of sound,3.0
9434,2876,GO:0009410,GPX1,response to xenobiotic stimulus,3.0
9435,2876,GO:0009609,GPX1,response to symbiotic bacterium,3.0
9436,2876,GO:0009650,GPX1,UV protection,3.0
9437,2876,GO:0010269,GPX1,response to selenium ion,3.0
9439,2876,GO:0010332,GPX1,response to gamma radiation,3.0
9440,2876,GO:0017124,GPX1,SH3 domain binding,3.0
9441,2876,GO:0018158,GPX1,protein oxidation,3.0
9442,2876,GO:0019369,GPX1,arachidonic acid metabolic process,3.0
9443,2876,GO:0019372,GPX1,lipoxygenase pathway,3.0
9445,2876,GO:0033194,GPX1,response to hydroperoxide,3.0
9446,2876,GO:0033599,GPX1,regulation of mammary gland epithelial cell proliferation,3.0
9447,2876,GO:0034599,GPX1,cellular response to oxidative stress,3.0
9449,2876,GO:0040029,GPX1,"regulation of gene expression, epigenetic",3.0
9450,2876,GO:0042311,GPX1,vasodilation,3.0
9451,2876,GO:0042542,GPX1,response to hydrogen peroxide,3.0
9453,2876,GO:0042744,GPX1,hydrogen peroxide catabolic process,3.0
9455,2876,GO:0043154,GPX1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
9456,2876,GO:0043403,GPX1,skeletal muscle tissue regeneration,3.0
9457,2876,GO:0043534,GPX1,blood vessel endothelial cell migration,3.0
9458,2876,GO:0045444,GPX1,fat cell differentiation,3.0
9459,2876,GO:0045454,GPX1,cell redox homeostasis,3.0
9460,2876,GO:0047066,GPX1,phospholipid-hydroperoxide glutathione peroxidase activity,3.0
9461,2876,GO:0048741,GPX1,skeletal muscle fiber development,3.0
9462,2876,GO:0051450,GPX1,myoblast proliferation,3.0
9463,2876,GO:0051702,GPX1,biological process involved in interaction with symbiont,3.0
9464,2876,GO:0051897,GPX1,positive regulation of protein kinase B signaling,3.0
9465,2876,GO:0060047,GPX1,heart contraction,3.0
9466,2876,GO:0060055,GPX1,angiogenesis involved in wound healing,3.0
9467,2876,GO:0061136,GPX1,regulation of proteasomal protein catabolic process,3.0
9468,2876,GO:0090201,GPX1,negative regulation of release of cytochrome c from mitochondria,3.0
9469,2876,GO:0097413,GPX1,Lewy body,3.0
9470,2876,GO:0098869,GPX1,cellular oxidant detoxification,3.0
9471,2876,GO:1902042,GPX1,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,3.0
9472,2876,GO:1902176,GPX1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,3.0
9473,2876,GO:1902905,GPX1,positive regulation of supramolecular fiber organization,3.0
9573,2895,GO:0004970,GRID2,ionotropic glutamate receptor activity,3.0
9574,2895,GO:0005515,GRID2,protein binding,3.0
9575,2895,GO:0005886,GRID2,plasma membrane,3.0
9577,2895,GO:0005887,GRID2,integral component of plasma membrane,3.0
9578,2895,GO:0007157,GRID2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
9579,2895,GO:0007215,GRID2,glutamate receptor signaling pathway,3.0
9580,2895,GO:0008066,GRID2,glutamate receptor activity,3.0
9581,2895,GO:0008328,GRID2,ionotropic glutamate receptor complex,3.0
9582,2895,GO:0010975,GRID2,regulation of neuron projection development,3.0
9583,2895,GO:0015276,GRID2,ligand-gated ion channel activity,3.0
9584,2895,GO:0021707,GRID2,cerebellar granule cell differentiation,3.0
9585,2895,GO:0030165,GRID2,PDZ domain binding,3.0
9586,2895,GO:0034220,GRID2,ion transmembrane transport,3.0
9587,2895,GO:0034613,GRID2,cellular protein localization,3.0
9588,2895,GO:0035235,GRID2,ionotropic glutamate receptor signaling pathway,3.0
9589,2895,GO:0035249,GRID2,"synaptic transmission, glutamatergic",3.0
9591,2895,GO:0038023,GRID2,signaling receptor activity,3.0
9592,2895,GO:0043197,GRID2,dendritic spine,3.0
9593,2895,GO:0043523,GRID2,regulation of neuron apoptotic process,3.0
9594,2895,GO:0045202,GRID2,synapse,3.0
9595,2895,GO:0045211,GRID2,postsynaptic membrane,3.0
9596,2895,GO:0050804,GRID2,modulation of chemical synaptic transmission,3.0
9597,2895,GO:0051965,GRID2,positive regulation of synapse assembly,3.0
9598,2895,GO:0060079,GRID2,excitatory postsynaptic potential,3.0
9599,2895,GO:0060134,GRID2,prepulse inhibition,3.0
9600,2895,GO:0097110,GRID2,scaffold protein binding,3.0
9601,2895,GO:0098978,GRID2,glutamatergic synapse,3.0
9602,2895,GO:0099151,GRID2,regulation of postsynaptic density assembly,3.0
9603,2895,GO:1900454,GRID2,positive regulation of long-term synaptic depression,3.0
9604,2895,GO:1904315,GRID2,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,3.0
9605,2895,GO:1904861,GRID2,excitatory synapse assembly,3.0
9606,392862,GO:0045211,GRID2IP,postsynaptic membrane,3.0
9607,392862,GO:0060292,GRID2IP,long-term synaptic depression,3.0
9745,2395,GO:0004322,FXN,ferroxidase activity,3.0
9747,2395,GO:0005515,FXN,protein binding,3.0
9748,2395,GO:0005739,FXN,mitochondrion,3.0
9750,2395,GO:0005759,FXN,mitochondrial matrix,3.0
9753,2395,GO:0005829,FXN,cytosol,3.0
9754,2395,GO:0006119,FXN,oxidative phosphorylation,3.0
9755,2395,GO:0006783,FXN,heme biosynthetic process,3.0
9756,2395,GO:0006811,FXN,ion transport,3.0
9757,2395,GO:0006879,FXN,cellular iron ion homeostasis,3.0
9759,2395,GO:0007628,FXN,adult walking behavior,3.0
9760,2395,GO:0008198,FXN,ferrous iron binding,3.0
9762,2395,GO:0008199,FXN,ferric iron binding,3.0
9764,2395,GO:0008284,FXN,positive regulation of cell population proliferation,3.0
9765,2395,GO:0009060,FXN,aerobic respiration,3.0
9766,2395,GO:0009792,FXN,embryo development ending in birth or egg hatching,3.0
9767,2395,GO:0010039,FXN,response to iron ion,3.0
9768,2395,GO:0010722,FXN,regulation of ferrochelatase activity,3.0
9769,2395,GO:0016226,FXN,iron-sulfur cluster assembly,3.0
9770,2395,GO:0016540,FXN,protein autoprocessing,3.0
9771,2395,GO:0018283,FXN,iron incorporation into metallo-sulfur cluster,3.0
9773,2395,GO:0019230,FXN,proprioception,3.0
9774,2395,GO:0030307,FXN,positive regulation of cell growth,3.0
9775,2395,GO:0034986,FXN,iron chaperone activity,3.0
9777,2395,GO:0040015,FXN,negative regulation of multicellular organism growth,3.0
9778,2395,GO:0043066,FXN,negative regulation of apoptotic process,3.0
9779,2395,GO:0043085,FXN,positive regulation of catalytic activity,3.0
9780,2395,GO:0044281,FXN,small molecule metabolic process,3.0
9781,2395,GO:0046621,FXN,negative regulation of organ growth,3.0
9782,2395,GO:0051349,FXN,positive regulation of lyase activity,3.0
9784,2395,GO:0051537,FXN,"2 iron, 2 sulfur cluster binding",3.0
9786,2395,GO:0070301,FXN,cellular response to hydrogen peroxide,3.0
9787,2395,GO:0090201,FXN,negative regulation of release of cytochrome c from mitochondria,3.0
9788,2395,GO:1904231,FXN,positive regulation of succinate dehydrogenase activity,3.0
9789,2395,GO:1904234,FXN,positive regulation of aconitate hydratase activity,3.0
9790,2395,GO:1990221,FXN,L-cysteine desulfurase complex,3.0
9909,2899,GO:0001640,GRIK3,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,3.0
9910,2899,GO:0004970,GRIK3,ionotropic glutamate receptor activity,3.0
9912,2899,GO:0005886,GRIK3,plasma membrane,3.0
9914,2899,GO:0005887,GRIK3,integral component of plasma membrane,3.0
9915,2899,GO:0007196,GRIK3,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,3.0
9916,2899,GO:0007215,GRIK3,glutamate receptor signaling pathway,3.0
9917,2899,GO:0007216,GRIK3,G protein-coupled glutamate receptor signaling pathway,3.0
9918,2899,GO:0008066,GRIK3,glutamate receptor activity,3.0
9920,2899,GO:0015276,GRIK3,ligand-gated ion channel activity,3.0
9921,2899,GO:0015277,GRIK3,kainate selective glutamate receptor activity,3.0
9923,2899,GO:0030424,GRIK3,axon,3.0
9924,2899,GO:0030425,GRIK3,dendrite,3.0
9925,2899,GO:0032839,GRIK3,dendrite cytoplasm,3.0
9926,2899,GO:0032983,GRIK3,kainate selective glutamate receptor complex,3.0
9927,2899,GO:0034220,GRIK3,ion transmembrane transport,3.0
9928,2899,GO:0035235,GRIK3,ionotropic glutamate receptor signaling pathway,3.0
9929,2899,GO:0035249,GRIK3,"synaptic transmission, glutamatergic",3.0
9930,2899,GO:0038023,GRIK3,signaling receptor activity,3.0
9931,2899,GO:0042391,GRIK3,regulation of membrane potential,3.0
9933,2899,GO:0042734,GRIK3,presynaptic membrane,3.0
9934,2899,GO:0043195,GRIK3,terminal bouton,3.0
9935,2899,GO:0043204,GRIK3,perikaryon,3.0
9936,2899,GO:0045211,GRIK3,postsynaptic membrane,3.0
9937,2899,GO:0050804,GRIK3,modulation of chemical synaptic transmission,3.0
9938,2899,GO:0051967,GRIK3,"negative regulation of synaptic transmission, glutamatergic",3.0
9939,2899,GO:0060078,GRIK3,regulation of postsynaptic membrane potential,3.0
9940,2899,GO:1904315,GRIK3,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,3.0
9941,2900,GO:0005886,GRIK4,plasma membrane,3.0
9943,2900,GO:0005887,GRIK4,integral component of plasma membrane,3.0
9944,2900,GO:0007215,GRIK4,glutamate receptor signaling pathway,3.0
9945,2900,GO:0007268,GRIK4,chemical synaptic transmission,3.0
9946,2900,GO:0008066,GRIK4,glutamate receptor activity,3.0
9947,2900,GO:0015276,GRIK4,ligand-gated ion channel activity,3.0
9948,2900,GO:0015277,GRIK4,kainate selective glutamate receptor activity,3.0
9949,2900,GO:0032983,GRIK4,kainate selective glutamate receptor complex,3.0
9950,2900,GO:0034220,GRIK4,ion transmembrane transport,3.0
9951,2900,GO:0035235,GRIK4,ionotropic glutamate receptor signaling pathway,3.0
9952,2900,GO:0035249,GRIK4,"synaptic transmission, glutamatergic",3.0
9953,2900,GO:0038023,GRIK4,signaling receptor activity,3.0
9954,2900,GO:0042734,GRIK4,presynaptic membrane,3.0
9955,2900,GO:0045211,GRIK4,postsynaptic membrane,3.0
9956,2900,GO:0050804,GRIK4,modulation of chemical synaptic transmission,3.0
9957,2900,GO:0060078,GRIK4,regulation of postsynaptic membrane potential,3.0
9958,2900,GO:0098686,GRIK4,hippocampal mossy fiber to CA3 synapse,3.0
9959,2900,GO:0099055,GRIK4,integral component of postsynaptic membrane,3.0
9960,2900,GO:1904315,GRIK4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,3.0
10224,2915,GO:0001932,GRM5,regulation of protein phosphorylation,3.0
10225,2915,GO:0004930,GRM5,G protein-coupled receptor activity,3.0
10226,2915,GO:0005515,GRM5,protein binding,3.0
10227,2915,GO:0005737,GRM5,cytoplasm,3.0
10228,2915,GO:0005886,GRM5,plasma membrane,3.0
10229,2915,GO:0005887,GRM5,integral component of plasma membrane,3.0
10231,2915,GO:0006417,GRM5,regulation of translation,3.0
10232,2915,GO:0006448,GRM5,regulation of translational elongation,3.0
10233,2915,GO:0007186,GRM5,G protein-coupled receptor signaling pathway,3.0
10234,2915,GO:0007206,GRM5,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,3.0
10235,2915,GO:0007216,GRM5,G protein-coupled glutamate receptor signaling pathway,3.0
10237,2915,GO:0007268,GRM5,chemical synaptic transmission,3.0
10238,2915,GO:0007611,GRM5,learning or memory,3.0
10239,2915,GO:0007612,GRM5,learning,3.0
10240,2915,GO:0007626,GRM5,locomotory behavior,3.0
10241,2915,GO:0008066,GRM5,glutamate receptor activity,3.0
10243,2915,GO:0030296,GRM5,protein tyrosine kinase activator activity,3.0
10244,2915,GO:0035584,GRM5,calcium-mediated signaling using intracellular calcium source,3.0
10245,2915,GO:0042802,GRM5,identical protein binding,3.0
10246,2915,GO:0043005,GRM5,neuron projection,3.0
10247,2915,GO:0048169,GRM5,regulation of long-term neuronal synaptic plasticity,3.0
10248,2915,GO:0050808,GRM5,synapse organization,3.0
10249,2915,GO:0050890,GRM5,cognition,3.0
10250,2915,GO:0051966,GRM5,"regulation of synaptic transmission, glutamatergic",3.0
10251,2915,GO:0060078,GRM5,regulation of postsynaptic membrane potential,3.0
10252,2915,GO:0061098,GRM5,positive regulation of protein tyrosine kinase activity,3.0
10253,2915,GO:0090647,GRM5,modulation of age-related behavioral decline,3.0
10254,2915,GO:0098839,GRM5,postsynaptic density membrane,3.0
10255,2915,GO:0099530,GRM5,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,3.0
10256,2915,GO:0099553,GRM5,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",3.0
10257,2915,GO:0099566,GRM5,regulation of postsynaptic cytosolic calcium ion concentration,3.0
10258,2915,GO:0099583,GRM5,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,3.0
10259,2915,GO:1902938,GRM5,regulation of intracellular calcium activated chloride channel activity,3.0
10260,2915,GO:1904646,GRM5,cellular response to amyloid-beta,3.0
10262,2915,GO:1990782,GRM5,protein tyrosine kinase binding,3.0
10263,2917,GO:0001642,GRM7,group III metabotropic glutamate receptor activity,3.0
10265,2917,GO:0001662,GRM7,behavioral fear response,3.0
10266,2917,GO:0005886,GRM7,plasma membrane,3.0
10267,2917,GO:0005887,GRM7,integral component of plasma membrane,3.0
10269,2917,GO:0005938,GRM7,cell cortex,3.0
10270,2917,GO:0007186,GRM7,G protein-coupled receptor signaling pathway,3.0
10271,2917,GO:0007196,GRM7,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,3.0
10272,2917,GO:0007216,GRM7,G protein-coupled glutamate receptor signaling pathway,3.0
10273,2917,GO:0007268,GRM7,chemical synaptic transmission,3.0
10274,2917,GO:0007605,GRM7,sensory perception of sound,3.0
10275,2917,GO:0008066,GRM7,glutamate receptor activity,3.0
10277,2917,GO:0010855,GRM7,adenylate cyclase inhibitor activity,3.0
10278,2917,GO:0014050,GRM7,negative regulation of glutamate secretion,3.0
10279,2917,GO:0016021,GRM7,integral component of membrane,3.0
10280,2917,GO:0030424,GRM7,axon,3.0
10281,2917,GO:0030425,GRM7,dendrite,3.0
10282,2917,GO:0031279,GRM7,regulation of cyclase activity,3.0
10283,2917,GO:0032279,GRM7,asymmetric synapse,3.0
10284,2917,GO:0043198,GRM7,dendritic shaft,3.0
10285,2917,GO:0043235,GRM7,receptor complex,3.0
10286,2917,GO:0045211,GRM7,postsynaptic membrane,3.0
10287,2917,GO:0048786,GRM7,presynaptic active zone,3.0
10288,2917,GO:0051966,GRM7,"regulation of synaptic transmission, glutamatergic",3.0
10289,2917,GO:0070905,GRM7,serine binding,3.0
10290,2969,GO:0000981,GTF2I,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
10291,2969,GO:0001102,GTF2I,RNA polymerase II activating transcription factor binding,3.0
10292,2969,GO:0001228,GTF2I,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
10293,2969,GO:0003677,GTF2I,DNA binding,3.0
10294,2969,GO:0003700,GTF2I,DNA-binding transcription factor activity,3.0
10295,2969,GO:0005515,GTF2I,protein binding,3.0
10296,2969,GO:0005634,GTF2I,nucleus,3.0
10298,2969,GO:0005654,GTF2I,nucleoplasm,3.0
10299,2969,GO:0005737,GTF2I,cytoplasm,3.0
10300,2969,GO:0016020,GTF2I,membrane,3.0
10301,2969,GO:0016525,GTF2I,negative regulation of angiogenesis,3.0
10302,2969,GO:0045944,GTF2I,positive regulation of transcription by RNA polymerase II,3.0
10303,2969,GO:0051481,GTF2I,negative regulation of cytosolic calcium ion concentration,3.0
10304,2969,GO:0100026,GTF2I,positive regulation of DNA repair by transcription from RNA polymerase II promoter,3.0
10305,2977,GO:0004383,GUCY1A2,guanylate cyclase activity,3.0
10306,2977,GO:0005515,GUCY1A2,protein binding,3.0
10307,2977,GO:0005525,GUCY1A2,GTP binding,3.0
10308,2977,GO:0005737,GUCY1A2,cytoplasm,3.0
10309,2977,GO:0006182,GUCY1A2,cGMP biosynthetic process,3.0
10310,2977,GO:0007165,GUCY1A2,signal transduction,3.0
10311,2977,GO:0010750,GUCY1A2,positive regulation of nitric oxide mediated signal transduction,3.0
10312,2977,GO:0020037,GUCY1A2,heme binding,3.0
10313,2977,GO:0035556,GUCY1A2,intracellular signal transduction,3.0
10314,2977,GO:0044877,GUCY1A2,protein-containing complex binding,3.0
10385,8970,GO:0000786,H2BC11,nucleosome,3.0
10386,8970,GO:0001530,H2BC11,lipopolysaccharide binding,3.0
10387,8970,GO:0002227,H2BC11,innate immune response in mucosa,3.0
10388,8970,GO:0003677,H2BC11,DNA binding,3.0
10390,8970,GO:0005515,H2BC11,protein binding,3.0
10391,8970,GO:0005615,H2BC11,extracellular space,3.0
10392,8970,GO:0005634,H2BC11,nucleus,3.0
10394,8970,GO:0005654,H2BC11,nucleoplasm,3.0
10396,8970,GO:0005829,H2BC11,cytosol,3.0
10397,8970,GO:0005886,H2BC11,plasma membrane,3.0
10398,8970,GO:0006334,H2BC11,nucleosome assembly,3.0
10400,8970,GO:0010804,H2BC11,negative regulation of tumor necrosis factor-mediated signaling pathway,3.0
10401,8970,GO:0016567,H2BC11,protein ubiquitination,3.0
10402,8970,GO:0019731,H2BC11,antibacterial humoral response,3.0
10403,8970,GO:0031640,H2BC11,killing of cells of other organism,3.0
10404,8970,GO:0046982,H2BC11,protein heterodimerization activity,3.0
10405,8970,GO:0050829,H2BC11,defense response to Gram-negative bacterium,3.0
10406,8970,GO:0050830,H2BC11,defense response to Gram-positive bacterium,3.0
10407,8970,GO:0061844,H2BC11,antimicrobial humoral immune response mediated by antimicrobial peptide,3.0
10408,9759,GO:0000118,HDAC4,histone deacetylase complex,3.0
10409,9759,GO:0000122,HDAC4,negative regulation of transcription by RNA polymerase II,3.0
10412,9759,GO:0000976,HDAC4,transcription regulatory region sequence-specific DNA binding,3.0
10413,9759,GO:0000978,HDAC4,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
10414,9759,GO:0001085,HDAC4,RNA polymerase II transcription factor binding,3.0
10415,9759,GO:0001501,HDAC4,skeletal system development,3.0
10416,9759,GO:0002076,HDAC4,osteoblast development,3.0
10417,9759,GO:0003714,HDAC4,transcription corepressor activity,3.0
10418,9759,GO:0004407,HDAC4,histone deacetylase activity,3.0
10419,9759,GO:0005515,HDAC4,protein binding,3.0
10420,9759,GO:0005634,HDAC4,nucleus,3.0
10421,9759,GO:0005654,HDAC4,nucleoplasm,3.0
10423,9759,GO:0005737,HDAC4,cytoplasm,3.0
10424,9759,GO:0005829,HDAC4,cytosol,3.0
10425,9759,GO:0006338,HDAC4,chromatin remodeling,3.0
10426,9759,GO:0006476,HDAC4,protein deacetylation,3.0
10427,9759,GO:0006954,HDAC4,inflammatory response,3.0
10428,9759,GO:0007399,HDAC4,nervous system development,3.0
10429,9759,GO:0008134,HDAC4,transcription factor binding,3.0
10430,9759,GO:0008270,HDAC4,zinc ion binding,3.0
10431,9759,GO:0008284,HDAC4,positive regulation of cell population proliferation,3.0
10432,9759,GO:0008285,HDAC4,negative regulation of cell population proliferation,3.0
10433,9759,GO:0010592,HDAC4,positive regulation of lamellipodium assembly,3.0
10434,9759,GO:0010832,HDAC4,negative regulation of myotube differentiation,3.0
10435,9759,GO:0010882,HDAC4,regulation of cardiac muscle contraction by calcium ion signaling,3.0
10436,9759,GO:0014894,HDAC4,response to denervation involved in regulation of muscle adaptation,3.0
10437,9759,GO:0014898,HDAC4,cardiac muscle hypertrophy in response to stress,3.0
10438,9759,GO:0014911,HDAC4,positive regulation of smooth muscle cell migration,3.0
10439,9759,GO:0016575,HDAC4,histone deacetylation,3.0
10441,9759,GO:0016607,HDAC4,nuclear speck,3.0
10442,9759,GO:0016925,HDAC4,protein sumoylation,3.0
10443,9759,GO:0017053,HDAC4,transcription repressor complex,3.0
10444,9759,GO:0019789,HDAC4,SUMO transferase activity,3.0
10445,9759,GO:0019901,HDAC4,protein kinase binding,3.0
10446,9759,GO:0030018,HDAC4,Z disc,3.0
10447,9759,GO:0030183,HDAC4,B cell differentiation,3.0
10448,9759,GO:0030955,HDAC4,potassium ion binding,3.0
10449,9759,GO:0031594,HDAC4,neuromuscular junction,3.0
10450,9759,GO:0031672,HDAC4,A band,3.0
10451,9759,GO:0032041,HDAC4,NAD-dependent histone deacetylase activity (H3-K14 specific),3.0
10452,9759,GO:0033235,HDAC4,positive regulation of protein sumoylation,3.0
10453,9759,GO:0033558,HDAC4,protein deacetylase activity,3.0
10455,9759,GO:0033613,HDAC4,activating transcription factor binding,3.0
10456,9759,GO:0034983,HDAC4,peptidyl-lysine deacetylation,3.0
10457,9759,GO:0040029,HDAC4,"regulation of gene expression, epigenetic",3.0
10458,9759,GO:0042113,HDAC4,B cell activation,3.0
10459,9759,GO:0042493,HDAC4,response to drug,3.0
10460,9759,GO:0042641,HDAC4,actomyosin,3.0
10461,9759,GO:0042802,HDAC4,identical protein binding,3.0
10462,9759,GO:0042826,HDAC4,histone deacetylase binding,3.0
10463,9759,GO:0043393,HDAC4,regulation of protein binding,3.0
10464,9759,GO:0043433,HDAC4,negative regulation of DNA-binding transcription factor activity,3.0
10465,9759,GO:0043525,HDAC4,positive regulation of neuron apoptotic process,3.0
10466,9759,GO:0043565,HDAC4,sequence-specific DNA binding,3.0
10467,9759,GO:0045668,HDAC4,negative regulation of osteoblast differentiation,3.0
10468,9759,GO:0045820,HDAC4,negative regulation of glycolytic process,3.0
10469,9759,GO:0045892,HDAC4,"negative regulation of transcription, DNA-templated",3.0
10471,9759,GO:0045893,HDAC4,"positive regulation of transcription, DNA-templated",3.0
10472,9759,GO:0045944,HDAC4,positive regulation of transcription by RNA polymerase II,3.0
10474,9759,GO:0048661,HDAC4,positive regulation of smooth muscle cell proliferation,3.0
10475,9759,GO:0048742,HDAC4,regulation of skeletal muscle fiber development,3.0
10476,9759,GO:0051091,HDAC4,positive regulation of DNA-binding transcription factor activity,3.0
10477,9759,GO:0070491,HDAC4,repressing transcription factor binding,3.0
10478,9759,GO:0070555,HDAC4,response to interleukin-1,3.0
10479,9759,GO:0070932,HDAC4,histone H3 deacetylation,3.0
10480,9759,GO:0070933,HDAC4,histone H4 deacetylation,3.0
10481,9759,GO:0071260,HDAC4,cellular response to mechanical stimulus,3.0
10482,9759,GO:0071356,HDAC4,cellular response to tumor necrosis factor,3.0
10483,9759,GO:0071374,HDAC4,cellular response to parathyroid hormone stimulus,3.0
10484,9759,GO:1902437,HDAC4,positive regulation of male mating behavior,3.0
10485,9759,GO:1902894,HDAC4,negative regulation of pri-miRNA transcription by RNA polymerase II,3.0
10486,9759,GO:1903428,HDAC4,positive regulation of reactive oxygen species biosynthetic process,3.0
10487,9759,GO:1990841,HDAC4,promoter-specific chromatin binding,3.0
10591,3115,GO:0000139,HLA-DPB1,Golgi membrane,3.0
10592,3115,GO:0002250,HLA-DPB1,adaptive immune response,3.0
10593,3115,GO:0005515,HLA-DPB1,protein binding,3.0
10594,3115,GO:0005765,HLA-DPB1,lysosomal membrane,3.0
10595,3115,GO:0005886,HLA-DPB1,plasma membrane,3.0
10596,3115,GO:0009986,HLA-DPB1,cell surface,3.0
10597,3115,GO:0010008,HLA-DPB1,endosome membrane,3.0
10598,3115,GO:0012507,HLA-DPB1,ER to Golgi transport vesicle membrane,3.0
10599,3115,GO:0016020,HLA-DPB1,membrane,3.0
10600,3115,GO:0019886,HLA-DPB1,antigen processing and presentation of exogenous peptide antigen via MHC class II,3.0
10602,3115,GO:0030658,HLA-DPB1,transport vesicle membrane,3.0
10603,3115,GO:0030666,HLA-DPB1,endocytic vesicle membrane,3.0
10604,3115,GO:0030669,HLA-DPB1,clathrin-coated endocytic vesicle membrane,3.0
10605,3115,GO:0032588,HLA-DPB1,trans-Golgi network membrane,3.0
10606,3115,GO:0032729,HLA-DPB1,positive regulation of interferon-gamma production,3.0
10607,3115,GO:0042102,HLA-DPB1,positive regulation of T cell proliferation,3.0
10608,3115,GO:0042605,HLA-DPB1,peptide antigen binding,3.0
10609,3115,GO:0042613,HLA-DPB1,MHC class II protein complex,3.0
10610,3115,GO:0050852,HLA-DPB1,T cell receptor signaling pathway,3.0
10611,3115,GO:0050870,HLA-DPB1,positive regulation of T cell activation,3.0
10612,3115,GO:0060333,HLA-DPB1,interferon-gamma-mediated signaling pathway,3.0
10613,3115,GO:0071556,HLA-DPB1,integral component of lumenal side of endoplasmic reticulum membrane,3.0
10754,9456,GO:0005515,HOMER1,protein binding,3.0
10755,9456,GO:0005737,HOMER1,cytoplasm,3.0
10756,9456,GO:0005829,HOMER1,cytosol,3.0
10757,9456,GO:0005886,HOMER1,plasma membrane,3.0
10758,9456,GO:0007206,HOMER1,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,3.0
10759,9456,GO:0007216,HOMER1,G protein-coupled glutamate receptor signaling pathway,3.0
10760,9456,GO:0007268,HOMER1,chemical synaptic transmission,3.0
10761,9456,GO:0009967,HOMER1,positive regulation of signal transduction,3.0
10762,9456,GO:0014069,HOMER1,postsynaptic density,3.0
10763,9456,GO:0030425,HOMER1,dendrite,3.0
10764,9456,GO:0035256,HOMER1,G protein-coupled glutamate receptor binding,3.0
10765,9456,GO:0035591,HOMER1,signaling adaptor activity,3.0
10766,9456,GO:0043197,HOMER1,dendritic spine,3.0
10767,9456,GO:0044309,HOMER1,neuron spine,3.0
10768,9456,GO:0044325,HOMER1,ion channel binding,3.0
10769,9456,GO:0051262,HOMER1,protein tetramerization,3.0
10770,9456,GO:0051592,HOMER1,response to calcium ion,3.0
10771,9456,GO:0051966,HOMER1,"regulation of synaptic transmission, glutamatergic",3.0
10772,9456,GO:1902950,HOMER1,regulation of dendritic spine maintenance,3.0
10773,9456,GO:2001256,HOMER1,regulation of store-operated calcium entry,3.0
10775,9456,GO:2001257,HOMER1,regulation of cation channel activity,3.0
10875,2944,GO:0004364,GSTM1,glutathione transferase activity,3.0
10877,2944,GO:0005737,GSTM1,cytoplasm,3.0
10878,2944,GO:0005829,GSTM1,cytosol,3.0
10880,2944,GO:0006693,GSTM1,prostaglandin metabolic process,3.0
10881,2944,GO:0006749,GSTM1,glutathione metabolic process,3.0
10883,2944,GO:0018916,GSTM1,nitrobenzene metabolic process,3.0
10884,2944,GO:0019899,GSTM1,enzyme binding,3.0
10885,2944,GO:0042178,GSTM1,xenobiotic catabolic process,3.0
10886,2944,GO:0042803,GSTM1,protein homodimerization activity,3.0
10887,2944,GO:0043295,GSTM1,glutathione binding,3.0
10888,2944,GO:0045171,GSTM1,intercellular bridge,3.0
10889,2944,GO:0051122,GSTM1,hepoxilin biosynthetic process,3.0
10890,2944,GO:0070458,GSTM1,cellular detoxification of nitrogen compound,3.0
10891,2944,GO:1901687,GSTM1,glutathione derivative biosynthetic process,3.0
10893,3105,GO:0000139,HLA-A,Golgi membrane,3.0
10894,3105,GO:0001913,HLA-A,T cell mediated cytotoxicity,3.0
10895,3105,GO:0001916,HLA-A,positive regulation of T cell mediated cytotoxicity,3.0
10896,3105,GO:0002419,HLA-A,T cell mediated cytotoxicity directed against tumor cell target,3.0
10897,3105,GO:0002474,HLA-A,antigen processing and presentation of peptide antigen via MHC class I,3.0
10898,3105,GO:0002479,HLA-A,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",3.0
10899,3105,GO:0002480,HLA-A,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",3.0
10900,3105,GO:0002485,HLA-A,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent",3.0
10901,3105,GO:0002486,HLA-A,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.0
10902,3105,GO:0002726,HLA-A,positive regulation of T cell cytokine production,3.0
10903,3105,GO:0003723,HLA-A,RNA binding,3.0
10904,3105,GO:0005102,HLA-A,signaling receptor binding,3.0
10905,3105,GO:0005515,HLA-A,protein binding,3.0
10906,3105,GO:0005783,HLA-A,endoplasmic reticulum,3.0
10907,3105,GO:0005789,HLA-A,endoplasmic reticulum membrane,3.0
10908,3105,GO:0005794,HLA-A,Golgi apparatus,3.0
10909,3105,GO:0005797,HLA-A,Golgi medial cisterna,3.0
10910,3105,GO:0005886,HLA-A,plasma membrane,3.0
10912,3105,GO:0005887,HLA-A,integral component of plasma membrane,3.0
10913,3105,GO:0006955,HLA-A,immune response,3.0
10915,3105,GO:0009986,HLA-A,cell surface,3.0
10916,3105,GO:0012507,HLA-A,ER to Golgi transport vesicle membrane,3.0
10917,3105,GO:0016020,HLA-A,membrane,3.0
10918,3105,GO:0016032,HLA-A,viral process,3.0
10919,3105,GO:0016045,HLA-A,detection of bacterium,3.0
10920,3105,GO:0016567,HLA-A,protein ubiquitination,3.0
10921,3105,GO:0019731,HLA-A,antibacterial humoral response,3.0
10922,3105,GO:0019885,HLA-A,antigen processing and presentation of endogenous peptide antigen via MHC class I,3.0
10923,3105,GO:0030670,HLA-A,phagocytic vesicle membrane,3.0
10924,3105,GO:0030881,HLA-A,beta-2-microglobulin binding,3.0
10927,3105,GO:0031901,HLA-A,early endosome membrane,3.0
10928,3105,GO:0032729,HLA-A,positive regulation of interferon-gamma production,3.0
10929,3105,GO:0036037,HLA-A,"CD8-positive, alpha-beta T cell activation",3.0
10930,3105,GO:0042270,HLA-A,protection from natural killer cell mediated cytotoxicity,3.0
10932,3105,GO:0042590,HLA-A,antigen processing and presentation of exogenous peptide antigen via MHC class I,3.0
10933,3105,GO:0042605,HLA-A,peptide antigen binding,3.0
10935,3105,GO:0042608,HLA-A,T cell receptor binding,3.0
10936,3105,GO:0042610,HLA-A,CD8 receptor binding,3.0
10937,3105,GO:0042612,HLA-A,MHC class I protein complex,3.0
10938,3105,GO:0042824,HLA-A,MHC class I peptide loading complex,3.0
10939,3105,GO:0046977,HLA-A,TAP binding,3.0
10940,3105,GO:0050776,HLA-A,regulation of immune response,3.0
10941,3105,GO:0050830,HLA-A,defense response to Gram-positive bacterium,3.0
10942,3105,GO:0050852,HLA-A,T cell receptor signaling pathway,3.0
10943,3105,GO:0055038,HLA-A,recycling endosome membrane,3.0
10944,3105,GO:0060333,HLA-A,interferon-gamma-mediated signaling pathway,3.0
10945,3105,GO:0060337,HLA-A,type I interferon signaling pathway,3.0
10946,3105,GO:0062061,HLA-A,TAP complex binding,3.0
10947,3105,GO:0070062,HLA-A,extracellular exosome,3.0
10948,3105,GO:0070971,HLA-A,endoplasmic reticulum exit site,3.0
10949,3105,GO:0071556,HLA-A,integral component of lumenal side of endoplasmic reticulum membrane,3.0
10950,3105,GO:2000566,HLA-A,"positive regulation of CD8-positive, alpha-beta T cell proliferation",3.0
10951,3105,GO:2000568,HLA-A,positive regulation of memory T cell activation,3.0
10952,3105,GO:2001187,HLA-A,"positive regulation of CD8-positive, alpha-beta T cell activation",3.0
10953,3106,GO:0000139,HLA-B,Golgi membrane,3.0
10954,3106,GO:0001916,HLA-B,positive regulation of T cell mediated cytotoxicity,3.0
10955,3106,GO:0002250,HLA-B,adaptive immune response,3.0
10956,3106,GO:0002474,HLA-B,antigen processing and presentation of peptide antigen via MHC class I,3.0
10957,3106,GO:0002479,HLA-B,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",3.0
10958,3106,GO:0002480,HLA-B,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",3.0
10959,3106,GO:0002486,HLA-B,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.0
10960,3106,GO:0002667,HLA-B,regulation of T cell anergy,3.0
10961,3106,GO:0005102,HLA-B,signaling receptor binding,3.0
10962,3106,GO:0005515,HLA-B,protein binding,3.0
10963,3106,GO:0005783,HLA-B,endoplasmic reticulum,3.0
10964,3106,GO:0005794,HLA-B,Golgi apparatus,3.0
10965,3106,GO:0005886,HLA-B,plasma membrane,3.0
10966,3106,GO:0005887,HLA-B,integral component of plasma membrane,3.0
10967,3106,GO:0006952,HLA-B,defense response,3.0
10968,3106,GO:0006955,HLA-B,immune response,3.0
10970,3106,GO:0009986,HLA-B,cell surface,3.0
10972,3106,GO:0012507,HLA-B,ER to Golgi transport vesicle membrane,3.0
10973,3106,GO:0016020,HLA-B,membrane,3.0
10975,3106,GO:0016032,HLA-B,viral process,3.0
10976,3106,GO:0016045,HLA-B,detection of bacterium,3.0
10977,3106,GO:0030667,HLA-B,secretory granule membrane,3.0
10978,3106,GO:0030670,HLA-B,phagocytic vesicle membrane,3.0
10979,3106,GO:0031901,HLA-B,early endosome membrane,3.0
10980,3106,GO:0032655,HLA-B,regulation of interleukin-12 production,3.0
10981,3106,GO:0032675,HLA-B,regulation of interleukin-6 production,3.0
10982,3106,GO:0042270,HLA-B,protection from natural killer cell mediated cytotoxicity,3.0
10983,3106,GO:0042605,HLA-B,peptide antigen binding,3.0
10984,3106,GO:0042612,HLA-B,MHC class I protein complex,3.0
10985,3106,GO:0043312,HLA-B,neutrophil degranulation,3.0
10986,3106,GO:0046977,HLA-B,TAP binding,3.0
10988,3106,GO:0050776,HLA-B,regulation of immune response,3.0
10989,3106,GO:0051087,HLA-B,chaperone binding,3.0
10990,3106,GO:0055038,HLA-B,recycling endosome membrane,3.0
10991,3106,GO:0060333,HLA-B,interferon-gamma-mediated signaling pathway,3.0
10992,3106,GO:0060337,HLA-B,type I interferon signaling pathway,3.0
10993,3106,GO:0070062,HLA-B,extracellular exosome,3.0
10994,3106,GO:0071556,HLA-B,integral component of lumenal side of endoplasmic reticulum membrane,3.0
10995,3106,GO:2001198,HLA-B,regulation of dendritic cell differentiation,3.0
10996,3123,GO:0000139,HLA-DRB1,Golgi membrane,3.0
10997,3123,GO:0001934,HLA-DRB1,positive regulation of protein phosphorylation,3.0
10998,3123,GO:0002381,HLA-DRB1,immunoglobulin production involved in immunoglobulin-mediated immune response,3.0
10999,3123,GO:0002437,HLA-DRB1,inflammatory response to antigenic stimulus,3.0
11000,3123,GO:0002455,HLA-DRB1,humoral immune response mediated by circulating immunoglobulin,3.0
11001,3123,GO:0002503,HLA-DRB1,peptide antigen assembly with MHC class II protein complex,3.0
11002,3123,GO:0002862,HLA-DRB1,negative regulation of inflammatory response to antigenic stimulus,3.0
11003,3123,GO:0005200,HLA-DRB1,structural constituent of cytoskeleton,3.0
11004,3123,GO:0005515,HLA-DRB1,protein binding,3.0
11005,3123,GO:0005615,HLA-DRB1,extracellular space,3.0
11006,3123,GO:0005765,HLA-DRB1,lysosomal membrane,3.0
11008,3123,GO:0005882,HLA-DRB1,intermediate filament,3.0
11009,3123,GO:0005886,HLA-DRB1,plasma membrane,3.0
11010,3123,GO:0005887,HLA-DRB1,integral component of plasma membrane,3.0
11011,3123,GO:0006955,HLA-DRB1,immune response,3.0
11015,3123,GO:0007010,HLA-DRB1,cytoskeleton organization,3.0
11016,3123,GO:0007165,HLA-DRB1,signal transduction,3.0
11018,3123,GO:0008544,HLA-DRB1,epidermis development,3.0
11019,3123,GO:0009897,HLA-DRB1,external side of plasma membrane,3.0
11020,3123,GO:0009986,HLA-DRB1,cell surface,3.0
11021,3123,GO:0012507,HLA-DRB1,ER to Golgi transport vesicle membrane,3.0
11022,3123,GO:0016020,HLA-DRB1,membrane,3.0
11025,3123,GO:0016045,HLA-DRB1,detection of bacterium,3.0
11026,3123,GO:0019886,HLA-DRB1,antigen processing and presentation of exogenous peptide antigen via MHC class II,3.0
11027,3123,GO:0023026,HLA-DRB1,MHC class II protein complex binding,3.0
11028,3123,GO:0030225,HLA-DRB1,macrophage differentiation,3.0
11029,3123,GO:0030247,HLA-DRB1,polysaccharide binding,3.0
11030,3123,GO:0030658,HLA-DRB1,transport vesicle membrane,3.0
11031,3123,GO:0030666,HLA-DRB1,endocytic vesicle membrane,3.0
11032,3123,GO:0030669,HLA-DRB1,clathrin-coated endocytic vesicle membrane,3.0
11033,3123,GO:0031902,HLA-DRB1,late endosome membrane,3.0
11034,3123,GO:0032395,HLA-DRB1,MHC class II receptor activity,3.0
11037,3123,GO:0032588,HLA-DRB1,trans-Golgi network membrane,3.0
11038,3123,GO:0032653,HLA-DRB1,regulation of interleukin-10 production,3.0
11039,3123,GO:0032673,HLA-DRB1,regulation of interleukin-4 production,3.0
11040,3123,GO:0032689,HLA-DRB1,negative regulation of interferon-gamma production,3.0
11041,3123,GO:0033674,HLA-DRB1,positive regulation of kinase activity,3.0
11042,3123,GO:0035774,HLA-DRB1,positive regulation of insulin secretion involved in cellular response to glucose stimulus,3.0
11043,3123,GO:0042088,HLA-DRB1,T-helper 1 type immune response,3.0
11044,3123,GO:0042130,HLA-DRB1,negative regulation of T cell proliferation,3.0
11045,3123,GO:0042605,HLA-DRB1,peptide antigen binding,3.0
11046,3123,GO:0042609,HLA-DRB1,CD4 receptor binding,3.0
11047,3123,GO:0042613,HLA-DRB1,MHC class II protein complex,3.0
11049,3123,GO:0043123,HLA-DRB1,positive regulation of I-kappaB kinase/NF-kappaB signaling,3.0
11050,3123,GO:0043410,HLA-DRB1,positive regulation of MAPK cascade,3.0
11051,3123,GO:0045657,HLA-DRB1,positive regulation of monocyte differentiation,3.0
11052,3123,GO:0045893,HLA-DRB1,"positive regulation of transcription, DNA-templated",3.0
11053,3123,GO:0046598,HLA-DRB1,positive regulation of viral entry into host cell,3.0
11054,3123,GO:0050852,HLA-DRB1,T cell receptor signaling pathway,3.0
11055,3123,GO:0051262,HLA-DRB1,protein tetramerization,3.0
11056,3123,GO:0060333,HLA-DRB1,interferon-gamma-mediated signaling pathway,3.0
11057,3123,GO:0070062,HLA-DRB1,extracellular exosome,3.0
11058,3123,GO:0070374,HLA-DRB1,positive regulation of ERK1 and ERK2 cascade,3.0
11059,3123,GO:0071556,HLA-DRB1,integral component of lumenal side of endoplasmic reticulum membrane,3.0
11060,3135,GO:0000139,HLA-G,Golgi membrane,3.0
11061,3135,GO:0001915,HLA-G,negative regulation of T cell mediated cytotoxicity,3.0
11062,3135,GO:0001916,HLA-G,positive regulation of T cell mediated cytotoxicity,3.0
11063,3135,GO:0002451,HLA-G,peripheral B cell tolerance induction,3.0
11064,3135,GO:0002474,HLA-G,antigen processing and presentation of peptide antigen via MHC class I,3.0
11065,3135,GO:0002476,HLA-G,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,3.0
11067,3135,GO:0002479,HLA-G,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",3.0
11068,3135,GO:0002480,HLA-G,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",3.0
11069,3135,GO:0002486,HLA-G,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.0
11070,3135,GO:0002645,HLA-G,positive regulation of tolerance induction,3.0
11071,3135,GO:0002666,HLA-G,positive regulation of T cell tolerance induction,3.0
11072,3135,GO:0002729,HLA-G,positive regulation of natural killer cell cytokine production,3.0
11073,3135,GO:0002767,HLA-G,immune response-inhibiting cell surface receptor signaling pathway,3.0
11074,3135,GO:0005102,HLA-G,signaling receptor binding,3.0
11076,3135,GO:0005515,HLA-G,protein binding,3.0
11077,3135,GO:0005615,HLA-G,extracellular space,3.0
11078,3135,GO:0005769,HLA-G,early endosome,3.0
11079,3135,GO:0005886,HLA-G,plasma membrane,3.0
11081,3135,GO:0006955,HLA-G,immune response,3.0
11082,3135,GO:0006968,HLA-G,cellular defense response,3.0
11083,3135,GO:0009897,HLA-G,external side of plasma membrane,3.0
11084,3135,GO:0012507,HLA-G,ER to Golgi transport vesicle membrane,3.0
11085,3135,GO:0016020,HLA-G,membrane,3.0
11086,3135,GO:0016525,HLA-G,negative regulation of angiogenesis,3.0
11087,3135,GO:0030670,HLA-G,phagocytic vesicle membrane,3.0
11088,3135,GO:0031527,HLA-G,filopodium membrane,3.0
11089,3135,GO:0031901,HLA-G,early endosome membrane,3.0
11090,3135,GO:0032735,HLA-G,positive regulation of interleukin-12 production,3.0
11091,3135,GO:0033106,HLA-G,cis-Golgi network membrane,3.0
11092,3135,GO:0042130,HLA-G,negative regulation of T cell proliferation,3.0
11093,3135,GO:0042270,HLA-G,protection from natural killer cell mediated cytotoxicity,3.0
11094,3135,GO:0042605,HLA-G,peptide antigen binding,3.0
11096,3135,GO:0042610,HLA-G,CD8 receptor binding,3.0
11097,3135,GO:0042612,HLA-G,MHC class I protein complex,3.0
11098,3135,GO:0042802,HLA-G,identical protein binding,3.0
11099,3135,GO:0042803,HLA-G,protein homodimerization activity,3.0
11100,3135,GO:0045591,HLA-G,positive regulation of regulatory T cell differentiation,3.0
11101,3135,GO:0045953,HLA-G,negative regulation of natural killer cell mediated cytotoxicity,3.0
11103,3135,GO:0050776,HLA-G,regulation of immune response,3.0
11104,3135,GO:0050777,HLA-G,negative regulation of immune response,3.0
11105,3135,GO:0051898,HLA-G,negative regulation of protein kinase B signaling,3.0
11106,3135,GO:0055038,HLA-G,recycling endosome membrane,3.0
11107,3135,GO:0060333,HLA-G,interferon-gamma-mediated signaling pathway,3.0
11108,3135,GO:0060337,HLA-G,type I interferon signaling pathway,3.0
11109,3135,GO:0060907,HLA-G,positive regulation of macrophage cytokine production,3.0
11110,3135,GO:0070207,HLA-G,protein homotrimerization,3.0
11111,3135,GO:0070317,HLA-G,negative regulation of G0 to G1 transition,3.0
11112,3135,GO:0071556,HLA-G,integral component of lumenal side of endoplasmic reticulum membrane,3.0
11113,3135,GO:2000353,HLA-G,positive regulation of endothelial cell apoptotic process,3.0
11114,3135,GO:2000774,HLA-G,positive regulation of cellular senescence,3.0
11115,3135,GO:2001199,HLA-G,negative regulation of dendritic cell differentiation,3.0
11137,222537,GO:0000139,HS3ST5,Golgi membrane,3.0
11138,222537,GO:0005515,HS3ST5,protein binding,3.0
11139,222537,GO:0006024,HS3ST5,glycosaminoglycan biosynthetic process,3.0
11140,222537,GO:0006477,HS3ST5,protein sulfation,3.0
11141,222537,GO:0008467,HS3ST5,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,3.0
11143,222537,GO:0015015,HS3ST5,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification",3.0
11144,222537,GO:0016021,HS3ST5,integral component of membrane,3.0
11145,222537,GO:0046596,HS3ST5,regulation of viral entry into host cell,3.0
11146,222537,GO:0050656,HS3ST5,3'-phosphoadenosine 5'-phosphosulfate binding,3.0
11147,222537,GO:0050819,HS3ST5,negative regulation of coagulation,3.0
11148,3290,GO:0003845,HSD11B1,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,3.0
11149,3290,GO:0005496,HSD11B1,steroid binding,3.0
11150,3290,GO:0005789,HSD11B1,endoplasmic reticulum membrane,3.0
11151,3290,GO:0006704,HSD11B1,glucocorticoid biosynthetic process,3.0
11152,3290,GO:0006706,HSD11B1,steroid catabolic process,3.0
11153,3290,GO:0016020,HSD11B1,membrane,3.0
11154,3290,GO:0030176,HSD11B1,integral component of endoplasmic reticulum membrane,3.0
11155,3290,GO:0030324,HSD11B1,lung development,3.0
11156,3290,GO:0042803,HSD11B1,protein homodimerization activity,3.0
11157,3290,GO:0050661,HSD11B1,NADP binding,3.0
11158,3290,GO:0055114,HSD11B1,oxidation-reduction process,3.0
11159,3290,GO:0070524,HSD11B1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,3.0
11160,3351,GO:0002031,HTR1B,G protein-coupled receptor internalization,3.0
11161,3351,GO:0004993,HTR1B,G protein-coupled serotonin receptor activity,3.0
11163,3351,GO:0005515,HTR1B,protein binding,3.0
11164,3351,GO:0005737,HTR1B,cytoplasm,3.0
11165,3351,GO:0005886,HTR1B,plasma membrane,3.0
11167,3351,GO:0005887,HTR1B,integral component of plasma membrane,3.0
11169,3351,GO:0007186,HTR1B,G protein-coupled receptor signaling pathway,3.0
11170,3351,GO:0007187,HTR1B,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",3.0
11171,3351,GO:0007193,HTR1B,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,3.0
11172,3351,GO:0007198,HTR1B,adenylate cyclase-inhibiting serotonin receptor signaling pathway,3.0
11174,3351,GO:0007205,HTR1B,protein kinase C-activating G protein-coupled receptor signaling pathway,3.0
11175,3351,GO:0007268,HTR1B,chemical synaptic transmission,3.0
11176,3351,GO:0008144,HTR1B,drug binding,3.0
11177,3351,GO:0014053,HTR1B,negative regulation of gamma-aminobutyric acid secretion,3.0
11178,3351,GO:0014059,HTR1B,regulation of dopamine secretion,3.0
11179,3351,GO:0014063,HTR1B,negative regulation of serotonin secretion,3.0
11180,3351,GO:0030425,HTR1B,dendrite,3.0
11181,3351,GO:0030594,HTR1B,neurotransmitter receptor activity,3.0
11182,3351,GO:0032229,HTR1B,"negative regulation of synaptic transmission, GABAergic",3.0
11183,3351,GO:0035690,HTR1B,cellular response to drug,3.0
11184,3351,GO:0042220,HTR1B,response to cocaine,3.0
11185,3351,GO:0042310,HTR1B,vasoconstriction,3.0
11186,3351,GO:0042756,HTR1B,drinking behavior,3.0
11187,3351,GO:0044305,HTR1B,calyx of Held,3.0
11188,3351,GO:0045471,HTR1B,response to ethanol,3.0
11189,3351,GO:0046849,HTR1B,bone remodeling,3.0
11190,3351,GO:0050795,HTR1B,regulation of behavior,3.0
11191,3351,GO:0051378,HTR1B,serotonin binding,3.0
11192,3351,GO:0051385,HTR1B,response to mineralocorticoid,3.0
11193,3351,GO:0051967,HTR1B,"negative regulation of synaptic transmission, glutamatergic",3.0
11194,3351,GO:0071312,HTR1B,cellular response to alkaloid,3.0
11195,3351,GO:0071502,HTR1B,cellular response to temperature stimulus,3.0
11196,3351,GO:0098666,HTR1B,G protein-coupled serotonin receptor complex,3.0
11197,3351,GO:0099056,HTR1B,integral component of presynaptic membrane,3.0
11198,3351,GO:0099154,HTR1B,serotonergic synapse,3.0
11199,3351,GO:0099509,HTR1B,regulation of presynaptic cytosolic calcium ion concentration,3.0
11200,3351,GO:0099626,HTR1B,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,3.0
11201,3351,GO:1904707,HTR1B,positive regulation of vascular associated smooth muscle cell proliferation,3.0
11202,3359,GO:0004888,HTR3A,transmembrane signaling receptor activity,3.0
11203,3359,GO:0005515,HTR3A,protein binding,3.0
11204,3359,GO:0005737,HTR3A,cytoplasm,3.0
11205,3359,GO:0005886,HTR3A,plasma membrane,3.0
11206,3359,GO:0005887,HTR3A,integral component of plasma membrane,3.0
11207,3359,GO:0007165,HTR3A,signal transduction,3.0
11208,3359,GO:0007210,HTR3A,serotonin receptor signaling pathway,3.0
11209,3359,GO:0007268,HTR3A,chemical synaptic transmission,3.0
11211,3359,GO:0022850,HTR3A,serotonin-gated cation-selective channel activity,3.0
11213,3359,GO:0030424,HTR3A,axon,3.0
11214,3359,GO:0030594,HTR3A,neurotransmitter receptor activity,3.0
11215,3359,GO:0032154,HTR3A,cleavage furrow,3.0
11216,3359,GO:0032414,HTR3A,positive regulation of ion transmembrane transporter activity,3.0
11217,3359,GO:0034220,HTR3A,ion transmembrane transport,3.0
11218,3359,GO:0042220,HTR3A,response to cocaine,3.0
11219,3359,GO:0042391,HTR3A,regulation of membrane potential,3.0
11220,3359,GO:0043005,HTR3A,neuron projection,3.0
11221,3359,GO:0043025,HTR3A,neuronal cell body,3.0
11222,3359,GO:0045202,HTR3A,synapse,3.0
11223,3359,GO:0045211,HTR3A,postsynaptic membrane,3.0
11224,3359,GO:0045471,HTR3A,response to ethanol,3.0
11225,3359,GO:0050877,HTR3A,nervous system process,3.0
11226,3359,GO:0051378,HTR3A,serotonin binding,3.0
11227,3359,GO:0071363,HTR3A,cellular response to growth factor stimulus,3.0
11228,3359,GO:0099056,HTR3A,integral component of presynaptic membrane,3.0
11229,3359,GO:1904602,HTR3A,serotonin-activated cation-selective channel complex,3.0
11230,170572,GO:0004888,HTR3C,transmembrane signaling receptor activity,3.0
11231,170572,GO:0005515,HTR3C,protein binding,3.0
11232,170572,GO:0005886,HTR3C,plasma membrane,3.0
11233,170572,GO:0005887,HTR3C,integral component of plasma membrane,3.0
11234,170572,GO:0007165,HTR3C,signal transduction,3.0
11235,170572,GO:0007210,HTR3C,serotonin receptor signaling pathway,3.0
11236,170572,GO:0007268,HTR3C,chemical synaptic transmission,3.0
11238,170572,GO:0022850,HTR3C,serotonin-gated cation-selective channel activity,3.0
11240,170572,GO:0030594,HTR3C,neurotransmitter receptor activity,3.0
11241,170572,GO:0034220,HTR3C,ion transmembrane transport,3.0
11242,170572,GO:0042391,HTR3C,regulation of membrane potential,3.0
11243,170572,GO:0043005,HTR3C,neuron projection,3.0
11244,170572,GO:0045202,HTR3C,synapse,3.0
11245,170572,GO:0050877,HTR3C,nervous system process,3.0
11284,54768,GO:0002064,HYDIN,epithelial cell development,3.0
11285,54768,GO:0003341,HYDIN,cilium movement,3.0
11286,54768,GO:0021591,HYDIN,ventricular system development,3.0
11287,54768,GO:0060438,HYDIN,trachea development,3.0
11288,54768,GO:1904158,HYDIN,axonemal central apparatus assembly,3.0
11289,54768,GO:1990716,HYDIN,axonemal central apparatus,3.0
11290,54768,GO:1990718,HYDIN,axonemal central pair projection,3.0
11305,7850,GO:0004908,IL1R2,interleukin-1 receptor activity,3.0
11306,7850,GO:0004910,IL1R2,"interleukin-1, type II, blocking receptor activity",3.0
11307,7850,GO:0005515,IL1R2,protein binding,3.0
11308,7850,GO:0005576,IL1R2,extracellular region,3.0
11309,7850,GO:0005737,IL1R2,cytoplasm,3.0
11310,7850,GO:0005886,IL1R2,plasma membrane,3.0
11311,7850,GO:0006955,IL1R2,immune response,3.0
11312,7850,GO:0010955,IL1R2,negative regulation of protein processing,3.0
11313,7850,GO:0016021,IL1R2,integral component of membrane,3.0
11314,7850,GO:0019221,IL1R2,cytokine-mediated signaling pathway,3.0
11315,7850,GO:0019966,IL1R2,interleukin-1 binding,3.0
11316,7850,GO:0032690,IL1R2,negative regulation of interleukin-1 alpha production,3.0
11317,7850,GO:0070498,IL1R2,interleukin-1-mediated signaling pathway,3.0
11318,7850,GO:1900016,IL1R2,negative regulation of cytokine production involved in inflammatory response,3.0
11319,7850,GO:2000660,IL1R2,negative regulation of interleukin-1-mediated signaling pathway,3.0
11320,11141,GO:0005102,IL1RAPL1,signaling receptor binding,3.0
11321,11141,GO:0005515,IL1RAPL1,protein binding,3.0
11322,11141,GO:0005737,IL1RAPL1,cytoplasm,3.0
11323,11141,GO:0005886,IL1RAPL1,plasma membrane,3.0
11325,11141,GO:0007157,IL1RAPL1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,3.0
11326,11141,GO:0007165,IL1RAPL1,signal transduction,3.0
11327,11141,GO:0009986,IL1RAPL1,cell surface,3.0
11328,11141,GO:0010975,IL1RAPL1,regulation of neuron projection development,3.0
11329,11141,GO:0016021,IL1RAPL1,integral component of membrane,3.0
11330,11141,GO:0019966,IL1RAPL1,interleukin-1 binding,3.0
11331,11141,GO:0030182,IL1RAPL1,neuron differentiation,3.0
11332,11141,GO:0030424,IL1RAPL1,axon,3.0
11333,11141,GO:0030425,IL1RAPL1,dendrite,3.0
11334,11141,GO:0045211,IL1RAPL1,postsynaptic membrane,3.0
11335,11141,GO:0045920,IL1RAPL1,negative regulation of exocytosis,3.0
11337,11141,GO:0050135,IL1RAPL1,NAD(P)+ nucleosidase activity,3.0
11338,11141,GO:0050775,IL1RAPL1,positive regulation of dendrite morphogenesis,3.0
11339,11141,GO:0051965,IL1RAPL1,positive regulation of synapse assembly,3.0
11340,11141,GO:0061809,IL1RAPL1,"NAD+ nucleotidase, cyclic ADP-ribose generating",3.0
11341,11141,GO:0071345,IL1RAPL1,cellular response to cytokine stimulus,3.0
11342,11141,GO:0097105,IL1RAPL1,presynaptic membrane assembly,3.0
11343,11141,GO:0098978,IL1RAPL1,glutamatergic synapse,3.0
11345,11141,GO:0099175,IL1RAPL1,regulation of postsynapse organization,3.0
11347,11141,GO:0099545,IL1RAPL1,trans-synaptic signaling by trans-synaptic complex,3.0
11349,11141,GO:1905606,IL1RAPL1,regulation of presynapse assembly,3.0
11351,26280,GO:0004908,IL1RAPL2,interleukin-1 receptor activity,3.0
11352,26280,GO:0004910,IL1RAPL2,"interleukin-1, type II, blocking receptor activity",3.0
11353,26280,GO:0005886,IL1RAPL2,plasma membrane,3.0
11354,26280,GO:0007417,IL1RAPL2,central nervous system development,3.0
11355,26280,GO:0016021,IL1RAPL2,integral component of membrane,3.0
11356,26280,GO:0019221,IL1RAPL2,cytokine-mediated signaling pathway,3.0
11357,26280,GO:0050135,IL1RAPL2,NAD(P)+ nucleosidase activity,3.0
11358,26280,GO:0061809,IL1RAPL2,"NAD+ nucleotidase, cyclic ADP-ribose generating",3.0
11359,26280,GO:0098978,IL1RAPL2,glutamatergic synapse,3.0
11361,26280,GO:1905606,IL1RAPL2,regulation of presynapse assembly,3.0
11379,83943,GO:0001541,IMMP2L,ovarian follicle development,3.0
11380,83943,GO:0004252,IMMP2L,serine-type endopeptidase activity,3.0
11381,83943,GO:0006465,IMMP2L,signal peptide processing,3.0
11382,83943,GO:0006627,IMMP2L,protein processing involved in protein targeting to mitochondrion,3.0
11384,83943,GO:0006801,IMMP2L,superoxide metabolic process,3.0
11385,83943,GO:0006974,IMMP2L,cellular response to DNA damage stimulus,3.0
11386,83943,GO:0007283,IMMP2L,spermatogenesis,3.0
11387,83943,GO:0007420,IMMP2L,brain development,3.0
11388,83943,GO:0008015,IMMP2L,blood circulation,3.0
11389,83943,GO:0008233,IMMP2L,peptidase activity,3.0
11390,83943,GO:0016021,IMMP2L,integral component of membrane,3.0
11391,83943,GO:0022904,IMMP2L,respiratory electron transport chain,3.0
11392,83943,GO:0030728,IMMP2L,ovulation,3.0
11393,83943,GO:0033108,IMMP2L,mitochondrial respiratory chain complex assembly,3.0
11394,83943,GO:0042720,IMMP2L,mitochondrial inner membrane peptidase complex,3.0
11396,83943,GO:0061300,IMMP2L,cerebellum vasculature development,3.0
11397,3628,GO:0004441,INPP1,"inositol-1,4-bisphosphate 1-phosphatase activity",3.0
11398,3628,GO:0005515,INPP1,protein binding,3.0
11399,3628,GO:0005829,INPP1,cytosol,3.0
11400,3628,GO:0006796,INPP1,phosphate-containing compound metabolic process,3.0
11401,3628,GO:0007165,INPP1,signal transduction,3.0
11402,3628,GO:0043647,INPP1,inositol phosphate metabolic process,3.0
11403,3628,GO:0046854,INPP1,phosphatidylinositol phosphorylation,3.0
11404,3628,GO:0046855,INPP1,inositol phosphate dephosphorylation,3.0
11405,3628,GO:0046872,INPP1,metal ion binding,3.0
11426,128239,GO:0000082,IQGAP3,G1/S transition of mitotic cell cycle,3.0
11427,128239,GO:0000187,IQGAP3,activation of MAPK activity,3.0
11428,128239,GO:0005096,IQGAP3,GTPase activator activity,3.0
11429,128239,GO:0005515,IQGAP3,protein binding,3.0
11430,128239,GO:0005516,IQGAP3,calmodulin binding,3.0
11432,128239,GO:0005737,IQGAP3,cytoplasm,3.0
11433,128239,GO:0005829,IQGAP3,cytosol,3.0
11434,128239,GO:0005911,IQGAP3,cell-cell junction,3.0
11435,128239,GO:0007265,IQGAP3,Ras protein signal transduction,3.0
11436,128239,GO:0008361,IQGAP3,regulation of cell size,3.0
11437,128239,GO:0010628,IQGAP3,positive regulation of gene expression,3.0
11438,128239,GO:0010629,IQGAP3,negative regulation of gene expression,3.0
11439,128239,GO:0016328,IQGAP3,lateral plasma membrane,3.0
11440,128239,GO:0031267,IQGAP3,small GTPase binding,3.0
11441,128239,GO:0032956,IQGAP3,regulation of actin cytoskeleton organization,3.0
11442,128239,GO:0033601,IQGAP3,positive regulation of mammary gland epithelial cell proliferation,3.0
11443,128239,GO:0043547,IQGAP3,positive regulation of GTPase activity,3.0
11444,128239,GO:0051015,IQGAP3,actin filament binding,3.0
11445,128239,GO:0070371,IQGAP3,ERK1 and ERK2 cascade,3.0
11446,128239,GO:0070856,IQGAP3,myosin VI light chain binding,3.0
11447,128239,GO:0071310,IQGAP3,cellular response to organic substance,3.0
11571,3708,GO:0001666,ITPR1,response to hypoxia,3.0
11572,3708,GO:0005220,ITPR1,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",3.0
11575,3708,GO:0005509,ITPR1,calcium ion binding,3.0
11576,3708,GO:0005515,ITPR1,protein binding,3.0
11577,3708,GO:0005637,ITPR1,nuclear inner membrane,3.0
11578,3708,GO:0005730,ITPR1,nucleolus,3.0
11579,3708,GO:0005783,ITPR1,endoplasmic reticulum,3.0
11581,3708,GO:0005789,ITPR1,endoplasmic reticulum membrane,3.0
11583,3708,GO:0005886,ITPR1,plasma membrane,3.0
11584,3708,GO:0005955,ITPR1,calcineurin complex,3.0
11585,3708,GO:0006816,ITPR1,calcium ion transport,3.0
11586,3708,GO:0007165,ITPR1,signal transduction,3.0
11587,3708,GO:0009791,ITPR1,post-embryonic development,3.0
11588,3708,GO:0010506,ITPR1,regulation of autophagy,3.0
11589,3708,GO:0014069,ITPR1,postsynaptic density,3.0
11590,3708,GO:0015085,ITPR1,calcium ion transmembrane transporter activity,3.0
11591,3708,GO:0015278,ITPR1,calcium-release channel activity,3.0
11592,3708,GO:0016020,ITPR1,membrane,3.0
11593,3708,GO:0016021,ITPR1,integral component of membrane,3.0
11594,3708,GO:0016529,ITPR1,sarcoplasmic reticulum,3.0
11595,3708,GO:0019855,ITPR1,calcium channel inhibitor activity,3.0
11596,3708,GO:0030168,ITPR1,platelet activation,3.0
11597,3708,GO:0030658,ITPR1,transport vesicle membrane,3.0
11598,3708,GO:0030659,ITPR1,cytoplasmic vesicle membrane,3.0
11599,3708,GO:0030667,ITPR1,secretory granule membrane,3.0
11600,3708,GO:0031088,ITPR1,platelet dense granule membrane,3.0
11601,3708,GO:0031094,ITPR1,platelet dense tubular network,3.0
11602,3708,GO:0031095,ITPR1,platelet dense tubular network membrane,3.0
11603,3708,GO:0032469,ITPR1,endoplasmic reticulum calcium ion homeostasis,3.0
11604,3708,GO:0035091,ITPR1,phosphatidylinositol binding,3.0
11606,3708,GO:0042045,ITPR1,epithelial fluid transport,3.0
11607,3708,GO:0048016,ITPR1,inositol phosphate-mediated signaling,3.0
11608,3708,GO:0048471,ITPR1,perinuclear region of cytoplasm,3.0
11609,3708,GO:0050796,ITPR1,regulation of insulin secretion,3.0
11610,3708,GO:0050849,ITPR1,negative regulation of calcium-mediated signaling,3.0
11611,3708,GO:0050882,ITPR1,voluntary musculoskeletal movement,3.0
11612,3708,GO:0051209,ITPR1,release of sequestered calcium ion into cytosol,3.0
11614,3708,GO:0070059,ITPR1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,3.0
11615,3708,GO:0070679,ITPR1,"inositol 1,4,5 trisphosphate binding",3.0
11616,3708,GO:1903779,ITPR1,regulation of cardiac conduction,3.0
11617,6453,GO:0005085,ITSN1,guanyl-nucleotide exchange factor activity,3.0
11618,6453,GO:0005509,ITSN1,calcium ion binding,3.0
11619,6453,GO:0005515,ITSN1,protein binding,3.0
11620,6453,GO:0005635,ITSN1,nuclear envelope,3.0
11621,6453,GO:0005737,ITSN1,cytoplasm,3.0
11622,6453,GO:0005829,ITSN1,cytosol,3.0
11623,6453,GO:0005886,ITSN1,plasma membrane,3.0
11625,6453,GO:0005905,ITSN1,clathrin-coated pit,3.0
11628,6453,GO:0006887,ITSN1,exocytosis,3.0
11629,6453,GO:0006897,ITSN1,endocytosis,3.0
11630,6453,GO:0007186,ITSN1,G protein-coupled receptor signaling pathway,3.0
11631,6453,GO:0007420,ITSN1,brain development,3.0
11632,6453,GO:0015031,ITSN1,protein transport,3.0
11633,6453,GO:0016032,ITSN1,viral process,3.0
11634,6453,GO:0016197,ITSN1,endosomal transport,3.0
11635,6453,GO:0030027,ITSN1,lamellipodium,3.0
11636,6453,GO:0033674,ITSN1,positive regulation of kinase activity,3.0
11637,6453,GO:0034613,ITSN1,cellular protein localization,3.0
11638,6453,GO:0035556,ITSN1,intracellular signal transduction,3.0
11639,6453,GO:0042734,ITSN1,presynaptic membrane,3.0
11640,6453,GO:0043025,ITSN1,neuronal cell body,3.0
11641,6453,GO:0043065,ITSN1,positive regulation of apoptotic process,3.0
11642,6453,GO:0043197,ITSN1,dendritic spine,3.0
11643,6453,GO:0048013,ITSN1,ephrin receptor signaling pathway,3.0
11644,6453,GO:0051056,ITSN1,regulation of small GTPase mediated signal transduction,3.0
11645,6453,GO:0055037,ITSN1,recycling endosome,3.0
11646,6453,GO:0060090,ITSN1,molecular adaptor activity,3.0
11648,6453,GO:0060124,ITSN1,positive regulation of growth hormone secretion,3.0
11649,6453,GO:0060999,ITSN1,positive regulation of dendritic spine development,3.0
11650,6453,GO:0061024,ITSN1,membrane organization,3.0
11651,6453,GO:0070064,ITSN1,proline-rich region binding,3.0
11652,6453,GO:0097440,ITSN1,apical dendrite,3.0
11653,6453,GO:0097708,ITSN1,intracellular vesicle,3.0
11654,6453,GO:0098978,ITSN1,glutamatergic synapse,3.0
11655,6453,GO:0150007,ITSN1,clathrin-dependent synaptic vesicle endocytosis,3.0
11656,6453,GO:1905274,ITSN1,regulation of modification of postsynaptic actin cytoskeleton,3.0
11657,6453,GO:2001288,ITSN1,positive regulation of caveolin-mediated endocytosis,3.0
11687,221037,GO:0000118,JMJD1C,histone deacetylase complex,3.0
11688,221037,GO:0000785,JMJD1C,chromatin,3.0
11689,221037,GO:0003712,JMJD1C,transcription coregulator activity,3.0
11690,221037,GO:0005515,JMJD1C,protein binding,3.0
11691,221037,GO:0005654,JMJD1C,nucleoplasm,3.0
11692,221037,GO:0006355,JMJD1C,"regulation of transcription, DNA-templated",3.0
11693,221037,GO:0006357,JMJD1C,regulation of transcription by RNA polymerase II,3.0
11694,221037,GO:0007596,JMJD1C,blood coagulation,3.0
11695,221037,GO:0031490,JMJD1C,chromatin DNA binding,3.0
11696,221037,GO:0032454,JMJD1C,histone demethylase activity (H3-K9 specific),3.0
11698,221037,GO:0033169,JMJD1C,histone H3-K9 demethylation,3.0
11699,221037,GO:0046872,JMJD1C,metal ion binding,3.0
11700,221037,GO:0046966,JMJD1C,thyroid hormone receptor binding,3.0
11701,221037,GO:0051213,JMJD1C,dioxygenase activity,3.0
11702,221037,GO:0055114,JMJD1C,oxidation-reduction process,3.0
11703,23189,GO:0005515,KANK1,protein binding,3.0
11704,23189,GO:0005634,KANK1,nucleus,3.0
11705,23189,GO:0005737,KANK1,cytoplasm,3.0
11707,23189,GO:0005856,KANK1,cytoskeleton,3.0
11708,23189,GO:0005886,KANK1,plasma membrane,3.0
11709,23189,GO:0008013,KANK1,beta-catenin binding,3.0
11710,23189,GO:0008283,KANK1,cell population proliferation,3.0
11711,23189,GO:0010977,KANK1,negative regulation of neuron projection development,3.0
11712,23189,GO:0030036,KANK1,actin cytoskeleton organization,3.0
11713,23189,GO:0030177,KANK1,positive regulation of Wnt signaling pathway,3.0
11714,23189,GO:0030336,KANK1,negative regulation of cell migration,3.0
11715,23189,GO:0030837,KANK1,negative regulation of actin filament polymerization,3.0
11717,23189,GO:0032587,KANK1,ruffle membrane,3.0
11718,23189,GO:0035023,KANK1,regulation of Rho protein signal transduction,3.0
11719,23189,GO:0035024,KANK1,negative regulation of Rho protein signal transduction,3.0
11720,23189,GO:0046627,KANK1,negative regulation of insulin receptor signaling pathway,3.0
11721,23189,GO:0090263,KANK1,positive regulation of canonical Wnt signaling pathway,3.0
11722,23189,GO:0090303,KANK1,positive regulation of wound healing,3.0
11723,23189,GO:0090521,KANK1,glomerular visceral epithelial cell migration,3.0
11724,23189,GO:1900025,KANK1,negative regulation of substrate adhesion-dependent cell spreading,3.0
11725,23189,GO:1900028,KANK1,negative regulation of ruffle assembly,3.0
11726,23189,GO:2000114,KANK1,regulation of establishment of cell polarity,3.0
11727,23189,GO:2000393,KANK1,negative regulation of lamellipodium morphogenesis,3.0
11838,84056,GO:0000922,KATNAL1,spindle pole,3.0
11839,84056,GO:0005515,KATNAL1,protein binding,3.0
11840,84056,GO:0005524,KATNAL1,ATP binding,3.0
11841,84056,GO:0005634,KATNAL1,nucleus,3.0
11842,84056,GO:0005737,KATNAL1,cytoplasm,3.0
11843,84056,GO:0005813,KATNAL1,centrosome,3.0
11844,84056,GO:0005819,KATNAL1,spindle,3.0
11845,84056,GO:0005874,KATNAL1,microtubule,3.0
11846,84056,GO:0007283,KATNAL1,spermatogenesis,3.0
11847,84056,GO:0008017,KATNAL1,microtubule binding,3.0
11848,84056,GO:0008568,KATNAL1,microtubule-severing ATPase activity,3.0
11850,84056,GO:0015630,KATNAL1,microtubule cytoskeleton,3.0
11851,84056,GO:0016853,KATNAL1,isomerase activity,3.0
11852,84056,GO:0016887,KATNAL1,ATPase activity,3.0
11853,84056,GO:0031122,KATNAL1,cytoplasmic microtubule organization,3.0
11854,84056,GO:0042802,KATNAL1,identical protein binding,3.0
11855,84056,GO:0051013,KATNAL1,microtubule severing,3.0
11916,3746,GO:0005249,KCNC1,voltage-gated potassium channel activity,3.0
11917,3746,GO:0005251,KCNC1,delayed rectifier potassium channel activity,3.0
11919,3746,GO:0005515,KCNC1,protein binding,3.0
11920,3746,GO:0005886,KCNC1,plasma membrane,3.0
11921,3746,GO:0006813,KCNC1,potassium ion transport,3.0
11922,3746,GO:0008076,KCNC1,voltage-gated potassium channel complex,3.0
11925,3746,GO:0009636,KCNC1,response to toxic substance,3.0
11926,3746,GO:0009642,KCNC1,response to light intensity,3.0
11927,3746,GO:0009986,KCNC1,cell surface,3.0
11928,3746,GO:0010996,KCNC1,response to auditory stimulus,3.0
11929,3746,GO:0014075,KCNC1,response to amine,3.0
11930,3746,GO:0016021,KCNC1,integral component of membrane,3.0
11931,3746,GO:0019894,KCNC1,kinesin binding,3.0
11932,3746,GO:0021549,KCNC1,cerebellum development,3.0
11933,3746,GO:0021759,KCNC1,globus pallidus development,3.0
11934,3746,GO:0030424,KCNC1,axon,3.0
11935,3746,GO:0030673,KCNC1,axolemma,3.0
11936,3746,GO:0032590,KCNC1,dendrite membrane,3.0
11937,3746,GO:0032809,KCNC1,neuronal cell body membrane,3.0
11939,3746,GO:0035690,KCNC1,cellular response to drug,3.0
11940,3746,GO:0035864,KCNC1,response to potassium ion,3.0
11941,3746,GO:0044325,KCNC1,ion channel binding,3.0
11942,3746,GO:0051260,KCNC1,protein homooligomerization,3.0
11943,3746,GO:0051262,KCNC1,protein tetramerization,3.0
11944,3746,GO:0071774,KCNC1,response to fibroblast growth factor,3.0
11945,3746,GO:0071805,KCNC1,potassium ion transmembrane transport,3.0
11947,3746,GO:0099056,KCNC1,integral component of presynaptic membrane,3.0
11948,3746,GO:0099505,KCNC1,regulation of presynaptic membrane potential,3.0
11949,3746,GO:0099508,KCNC1,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,3.0
11950,3746,GO:1903818,KCNC1,positive regulation of voltage-gated potassium channel activity,3.0
11951,3746,GO:1990089,KCNC1,response to nerve growth factor,3.0
11952,3751,GO:0001508,KCND2,action potential,3.0
11953,3751,GO:0005249,KCND2,voltage-gated potassium channel activity,3.0
11957,3751,GO:0005250,KCND2,A-type (transient outward) potassium channel activity,3.0
11960,3751,GO:0005515,KCND2,protein binding,3.0
11961,3751,GO:0005886,KCND2,plasma membrane,3.0
11962,3751,GO:0005887,KCND2,integral component of plasma membrane,3.0
11963,3751,GO:0007268,KCND2,chemical synaptic transmission,3.0
11964,3751,GO:0008076,KCND2,voltage-gated potassium channel complex,3.0
11966,3751,GO:0014069,KCND2,postsynaptic density,3.0
11967,3751,GO:0016021,KCND2,integral component of membrane,3.0
11968,3751,GO:0031226,KCND2,intrinsic component of plasma membrane,3.0
11969,3751,GO:0032809,KCND2,neuronal cell body membrane,3.0
11970,3751,GO:0034765,KCND2,regulation of ion transmembrane transport,3.0
11971,3751,GO:0043197,KCND2,dendritic spine,3.0
11974,3751,GO:0043204,KCND2,perikaryon,3.0
11975,3751,GO:0044853,KCND2,plasma membrane raft,3.0
11976,3751,GO:0045211,KCND2,postsynaptic membrane,3.0
11978,3751,GO:0046872,KCND2,metal ion binding,3.0
11979,3751,GO:0051260,KCND2,protein homooligomerization,3.0
11980,3751,GO:0060078,KCND2,regulation of postsynaptic membrane potential,3.0
11981,3751,GO:0061337,KCND2,cardiac conduction,3.0
11982,3751,GO:0071456,KCND2,cellular response to hypoxia,3.0
11983,3751,GO:0071805,KCND2,potassium ion transmembrane transport,3.0
11985,3751,GO:1905030,KCND2,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,3.0
11986,3752,GO:0005249,KCND3,voltage-gated potassium channel activity,3.0
11987,3752,GO:0005250,KCND3,A-type (transient outward) potassium channel activity,3.0
11988,3752,GO:0005515,KCND3,protein binding,3.0
11989,3752,GO:0005886,KCND3,plasma membrane,3.0
11990,3752,GO:0006813,KCND3,potassium ion transport,3.0
11991,3752,GO:0008076,KCND3,voltage-gated potassium channel complex,3.0
11993,3752,GO:0014069,KCND3,postsynaptic density,3.0
11994,3752,GO:0016021,KCND3,integral component of membrane,3.0
11995,3752,GO:0034765,KCND3,regulation of ion transmembrane transport,3.0
11996,3752,GO:0042383,KCND3,sarcolemma,3.0
11997,3752,GO:0043025,KCND3,neuronal cell body,3.0
11998,3752,GO:0043197,KCND3,dendritic spine,3.0
11999,3752,GO:0044325,KCND3,ion channel binding,3.0
12000,3752,GO:0045211,KCND3,postsynaptic membrane,3.0
12001,3752,GO:0046872,KCND3,metal ion binding,3.0
12002,3752,GO:0051260,KCND3,protein homooligomerization,3.0
12003,3752,GO:0061337,KCND3,cardiac conduction,3.0
12004,3752,GO:0071805,KCND3,potassium ion transmembrane transport,3.0
12005,3752,GO:0086008,KCND3,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,3.0
12006,3752,GO:0086009,KCND3,membrane repolarization,3.0
12007,3752,GO:0086013,KCND3,membrane repolarization during cardiac muscle cell action potential,3.0
12008,3752,GO:0086091,KCND3,regulation of heart rate by cardiac conduction,3.0
12009,3752,GO:0097623,KCND3,potassium ion export across plasma membrane,3.0
12012,3752,GO:0098915,KCND3,membrane repolarization during ventricular cardiac muscle cell action potential,3.0
12013,3752,GO:0099625,KCND3,ventricular cardiac muscle cell membrane repolarization,3.0
12014,3752,GO:1902282,KCND3,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,3.0
12036,3772,GO:0005242,KCNJ15,inward rectifier potassium channel activity,3.0
12037,3772,GO:0005515,KCNJ15,protein binding,3.0
12038,3772,GO:0005886,KCNJ15,plasma membrane,3.0
12040,3772,GO:0005887,KCNJ15,integral component of plasma membrane,3.0
12041,3772,GO:0006813,KCNJ15,potassium ion transport,3.0
12042,3772,GO:0034765,KCNJ15,regulation of ion transmembrane transport,3.0
12043,3772,GO:1990573,KCNJ15,potassium ion import across plasma membrane,3.0
12044,10089,GO:0005244,KCNK7,voltage-gated ion channel activity,3.0
12045,10089,GO:0005267,KCNK7,potassium channel activity,3.0
12046,10089,GO:0005886,KCNK7,plasma membrane,3.0
12047,10089,GO:0005887,KCNK7,integral component of plasma membrane,3.0
12048,10089,GO:0006813,KCNK7,potassium ion transport,3.0
12049,10089,GO:0022841,KCNK7,potassium ion leak channel activity,3.0
12050,10089,GO:0030322,KCNK7,stabilization of membrane potential,3.0
12051,10089,GO:0034765,KCNK7,regulation of ion transmembrane transport,3.0
12052,10089,GO:0071805,KCNK7,potassium ion transmembrane transport,3.0
12053,3778,GO:0001666,KCNMA1,response to hypoxia,3.0
12054,3778,GO:0003779,KCNMA1,actin binding,3.0
12055,3778,GO:0005249,KCNMA1,voltage-gated potassium channel activity,3.0
12057,3778,GO:0005515,KCNMA1,protein binding,3.0
12058,3778,GO:0005886,KCNMA1,plasma membrane,3.0
12059,3778,GO:0005901,KCNMA1,caveola,3.0
12060,3778,GO:0006813,KCNMA1,potassium ion transport,3.0
12061,3778,GO:0006970,KCNMA1,response to osmotic stress,3.0
12062,3778,GO:0008076,KCNMA1,voltage-gated potassium channel complex,3.0
12063,3778,GO:0015269,KCNMA1,calcium-activated potassium channel activity,3.0
12064,3778,GO:0016021,KCNMA1,integral component of membrane,3.0
12065,3778,GO:0016324,KCNMA1,apical plasma membrane,3.0
12066,3778,GO:0030007,KCNMA1,cellular potassium ion homeostasis,3.0
12067,3778,GO:0034465,KCNMA1,response to carbon monoxide,3.0
12069,3778,GO:0034765,KCNMA1,regulation of ion transmembrane transport,3.0
12070,3778,GO:0042391,KCNMA1,regulation of membrane potential,3.0
12071,3778,GO:0043065,KCNMA1,positive regulation of apoptotic process,3.0
12072,3778,GO:0045211,KCNMA1,postsynaptic membrane,3.0
12073,3778,GO:0045794,KCNMA1,negative regulation of cell volume,3.0
12074,3778,GO:0046872,KCNMA1,metal ion binding,3.0
12075,3778,GO:0051592,KCNMA1,response to calcium ion,3.0
12076,3778,GO:0060072,KCNMA1,large conductance calcium-activated potassium channel activity,3.0
12079,3778,GO:0060073,KCNMA1,micturition,3.0
12080,3778,GO:0060083,KCNMA1,smooth muscle contraction involved in micturition,3.0
12081,3778,GO:0060087,KCNMA1,relaxation of vascular associated smooth muscle,3.0
12082,3778,GO:0071805,KCNMA1,potassium ion transmembrane transport,3.0
12083,3479,GO:0000187,IGF1,activation of MAPK activity,3.0
12084,3479,GO:0001501,IGF1,skeletal system development,3.0
12085,3479,GO:0001775,IGF1,cell activation,3.0
12086,3479,GO:0002576,IGF1,platelet degranulation,3.0
12087,3479,GO:0005158,IGF1,insulin receptor binding,3.0
12088,3479,GO:0005159,IGF1,insulin-like growth factor receptor binding,3.0
12091,3479,GO:0005178,IGF1,integrin binding,3.0
12092,3479,GO:0005179,IGF1,hormone activity,3.0
12093,3479,GO:0005515,IGF1,protein binding,3.0
12094,3479,GO:0005576,IGF1,extracellular region,3.0
12096,3479,GO:0005615,IGF1,extracellular space,3.0
12097,3479,GO:0007165,IGF1,signal transduction,3.0
12098,3479,GO:0007265,IGF1,Ras protein signal transduction,3.0
12099,3479,GO:0007517,IGF1,muscle organ development,3.0
12100,3479,GO:0008083,IGF1,growth factor activity,3.0
12101,3479,GO:0008283,IGF1,cell population proliferation,3.0
12102,3479,GO:0008284,IGF1,positive regulation of cell population proliferation,3.0
12104,3479,GO:0009408,IGF1,response to heat,3.0
12105,3479,GO:0009441,IGF1,glycolate metabolic process,3.0
12106,3479,GO:0010468,IGF1,regulation of gene expression,3.0
12107,3479,GO:0010560,IGF1,positive regulation of glycoprotein biosynthetic process,3.0
12108,3479,GO:0010613,IGF1,positive regulation of cardiac muscle hypertrophy,3.0
12110,3479,GO:0010628,IGF1,positive regulation of gene expression,3.0
12111,3479,GO:0010629,IGF1,negative regulation of gene expression,3.0
12112,3479,GO:0014065,IGF1,phosphatidylinositol 3-kinase signaling,3.0
12113,3479,GO:0014068,IGF1,positive regulation of phosphatidylinositol 3-kinase signaling,3.0
12114,3479,GO:0014834,IGF1,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,3.0
12115,3479,GO:0014896,IGF1,muscle hypertrophy,3.0
12116,3479,GO:0014904,IGF1,myotube cell development,3.0
12117,3479,GO:0014911,IGF1,positive regulation of smooth muscle cell migration,3.0
12118,3479,GO:0016942,IGF1,insulin-like growth factor binding protein complex,3.0
12119,3479,GO:0030166,IGF1,proteoglycan biosynthetic process,3.0
12121,3479,GO:0030335,IGF1,positive regulation of cell migration,3.0
12122,3479,GO:0031093,IGF1,platelet alpha granule lumen,3.0
12123,3479,GO:0032148,IGF1,activation of protein kinase B activity,3.0
12124,3479,GO:0032691,IGF1,negative regulation of interleukin-1 beta production,3.0
12125,3479,GO:0032720,IGF1,negative regulation of tumor necrosis factor production,3.0
12126,3479,GO:0034392,IGF1,negative regulation of smooth muscle cell apoptotic process,3.0
12127,3479,GO:0035630,IGF1,bone mineralization involved in bone maturation,3.0
12128,3479,GO:0035867,IGF1,alphav-beta3 integrin-IGF-1-IGF1R complex,3.0
12129,3479,GO:0040014,IGF1,regulation of multicellular organism growth,3.0
12130,3479,GO:0042060,IGF1,wound healing,3.0
12131,3479,GO:0042104,IGF1,positive regulation of activated T cell proliferation,3.0
12132,3479,GO:0042531,IGF1,positive regulation of tyrosine phosphorylation of STAT protein,3.0
12133,3479,GO:0042567,IGF1,insulin-like growth factor ternary complex,3.0
12134,3479,GO:0043066,IGF1,negative regulation of apoptotic process,3.0
12135,3479,GO:0043388,IGF1,positive regulation of DNA binding,3.0
12136,3479,GO:0043410,IGF1,positive regulation of MAPK cascade,3.0
12137,3479,GO:0043491,IGF1,protein kinase B signaling,3.0
12138,3479,GO:0043568,IGF1,positive regulation of insulin-like growth factor receptor signaling pathway,3.0
12139,3479,GO:0044267,IGF1,cellular protein metabolic process,3.0
12140,3479,GO:0045445,IGF1,myoblast differentiation,3.0
12141,3479,GO:0045669,IGF1,positive regulation of osteoblast differentiation,3.0
12142,3479,GO:0045725,IGF1,positive regulation of glycogen biosynthetic process,3.0
12143,3479,GO:0045821,IGF1,positive regulation of glycolytic process,3.0
12144,3479,GO:0045840,IGF1,positive regulation of mitotic nuclear division,3.0
12145,3479,GO:0045893,IGF1,"positive regulation of transcription, DNA-templated",3.0
12147,3479,GO:0045944,IGF1,positive regulation of transcription by RNA polymerase II,3.0
12148,3479,GO:0046326,IGF1,positive regulation of glucose import,3.0
12149,3479,GO:0046579,IGF1,positive regulation of Ras protein signal transduction,3.0
12150,3479,GO:0048009,IGF1,insulin-like growth factor receptor signaling pathway,3.0
12151,3479,GO:0048015,IGF1,phosphatidylinositol-mediated signaling,3.0
12152,3479,GO:0048146,IGF1,positive regulation of fibroblast proliferation,3.0
12153,3479,GO:0048661,IGF1,positive regulation of smooth muscle cell proliferation,3.0
12154,3479,GO:0050679,IGF1,positive regulation of epithelial cell proliferation,3.0
12155,3479,GO:0050714,IGF1,positive regulation of protein secretion,3.0
12156,3479,GO:0050731,IGF1,positive regulation of peptidyl-tyrosine phosphorylation,3.0
12157,3479,GO:0050821,IGF1,protein stabilization,3.0
12158,3479,GO:0051450,IGF1,myoblast proliferation,3.0
12159,3479,GO:0060283,IGF1,negative regulation of oocyte development,3.0
12160,3479,GO:0061051,IGF1,positive regulation of cell growth involved in cardiac muscle cell development,3.0
12162,3479,GO:0070371,IGF1,ERK1 and ERK2 cascade,3.0
12163,3479,GO:0070382,IGF1,exocytic vesicle,3.0
12164,3479,GO:0070886,IGF1,positive regulation of calcineurin-NFAT signaling cascade,3.0
12165,3479,GO:0090201,IGF1,negative regulation of release of cytochrome c from mitochondria,3.0
12166,3479,GO:0150079,IGF1,negative regulation of neuroinflammatory response,3.0
12167,3479,GO:1902430,IGF1,negative regulation of amyloid-beta formation,3.0
12168,3479,GO:1904075,IGF1,positive regulation of trophectodermal cell proliferation,3.0
12169,3479,GO:1904646,IGF1,cellular response to amyloid-beta,3.0
12170,3479,GO:1904707,IGF1,positive regulation of vascular associated smooth muscle cell proliferation,3.0
12171,3479,GO:1905460,IGF1,negative regulation of vascular associated smooth muscle cell apoptotic process,3.0
12172,3479,GO:2000679,IGF1,positive regulation of transcription regulatory region DNA binding,3.0
12173,3479,GO:2001237,IGF1,negative regulation of extrinsic apoptotic signaling pathway,3.0
12232,253980,GO:0004842,KCTD13,ubiquitin-protein transferase activity,3.0
12234,253980,GO:0005515,KCTD13,protein binding,3.0
12235,253980,GO:0005654,KCTD13,nucleoplasm,3.0
12236,253980,GO:0006260,KCTD13,DNA replication,3.0
12237,253980,GO:0016477,KCTD13,cell migration,3.0
12238,253980,GO:0016567,KCTD13,protein ubiquitination,3.0
12241,253980,GO:0016604,KCTD13,nuclear body,3.0
12242,253980,GO:0019904,KCTD13,protein domain specific binding,3.0
12243,253980,GO:0031267,KCTD13,small GTPase binding,3.0
12245,253980,GO:0031463,KCTD13,Cul3-RING ubiquitin ligase complex,3.0
12247,253980,GO:0035024,KCTD13,negative regulation of Rho protein signal transduction,3.0
12250,253980,GO:0042802,KCTD13,identical protein binding,3.0
12251,253980,GO:0043149,KCTD13,stress fiber assembly,3.0
12252,253980,GO:0043161,KCTD13,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
12254,253980,GO:0045740,KCTD13,positive regulation of DNA replication,3.0
12255,253980,GO:0050806,KCTD13,positive regulation of synaptic transmission,3.0
12256,253980,GO:0051260,KCTD13,protein homooligomerization,3.0
12257,253980,GO:0061351,KCTD13,neural precursor cell proliferation,3.0
12258,221656,GO:0000122,KDM1B,negative regulation of transcription by RNA polymerase II,3.0
12259,221656,GO:0000785,KDM1B,chromatin,3.0
12260,221656,GO:0000786,KDM1B,nucleosome,3.0
12261,221656,GO:0003682,KDM1B,chromatin binding,3.0
12262,221656,GO:0005515,KDM1B,protein binding,3.0
12263,221656,GO:0005634,KDM1B,nucleus,3.0
12264,221656,GO:0005654,KDM1B,nucleoplasm,3.0
12265,221656,GO:0006349,KDM1B,regulation of gene expression by genetic imprinting,3.0
12266,221656,GO:0007275,KDM1B,multicellular organism development,3.0
12267,221656,GO:0008134,KDM1B,transcription factor binding,3.0
12268,221656,GO:0008270,KDM1B,zinc ion binding,3.0
12269,221656,GO:0016491,KDM1B,oxidoreductase activity,3.0
12270,221656,GO:0016579,KDM1B,protein deubiquitination,3.0
12271,221656,GO:0034648,KDM1B,histone demethylase activity (H3-dimethyl-K4 specific),3.0
12274,221656,GO:0034649,KDM1B,histone demethylase activity (H3-monomethyl-K4 specific),3.0
12276,221656,GO:0034720,KDM1B,histone H3-K4 demethylation,3.0
12278,221656,GO:0042393,KDM1B,histone binding,3.0
12279,221656,GO:0043046,KDM1B,DNA methylation involved in gamete generation,3.0
12280,221656,GO:0044030,KDM1B,regulation of DNA methylation,3.0
12281,221656,GO:0045944,KDM1B,positive regulation of transcription by RNA polymerase II,3.0
12282,221656,GO:0050660,KDM1B,flavin adenine dinucleotide binding,3.0
12283,221656,GO:0055114,KDM1B,oxidation-reduction process,3.0
12284,221656,GO:0071949,KDM1B,FAD binding,3.0
12300,23030,GO:0005654,KDM4B,nucleoplasm,3.0
12301,23030,GO:0006338,KDM4B,chromatin remodeling,3.0
12302,23030,GO:0032452,KDM4B,histone demethylase activity,3.0
12303,23030,GO:0032454,KDM4B,histone demethylase activity (H3-K9 specific),3.0
12307,23030,GO:0033169,KDM4B,histone H3-K9 demethylation,3.0
12309,23030,GO:0035097,KDM4B,histone methyltransferase complex,3.0
12310,23030,GO:0046872,KDM4B,metal ion binding,3.0
12311,23030,GO:0051864,KDM4B,histone demethylase activity (H3-K36 specific),3.0
12312,23030,GO:0055114,KDM4B,oxidation-reduction process,3.0
12313,23030,GO:0070544,KDM4B,histone H3-K36 demethylation,3.0
12452,202559,GO:0000381,KHDRBS2,"regulation of alternative mRNA splicing, via spliceosome",3.0
12453,202559,GO:0003729,KHDRBS2,mRNA binding,3.0
12454,202559,GO:0005515,KHDRBS2,protein binding,3.0
12455,202559,GO:0005634,KHDRBS2,nucleus,3.0
12456,202559,GO:0005654,KHDRBS2,nucleoplasm,3.0
12457,202559,GO:0006397,KHDRBS2,mRNA processing,3.0
12458,202559,GO:0008143,KHDRBS2,poly(A) binding,3.0
12459,202559,GO:0008266,KHDRBS2,poly(U) RNA binding,3.0
12460,202559,GO:0017124,KHDRBS2,SH3 domain binding,3.0
12461,202559,GO:0042169,KHDRBS2,SH2 domain binding,3.0
12467,23303,GO:0003777,KIF13B,microtubule motor activity,3.0
12469,23303,GO:0005515,KIF13B,protein binding,3.0
12470,23303,GO:0005524,KIF13B,ATP binding,3.0
12471,23303,GO:0005737,KIF13B,cytoplasm,3.0
12472,23303,GO:0005871,KIF13B,kinesin complex,3.0
12473,23303,GO:0005874,KIF13B,microtubule,3.0
12474,23303,GO:0006605,KIF13B,protein targeting,3.0
12475,23303,GO:0007018,KIF13B,microtubule-based movement,3.0
12477,23303,GO:0007165,KIF13B,signal transduction,3.0
12478,23303,GO:0008017,KIF13B,microtubule binding,3.0
12479,23303,GO:0016887,KIF13B,ATPase activity,3.0
12480,23303,GO:0019901,KIF13B,protein kinase binding,3.0
12481,23303,GO:0030424,KIF13B,axon,3.0
12482,23303,GO:0042110,KIF13B,T cell activation,3.0
12483,23303,GO:0050770,KIF13B,regulation of axonogenesis,3.0
12484,23303,GO:0071889,KIF13B,14-3-3 protein binding,3.0
12538,3800,GO:0003777,KIF5C,microtubule motor activity,3.0
12539,3800,GO:0005515,KIF5C,protein binding,3.0
12540,3800,GO:0005524,KIF5C,ATP binding,3.0
12541,3800,GO:0005871,KIF5C,kinesin complex,3.0
12542,3800,GO:0005874,KIF5C,microtubule,3.0
12543,3800,GO:0006996,KIF5C,organelle organization,3.0
12544,3800,GO:0007018,KIF5C,microtubule-based movement,3.0
12545,3800,GO:0007411,KIF5C,axon guidance,3.0
12546,3800,GO:0008017,KIF5C,microtubule binding,3.0
12547,3800,GO:0008045,KIF5C,motor neuron axon guidance,3.0
12548,3800,GO:0008574,KIF5C,"ATP-dependent microtubule motor activity, plus-end-directed",3.0
12549,3800,GO:0016887,KIF5C,ATPase activity,3.0
12550,3800,GO:0030705,KIF5C,cytoskeleton-dependent intracellular transport,3.0
12551,3800,GO:0032839,KIF5C,dendrite cytoplasm,3.0
12552,3800,GO:0035253,KIF5C,ciliary rootlet,3.0
12553,3800,GO:0043025,KIF5C,neuronal cell body,3.0
12554,3800,GO:0044295,KIF5C,axonal growth cone,3.0
12555,3800,GO:0048489,KIF5C,synaptic vesicle transport,3.0
12556,3800,GO:0051028,KIF5C,mRNA transport,3.0
12557,3800,GO:0098971,KIF5C,anterograde dendritic transport of neurotransmitter receptor complex,3.0
12558,3800,GO:0099641,KIF5C,anterograde axonal protein transport,3.0
12559,3800,GO:0150034,KIF5C,distal axon,3.0
12560,3800,GO:1904115,KIF5C,axon cytoplasm,3.0
12583,83855,GO:0000122,KLF16,negative regulation of transcription by RNA polymerase II,3.0
12584,83855,GO:0000785,KLF16,chromatin,3.0
12586,83855,GO:0000978,KLF16,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
12587,83855,GO:0000981,KLF16,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
12589,83855,GO:0001227,KLF16,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
12590,83855,GO:0005515,KLF16,protein binding,3.0
12591,83855,GO:0006357,KLF16,regulation of transcription by RNA polymerase II,3.0
12592,83855,GO:0007212,KLF16,dopamine receptor signaling pathway,3.0
12593,83855,GO:0046872,KLF16,metal ion binding,3.0
12594,83855,GO:1990837,KLF16,sequence-specific double-stranded DNA binding,3.0
12701,3827,GO:0002576,KNG1,platelet degranulation,3.0
12702,3827,GO:0004866,KNG1,endopeptidase inhibitor activity,3.0
12703,3827,GO:0004869,KNG1,cysteine-type endopeptidase inhibitor activity,3.0
12705,3827,GO:0005102,KNG1,signaling receptor binding,3.0
12706,3827,GO:0005515,KNG1,protein binding,3.0
12707,3827,GO:0005576,KNG1,extracellular region,3.0
12711,3827,GO:0005615,KNG1,extracellular space,3.0
12712,3827,GO:0005788,KNG1,endoplasmic reticulum lumen,3.0
12713,3827,GO:0005886,KNG1,plasma membrane,3.0
12714,3827,GO:0006954,KNG1,inflammatory response,3.0
12715,3827,GO:0007162,KNG1,negative regulation of cell adhesion,3.0
12716,3827,GO:0007186,KNG1,G protein-coupled receptor signaling pathway,3.0
12717,3827,GO:0007204,KNG1,positive regulation of cytosolic calcium ion concentration,3.0
12719,3827,GO:0007597,KNG1,"blood coagulation, intrinsic pathway",3.0
12720,3827,GO:0008201,KNG1,heparin binding,3.0
12721,3827,GO:0008270,KNG1,zinc ion binding,3.0
12722,3827,GO:0010951,KNG1,negative regulation of endopeptidase activity,3.0
12723,3827,GO:0030195,KNG1,negative regulation of blood coagulation,3.0
12725,3827,GO:0031093,KNG1,platelet alpha granule lumen,3.0
12726,3827,GO:0042311,KNG1,vasodilation,3.0
12727,3827,GO:0043065,KNG1,positive regulation of apoptotic process,3.0
12728,3827,GO:0043687,KNG1,post-translational protein modification,3.0
12729,3827,GO:0044267,KNG1,cellular protein metabolic process,3.0
12730,3827,GO:0045861,KNG1,negative regulation of proteolysis,3.0
12731,3827,GO:0062023,KNG1,collagen-containing extracellular matrix,3.0
12732,3827,GO:0070062,KNG1,extracellular exosome,3.0
12733,3827,GO:0072562,KNG1,blood microparticle,3.0
12752,11103,GO:0003723,KRR1,RNA binding,3.0
12753,11103,GO:0005515,KRR1,protein binding,3.0
12754,11103,GO:0005654,KRR1,nucleoplasm,3.0
12756,11103,GO:0005730,KRR1,nucleolus,3.0
12758,11103,GO:0005737,KRR1,cytoplasm,3.0
12759,11103,GO:0006364,KRR1,rRNA processing,3.0
12760,11103,GO:0016020,KRR1,membrane,3.0
12761,11103,GO:0032040,KRR1,small-subunit processome,3.0
12762,11103,GO:0045171,KRR1,intercellular bridge,3.0
12763,353288,GO:0005198,KRT26,structural molecule activity,3.0
12764,353288,GO:0005515,KRT26,protein binding,3.0
12765,353288,GO:0005829,KRT26,cytosol,3.0
12766,353288,GO:0005882,KRT26,intermediate filament,3.0
12767,353288,GO:0031424,KRT26,keratinization,3.0
12768,353288,GO:0070062,KRT26,extracellular exosome,3.0
12769,353288,GO:0070268,KRT26,cornification,3.0
12770,284217,GO:0002011,LAMA1,morphogenesis of an epithelial sheet,3.0
12771,284217,GO:0005102,LAMA1,signaling receptor binding,3.0
12772,284217,GO:0005201,LAMA1,extracellular matrix structural constituent,3.0
12774,284217,GO:0005515,LAMA1,protein binding,3.0
12775,284217,GO:0005576,LAMA1,extracellular region,3.0
12776,284217,GO:0005604,LAMA1,basement membrane,3.0
12778,284217,GO:0005606,LAMA1,laminin-1 complex,3.0
12780,284217,GO:0005608,LAMA1,laminin-3 complex,3.0
12781,284217,GO:0005615,LAMA1,extracellular space,3.0
12782,284217,GO:0005911,LAMA1,cell-cell junction,3.0
12783,284217,GO:0006468,LAMA1,protein phosphorylation,3.0
12784,284217,GO:0007155,LAMA1,cell adhesion,3.0
12785,284217,GO:0007166,LAMA1,cell surface receptor signaling pathway,3.0
12786,284217,GO:0007411,LAMA1,axon guidance,3.0
12787,284217,GO:0008022,LAMA1,protein C-terminus binding,3.0
12788,284217,GO:0009887,LAMA1,animal organ morphogenesis,3.0
12789,284217,GO:0009888,LAMA1,tissue development,3.0
12790,284217,GO:0016020,LAMA1,membrane,3.0
12791,284217,GO:0030155,LAMA1,regulation of cell adhesion,3.0
12792,284217,GO:0030198,LAMA1,extracellular matrix organization,3.0
12793,284217,GO:0030334,LAMA1,regulation of cell migration,3.0
12794,284217,GO:0031012,LAMA1,extracellular matrix,3.0
12795,284217,GO:0043010,LAMA1,camera-type eye development,3.0
12796,284217,GO:0043208,LAMA1,glycosphingolipid binding,3.0
12797,284217,GO:0045198,LAMA1,establishment of epithelial cell apical/basal polarity,3.0
12798,284217,GO:0045995,LAMA1,regulation of embryonic development,3.0
12799,284217,GO:0048514,LAMA1,blood vessel morphogenesis,3.0
12800,284217,GO:0060441,LAMA1,epithelial tube branching involved in lung morphogenesis,3.0
12801,284217,GO:0060445,LAMA1,branching involved in salivary gland morphogenesis,3.0
12802,284217,GO:0061304,LAMA1,retinal blood vessel morphogenesis,3.0
12803,284217,GO:0062023,LAMA1,collagen-containing extracellular matrix,3.0
12846,81887,GO:0000460,LAS1L,maturation of 5.8S rRNA,3.0
12847,81887,GO:0000470,LAS1L,maturation of LSU-rRNA,3.0
12848,81887,GO:0003723,LAS1L,RNA binding,3.0
12849,81887,GO:0004519,LAS1L,endonuclease activity,3.0
12850,81887,GO:0005515,LAS1L,protein binding,3.0
12851,81887,GO:0005654,LAS1L,nucleoplasm,3.0
12852,81887,GO:0005730,LAS1L,nucleolus,3.0
12853,81887,GO:0006364,LAS1L,rRNA processing,3.0
12854,81887,GO:0016020,LAS1L,membrane,3.0
12855,81887,GO:0030687,LAS1L,"preribosome, large subunit precursor",3.0
12856,81887,GO:0071339,LAS1L,MLL1 complex,3.0
12857,81887,GO:0090305,LAS1L,nucleic acid phosphodiester bond hydrolysis,3.0
12858,81887,GO:0090730,LAS1L,Las1 complex,3.0
12896,3949,GO:0001540,LDLR,amyloid-beta binding,3.0
12897,3949,GO:0001618,LDLR,virus receptor activity,3.0
12898,3949,GO:0002020,LDLR,protease binding,3.0
12899,3949,GO:0005041,LDLR,low-density lipoprotein particle receptor activity,3.0
12903,3949,GO:0005509,LDLR,calcium ion binding,3.0
12904,3949,GO:0005515,LDLR,protein binding,3.0
12905,3949,GO:0005764,LDLR,lysosome,3.0
12906,3949,GO:0005769,LDLR,early endosome,3.0
12907,3949,GO:0005770,LDLR,late endosome,3.0
12908,3949,GO:0005794,LDLR,Golgi apparatus,3.0
12909,3949,GO:0005886,LDLR,plasma membrane,3.0
12911,3949,GO:0005887,LDLR,integral component of plasma membrane,3.0
12912,3949,GO:0005905,LDLR,clathrin-coated pit,3.0
12913,3949,GO:0006629,LDLR,lipid metabolic process,3.0
12914,3949,GO:0006897,LDLR,endocytosis,3.0
12915,3949,GO:0006898,LDLR,receptor-mediated endocytosis,3.0
12917,3949,GO:0006909,LDLR,phagocytosis,3.0
12918,3949,GO:0007616,LDLR,long-term memory,3.0
12919,3949,GO:0008203,LDLR,cholesterol metabolic process,3.0
12920,3949,GO:0009897,LDLR,external side of plasma membrane,3.0
12921,3949,GO:0009986,LDLR,cell surface,3.0
12923,3949,GO:0010008,LDLR,endosome membrane,3.0
12924,3949,GO:0010628,LDLR,positive regulation of gene expression,3.0
12925,3949,GO:0010629,LDLR,negative regulation of gene expression,3.0
12926,3949,GO:0010867,LDLR,positive regulation of triglyceride biosynthetic process,3.0
12927,3949,GO:0010899,LDLR,regulation of phosphatidylcholine catabolic process,3.0
12928,3949,GO:0015914,LDLR,phospholipid transport,3.0
12929,3949,GO:0016020,LDLR,membrane,3.0
12930,3949,GO:0016323,LDLR,basolateral plasma membrane,3.0
12931,3949,GO:0030169,LDLR,low-density lipoprotein particle binding,3.0
12932,3949,GO:0030229,LDLR,very-low-density lipoprotein particle receptor activity,3.0
12933,3949,GO:0030299,LDLR,intestinal cholesterol absorption,3.0
12934,3949,GO:0030301,LDLR,cholesterol transport,3.0
12936,3949,GO:0030669,LDLR,clathrin-coated endocytic vesicle membrane,3.0
12937,3949,GO:0032050,LDLR,clathrin heavy chain binding,3.0
12938,3949,GO:0034362,LDLR,low-density lipoprotein particle,3.0
12939,3949,GO:0034381,LDLR,plasma lipoprotein particle clearance,3.0
12941,3949,GO:0034382,LDLR,chylomicron remnant clearance,3.0
12942,3949,GO:0034383,LDLR,low-density lipoprotein particle clearance,3.0
12944,3949,GO:0034384,LDLR,high-density lipoprotein particle clearance,3.0
12945,3949,GO:0036020,LDLR,endolysosome membrane,3.0
12946,3949,GO:0036477,LDLR,somatodendritic compartment,3.0
12947,3949,GO:0042159,LDLR,lipoprotein catabolic process,3.0
12948,3949,GO:0042632,LDLR,cholesterol homeostasis,3.0
12951,3949,GO:0042802,LDLR,identical protein binding,3.0
12952,3949,GO:0043235,LDLR,receptor complex,3.0
12953,3949,GO:0045177,LDLR,apical part of cell,3.0
12954,3949,GO:0046718,LDLR,viral entry into host cell,3.0
12955,3949,GO:0048844,LDLR,artery morphogenesis,3.0
12956,3949,GO:0050729,LDLR,positive regulation of inflammatory response,3.0
12957,3949,GO:0051246,LDLR,regulation of protein metabolic process,3.0
12958,3949,GO:0051248,LDLR,negative regulation of protein metabolic process,3.0
12959,3949,GO:0061024,LDLR,membrane organization,3.0
12960,3949,GO:0061771,LDLR,response to caloric restriction,3.0
12961,3949,GO:0061889,LDLR,negative regulation of astrocyte activation,3.0
12962,3949,GO:0070508,LDLR,cholesterol import,3.0
12964,3949,GO:0071398,LDLR,cellular response to fatty acid,3.0
12965,3949,GO:0071404,LDLR,cellular response to low-density lipoprotein particle stimulus,3.0
12966,3949,GO:0090118,LDLR,receptor-mediated endocytosis involved in cholesterol transport,3.0
12967,3949,GO:0090181,LDLR,regulation of cholesterol metabolic process,3.0
12968,3949,GO:0097242,LDLR,amyloid-beta clearance,3.0
12969,3949,GO:0097443,LDLR,sorting endosome,3.0
12970,3949,GO:0150094,LDLR,amyloid-beta clearance by cellular catabolic process,3.0
12971,3949,GO:1903979,LDLR,negative regulation of microglial cell activation,3.0
12972,3949,GO:1905167,LDLR,positive regulation of lysosomal protein catabolic process,3.0
12973,3949,GO:1905907,LDLR,negative regulation of amyloid fibril formation,3.0
12974,3949,GO:1990666,LDLR,PCSK9-LDLR complex,3.0
12997,3952,GO:0000122,LEP,negative regulation of transcription by RNA polymerase II,3.0
12998,3952,GO:0001525,LEP,angiogenesis,3.0
12999,3952,GO:0001542,LEP,ovulation from ovarian follicle,3.0
13000,3952,GO:0001666,LEP,response to hypoxia,3.0
13001,3952,GO:0001890,LEP,placenta development,3.0
13002,3952,GO:0001934,LEP,positive regulation of protein phosphorylation,3.0
13003,3952,GO:0001936,LEP,regulation of endothelial cell proliferation,3.0
13004,3952,GO:0002021,LEP,response to dietary excess,3.0
13005,3952,GO:0003300,LEP,cardiac muscle hypertrophy,3.0
13006,3952,GO:0005179,LEP,hormone activity,3.0
13007,3952,GO:0005515,LEP,protein binding,3.0
13008,3952,GO:0005576,LEP,extracellular region,3.0
13009,3952,GO:0005615,LEP,extracellular space,3.0
13011,3952,GO:0005829,LEP,cytosol,3.0
13012,3952,GO:0006006,LEP,glucose metabolic process,3.0
13013,3952,GO:0006111,LEP,regulation of gluconeogenesis,3.0
13014,3952,GO:0006112,LEP,energy reserve metabolic process,3.0
13015,3952,GO:0006114,LEP,glycerol biosynthetic process,3.0
13016,3952,GO:0006629,LEP,lipid metabolic process,3.0
13017,3952,GO:0006635,LEP,fatty acid beta-oxidation,3.0
13018,3952,GO:0006909,LEP,phagocytosis,3.0
13019,3952,GO:0007260,LEP,tyrosine phosphorylation of STAT protein,3.0
13020,3952,GO:0007565,LEP,female pregnancy,3.0
13021,3952,GO:0007623,LEP,circadian rhythm,3.0
13022,3952,GO:0008203,LEP,cholesterol metabolic process,3.0
13023,3952,GO:0008206,LEP,bile acid metabolic process,3.0
13024,3952,GO:0008217,LEP,regulation of blood pressure,3.0
13025,3952,GO:0008340,LEP,determination of adult lifespan,3.0
13026,3952,GO:0008343,LEP,adult feeding behavior,3.0
13027,3952,GO:0010507,LEP,negative regulation of autophagy,3.0
13028,3952,GO:0010888,LEP,negative regulation of lipid storage,3.0
13029,3952,GO:0014068,LEP,positive regulation of phosphatidylinositol 3-kinase signaling,3.0
13032,3952,GO:0014823,LEP,response to activity,3.0
13033,3952,GO:0019953,LEP,sexual reproduction,3.0
13034,3952,GO:0021954,LEP,central nervous system neuron development,3.0
13035,3952,GO:0030073,LEP,insulin secretion,3.0
13036,3952,GO:0030217,LEP,T cell differentiation,3.0
13037,3952,GO:0030300,LEP,regulation of intestinal cholesterol absorption,3.0
13038,3952,GO:0032008,LEP,positive regulation of TOR signaling,3.0
13040,3952,GO:0032099,LEP,negative regulation of appetite,3.0
13041,3952,GO:0032310,LEP,prostaglandin secretion,3.0
13042,3952,GO:0032355,LEP,response to estradiol,3.0
13043,3952,GO:0032615,LEP,interleukin-12 production,3.0
13044,3952,GO:0032635,LEP,interleukin-6 production,3.0
13045,3952,GO:0032637,LEP,interleukin-8 production,3.0
13046,3952,GO:0032760,LEP,positive regulation of tumor necrosis factor production,3.0
13047,3952,GO:0032814,LEP,regulation of natural killer cell activation,3.0
13048,3952,GO:0032817,LEP,regulation of natural killer cell proliferation,3.0
13049,3952,GO:0032868,LEP,response to insulin,3.0
13050,3952,GO:0032869,LEP,cellular response to insulin stimulus,3.0
13051,3952,GO:0033197,LEP,response to vitamin E,3.0
13052,3952,GO:0033210,LEP,leptin-mediated signaling pathway,3.0
13053,3952,GO:0033686,LEP,positive regulation of luteinizing hormone secretion,3.0
13054,3952,GO:0035360,LEP,positive regulation of peroxisome proliferator activated receptor signaling pathway,3.0
13055,3952,GO:0035556,LEP,intracellular signal transduction,3.0
13056,3952,GO:0035630,LEP,bone mineralization involved in bone maturation,3.0
13057,3952,GO:0035904,LEP,aorta development,3.0
13058,3952,GO:0038108,LEP,negative regulation of appetite by leptin-mediated signaling pathway,3.0
13060,3952,GO:0042102,LEP,positive regulation of T cell proliferation,3.0
13061,3952,GO:0042269,LEP,regulation of natural killer cell mediated cytotoxicity,3.0
13062,3952,GO:0042307,LEP,positive regulation of protein import into nucleus,3.0
13063,3952,GO:0042445,LEP,hormone metabolic process,3.0
13064,3952,GO:0042531,LEP,positive regulation of tyrosine phosphorylation of STAT protein,3.0
13065,3952,GO:0042593,LEP,glucose homeostasis,3.0
13066,3952,GO:0042755,LEP,eating behavior,3.0
13067,3952,GO:0043066,LEP,negative regulation of apoptotic process,3.0
13068,3952,GO:0043270,LEP,positive regulation of ion transport,3.0
13069,3952,GO:0043410,LEP,positive regulation of MAPK cascade,3.0
13071,3952,GO:0044320,LEP,cellular response to leptin stimulus,3.0
13072,3952,GO:0045471,LEP,response to ethanol,3.0
13073,3952,GO:0045765,LEP,regulation of angiogenesis,3.0
13074,3952,GO:0045906,LEP,negative regulation of vasoconstriction,3.0
13075,3952,GO:0046325,LEP,negative regulation of glucose import,3.0
13076,3952,GO:0046427,LEP,positive regulation of receptor signaling pathway via JAK-STAT,3.0
13078,3952,GO:0046628,LEP,positive regulation of insulin receptor signaling pathway,3.0
13079,3952,GO:0046850,LEP,regulation of bone remodeling,3.0
13080,3952,GO:0046881,LEP,positive regulation of follicle-stimulating hormone secretion,3.0
13081,3952,GO:0048639,LEP,positive regulation of developmental growth,3.0
13082,3952,GO:0050796,LEP,regulation of insulin secretion,3.0
13083,3952,GO:0050810,LEP,regulation of steroid biosynthetic process,3.0
13084,3952,GO:0050892,LEP,intestinal absorption,3.0
13085,3952,GO:0050901,LEP,leukocyte tethering or rolling,3.0
13086,3952,GO:0050999,LEP,regulation of nitric-oxide synthase activity,3.0
13087,3952,GO:0051428,LEP,peptide hormone receptor binding,3.0
13088,3952,GO:0051541,LEP,elastin metabolic process,3.0
13089,3952,GO:0051726,LEP,regulation of cell cycle,3.0
13090,3952,GO:0051897,LEP,positive regulation of protein kinase B signaling,3.0
13091,3952,GO:0060587,LEP,regulation of lipoprotein lipid oxidation,3.0
13092,3952,GO:0060612,LEP,adipose tissue development,3.0
13093,3952,GO:0061037,LEP,negative regulation of cartilage development,3.0
13094,3952,GO:0070093,LEP,negative regulation of glucagon secretion,3.0
13095,3952,GO:0071298,LEP,cellular response to L-ascorbic acid,3.0
13096,3952,GO:0071300,LEP,cellular response to retinoic acid,3.0
13097,3952,GO:0090335,LEP,regulation of brown fat cell differentiation,3.0
13098,3952,GO:0098868,LEP,bone growth,3.0
13099,3952,GO:0120162,LEP,positive regulation of cold-induced thermogenesis,3.0
13100,3952,GO:1900015,LEP,regulation of cytokine production involved in inflammatory response,3.0
13101,3952,GO:1900745,LEP,positive regulation of p38MAPK cascade,3.0
13103,3952,GO:1904651,LEP,positive regulation of fat cell apoptotic process,3.0
13104,3952,GO:1990051,LEP,activation of protein kinase C activity,3.0
13106,3952,GO:1990460,LEP,leptin receptor binding,3.0
13107,3952,GO:2000379,LEP,positive regulation of reactive oxygen species metabolic process,3.0
13108,3952,GO:2000486,LEP,negative regulation of glutamine transport,3.0
13109,3952,GO:2000491,LEP,positive regulation of hepatic stellate cell activation,3.0
13110,10288,GO:0001540,LILRB2,amyloid-beta binding,3.0
13112,10288,GO:0002250,LILRB2,adaptive immune response,3.0
13113,10288,GO:0002578,LILRB2,negative regulation of antigen processing and presentation,3.0
13114,10288,GO:0002645,LILRB2,positive regulation of tolerance induction,3.0
13115,10288,GO:0002666,LILRB2,positive regulation of T cell tolerance induction,3.0
13116,10288,GO:0002767,LILRB2,immune response-inhibiting cell surface receptor signaling pathway,3.0
13118,10288,GO:0002774,LILRB2,Fc receptor mediated inhibitory signaling pathway,3.0
13119,10288,GO:0005515,LILRB2,protein binding,3.0
13120,10288,GO:0005615,LILRB2,extracellular space,3.0
13121,10288,GO:0005737,LILRB2,cytoplasm,3.0
13122,10288,GO:0005886,LILRB2,plasma membrane,3.0
13123,10288,GO:0005887,LILRB2,integral component of plasma membrane,3.0
13124,10288,GO:0006955,LILRB2,immune response,3.0
13125,10288,GO:0006968,LILRB2,cellular defense response,3.0
13126,10288,GO:0007165,LILRB2,signal transduction,3.0
13128,10288,GO:0007166,LILRB2,cell surface receptor signaling pathway,3.0
13129,10288,GO:0007267,LILRB2,cell-cell signaling,3.0
13130,10288,GO:0007611,LILRB2,learning or memory,3.0
13131,10288,GO:0008157,LILRB2,protein phosphatase 1 binding,3.0
13132,10288,GO:0009986,LILRB2,cell surface,3.0
13133,10288,GO:0016020,LILRB2,membrane,3.0
13134,10288,GO:0023025,LILRB2,MHC class Ib protein complex binding,3.0
13135,10288,GO:0023029,LILRB2,MHC class Ib protein binding,3.0
13137,10288,GO:0032396,LILRB2,inhibitory MHC class I receptor activity,3.0
13139,10288,GO:0032755,LILRB2,positive regulation of interleukin-6 production,3.0
13140,10288,GO:0034113,LILRB2,heterotypic cell-cell adhesion,3.0
13141,10288,GO:0035307,LILRB2,positive regulation of protein dephosphorylation,3.0
13142,10288,GO:0042102,LILRB2,positive regulation of T cell proliferation,3.0
13143,10288,GO:0042130,LILRB2,negative regulation of T cell proliferation,3.0
13145,10288,GO:0042288,LILRB2,MHC class I protein binding,3.0
13147,10288,GO:0042803,LILRB2,protein homodimerization activity,3.0
13148,10288,GO:0043312,LILRB2,neutrophil degranulation,3.0
13149,10288,GO:0044877,LILRB2,protein-containing complex binding,3.0
13150,10288,GO:0045591,LILRB2,positive regulation of regulatory T cell differentiation,3.0
13151,10288,GO:0050776,LILRB2,regulation of immune response,3.0
13152,10288,GO:0050839,LILRB2,cell adhesion molecule binding,3.0
13153,10288,GO:0051248,LILRB2,negative regulation of protein metabolic process,3.0
13154,10288,GO:0051926,LILRB2,negative regulation of calcium ion transport,3.0
13155,10288,GO:0070821,LILRB2,tertiary granule membrane,3.0
13156,10288,GO:0071222,LILRB2,cellular response to lipopolysaccharide,3.0
13157,10288,GO:0101003,LILRB2,ficolin-1-rich granule membrane,3.0
13158,10288,GO:0140105,LILRB2,interleukin-10-mediated signaling pathway,3.0
13159,10288,GO:1900271,LILRB2,regulation of long-term synaptic potentiation,3.0
13160,10288,GO:1900454,LILRB2,positive regulation of long-term synaptic depression,3.0
13161,10288,GO:1905875,LILRB2,negative regulation of postsynaptic density organization,3.0
13162,10288,GO:2000524,LILRB2,negative regulation of T cell costimulation,3.0
13163,10288,GO:2001198,LILRB2,regulation of dendritic cell differentiation,3.0
13164,64130,GO:0005515,LIN7B,protein binding,3.0
13165,64130,GO:0005886,LIN7B,plasma membrane,3.0
13166,64130,GO:0005911,LIN7B,cell-cell junction,3.0
13167,64130,GO:0005923,LIN7B,bicellular tight junction,3.0
13168,64130,GO:0006887,LIN7B,exocytosis,3.0
13169,64130,GO:0007269,LIN7B,neurotransmitter secretion,3.0
13171,64130,GO:0015031,LIN7B,protein transport,3.0
13172,64130,GO:0016323,LIN7B,basolateral plasma membrane,3.0
13173,64130,GO:0019904,LIN7B,protein domain specific binding,3.0
13174,64130,GO:0045199,LIN7B,maintenance of epithelial cell apical/basal polarity,3.0
13175,64130,GO:0045202,LIN7B,synapse,3.0
13176,64130,GO:0097016,LIN7B,L27 domain binding,3.0
13177,64130,GO:0097025,LIN7B,MPP7-DLG1-LIN7 complex,3.0
13178,64130,GO:0098793,LIN7B,presynapse,3.0
13179,64130,GO:0098839,LIN7B,postsynaptic density membrane,3.0
13180,64130,GO:1903361,LIN7B,protein localization to basolateral plasma membrane,3.0
13181,987,GO:0003674,LRBA,molecular_function,3.0
13182,987,GO:0005764,LRBA,lysosome,3.0
13183,987,GO:0005783,LRBA,endoplasmic reticulum,3.0
13184,987,GO:0005794,LRBA,Golgi apparatus,3.0
13185,987,GO:0005829,LRBA,cytosol,3.0
13186,987,GO:0005886,LRBA,plasma membrane,3.0
13187,987,GO:0008104,LRBA,protein localization,3.0
13188,987,GO:0008150,LRBA,biological_process,3.0
13189,987,GO:0016020,LRBA,membrane,3.0
13191,987,GO:0016021,LRBA,integral component of membrane,3.0
13192,987,GO:0019901,LRBA,protein kinase binding,3.0
13193,57497,GO:0005886,LRFN2,plasma membrane,3.0
13194,57497,GO:0009986,LRFN2,cell surface,3.0
13195,57497,GO:0050804,LRFN2,modulation of chemical synaptic transmission,3.0
13196,57497,GO:0098685,LRFN2,Schaffer collateral - CA1 synapse,3.0
13197,57497,GO:0099061,LRFN2,integral component of postsynaptic density membrane,3.0
13198,57497,GO:0099175,LRFN2,regulation of postsynapse organization,3.0
13199,145581,GO:0005515,LRFN5,protein binding,3.0
13200,145581,GO:0009986,LRFN5,cell surface,3.0
13201,145581,GO:0043031,LRFN5,negative regulation of macrophage activation,3.0
13202,145581,GO:0050728,LRFN5,negative regulation of inflammatory response,3.0
13203,145581,GO:0098978,LRFN5,glutamatergic synapse,3.0
13204,145581,GO:0098982,LRFN5,GABA-ergic synapse,3.0
13205,145581,GO:0099061,LRFN5,integral component of postsynaptic density membrane,3.0
13206,145581,GO:0099560,LRFN5,synaptic membrane adhesion,3.0
13207,145581,GO:1905606,LRFN5,regulation of presynapse assembly,3.0
13328,4036,GO:0001523,LRP2,retinoid metabolic process,3.0
13329,4036,GO:0001822,LRP2,kidney development,3.0
13330,4036,GO:0001843,LRP2,neural tube closure,3.0
13331,4036,GO:0003139,LRP2,secondary heart field specification,3.0
13332,4036,GO:0003148,LRP2,outflow tract septum morphogenesis,3.0
13333,4036,GO:0003223,LRP2,ventricular compact myocardium morphogenesis,3.0
13334,4036,GO:0003281,LRP2,ventricular septum development,3.0
13335,4036,GO:0005509,LRP2,calcium ion binding,3.0
13336,4036,GO:0005515,LRP2,protein binding,3.0
13337,4036,GO:0005764,LRP2,lysosome,3.0
13338,4036,GO:0005765,LRP2,lysosomal membrane,3.0
13339,4036,GO:0005783,LRP2,endoplasmic reticulum,3.0
13340,4036,GO:0005794,LRP2,Golgi apparatus,3.0
13341,4036,GO:0005886,LRP2,plasma membrane,3.0
13343,4036,GO:0005905,LRP2,clathrin-coated pit,3.0
13344,4036,GO:0006629,LRP2,lipid metabolic process,3.0
13345,4036,GO:0006897,LRP2,endocytosis,3.0
13346,4036,GO:0006898,LRP2,receptor-mediated endocytosis,3.0
13349,4036,GO:0007605,LRP2,sensory perception of sound,3.0
13350,4036,GO:0008283,LRP2,cell population proliferation,3.0
13351,4036,GO:0008584,LRP2,male gonad development,3.0
13352,4036,GO:0009897,LRP2,external side of plasma membrane,3.0
13353,4036,GO:0015031,LRP2,protein transport,3.0
13354,4036,GO:0016021,LRP2,integral component of membrane,3.0
13355,4036,GO:0016324,LRP2,apical plasma membrane,3.0
13358,4036,GO:0017124,LRP2,SH3 domain binding,3.0
13359,4036,GO:0030001,LRP2,metal ion transport,3.0
13360,4036,GO:0030139,LRP2,endocytic vesicle,3.0
13361,4036,GO:0030424,LRP2,axon,3.0
13362,4036,GO:0030425,LRP2,dendrite,3.0
13363,4036,GO:0030514,LRP2,negative regulation of BMP signaling pathway,3.0
13364,4036,GO:0030665,LRP2,clathrin-coated vesicle membrane,3.0
13365,4036,GO:0030900,LRP2,forebrain development,3.0
13366,4036,GO:0031526,LRP2,brush border membrane,3.0
13367,4036,GO:0031904,LRP2,endosome lumen,3.0
13368,4036,GO:0031994,LRP2,insulin-like growth factor I binding,3.0
13369,4036,GO:0035904,LRP2,aorta development,3.0
13370,4036,GO:0042359,LRP2,vitamin D metabolic process,3.0
13371,4036,GO:0042562,LRP2,hormone binding,3.0
13372,4036,GO:0043066,LRP2,negative regulation of apoptotic process,3.0
13373,4036,GO:0043235,LRP2,receptor complex,3.0
13376,4036,GO:0044321,LRP2,response to leptin,3.0
13377,4036,GO:0045056,LRP2,transcytosis,3.0
13378,4036,GO:0050769,LRP2,positive regulation of neurogenesis,3.0
13379,4036,GO:0051087,LRP2,chaperone binding,3.0
13381,4036,GO:0051897,LRP2,positive regulation of protein kinase B signaling,3.0
13382,4036,GO:0060068,LRP2,vagina development,3.0
13383,4036,GO:0060982,LRP2,coronary artery morphogenesis,3.0
13384,4036,GO:0061024,LRP2,membrane organization,3.0
13385,4036,GO:0061156,LRP2,pulmonary artery morphogenesis,3.0
13386,4036,GO:0070062,LRP2,extracellular exosome,3.0
13387,4036,GO:0070447,LRP2,positive regulation of oligodendrocyte progenitor proliferation,3.0
13388,4036,GO:0071363,LRP2,cellular response to growth factor stimulus,3.0
13389,4036,GO:0097242,LRP2,amyloid-beta clearance,3.0
13390,4036,GO:0140058,LRP2,neuron projection arborization,3.0
13391,4036,GO:0140318,LRP2,protein transporter activity,3.0
13392,4036,GO:0150104,LRP2,transport across blood-brain barrier,3.0
13393,4036,GO:1904447,LRP2,folate import across plasma membrane,3.0
13394,4036,GO:1905167,LRP2,positive regulation of lysosomal protein catabolic process,3.0
13395,55227,GO:0005829,LRRC1,cytosol,3.0
13396,55227,GO:0016020,LRRC1,membrane,3.0
13397,64101,GO:0005515,LRRC4,protein binding,3.0
13398,64101,GO:0043197,LRRC4,dendritic spine,3.0
13399,64101,GO:0050804,LRRC4,modulation of chemical synaptic transmission,3.0
13400,64101,GO:0060076,LRRC4,excitatory synapse,3.0
13401,64101,GO:0097119,LRRC4,postsynaptic density protein 95 clustering,3.0
13402,64101,GO:0098685,LRRC4,Schaffer collateral - CA1 synapse,3.0
13403,64101,GO:0098978,LRRC4,glutamatergic synapse,3.0
13404,64101,GO:0099061,LRRC4,integral component of postsynaptic density membrane,3.0
13405,64101,GO:0099560,LRRC4,synaptic membrane adhesion,3.0
13406,64101,GO:1904861,LRRC4,excitatory synapse assembly,3.0
13448,4128,GO:0005515,MAOA,protein binding,3.0
13449,4128,GO:0005739,MAOA,mitochondrion,3.0
13451,4128,GO:0005741,MAOA,mitochondrial outer membrane,3.0
13452,4128,GO:0005829,MAOA,cytosol,3.0
13453,4128,GO:0006576,MAOA,cellular biogenic amine metabolic process,3.0
13454,4128,GO:0008131,MAOA,primary amine oxidase activity,3.0
13455,4128,GO:0009967,MAOA,positive regulation of signal transduction,3.0
13456,4128,GO:0016021,MAOA,integral component of membrane,3.0
13457,4128,GO:0019221,MAOA,cytokine-mediated signaling pathway,3.0
13458,4128,GO:0042133,MAOA,neurotransmitter metabolic process,3.0
13459,4128,GO:0042135,MAOA,neurotransmitter catabolic process,3.0
13460,4128,GO:0042420,MAOA,dopamine catabolic process,3.0
13461,4128,GO:0055114,MAOA,oxidation-reduction process,3.0
13462,4129,GO:0005515,MAOB,protein binding,3.0
13463,4129,GO:0005739,MAOB,mitochondrion,3.0
13464,4129,GO:0005740,MAOB,mitochondrial envelope,3.0
13465,4129,GO:0005741,MAOB,mitochondrial outer membrane,3.0
13466,4129,GO:0008131,MAOB,primary amine oxidase activity,3.0
13467,4129,GO:0009055,MAOB,electron transfer activity,3.0
13468,4129,GO:0009636,MAOB,response to toxic substance,3.0
13469,4129,GO:0010044,MAOB,response to aluminum ion,3.0
13470,4129,GO:0010269,MAOB,response to selenium ion,3.0
13471,4129,GO:0014063,MAOB,negative regulation of serotonin secretion,3.0
13472,4129,GO:0016021,MAOB,integral component of membrane,3.0
13473,4129,GO:0021762,MAOB,substantia nigra development,3.0
13474,4129,GO:0022900,MAOB,electron transport chain,3.0
13475,4129,GO:0032496,MAOB,response to lipopolysaccharide,3.0
13476,4129,GO:0042135,MAOB,neurotransmitter catabolic process,3.0
13477,4129,GO:0042420,MAOB,dopamine catabolic process,3.0
13478,4129,GO:0042493,MAOB,response to drug,3.0
13479,4129,GO:0042802,MAOB,identical protein binding,3.0
13480,4129,GO:0045471,MAOB,response to ethanol,3.0
13481,4129,GO:0045964,MAOB,positive regulation of dopamine metabolic process,3.0
13482,4129,GO:0050660,MAOB,flavin adenine dinucleotide binding,3.0
13483,4129,GO:0050665,MAOB,hydrogen peroxide biosynthetic process,3.0
13484,4129,GO:0051412,MAOB,response to corticosterone,3.0
13485,5595,GO:0000165,MAPK3,MAPK cascade,3.0
13487,5595,GO:0000186,MAPK3,activation of MAPKK activity,3.0
13488,5595,GO:0000187,MAPK3,activation of MAPK activity,3.0
13489,5595,GO:0001784,MAPK3,phosphotyrosine residue binding,3.0
13490,5595,GO:0001934,MAPK3,positive regulation of protein phosphorylation,3.0
13491,5595,GO:0002720,MAPK3,positive regulation of cytokine production involved in immune response,3.0
13492,5595,GO:0004707,MAPK3,MAP kinase activity,3.0
13495,5595,GO:0004708,MAPK3,MAP kinase kinase activity,3.0
13496,5595,GO:0005515,MAPK3,protein binding,3.0
13497,5595,GO:0005524,MAPK3,ATP binding,3.0
13498,5595,GO:0005634,MAPK3,nucleus,3.0
13500,5595,GO:0005635,MAPK3,nuclear envelope,3.0
13501,5595,GO:0005654,MAPK3,nucleoplasm,3.0
13502,5595,GO:0005737,MAPK3,cytoplasm,3.0
13504,5595,GO:0005739,MAPK3,mitochondrion,3.0
13505,5595,GO:0005769,MAPK3,early endosome,3.0
13506,5595,GO:0005770,MAPK3,late endosome,3.0
13507,5595,GO:0005794,MAPK3,Golgi apparatus,3.0
13508,5595,GO:0005829,MAPK3,cytosol,3.0
13509,5595,GO:0005856,MAPK3,cytoskeleton,3.0
13510,5595,GO:0005886,MAPK3,plasma membrane,3.0
13511,5595,GO:0005901,MAPK3,caveola,3.0
13513,5595,GO:0005925,MAPK3,focal adhesion,3.0
13514,5595,GO:0006361,MAPK3,transcription initiation from RNA polymerase I promoter,3.0
13515,5595,GO:0006468,MAPK3,protein phosphorylation,3.0
13516,5595,GO:0006915,MAPK3,apoptotic process,3.0
13517,5595,GO:0006975,MAPK3,DNA damage induced protein phosphorylation,3.0
13518,5595,GO:0007049,MAPK3,cell cycle,3.0
13519,5595,GO:0007166,MAPK3,cell surface receptor signaling pathway,3.0
13520,5595,GO:0007411,MAPK3,axon guidance,3.0
13521,5595,GO:0007568,MAPK3,aging,3.0
13522,5595,GO:0008543,MAPK3,fibroblast growth factor receptor signaling pathway,3.0
13523,5595,GO:0009636,MAPK3,response to toxic substance,3.0
13524,5595,GO:0010468,MAPK3,regulation of gene expression,3.0
13525,5595,GO:0010628,MAPK3,positive regulation of gene expression,3.0
13526,5595,GO:0010759,MAPK3,positive regulation of macrophage chemotaxis,3.0
13527,5595,GO:0014066,MAPK3,regulation of phosphatidylinositol 3-kinase signaling,3.0
13528,5595,GO:0016032,MAPK3,viral process,3.0
13529,5595,GO:0016310,MAPK3,phosphorylation,3.0
13530,5595,GO:0018105,MAPK3,peptidyl-serine phosphorylation,3.0
13531,5595,GO:0019233,MAPK3,sensory perception of pain,3.0
13532,5595,GO:0019369,MAPK3,arachidonic acid metabolic process,3.0
13533,5595,GO:0019902,MAPK3,phosphatase binding,3.0
13534,5595,GO:0030168,MAPK3,platelet activation,3.0
13535,5595,GO:0030278,MAPK3,regulation of ossification,3.0
13536,5595,GO:0030509,MAPK3,BMP signaling pathway,3.0
13537,5595,GO:0030641,MAPK3,regulation of cellular pH,3.0
13538,5595,GO:0030878,MAPK3,thyroid gland development,3.0
13539,5595,GO:0031143,MAPK3,pseudopodium,3.0
13540,5595,GO:0031281,MAPK3,positive regulation of cyclase activity,3.0
13541,5595,GO:0031663,MAPK3,lipopolysaccharide-mediated signaling pathway,3.0
13542,5595,GO:0032212,MAPK3,positive regulation of telomere maintenance via telomerase,3.0
13543,5595,GO:0032872,MAPK3,regulation of stress-activated MAPK cascade,3.0
13544,5595,GO:0032991,MAPK3,protein-containing complex,3.0
13545,5595,GO:0033129,MAPK3,positive regulation of histone phosphorylation,3.0
13546,5595,GO:0034198,MAPK3,cellular response to amino acid starvation,3.0
13547,5595,GO:0034614,MAPK3,cellular response to reactive oxygen species,3.0
13548,5595,GO:0035066,MAPK3,positive regulation of histone acetylation,3.0
13549,5595,GO:0035556,MAPK3,intracellular signal transduction,3.0
13550,5595,GO:0038083,MAPK3,peptidyl-tyrosine autophosphorylation,3.0
13551,5595,GO:0038095,MAPK3,Fc-epsilon receptor signaling pathway,3.0
13552,5595,GO:0038096,MAPK3,Fc-gamma receptor signaling pathway involved in phagocytosis,3.0
13553,5595,GO:0042473,MAPK3,outer ear morphogenesis,3.0
13554,5595,GO:0042802,MAPK3,identical protein binding,3.0
13555,5595,GO:0043330,MAPK3,response to exogenous dsRNA,3.0
13556,5595,GO:0045727,MAPK3,positive regulation of translation,3.0
13557,5595,GO:0045944,MAPK3,positive regulation of transcription by RNA polymerase II,3.0
13558,5595,GO:0046697,MAPK3,decidualization,3.0
13559,5595,GO:0048538,MAPK3,thymus development,3.0
13560,5595,GO:0051090,MAPK3,regulation of DNA-binding transcription factor activity,3.0
13561,5595,GO:0051216,MAPK3,cartilage development,3.0
13562,5595,GO:0051403,MAPK3,stress-activated MAPK cascade,3.0
13563,5595,GO:0051493,MAPK3,regulation of cytoskeleton organization,3.0
13564,5595,GO:0051973,MAPK3,positive regulation of telomerase activity,3.0
13565,5595,GO:0060020,MAPK3,Bergmann glial cell differentiation,3.0
13566,5595,GO:0060324,MAPK3,face development,3.0
13567,5595,GO:0060425,MAPK3,lung morphogenesis,3.0
13568,5595,GO:0060440,MAPK3,trachea formation,3.0
13569,5595,GO:0061308,MAPK3,cardiac neural crest cell development involved in heart development,3.0
13570,5595,GO:0065003,MAPK3,protein-containing complex assembly,3.0
13571,5595,GO:0070371,MAPK3,ERK1 and ERK2 cascade,3.0
13572,5595,GO:0070374,MAPK3,positive regulation of ERK1 and ERK2 cascade,3.0
13573,5595,GO:0070498,MAPK3,interleukin-1-mediated signaling pathway,3.0
13574,5595,GO:0070849,MAPK3,response to epidermal growth factor,3.0
13575,5595,GO:0071260,MAPK3,cellular response to mechanical stimulus,3.0
13576,5595,GO:0071276,MAPK3,cellular response to cadmium ion,3.0
13577,5595,GO:0071356,MAPK3,cellular response to tumor necrosis factor,3.0
13578,5595,GO:0072584,MAPK3,caveolin-mediated endocytosis,3.0
13579,5595,GO:0090170,MAPK3,regulation of Golgi inheritance,3.0
13580,5595,GO:0097110,MAPK3,scaffold protein binding,3.0
13581,5595,GO:0120041,MAPK3,positive regulation of macrophage proliferation,3.0
13582,5595,GO:1900034,MAPK3,regulation of cellular response to heat,3.0
13583,5595,GO:1903351,MAPK3,cellular response to dopamine,3.0
13584,5595,GO:1904355,MAPK3,positive regulation of telomere capping,3.0
13585,5595,GO:1904417,MAPK3,positive regulation of xenophagy,3.0
13586,5595,GO:1905050,MAPK3,positive regulation of metallopeptidase activity,3.0
13587,5595,GO:2000641,MAPK3,regulation of early endosome to late endosome transport,3.0
13588,5595,GO:2000657,MAPK3,negative regulation of apolipoprotein binding,3.0
13589,4139,GO:0000226,MARK1,microtubule cytoskeleton organization,3.0
13591,4139,GO:0000287,MARK1,magnesium ion binding,3.0
13592,4139,GO:0001764,MARK1,neuron migration,3.0
13593,4139,GO:0001786,MARK1,phosphatidylserine binding,3.0
13594,4139,GO:0004674,MARK1,protein serine/threonine kinase activity,3.0
13597,4139,GO:0005515,MARK1,protein binding,3.0
13598,4139,GO:0005524,MARK1,ATP binding,3.0
13599,4139,GO:0005546,MARK1,"phosphatidylinositol-4,5-bisphosphate binding",3.0
13600,4139,GO:0005737,MARK1,cytoplasm,3.0
13603,4139,GO:0005856,MARK1,cytoskeleton,3.0
13604,4139,GO:0005886,MARK1,plasma membrane,3.0
13605,4139,GO:0006468,MARK1,protein phosphorylation,3.0
13607,4139,GO:0007010,MARK1,cytoskeleton organization,3.0
13608,4139,GO:0010975,MARK1,regulation of neuron projection development,3.0
13609,4139,GO:0015630,MARK1,microtubule cytoskeleton,3.0
13610,4139,GO:0016055,MARK1,Wnt signaling pathway,3.0
13611,4139,GO:0018105,MARK1,peptidyl-serine phosphorylation,3.0
13612,4139,GO:0030425,MARK1,dendrite,3.0
13613,4139,GO:0035556,MARK1,intracellular signal transduction,3.0
13615,4139,GO:0048156,MARK1,tau protein binding,3.0
13616,4139,GO:0050321,MARK1,tau-protein kinase activity,3.0
13620,4139,GO:0050773,MARK1,regulation of dendrite development,3.0
13621,4139,GO:0051654,MARK1,establishment of mitochondrion localization,3.0
13622,4139,GO:0070300,MARK1,phosphatidic acid binding,3.0
13623,4139,GO:0106310,MARK1,protein serine kinase activity,3.0
13624,4139,GO:0106311,MARK1,protein threonine kinase activity,3.0
13625,4152,GO:0003677,MBD1,DNA binding,3.0
13626,4152,GO:0005515,MBD1,protein binding,3.0
13627,4152,GO:0005634,MBD1,nucleus,3.0
13628,4152,GO:0005654,MBD1,nucleoplasm,3.0
13629,4152,GO:0005694,MBD1,chromosome,3.0
13630,4152,GO:0006366,MBD1,transcription by RNA polymerase II,3.0
13631,4152,GO:0008270,MBD1,zinc ion binding,3.0
13632,4152,GO:0008327,MBD1,methyl-CpG binding,3.0
13634,4152,GO:0010385,MBD1,double-stranded methylated DNA binding,3.0
13635,4152,GO:0016363,MBD1,nuclear matrix,3.0
13636,4152,GO:0016607,MBD1,nuclear speck,3.0
13637,4152,GO:0045322,MBD1,unmethylated CpG binding,3.0
13638,4152,GO:0045892,MBD1,"negative regulation of transcription, DNA-templated",3.0
13639,53615,GO:0000785,MBD3,chromatin,3.0
13640,53615,GO:0003677,MBD3,DNA binding,3.0
13641,53615,GO:0005515,MBD3,protein binding,3.0
13642,53615,GO:0005654,MBD3,nucleoplasm,3.0
13643,53615,GO:0007420,MBD3,brain development,3.0
13644,53615,GO:0007507,MBD3,heart development,3.0
13645,53615,GO:0007568,MBD3,aging,3.0
13646,53615,GO:0008327,MBD3,methyl-CpG binding,3.0
13647,53615,GO:0016581,MBD3,NuRD complex,3.0
13648,53615,GO:0031492,MBD3,nucleosomal DNA binding,3.0
13649,53615,GO:0031667,MBD3,response to nutrient levels,3.0
13650,53615,GO:0032355,MBD3,response to estradiol,3.0
13651,53615,GO:0032991,MBD3,protein-containing complex,3.0
13652,53615,GO:0043044,MBD3,ATP-dependent chromatin remodeling,3.0
13653,53615,GO:0044030,MBD3,regulation of DNA methylation,3.0
13654,53615,GO:0048568,MBD3,embryonic organ development,3.0
13655,53615,GO:1901796,MBD3,regulation of signal transduction by p53 class mediator,3.0
13656,8930,GO:0003677,MBD4,DNA binding,3.0
13657,8930,GO:0003696,MBD4,satellite DNA binding,3.0
13658,8930,GO:0004520,MBD4,endodeoxyribonuclease activity,3.0
13659,8930,GO:0005515,MBD4,protein binding,3.0
13660,8930,GO:0005634,MBD4,nucleus,3.0
13661,8930,GO:0005654,MBD4,nucleoplasm,3.0
13662,8930,GO:0006281,MBD4,DNA repair,3.0
13663,8930,GO:0008263,MBD4,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,3.0
13664,8930,GO:0016607,MBD4,nuclear speck,3.0
13665,8930,GO:0019104,MBD4,DNA N-glycosylase activity,3.0
13666,8930,GO:0032355,MBD4,response to estradiol,3.0
13667,8930,GO:0045008,MBD4,depyrimidination,3.0
13686,114785,GO:0001650,MBD6,fibrillar center,3.0
13687,114785,GO:0003677,MBD6,DNA binding,3.0
13688,114785,GO:0003682,MBD6,chromatin binding,3.0
13690,114785,GO:0005515,MBD6,protein binding,3.0
13691,114785,GO:0005634,MBD6,nucleus,3.0
13693,114785,GO:0005654,MBD6,nucleoplasm,3.0
13695,114785,GO:0005694,MBD6,chromosome,3.0
13696,114785,GO:0010369,MBD6,chromocenter,3.0
13698,114785,GO:0016579,MBD6,protein deubiquitination,3.0
13726,4173,GO:0000082,MCM4,G1/S transition of mitotic cell cycle,3.0
13727,4173,GO:0000727,MCM4,double-strand break repair via break-induced replication,3.0
13728,4173,GO:0000781,MCM4,"chromosome, telomeric region",3.0
13729,4173,GO:0003678,MCM4,DNA helicase activity,3.0
13730,4173,GO:0003688,MCM4,DNA replication origin binding,3.0
13731,4173,GO:0003697,MCM4,single-stranded DNA binding,3.0
13732,4173,GO:0005515,MCM4,protein binding,3.0
13733,4173,GO:0005524,MCM4,ATP binding,3.0
13734,4173,GO:0005634,MCM4,nucleus,3.0
13736,4173,GO:0005654,MCM4,nucleoplasm,3.0
13738,4173,GO:0006260,MCM4,DNA replication,3.0
13740,4173,GO:0006267,MCM4,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,3.0
13741,4173,GO:0006268,MCM4,DNA unwinding involved in DNA replication,3.0
13742,4173,GO:0006271,MCM4,DNA strand elongation involved in DNA replication,3.0
13743,4173,GO:0016020,MCM4,membrane,3.0
13744,4173,GO:0042555,MCM4,MCM complex,3.0
13746,4173,GO:0071162,MCM4,CMG complex,3.0
13747,4173,GO:1902975,MCM4,mitotic DNA replication initiation,3.0
13748,4175,GO:0000082,MCM6,G1/S transition of mitotic cell cycle,3.0
13749,4175,GO:0000727,MCM6,double-strand break repair via break-induced replication,3.0
13750,4175,GO:0000781,MCM6,"chromosome, telomeric region",3.0
13751,4175,GO:0003678,MCM6,DNA helicase activity,3.0
13752,4175,GO:0003688,MCM6,DNA replication origin binding,3.0
13753,4175,GO:0003697,MCM6,single-stranded DNA binding,3.0
13754,4175,GO:0005515,MCM6,protein binding,3.0
13755,4175,GO:0005524,MCM6,ATP binding,3.0
13756,4175,GO:0005634,MCM6,nucleus,3.0
13759,4175,GO:0005654,MCM6,nucleoplasm,3.0
13761,4175,GO:0006260,MCM6,DNA replication,3.0
13763,4175,GO:0006267,MCM6,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,3.0
13764,4175,GO:0006268,MCM6,DNA unwinding involved in DNA replication,3.0
13765,4175,GO:0006270,MCM6,DNA replication initiation,3.0
13766,4175,GO:0042555,MCM6,MCM complex,3.0
13768,4175,GO:0042802,MCM6,identical protein binding,3.0
13769,4175,GO:0071162,MCM6,CMG complex,3.0
13770,4175,GO:1902969,MCM6,mitotic DNA replication,3.0
13771,4175,GO:1990518,MCM6,single-stranded 3'-5' DNA helicase activity,3.0
13772,79648,GO:0000122,MCPH1,negative regulation of transcription by RNA polymerase II,3.0
13773,79648,GO:0000132,MCPH1,establishment of mitotic spindle orientation,3.0
13774,79648,GO:0000278,MCPH1,mitotic cell cycle,3.0
13775,79648,GO:0005515,MCPH1,protein binding,3.0
13776,79648,GO:0005654,MCPH1,nucleoplasm,3.0
13777,79648,GO:0005737,MCPH1,cytoplasm,3.0
13778,79648,GO:0005815,MCPH1,microtubule organizing center,3.0
13779,79648,GO:0021987,MCPH1,cerebral cortex development,3.0
13780,79648,GO:0042802,MCPH1,identical protein binding,3.0
13781,79648,GO:0043549,MCPH1,regulation of kinase activity,3.0
13782,79648,GO:0046605,MCPH1,regulation of centrosome cycle,3.0
13783,79648,GO:0050727,MCPH1,regulation of inflammatory response,3.0
13784,79648,GO:0060348,MCPH1,bone development,3.0
13785,79648,GO:0060623,MCPH1,regulation of chromosome condensation,3.0
13786,79648,GO:0071539,MCPH1,protein localization to centrosome,3.0
13787,79648,GO:0071850,MCPH1,mitotic cell cycle arrest,3.0
13788,79648,GO:0097150,MCPH1,neuronal stem cell population maintenance,3.0
13789,161357,GO:0005576,MDGA2,extracellular region,3.0
13790,161357,GO:0005886,MDGA2,plasma membrane,3.0
13791,161357,GO:0007389,MDGA2,pattern specification process,3.0
13792,161357,GO:0021522,MDGA2,spinal cord motor neuron differentiation,3.0
13793,161357,GO:0031225,MDGA2,anchored component of membrane,3.0
13858,84445,GO:0000281,LZTS2,mitotic cytokinesis,3.0
13859,84445,GO:0005515,LZTS2,protein binding,3.0
13860,84445,GO:0005813,LZTS2,centrosome,3.0
13861,84445,GO:0005829,LZTS2,cytosol,3.0
13862,84445,GO:0005874,LZTS2,microtubule,3.0
13863,84445,GO:0005886,LZTS2,plasma membrane,3.0
13864,84445,GO:0008285,LZTS2,negative regulation of cell population proliferation,3.0
13865,84445,GO:0016055,LZTS2,Wnt signaling pathway,3.0
13866,84445,GO:0030496,LZTS2,midbody,3.0
13867,84445,GO:0031982,LZTS2,vesicle,3.0
13868,84445,GO:0051013,LZTS2,microtubule severing,3.0
13869,84445,GO:0051168,LZTS2,nuclear export,3.0
13870,84445,GO:0051255,LZTS2,spindle midzone assembly,3.0
13871,84445,GO:0060682,LZTS2,primary ureteric bud growth,3.0
13872,84445,GO:0072197,LZTS2,ureter morphogenesis,3.0
13873,84445,GO:0090090,LZTS2,negative regulation of canonical Wnt signaling pathway,3.0
13874,84445,GO:1900181,LZTS2,negative regulation of protein localization to nucleus,3.0
13921,116931,GO:0003713,MED12L,transcription coactivator activity,3.0
13922,116931,GO:0005515,MED12L,protein binding,3.0
13923,116931,GO:0006357,MED12L,regulation of transcription by RNA polymerase II,3.0
13924,116931,GO:0008013,MED12L,beta-catenin binding,3.0
13925,116931,GO:0016592,MED12L,mediator complex,3.0
13926,116931,GO:1903508,MED12L,positive regulation of nucleic acid-templated transcription,3.0
13950,4208,GO:0000122,MEF2C,negative regulation of transcription by RNA polymerase II,3.0
13951,4208,GO:0000165,MEF2C,MAPK cascade,3.0
13953,4208,GO:0000785,MEF2C,chromatin,3.0
13955,4208,GO:0000976,MEF2C,transcription regulatory region sequence-specific DNA binding,3.0
13956,4208,GO:0000977,MEF2C,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
13957,4208,GO:0000978,MEF2C,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
13958,4208,GO:0000981,MEF2C,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
13962,4208,GO:0001228,MEF2C,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
13963,4208,GO:0001568,MEF2C,blood vessel development,3.0
13964,4208,GO:0001649,MEF2C,osteoblast differentiation,3.0
13965,4208,GO:0001764,MEF2C,neuron migration,3.0
13966,4208,GO:0001782,MEF2C,B cell homeostasis,3.0
13967,4208,GO:0001947,MEF2C,heart looping,3.0
13968,4208,GO:0001958,MEF2C,endochondral ossification,3.0
13969,4208,GO:0001974,MEF2C,blood vessel remodeling,3.0
13970,4208,GO:0002062,MEF2C,chondrocyte differentiation,3.0
13971,4208,GO:0002467,MEF2C,germinal center formation,3.0
13972,4208,GO:0002634,MEF2C,regulation of germinal center formation,3.0
13973,4208,GO:0003138,MEF2C,primary heart field specification,3.0
13974,4208,GO:0003139,MEF2C,secondary heart field specification,3.0
13975,4208,GO:0003151,MEF2C,outflow tract morphogenesis,3.0
13976,4208,GO:0003185,MEF2C,sinoatrial valve morphogenesis,3.0
13977,4208,GO:0003211,MEF2C,cardiac ventricle formation,3.0
13978,4208,GO:0003680,MEF2C,minor groove of adenine-thymine-rich DNA binding,3.0
13979,4208,GO:0003682,MEF2C,chromatin binding,3.0
13980,4208,GO:0003700,MEF2C,DNA-binding transcription factor activity,3.0
13981,4208,GO:0005515,MEF2C,protein binding,3.0
13982,4208,GO:0005634,MEF2C,nucleus,3.0
13983,4208,GO:0005654,MEF2C,nucleoplasm,3.0
13985,4208,GO:0005737,MEF2C,cytoplasm,3.0
13986,4208,GO:0006355,MEF2C,"regulation of transcription, DNA-templated",3.0
13987,4208,GO:0006357,MEF2C,regulation of transcription by RNA polymerase II,3.0
13988,4208,GO:0006915,MEF2C,apoptotic process,3.0
13989,4208,GO:0006959,MEF2C,humoral immune response,3.0
13990,4208,GO:0007399,MEF2C,nervous system development,3.0
13991,4208,GO:0007507,MEF2C,heart development,3.0
13995,4208,GO:0007517,MEF2C,muscle organ development,3.0
13996,4208,GO:0007519,MEF2C,skeletal muscle tissue development,3.0
13997,4208,GO:0007521,MEF2C,muscle cell fate determination,3.0
13998,4208,GO:0007611,MEF2C,learning or memory,3.0
13999,4208,GO:0010628,MEF2C,positive regulation of gene expression,3.0
14000,4208,GO:0010629,MEF2C,negative regulation of gene expression,3.0
14001,4208,GO:0010694,MEF2C,positive regulation of alkaline phosphatase activity,3.0
14002,4208,GO:0014033,MEF2C,neural crest cell differentiation,3.0
14003,4208,GO:0014898,MEF2C,cardiac muscle hypertrophy in response to stress,3.0
14004,4208,GO:0014902,MEF2C,myotube differentiation,3.0
14005,4208,GO:0016528,MEF2C,sarcoplasm,3.0
14006,4208,GO:0016607,MEF2C,nuclear speck,3.0
14007,4208,GO:0030154,MEF2C,cell differentiation,3.0
14008,4208,GO:0030182,MEF2C,neuron differentiation,3.0
14010,4208,GO:0030220,MEF2C,platelet formation,3.0
14011,4208,GO:0030224,MEF2C,monocyte differentiation,3.0
14012,4208,GO:0030279,MEF2C,negative regulation of ossification,3.0
14013,4208,GO:0030318,MEF2C,melanocyte differentiation,3.0
14014,4208,GO:0030501,MEF2C,positive regulation of bone mineralization,3.0
14015,4208,GO:0030890,MEF2C,positive regulation of B cell proliferation,3.0
14016,4208,GO:0032991,MEF2C,protein-containing complex,3.0
14017,4208,GO:0033613,MEF2C,activating transcription factor binding,3.0
14018,4208,GO:0035690,MEF2C,cellular response to drug,3.0
14019,4208,GO:0035914,MEF2C,skeletal muscle cell differentiation,3.0
14020,4208,GO:0035984,MEF2C,cellular response to trichostatin A,3.0
14021,4208,GO:0042100,MEF2C,B cell proliferation,3.0
14022,4208,GO:0042826,MEF2C,histone deacetylase binding,3.0
14023,4208,GO:0043231,MEF2C,intracellular membrane-bounded organelle,3.0
14024,4208,GO:0043523,MEF2C,regulation of neuron apoptotic process,3.0
14025,4208,GO:0043524,MEF2C,negative regulation of neuron apoptotic process,3.0
14026,4208,GO:0043537,MEF2C,negative regulation of blood vessel endothelial cell migration,3.0
14027,4208,GO:0045652,MEF2C,regulation of megakaryocyte differentiation,3.0
14028,4208,GO:0045663,MEF2C,positive regulation of myoblast differentiation,3.0
14029,4208,GO:0045666,MEF2C,positive regulation of neuron differentiation,3.0
14030,4208,GO:0045669,MEF2C,positive regulation of osteoblast differentiation,3.0
14031,4208,GO:0045893,MEF2C,"positive regulation of transcription, DNA-templated",3.0
14032,4208,GO:0045944,MEF2C,positive regulation of transcription by RNA polymerase II,3.0
14035,4208,GO:0046928,MEF2C,regulation of neurotransmitter secretion,3.0
14036,4208,GO:0046982,MEF2C,protein heterodimerization activity,3.0
14037,4208,GO:0048167,MEF2C,regulation of synaptic plasticity,3.0
14038,4208,GO:0048643,MEF2C,positive regulation of skeletal muscle tissue development,3.0
14039,4208,GO:0048666,MEF2C,neuron development,3.0
14040,4208,GO:0048667,MEF2C,cell morphogenesis involved in neuron differentiation,3.0
14041,4208,GO:0048703,MEF2C,embryonic viscerocranium morphogenesis,3.0
14042,4208,GO:0050853,MEF2C,B cell receptor signaling pathway,3.0
14043,4208,GO:0051145,MEF2C,smooth muscle cell differentiation,3.0
14044,4208,GO:0051149,MEF2C,positive regulation of muscle cell differentiation,3.0
14045,4208,GO:0051963,MEF2C,regulation of synapse assembly,3.0
14046,4208,GO:0051966,MEF2C,"regulation of synaptic transmission, glutamatergic",3.0
14047,4208,GO:0055012,MEF2C,ventricular cardiac muscle cell differentiation,3.0
14048,4208,GO:0060021,MEF2C,roof of mouth development,3.0
14049,4208,GO:0060025,MEF2C,regulation of synaptic activity,3.0
14050,4208,GO:0060045,MEF2C,positive regulation of cardiac muscle cell proliferation,3.0
14051,4208,GO:0060079,MEF2C,excitatory postsynaptic potential,3.0
14052,4208,GO:0060297,MEF2C,regulation of sarcomere organization,3.0
14053,4208,GO:0060536,MEF2C,cartilage morphogenesis,3.0
14054,4208,GO:0060998,MEF2C,regulation of dendritic spine development,3.0
14055,4208,GO:0061333,MEF2C,renal tubule morphogenesis,3.0
14056,4208,GO:0071222,MEF2C,cellular response to lipopolysaccharide,3.0
14057,4208,GO:0071277,MEF2C,cellular response to calcium ion,3.0
14058,4208,GO:0071374,MEF2C,cellular response to parathyroid hormone stimulus,3.0
14059,4208,GO:0071498,MEF2C,cellular response to fluid shear stress,3.0
14060,4208,GO:0071560,MEF2C,cellular response to transforming growth factor beta stimulus,3.0
14061,4208,GO:0071837,MEF2C,HMG box domain binding,3.0
14062,4208,GO:0071864,MEF2C,positive regulation of cell proliferation in bone marrow,3.0
14063,4208,GO:0072102,MEF2C,glomerulus morphogenesis,3.0
14064,4208,GO:0072160,MEF2C,nephron tubule epithelial cell differentiation,3.0
14065,4208,GO:0098794,MEF2C,postsynapse,3.0
14066,4208,GO:1904706,MEF2C,negative regulation of vascular associated smooth muscle cell proliferation,3.0
14068,4208,GO:1904753,MEF2C,negative regulation of vascular associated smooth muscle cell migration,3.0
14070,4208,GO:1905563,MEF2C,negative regulation of vascular endothelial cell proliferation,3.0
14071,4208,GO:1990837,MEF2C,sequence-specific double-stranded DNA binding,3.0
14072,4208,GO:2000111,MEF2C,positive regulation of macrophage apoptotic process,3.0
14073,4208,GO:2000310,MEF2C,regulation of NMDA receptor activity,3.0
14074,4208,GO:2000311,MEF2C,regulation of AMPA receptor activity,3.0
14075,4208,GO:2000727,MEF2C,positive regulation of cardiac muscle cell differentiation,3.0
14076,4208,GO:2000987,MEF2C,positive regulation of behavioral fear response,3.0
14077,4208,GO:2001013,MEF2C,epithelial cell proliferation involved in renal tubule morphogenesis,3.0
14078,4208,GO:2001016,MEF2C,positive regulation of skeletal muscle cell differentiation,3.0
14079,84466,GO:0001849,MEGF10,complement component C1q complex binding,3.0
14080,84466,GO:0001891,MEGF10,phagocytic cup,3.0
14081,84466,GO:0005044,MEGF10,scavenger receptor activity,3.0
14082,84466,GO:0005112,MEGF10,Notch binding,3.0
14084,84466,GO:0005886,MEGF10,plasma membrane,3.0
14085,84466,GO:0014719,MEGF10,skeletal muscle satellite cell activation,3.0
14086,84466,GO:0014816,MEGF10,skeletal muscle satellite cell differentiation,3.0
14087,84466,GO:0014841,MEGF10,skeletal muscle satellite cell proliferation,3.0
14088,84466,GO:0016021,MEGF10,integral component of membrane,3.0
14089,84466,GO:0022409,MEGF10,positive regulation of cell-cell adhesion,3.0
14090,84466,GO:0033002,MEGF10,muscle cell proliferation,3.0
14091,84466,GO:0034109,MEGF10,homotypic cell-cell adhesion,3.0
14092,84466,GO:0042995,MEGF10,cell projection,3.0
14093,84466,GO:0043277,MEGF10,apoptotic cell clearance,3.0
14094,84466,GO:0043652,MEGF10,engulfment of apoptotic cell,3.0
14095,84466,GO:0043654,MEGF10,recognition of apoptotic cell,3.0
14096,84466,GO:0048627,MEGF10,myoblast development,3.0
14097,84466,GO:0048641,MEGF10,regulation of skeletal muscle tissue development,3.0
14098,84466,GO:0051147,MEGF10,regulation of muscle cell differentiation,3.0
14099,84466,GO:0051451,MEGF10,myoblast migration,3.0
14100,84466,GO:0055001,MEGF10,muscle cell development,3.0
14101,84466,GO:1902742,MEGF10,apoptotic process involved in development,3.0
14102,84466,GO:2000288,MEGF10,positive regulation of myoblast proliferation,3.0
14103,84465,GO:0005515,MEGF11,protein binding,3.0
14104,84465,GO:0010842,MEGF11,retina layer formation,3.0
14105,84465,GO:0016021,MEGF11,integral component of membrane,3.0
14106,84465,GO:0016323,MEGF11,basolateral plasma membrane,3.0
14107,84465,GO:0034109,MEGF11,homotypic cell-cell adhesion,3.0
14138,51072,GO:0005515,MEMO1,protein binding,3.0
14139,51072,GO:0005634,MEMO1,nucleus,3.0
14140,51072,GO:0005829,MEMO1,cytosol,3.0
14142,51072,GO:0032886,MEMO1,regulation of microtubule-based process,3.0
14143,51072,GO:2000145,MEMO1,regulation of cell motility,3.0
14199,57534,GO:0001568,MIB1,blood vessel development,3.0
14200,57534,GO:0001701,MIB1,in utero embryonic development,3.0
14201,57534,GO:0001756,MIB1,somitogenesis,3.0
14202,57534,GO:0001841,MIB1,neural tube formation,3.0
14203,57534,GO:0001947,MIB1,heart looping,3.0
14204,57534,GO:0004842,MIB1,ubiquitin-protein transferase activity,3.0
14205,57534,GO:0005515,MIB1,protein binding,3.0
14206,57534,GO:0005737,MIB1,cytoplasm,3.0
14207,57534,GO:0005813,MIB1,centrosome,3.0
14208,57534,GO:0005829,MIB1,cytosol,3.0
14209,57534,GO:0005886,MIB1,plasma membrane,3.0
14210,57534,GO:0006511,MIB1,ubiquitin-dependent protein catabolic process,3.0
14211,57534,GO:0006897,MIB1,endocytosis,3.0
14212,57534,GO:0007219,MIB1,Notch signaling pathway,3.0
14213,57534,GO:0008270,MIB1,zinc ion binding,3.0
14214,57534,GO:0014069,MIB1,postsynaptic density,3.0
14215,57534,GO:0016567,MIB1,protein ubiquitination,3.0
14217,57534,GO:0031410,MIB1,cytoplasmic vesicle,3.0
14218,57534,GO:0045665,MIB1,negative regulation of neuron differentiation,3.0
14219,57534,GO:0045807,MIB1,positive regulation of endocytosis,3.0
14220,2315,GO:0005515,MLANA,protein binding,3.0
14221,2315,GO:0005789,MLANA,endoplasmic reticulum membrane,3.0
14223,2315,GO:0005794,MLANA,Golgi apparatus,3.0
14224,2315,GO:0005802,MLANA,trans-Golgi network,3.0
14226,2315,GO:0005887,MLANA,integral component of plasma membrane,3.0
14227,2315,GO:0042470,MLANA,melanosome,3.0
14229,4335,GO:0000122,MNT,negative regulation of transcription by RNA polymerase II,3.0
14231,4335,GO:0000785,MNT,chromatin,3.0
14233,4335,GO:0000977,MNT,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
14234,4335,GO:0000978,MNT,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
14235,4335,GO:0000981,MNT,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
14237,4335,GO:0001227,MNT,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
14239,4335,GO:0003682,MNT,chromatin binding,3.0
14240,4335,GO:0003700,MNT,DNA-binding transcription factor activity,3.0
14241,4335,GO:0005515,MNT,protein binding,3.0
14242,4335,GO:0005654,MNT,nucleoplasm,3.0
14243,4335,GO:0006357,MNT,regulation of transcription by RNA polymerase II,3.0
14244,4335,GO:0006366,MNT,transcription by RNA polymerase II,3.0
14245,4335,GO:0007275,MNT,multicellular organism development,3.0
14246,4335,GO:0007569,MNT,cell aging,3.0
14247,4335,GO:0008285,MNT,negative regulation of cell population proliferation,3.0
14248,4335,GO:0046983,MNT,protein dimerization activity,3.0
14249,4335,GO:0051726,MNT,regulation of cell cycle,3.0
14250,4335,GO:2001234,MNT,negative regulation of apoptotic signaling pathway,3.0
14251,51678,GO:0005515,MPP6,protein binding,3.0
14252,51678,GO:0005886,MPP6,plasma membrane,3.0
14253,51678,GO:0016020,MPP6,membrane,3.0
14254,51678,GO:0065003,MPP6,protein-containing complex assembly,3.0
14255,51678,GO:0070062,MPP6,extracellular exosome,3.0
14271,57496,GO:0003713,MRTFB,transcription coactivator activity,3.0
14273,57496,GO:0005515,MRTFB,protein binding,3.0
14274,57496,GO:0005634,MRTFB,nucleus,3.0
14276,57496,GO:0007517,MRTFB,muscle organ development,3.0
14277,57496,GO:0045296,MRTFB,cadherin binding,3.0
14278,57496,GO:0045844,MRTFB,positive regulation of striated muscle tissue development,3.0
14279,57496,GO:0045944,MRTFB,positive regulation of transcription by RNA polymerase II,3.0
14281,57496,GO:0051145,MRTFB,smooth muscle cell differentiation,3.0
14282,4481,GO:0001540,MSR1,amyloid-beta binding,3.0
14284,4481,GO:0005044,MSR1,scavenger receptor activity,3.0
14285,4481,GO:0005515,MSR1,protein binding,3.0
14286,4481,GO:0005581,MSR1,collagen trimer,3.0
14287,4481,GO:0005886,MSR1,plasma membrane,3.0
14289,4481,GO:0005887,MSR1,integral component of plasma membrane,3.0
14290,4481,GO:0006898,MSR1,receptor-mediated endocytosis,3.0
14293,4481,GO:0006911,MSR1,"phagocytosis, engulfment",3.0
14294,4481,GO:0009897,MSR1,external side of plasma membrane,3.0
14295,4481,GO:0010629,MSR1,negative regulation of gene expression,3.0
14296,4481,GO:0010744,MSR1,positive regulation of macrophage derived foam cell differentiation,3.0
14297,4481,GO:0010886,MSR1,positive regulation of cholesterol storage,3.0
14299,4481,GO:0016021,MSR1,integral component of membrane,3.0
14300,4481,GO:0030169,MSR1,low-density lipoprotein particle binding,3.0
14302,4481,GO:0030301,MSR1,cholesterol transport,3.0
14303,4481,GO:0030666,MSR1,endocytic vesicle membrane,3.0
14304,4481,GO:0034362,MSR1,low-density lipoprotein particle,3.0
14305,4481,GO:0034381,MSR1,plasma lipoprotein particle clearance,3.0
14307,4481,GO:0038024,MSR1,cargo receptor activity,3.0
14308,4481,GO:0097242,MSR1,amyloid-beta clearance,3.0
14310,4520,GO:0000978,MTF1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
14312,4520,GO:0000981,MTF1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
14313,4520,GO:0000987,MTF1,cis-regulatory region sequence-specific DNA binding,3.0
14314,4520,GO:0001228,MTF1,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
14316,4520,GO:0003677,MTF1,DNA binding,3.0
14317,4520,GO:0003700,MTF1,DNA-binding transcription factor activity,3.0
14318,4520,GO:0005515,MTF1,protein binding,3.0
14319,4520,GO:0005634,MTF1,nucleus,3.0
14320,4520,GO:0005654,MTF1,nucleoplasm,3.0
14322,4520,GO:0005737,MTF1,cytoplasm,3.0
14323,4520,GO:0006351,MTF1,"transcription, DNA-templated",3.0
14324,4520,GO:0006357,MTF1,regulation of transcription by RNA polymerase II,3.0
14325,4520,GO:0006979,MTF1,response to oxidative stress,3.0
14326,4520,GO:0007417,MTF1,central nervous system development,3.0
14327,4520,GO:0010038,MTF1,response to metal ion,3.0
14328,4520,GO:0035035,MTF1,histone acetyltransferase binding,3.0
14329,4520,GO:0045944,MTF1,positive regulation of transcription by RNA polymerase II,3.0
14331,4520,GO:0046686,MTF1,response to cadmium ion,3.0
14332,4520,GO:0046872,MTF1,metal ion binding,3.0
14333,4520,GO:0071294,MTF1,cellular response to zinc ion,3.0
14334,4520,GO:1990079,MTF1,cartilage homeostasis,3.0
14335,4520,GO:1990837,MTF1,sequence-specific double-stranded DNA binding,3.0
14336,4524,GO:0001666,MTHFR,response to hypoxia,3.0
14337,4524,GO:0001843,MTHFR,neural tube closure,3.0
14339,4524,GO:0004489,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H) activity,3.0
14343,4524,GO:0005829,MTHFR,cytosol,3.0
14345,4524,GO:0006555,MTHFR,methionine metabolic process,3.0
14346,4524,GO:0009086,MTHFR,methionine biosynthetic process,3.0
14347,4524,GO:0031060,MTHFR,regulation of histone methylation,3.0
14348,4524,GO:0033274,MTHFR,response to vitamin B2,3.0
14349,4524,GO:0035999,MTHFR,tetrahydrofolate interconversion,3.0
14354,4524,GO:0042493,MTHFR,response to drug,3.0
14355,4524,GO:0043200,MTHFR,response to amino acid,3.0
14356,4524,GO:0044877,MTHFR,protein-containing complex binding,3.0
14357,4524,GO:0045202,MTHFR,synapse,3.0
14358,4524,GO:0046500,MTHFR,S-adenosylmethionine metabolic process,3.0
14359,4524,GO:0046655,MTHFR,folic acid metabolic process,3.0
14360,4524,GO:0050660,MTHFR,flavin adenine dinucleotide binding,3.0
14361,4524,GO:0050661,MTHFR,NADP binding,3.0
14362,4524,GO:0050667,MTHFR,homocysteine metabolic process,3.0
14363,4524,GO:0051593,MTHFR,response to folic acid,3.0
14364,4524,GO:0055114,MTHFR,oxidation-reduction process,3.0
14365,4524,GO:0070555,MTHFR,response to interleukin-1,3.0
14366,4524,GO:0070829,MTHFR,heterochromatin maintenance,3.0
14367,4524,GO:0071949,MTHFR,FAD binding,3.0
14368,4524,GO:0072341,MTHFR,modified amino acid binding,3.0
14527,10071,GO:0001558,MUC12,regulation of cell growth,3.0
14528,10071,GO:0002223,MUC12,stimulatory C-type lectin receptor signaling pathway,3.0
14529,10071,GO:0003674,MUC12,molecular_function,3.0
14530,10071,GO:0005796,MUC12,Golgi lumen,3.0
14531,10071,GO:0005886,MUC12,plasma membrane,3.0
14532,10071,GO:0005887,MUC12,integral component of plasma membrane,3.0
14533,10071,GO:0016266,MUC12,O-glycan processing,3.0
14534,4585,GO:0002223,MUC4,stimulatory C-type lectin receptor signaling pathway,3.0
14535,4585,GO:0005176,MUC4,ErbB-2 class receptor binding,3.0
14536,4585,GO:0005615,MUC4,extracellular space,3.0
14538,4585,GO:0005796,MUC4,Golgi lumen,3.0
14539,4585,GO:0005886,MUC4,plasma membrane,3.0
14540,4585,GO:0005887,MUC4,integral component of plasma membrane,3.0
14541,4585,GO:0007160,MUC4,cell-matrix adhesion,3.0
14542,4585,GO:0010469,MUC4,regulation of signaling receptor activity,3.0
14543,4585,GO:0016020,MUC4,membrane,3.0
14544,4585,GO:0016266,MUC4,O-glycan processing,3.0
14545,4585,GO:0030197,MUC4,"extracellular matrix constituent, lubricant activity",3.0
14546,4585,GO:0030277,MUC4,maintenance of gastrointestinal epithelium,3.0
14547,4585,GO:0031012,MUC4,extracellular matrix,3.0
14548,4585,GO:0031982,MUC4,vesicle,3.0
14549,4585,GO:0070062,MUC4,extracellular exosome,3.0
14612,4622,GO:0000146,MYH4,microfilament motor activity,3.0
14613,4622,GO:0003725,MYH4,double-stranded RNA binding,3.0
14614,4622,GO:0005516,MYH4,calmodulin binding,3.0
14615,4622,GO:0005524,MYH4,ATP binding,3.0
14616,4622,GO:0005859,MYH4,muscle myosin complex,3.0
14617,4622,GO:0006936,MYH4,muscle contraction,3.0
14618,4622,GO:0016887,MYH4,ATPase activity,3.0
14619,4622,GO:0030016,MYH4,myofibril,3.0
14620,4622,GO:0030017,MYH4,sarcomere,3.0
14621,4622,GO:0030048,MYH4,actin filament-based movement,3.0
14622,4622,GO:0030049,MYH4,muscle filament sliding,3.0
14623,4622,GO:0032982,MYH4,myosin filament,3.0
14624,4622,GO:0046034,MYH4,ATP metabolic process,3.0
14625,4622,GO:0051015,MYH4,actin filament binding,3.0
14626,23026,GO:0003774,MYO16,motor activity,3.0
14627,23026,GO:0005515,MYO16,protein binding,3.0
14628,23026,GO:0005524,MYO16,ATP binding,3.0
14629,23026,GO:0005654,MYO16,nucleoplasm,3.0
14631,23026,GO:0005737,MYO16,cytoplasm,3.0
14632,23026,GO:0005886,MYO16,plasma membrane,3.0
14633,23026,GO:0008285,MYO16,negative regulation of cell population proliferation,3.0
14634,23026,GO:0014065,MYO16,phosphatidylinositol 3-kinase signaling,3.0
14635,23026,GO:0016459,MYO16,myosin complex,3.0
14636,23026,GO:0019903,MYO16,protein phosphatase binding,3.0
14637,23026,GO:0021549,MYO16,cerebellum development,3.0
14638,23026,GO:0048471,MYO16,perinuclear region of cytoplasm,3.0
14640,23026,GO:0048812,MYO16,neuron projection morphogenesis,3.0
14641,23026,GO:0051015,MYO16,actin filament binding,3.0
14643,23026,GO:2000134,MYO16,negative regulation of G1/S transition of mitotic cell cycle,3.0
14645,4643,GO:0000146,MYO1E,microfilament motor activity,3.0
14647,4643,GO:0001570,MYO1E,vasculogenesis,3.0
14648,4643,GO:0001701,MYO1E,in utero embryonic development,3.0
14649,4643,GO:0003094,MYO1E,glomerular filtration,3.0
14650,4643,GO:0003774,MYO1E,motor activity,3.0
14651,4643,GO:0005515,MYO1E,protein binding,3.0
14652,4643,GO:0005516,MYO1E,calmodulin binding,3.0
14653,4643,GO:0005524,MYO1E,ATP binding,3.0
14654,4643,GO:0005737,MYO1E,cytoplasm,3.0
14656,4643,GO:0005856,MYO1E,cytoskeleton,3.0
14657,4643,GO:0005886,MYO1E,plasma membrane,3.0
14658,4643,GO:0005902,MYO1E,microvillus,3.0
14659,4643,GO:0005903,MYO1E,brush border,3.0
14660,4643,GO:0005912,MYO1E,adherens junction,3.0
14661,4643,GO:0006807,MYO1E,nitrogen compound metabolic process,3.0
14662,4643,GO:0006897,MYO1E,endocytosis,3.0
14663,4643,GO:0007015,MYO1E,actin filament organization,3.0
14664,4643,GO:0015629,MYO1E,actin cytoskeleton,3.0
14665,4643,GO:0016459,MYO1E,myosin complex,3.0
14666,4643,GO:0016887,MYO1E,ATPase activity,3.0
14667,4643,GO:0030048,MYO1E,actin filament-based movement,3.0
14668,4643,GO:0030050,MYO1E,vesicle transport along actin filament,3.0
14669,4643,GO:0030898,MYO1E,actin-dependent ATPase activity,3.0
14670,4643,GO:0031982,MYO1E,vesicle,3.0
14671,4643,GO:0032836,MYO1E,glomerular basement membrane development,3.0
14672,4643,GO:0035091,MYO1E,phosphatidylinositol binding,3.0
14673,4643,GO:0035166,MYO1E,post-embryonic hemopoiesis,3.0
14674,4643,GO:0045334,MYO1E,clathrin-coated endocytic vesicle,3.0
14675,4643,GO:0048008,MYO1E,platelet-derived growth factor receptor signaling pathway,3.0
14676,4643,GO:0051015,MYO1E,actin filament binding,3.0
14678,4643,GO:0070062,MYO1E,extracellular exosome,3.0
14679,4643,GO:0072015,MYO1E,glomerular visceral epithelial cell development,3.0
14748,55930,GO:0000146,MYO5C,microfilament motor activity,3.0
14749,55930,GO:0005516,MYO5C,calmodulin binding,3.0
14750,55930,GO:0005524,MYO5C,ATP binding,3.0
14751,55930,GO:0005737,MYO5C,cytoplasm,3.0
14752,55930,GO:0007015,MYO5C,actin filament organization,3.0
14753,55930,GO:0015629,MYO5C,actin cytoskeleton,3.0
14754,55930,GO:0016459,MYO5C,myosin complex,3.0
14755,55930,GO:0030050,MYO5C,vesicle transport along actin filament,3.0
14756,55930,GO:0030898,MYO5C,actin-dependent ATPase activity,3.0
14757,55930,GO:0031982,MYO5C,vesicle,3.0
14758,55930,GO:0051015,MYO5C,actin filament binding,3.0
14759,55930,GO:0070062,MYO5C,extracellular exosome,3.0
14836,4488,GO:0000122,MSX2,negative regulation of transcription by RNA polymerase II,3.0
14838,4488,GO:0000785,MSX2,chromatin,3.0
14839,4488,GO:0000976,MSX2,transcription regulatory region sequence-specific DNA binding,3.0
14840,4488,GO:0000977,MSX2,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
14841,4488,GO:0000981,MSX2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
14844,4488,GO:0001227,MSX2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
14845,4488,GO:0001649,MSX2,osteoblast differentiation,3.0
14846,4488,GO:0002063,MSX2,chondrocyte development,3.0
14847,4488,GO:0002076,MSX2,osteoblast development,3.0
14848,4488,GO:0003148,MSX2,outflow tract septum morphogenesis,3.0
14849,4488,GO:0003198,MSX2,epithelial to mesenchymal transition involved in endocardial cushion formation,3.0
14850,4488,GO:0003416,MSX2,endochondral bone growth,3.0
14851,4488,GO:0005515,MSX2,protein binding,3.0
14852,4488,GO:0005634,MSX2,nucleus,3.0
14853,4488,GO:0005829,MSX2,cytosol,3.0
14854,4488,GO:0006357,MSX2,regulation of transcription by RNA polymerase II,3.0
14855,4488,GO:0008134,MSX2,transcription factor binding,3.0
14856,4488,GO:0008285,MSX2,negative regulation of cell population proliferation,3.0
14857,4488,GO:0009952,MSX2,anterior/posterior pattern specification,3.0
14858,4488,GO:0016607,MSX2,nuclear speck,3.0
14859,4488,GO:0023019,MSX2,signal transduction involved in regulation of gene expression,3.0
14860,4488,GO:0030513,MSX2,positive regulation of BMP signaling pathway,3.0
14861,4488,GO:0032792,MSX2,negative regulation of CREB transcription factor activity,3.0
14862,4488,GO:0035115,MSX2,embryonic forelimb morphogenesis,3.0
14863,4488,GO:0035116,MSX2,embryonic hindlimb morphogenesis,3.0
14864,4488,GO:0035313,MSX2,"wound healing, spreading of epidermal cells",3.0
14865,4488,GO:0035880,MSX2,embryonic nail plate morphogenesis,3.0
14866,4488,GO:0043066,MSX2,negative regulation of apoptotic process,3.0
14867,4488,GO:0043565,MSX2,sequence-specific DNA binding,3.0
14868,4488,GO:0045599,MSX2,negative regulation of fat cell differentiation,3.0
14869,4488,GO:0045617,MSX2,negative regulation of keratinocyte differentiation,3.0
14870,4488,GO:0045669,MSX2,positive regulation of osteoblast differentiation,3.0
14871,4488,GO:0045892,MSX2,"negative regulation of transcription, DNA-templated",3.0
14872,4488,GO:0048598,MSX2,embryonic morphogenesis,3.0
14873,4488,GO:0048863,MSX2,stem cell differentiation,3.0
14874,4488,GO:0051795,MSX2,positive regulation of timing of catagen,3.0
14875,4488,GO:0060346,MSX2,bone trabecula formation,3.0
14876,4488,GO:0060363,MSX2,cranial suture morphogenesis,3.0
14877,4488,GO:0060364,MSX2,frontal suture morphogenesis,3.0
14878,4488,GO:0060444,MSX2,branching involved in mammary gland duct morphogenesis,3.0
14879,4488,GO:0061312,MSX2,BMP signaling pathway involved in heart development,3.0
14880,4488,GO:0070166,MSX2,enamel mineralization,3.0
14881,4488,GO:0071392,MSX2,cellular response to estradiol stimulus,3.0
14882,4488,GO:0090427,MSX2,activation of meiosis,3.0
14883,4488,GO:1990837,MSX2,sequence-specific double-stranded DNA binding,3.0
14884,4488,GO:2000678,MSX2,negative regulation of transcription regulatory region DNA binding,3.0
14885,4488,GO:2001055,MSX2,positive regulation of mesenchymal cell apoptotic process,3.0
14886,4638,GO:0001725,MYLK,stress fiber,3.0
14888,4638,GO:0003779,MYLK,actin binding,3.0
14889,4638,GO:0004672,MYLK,protein kinase activity,3.0
14890,4638,GO:0004687,MYLK,myosin light chain kinase activity,3.0
14892,4638,GO:0005515,MYLK,protein binding,3.0
14893,4638,GO:0005516,MYLK,calmodulin binding,3.0
14894,4638,GO:0005524,MYLK,ATP binding,3.0
14895,4638,GO:0005737,MYLK,cytoplasm,3.0
14897,4638,GO:0005829,MYLK,cytosol,3.0
14898,4638,GO:0005886,MYLK,plasma membrane,3.0
14899,4638,GO:0006468,MYLK,protein phosphorylation,3.0
14900,4638,GO:0006936,MYLK,muscle contraction,3.0
14901,4638,GO:0006939,MYLK,smooth muscle contraction,3.0
14902,4638,GO:0014820,MYLK,tonic smooth muscle contraction,3.0
14904,4638,GO:0015629,MYLK,actin cytoskeleton,3.0
14905,4638,GO:0030027,MYLK,lamellipodium,3.0
14907,4638,GO:0030335,MYLK,positive regulation of cell migration,3.0
14908,4638,GO:0032060,MYLK,bleb assembly,3.0
14909,4638,GO:0032154,MYLK,cleavage furrow,3.0
14911,4638,GO:0046872,MYLK,metal ion binding,3.0
14912,4638,GO:0051928,MYLK,positive regulation of calcium ion transport,3.0
14913,4638,GO:0060414,MYLK,aorta smooth muscle tissue morphogenesis,3.0
14914,4638,GO:0071476,MYLK,cellular hypotonic response,3.0
14915,4638,GO:0090303,MYLK,positive regulation of wound healing,3.0
14916,93649,GO:0000122,MYOCD,negative regulation of transcription by RNA polymerase II,3.0
14917,93649,GO:0000785,MYOCD,chromatin,3.0
14918,93649,GO:0001560,MYOCD,regulation of cell growth by extracellular stimulus,3.0
14919,93649,GO:0001570,MYOCD,vasculogenesis,3.0
14920,93649,GO:0001666,MYOCD,response to hypoxia,3.0
14921,93649,GO:0003231,MYOCD,cardiac ventricle development,3.0
14922,93649,GO:0003257,MYOCD,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,3.0
14923,93649,GO:0003713,MYOCD,transcription coactivator activity,3.0
14925,93649,GO:0005515,MYOCD,protein binding,3.0
14926,93649,GO:0005634,MYOCD,nucleus,3.0
14928,93649,GO:0008134,MYOCD,transcription factor binding,3.0
14929,93649,GO:0008284,MYOCD,positive regulation of cell population proliferation,3.0
14930,93649,GO:0008285,MYOCD,negative regulation of cell population proliferation,3.0
14931,93649,GO:0010667,MYOCD,negative regulation of cardiac muscle cell apoptotic process,3.0
14932,93649,GO:0010832,MYOCD,negative regulation of myotube differentiation,3.0
14933,93649,GO:0030511,MYOCD,positive regulation of transforming growth factor beta receptor signaling pathway,3.0
14934,93649,GO:0035035,MYOCD,histone acetyltransferase binding,3.0
14935,93649,GO:0035051,MYOCD,cardiocyte differentiation,3.0
14936,93649,GO:0035065,MYOCD,regulation of histone acetylation,3.0
14937,93649,GO:0035886,MYOCD,vascular associated smooth muscle cell differentiation,3.0
14938,93649,GO:0042826,MYOCD,histone deacetylase binding,3.0
14939,93649,GO:0043388,MYOCD,positive regulation of DNA binding,3.0
14940,93649,GO:0043954,MYOCD,cellular component maintenance,3.0
14941,93649,GO:0045661,MYOCD,regulation of myoblast differentiation,3.0
14942,93649,GO:0045736,MYOCD,negative regulation of cyclin-dependent protein serine/threonine kinase activity,3.0
14943,93649,GO:0045893,MYOCD,"positive regulation of transcription, DNA-templated",3.0
14944,93649,GO:0045944,MYOCD,positive regulation of transcription by RNA polymerase II,3.0
14946,93649,GO:0045987,MYOCD,positive regulation of smooth muscle contraction,3.0
14947,93649,GO:0048286,MYOCD,lung alveolus development,3.0
14948,93649,GO:0048565,MYOCD,digestive tract development,3.0
14949,93649,GO:0051091,MYOCD,positive regulation of DNA-binding transcription factor activity,3.0
14950,93649,GO:0051145,MYOCD,smooth muscle cell differentiation,3.0
14952,93649,GO:0051150,MYOCD,regulation of smooth muscle cell differentiation,3.0
14953,93649,GO:0051152,MYOCD,positive regulation of smooth muscle cell differentiation,3.0
14954,93649,GO:0055007,MYOCD,cardiac muscle cell differentiation,3.0
14956,93649,GO:0055012,MYOCD,ventricular cardiac muscle cell differentiation,3.0
14957,93649,GO:0060065,MYOCD,uterus development,3.0
14958,93649,GO:0060157,MYOCD,urinary bladder development,3.0
14959,93649,GO:0060354,MYOCD,negative regulation of cell adhesion molecule production,3.0
14960,93649,GO:0061629,MYOCD,RNA polymerase II-specific DNA-binding transcription factor binding,3.0
14961,93649,GO:0070412,MYOCD,R-SMAD binding,3.0
14962,93649,GO:0097070,MYOCD,ductus arteriosus closure,3.0
14963,93649,GO:1900222,MYOCD,negative regulation of amyloid-beta clearance,3.0
14964,93649,GO:1900239,MYOCD,regulation of phenotypic switching,3.0
14965,93649,GO:1903800,MYOCD,positive regulation of production of miRNAs involved in gene silencing by miRNA,3.0
14966,93649,GO:1904706,MYOCD,negative regulation of vascular associated smooth muscle cell proliferation,3.0
14967,93649,GO:1904753,MYOCD,negative regulation of vascular associated smooth muscle cell migration,3.0
14968,93649,GO:2000587,MYOCD,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,3.0
14969,93649,GO:2000721,MYOCD,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,3.0
14970,93649,GO:2000724,MYOCD,positive regulation of cardiac vascular smooth muscle cell differentiation,3.0
14971,93649,GO:2000727,MYOCD,positive regulation of cardiac muscle cell differentiation,3.0
14972,93649,GO:2001015,MYOCD,negative regulation of skeletal muscle cell differentiation,3.0
14973,254827,GO:0005515,NAALADL2,protein binding,3.0
14974,254827,GO:0005654,NAALADL2,nucleoplasm,3.0
14975,254827,GO:0016021,NAALADL2,integral component of membrane,3.0
15036,344148,GO:0001578,NCKAP5,microtubule bundle formation,3.0
15037,344148,GO:0005575,NCKAP5,cellular_component,3.0
15038,344148,GO:0007019,NCKAP5,microtubule depolymerization,3.0
15039,344148,GO:0008150,NCKAP5,biological_process,3.0
15040,344148,GO:0035371,NCKAP5,microtubule plus-end,3.0
15082,257194,GO:0005515,NEGR1,protein binding,3.0
15083,257194,GO:0005576,NEGR1,extracellular region,3.0
15084,257194,GO:0005886,NEGR1,plasma membrane,3.0
15085,257194,GO:0007626,NEGR1,locomotory behavior,3.0
15086,257194,GO:0007631,NEGR1,feeding behavior,3.0
15087,257194,GO:0010976,NEGR1,positive regulation of neuron projection development,3.0
15088,257194,GO:0031225,NEGR1,anchored component of membrane,3.0
15089,257194,GO:0098609,NEGR1,cell-cell adhesion,3.0
15090,4756,GO:0005515,NEO1,protein binding,3.0
15091,4756,GO:0005654,NEO1,nucleoplasm,3.0
15092,4756,GO:0005794,NEO1,Golgi apparatus,3.0
15093,4756,GO:0005886,NEO1,plasma membrane,3.0
15095,4756,GO:0005887,NEO1,integral component of plasma membrane,3.0
15096,4756,GO:0007155,NEO1,cell adhesion,3.0
15097,4756,GO:0007411,NEO1,axon guidance,3.0
15098,4756,GO:0030513,NEO1,positive regulation of BMP signaling pathway,3.0
15099,4756,GO:0038023,NEO1,signaling receptor activity,3.0
15100,4756,GO:0039706,NEO1,co-receptor binding,3.0
15101,4756,GO:0055072,NEO1,iron ion homeostasis,3.0
15102,4756,GO:0098797,NEO1,plasma membrane protein complex,3.0
15199,4774,GO:0000785,NFIA,chromatin,3.0
15200,4774,GO:0000978,NFIA,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
15202,4774,GO:0000981,NFIA,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
15204,4774,GO:0001228,NFIA,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
15205,4774,GO:0003682,NFIA,chromatin binding,3.0
15206,4774,GO:0003700,NFIA,DNA-binding transcription factor activity,3.0
15207,4774,GO:0005634,NFIA,nucleus,3.0
15210,4774,GO:0005654,NFIA,nucleoplasm,3.0
15211,4774,GO:0006260,NFIA,DNA replication,3.0
15212,4774,GO:0006355,NFIA,"regulation of transcription, DNA-templated",3.0
15213,4774,GO:0006357,NFIA,regulation of transcription by RNA polymerase II,3.0
15214,4774,GO:0008134,NFIA,transcription factor binding,3.0
15215,4774,GO:0019079,NFIA,viral genome replication,3.0
15216,4774,GO:0030054,NFIA,cell junction,3.0
15217,4774,GO:0045944,NFIA,positive regulation of transcription by RNA polymerase II,3.0
15218,4774,GO:0060074,NFIA,synapse maturation,3.0
15219,4774,GO:0072189,NFIA,ureter development,3.0
15220,4781,GO:0000785,NFIB,chromatin,3.0
15221,4781,GO:0000978,NFIB,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
15223,4781,GO:0000981,NFIB,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
15226,4781,GO:0001228,NFIB,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
15227,4781,GO:0001650,NFIB,fibrillar center,3.0
15228,4781,GO:0002062,NFIB,chondrocyte differentiation,3.0
15229,4781,GO:0003677,NFIB,DNA binding,3.0
15230,4781,GO:0005634,NFIB,nucleus,3.0
15232,4781,GO:0005654,NFIB,nucleoplasm,3.0
15233,4781,GO:0006260,NFIB,DNA replication,3.0
15234,4781,GO:0006357,NFIB,regulation of transcription by RNA polymerase II,3.0
15235,4781,GO:0007420,NFIB,brain development,3.0
15236,4781,GO:0009617,NFIB,response to bacterium,3.0
15237,4781,GO:0010001,NFIB,glial cell differentiation,3.0
15238,4781,GO:0021740,NFIB,principal sensory nucleus of trigeminal nerve development,3.0
15239,4781,GO:0021960,NFIB,anterior commissure morphogenesis,3.0
15240,4781,GO:0030902,NFIB,hindbrain development,3.0
15241,4781,GO:0044300,NFIB,cerebellar mossy fiber,3.0
15242,4781,GO:0045893,NFIB,"positive regulation of transcription, DNA-templated",3.0
15243,4781,GO:0045944,NFIB,positive regulation of transcription by RNA polymerase II,3.0
15244,4781,GO:0060486,NFIB,club cell differentiation,3.0
15245,4781,GO:0060509,NFIB,type I pneumocyte differentiation,3.0
15246,4781,GO:0060510,NFIB,type II pneumocyte differentiation,3.0
15247,4781,GO:0060662,NFIB,salivary gland cavitation,3.0
15248,4781,GO:0060689,NFIB,cell differentiation involved in salivary gland development,3.0
15249,4781,GO:0061141,NFIB,lung ciliated cell differentiation,3.0
15250,4781,GO:0071679,NFIB,commissural neuron axon guidance,3.0
15251,4781,GO:1902894,NFIB,negative regulation of pri-miRNA transcription by RNA polymerase II,3.0
15252,4781,GO:1990837,NFIB,sequence-specific double-stranded DNA binding,3.0
15253,4781,GO:2000791,NFIB,negative regulation of mesenchymal cell proliferation involved in lung development,3.0
15254,4781,GO:2000795,NFIB,negative regulation of epithelial cell proliferation involved in lung morphogenesis,3.0
15279,123606,GO:0005515,NIPA1,protein binding,3.0
15280,123606,GO:0005769,NIPA1,early endosome,3.0
15281,123606,GO:0005886,NIPA1,plasma membrane,3.0
15282,123606,GO:0015095,NIPA1,magnesium ion transmembrane transporter activity,3.0
15283,123606,GO:0015693,NIPA1,magnesium ion transport,3.0
15284,123606,GO:0016020,NIPA1,membrane,3.0
15285,123606,GO:0016021,NIPA1,integral component of membrane,3.0
15286,123606,GO:0055085,NIPA1,transmembrane transport,3.0
15287,123606,GO:1903830,NIPA1,magnesium ion transmembrane transport,3.0
15288,81614,GO:0005769,NIPA2,early endosome,3.0
15289,81614,GO:0005886,NIPA2,plasma membrane,3.0
15290,81614,GO:0015095,NIPA2,magnesium ion transmembrane transporter activity,3.0
15291,81614,GO:0015693,NIPA2,magnesium ion transport,3.0
15292,81614,GO:0016020,NIPA2,membrane,3.0
15293,81614,GO:0016021,NIPA2,integral component of membrane,3.0
15294,81614,GO:1903830,NIPA2,magnesium ion transmembrane transport,3.0
15627,22829,GO:0005515,NLGN4Y,protein binding,3.0
15628,22829,GO:0005886,NLGN4Y,plasma membrane,3.0
15629,22829,GO:0005887,NLGN4Y,integral component of plasma membrane,3.0
15630,22829,GO:0007158,NLGN4Y,neuron cell-cell adhesion,3.0
15632,22829,GO:0007268,NLGN4Y,chemical synaptic transmission,3.0
15633,22829,GO:0007612,NLGN4Y,learning,3.0
15634,22829,GO:0009986,NLGN4Y,cell surface,3.0
15635,22829,GO:0035176,NLGN4Y,social behavior,3.0
15636,22829,GO:0038023,NLGN4Y,signaling receptor activity,3.0
15637,22829,GO:0042043,NLGN4Y,neurexin family protein binding,3.0
15638,22829,GO:0045202,NLGN4Y,synapse,3.0
15639,22829,GO:0048488,NLGN4Y,synaptic vesicle endocytosis,3.0
15640,22829,GO:0050804,NLGN4Y,modulation of chemical synaptic transmission,3.0
15641,22829,GO:0050839,NLGN4Y,cell adhesion molecule binding,3.0
15642,22829,GO:0071625,NLGN4Y,vocalization behavior,3.0
15643,22829,GO:0089717,NLGN4Y,spanning component of membrane,3.0
15644,22829,GO:0097104,NLGN4Y,postsynaptic membrane assembly,3.0
15645,22829,GO:0097105,NLGN4Y,presynaptic membrane assembly,3.0
15646,22829,GO:0097110,NLGN4Y,scaffold protein binding,3.0
15647,22829,GO:0098793,NLGN4Y,presynapse,3.0
15648,22829,GO:0098839,NLGN4Y,postsynaptic density membrane,3.0
15649,22829,GO:0098983,NLGN4Y,"symmetric, GABA-ergic, inhibitory synapse",3.0
15650,22829,GO:0098985,NLGN4Y,"asymmetric, glutamatergic, excitatory synapse",3.0
15651,22829,GO:0099054,NLGN4Y,presynapse assembly,3.0
15652,9572,GO:0000122,NR1D1,negative regulation of transcription by RNA polymerase II,3.0
15655,9572,GO:0000785,NR1D1,chromatin,3.0
15657,9572,GO:0000976,NR1D1,transcription regulatory region sequence-specific DNA binding,3.0
15658,9572,GO:0000977,NR1D1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
15659,9572,GO:0000978,NR1D1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
15662,9572,GO:0000981,NR1D1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
15663,9572,GO:0001222,NR1D1,transcription corepressor binding,3.0
15665,9572,GO:0001227,NR1D1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
15666,9572,GO:0001678,NR1D1,cellular glucose homeostasis,3.0
15667,9572,GO:0003707,NR1D1,steroid hormone receptor activity,3.0
15668,9572,GO:0004879,NR1D1,nuclear receptor activity,3.0
15669,9572,GO:0005515,NR1D1,protein binding,3.0
15670,9572,GO:0005634,NR1D1,nucleus,3.0
15671,9572,GO:0005654,NR1D1,nucleoplasm,3.0
15672,9572,GO:0005737,NR1D1,cytoplasm,3.0
15673,9572,GO:0005978,NR1D1,glycogen biosynthetic process,3.0
15674,9572,GO:0006367,NR1D1,transcription initiation from RNA polymerase II promoter,3.0
15675,9572,GO:0007623,NR1D1,circadian rhythm,3.0
15676,9572,GO:0008270,NR1D1,zinc ion binding,3.0
15677,9572,GO:0009755,NR1D1,hormone-mediated signaling pathway,3.0
15678,9572,GO:0010498,NR1D1,proteasomal protein catabolic process,3.0
15679,9572,GO:0016604,NR1D1,nuclear body,3.0
15680,9572,GO:0019216,NR1D1,regulation of lipid metabolic process,3.0
15681,9572,GO:0020037,NR1D1,heme binding,3.0
15682,9572,GO:0030154,NR1D1,cell differentiation,3.0
15683,9572,GO:0030425,NR1D1,dendrite,3.0
15684,9572,GO:0030522,NR1D1,intracellular receptor signaling pathway,3.0
15685,9572,GO:0031648,NR1D1,protein destabilization,3.0
15686,9572,GO:0032922,NR1D1,circadian regulation of gene expression,3.0
15687,9572,GO:0034144,NR1D1,negative regulation of toll-like receptor 4 signaling pathway,3.0
15688,9572,GO:0042632,NR1D1,cholesterol homeostasis,3.0
15690,9572,GO:0042749,NR1D1,regulation of circadian sleep/wake cycle,3.0
15691,9572,GO:0042752,NR1D1,regulation of circadian rhythm,3.0
15692,9572,GO:0043124,NR1D1,negative regulation of I-kappaB kinase/NF-kappaB signaling,3.0
15693,9572,GO:0043197,NR1D1,dendritic spine,3.0
15694,9572,GO:0043401,NR1D1,steroid hormone mediated signaling pathway,3.0
15695,9572,GO:0044321,NR1D1,response to leptin,3.0
15697,9572,GO:0045598,NR1D1,regulation of fat cell differentiation,3.0
15698,9572,GO:0045892,NR1D1,"negative regulation of transcription, DNA-templated",3.0
15700,9572,GO:0045893,NR1D1,"positive regulation of transcription, DNA-templated",3.0
15701,9572,GO:0045944,NR1D1,positive regulation of transcription by RNA polymerase II,3.0
15702,9572,GO:0050728,NR1D1,negative regulation of inflammatory response,3.0
15703,9572,GO:0060086,NR1D1,circadian temperature homeostasis,3.0
15704,9572,GO:0061178,NR1D1,regulation of insulin secretion involved in cellular response to glucose stimulus,3.0
15705,9572,GO:0061469,NR1D1,regulation of type B pancreatic cell proliferation,3.0
15706,9572,GO:0061889,NR1D1,negative regulation of astrocyte activation,3.0
15707,9572,GO:0070859,NR1D1,positive regulation of bile acid biosynthetic process,3.0
15708,9572,GO:0070888,NR1D1,E-box binding,3.0
15709,9572,GO:0071222,NR1D1,cellular response to lipopolysaccharide,3.0
15710,9572,GO:0071347,NR1D1,cellular response to interleukin-1,3.0
15711,9572,GO:0071356,NR1D1,cellular response to tumor necrosis factor,3.0
15712,9572,GO:0120163,NR1D1,negative regulation of cold-induced thermogenesis,3.0
15713,9572,GO:0150079,NR1D1,negative regulation of neuroinflammatory response,3.0
15714,9572,GO:1903979,NR1D1,negative regulation of microglial cell activation,3.0
15715,9572,GO:1990837,NR1D1,sequence-specific double-stranded DNA binding,3.0
15716,7025,GO:0000122,NR2F1,negative regulation of transcription by RNA polymerase II,3.0
15718,7025,GO:0000785,NR2F1,chromatin,3.0
15719,7025,GO:0000978,NR2F1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
15721,7025,GO:0001227,NR2F1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
15722,7025,GO:0003700,NR2F1,DNA-binding transcription factor activity,3.0
15723,7025,GO:0004879,NR2F1,nuclear receptor activity,3.0
15724,7025,GO:0005515,NR2F1,protein binding,3.0
15725,7025,GO:0005634,NR2F1,nucleus,3.0
15726,7025,GO:0005654,NR2F1,nucleoplasm,3.0
15728,7025,GO:0005829,NR2F1,cytosol,3.0
15729,7025,GO:0006357,NR2F1,regulation of transcription by RNA polymerase II,3.0
15730,7025,GO:0006367,NR2F1,transcription initiation from RNA polymerase II promoter,3.0
15731,7025,GO:0007165,NR2F1,signal transduction,3.0
15732,7025,GO:0008270,NR2F1,zinc ion binding,3.0
15733,7025,GO:0010977,NR2F1,negative regulation of neuron projection development,3.0
15734,7025,GO:0030154,NR2F1,cell differentiation,3.0
15735,7025,GO:0030522,NR2F1,intracellular receptor signaling pathway,3.0
15736,7025,GO:0043565,NR2F1,sequence-specific DNA binding,3.0
15737,7025,GO:0044323,NR2F1,retinoic acid-responsive element binding,3.0
15738,7025,GO:0045944,NR2F1,positive regulation of transcription by RNA polymerase II,3.0
15739,7025,GO:0048856,NR2F1,anatomical structure development,3.0
15740,7025,GO:1990837,NR2F1,sequence-specific double-stranded DNA binding,3.0
15818,4897,GO:0001525,NRCAM,angiogenesis,3.0
15819,4897,GO:0001764,NRCAM,neuron migration,3.0
15820,4897,GO:0005515,NRCAM,protein binding,3.0
15821,4897,GO:0005576,NRCAM,extracellular region,3.0
15822,4897,GO:0005886,NRCAM,plasma membrane,3.0
15823,4897,GO:0005887,NRCAM,integral component of plasma membrane,3.0
15824,4897,GO:0007409,NRCAM,axonogenesis,3.0
15825,4897,GO:0007413,NRCAM,axonal fasciculation,3.0
15826,4897,GO:0007416,NRCAM,synapse assembly,3.0
15827,4897,GO:0007417,NRCAM,central nervous system development,3.0
15828,4897,GO:0008104,NRCAM,protein localization,3.0
15829,4897,GO:0009897,NRCAM,external side of plasma membrane,3.0
15830,4897,GO:0019227,NRCAM,neuronal action potential propagation,3.0
15831,4897,GO:0030506,NRCAM,ankyrin binding,3.0
15832,4897,GO:0030516,NRCAM,regulation of axon extension,3.0
15833,4897,GO:0031290,NRCAM,retinal ganglion cell axon guidance,3.0
15834,4897,GO:0034113,NRCAM,heterotypic cell-cell adhesion,3.0
15835,4897,GO:0043005,NRCAM,neuron projection,3.0
15836,4897,GO:0043194,NRCAM,axon initial segment,3.0
15837,4897,GO:0045162,NRCAM,clustering of voltage-gated sodium channels,3.0
15838,4897,GO:0045202,NRCAM,synapse,3.0
15839,4897,GO:0045666,NRCAM,positive regulation of neuron differentiation,3.0
15840,4897,GO:0086080,NRCAM,protein binding involved in heterotypic cell-cell adhesion,3.0
15841,4897,GO:0098609,NRCAM,cell-cell adhesion,3.0
15842,8828,GO:0001525,NRP2,angiogenesis,3.0
15843,8828,GO:0001938,NRP2,positive regulation of endothelial cell proliferation,3.0
15844,8828,GO:0002116,NRP2,semaphorin receptor complex,3.0
15845,8828,GO:0003148,NRP2,outflow tract septum morphogenesis,3.0
15846,8828,GO:0005021,NRP2,vascular endothelial growth factor-activated receptor activity,3.0
15847,8828,GO:0005515,NRP2,protein binding,3.0
15848,8828,GO:0005576,NRP2,extracellular region,3.0
15849,8828,GO:0005886,NRP2,plasma membrane,3.0
15850,8828,GO:0007155,NRP2,cell adhesion,3.0
15851,8828,GO:0007411,NRP2,axon guidance,3.0
15852,8828,GO:0008201,NRP2,heparin binding,3.0
15853,8828,GO:0010595,NRP2,positive regulation of endothelial cell migration,3.0
15854,8828,GO:0016020,NRP2,membrane,3.0
15855,8828,GO:0016021,NRP2,integral component of membrane,3.0
15856,8828,GO:0016032,NRP2,viral process,3.0
15857,8828,GO:0017154,NRP2,semaphorin receptor activity,3.0
15858,8828,GO:0019838,NRP2,growth factor binding,3.0
15859,8828,GO:0019955,NRP2,cytokine binding,3.0
15860,8828,GO:0021612,NRP2,facial nerve structural organization,3.0
15861,8828,GO:0021649,NRP2,vestibulocochlear nerve structural organization,3.0
15862,8828,GO:0021675,NRP2,nerve development,3.0
15863,8828,GO:0021828,NRP2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,3.0
15864,8828,GO:0030424,NRP2,axon,3.0
15865,8828,GO:0036486,NRP2,ventral trunk neural crest cell migration,3.0
15866,8828,GO:0038023,NRP2,signaling receptor activity,3.0
15867,8828,GO:0038084,NRP2,vascular endothelial growth factor signaling pathway,3.0
15868,8828,GO:0046872,NRP2,metal ion binding,3.0
15869,8828,GO:0048010,NRP2,vascular endothelial growth factor receptor signaling pathway,3.0
15870,8828,GO:0048846,NRP2,axon extension involved in axon guidance,3.0
15871,8828,GO:0050919,NRP2,negative chemotaxis,3.0
15872,8828,GO:0061549,NRP2,sympathetic ganglion development,3.0
15873,8828,GO:0061551,NRP2,trigeminal ganglion development,3.0
15874,8828,GO:0097374,NRP2,sensory neuron axon guidance,3.0
15875,8828,GO:0097490,NRP2,sympathetic neuron projection extension,3.0
15876,8828,GO:0097491,NRP2,sympathetic neuron projection guidance,3.0
15877,8828,GO:0098978,NRP2,glutamatergic synapse,3.0
15878,8828,GO:0099175,NRP2,regulation of postsynapse organization,3.0
15879,8828,GO:1901166,NRP2,neural crest cell migration involved in autonomic nervous system development,3.0
15880,8828,GO:1902285,NRP2,semaphorin-plexin signaling pathway involved in neuron projection guidance,3.0
15881,8828,GO:1903375,NRP2,facioacoustic ganglion development,3.0
15882,8828,GO:1904835,NRP2,dorsal root ganglion morphogenesis,3.0
15883,8828,GO:1990830,NRP2,cellular response to leukemia inhibitory factor,3.0
15932,29781,GO:0000796,NCAPH2,condensin complex,3.0
15933,29781,GO:0003682,NCAPH2,chromatin binding,3.0
15934,29781,GO:0005515,NCAPH2,protein binding,3.0
15935,29781,GO:0005634,NCAPH2,nucleus,3.0
15936,29781,GO:0005654,NCAPH2,nucleoplasm,3.0
15938,29781,GO:0007076,NCAPH2,mitotic chromosome condensation,3.0
15939,29781,GO:0010032,NCAPH2,meiotic chromosome condensation,3.0
15940,29781,GO:0016020,NCAPH2,membrane,3.0
15941,29781,GO:0030054,NCAPH2,cell junction,3.0
15942,29781,GO:0033077,NCAPH2,T cell differentiation in thymus,3.0
15943,29781,GO:0045171,NCAPH2,intercellular bridge,3.0
15944,29781,GO:0051306,NCAPH2,mitotic sister chromatid separation,3.0
15945,29781,GO:0051309,NCAPH2,female meiosis chromosome separation,3.0
16001,4698,GO:0005515,NDUFA5,protein binding,3.0
16002,4698,GO:0005743,NDUFA5,mitochondrial inner membrane,3.0
16003,4698,GO:0005747,NDUFA5,mitochondrial respiratory chain complex I,3.0
16006,4698,GO:0006120,NDUFA5,"mitochondrial electron transport, NADH to ubiquinone",3.0
16008,4698,GO:0008137,NDUFA5,NADH dehydrogenase (ubiquinone) activity,3.0
16010,4698,GO:0022904,NDUFA5,respiratory electron transport chain,3.0
16011,4698,GO:0032981,NDUFA5,mitochondrial respiratory chain complex I assembly,3.0
16023,4862,GO:0000785,NPAS2,chromatin,3.0
16024,4862,GO:0000978,NPAS2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
16026,4862,GO:0000981,NPAS2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
16028,4862,GO:0003677,NPAS2,DNA binding,3.0
16030,4862,GO:0003700,NPAS2,DNA-binding transcription factor activity,3.0
16031,4862,GO:0005515,NPAS2,protein binding,3.0
16032,4862,GO:0005634,NPAS2,nucleus,3.0
16033,4862,GO:0005654,NPAS2,nucleoplasm,3.0
16035,4862,GO:0005667,NPAS2,transcription regulator complex,3.0
16036,4862,GO:0005829,NPAS2,cytosol,3.0
16038,4862,GO:0006357,NPAS2,regulation of transcription by RNA polymerase II,3.0
16039,4862,GO:0006974,NPAS2,cellular response to DNA damage stimulus,3.0
16040,4862,GO:0007417,NPAS2,central nervous system development,3.0
16041,4862,GO:0007623,NPAS2,circadian rhythm,3.0
16042,4862,GO:0019216,NPAS2,regulation of lipid metabolic process,3.0
16043,4862,GO:0032922,NPAS2,circadian regulation of gene expression,3.0
16045,4862,GO:0042493,NPAS2,response to drug,3.0
16046,4862,GO:0045739,NPAS2,positive regulation of DNA repair,3.0
16047,4862,GO:0045893,NPAS2,"positive regulation of transcription, DNA-templated",3.0
16049,4862,GO:0045944,NPAS2,positive regulation of transcription by RNA polymerase II,3.0
16050,4862,GO:0046872,NPAS2,metal ion binding,3.0
16051,4862,GO:0046983,NPAS2,protein dimerization activity,3.0
16052,4862,GO:0051775,NPAS2,response to redox state,3.0
16053,4862,GO:0051879,NPAS2,Hsp90 protein binding,3.0
16054,4862,GO:0060548,NPAS2,negative regulation of cell death,3.0
16055,4862,GO:1990513,NPAS2,CLOCK-BMAL transcription complex,3.0
16056,4862,GO:1990837,NPAS2,sequence-specific double-stranded DNA binding,3.0
16057,4862,GO:2000987,NPAS2,positive regulation of behavioral fear response,3.0
16058,4862,GO:2001020,NPAS2,regulation of response to DNA damage stimulus,3.0
16119,22854,GO:0005515,NTNG1,protein binding,3.0
16120,22854,GO:0005576,NTNG1,extracellular region,3.0
16121,22854,GO:0005886,NTNG1,plasma membrane,3.0
16123,22854,GO:0007409,NTNG1,axonogenesis,3.0
16124,22854,GO:0009887,NTNG1,animal organ morphogenesis,3.0
16125,22854,GO:0009888,NTNG1,tissue development,3.0
16126,22854,GO:0010975,NTNG1,regulation of neuron projection development,3.0
16127,22854,GO:0016477,NTNG1,cell migration,3.0
16128,22854,GO:0034446,NTNG1,substrate adhesion-dependent cell spreading,3.0
16129,22854,GO:0043256,NTNG1,laminin complex,3.0
16130,22854,GO:0046658,NTNG1,anchored component of plasma membrane,3.0
16131,22854,GO:0050839,NTNG1,cell adhesion molecule binding,3.0
16132,22854,GO:0070831,NTNG1,basement membrane assembly,3.0
16133,22854,GO:0098632,NTNG1,cell-cell adhesion mediator activity,3.0
16135,22854,GO:0098978,NTNG1,glutamatergic synapse,3.0
16136,22854,GO:0099560,NTNG1,synaptic membrane adhesion,3.0
16137,22854,GO:0150011,NTNG1,regulation of neuron projection arborization,3.0
16138,22854,GO:2001222,NTNG1,regulation of neuron migration,3.0
16139,56160,GO:0000781,NSMCE3,"chromosome, telomeric region",3.0
16140,56160,GO:0005515,NSMCE3,protein binding,3.0
16141,56160,GO:0005654,NSMCE3,nucleoplasm,3.0
16142,56160,GO:0005737,NSMCE3,cytoplasm,3.0
16143,56160,GO:0006281,NSMCE3,DNA repair,3.0
16144,56160,GO:0006310,NSMCE3,DNA recombination,3.0
16145,56160,GO:0030915,NSMCE3,Smc5-Smc6 complex,3.0
16146,56160,GO:0031398,NSMCE3,positive regulation of protein ubiquitination,3.0
16147,56160,GO:0034644,NSMCE3,cellular response to UV,3.0
16148,56160,GO:0040008,NSMCE3,regulation of growth,3.0
16149,56160,GO:0046983,NSMCE3,protein dimerization activity,3.0
16150,56160,GO:0071478,NSMCE3,cellular response to radiation,3.0
16151,56160,GO:0072711,NSMCE3,cellular response to hydroxyurea,3.0
16175,4914,GO:0000139,NTRK1,Golgi membrane,3.0
16176,4914,GO:0000186,NTRK1,activation of MAPKK activity,3.0
16177,4914,GO:0001934,NTRK1,positive regulation of protein phosphorylation,3.0
16178,4914,GO:0004713,NTRK1,protein tyrosine kinase activity,3.0
16180,4914,GO:0004714,NTRK1,transmembrane receptor protein tyrosine kinase activity,3.0
16183,4914,GO:0005004,NTRK1,GPI-linked ephrin receptor activity,3.0
16184,4914,GO:0005030,NTRK1,neurotrophin receptor activity,3.0
16185,4914,GO:0005166,NTRK1,neurotrophin p75 receptor binding,3.0
16186,4914,GO:0005515,NTRK1,protein binding,3.0
16187,4914,GO:0005524,NTRK1,ATP binding,3.0
16188,4914,GO:0005769,NTRK1,early endosome,3.0
16189,4914,GO:0005770,NTRK1,late endosome,3.0
16190,4914,GO:0005886,NTRK1,plasma membrane,3.0
16192,4914,GO:0005887,NTRK1,integral component of plasma membrane,3.0
16194,4914,GO:0006468,NTRK1,protein phosphorylation,3.0
16195,4914,GO:0007169,NTRK1,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
16196,4914,GO:0007275,NTRK1,multicellular organism development,3.0
16197,4914,GO:0007411,NTRK1,axon guidance,3.0
16198,4914,GO:0007568,NTRK1,aging,3.0
16199,4914,GO:0007611,NTRK1,learning or memory,3.0
16200,4914,GO:0007623,NTRK1,circadian rhythm,3.0
16201,4914,GO:0008285,NTRK1,negative regulation of cell population proliferation,3.0
16202,4914,GO:0009314,NTRK1,response to radiation,3.0
16203,4914,GO:0009986,NTRK1,cell surface,3.0
16204,4914,GO:0010008,NTRK1,endosome membrane,3.0
16205,4914,GO:0010465,NTRK1,nerve growth factor receptor activity,3.0
16207,4914,GO:0010623,NTRK1,programmed cell death involved in cell development,3.0
16208,4914,GO:0010976,NTRK1,positive regulation of neuron projection development,3.0
16209,4914,GO:0014068,NTRK1,positive regulation of phosphatidylinositol 3-kinase signaling,3.0
16210,4914,GO:0018108,NTRK1,peptidyl-tyrosine phosphorylation,3.0
16211,4914,GO:0019900,NTRK1,kinase binding,3.0
16212,4914,GO:0021553,NTRK1,olfactory nerve development,3.0
16213,4914,GO:0030183,NTRK1,B cell differentiation,3.0
16214,4914,GO:0030424,NTRK1,axon,3.0
16215,4914,GO:0030425,NTRK1,dendrite,3.0
16216,4914,GO:0031667,NTRK1,response to nutrient levels,3.0
16217,4914,GO:0031901,NTRK1,early endosome membrane,3.0
16218,4914,GO:0031902,NTRK1,late endosome membrane,3.0
16219,4914,GO:0032991,NTRK1,protein-containing complex,3.0
16220,4914,GO:0033674,NTRK1,positive regulation of kinase activity,3.0
16221,4914,GO:0038083,NTRK1,peptidyl-tyrosine autophosphorylation,3.0
16222,4914,GO:0038180,NTRK1,nerve growth factor signaling pathway,3.0
16224,4914,GO:0042490,NTRK1,mechanoreceptor differentiation,3.0
16225,4914,GO:0042493,NTRK1,response to drug,3.0
16226,4914,GO:0042802,NTRK1,identical protein binding,3.0
16227,4914,GO:0042803,NTRK1,protein homodimerization activity,3.0
16228,4914,GO:0043025,NTRK1,neuronal cell body,3.0
16229,4914,GO:0043066,NTRK1,negative regulation of apoptotic process,3.0
16230,4914,GO:0043068,NTRK1,positive regulation of programmed cell death,3.0
16231,4914,GO:0043121,NTRK1,neurotrophin binding,3.0
16232,4914,GO:0043235,NTRK1,receptor complex,3.0
16234,4914,GO:0043410,NTRK1,positive regulation of MAPK cascade,3.0
16235,4914,GO:0043524,NTRK1,negative regulation of neuron apoptotic process,3.0
16236,4914,GO:0043547,NTRK1,positive regulation of GTPase activity,3.0
16237,4914,GO:0046579,NTRK1,positive regulation of Ras protein signal transduction,3.0
16238,4914,GO:0046777,NTRK1,protein autophosphorylation,3.0
16239,4914,GO:0048011,NTRK1,neurotrophin TRK receptor signaling pathway,3.0
16241,4914,GO:0048013,NTRK1,ephrin receptor signaling pathway,3.0
16242,4914,GO:0048015,NTRK1,phosphatidylinositol-mediated signaling,3.0
16243,4914,GO:0048406,NTRK1,nerve growth factor binding,3.0
16244,4914,GO:0048485,NTRK1,sympathetic nervous system development,3.0
16245,4914,GO:0048678,NTRK1,response to axon injury,3.0
16246,4914,GO:0050965,NTRK1,detection of temperature stimulus involved in sensory perception of pain,3.0
16247,4914,GO:0050966,NTRK1,detection of mechanical stimulus involved in sensory perception of pain,3.0
16248,4914,GO:0051092,NTRK1,positive regulation of NF-kappaB transcription factor activity,3.0
16249,4914,GO:0051599,NTRK1,response to hydrostatic pressure,3.0
16250,4914,GO:0051602,NTRK1,response to electrical stimulus,3.0
16251,4914,GO:0051896,NTRK1,regulation of protein kinase B signaling,3.0
16252,4914,GO:0051965,NTRK1,positive regulation of synapse assembly,3.0
16253,4914,GO:0051968,NTRK1,"positive regulation of synaptic transmission, glutamatergic",3.0
16254,4914,GO:0055038,NTRK1,recycling endosome membrane,3.0
16255,4914,GO:0060009,NTRK1,Sertoli cell development,3.0
16256,4914,GO:0060385,NTRK1,axonogenesis involved in innervation,3.0
16257,4914,GO:0061368,NTRK1,behavioral response to formalin induced pain,3.0
16258,4914,GO:0070374,NTRK1,positive regulation of ERK1 and ERK2 cascade,3.0
16260,4914,GO:0071316,NTRK1,cellular response to nicotine,3.0
16261,4914,GO:1904646,NTRK1,cellular response to amyloid-beta,3.0
16262,4914,GO:1990090,NTRK1,cellular response to nerve growth factor stimulus,3.0
16345,4916,GO:0000187,NTRK3,activation of MAPK activity,3.0
16346,4916,GO:0001764,NTRK3,neuron migration,3.0
16347,4916,GO:0001933,NTRK3,negative regulation of protein phosphorylation,3.0
16348,4916,GO:0001934,NTRK3,positive regulation of protein phosphorylation,3.0
16349,4916,GO:0002039,NTRK3,p53 binding,3.0
16350,4916,GO:0004714,NTRK3,transmembrane receptor protein tyrosine kinase activity,3.0
16351,4916,GO:0005004,NTRK3,GPI-linked ephrin receptor activity,3.0
16352,4916,GO:0005030,NTRK3,neurotrophin receptor activity,3.0
16354,4916,GO:0005515,NTRK3,protein binding,3.0
16355,4916,GO:0005524,NTRK3,ATP binding,3.0
16356,4916,GO:0005737,NTRK3,cytoplasm,3.0
16357,4916,GO:0005886,NTRK3,plasma membrane,3.0
16358,4916,GO:0005887,NTRK3,integral component of plasma membrane,3.0
16359,4916,GO:0007169,NTRK3,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
16361,4916,GO:0007275,NTRK3,multicellular organism development,3.0
16362,4916,GO:0007507,NTRK3,heart development,3.0
16363,4916,GO:0007623,NTRK3,circadian rhythm,3.0
16364,4916,GO:0008284,NTRK3,positive regulation of cell population proliferation,3.0
16365,4916,GO:0010628,NTRK3,positive regulation of gene expression,3.0
16366,4916,GO:0010863,NTRK3,positive regulation of phospholipase C activity,3.0
16367,4916,GO:0010976,NTRK3,positive regulation of neuron projection development,3.0
16368,4916,GO:0014068,NTRK3,positive regulation of phosphatidylinositol 3-kinase signaling,3.0
16370,4916,GO:0018108,NTRK3,peptidyl-tyrosine phosphorylation,3.0
16371,4916,GO:0019056,NTRK3,modulation by virus of host transcription,3.0
16372,4916,GO:0019227,NTRK3,neuronal action potential propagation,3.0
16373,4916,GO:0022011,NTRK3,myelination in peripheral nervous system,3.0
16374,4916,GO:0030335,NTRK3,positive regulation of cell migration,3.0
16375,4916,GO:0030424,NTRK3,axon,3.0
16376,4916,GO:0032148,NTRK3,activation of protein kinase B activity,3.0
16377,4916,GO:0033138,NTRK3,positive regulation of peptidyl-serine phosphorylation,3.0
16378,4916,GO:0033674,NTRK3,positive regulation of kinase activity,3.0
16379,4916,GO:0038179,NTRK3,neurotrophin signaling pathway,3.0
16380,4916,GO:0042490,NTRK3,mechanoreceptor differentiation,3.0
16381,4916,GO:0043065,NTRK3,positive regulation of apoptotic process,3.0
16382,4916,GO:0043121,NTRK3,neurotrophin binding,3.0
16383,4916,GO:0043235,NTRK3,receptor complex,3.0
16385,4916,GO:0043410,NTRK3,positive regulation of MAPK cascade,3.0
16386,4916,GO:0045471,NTRK3,response to ethanol,3.0
16387,4916,GO:0048013,NTRK3,ephrin receptor signaling pathway,3.0
16388,4916,GO:0048665,NTRK3,neuron fate specification,3.0
16389,4916,GO:0048678,NTRK3,response to axon injury,3.0
16390,4916,GO:0048691,NTRK3,positive regulation of axon extension involved in regeneration,3.0
16391,4916,GO:0048712,NTRK3,negative regulation of astrocyte differentiation,3.0
16392,4916,GO:0050927,NTRK3,positive regulation of positive chemotaxis,3.0
16393,4916,GO:0051388,NTRK3,positive regulation of neurotrophin TRK receptor signaling pathway,3.0
16394,4916,GO:0051412,NTRK3,response to corticosterone,3.0
16395,4916,GO:0051896,NTRK3,regulation of protein kinase B signaling,3.0
16396,4916,GO:0051965,NTRK3,positive regulation of synapse assembly,3.0
16397,4916,GO:0060548,NTRK3,negative regulation of cell death,3.0
16398,4916,GO:0070306,NTRK3,lens fiber cell differentiation,3.0
16399,4916,GO:0070374,NTRK3,positive regulation of ERK1 and ERK2 cascade,3.0
16400,4916,GO:0071300,NTRK3,cellular response to retinoic acid,3.0
16401,4916,GO:0090102,NTRK3,cochlea development,3.0
16402,4916,GO:0090630,NTRK3,activation of GTPase activity,3.0
16403,4916,GO:0098978,NTRK3,glutamatergic synapse,3.0
16404,4916,GO:0099055,NTRK3,integral component of postsynaptic membrane,3.0
16405,4916,GO:0099151,NTRK3,regulation of postsynaptic density assembly,3.0
16406,4916,GO:1990090,NTRK3,cellular response to nerve growth factor stimulus,3.0
16407,4916,GO:2000251,NTRK3,positive regulation of actin cytoskeleton reorganization,3.0
16448,55746,GO:0000777,NUP133,condensed chromosome kinetochore,3.0
16449,55746,GO:0000940,NUP133,condensed chromosome outer kinetochore,3.0
16450,55746,GO:0000972,NUP133,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,3.0
16451,55746,GO:0005515,NUP133,protein binding,3.0
16452,55746,GO:0005635,NUP133,nuclear envelope,3.0
16453,55746,GO:0005643,NUP133,nuclear pore,3.0
16454,55746,GO:0005829,NUP133,cytosol,3.0
16455,55746,GO:0006110,NUP133,regulation of glycolytic process,3.0
16456,55746,GO:0006406,NUP133,mRNA export from nucleus,3.0
16458,55746,GO:0006409,NUP133,tRNA export from nucleus,3.0
16459,55746,GO:0006606,NUP133,protein import into nucleus,3.0
16460,55746,GO:0006999,NUP133,nuclear pore organization,3.0
16461,55746,GO:0016020,NUP133,membrane,3.0
16462,55746,GO:0016032,NUP133,viral process,3.0
16463,55746,GO:0016925,NUP133,protein sumoylation,3.0
16464,55746,GO:0016973,NUP133,poly(A)+ mRNA export from nucleus,3.0
16465,55746,GO:0017056,NUP133,structural constituent of nuclear pore,3.0
16467,55746,GO:0019083,NUP133,viral transcription,3.0
16468,55746,GO:0021915,NUP133,neural tube development,3.0
16469,55746,GO:0022008,NUP133,neurogenesis,3.0
16470,55746,GO:0031080,NUP133,nuclear pore outer ring,3.0
16473,55746,GO:0031965,NUP133,nuclear membrane,3.0
16474,55746,GO:0043657,NUP133,host cell,3.0
16475,55746,GO:0048339,NUP133,paraxial mesoderm development,3.0
16476,55746,GO:0060964,NUP133,regulation of gene silencing by miRNA,3.0
16477,55746,GO:0061053,NUP133,somite development,3.0
16478,55746,GO:0072006,NUP133,nephron development,3.0
16479,55746,GO:0075733,NUP133,intracellular transport of virus,3.0
16480,55746,GO:1900034,NUP133,regulation of cellular response to heat,3.0
16481,30010,GO:0005102,NXPH1,signaling receptor binding,3.0
16482,30010,GO:0005576,NXPH1,extracellular region,3.0
16521,284451,GO:0005515,ODF3L2,protein binding,3.0
16522,284451,GO:0005856,ODF3L2,cytoskeleton,3.0
16523,284451,GO:0005881,ODF3L2,cytoplasmic microtubule,3.0
16525,8481,GO:0000086,OFD1,G2/M transition of mitotic cell cycle,3.0
16526,8481,GO:0000278,OFD1,mitotic cell cycle,3.0
16527,8481,GO:0005515,OFD1,protein binding,3.0
16528,8481,GO:0005576,OFD1,extracellular region,3.0
16529,8481,GO:0005634,OFD1,nucleus,3.0
16530,8481,GO:0005813,OFD1,centrosome,3.0
16532,8481,GO:0005814,OFD1,centriole,3.0
16533,8481,GO:0005829,OFD1,cytosol,3.0
16534,8481,GO:0005929,OFD1,cilium,3.0
16535,8481,GO:0007099,OFD1,centriole replication,3.0
16536,8481,GO:0010389,OFD1,regulation of G2/M transition of mitotic cell cycle,3.0
16537,8481,GO:0016020,OFD1,membrane,3.0
16538,8481,GO:0031514,OFD1,motile cilium,3.0
16539,8481,GO:0034451,OFD1,centriolar satellite,3.0
16540,8481,GO:0036064,OFD1,ciliary basal body,3.0
16542,8481,GO:0042802,OFD1,identical protein binding,3.0
16543,8481,GO:0043014,OFD1,alpha-tubulin binding,3.0
16544,8481,GO:0043015,OFD1,gamma-tubulin binding,3.0
16545,8481,GO:0060271,OFD1,cilium assembly,3.0
16547,8481,GO:0060287,OFD1,epithelial cilium movement involved in determination of left/right asymmetry,3.0
16548,8481,GO:0090307,OFD1,mitotic spindle assembly,3.0
16549,8481,GO:0097711,OFD1,ciliary basal body-plasma membrane docking,3.0
16584,26188,GO:0004930,OR1C1,G protein-coupled receptor activity,3.0
16585,26188,GO:0004984,OR1C1,olfactory receptor activity,3.0
16587,26188,GO:0005886,OR1C1,plasma membrane,3.0
16588,26188,GO:0007186,OR1C1,G protein-coupled receptor signaling pathway,3.0
16589,26188,GO:0007608,OR1C1,sensory perception of smell,3.0
16590,26188,GO:0016021,OR1C1,integral component of membrane,3.0
16591,26188,GO:0050911,OR1C1,detection of chemical stimulus involved in sensory perception of smell,3.0
16592,26245,GO:0004930,OR2M4,G protein-coupled receptor activity,3.0
16593,26245,GO:0004984,OR2M4,olfactory receptor activity,3.0
16594,26245,GO:0005886,OR2M4,plasma membrane,3.0
16595,26245,GO:0007186,OR2M4,G protein-coupled receptor signaling pathway,3.0
16596,26245,GO:0007608,OR2M4,sensory perception of smell,3.0
16597,26245,GO:0016021,OR2M4,integral component of membrane,3.0
16598,26245,GO:0050911,OR2M4,detection of chemical stimulus involved in sensory perception of smell,3.0
16599,127069,GO:0004930,OR2T10,G protein-coupled receptor activity,3.0
16600,127069,GO:0004984,OR2T10,olfactory receptor activity,3.0
16601,127069,GO:0005886,OR2T10,plasma membrane,3.0
16602,127069,GO:0007186,OR2T10,G protein-coupled receptor signaling pathway,3.0
16603,127069,GO:0016021,OR2T10,integral component of membrane,3.0
16604,127069,GO:0050911,OR2T10,detection of chemical stimulus involved in sensory perception of smell,3.0
16627,5013,GO:0000785,OTX1,chromatin,3.0
16628,5013,GO:0000978,OTX1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
16630,5013,GO:0000981,OTX1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
16632,5013,GO:0001228,OTX1,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
16633,5013,GO:0005515,OTX1,protein binding,3.0
16634,5013,GO:0005634,OTX1,nucleus,3.0
16635,5013,GO:0006357,OTX1,regulation of transcription by RNA polymerase II,3.0
16636,5013,GO:0009952,OTX1,anterior/posterior pattern specification,3.0
16637,5013,GO:0022037,OTX1,metencephalon development,3.0
16638,5013,GO:0030901,OTX1,midbrain development,3.0
16639,5013,GO:0042472,OTX1,inner ear morphogenesis,3.0
16640,5013,GO:0045944,OTX1,positive regulation of transcription by RNA polymerase II,3.0
16641,5013,GO:0048852,OTX1,diencephalon morphogenesis,3.0
16642,5013,GO:1990837,OTX1,sequence-specific double-stranded DNA binding,3.0
16666,10482,GO:0000346,NXF1,transcription export complex,3.0
16667,10482,GO:0003723,NXF1,RNA binding,3.0
16669,10482,GO:0003729,NXF1,mRNA binding,3.0
16670,10482,GO:0005515,NXF1,protein binding,3.0
16671,10482,GO:0005634,NXF1,nucleus,3.0
16673,10482,GO:0005643,NXF1,nuclear pore,3.0
16674,10482,GO:0005654,NXF1,nucleoplasm,3.0
16676,10482,GO:0005737,NXF1,cytoplasm,3.0
16677,10482,GO:0005829,NXF1,cytosol,3.0
16678,10482,GO:0006405,NXF1,RNA export from nucleus,3.0
16679,10482,GO:0006406,NXF1,mRNA export from nucleus,3.0
16681,10482,GO:0010494,NXF1,cytoplasmic stress granule,3.0
16682,10482,GO:0016032,NXF1,viral process,3.0
16683,10482,GO:0016607,NXF1,nuclear speck,3.0
16684,10482,GO:0016973,NXF1,poly(A)+ mRNA export from nucleus,3.0
16685,10482,GO:0042405,NXF1,nuclear inclusion body,3.0
16686,5020,GO:0001975,OXT,response to amphetamine,3.0
16687,5020,GO:0002027,OXT,regulation of heart rate,3.0
16688,5020,GO:0002125,OXT,maternal aggressive behavior,3.0
16689,5020,GO:0005184,OXT,neuropeptide hormone activity,3.0
16690,5020,GO:0005185,OXT,neurohypophyseal hormone activity,3.0
16691,5020,GO:0005515,OXT,protein binding,3.0
16692,5020,GO:0005576,OXT,extracellular region,3.0
16693,5020,GO:0005615,OXT,extracellular space,3.0
16694,5020,GO:0007165,OXT,signal transduction,3.0
16695,5020,GO:0007186,OXT,G protein-coupled receptor signaling pathway,3.0
16696,5020,GO:0007204,OXT,positive regulation of cytosolic calcium ion concentration,3.0
16697,5020,GO:0007507,OXT,heart development,3.0
16698,5020,GO:0007565,OXT,female pregnancy,3.0
16699,5020,GO:0007613,OXT,memory,3.0
16700,5020,GO:0007625,OXT,grooming behavior,3.0
16701,5020,GO:0009744,OXT,response to sucrose,3.0
16702,5020,GO:0010701,OXT,positive regulation of norepinephrine secretion,3.0
16703,5020,GO:0014823,OXT,response to activity,3.0
16704,5020,GO:0030141,OXT,secretory granule,3.0
16705,5020,GO:0030431,OXT,sleep,3.0
16706,5020,GO:0031855,OXT,oxytocin receptor binding,3.0
16707,5020,GO:0032094,OXT,response to food,3.0
16708,5020,GO:0032308,OXT,positive regulation of prostaglandin secretion,3.0
16709,5020,GO:0032355,OXT,response to estradiol,3.0
16710,5020,GO:0032526,OXT,response to retinoic acid,3.0
16711,5020,GO:0032570,OXT,response to progesterone,3.0
16712,5020,GO:0034695,OXT,response to prostaglandin E,3.0
16713,5020,GO:0035176,OXT,social behavior,3.0
16714,5020,GO:0035811,OXT,negative regulation of urine volume,3.0
16715,5020,GO:0035815,OXT,positive regulation of renal sodium excretion,3.0
16716,5020,GO:0042220,OXT,response to cocaine,3.0
16717,5020,GO:0042538,OXT,hyperosmotic salinity response,3.0
16718,5020,GO:0042711,OXT,maternal behavior,3.0
16719,5020,GO:0042713,OXT,sperm ejaculation,3.0
16720,5020,GO:0042755,OXT,eating behavior,3.0
16721,5020,GO:0042756,OXT,drinking behavior,3.0
16722,5020,GO:0043195,OXT,terminal bouton,3.0
16723,5020,GO:0043434,OXT,response to peptide hormone,3.0
16724,5020,GO:0045472,OXT,response to ether,3.0
16725,5020,GO:0045776,OXT,negative regulation of blood pressure,3.0
16726,5020,GO:0045777,OXT,positive regulation of blood pressure,3.0
16727,5020,GO:0045778,OXT,positive regulation of ossification,3.0
16728,5020,GO:0045925,OXT,positive regulation of female receptivity,3.0
16729,5020,GO:0050806,OXT,positive regulation of synaptic transmission,3.0
16730,5020,GO:0051384,OXT,response to glucocorticoid,3.0
16731,5020,GO:0051591,OXT,response to cAMP,3.0
16732,5020,GO:0051602,OXT,response to electrical stimulus,3.0
16733,5020,GO:0051930,OXT,regulation of sensory perception of pain,3.0
16734,5020,GO:0051965,OXT,positive regulation of synapse assembly,3.0
16735,5020,GO:0060179,OXT,male mating behavior,3.0
16736,5020,GO:0060406,OXT,positive regulation of penile erection,3.0
16737,5020,GO:0060450,OXT,positive regulation of hindgut contraction,3.0
16738,5020,GO:0060455,OXT,negative regulation of gastric acid secretion,3.0
16739,5020,GO:0070474,OXT,positive regulation of uterine smooth muscle contraction,3.0
16740,5020,GO:0120162,OXT,positive regulation of cold-induced thermogenesis,3.0
16845,5049,GO:0001650,PAFAH1B2,fibrillar center,3.0
16846,5049,GO:0003847,PAFAH1B2,1-alkyl-2-acetylglycerophosphocholine esterase activity,3.0
16847,5049,GO:0005515,PAFAH1B2,protein binding,3.0
16848,5049,GO:0005576,PAFAH1B2,extracellular region,3.0
16849,5049,GO:0005730,PAFAH1B2,nucleolus,3.0
16850,5049,GO:0005737,PAFAH1B2,cytoplasm,3.0
16852,5049,GO:0005829,PAFAH1B2,cytosol,3.0
16854,5049,GO:0005886,PAFAH1B2,plasma membrane,3.0
16855,5049,GO:0006629,PAFAH1B2,lipid metabolic process,3.0
16856,5049,GO:0007283,PAFAH1B2,spermatogenesis,3.0
16857,5049,GO:0007420,PAFAH1B2,brain development,3.0
16858,5049,GO:0008247,PAFAH1B2,1-alkyl-2-acetylglycerophosphocholine esterase complex,3.0
16859,5049,GO:0016042,PAFAH1B2,lipid catabolic process,3.0
16860,5049,GO:0016239,PAFAH1B2,positive regulation of macroautophagy,3.0
16861,5049,GO:0034774,PAFAH1B2,secretory granule lumen,3.0
16862,5049,GO:0042803,PAFAH1B2,protein homodimerization activity,3.0
16863,5049,GO:0043312,PAFAH1B2,neutrophil degranulation,3.0
16864,5049,GO:0044877,PAFAH1B2,protein-containing complex binding,3.0
16865,5049,GO:0046982,PAFAH1B2,protein heterodimerization activity,3.0
16866,5049,GO:0047179,PAFAH1B2,platelet-activating factor acetyltransferase activity,3.0
16867,5049,GO:0070062,PAFAH1B2,extracellular exosome,3.0
16868,5049,GO:1904813,PAFAH1B2,ficolin-1-rich granule lumen,3.0
17012,64895,GO:0003723,PAPOLG,RNA binding,3.0
17013,64895,GO:0004652,PAPOLG,polynucleotide adenylyltransferase activity,3.0
17015,64895,GO:0005524,PAPOLG,ATP binding,3.0
17016,64895,GO:0005634,PAPOLG,nucleus,3.0
17018,64895,GO:0005654,PAPOLG,nucleoplasm,3.0
17019,64895,GO:0005829,PAPOLG,cytosol,3.0
17020,64895,GO:0006378,PAPOLG,mRNA polyadenylation,3.0
17021,64895,GO:0016020,PAPOLG,membrane,3.0
17022,64895,GO:0016604,PAPOLG,nuclear body,3.0
17023,64895,GO:0043631,PAPOLG,RNA polyadenylation,3.0
17024,64895,GO:0046872,PAPOLG,metal ion binding,3.0
17043,10207,GO:0005515,PATJ,protein binding,3.0
17044,10207,GO:0005813,PATJ,centrosome,3.0
17045,10207,GO:0005829,PATJ,cytosol,3.0
17046,10207,GO:0005886,PATJ,plasma membrane,3.0
17047,10207,GO:0005923,PATJ,bicellular tight junction,3.0
17048,10207,GO:0016324,PATJ,apical plasma membrane,3.0
17049,10207,GO:0030054,PATJ,cell junction,3.0
17050,10207,GO:0034451,PATJ,centriolar satellite,3.0
17051,10207,GO:0035089,PATJ,establishment of apical/basal cell polarity,3.0
17052,10207,GO:0035556,PATJ,intracellular signal transduction,3.0
17053,10207,GO:0048471,PATJ,perinuclear region of cytoplasm,3.0
17054,10207,GO:0070062,PATJ,extracellular exosome,3.0
17055,10207,GO:0070830,PATJ,bicellular tight junction assembly,3.0
17056,10207,GO:0120192,PATJ,tight junction assembly,3.0
17169,5087,GO:0000785,PBX1,chromatin,3.0
17171,5087,GO:0000977,PBX1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
17172,5087,GO:0000978,PBX1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
17173,5087,GO:0000981,PBX1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
17175,5087,GO:0001228,PBX1,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
17176,5087,GO:0001654,PBX1,eye development,3.0
17177,5087,GO:0001658,PBX1,branching involved in ureteric bud morphogenesis,3.0
17178,5087,GO:0003677,PBX1,DNA binding,3.0
17179,5087,GO:0003700,PBX1,DNA-binding transcription factor activity,3.0
17180,5087,GO:0005515,PBX1,protein binding,3.0
17181,5087,GO:0005634,PBX1,nucleus,3.0
17182,5087,GO:0005654,PBX1,nucleoplasm,3.0
17184,5087,GO:0005737,PBX1,cytoplasm,3.0
17185,5087,GO:0006357,PBX1,regulation of transcription by RNA polymerase II,3.0
17186,5087,GO:0006694,PBX1,steroid biosynthetic process,3.0
17187,5087,GO:0007221,PBX1,positive regulation of transcription of Notch receptor target,3.0
17188,5087,GO:0007420,PBX1,brain development,3.0
17189,5087,GO:0007548,PBX1,sex differentiation,3.0
17190,5087,GO:0008284,PBX1,positive regulation of cell population proliferation,3.0
17191,5087,GO:0009887,PBX1,animal organ morphogenesis,3.0
17192,5087,GO:0009952,PBX1,anterior/posterior pattern specification,3.0
17193,5087,GO:0009954,PBX1,proximal/distal pattern formation,3.0
17194,5087,GO:0010971,PBX1,positive regulation of G2/M transition of mitotic cell cycle,3.0
17195,5087,GO:0030278,PBX1,regulation of ossification,3.0
17196,5087,GO:0030325,PBX1,adrenal gland development,3.0
17197,5087,GO:0030326,PBX1,embryonic limb morphogenesis,3.0
17198,5087,GO:0035019,PBX1,somatic stem cell population maintenance,3.0
17199,5087,GO:0035162,PBX1,embryonic hemopoiesis,3.0
17200,5087,GO:0045665,PBX1,negative regulation of neuron differentiation,3.0
17201,5087,GO:0048536,PBX1,spleen development,3.0
17202,5087,GO:0048538,PBX1,thymus development,3.0
17203,5087,GO:0048568,PBX1,embryonic organ development,3.0
17204,5087,GO:0048666,PBX1,neuron development,3.0
17205,5087,GO:0048706,PBX1,embryonic skeletal system development,3.0
17206,5087,GO:0090575,PBX1,RNA polymerase II transcription regulator complex,3.0
17207,5087,GO:1990837,PBX1,sequence-specific double-stranded DNA binding,3.0
17235,57575,GO:0005509,PCDH10,calcium ion binding,3.0
17236,57575,GO:0005887,PCDH10,integral component of plasma membrane,3.0
17237,57575,GO:0007155,PCDH10,cell adhesion,3.0
17238,57575,GO:0007156,PCDH10,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17239,27328,GO:0005509,PCDH11X,calcium ion binding,3.0
17240,27328,GO:0005886,PCDH11X,plasma membrane,3.0
17241,27328,GO:0005887,PCDH11X,integral component of plasma membrane,3.0
17242,27328,GO:0007155,PCDH11X,cell adhesion,3.0
17243,27328,GO:0007156,PCDH11X,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17244,27328,GO:0010923,PCDH11X,negative regulation of phosphatase activity,3.0
17245,65217,GO:0001750,PCDH15,photoreceptor outer segment,3.0
17246,65217,GO:0005509,PCDH15,calcium ion binding,3.0
17247,65217,GO:0005576,PCDH15,extracellular region,3.0
17248,65217,GO:0005887,PCDH15,integral component of plasma membrane,3.0
17249,65217,GO:0007155,PCDH15,cell adhesion,3.0
17250,65217,GO:0007156,PCDH15,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17251,65217,GO:0007605,PCDH15,sensory perception of sound,3.0
17252,65217,GO:0032420,PCDH15,stereocilium,3.0
17253,65217,GO:0045202,PCDH15,synapse,3.0
17254,65217,GO:0045494,PCDH15,photoreceptor cell maintenance,3.0
17255,65217,GO:0048839,PCDH15,inner ear development,3.0
17256,65217,GO:0050953,PCDH15,sensory perception of light stimulus,3.0
17257,65217,GO:0050957,PCDH15,equilibrioception,3.0
17263,5101,GO:0005509,PCDH9,calcium ion binding,3.0
17264,5101,GO:0005887,PCDH9,integral component of plasma membrane,3.0
17265,5101,GO:0007155,PCDH9,cell adhesion,3.0
17266,5101,GO:0007156,PCDH9,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17267,5101,GO:0030426,PCDH9,growth cone,3.0
17268,5101,GO:0044291,PCDH9,cell-cell contact zone,3.0
17269,56147,GO:0005509,PCDHA1,calcium ion binding,3.0
17270,56147,GO:0005576,PCDHA1,extracellular region,3.0
17271,56147,GO:0005783,PCDHA1,endoplasmic reticulum,3.0
17272,56147,GO:0005887,PCDHA1,integral component of plasma membrane,3.0
17273,56147,GO:0007155,PCDHA1,cell adhesion,3.0
17274,56147,GO:0007156,PCDHA1,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17275,56147,GO:0007399,PCDHA1,nervous system development,3.0
17276,56139,GO:0005509,PCDHA10,calcium ion binding,3.0
17277,56139,GO:0005576,PCDHA10,extracellular region,3.0
17278,56139,GO:0005887,PCDHA10,integral component of plasma membrane,3.0
17279,56139,GO:0007155,PCDHA10,cell adhesion,3.0
17280,56139,GO:0007156,PCDHA10,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17281,56139,GO:0007399,PCDHA10,nervous system development,3.0
17282,56138,GO:0005509,PCDHA11,calcium ion binding,3.0
17283,56138,GO:0005887,PCDHA11,integral component of plasma membrane,3.0
17284,56138,GO:0007155,PCDHA11,cell adhesion,3.0
17285,56138,GO:0007156,PCDHA11,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17286,56138,GO:0007399,PCDHA11,nervous system development,3.0
17287,56137,GO:0005509,PCDHA12,calcium ion binding,3.0
17288,56137,GO:0005887,PCDHA12,integral component of plasma membrane,3.0
17289,56137,GO:0007155,PCDHA12,cell adhesion,3.0
17290,56137,GO:0007156,PCDHA12,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17291,56136,GO:0005509,PCDHA13,calcium ion binding,3.0
17292,56136,GO:0005887,PCDHA13,integral component of plasma membrane,3.0
17293,56136,GO:0007155,PCDHA13,cell adhesion,3.0
17294,56136,GO:0007156,PCDHA13,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17295,56146,GO:0005509,PCDHA2,calcium ion binding,3.0
17296,56146,GO:0005634,PCDHA2,nucleus,3.0
17297,56146,GO:0005783,PCDHA2,endoplasmic reticulum,3.0
17298,56146,GO:0005887,PCDHA2,integral component of plasma membrane,3.0
17299,56146,GO:0007155,PCDHA2,cell adhesion,3.0
17300,56146,GO:0007156,PCDHA2,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17301,56146,GO:0007399,PCDHA2,nervous system development,3.0
17302,56145,GO:0005509,PCDHA3,calcium ion binding,3.0
17303,56145,GO:0005887,PCDHA3,integral component of plasma membrane,3.0
17304,56145,GO:0007155,PCDHA3,cell adhesion,3.0
17305,56145,GO:0007156,PCDHA3,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17306,56145,GO:0007399,PCDHA3,nervous system development,3.0
17307,56144,GO:0005509,PCDHA4,calcium ion binding,3.0
17308,56144,GO:0005515,PCDHA4,protein binding,3.0
17309,56144,GO:0005887,PCDHA4,integral component of plasma membrane,3.0
17310,56144,GO:0007155,PCDHA4,cell adhesion,3.0
17311,56144,GO:0007156,PCDHA4,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17312,56144,GO:0007399,PCDHA4,nervous system development,3.0
17313,56144,GO:0042802,PCDHA4,identical protein binding,3.0
17314,56143,GO:0005509,PCDHA5,calcium ion binding,3.0
17315,56143,GO:0005887,PCDHA5,integral component of plasma membrane,3.0
17316,56143,GO:0007155,PCDHA5,cell adhesion,3.0
17317,56143,GO:0007156,PCDHA5,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17318,56143,GO:0007399,PCDHA5,nervous system development,3.0
17319,56142,GO:0005509,PCDHA6,calcium ion binding,3.0
17320,56142,GO:0005576,PCDHA6,extracellular region,3.0
17321,56142,GO:0005887,PCDHA6,integral component of plasma membrane,3.0
17322,56142,GO:0007155,PCDHA6,cell adhesion,3.0
17323,56142,GO:0007156,PCDHA6,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17324,56142,GO:0007399,PCDHA6,nervous system development,3.0
17325,56141,GO:0005509,PCDHA7,calcium ion binding,3.0
17326,56141,GO:0005887,PCDHA7,integral component of plasma membrane,3.0
17328,56141,GO:0007155,PCDHA7,cell adhesion,3.0
17329,56141,GO:0007156,PCDHA7,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17330,56141,GO:0007399,PCDHA7,nervous system development,3.0
17331,56141,GO:0009988,PCDHA7,cell-cell recognition,3.0
17332,56141,GO:0042802,PCDHA7,identical protein binding,3.0
17333,56140,GO:0005509,PCDHA8,calcium ion binding,3.0
17334,56140,GO:0005887,PCDHA8,integral component of plasma membrane,3.0
17335,56140,GO:0007155,PCDHA8,cell adhesion,3.0
17336,56140,GO:0007156,PCDHA8,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17337,56140,GO:0007399,PCDHA8,nervous system development,3.0
17338,9752,GO:0005509,PCDHA9,calcium ion binding,3.0
17339,9752,GO:0005887,PCDHA9,integral component of plasma membrane,3.0
17340,9752,GO:0007155,PCDHA9,cell adhesion,3.0
17341,9752,GO:0007156,PCDHA9,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17342,56135,GO:0005509,PCDHAC1,calcium ion binding,3.0
17343,56135,GO:0005887,PCDHAC1,integral component of plasma membrane,3.0
17344,56135,GO:0007155,PCDHAC1,cell adhesion,3.0
17345,56135,GO:0007156,PCDHAC1,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
17346,56135,GO:0007399,PCDHAC1,nervous system development,3.0
17347,5108,GO:0000086,PCM1,G2/M transition of mitotic cell cycle,3.0
17348,5108,GO:0000242,PCM1,pericentriolar material,3.0
17349,5108,GO:0001764,PCM1,neuron migration,3.0
17350,5108,GO:0005515,PCM1,protein binding,3.0
17351,5108,GO:0005737,PCM1,cytoplasm,3.0
17352,5108,GO:0005813,PCM1,centrosome,3.0
17355,5108,GO:0005814,PCM1,centriole,3.0
17356,5108,GO:0005829,PCM1,cytosol,3.0
17358,5108,GO:0007098,PCM1,centrosome cycle,3.0
17360,5108,GO:0010389,PCM1,regulation of G2/M transition of mitotic cell cycle,3.0
17361,5108,GO:0016020,PCM1,membrane,3.0
17362,5108,GO:0022027,PCM1,interkinetic nuclear migration,3.0
17363,5108,GO:0031122,PCM1,cytoplasmic microtubule organization,3.0
17364,5108,GO:0031965,PCM1,nuclear membrane,3.0
17365,5108,GO:0032991,PCM1,protein-containing complex,3.0
17366,5108,GO:0034451,PCM1,centriolar satellite,3.0
17368,5108,GO:0034453,PCM1,microtubule anchoring,3.0
17369,5108,GO:0034454,PCM1,microtubule anchoring at centrosome,3.0
17370,5108,GO:0035176,PCM1,social behavior,3.0
17371,5108,GO:0035735,PCM1,intraciliary transport involved in cilium assembly,3.0
17373,5108,GO:0035869,PCM1,ciliary transition zone,3.0
17374,5108,GO:0036064,PCM1,ciliary basal body,3.0
17375,5108,GO:0042802,PCM1,identical protein binding,3.0
17376,5108,GO:0045177,PCM1,apical part of cell,3.0
17377,5108,GO:0050768,PCM1,negative regulation of neurogenesis,3.0
17378,5108,GO:0060271,PCM1,cilium assembly,3.0
17379,5108,GO:0071539,PCM1,protein localization to centrosome,3.0
17382,5108,GO:0090316,PCM1,positive regulation of intracellular protein transport,3.0
17383,5108,GO:0097150,PCM1,neuronal stem cell population maintenance,3.0
17384,5108,GO:0097711,PCM1,ciliary basal body-plasma membrane docking,3.0
17385,5108,GO:0097730,PCM1,non-motile cilium,3.0
17386,5108,GO:1905515,PCM1,non-motile cilium assembly,3.0
17387,5133,GO:0002250,PDCD1,adaptive immune response,3.0
17388,5133,GO:0002644,PDCD1,negative regulation of tolerance induction,3.0
17389,5133,GO:0005515,PDCD1,protein binding,3.0
17390,5133,GO:0005886,PDCD1,plasma membrane,3.0
17391,5133,GO:0006915,PDCD1,apoptotic process,3.0
17392,5133,GO:0006959,PDCD1,humoral immune response,3.0
17393,5133,GO:0007275,PDCD1,multicellular organism development,3.0
17394,5133,GO:0009897,PDCD1,external side of plasma membrane,3.0
17395,5133,GO:0016021,PDCD1,integral component of membrane,3.0
17396,5133,GO:0031295,PDCD1,T cell costimulation,3.0
17397,5133,GO:0043066,PDCD1,negative regulation of apoptotic process,3.0
17398,5133,GO:0050776,PDCD1,regulation of immune response,3.0
17399,5133,GO:0050777,PDCD1,negative regulation of immune response,3.0
17400,5133,GO:0070234,PDCD1,positive regulation of T cell apoptotic process,3.0
17402,5137,GO:0004114,PDE1C,"3',5'-cyclic-nucleotide phosphodiesterase activity",3.0
17403,5137,GO:0004117,PDE1C,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,3.0
17404,5137,GO:0005516,PDE1C,calmodulin binding,3.0
17405,5137,GO:0005829,PDE1C,cytosol,3.0
17406,5137,GO:0007165,PDE1C,signal transduction,3.0
17407,5137,GO:0043025,PDE1C,neuronal cell body,3.0
17408,5137,GO:0046872,PDE1C,metal ion binding,3.0
17409,5137,GO:0048101,PDE1C,"calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity",3.0
17410,5164,GO:0004672,PDK2,protein kinase activity,3.0
17411,5164,GO:0004674,PDK2,protein serine/threonine kinase activity,3.0
17412,5164,GO:0004740,PDK2,pyruvate dehydrogenase (acetyl-transferring) kinase activity,3.0
17413,5164,GO:0005515,PDK2,protein binding,3.0
17414,5164,GO:0005524,PDK2,ATP binding,3.0
17415,5164,GO:0005654,PDK2,nucleoplasm,3.0
17416,5164,GO:0005739,PDK2,mitochondrion,3.0
17418,5164,GO:0005759,PDK2,mitochondrial matrix,3.0
17419,5164,GO:0005829,PDK2,cytosol,3.0
17420,5164,GO:0005967,PDK2,mitochondrial pyruvate dehydrogenase complex,3.0
17421,5164,GO:0006006,PDK2,glucose metabolic process,3.0
17422,5164,GO:0006111,PDK2,regulation of gluconeogenesis,3.0
17423,5164,GO:0006468,PDK2,protein phosphorylation,3.0
17424,5164,GO:0006885,PDK2,regulation of pH,3.0
17425,5164,GO:0008286,PDK2,insulin receptor signaling pathway,3.0
17426,5164,GO:0010510,PDK2,regulation of acetyl-CoA biosynthetic process from pyruvate,3.0
17428,5164,GO:0010565,PDK2,regulation of cellular ketone metabolic process,3.0
17429,5164,GO:0010906,PDK2,regulation of glucose metabolic process,3.0
17430,5164,GO:0031670,PDK2,cellular response to nutrient,3.0
17431,5164,GO:0034614,PDK2,cellular response to reactive oxygen species,3.0
17432,5164,GO:0042593,PDK2,glucose homeostasis,3.0
17434,5164,GO:0042803,PDK2,protein homodimerization activity,3.0
17435,5164,GO:0050848,PDK2,regulation of calcium-mediated signaling,3.0
17436,5164,GO:0072332,PDK2,intrinsic apoptotic signaling pathway by p53 class mediator,3.0
17437,5164,GO:1904183,PDK2,negative regulation of pyruvate dehydrogenase activity,3.0
17438,5187,GO:0000122,PER1,negative regulation of transcription by RNA polymerase II,3.0
17440,5187,GO:0000976,PER1,transcription regulatory region sequence-specific DNA binding,3.0
17441,5187,GO:0000978,PER1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
17442,5187,GO:0001222,PER1,transcription corepressor binding,3.0
17443,5187,GO:0002028,PER1,regulation of sodium ion transport,3.0
17444,5187,GO:0005515,PER1,protein binding,3.0
17445,5187,GO:0005634,PER1,nucleus,3.0
17446,5187,GO:0005654,PER1,nucleoplasm,3.0
17447,5187,GO:0005737,PER1,cytoplasm,3.0
17449,5187,GO:0005829,PER1,cytosol,3.0
17450,5187,GO:0007623,PER1,circadian rhythm,3.0
17451,5187,GO:0009649,PER1,entrainment of circadian clock,3.0
17452,5187,GO:0010608,PER1,posttranscriptional regulation of gene expression,3.0
17453,5187,GO:0019900,PER1,kinase binding,3.0
17454,5187,GO:0031490,PER1,chromatin DNA binding,3.0
17455,5187,GO:0031625,PER1,ubiquitin protein ligase binding,3.0
17456,5187,GO:0032922,PER1,circadian regulation of gene expression,3.0
17458,5187,GO:0042634,PER1,regulation of hair cycle,3.0
17459,5187,GO:0042752,PER1,regulation of circadian rhythm,3.0
17460,5187,GO:0043124,PER1,negative regulation of I-kappaB kinase/NF-kappaB signaling,3.0
17461,5187,GO:0043153,PER1,entrainment of circadian clock by photoperiod,3.0
17463,5187,GO:0043966,PER1,histone H3 acetylation,3.0
17464,5187,GO:0043967,PER1,histone H4 acetylation,3.0
17465,5187,GO:0045892,PER1,"negative regulation of transcription, DNA-templated",3.0
17466,5187,GO:0045944,PER1,positive regulation of transcription by RNA polymerase II,3.0
17467,5187,GO:0046329,PER1,negative regulation of JNK cascade,3.0
17468,5187,GO:0051591,PER1,response to cAMP,3.0
17469,5187,GO:0070888,PER1,E-box binding,3.0
17470,5187,GO:0070932,PER1,histone H3 deacetylation,3.0
17471,5187,GO:0097167,PER1,circadian regulation of translation,3.0
17472,5187,GO:1900015,PER1,regulation of cytokine production involved in inflammatory response,3.0
17473,5187,GO:1900744,PER1,regulation of p38MAPK cascade,3.0
17474,5187,GO:2000323,PER1,negative regulation of glucocorticoid receptor signaling pathway,3.0
17513,5191,GO:0001764,PEX7,neuron migration,3.0
17514,5191,GO:0001958,PEX7,endochondral ossification,3.0
17515,5191,GO:0005053,PEX7,peroxisome matrix targeting signal-2 binding,3.0
17517,5191,GO:0005515,PEX7,protein binding,3.0
17518,5191,GO:0005777,PEX7,peroxisome,3.0
17519,5191,GO:0005778,PEX7,peroxisomal membrane,3.0
17520,5191,GO:0005782,PEX7,peroxisomal matrix,3.0
17522,5191,GO:0005829,PEX7,cytosol,3.0
17525,5191,GO:0006625,PEX7,protein targeting to peroxisome,3.0
17526,5191,GO:0006635,PEX7,fatty acid beta-oxidation,3.0
17527,5191,GO:0007031,PEX7,peroxisome organization,3.0
17528,5191,GO:0008611,PEX7,ether lipid biosynthetic process,3.0
17529,5191,GO:0016558,PEX7,protein import into peroxisome matrix,3.0
17532,5191,GO:0019899,PEX7,enzyme binding,3.0
17533,5191,GO:0042803,PEX7,protein homodimerization activity,3.0
17626,157310,GO:0005515,PEBP4,protein binding,3.0
17627,157310,GO:0005764,PEBP4,lysosome,3.0
17628,157310,GO:0070062,PEBP4,extracellular exosome,3.0
17681,5307,GO:0000785,PITX1,chromatin,3.0
17682,5307,GO:0000978,PITX1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
17683,5307,GO:0000981,PITX1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
17685,5307,GO:0001085,PITX1,RNA polymerase II transcription factor binding,3.0
17686,5307,GO:0001228,PITX1,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
17687,5307,GO:0001501,PITX1,skeletal system development,3.0
17688,5307,GO:0003700,PITX1,DNA-binding transcription factor activity,3.0
17689,5307,GO:0005515,PITX1,protein binding,3.0
17690,5307,GO:0005634,PITX1,nucleus,3.0
17692,5307,GO:0005667,PITX1,transcription regulator complex,3.0
17693,5307,GO:0005737,PITX1,cytoplasm,3.0
17694,5307,GO:0006357,PITX1,regulation of transcription by RNA polymerase II,3.0
17695,5307,GO:0009653,PITX1,anatomical structure morphogenesis,3.0
17696,5307,GO:0014707,PITX1,branchiomeric skeletal muscle development,3.0
17697,5307,GO:0021983,PITX1,pituitary gland development,3.0
17698,5307,GO:0035116,PITX1,embryonic hindlimb morphogenesis,3.0
17699,5307,GO:0045892,PITX1,"negative regulation of transcription, DNA-templated",3.0
17700,5307,GO:0045944,PITX1,positive regulation of transcription by RNA polymerase II,3.0
17701,5307,GO:0048625,PITX1,myoblast fate commitment,3.0
17702,5307,GO:0051216,PITX1,cartilage development,3.0
17703,5307,GO:1990837,PITX1,sequence-specific double-stranded DNA binding,3.0
17704,5329,GO:0001934,PLAUR,positive regulation of protein phosphorylation,3.0
17705,5329,GO:0005102,PLAUR,signaling receptor binding,3.0
17706,5329,GO:0005515,PLAUR,protein binding,3.0
17707,5329,GO:0005576,PLAUR,extracellular region,3.0
17708,5329,GO:0005788,PLAUR,endoplasmic reticulum lumen,3.0
17709,5329,GO:0005789,PLAUR,endoplasmic reticulum membrane,3.0
17710,5329,GO:0005886,PLAUR,plasma membrane,3.0
17713,5329,GO:0005887,PLAUR,integral component of plasma membrane,3.0
17714,5329,GO:0005925,PLAUR,focal adhesion,3.0
17715,5329,GO:0006935,PLAUR,chemotaxis,3.0
17716,5329,GO:0007165,PLAUR,signal transduction,3.0
17717,5329,GO:0007596,PLAUR,blood coagulation,3.0
17718,5329,GO:0009986,PLAUR,cell surface,3.0
17719,5329,GO:0016021,PLAUR,integral component of membrane,3.0
17720,5329,GO:0019898,PLAUR,extrinsic component of membrane,3.0
17721,5329,GO:0019899,PLAUR,enzyme binding,3.0
17722,5329,GO:0019904,PLAUR,protein domain specific binding,3.0
17723,5329,GO:0030162,PLAUR,regulation of proteolysis,3.0
17724,5329,GO:0030377,PLAUR,urokinase plasminogen activator receptor activity,3.0
17725,5329,GO:0031225,PLAUR,anchored component of membrane,3.0
17726,5329,GO:0034112,PLAUR,positive regulation of homotypic cell-cell adhesion,3.0
17727,5329,GO:0035579,PLAUR,specific granule membrane,3.0
17728,5329,GO:0038023,PLAUR,signaling receptor activity,3.0
17729,5329,GO:0038195,PLAUR,urokinase plasminogen activator signaling pathway,3.0
17730,5329,GO:0042730,PLAUR,fibrinolysis,3.0
17731,5329,GO:0043066,PLAUR,negative regulation of apoptotic process,3.0
17732,5329,GO:0043312,PLAUR,neutrophil degranulation,3.0
17733,5329,GO:0043388,PLAUR,positive regulation of DNA binding,3.0
17734,5329,GO:0045742,PLAUR,positive regulation of epidermal growth factor receptor signaling pathway,3.0
17735,5329,GO:0071438,PLAUR,invadopodium membrane,3.0
17736,5329,GO:0090200,PLAUR,positive regulation of release of cytochrome c from mitochondria,3.0
17737,5329,GO:2001243,PLAUR,negative regulation of intrinsic apoptotic signaling pathway,3.0
17738,5329,GO:2001268,PLAUR,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,3.0
17795,84812,GO:0004435,PLCD4,phosphatidylinositol phospholipase C activity,3.0
17796,84812,GO:0005085,PLCD4,guanyl-nucleotide exchange factor activity,3.0
17797,84812,GO:0005509,PLCD4,calcium ion binding,3.0
17798,84812,GO:0005515,PLCD4,protein binding,3.0
17799,84812,GO:0005789,PLCD4,endoplasmic reticulum membrane,3.0
17800,84812,GO:0005829,PLCD4,cytosol,3.0
17801,84812,GO:0005886,PLCD4,plasma membrane,3.0
17802,84812,GO:0007340,PLCD4,acrosome reaction,3.0
17803,84812,GO:0016042,PLCD4,lipid catabolic process,3.0
17804,84812,GO:0031965,PLCD4,nuclear membrane,3.0
17805,84812,GO:0043647,PLCD4,inositol phosphate metabolic process,3.0
17806,84812,GO:0046488,PLCD4,phosphatidylinositol metabolic process,3.0
17807,84812,GO:0048015,PLCD4,phosphatidylinositol-mediated signaling,3.0
17808,5350,GO:0002026,PLN,regulation of the force of heart contraction,3.0
17809,5350,GO:0004857,PLN,enzyme inhibitor activity,3.0
17810,5350,GO:0005515,PLN,protein binding,3.0
17811,5350,GO:0005739,PLN,mitochondrion,3.0
17812,5350,GO:0005783,PLN,endoplasmic reticulum,3.0
17813,5350,GO:0006816,PLN,calcium ion transport,3.0
17814,5350,GO:0007219,PLN,Notch signaling pathway,3.0
17815,5350,GO:0008015,PLN,blood circulation,3.0
17816,5350,GO:0008016,PLN,regulation of heart contraction,3.0
17817,5350,GO:0010043,PLN,response to zinc ion,3.0
17818,5350,GO:0010459,PLN,negative regulation of heart rate,3.0
17819,5350,GO:0010881,PLN,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,3.0
17820,5350,GO:0016020,PLN,membrane,3.0
17821,5350,GO:0031966,PLN,mitochondrial membrane,3.0
17822,5350,GO:0031982,PLN,vesicle,3.0
17823,5350,GO:0032780,PLN,negative regulation of ATPase activity,3.0
17825,5350,GO:0032868,PLN,response to insulin,3.0
17826,5350,GO:0033017,PLN,sarcoplasmic reticulum membrane,3.0
17828,5350,GO:0033574,PLN,response to testosterone,3.0
17829,5350,GO:0042030,PLN,ATPase inhibitor activity,3.0
17831,5350,GO:0042802,PLN,identical protein binding,3.0
17832,5350,GO:0042803,PLN,protein homodimerization activity,3.0
17833,5350,GO:0043086,PLN,negative regulation of catalytic activity,3.0
17834,5350,GO:0048471,PLN,perinuclear region of cytoplasm,3.0
17835,5350,GO:0048738,PLN,cardiac muscle tissue development,3.0
17836,5350,GO:0051117,PLN,ATPase binding,3.0
17837,5350,GO:0051480,PLN,regulation of cytosolic calcium ion concentration,3.0
17838,5350,GO:0051924,PLN,regulation of calcium ion transport,3.0
17840,5350,GO:0051926,PLN,negative regulation of calcium ion transport,3.0
17841,5350,GO:0055119,PLN,relaxation of cardiac muscle,3.0
17842,5350,GO:0060314,PLN,regulation of ryanodine-sensitive calcium-release channel activity,3.0
17843,5350,GO:0086004,PLN,regulation of cardiac muscle cell contraction,3.0
17844,5350,GO:0086023,PLN,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,3.0
17845,5350,GO:0086036,PLN,regulation of cardiac muscle cell membrane potential,3.0
17846,5350,GO:0086092,PLN,regulation of the force of heart contraction by cardiac conduction,3.0
17847,5350,GO:0090281,PLN,negative regulation of calcium ion import,3.0
17848,5350,GO:0090534,PLN,calcium ion-transporting ATPase complex,3.0
17849,5350,GO:1901020,PLN,negative regulation of calcium ion transmembrane transporter activity,3.0
17851,5350,GO:1901877,PLN,negative regulation of calcium ion binding,3.0
17853,5350,GO:1901894,PLN,regulation of ATPase-coupled calcium transmembrane transporter activity,3.0
17854,5350,GO:1901895,PLN,negative regulation of ATPase-coupled calcium transmembrane transporter activity,3.0
17855,5350,GO:1901897,PLN,regulation of relaxation of cardiac muscle,3.0
17856,5350,GO:1902081,PLN,negative regulation of calcium ion import into sarcoplasmic reticulum,3.0
17857,55558,GO:0002116,PLXNA3,semaphorin receptor complex,3.0
17859,55558,GO:0004888,PLXNA3,transmembrane signaling receptor activity,3.0
17860,55558,GO:0005515,PLXNA3,protein binding,3.0
17861,55558,GO:0005886,PLXNA3,plasma membrane,3.0
17862,55558,GO:0005887,PLXNA3,integral component of plasma membrane,3.0
17863,55558,GO:0007162,PLXNA3,negative regulation of cell adhesion,3.0
17864,55558,GO:0007275,PLXNA3,multicellular organism development,3.0
17865,55558,GO:0008360,PLXNA3,regulation of cell shape,3.0
17866,55558,GO:0016020,PLXNA3,membrane,3.0
17867,55558,GO:0017154,PLXNA3,semaphorin receptor activity,3.0
17868,55558,GO:0021612,PLXNA3,facial nerve structural organization,3.0
17869,55558,GO:0021637,PLXNA3,trigeminal nerve structural organization,3.0
17870,55558,GO:0021766,PLXNA3,hippocampus development,3.0
17871,55558,GO:0021785,PLXNA3,branchiomotor neuron axon guidance,3.0
17872,55558,GO:0021860,PLXNA3,pyramidal neuron development,3.0
17873,55558,GO:0030334,PLXNA3,regulation of cell migration,3.0
17874,55558,GO:0043087,PLXNA3,regulation of GTPase activity,3.0
17875,55558,GO:0048843,PLXNA3,negative regulation of axon extension involved in axon guidance,3.0
17876,55558,GO:0050772,PLXNA3,positive regulation of axonogenesis,3.0
17877,55558,GO:0050919,PLXNA3,negative chemotaxis,3.0
17878,55558,GO:0051495,PLXNA3,positive regulation of cytoskeleton organization,3.0
17879,55558,GO:0071526,PLXNA3,semaphorin-plexin signaling pathway,3.0
17880,55558,GO:1902287,PLXNA3,semaphorin-plexin signaling pathway involved in axon guidance,3.0
17881,55558,GO:1990138,PLXNA3,neuron projection extension,3.0
17942,375775,GO:0004622,PNPLA7,lysophospholipase activity,3.0
17943,375775,GO:0005783,PNPLA7,endoplasmic reticulum,3.0
17944,375775,GO:0005789,PNPLA7,endoplasmic reticulum membrane,3.0
17945,375775,GO:0005811,PNPLA7,lipid droplet,3.0
17946,375775,GO:0016021,PNPLA7,integral component of membrane,3.0
17947,375775,GO:0034638,PNPLA7,phosphatidylcholine catabolic process,3.0
17948,375775,GO:0102545,PNPLA7,phosphatidyl phospholipase B activity,3.0
17962,23649,GO:0000082,POLA2,G1/S transition of mitotic cell cycle,3.0
17963,23649,GO:0003674,POLA2,molecular_function,3.0
17964,23649,GO:0003677,POLA2,DNA binding,3.0
17965,23649,GO:0005515,POLA2,protein binding,3.0
17966,23649,GO:0005654,POLA2,nucleoplasm,3.0
17968,23649,GO:0005658,POLA2,alpha DNA polymerase:primase complex,3.0
17970,23649,GO:0005829,POLA2,cytosol,3.0
17971,23649,GO:0006260,POLA2,DNA replication,3.0
17972,23649,GO:0006270,POLA2,DNA replication initiation,3.0
17974,23649,GO:0032201,POLA2,telomere maintenance via semi-conservative replication,3.0
17991,10585,GO:0000030,POMT1,mannosyltransferase activity,3.0
17992,10585,GO:0001669,POMT1,acrosomal vesicle,3.0
17993,10585,GO:0004169,POMT1,dolichyl-phosphate-mannose-protein mannosyltransferase activity,3.0
17994,10585,GO:0005783,POMT1,endoplasmic reticulum,3.0
17995,10585,GO:0005789,POMT1,endoplasmic reticulum membrane,3.0
17998,10585,GO:0005975,POMT1,carbohydrate metabolic process,3.0
17999,10585,GO:0006493,POMT1,protein O-linked glycosylation,3.0
18000,10585,GO:0007275,POMT1,multicellular organism development,3.0
18001,10585,GO:0016021,POMT1,integral component of membrane,3.0
18002,10585,GO:0016529,POMT1,sarcoplasmic reticulum,3.0
18003,10585,GO:0030198,POMT1,extracellular matrix organization,3.0
18004,10585,GO:0035269,POMT1,protein O-linked mannosylation,3.0
18006,10585,GO:0046872,POMT1,metal ion binding,3.0
18007,10585,GO:1904100,POMT1,positive regulation of protein O-linked glycosylation,3.0
18008,25913,GO:0000781,POT1,"chromosome, telomeric region",3.0
18010,25913,GO:0000783,POT1,nuclear telomere cap complex,3.0
18012,25913,GO:0005515,POT1,protein binding,3.0
18013,25913,GO:0005654,POT1,nucleoplasm,3.0
18015,25913,GO:0007004,POT1,telomere maintenance via telomerase,3.0
18016,25913,GO:0010521,POT1,telomerase inhibitor activity,3.0
18018,25913,GO:0016233,POT1,telomere capping,3.0
18022,25913,GO:0017151,POT1,DEAD/H-box RNA helicase binding,3.0
18023,25913,GO:0032202,POT1,telomere assembly,3.0
18024,25913,GO:0032210,POT1,regulation of telomere maintenance via telomerase,3.0
18026,25913,GO:0032211,POT1,negative regulation of telomere maintenance via telomerase,3.0
18028,25913,GO:0032212,POT1,positive regulation of telomere maintenance via telomerase,3.0
18030,25913,GO:0032508,POT1,DNA duplex unwinding,3.0
18031,25913,GO:0042162,POT1,telomeric DNA binding,3.0
18032,25913,GO:0043047,POT1,single-stranded telomeric DNA binding,3.0
18034,25913,GO:0051096,POT1,positive regulation of helicase activity,3.0
18035,25913,GO:0051973,POT1,positive regulation of telomerase activity,3.0
18037,25913,GO:0051974,POT1,negative regulation of telomerase activity,3.0
18039,25913,GO:0060383,POT1,positive regulation of DNA strand elongation,3.0
18040,25913,GO:0061820,POT1,telomeric D-loop disassembly,3.0
18041,25913,GO:0061821,POT1,telomeric D-loop binding,3.0
18042,25913,GO:0061849,POT1,telomeric G-quadruplex DNA binding,3.0
18043,25913,GO:0070187,POT1,shelterin complex,3.0
18046,25913,GO:0070200,POT1,establishment of protein localization to telomere,3.0
18047,25913,GO:0098505,POT1,G-rich strand telomeric DNA binding,3.0
18049,25913,GO:1905773,POT1,8-hydroxy-2'-deoxyguanosine DNA binding,3.0
18050,25913,GO:1905774,POT1,regulation of DNA helicase activity,3.0
18051,25913,GO:1905776,POT1,positive regulation of DNA helicase activity,3.0
18052,25913,GO:1990955,POT1,G-rich single-stranded DNA binding,3.0
18053,25913,GO:2001032,POT1,regulation of double-strand break repair via nonhomologous end joining,3.0
18083,8500,GO:0005515,PPFIA1,protein binding,3.0
18084,8500,GO:0005737,PPFIA1,cytoplasm,3.0
18085,8500,GO:0005829,PPFIA1,cytosol,3.0
18087,8500,GO:0005925,PPFIA1,focal adhesion,3.0
18088,8500,GO:0007160,PPFIA1,cell-matrix adhesion,3.0
18089,8500,GO:0007165,PPFIA1,signal transduction,3.0
18090,8500,GO:0007269,PPFIA1,neurotransmitter secretion,3.0
18091,8500,GO:0014047,PPFIA1,glutamate secretion,3.0
18092,8500,GO:0048786,PPFIA1,presynaptic active zone,3.0
18094,8500,GO:0050808,PPFIA1,synapse organization,3.0
18095,8500,GO:0051497,PPFIA1,negative regulation of stress fiber assembly,3.0
18096,8500,GO:1903077,PPFIA1,negative regulation of protein localization to plasma membrane,3.0
18097,8493,GO:0000086,PPM1D,G2/M transition of mitotic cell cycle,3.0
18098,8493,GO:0004674,PPM1D,protein serine/threonine kinase activity,3.0
18099,8493,GO:0004722,PPM1D,protein serine/threonine phosphatase activity,3.0
18100,8493,GO:0005515,PPM1D,protein binding,3.0
18101,8493,GO:0005634,PPM1D,nucleus,3.0
18103,8493,GO:0005654,PPM1D,nucleoplasm,3.0
18104,8493,GO:0005829,PPM1D,cytosol,3.0
18106,8493,GO:0006306,PPM1D,DNA methylation,3.0
18107,8493,GO:0006342,PPM1D,chromatin silencing,3.0
18108,8493,GO:0006367,PPM1D,transcription initiation from RNA polymerase II promoter,3.0
18109,8493,GO:0006468,PPM1D,protein phosphorylation,3.0
18110,8493,GO:0006470,PPM1D,protein dephosphorylation,3.0
18111,8493,GO:0008285,PPM1D,negative regulation of cell population proliferation,3.0
18112,8493,GO:0009267,PPM1D,cellular response to starvation,3.0
18113,8493,GO:0009314,PPM1D,response to radiation,3.0
18114,8493,GO:0009617,PPM1D,response to bacterium,3.0
18115,8493,GO:0030330,PPM1D,"DNA damage response, signal transduction by p53 class mediator",3.0
18116,8493,GO:0035970,PPM1D,peptidyl-threonine dephosphorylation,3.0
18117,8493,GO:0045814,PPM1D,"negative regulation of gene expression, epigenetic",3.0
18118,8493,GO:0046872,PPM1D,metal ion binding,3.0
18119,8493,GO:0051019,PPM1D,mitogen-activated protein kinase binding,3.0
18121,8493,GO:0106306,PPM1D,protein serine phosphatase activity,3.0
18122,8493,GO:0106307,PPM1D,protein threonine phosphatase activity,3.0
18176,5519,GO:0000159,PPP2R1B,protein phosphatase type 2A complex,3.0
18177,5519,GO:0004722,PPP2R1B,protein serine/threonine phosphatase activity,3.0
18178,5519,GO:0005515,PPP2R1B,protein binding,3.0
18179,5519,GO:0005737,PPP2R1B,cytoplasm,3.0
18180,5519,GO:0006470,PPP2R1B,protein dephosphorylation,3.0
18181,5519,GO:0008287,PPP2R1B,protein serine/threonine phosphatase complex,3.0
18182,5519,GO:0019888,PPP2R1B,protein phosphatase regulator activity,3.0
18183,5519,GO:0043666,PPP2R1B,regulation of phosphoprotein phosphatase activity,3.0
18184,5519,GO:0045121,PPP2R1B,membrane raft,3.0
18185,5519,GO:0060561,PPP2R1B,apoptotic process involved in morphogenesis,3.0
18186,5519,GO:0070062,PPP2R1B,extracellular exosome,3.0
18187,5519,GO:2001241,PPP2R1B,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,3.0
18254,5575,GO:0003091,PRKAR1B,renal water homeostasis,3.0
18255,5575,GO:0004862,PRKAR1B,cAMP-dependent protein kinase inhibitor activity,3.0
18256,5575,GO:0005515,PRKAR1B,protein binding,3.0
18257,5575,GO:0005771,PRKAR1B,multivesicular body,3.0
18258,5575,GO:0005829,PRKAR1B,cytosol,3.0
18259,5575,GO:0005886,PRKAR1B,plasma membrane,3.0
18260,5575,GO:0005952,PRKAR1B,cAMP-dependent protein kinase complex,3.0
18262,5575,GO:0006468,PRKAR1B,protein phosphorylation,3.0
18263,5575,GO:0007596,PRKAR1B,blood coagulation,3.0
18264,5575,GO:0007611,PRKAR1B,learning or memory,3.0
18265,5575,GO:0008603,PRKAR1B,cAMP-dependent protein kinase regulator activity,3.0
18268,5575,GO:0010738,PRKAR1B,regulation of protein kinase A signaling,3.0
18269,5575,GO:0030552,PRKAR1B,cAMP binding,3.0
18270,5575,GO:0034199,PRKAR1B,activation of protein kinase A activity,3.0
18271,5575,GO:0034236,PRKAR1B,protein kinase A catalytic subunit binding,3.0
18272,5575,GO:0043949,PRKAR1B,regulation of cAMP-mediated signaling,3.0
18273,5575,GO:0050804,PRKAR1B,modulation of chemical synaptic transmission,3.0
18274,5575,GO:0071377,PRKAR1B,cellular response to glucagon stimulus,3.0
18275,5575,GO:0097546,PRKAR1B,ciliary base,3.0
18276,5575,GO:0098685,PRKAR1B,Schaffer collateral - CA1 synapse,3.0
18277,5575,GO:0098686,PRKAR1B,hippocampal mossy fiber to CA3 synapse,3.0
18278,5575,GO:0098693,PRKAR1B,regulation of synaptic vesicle cycle,3.0
18279,5575,GO:0098978,PRKAR1B,glutamatergic synapse,3.0
18280,5575,GO:2000480,PRKAR1B,negative regulation of cAMP-dependent protein kinase activity,3.0
18281,5578,GO:0001525,PRKCA,angiogenesis,3.0
18282,5578,GO:0001938,PRKCA,positive regulation of endothelial cell proliferation,3.0
18283,5578,GO:0002159,PRKCA,desmosome assembly,3.0
18284,5578,GO:0004672,PRKCA,protein kinase activity,3.0
18285,5578,GO:0004674,PRKCA,protein serine/threonine kinase activity,3.0
18288,5578,GO:0004697,PRKCA,protein kinase C activity,3.0
18289,5578,GO:0004698,PRKCA,calcium-dependent protein kinase C activity,3.0
18290,5578,GO:0005178,PRKCA,integrin binding,3.0
18291,5578,GO:0005515,PRKCA,protein binding,3.0
18292,5578,GO:0005524,PRKCA,ATP binding,3.0
18293,5578,GO:0005654,PRKCA,nucleoplasm,3.0
18294,5578,GO:0005737,PRKCA,cytoplasm,3.0
18295,5578,GO:0005739,PRKCA,mitochondrion,3.0
18296,5578,GO:0005783,PRKCA,endoplasmic reticulum,3.0
18297,5578,GO:0005829,PRKCA,cytosol,3.0
18299,5578,GO:0005886,PRKCA,plasma membrane,3.0
18301,5578,GO:0006468,PRKCA,protein phosphorylation,3.0
18302,5578,GO:0007077,PRKCA,mitotic nuclear envelope disassembly,3.0
18303,5578,GO:0007155,PRKCA,cell adhesion,3.0
18304,5578,GO:0007411,PRKCA,axon guidance,3.0
18305,5578,GO:0008270,PRKCA,zinc ion binding,3.0
18306,5578,GO:0010595,PRKCA,positive regulation of endothelial cell migration,3.0
18307,5578,GO:0010613,PRKCA,positive regulation of cardiac muscle hypertrophy,3.0
18308,5578,GO:0018105,PRKCA,peptidyl-serine phosphorylation,3.0
18310,5578,GO:0018107,PRKCA,peptidyl-threonine phosphorylation,3.0
18311,5578,GO:0019899,PRKCA,enzyme binding,3.0
18312,5578,GO:0030168,PRKCA,platelet activation,3.0
18313,5578,GO:0030335,PRKCA,positive regulation of cell migration,3.0
18314,5578,GO:0031666,PRKCA,positive regulation of lipopolysaccharide-mediated signaling pathway,3.0
18315,5578,GO:0031966,PRKCA,mitochondrial membrane,3.0
18316,5578,GO:0034351,PRKCA,negative regulation of glial cell apoptotic process,3.0
18317,5578,GO:0035403,PRKCA,histone kinase activity (H3-T6 specific),3.0
18318,5578,GO:0035408,PRKCA,histone H3-T6 phosphorylation,3.0
18319,5578,GO:0035556,PRKCA,intracellular signal transduction,3.0
18320,5578,GO:0035866,PRKCA,alphav-beta3 integrin-PKCalpha complex,3.0
18321,5578,GO:0038128,PRKCA,ERBB2 signaling pathway,3.0
18322,5578,GO:0043488,PRKCA,regulation of mRNA stability,3.0
18323,5578,GO:0043536,PRKCA,positive regulation of blood vessel endothelial cell migration,3.0
18324,5578,GO:0045651,PRKCA,positive regulation of macrophage differentiation,3.0
18325,5578,GO:0045766,PRKCA,positive regulation of angiogenesis,3.0
18326,5578,GO:0045780,PRKCA,positive regulation of bone resorption,3.0
18327,5578,GO:0045785,PRKCA,positive regulation of cell adhesion,3.0
18328,5578,GO:0045931,PRKCA,positive regulation of mitotic cell cycle,3.0
18329,5578,GO:0048471,PRKCA,perinuclear region of cytoplasm,3.0
18330,5578,GO:0050796,PRKCA,regulation of insulin secretion,3.0
18331,5578,GO:0070062,PRKCA,extracellular exosome,3.0
18332,5578,GO:0070374,PRKCA,positive regulation of ERK1 and ERK2 cascade,3.0
18333,5578,GO:0070555,PRKCA,response to interleukin-1,3.0
18334,5578,GO:0090330,PRKCA,regulation of platelet aggregation,3.0
18335,5578,GO:0097190,PRKCA,apoptotic signaling pathway,3.0
18336,5578,GO:0106071,PRKCA,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
18337,5578,GO:2000707,PRKCA,positive regulation of dense core granule biogenesis,3.0
18522,5591,GO:0000460,PRKDC,maturation of 5.8S rRNA,3.0
18523,5591,GO:0000723,PRKDC,telomere maintenance,3.0
18524,5591,GO:0000781,PRKDC,"chromosome, telomeric region",3.0
18525,5591,GO:0001756,PRKDC,somitogenesis,3.0
18526,5591,GO:0001933,PRKDC,negative regulation of protein phosphorylation,3.0
18527,5591,GO:0002218,PRKDC,activation of innate immune response,3.0
18528,5591,GO:0002326,PRKDC,B cell lineage commitment,3.0
18529,5591,GO:0002328,PRKDC,pro-B cell differentiation,3.0
18530,5591,GO:0002360,PRKDC,T cell lineage commitment,3.0
18531,5591,GO:0002638,PRKDC,negative regulation of immunoglobulin production,3.0
18532,5591,GO:0003690,PRKDC,double-stranded DNA binding,3.0
18533,5591,GO:0003723,PRKDC,RNA binding,3.0
18534,5591,GO:0004672,PRKDC,protein kinase activity,3.0
18536,5591,GO:0004674,PRKDC,protein serine/threonine kinase activity,3.0
18539,5591,GO:0004677,PRKDC,DNA-dependent protein kinase activity,3.0
18540,5591,GO:0005515,PRKDC,protein binding,3.0
18541,5591,GO:0005524,PRKDC,ATP binding,3.0
18542,5591,GO:0005634,PRKDC,nucleus,3.0
18544,5591,GO:0005654,PRKDC,nucleoplasm,3.0
18546,5591,GO:0005667,PRKDC,transcription regulator complex,3.0
18547,5591,GO:0005730,PRKDC,nucleolus,3.0
18548,5591,GO:0005829,PRKDC,cytosol,3.0
18549,5591,GO:0005958,PRKDC,DNA-dependent protein kinase-DNA ligase 4 complex,3.0
18550,5591,GO:0006302,PRKDC,double-strand break repair,3.0
18552,5591,GO:0006303,PRKDC,double-strand break repair via nonhomologous end joining,3.0
18553,5591,GO:0006464,PRKDC,cellular protein modification process,3.0
18554,5591,GO:0006468,PRKDC,protein phosphorylation,3.0
18556,5591,GO:0006974,PRKDC,cellular response to DNA damage stimulus,3.0
18557,5591,GO:0007420,PRKDC,brain development,3.0
18558,5591,GO:0007507,PRKDC,heart development,3.0
18559,5591,GO:0008134,PRKDC,transcription factor binding,3.0
18560,5591,GO:0008630,PRKDC,intrinsic apoptotic signaling pathway in response to DNA damage,3.0
18561,5591,GO:0010332,PRKDC,response to gamma radiation,3.0
18562,5591,GO:0014823,PRKDC,response to activity,3.0
18563,5591,GO:0016020,PRKDC,membrane,3.0
18564,5591,GO:0016233,PRKDC,telomere capping,3.0
18565,5591,GO:0016567,PRKDC,protein ubiquitination,3.0
18566,5591,GO:0018105,PRKDC,peptidyl-serine phosphorylation,3.0
18567,5591,GO:0018107,PRKDC,peptidyl-threonine phosphorylation,3.0
18568,5591,GO:0019899,PRKDC,enzyme binding,3.0
18569,5591,GO:0019904,PRKDC,protein domain specific binding,3.0
18570,5591,GO:0031648,PRKDC,protein destabilization,3.0
18571,5591,GO:0032040,PRKDC,small-subunit processome,3.0
18572,5591,GO:0032481,PRKDC,positive regulation of type I interferon production,3.0
18573,5591,GO:0032869,PRKDC,cellular response to insulin stimulus,3.0
18574,5591,GO:0032991,PRKDC,protein-containing complex,3.0
18575,5591,GO:0032993,PRKDC,protein-DNA complex,3.0
18576,5591,GO:0033077,PRKDC,T cell differentiation in thymus,3.0
18577,5591,GO:0033152,PRKDC,immunoglobulin V(D)J recombination,3.0
18578,5591,GO:0033153,PRKDC,T cell receptor V(D)J recombination,3.0
18579,5591,GO:0034462,PRKDC,small-subunit processome assembly,3.0
18580,5591,GO:0034511,PRKDC,U3 snoRNA binding,3.0
18581,5591,GO:0035234,PRKDC,ectopic germ cell programmed cell death,3.0
18582,5591,GO:0042752,PRKDC,regulation of circadian rhythm,3.0
18583,5591,GO:0043065,PRKDC,positive regulation of apoptotic process,3.0
18584,5591,GO:0043066,PRKDC,negative regulation of apoptotic process,3.0
18585,5591,GO:0045087,PRKDC,innate immune response,3.0
18586,5591,GO:0045621,PRKDC,positive regulation of lymphocyte differentiation,3.0
18587,5591,GO:0045648,PRKDC,positive regulation of erythrocyte differentiation,3.0
18588,5591,GO:0045727,PRKDC,positive regulation of translation,3.0
18589,5591,GO:0045944,PRKDC,positive regulation of transcription by RNA polymerase II,3.0
18590,5591,GO:0048146,PRKDC,positive regulation of fibroblast proliferation,3.0
18591,5591,GO:0048511,PRKDC,rhythmic process,3.0
18592,5591,GO:0048536,PRKDC,spleen development,3.0
18593,5591,GO:0048538,PRKDC,thymus development,3.0
18594,5591,GO:0048639,PRKDC,positive regulation of developmental growth,3.0
18595,5591,GO:0048660,PRKDC,regulation of smooth muscle cell proliferation,3.0
18596,5591,GO:0050678,PRKDC,regulation of epithelial cell proliferation,3.0
18597,5591,GO:0070419,PRKDC,nonhomologous end joining complex,3.0
18598,5591,GO:0072431,PRKDC,signal transduction involved in mitotic G1 DNA damage checkpoint,3.0
18599,5591,GO:0097681,PRKDC,double-strand break repair via alternative nonhomologous end joining,3.0
18600,5591,GO:0106310,PRKDC,protein serine kinase activity,3.0
18601,5591,GO:0106311,PRKDC,protein threonine kinase activity,3.0
18602,5591,GO:1902036,PRKDC,regulation of hematopoietic stem cell differentiation,3.0
18603,5591,GO:1905221,PRKDC,positive regulation of platelet formation,3.0
18604,5591,GO:2000773,PRKDC,negative regulation of cellular senescence,3.0
18605,5591,GO:2001034,PRKDC,positive regulation of double-strand break repair via nonhomologous end joining,3.0
18606,5591,GO:2001229,PRKDC,negative regulation of response to gamma radiation,3.0
18812,55015,GO:0000243,PRPF39,commitment complex,3.0
18813,55015,GO:0000395,PRPF39,mRNA 5'-splice site recognition,3.0
18814,55015,GO:0005515,PRPF39,protein binding,3.0
18815,55015,GO:0005685,PRPF39,U1 snRNP,3.0
18816,55015,GO:0071004,PRPF39,U2-type prespliceosome,3.0
18820,158471,GO:0004309,PRUNE2,exopolyphosphatase activity,3.0
18821,158471,GO:0005737,PRUNE2,cytoplasm,3.0
18822,158471,GO:0006798,PRUNE2,polyphosphate catabolic process,3.0
18823,158471,GO:0006915,PRUNE2,apoptotic process,3.0
18824,158471,GO:0046872,PRUNE2,metal ion binding,3.0
18825,23362,GO:0005085,PSD3,guanyl-nucleotide exchange factor activity,3.0
18826,23362,GO:0014069,PSD3,postsynaptic density,3.0
18827,23362,GO:0032012,PSD3,regulation of ARF protein signal transduction,3.0
18828,23362,GO:0032587,PSD3,ruffle membrane,3.0
18870,58155,GO:0003723,PTBP2,RNA binding,3.0
18871,58155,GO:0003729,PTBP2,mRNA binding,3.0
18872,58155,GO:0005634,PTBP2,nucleus,3.0
18873,58155,GO:0005681,PTBP2,spliceosomal complex,3.0
18874,58155,GO:0006376,PTBP2,mRNA splice site selection,3.0
18875,58155,GO:0006417,PTBP2,regulation of translation,3.0
18876,58155,GO:0021510,PTBP2,spinal cord development,3.0
18877,58155,GO:0021549,PTBP2,cerebellum development,3.0
18878,58155,GO:0030426,PTBP2,growth cone,3.0
18879,58155,GO:0033119,PTBP2,negative regulation of RNA splicing,3.0
18881,58155,GO:0043025,PTBP2,neuronal cell body,3.0
18882,58155,GO:0043484,PTBP2,regulation of RNA splicing,3.0
18883,58155,GO:2000177,PTBP2,regulation of neural precursor cell proliferation,3.0
19068,56134,GO:0005509,PCDHAC2,calcium ion binding,3.0
19069,56134,GO:0005887,PCDHAC2,integral component of plasma membrane,3.0
19070,56134,GO:0007155,PCDHAC2,cell adhesion,3.0
19071,56134,GO:0007156,PCDHAC2,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
19072,56134,GO:0007399,PCDHAC2,nervous system development,3.0
19151,5294,GO:0001525,PIK3CG,angiogenesis,3.0
19152,5294,GO:0001816,PIK3CG,cytokine production,3.0
19153,5294,GO:0002250,PIK3CG,adaptive immune response,3.0
19154,5294,GO:0002407,PIK3CG,dendritic cell chemotaxis,3.0
19155,5294,GO:0002675,PIK3CG,positive regulation of acute inflammatory response,3.0
19156,5294,GO:0002679,PIK3CG,respiratory burst involved in defense response,3.0
19157,5294,GO:0003376,PIK3CG,sphingosine-1-phosphate receptor signaling pathway,3.0
19158,5294,GO:0004672,PIK3CG,protein kinase activity,3.0
19159,5294,GO:0005515,PIK3CG,protein binding,3.0
19160,5294,GO:0005524,PIK3CG,ATP binding,3.0
19161,5294,GO:0005737,PIK3CG,cytoplasm,3.0
19163,5294,GO:0005829,PIK3CG,cytosol,3.0
19165,5294,GO:0005886,PIK3CG,plasma membrane,3.0
19167,5294,GO:0005942,PIK3CG,phosphatidylinositol 3-kinase complex,3.0
19168,5294,GO:0005943,PIK3CG,"phosphatidylinositol 3-kinase complex, class IA",3.0
19169,5294,GO:0005944,PIK3CG,"phosphatidylinositol 3-kinase complex, class IB",3.0
19171,5294,GO:0006468,PIK3CG,protein phosphorylation,3.0
19172,5294,GO:0006661,PIK3CG,phosphatidylinositol biosynthetic process,3.0
19173,5294,GO:0006897,PIK3CG,endocytosis,3.0
19174,5294,GO:0006954,PIK3CG,inflammatory response,3.0
19175,5294,GO:0007186,PIK3CG,G protein-coupled receptor signaling pathway,3.0
19176,5294,GO:0007204,PIK3CG,positive regulation of cytosolic calcium ion concentration,3.0
19177,5294,GO:0010595,PIK3CG,positive regulation of endothelial cell migration,3.0
19178,5294,GO:0010818,PIK3CG,T cell chemotaxis,3.0
19179,5294,GO:0010897,PIK3CG,negative regulation of triglyceride catabolic process,3.0
19180,5294,GO:0014065,PIK3CG,phosphatidylinositol 3-kinase signaling,3.0
19184,5294,GO:0014068,PIK3CG,positive regulation of phosphatidylinositol 3-kinase signaling,3.0
19185,5294,GO:0016020,PIK3CG,membrane,3.0
19188,5294,GO:0016301,PIK3CG,kinase activity,3.0
19189,5294,GO:0016303,PIK3CG,1-phosphatidylinositol-3-kinase activity,3.0
19191,5294,GO:0016310,PIK3CG,phosphorylation,3.0
19192,5294,GO:0016477,PIK3CG,cell migration,3.0
19193,5294,GO:0030168,PIK3CG,platelet activation,3.0
19194,5294,GO:0030593,PIK3CG,neutrophil chemotaxis,3.0
19195,5294,GO:0032252,PIK3CG,secretory granule localization,3.0
19196,5294,GO:0033628,PIK3CG,regulation of cell adhesion mediated by integrin,3.0
19197,5294,GO:0035004,PIK3CG,phosphatidylinositol 3-kinase activity,3.0
19198,5294,GO:0035005,PIK3CG,1-phosphatidylinositol-4-phosphate 3-kinase activity,3.0
19200,5294,GO:0035022,PIK3CG,positive regulation of Rac protein signal transduction,3.0
19201,5294,GO:0035747,PIK3CG,natural killer cell chemotaxis,3.0
19202,5294,GO:0036092,PIK3CG,phosphatidylinositol-3-phosphate biosynthetic process,3.0
19203,5294,GO:0042098,PIK3CG,T cell proliferation,3.0
19204,5294,GO:0042110,PIK3CG,T cell activation,3.0
19205,5294,GO:0042802,PIK3CG,identical protein binding,3.0
19206,5294,GO:0043303,PIK3CG,mast cell degranulation,3.0
19207,5294,GO:0043406,PIK3CG,positive regulation of MAP kinase activity,3.0
19208,5294,GO:0045087,PIK3CG,innate immune response,3.0
19209,5294,GO:0046854,PIK3CG,phosphatidylinositol phosphorylation,3.0
19210,5294,GO:0046875,PIK3CG,ephrin receptor binding,3.0
19211,5294,GO:0046934,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",3.0
19212,5294,GO:0048015,PIK3CG,phosphatidylinositol-mediated signaling,3.0
19213,5294,GO:0051897,PIK3CG,positive regulation of protein kinase B signaling,3.0
19214,5294,GO:0052742,PIK3CG,phosphatidylinositol kinase activity,3.0
19215,5294,GO:0052812,PIK3CG,"phosphatidylinositol-3,4-bisphosphate 5-kinase activity",3.0
19216,5294,GO:0055118,PIK3CG,negative regulation of cardiac muscle contraction,3.0
19217,5294,GO:0070527,PIK3CG,platelet aggregation,3.0
19218,5294,GO:0071320,PIK3CG,cellular response to cAMP,3.0
19219,5294,GO:0072672,PIK3CG,neutrophil extravasation,3.0
19220,5294,GO:0097284,PIK3CG,hepatocyte apoptotic process,3.0
19221,5294,GO:0106310,PIK3CG,protein serine kinase activity,3.0
19222,5294,GO:0106311,PIK3CG,protein threonine kinase activity,3.0
19223,5294,GO:1903169,PIK3CG,regulation of calcium ion transmembrane transport,3.0
19224,5294,GO:2000270,PIK3CG,negative regulation of fibroblast apoptotic process,3.0
19225,64219,GO:0005515,PJA1,protein binding,3.0
19226,64219,GO:0005737,PJA1,cytoplasm,3.0
19227,64219,GO:0016567,PJA1,protein ubiquitination,3.0
19228,64219,GO:0030163,PJA1,protein catabolic process,3.0
19229,64219,GO:0046872,PJA1,metal ion binding,3.0
19230,64219,GO:0061630,PJA1,ubiquitin protein ligase activity,3.0
19231,11128,GO:0003677,POLR3A,DNA binding,3.0
19232,11128,GO:0003682,POLR3A,chromatin binding,3.0
19233,11128,GO:0003899,POLR3A,DNA-directed 5'-3' RNA polymerase activity,3.0
19235,11128,GO:0005654,POLR3A,nucleoplasm,3.0
19237,11128,GO:0005666,POLR3A,RNA polymerase III complex,3.0
19239,11128,GO:0005829,POLR3A,cytosol,3.0
19240,11128,GO:0006351,POLR3A,"transcription, DNA-templated",3.0
19241,11128,GO:0016020,POLR3A,membrane,3.0
19242,11128,GO:0032481,POLR3A,positive regulation of type I interferon production,3.0
19243,11128,GO:0032728,POLR3A,positive regulation of interferon-beta production,3.0
19244,11128,GO:0045087,POLR3A,innate immune response,3.0
19245,11128,GO:0046872,POLR3A,metal ion binding,3.0
19246,11128,GO:0051607,POLR3A,defense response to virus,3.0
19281,84152,GO:0001975,PPP1R1B,response to amphetamine,3.0
19282,84152,GO:0004860,PPP1R1B,protein kinase inhibitor activity,3.0
19283,84152,GO:0004864,PPP1R1B,protein phosphatase inhibitor activity,3.0
19285,84152,GO:0005515,PPP1R1B,protein binding,3.0
19286,84152,GO:0005634,PPP1R1B,nucleus,3.0
19287,84152,GO:0005737,PPP1R1B,cytoplasm,3.0
19288,84152,GO:0005829,PPP1R1B,cytosol,3.0
19289,84152,GO:0006351,PPP1R1B,"transcription, DNA-templated",3.0
19290,84152,GO:0006469,PPP1R1B,negative regulation of protein kinase activity,3.0
19291,84152,GO:0007165,PPP1R1B,signal transduction,3.0
19292,84152,GO:0007613,PPP1R1B,memory,3.0
19293,84152,GO:0007621,PPP1R1B,negative regulation of female receptivity,3.0
19294,84152,GO:0007626,PPP1R1B,locomotory behavior,3.0
19295,84152,GO:0008542,PPP1R1B,visual learning,3.0
19296,84152,GO:0019888,PPP1R1B,protein phosphatase regulator activity,3.0
19297,84152,GO:0031748,PPP1R1B,D1 dopamine receptor binding,3.0
19298,84152,GO:0031749,PPP1R1B,D2 dopamine receptor binding,3.0
19299,84152,GO:0031750,PPP1R1B,D3 dopamine receptor binding,3.0
19300,84152,GO:0031751,PPP1R1B,D4 dopamine receptor binding,3.0
19301,84152,GO:0031752,PPP1R1B,D5 dopamine receptor binding,3.0
19302,84152,GO:0032515,PPP1R1B,negative regulation of phosphoprotein phosphatase activity,3.0
19303,84152,GO:0035094,PPP1R1B,response to nicotine,3.0
19304,84152,GO:0035556,PPP1R1B,intracellular signal transduction,3.0
19305,84152,GO:0043025,PPP1R1B,neuronal cell body,3.0
19306,84152,GO:0043278,PPP1R1B,response to morphine,3.0
19307,84152,GO:0044326,PPP1R1B,dendritic spine neck,3.0
19308,84152,GO:0044327,PPP1R1B,dendritic spine head,3.0
19309,84152,GO:0048148,PPP1R1B,behavioral response to cocaine,3.0
19429,5743,GO:0001516,PTGS2,prostaglandin biosynthetic process,3.0
19432,5743,GO:0001525,PTGS2,angiogenesis,3.0
19433,5743,GO:0004601,PTGS2,peroxidase activity,3.0
19434,5743,GO:0004666,PTGS2,prostaglandin-endoperoxide synthase activity,3.0
19435,5743,GO:0005515,PTGS2,protein binding,3.0
19436,5743,GO:0005637,PTGS2,nuclear inner membrane,3.0
19437,5743,GO:0005640,PTGS2,nuclear outer membrane,3.0
19438,5743,GO:0005737,PTGS2,cytoplasm,3.0
19440,5743,GO:0005783,PTGS2,endoplasmic reticulum,3.0
19441,5743,GO:0005788,PTGS2,endoplasmic reticulum lumen,3.0
19442,5743,GO:0005789,PTGS2,endoplasmic reticulum membrane,3.0
19443,5743,GO:0005901,PTGS2,caveola,3.0
19444,5743,GO:0006954,PTGS2,inflammatory response,3.0
19445,5743,GO:0006979,PTGS2,response to oxidative stress,3.0
19446,5743,GO:0007566,PTGS2,embryo implantation,3.0
19447,5743,GO:0007568,PTGS2,aging,3.0
19448,5743,GO:0007612,PTGS2,learning,3.0
19449,5743,GO:0007613,PTGS2,memory,3.0
19450,5743,GO:0008217,PTGS2,regulation of blood pressure,3.0
19451,5743,GO:0008285,PTGS2,negative regulation of cell population proliferation,3.0
19452,5743,GO:0009750,PTGS2,response to fructose,3.0
19453,5743,GO:0010042,PTGS2,response to manganese ion,3.0
19454,5743,GO:0010226,PTGS2,response to lithium ion,3.0
19455,5743,GO:0010575,PTGS2,positive regulation of vascular endothelial growth factor production,3.0
19456,5743,GO:0016702,PTGS2,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",3.0
19457,5743,GO:0019221,PTGS2,cytokine-mediated signaling pathway,3.0
19458,5743,GO:0019233,PTGS2,sensory perception of pain,3.0
19459,5743,GO:0019371,PTGS2,cyclooxygenase pathway,3.0
19461,5743,GO:0019372,PTGS2,lipoxygenase pathway,3.0
19462,5743,GO:0019899,PTGS2,enzyme binding,3.0
19463,5743,GO:0020037,PTGS2,heme binding,3.0
19464,5743,GO:0030282,PTGS2,bone mineralization,3.0
19465,5743,GO:0030728,PTGS2,ovulation,3.0
19466,5743,GO:0031394,PTGS2,positive regulation of prostaglandin biosynthetic process,3.0
19467,5743,GO:0031622,PTGS2,positive regulation of fever generation,3.0
19468,5743,GO:0031915,PTGS2,positive regulation of synaptic plasticity,3.0
19469,5743,GO:0032227,PTGS2,"negative regulation of synaptic transmission, dopaminergic",3.0
19470,5743,GO:0032355,PTGS2,response to estradiol,3.0
19471,5743,GO:0032496,PTGS2,response to lipopolysaccharide,3.0
19472,5743,GO:0032991,PTGS2,protein-containing complex,3.0
19473,5743,GO:0033138,PTGS2,positive regulation of peptidyl-serine phosphorylation,3.0
19474,5743,GO:0033280,PTGS2,response to vitamin D,3.0
19475,5743,GO:0034356,PTGS2,NAD biosynthesis via nicotinamide riboside salvage pathway,3.0
19476,5743,GO:0034605,PTGS2,cellular response to heat,3.0
19477,5743,GO:0034612,PTGS2,response to tumor necrosis factor,3.0
19478,5743,GO:0034644,PTGS2,cellular response to UV,3.0
19479,5743,GO:0035633,PTGS2,maintenance of blood-brain barrier,3.0
19480,5743,GO:0042307,PTGS2,positive regulation of protein import into nucleus,3.0
19481,5743,GO:0042493,PTGS2,response to drug,3.0
19482,5743,GO:0042633,PTGS2,hair cycle,3.0
19483,5743,GO:0042759,PTGS2,long-chain fatty acid biosynthetic process,3.0
19484,5743,GO:0042803,PTGS2,protein homodimerization activity,3.0
19485,5743,GO:0043005,PTGS2,neuron projection,3.0
19486,5743,GO:0043065,PTGS2,positive regulation of apoptotic process,3.0
19487,5743,GO:0043154,PTGS2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
19488,5743,GO:0045429,PTGS2,positive regulation of nitric oxide biosynthetic process,3.0
19489,5743,GO:0045786,PTGS2,negative regulation of cell cycle,3.0
19490,5743,GO:0045907,PTGS2,positive regulation of vasoconstriction,3.0
19491,5743,GO:0045986,PTGS2,negative regulation of smooth muscle contraction,3.0
19492,5743,GO:0045987,PTGS2,positive regulation of smooth muscle contraction,3.0
19493,5743,GO:0046697,PTGS2,decidualization,3.0
19494,5743,GO:0046872,PTGS2,metal ion binding,3.0
19495,5743,GO:0048661,PTGS2,positive regulation of smooth muscle cell proliferation,3.0
19496,5743,GO:0050727,PTGS2,regulation of inflammatory response,3.0
19497,5743,GO:0050873,PTGS2,brown fat cell differentiation,3.0
19498,5743,GO:0051384,PTGS2,response to glucocorticoid,3.0
19499,5743,GO:0051926,PTGS2,negative regulation of calcium ion transport,3.0
19500,5743,GO:0051968,PTGS2,"positive regulation of synaptic transmission, glutamatergic",3.0
19501,5743,GO:0055114,PTGS2,oxidation-reduction process,3.0
19502,5743,GO:0070542,PTGS2,response to fatty acid,3.0
19503,5743,GO:0071260,PTGS2,cellular response to mechanical stimulus,3.0
19504,5743,GO:0071284,PTGS2,cellular response to lead ion,3.0
19505,5743,GO:0071318,PTGS2,cellular response to ATP,3.0
19506,5743,GO:0071456,PTGS2,cellular response to hypoxia,3.0
19507,5743,GO:0071471,PTGS2,cellular response to non-ionic osmotic stress,3.0
19508,5743,GO:0071498,PTGS2,cellular response to fluid shear stress,3.0
19509,5743,GO:0071636,PTGS2,positive regulation of transforming growth factor beta production,3.0
19510,5743,GO:0090050,PTGS2,positive regulation of cell migration involved in sprouting angiogenesis,3.0
19511,5743,GO:0090271,PTGS2,positive regulation of fibroblast growth factor production,3.0
19512,5743,GO:0090336,PTGS2,positive regulation of brown fat cell differentiation,3.0
19513,5743,GO:0090362,PTGS2,positive regulation of platelet-derived growth factor production,3.0
19514,5743,GO:0097756,PTGS2,negative regulation of blood vessel diameter,3.0
19515,5743,GO:0098869,PTGS2,cellular oxidant detoxification,3.0
19516,5743,GO:0150077,PTGS2,regulation of neuroinflammatory response,3.0
19517,5743,GO:1902219,PTGS2,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,3.0
19518,5743,GO:1990776,PTGS2,response to angiotensin,3.0
19639,5787,GO:0001525,PTPRB,angiogenesis,3.0
19640,5787,GO:0005001,PTPRB,transmembrane receptor protein tyrosine phosphatase activity,3.0
19641,5787,GO:0005515,PTPRB,protein binding,3.0
19642,5787,GO:0005886,PTPRB,plasma membrane,3.0
19643,5787,GO:0005887,PTPRB,integral component of plasma membrane,3.0
19644,5787,GO:0006470,PTPRB,protein dephosphorylation,3.0
19645,5787,GO:0006796,PTPRB,phosphate-containing compound metabolic process,3.0
19646,5787,GO:0016311,PTPRB,dephosphorylation,3.0
19647,5787,GO:0035579,PTPRB,specific granule membrane,3.0
19648,5787,GO:0043235,PTPRB,receptor complex,3.0
19650,5787,GO:0043312,PTPRB,neutrophil degranulation,3.0
19651,5787,GO:0045296,PTPRB,cadherin binding,3.0
19653,5787,GO:0070821,PTPRB,tertiary granule membrane,3.0
19654,5787,GO:1990264,PTPRB,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,3.0
19655,5788,GO:0000187,PTPRC,activation of MAPK activity,3.0
19656,5788,GO:0001779,PTPRC,natural killer cell differentiation,3.0
19657,5788,GO:0001915,PTPRC,negative regulation of T cell mediated cytotoxicity,3.0
19658,5788,GO:0001916,PTPRC,positive regulation of T cell mediated cytotoxicity,3.0
19659,5788,GO:0001960,PTPRC,negative regulation of cytokine-mediated signaling pathway,3.0
19660,5788,GO:0002244,PTPRC,hematopoietic progenitor cell differentiation,3.0
19661,5788,GO:0002377,PTPRC,immunoglobulin production,3.0
19662,5788,GO:0002925,PTPRC,positive regulation of humoral immune response mediated by circulating immunoglobulin,3.0
19663,5788,GO:0004725,PTPRC,protein tyrosine phosphatase activity,3.0
19667,5788,GO:0005001,PTPRC,transmembrane receptor protein tyrosine phosphatase activity,3.0
19668,5788,GO:0005102,PTPRC,signaling receptor binding,3.0
19669,5788,GO:0005515,PTPRC,protein binding,3.0
19670,5788,GO:0005886,PTPRC,plasma membrane,3.0
19672,5788,GO:0005887,PTPRC,integral component of plasma membrane,3.0
19673,5788,GO:0005925,PTPRC,focal adhesion,3.0
19674,5788,GO:0006469,PTPRC,negative regulation of protein kinase activity,3.0
19677,5788,GO:0006470,PTPRC,protein dephosphorylation,3.0
19679,5788,GO:0006933,PTPRC,negative regulation of cell adhesion involved in substrate-bound cell migration,3.0
19680,5788,GO:0007159,PTPRC,leukocyte cell-cell adhesion,3.0
19681,5788,GO:0007166,PTPRC,cell surface receptor signaling pathway,3.0
19682,5788,GO:0008201,PTPRC,heparin binding,3.0
19683,5788,GO:0009897,PTPRC,external side of plasma membrane,3.0
19684,5788,GO:0009898,PTPRC,cytoplasmic side of plasma membrane,3.0
19685,5788,GO:0009986,PTPRC,cell surface,3.0
19686,5788,GO:0010332,PTPRC,response to gamma radiation,3.0
19687,5788,GO:0010468,PTPRC,regulation of gene expression,3.0
19688,5788,GO:0016020,PTPRC,membrane,3.0
19689,5788,GO:0016021,PTPRC,integral component of membrane,3.0
19690,5788,GO:0016032,PTPRC,viral process,3.0
19691,5788,GO:0016311,PTPRC,dephosphorylation,3.0
19692,5788,GO:0019901,PTPRC,protein kinase binding,3.0
19693,5788,GO:0030183,PTPRC,B cell differentiation,3.0
19694,5788,GO:0030217,PTPRC,T cell differentiation,3.0
19695,5788,GO:0030506,PTPRC,ankyrin binding,3.0
19696,5788,GO:0030507,PTPRC,spectrin binding,3.0
19697,5788,GO:0030667,PTPRC,secretory granule membrane,3.0
19698,5788,GO:0030890,PTPRC,positive regulation of B cell proliferation,3.0
19699,5788,GO:0031668,PTPRC,cellular response to extracellular stimulus,3.0
19700,5788,GO:0031953,PTPRC,negative regulation of protein autophosphorylation,3.0
19701,5788,GO:0032059,PTPRC,bleb,3.0
19702,5788,GO:0032677,PTPRC,regulation of interleukin-8 production,3.0
19703,5788,GO:0032703,PTPRC,negative regulation of interleukin-2 production,3.0
19704,5788,GO:0032743,PTPRC,positive regulation of interleukin-2 production,3.0
19705,5788,GO:0032760,PTPRC,positive regulation of tumor necrosis factor production,3.0
19706,5788,GO:0034113,PTPRC,heterotypic cell-cell adhesion,3.0
19707,5788,GO:0035335,PTPRC,peptidyl-tyrosine dephosphorylation,3.0
19708,5788,GO:0035584,PTPRC,calcium-mediated signaling using intracellular calcium source,3.0
19709,5788,GO:0042098,PTPRC,T cell proliferation,3.0
19710,5788,GO:0042100,PTPRC,B cell proliferation,3.0
19711,5788,GO:0042102,PTPRC,positive regulation of T cell proliferation,3.0
19712,5788,GO:0042110,PTPRC,T cell activation,3.0
19713,5788,GO:0043312,PTPRC,neutrophil degranulation,3.0
19714,5788,GO:0043395,PTPRC,heparan sulfate proteoglycan binding,3.0
19715,5788,GO:0043410,PTPRC,positive regulation of MAPK cascade,3.0
19716,5788,GO:0044770,PTPRC,cell cycle phase transition,3.0
19717,5788,GO:0044855,PTPRC,plasma membrane raft distribution,3.0
19718,5788,GO:0045059,PTPRC,positive thymic T cell selection,3.0
19719,5788,GO:0045060,PTPRC,negative thymic T cell selection,3.0
19720,5788,GO:0045121,PTPRC,membrane raft,3.0
19721,5788,GO:0045588,PTPRC,positive regulation of gamma-delta T cell differentiation,3.0
19722,5788,GO:0045860,PTPRC,positive regulation of protein kinase activity,3.0
19723,5788,GO:0046425,PTPRC,regulation of receptor signaling pathway via JAK-STAT,3.0
19724,5788,GO:0046641,PTPRC,positive regulation of alpha-beta T cell proliferation,3.0
19725,5788,GO:0048304,PTPRC,positive regulation of isotype switching to IgG isotypes,3.0
19726,5788,GO:0048539,PTPRC,bone marrow development,3.0
19727,5788,GO:0048864,PTPRC,stem cell development,3.0
19728,5788,GO:0050731,PTPRC,positive regulation of peptidyl-tyrosine phosphorylation,3.0
19730,5788,GO:0050764,PTPRC,regulation of phagocytosis,3.0
19731,5788,GO:0050852,PTPRC,T cell receptor signaling pathway,3.0
19733,5788,GO:0050853,PTPRC,B cell receptor signaling pathway,3.0
19734,5788,GO:0050857,PTPRC,positive regulation of antigen receptor-mediated signaling pathway,3.0
19735,5788,GO:0051209,PTPRC,release of sequestered calcium ion into cytosol,3.0
19736,5788,GO:0051607,PTPRC,defense response to virus,3.0
19737,5788,GO:0051726,PTPRC,regulation of cell cycle,3.0
19738,5788,GO:0061097,PTPRC,regulation of protein tyrosine kinase activity,3.0
19739,5788,GO:0061099,PTPRC,negative regulation of protein tyrosine kinase activity,3.0
19740,5788,GO:0070062,PTPRC,extracellular exosome,3.0
19741,5788,GO:0070373,PTPRC,negative regulation of ERK1 and ERK2 cascade,3.0
19742,5788,GO:0070374,PTPRC,positive regulation of ERK1 and ERK2 cascade,3.0
19743,5788,GO:0098857,PTPRC,membrane microdomain,3.0
19744,5788,GO:1903615,PTPRC,positive regulation of protein tyrosine phosphatase activity,3.0
19745,5788,GO:1903979,PTPRC,negative regulation of microglial cell activation,3.0
19746,5788,GO:1904155,PTPRC,DN2 thymocyte differentiation,3.0
19747,5788,GO:1905451,PTPRC,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,3.0
19748,5788,GO:2000473,PTPRC,positive regulation of hematopoietic stem cell migration,3.0
19749,5788,GO:2000648,PTPRC,positive regulation of stem cell proliferation,3.0
19750,5788,GO:2001238,PTPRC,positive regulation of extrinsic apoptotic signaling pathway,3.0
19751,11122,GO:0004725,PTPRT,protein tyrosine phosphatase activity,3.0
19753,11122,GO:0005001,PTPRT,transmembrane receptor protein tyrosine phosphatase activity,3.0
19754,11122,GO:0005515,PTPRT,protein binding,3.0
19755,11122,GO:0005886,PTPRT,plasma membrane,3.0
19756,11122,GO:0005887,PTPRT,integral component of plasma membrane,3.0
19757,11122,GO:0006470,PTPRT,protein dephosphorylation,3.0
19759,11122,GO:0007155,PTPRT,cell adhesion,3.0
19760,11122,GO:0007156,PTPRT,homophilic cell adhesion via plasma membrane adhesion molecules,3.0
19761,11122,GO:0007165,PTPRT,signal transduction,3.0
19762,11122,GO:0007169,PTPRT,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
19763,11122,GO:0008013,PTPRT,beta-catenin binding,3.0
19764,11122,GO:0009986,PTPRT,cell surface,3.0
19765,11122,GO:0016021,PTPRT,integral component of membrane,3.0
19766,11122,GO:0019903,PTPRT,protein phosphatase binding,3.0
19767,11122,GO:0030336,PTPRT,negative regulation of cell migration,3.0
19768,11122,GO:0035335,PTPRT,peptidyl-tyrosine dephosphorylation,3.0
19769,11122,GO:0042803,PTPRT,protein homodimerization activity,3.0
19770,11122,GO:0045294,PTPRT,alpha-catenin binding,3.0
19771,11122,GO:0045295,PTPRT,gamma-catenin binding,3.0
19772,11122,GO:0045296,PTPRT,cadherin binding,3.0
19773,11122,GO:0070097,PTPRT,delta-catenin binding,3.0
19774,11122,GO:0071354,PTPRT,cellular response to interleukin-6,3.0
19775,11122,GO:0097677,PTPRT,STAT family protein binding,3.0
19776,11122,GO:1904893,PTPRT,negative regulation of receptor signaling pathway via STAT,3.0
19778,11122,GO:1990264,PTPRT,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,3.0
19779,7837,GO:0001960,PXDN,negative regulation of cytokine-mediated signaling pathway,3.0
19780,7837,GO:0004601,PXDN,peroxidase activity,3.0
19782,7837,GO:0005152,PXDN,interleukin-1 receptor antagonist activity,3.0
19783,7837,GO:0005201,PXDN,extracellular matrix structural constituent,3.0
19785,7837,GO:0005576,PXDN,extracellular region,3.0
19786,7837,GO:0005615,PXDN,extracellular space,3.0
19788,7837,GO:0005783,PXDN,endoplasmic reticulum,3.0
19789,7837,GO:0006955,PXDN,immune response,3.0
19790,7837,GO:0006979,PXDN,response to oxidative stress,3.0
19791,7837,GO:0019806,PXDN,bromide peroxidase activity,3.0
19792,7837,GO:0020037,PXDN,heme binding,3.0
19793,7837,GO:0030198,PXDN,extracellular matrix organization,3.0
19794,7837,GO:0030199,PXDN,collagen fibril organization,3.0
19795,7837,GO:0042744,PXDN,hydrogen peroxide catabolic process,3.0
19796,7837,GO:0046872,PXDN,metal ion binding,3.0
19797,7837,GO:0055114,PXDN,oxidation-reduction process,3.0
19798,7837,GO:0062023,PXDN,collagen-containing extracellular matrix,3.0
19800,7837,GO:0070062,PXDN,extracellular exosome,3.0
19801,7837,GO:0070831,PXDN,basement membrane assembly,3.0
19802,7837,GO:0098869,PXDN,cellular oxidant detoxification,3.0
19825,26056,GO:0000139,RAB11FIP5,Golgi membrane,3.0
19826,26056,GO:0005515,RAB11FIP5,protein binding,3.0
19827,26056,GO:0005739,RAB11FIP5,mitochondrion,3.0
19828,26056,GO:0005741,RAB11FIP5,mitochondrial outer membrane,3.0
19829,26056,GO:0005769,RAB11FIP5,early endosome,3.0
19831,26056,GO:0005794,RAB11FIP5,Golgi apparatus,3.0
19832,26056,GO:0030141,RAB11FIP5,secretory granule,3.0
19834,26056,GO:0030658,RAB11FIP5,transport vesicle membrane,3.0
19835,26056,GO:0031267,RAB11FIP5,small GTPase binding,3.0
19836,26056,GO:0031901,RAB11FIP5,early endosome membrane,3.0
19837,26056,GO:0034451,RAB11FIP5,centriolar satellite,3.0
19838,26056,GO:0035773,RAB11FIP5,insulin secretion involved in cellular response to glucose stimulus,3.0
19839,26056,GO:0043015,RAB11FIP5,gamma-tubulin binding,3.0
19840,26056,GO:0043231,RAB11FIP5,intracellular membrane-bounded organelle,3.0
19842,26056,GO:0045055,RAB11FIP5,regulated exocytosis,3.0
19844,26056,GO:0045335,RAB11FIP5,phagocytic vesicle,3.0
19845,26056,GO:0055037,RAB11FIP5,recycling endosome,3.0
19847,26056,GO:0055038,RAB11FIP5,recycling endosome membrane,3.0
19848,26056,GO:0070164,RAB11FIP5,negative regulation of adiponectin secretion,3.0
19849,26056,GO:0071468,RAB11FIP5,cellular response to acidic pH,3.0
19850,26056,GO:2000008,RAB11FIP5,regulation of protein localization to cell surface,3.0
19869,116442,GO:0000139,RAB39B,Golgi membrane,3.0
19870,116442,GO:0003924,RAB39B,GTPase activity,3.0
19871,116442,GO:0005515,RAB39B,protein binding,3.0
19872,116442,GO:0005525,RAB39B,GTP binding,3.0
19873,116442,GO:0005794,RAB39B,Golgi apparatus,3.0
19875,116442,GO:0005886,RAB39B,plasma membrane,3.0
19876,116442,GO:0006914,RAB39B,autophagy,3.0
19877,116442,GO:0010506,RAB39B,regulation of autophagy,3.0
19878,116442,GO:0015031,RAB39B,protein transport,3.0
19879,116442,GO:0016192,RAB39B,vesicle-mediated transport,3.0
19880,116442,GO:0030659,RAB39B,cytoplasmic vesicle membrane,3.0
19881,116442,GO:0031489,RAB39B,myosin V binding,3.0
19882,116442,GO:0031982,RAB39B,vesicle,3.0
19883,116442,GO:0032482,RAB39B,Rab protein signal transduction,3.0
19884,116442,GO:0043005,RAB39B,neuron projection,3.0
19885,116442,GO:0050808,RAB39B,synapse organization,3.0
20022,642636,GO:0000779,RAD21L1,"condensed chromosome, centromeric region",3.0
20023,642636,GO:0000785,RAD21L1,chromatin,3.0
20024,642636,GO:0000795,RAD21L1,synaptonemal complex,3.0
20025,642636,GO:0000800,RAD21L1,lateral element,3.0
20026,642636,GO:0003682,RAD21L1,chromatin binding,3.0
20027,642636,GO:0005634,RAD21L1,nucleus,3.0
20028,642636,GO:0005694,RAD21L1,chromosome,3.0
20029,642636,GO:0007064,RAD21L1,mitotic sister chromatid cohesion,3.0
20030,642636,GO:0007130,RAD21L1,synaptonemal complex assembly,3.0
20031,642636,GO:0007283,RAD21L1,spermatogenesis,3.0
20032,642636,GO:0009566,RAD21L1,fertilization,3.0
20033,642636,GO:0030893,RAD21L1,meiotic cohesin complex,3.0
20034,642636,GO:0034990,RAD21L1,nuclear mitotic cohesin complex,3.0
20035,642636,GO:0034991,RAD21L1,nuclear meiotic cohesin complex,3.0
20036,642636,GO:0051177,RAD21L1,meiotic sister chromatid cohesion,3.0
20037,642636,GO:0070197,RAD21L1,meiotic attachment of telomere to nuclear envelope,3.0
20038,642636,GO:0072520,RAD21L1,seminiferous tubule development,3.0
20039,642636,GO:1990414,RAD21L1,replication-born double-strand break repair via sister chromatid exchange,3.0
20102,11069,GO:0005085,RAPGEF4,guanyl-nucleotide exchange factor activity,3.0
20104,11069,GO:0005515,RAPGEF4,protein binding,3.0
20105,11069,GO:0005829,RAPGEF4,cytosol,3.0
20106,11069,GO:0005886,RAPGEF4,plasma membrane,3.0
20107,11069,GO:0007186,RAPGEF4,G protein-coupled receptor signaling pathway,3.0
20108,11069,GO:0007264,RAPGEF4,small GTPase mediated signal transduction,3.0
20109,11069,GO:0016020,RAPGEF4,membrane,3.0
20110,11069,GO:0017156,RAPGEF4,calcium-ion regulated exocytosis,3.0
20111,11069,GO:0017157,RAPGEF4,regulation of exocytosis,3.0
20112,11069,GO:0019933,RAPGEF4,cAMP-mediated signaling,3.0
20113,11069,GO:0030073,RAPGEF4,insulin secretion,3.0
20114,11069,GO:0030552,RAPGEF4,cAMP binding,3.0
20115,11069,GO:0031267,RAPGEF4,small GTPase binding,3.0
20116,11069,GO:0050796,RAPGEF4,regulation of insulin secretion,3.0
20117,11069,GO:0098686,RAPGEF4,hippocampal mossy fiber to CA3 synapse,3.0
20118,11069,GO:0098693,RAPGEF4,regulation of synaptic vesicle cycle,3.0
20119,83593,GO:0005515,RASSF5,protein binding,3.0
20120,83593,GO:0005634,RASSF5,nucleus,3.0
20122,83593,GO:0005737,RASSF5,cytoplasm,3.0
20123,83593,GO:0005874,RASSF5,microtubule,3.0
20124,83593,GO:0006915,RASSF5,apoptotic process,3.0
20125,83593,GO:0007165,RASSF5,signal transduction,3.0
20126,83593,GO:0008285,RASSF5,negative regulation of cell population proliferation,3.0
20127,83593,GO:0031267,RASSF5,small GTPase binding,3.0
20128,83593,GO:0031398,RASSF5,positive regulation of protein ubiquitination,3.0
20129,83593,GO:0035556,RASSF5,intracellular signal transduction,3.0
20130,83593,GO:0042981,RASSF5,regulation of apoptotic process,3.0
20131,83593,GO:0046872,RASSF5,metal ion binding,3.0
20132,83593,GO:1900180,RASSF5,regulation of protein localization to nucleus,3.0
20156,221035,GO:0005515,REEP3,protein binding,3.0
20157,221035,GO:0005789,REEP3,endoplasmic reticulum membrane,3.0
20158,221035,GO:0005881,REEP3,cytoplasmic microtubule,3.0
20159,221035,GO:0006998,REEP3,nuclear envelope organization,3.0
20160,221035,GO:0007084,REEP3,mitotic nuclear envelope reassembly,3.0
20161,221035,GO:0008017,REEP3,microtubule binding,3.0
20162,221035,GO:0016020,REEP3,membrane,3.0
20163,221035,GO:0016021,REEP3,integral component of membrane,3.0
20164,221035,GO:0051301,REEP3,cell division,3.0
20165,221035,GO:0071782,REEP3,endoplasmic reticulum tubular network,3.0
20166,221035,GO:0071786,REEP3,endoplasmic reticulum tubular network organization,3.0
20272,6000,GO:0003924,RGS7,GTPase activity,3.0
20273,6000,GO:0005096,RGS7,GTPase activator activity,3.0
20274,6000,GO:0005829,RGS7,cytosol,3.0
20275,6000,GO:0005886,RGS7,plasma membrane,3.0
20276,6000,GO:0006457,RGS7,protein folding,3.0
20277,6000,GO:0007186,RGS7,G protein-coupled receptor signaling pathway,3.0
20278,6000,GO:0009968,RGS7,negative regulation of signal transduction,3.0
20279,6000,GO:0031681,RGS7,G-protein beta-subunit binding,3.0
20280,6000,GO:0035556,RGS7,intracellular signal transduction,3.0
20281,6000,GO:0043547,RGS7,positive regulation of GTPase activity,3.0
20348,9783,GO:0005515,RIMS3,protein binding,3.0
20349,9783,GO:0017156,RIMS3,calcium-ion regulated exocytosis,3.0
20350,9783,GO:0031267,RIMS3,small GTPase binding,3.0
20351,9783,GO:0042391,RIMS3,regulation of membrane potential,3.0
20353,9783,GO:0042734,RIMS3,presynaptic membrane,3.0
20354,9783,GO:0044325,RIMS3,ion channel binding,3.0
20356,9783,GO:0048167,RIMS3,regulation of synaptic plasticity,3.0
20357,9783,GO:0048786,RIMS3,presynaptic active zone,3.0
20358,9783,GO:0048788,RIMS3,cytoskeleton of presynaptic active zone,3.0
20359,9783,GO:0048791,RIMS3,calcium ion-regulated exocytosis of neurotransmitter,3.0
20360,9783,GO:0050806,RIMS3,positive regulation of synaptic transmission,3.0
20361,9783,GO:2000300,RIMS3,regulation of synaptic vesicle exocytosis,3.0
20385,84282,GO:0000209,RNF135,protein polyubiquitination,3.0
20386,84282,GO:0004842,RNF135,ubiquitin-protein transferase activity,3.0
20388,84282,GO:0005515,RNF135,protein binding,3.0
20389,84282,GO:0005737,RNF135,cytoplasm,3.0
20391,84282,GO:0005829,RNF135,cytosol,3.0
20392,84282,GO:0010494,RNF135,cytoplasmic stress granule,3.0
20393,84282,GO:0010994,RNF135,free ubiquitin chain polymerization,3.0
20394,84282,GO:0016567,RNF135,protein ubiquitination,3.0
20395,84282,GO:0032480,RNF135,negative regulation of type I interferon production,3.0
20396,84282,GO:0032728,RNF135,positive regulation of interferon-beta production,3.0
20397,84282,GO:0039529,RNF135,RIG-I signaling pathway,3.0
20399,84282,GO:0039552,RNF135,RIG-I binding,3.0
20400,84282,GO:0042802,RNF135,identical protein binding,3.0
20401,84282,GO:0043021,RNF135,ribonucleoprotein complex binding,3.0
20404,84282,GO:0045087,RNF135,innate immune response,3.0
20405,84282,GO:0045088,RNF135,regulation of innate immune response,3.0
20407,84282,GO:0046872,RNF135,metal ion binding,3.0
20408,84282,GO:0051260,RNF135,protein homooligomerization,3.0
20409,84282,GO:0061630,RNF135,ubiquitin protein ligase activity,3.0
20410,84282,GO:0070534,RNF135,protein K63-linked ubiquitination,3.0
20411,84282,GO:0140374,RNF135,antiviral innate immune response,3.0
20412,84282,GO:1990904,RNF135,ribonucleoprotein complex,3.0
20413,64320,GO:0004842,RNF25,ubiquitin-protein transferase activity,3.0
20414,64320,GO:0005515,RNF25,protein binding,3.0
20415,64320,GO:0005634,RNF25,nucleus,3.0
20417,64320,GO:0005829,RNF25,cytosol,3.0
20418,64320,GO:0016567,RNF25,protein ubiquitination,3.0
20421,64320,GO:0046872,RNF25,metal ion binding,3.0
20422,64320,GO:0051059,RNF25,NF-kappaB binding,3.0
20423,64320,GO:0051092,RNF25,positive regulation of NF-kappaB transcription factor activity,3.0
20425,64320,GO:0061630,RNF25,ubiquitin protein ligase activity,3.0
20426,152006,GO:0005515,RNF38,protein binding,3.0
20427,152006,GO:0005634,RNF38,nucleus,3.0
20428,152006,GO:0005654,RNF38,nucleoplasm,3.0
20429,152006,GO:0008584,RNF38,male gonad development,3.0
20430,152006,GO:0016567,RNF38,protein ubiquitination,3.0
20432,152006,GO:0036126,RNF38,sperm flagellum,3.0
20433,152006,GO:0046872,RNF38,metal ion binding,3.0
20434,152006,GO:0061630,RNF38,ubiquitin protein ligase activity,3.0
20557,6134,GO:0000027,RPL10,ribosomal large subunit assembly,3.0
20558,6134,GO:0000122,RPL10,negative regulation of transcription by RNA polymerase II,3.0
20559,6134,GO:0000184,RPL10,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.0
20560,6134,GO:0003723,RPL10,RNA binding,3.0
20561,6134,GO:0003735,RPL10,structural constituent of ribosome,3.0
20565,6134,GO:0005515,RPL10,protein binding,3.0
20566,6134,GO:0005634,RPL10,nucleus,3.0
20567,6134,GO:0005783,RPL10,endoplasmic reticulum,3.0
20568,6134,GO:0005790,RPL10,smooth endoplasmic reticulum,3.0
20569,6134,GO:0005829,RPL10,cytosol,3.0
20571,6134,GO:0006412,RPL10,translation,3.0
20573,6134,GO:0006413,RPL10,translational initiation,3.0
20574,6134,GO:0006417,RPL10,regulation of translation,3.0
20575,6134,GO:0006614,RPL10,SRP-dependent cotranslational protein targeting to membrane,3.0
20576,6134,GO:0016020,RPL10,membrane,3.0
20577,6134,GO:0019083,RPL10,viral transcription,3.0
20578,6134,GO:0022625,RPL10,cytosolic large ribosomal subunit,3.0
20581,6134,GO:0032991,RPL10,protein-containing complex,3.0
20582,6134,GO:0043066,RPL10,negative regulation of apoptotic process,3.0
20583,6134,GO:0045182,RPL10,translation regulator activity,3.0
20584,6134,GO:1990403,RPL10,embryonic brain development,3.0
20585,6196,GO:0000287,RPS6KA2,magnesium ion binding,3.0
20586,6196,GO:0004674,RPS6KA2,protein serine/threonine kinase activity,3.0
20588,6196,GO:0004711,RPS6KA2,ribosomal protein S6 kinase activity,3.0
20589,6196,GO:0004712,RPS6KA2,protein serine/threonine/tyrosine kinase activity,3.0
20590,6196,GO:0005515,RPS6KA2,protein binding,3.0
20591,6196,GO:0005524,RPS6KA2,ATP binding,3.0
20592,6196,GO:0005634,RPS6KA2,nucleus,3.0
20593,6196,GO:0005654,RPS6KA2,nucleoplasm,3.0
20596,6196,GO:0005737,RPS6KA2,cytoplasm,3.0
20598,6196,GO:0005829,RPS6KA2,cytosol,3.0
20599,6196,GO:0006468,RPS6KA2,protein phosphorylation,3.0
20600,6196,GO:0007165,RPS6KA2,signal transduction,3.0
20601,6196,GO:0008285,RPS6KA2,negative regulation of cell population proliferation,3.0
20602,6196,GO:0018105,RPS6KA2,peptidyl-serine phosphorylation,3.0
20603,6196,GO:0035556,RPS6KA2,intracellular signal transduction,3.0
20604,6196,GO:0043065,RPS6KA2,positive regulation of apoptotic process,3.0
20605,6196,GO:0045786,RPS6KA2,negative regulation of cell cycle,3.0
20606,6196,GO:0106310,RPS6KA2,protein serine kinase activity,3.0
20607,6196,GO:0106311,RPS6KA2,protein threonine kinase activity,3.0
20608,6197,GO:0000287,RPS6KA3,magnesium ion binding,3.0
20609,6197,GO:0001501,RPS6KA3,skeletal system development,3.0
20610,6197,GO:0002224,RPS6KA3,toll-like receptor signaling pathway,3.0
20611,6197,GO:0004672,RPS6KA3,protein kinase activity,3.0
20612,6197,GO:0004674,RPS6KA3,protein serine/threonine kinase activity,3.0
20614,6197,GO:0004711,RPS6KA3,ribosomal protein S6 kinase activity,3.0
20615,6197,GO:0005515,RPS6KA3,protein binding,3.0
20616,6197,GO:0005524,RPS6KA3,ATP binding,3.0
20617,6197,GO:0005654,RPS6KA3,nucleoplasm,3.0
20619,6197,GO:0005737,RPS6KA3,cytoplasm,3.0
20620,6197,GO:0005829,RPS6KA3,cytosol,3.0
20621,6197,GO:0006915,RPS6KA3,apoptotic process,3.0
20622,6197,GO:0007049,RPS6KA3,cell cycle,3.0
20623,6197,GO:0007165,RPS6KA3,signal transduction,3.0
20624,6197,GO:0007417,RPS6KA3,central nervous system development,3.0
20625,6197,GO:0018105,RPS6KA3,peptidyl-serine phosphorylation,3.0
20627,6197,GO:0019901,RPS6KA3,protein kinase binding,3.0
20628,6197,GO:0030307,RPS6KA3,positive regulation of cell growth,3.0
20629,6197,GO:0032496,RPS6KA3,response to lipopolysaccharide,3.0
20630,6197,GO:0035556,RPS6KA3,intracellular signal transduction,3.0
20631,6197,GO:0043027,RPS6KA3,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,3.0
20632,6197,GO:0043066,RPS6KA3,negative regulation of apoptotic process,3.0
20633,6197,GO:0043154,RPS6KA3,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
20634,6197,GO:0043555,RPS6KA3,regulation of translation in response to stress,3.0
20635,6197,GO:0043620,RPS6KA3,regulation of DNA-templated transcription in response to stress,3.0
20636,6197,GO:0045597,RPS6KA3,positive regulation of cell differentiation,3.0
20637,6197,GO:0045944,RPS6KA3,positive regulation of transcription by RNA polymerase II,3.0
20638,6197,GO:0106310,RPS6KA3,protein serine kinase activity,3.0
20639,6197,GO:0106311,RPS6KA3,protein threonine kinase activity,3.0
20663,148398,GO:0003682,SAMD11,chromatin binding,3.0
20664,148398,GO:0005515,SAMD11,protein binding,3.0
20665,148398,GO:0005634,SAMD11,nucleus,3.0
20666,148398,GO:0042393,SAMD11,histone binding,3.0
20667,148398,GO:0045892,SAMD11,"negative regulation of transcription, DNA-templated",3.0
20668,23328,GO:0000209,SASH1,protein polyubiquitination,3.0
20669,23328,GO:0001965,SASH1,G-protein alpha-subunit binding,3.0
20670,23328,GO:0005515,SASH1,protein binding,3.0
20671,23328,GO:0005737,SASH1,cytoplasm,3.0
20672,23328,GO:0008022,SASH1,protein C-terminus binding,3.0
20673,23328,GO:0010595,SASH1,positive regulation of endothelial cell migration,3.0
20674,23328,GO:0010632,SASH1,regulation of epithelial cell migration,3.0
20675,23328,GO:0019901,SASH1,protein kinase binding,3.0
20676,23328,GO:0031435,SASH1,mitogen-activated protein kinase kinase kinase binding,3.0
20678,23328,GO:0031666,SASH1,positive regulation of lipopolysaccharide-mediated signaling pathway,3.0
20679,23328,GO:0032991,SASH1,protein-containing complex,3.0
20680,23328,GO:0043507,SASH1,positive regulation of JUN kinase activity,3.0
20682,23328,GO:0045766,SASH1,positive regulation of angiogenesis,3.0
20683,23328,GO:0060090,SASH1,molecular adaptor activity,3.0
20684,23328,GO:1900044,SASH1,regulation of protein K63-linked ubiquitination,3.0
20685,23328,GO:1900745,SASH1,positive regulation of p38MAPK cascade,3.0
20686,23328,GO:1901224,SASH1,positive regulation of NIK/NF-kappaB signaling,3.0
20688,23328,GO:1902498,SASH1,regulation of protein autoubiquitination,3.0
20689,23314,GO:0000118,SATB2,histone deacetylase complex,3.0
20690,23314,GO:0000785,SATB2,chromatin,3.0
20692,23314,GO:0000977,SATB2,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
20693,23314,GO:0000978,SATB2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
20695,23314,GO:0000981,SATB2,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
20697,23314,GO:0001228,SATB2,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
20698,23314,GO:0001764,SATB2,neuron migration,3.0
20699,23314,GO:0002076,SATB2,osteoblast development,3.0
20700,23314,GO:0003682,SATB2,chromatin binding,3.0
20701,23314,GO:0005515,SATB2,protein binding,3.0
20702,23314,GO:0005654,SATB2,nucleoplasm,3.0
20704,23314,GO:0005667,SATB2,transcription regulator complex,3.0
20705,23314,GO:0006338,SATB2,chromatin remodeling,3.0
20706,23314,GO:0006357,SATB2,regulation of transcription by RNA polymerase II,3.0
20707,23314,GO:0009880,SATB2,embryonic pattern specification,3.0
20708,23314,GO:0016363,SATB2,nuclear matrix,3.0
20709,23314,GO:0021902,SATB2,commitment of neuronal cell to specific neuron type in forebrain,3.0
20710,23314,GO:0042826,SATB2,histone deacetylase binding,3.0
20711,23314,GO:0045944,SATB2,positive regulation of transcription by RNA polymerase II,3.0
20712,23314,GO:0048704,SATB2,embryonic skeletal system morphogenesis,3.0
20713,23314,GO:0051216,SATB2,cartilage development,3.0
20714,23314,GO:0060021,SATB2,roof of mouth development,3.0
20715,23314,GO:0071310,SATB2,cellular response to organic substance,3.0
20716,9699,GO:0005515,RIMS2,protein binding,3.0
20717,9699,GO:0006886,RIMS2,intracellular protein transport,3.0
20718,9699,GO:0010628,RIMS2,positive regulation of gene expression,3.0
20719,9699,GO:0017156,RIMS2,calcium-ion regulated exocytosis,3.0
20720,9699,GO:0017157,RIMS2,regulation of exocytosis,3.0
20721,9699,GO:0019933,RIMS2,cAMP-mediated signaling,3.0
20722,9699,GO:0030073,RIMS2,insulin secretion,3.0
20723,9699,GO:0031267,RIMS2,small GTPase binding,3.0
20724,9699,GO:0042391,RIMS2,regulation of membrane potential,3.0
20726,9699,GO:0042734,RIMS2,presynaptic membrane,3.0
20727,9699,GO:0042995,RIMS2,cell projection,3.0
20728,9699,GO:0044325,RIMS2,ion channel binding,3.0
20730,9699,GO:0046872,RIMS2,metal ion binding,3.0
20731,9699,GO:0048167,RIMS2,regulation of synaptic plasticity,3.0
20732,9699,GO:0048786,RIMS2,presynaptic active zone,3.0
20733,9699,GO:0048788,RIMS2,cytoskeleton of presynaptic active zone,3.0
20734,9699,GO:0048791,RIMS2,calcium ion-regulated exocytosis of neurotransmitter,3.0
20736,9699,GO:0050806,RIMS2,positive regulation of synaptic transmission,3.0
20737,9699,GO:0061669,RIMS2,spontaneous neurotransmitter secretion,3.0
20738,9699,GO:0070062,RIMS2,extracellular exosome,3.0
20739,9699,GO:0097151,RIMS2,positive regulation of inhibitory postsynaptic potential,3.0
20740,9699,GO:1903861,RIMS2,positive regulation of dendrite extension,3.0
20741,9699,GO:2000300,RIMS2,regulation of synaptic vesicle exocytosis,3.0
20742,9699,GO:2000463,RIMS2,positive regulation of excitatory postsynaptic potential,3.0
20810,152579,GO:0003674,SCFD2,molecular_function,3.0
20811,152579,GO:0005575,SCFD2,cellular_component,3.0
20812,152579,GO:0005886,SCFD2,plasma membrane,3.0
20813,152579,GO:0006886,SCFD2,intracellular protein transport,3.0
20814,152579,GO:0006904,SCFD2,vesicle docking involved in exocytosis,3.0
20815,152579,GO:0008150,SCFD2,biological_process,3.0
20816,152579,GO:0016192,SCFD2,vesicle-mediated transport,3.0
20817,152579,GO:0019905,SCFD2,syntaxin binding,3.0
20818,152579,GO:0030141,SCFD2,secretory granule,3.0
20898,158800,GO:0000785,RHOXF1,chromatin,3.0
20900,158800,GO:0000977,RHOXF1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
20901,158800,GO:0000981,RHOXF1,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
20903,158800,GO:0003677,RHOXF1,DNA binding,3.0
20904,158800,GO:0003700,RHOXF1,DNA-binding transcription factor activity,3.0
20905,158800,GO:0005515,RHOXF1,protein binding,3.0
20906,158800,GO:0005634,RHOXF1,nucleus,3.0
20907,158800,GO:0006355,RHOXF1,"regulation of transcription, DNA-templated",3.0
20908,158800,GO:0006357,RHOXF1,regulation of transcription by RNA polymerase II,3.0
20909,158800,GO:0007275,RHOXF1,multicellular organism development,3.0
20910,158800,GO:0007276,RHOXF1,gamete generation,3.0
20911,158800,GO:0010628,RHOXF1,positive regulation of gene expression,3.0
20912,158800,GO:0019953,RHOXF1,sexual reproduction,3.0
20913,158800,GO:0030518,RHOXF1,intracellular steroid hormone receptor signaling pathway,3.0
20914,158800,GO:0048484,RHOXF1,enteric nervous system development,3.0
20915,158800,GO:1990837,RHOXF1,sequence-specific double-stranded DNA binding,3.0
20916,6014,GO:0000165,RIT2,MAPK cascade,3.0
20917,6014,GO:0003682,RIT2,chromatin binding,3.0
20918,6014,GO:0003924,RIT2,GTPase activity,3.0
20921,6014,GO:0005515,RIT2,protein binding,3.0
20922,6014,GO:0005516,RIT2,calmodulin binding,3.0
20925,6014,GO:0005525,RIT2,GTP binding,3.0
20927,6014,GO:0005634,RIT2,nucleus,3.0
20929,6014,GO:0005737,RIT2,cytoplasm,3.0
20930,6014,GO:0005886,RIT2,plasma membrane,3.0
20934,6014,GO:0007189,RIT2,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3.0
20935,6014,GO:0007264,RIT2,small GTPase mediated signal transduction,3.0
20936,6014,GO:0007265,RIT2,Ras protein signal transduction,3.0
20938,6014,GO:0007268,RIT2,chemical synaptic transmission,3.0
20939,6014,GO:0010976,RIT2,positive regulation of neuron projection development,3.0
20942,6014,GO:0010977,RIT2,negative regulation of neuron projection development,3.0
20943,6014,GO:0019003,RIT2,GDP binding,3.0
20944,6014,GO:0030100,RIT2,regulation of endocytosis,3.0
20945,6014,GO:0030215,RIT2,semaphorin receptor binding,3.0
20946,6014,GO:0032489,RIT2,regulation of Cdc42 protein signal transduction,3.0
20947,6014,GO:0032507,RIT2,maintenance of protein location in cell,3.0
20948,6014,GO:0035556,RIT2,intracellular signal transduction,3.0
20949,6014,GO:0042802,RIT2,identical protein binding,3.0
20950,6014,GO:0043005,RIT2,neuron projection,3.0
20951,6014,GO:0043410,RIT2,positive regulation of MAPK cascade,3.0
20952,6014,GO:0044297,RIT2,cell body,3.0
20953,6014,GO:0045121,RIT2,membrane raft,3.0
20954,6014,GO:0045202,RIT2,synapse,3.0
20955,6014,GO:0045944,RIT2,positive regulation of transcription by RNA polymerase II,3.0
20956,6014,GO:0050848,RIT2,regulation of calcium-mediated signaling,3.0
20957,6014,GO:0097447,RIT2,dendritic tree,3.0
20958,6329,GO:0001518,SCN4A,voltage-gated sodium channel complex,3.0
20960,6329,GO:0005244,SCN4A,voltage-gated ion channel activity,3.0
20961,6329,GO:0005248,SCN4A,voltage-gated sodium channel activity,3.0
20963,6329,GO:0005515,SCN4A,protein binding,3.0
20964,6329,GO:0005887,SCN4A,integral component of plasma membrane,3.0
20965,6329,GO:0006814,SCN4A,sodium ion transport,3.0
20966,6329,GO:0006936,SCN4A,muscle contraction,3.0
20967,6329,GO:0019228,SCN4A,neuronal action potential,3.0
20968,6329,GO:0030424,SCN4A,axon,3.0
20969,6329,GO:0034765,SCN4A,regulation of ion transmembrane transport,3.0
20970,6329,GO:0035725,SCN4A,sodium ion transmembrane transport,3.0
20972,6329,GO:0086010,SCN4A,membrane depolarization during action potential,3.0
20973,6329,GO:0100001,SCN4A,regulation of skeletal muscle contraction by action potential,3.0
21019,6342,GO:0000062,SCP2,fatty-acyl-CoA binding,3.0
21020,6342,GO:0003988,SCP2,acetyl-CoA C-acyltransferase activity,3.0
21021,6342,GO:0005102,SCP2,signaling receptor binding,3.0
21022,6342,GO:0005515,SCP2,protein binding,3.0
21023,6342,GO:0005654,SCP2,nucleoplasm,3.0
21024,6342,GO:0005739,SCP2,mitochondrion,3.0
21025,6342,GO:0005777,SCP2,peroxisome,3.0
21026,6342,GO:0005782,SCP2,peroxisomal matrix,3.0
21027,6342,GO:0005829,SCP2,cytosol,3.0
21028,6342,GO:0006625,SCP2,protein targeting to peroxisome,3.0
21029,6342,GO:0006635,SCP2,fatty acid beta-oxidation,3.0
21030,6342,GO:0006694,SCP2,steroid biosynthetic process,3.0
21031,6342,GO:0006699,SCP2,bile acid biosynthetic process,3.0
21032,6342,GO:0008206,SCP2,bile acid metabolic process,3.0
21033,6342,GO:0015485,SCP2,cholesterol binding,3.0
21034,6342,GO:0015914,SCP2,phospholipid transport,3.0
21035,6342,GO:0016020,SCP2,membrane,3.0
21036,6342,GO:0032385,SCP2,positive regulation of intracellular cholesterol transport,3.0
21038,6342,GO:0032934,SCP2,sterol binding,3.0
21039,6342,GO:0032991,SCP2,protein-containing complex,3.0
21040,6342,GO:0033540,SCP2,fatty acid beta-oxidation using acyl-CoA oxidase,3.0
21041,6342,GO:0033814,SCP2,propanoyl-CoA C-acyltransferase activity,3.0
21042,6342,GO:0036042,SCP2,long-chain fatty acyl-CoA binding,3.0
21043,6342,GO:0036109,SCP2,alpha-linolenic acid metabolic process,3.0
21044,6342,GO:0043231,SCP2,intracellular membrane-bounded organelle,3.0
21045,6342,GO:0050632,SCP2,propionyl-CoA C2-trimethyltridecanoyltransferase activity,3.0
21047,6342,GO:0050633,SCP2,acetyl-CoA C-myristoyltransferase activity,3.0
21048,6342,GO:0070538,SCP2,oleic acid binding,3.0
21049,6342,GO:1901373,SCP2,lipid hydroperoxide transport,3.0
21050,6383,GO:0001523,SDC2,retinoid metabolic process,3.0
21051,6383,GO:0005515,SDC2,protein binding,3.0
21052,6383,GO:0005788,SDC2,endoplasmic reticulum lumen,3.0
21053,6383,GO:0005796,SDC2,Golgi lumen,3.0
21054,6383,GO:0005886,SDC2,plasma membrane,3.0
21055,6383,GO:0006024,SDC2,glycosaminoglycan biosynthetic process,3.0
21056,6383,GO:0006027,SDC2,glycosaminoglycan catabolic process,3.0
21057,6383,GO:0008150,SDC2,biological_process,3.0
21058,6383,GO:0009986,SDC2,cell surface,3.0
21059,6383,GO:0016021,SDC2,integral component of membrane,3.0
21060,6383,GO:0016477,SDC2,cell migration,3.0
21061,6383,GO:0030165,SDC2,PDZ domain binding,3.0
21062,6383,GO:0042802,SDC2,identical protein binding,3.0
21063,6383,GO:0043202,SDC2,lysosomal lumen,3.0
21064,6383,GO:0043687,SDC2,post-translational protein modification,3.0
21065,6383,GO:0044267,SDC2,cellular protein metabolic process,3.0
21066,6383,GO:0048013,SDC2,ephrin receptor signaling pathway,3.0
21067,6383,GO:0048813,SDC2,dendrite morphogenesis,3.0
21068,6383,GO:0048814,SDC2,regulation of dendrite morphogenesis,3.0
21069,6383,GO:0050900,SDC2,leukocyte migration,3.0
21070,6383,GO:0062023,SDC2,collagen-containing extracellular matrix,3.0
21107,5054,GO:0001525,SERPINE1,angiogenesis,3.0
21108,5054,GO:0002020,SERPINE1,protease binding,3.0
21109,5054,GO:0002576,SERPINE1,platelet degranulation,3.0
21110,5054,GO:0004867,SERPINE1,serine-type endopeptidase inhibitor activity,3.0
21112,5054,GO:0005102,SERPINE1,signaling receptor binding,3.0
21113,5054,GO:0005515,SERPINE1,protein binding,3.0
21114,5054,GO:0005576,SERPINE1,extracellular region,3.0
21116,5054,GO:0005615,SERPINE1,extracellular space,3.0
21118,5054,GO:0005886,SERPINE1,plasma membrane,3.0
21119,5054,GO:0007623,SERPINE1,circadian rhythm,3.0
21120,5054,GO:0010469,SERPINE1,regulation of signaling receptor activity,3.0
21121,5054,GO:0010757,SERPINE1,negative regulation of plasminogen activation,3.0
21123,5054,GO:0010951,SERPINE1,negative regulation of endopeptidase activity,3.0
21125,5054,GO:0014912,SERPINE1,negative regulation of smooth muscle cell migration,3.0
21126,5054,GO:0030194,SERPINE1,positive regulation of blood coagulation,3.0
21127,5054,GO:0030195,SERPINE1,negative regulation of blood coagulation,3.0
21128,5054,GO:0030198,SERPINE1,extracellular matrix organization,3.0
21129,5054,GO:0030336,SERPINE1,negative regulation of cell migration,3.0
21130,5054,GO:0031093,SERPINE1,platelet alpha granule lumen,3.0
21131,5054,GO:0032757,SERPINE1,positive regulation of interleukin-8 production,3.0
21132,5054,GO:0033629,SERPINE1,negative regulation of cell adhesion mediated by integrin,3.0
21133,5054,GO:0035491,SERPINE1,positive regulation of leukotriene production involved in inflammatory response,3.0
21134,5054,GO:0042730,SERPINE1,fibrinolysis,3.0
21135,5054,GO:0045766,SERPINE1,positive regulation of angiogenesis,3.0
21136,5054,GO:0045944,SERPINE1,positive regulation of transcription by RNA polymerase II,3.0
21137,5054,GO:0048260,SERPINE1,positive regulation of receptor-mediated endocytosis,3.0
21138,5054,GO:0050729,SERPINE1,positive regulation of inflammatory response,3.0
21139,5054,GO:0050829,SERPINE1,defense response to Gram-negative bacterium,3.0
21140,5054,GO:0051918,SERPINE1,negative regulation of fibrinolysis,3.0
21141,5054,GO:0061044,SERPINE1,negative regulation of vascular wound healing,3.0
21142,5054,GO:0061045,SERPINE1,negative regulation of wound healing,3.0
21143,5054,GO:0062023,SERPINE1,collagen-containing extracellular matrix,3.0
21146,5054,GO:0070062,SERPINE1,extracellular exosome,3.0
21147,5054,GO:0071222,SERPINE1,cellular response to lipopolysaccharide,3.0
21148,5054,GO:0090026,SERPINE1,positive regulation of monocyte chemotaxis,3.0
21149,5054,GO:0090399,SERPINE1,replicative senescence,3.0
21150,5054,GO:0097187,SERPINE1,dentinogenesis,3.0
21151,5054,GO:1901331,SERPINE1,positive regulation of odontoblast differentiation,3.0
21152,5054,GO:1902042,SERPINE1,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,3.0
21153,5054,GO:2000098,SERPINE1,negative regulation of smooth muscle cell-matrix adhesion,3.0
21154,5054,GO:2000352,SERPINE1,negative regulation of endothelial cell apoptotic process,3.0
21188,23067,GO:0003723,SETD1B,RNA binding,3.0
21189,23067,GO:0005515,SETD1B,protein binding,3.0
21190,23067,GO:0005654,SETD1B,nucleoplasm,3.0
21192,23067,GO:0005694,SETD1B,chromosome,3.0
21193,23067,GO:0016607,SETD1B,nuclear speck,3.0
21194,23067,GO:0035097,SETD1B,histone methyltransferase complex,3.0
21195,23067,GO:0042800,SETD1B,histone methyltransferase activity (H3-K4 specific),3.0
21196,23067,GO:0044648,SETD1B,histone H3-K4 dimethylation,3.0
21197,23067,GO:0048188,SETD1B,Set1C/COMPASS complex,3.0
21198,23067,GO:0051568,SETD1B,histone H3-K4 methylation,3.0
21199,23067,GO:0080182,SETD1B,histone H3-K4 trimethylation,3.0
21200,23067,GO:0097692,SETD1B,histone H3-K4 monomethylation,3.0
21257,9869,GO:0003677,SETDB1,DNA binding,3.0
21258,9869,GO:0003682,SETDB1,chromatin binding,3.0
21259,9869,GO:0005515,SETDB1,protein binding,3.0
21260,9869,GO:0005634,SETDB1,nucleus,3.0
21262,9869,GO:0005654,SETDB1,nucleoplasm,3.0
21264,9869,GO:0005694,SETDB1,chromosome,3.0
21265,9869,GO:0005737,SETDB1,cytoplasm,3.0
21266,9869,GO:0007265,SETDB1,Ras protein signal transduction,3.0
21267,9869,GO:0008270,SETDB1,zinc ion binding,3.0
21268,9869,GO:0010629,SETDB1,negative regulation of gene expression,3.0
21269,9869,GO:0018024,SETDB1,histone-lysine N-methyltransferase activity,3.0
21270,9869,GO:0043231,SETDB1,intracellular membrane-bounded organelle,3.0
21271,9869,GO:0045869,SETDB1,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,3.0
21272,9869,GO:0046974,SETDB1,histone methyltransferase activity (H3-K9 specific),3.0
21274,9869,GO:0051567,SETDB1,histone H3-K9 methylation,3.0
21275,9869,GO:0070828,SETDB1,heterochromatin organization,3.0
21276,9869,GO:0090309,SETDB1,positive regulation of DNA methylation-dependent heterochromatin assembly,3.0
21279,9869,GO:1990841,SETDB1,promoter-specific chromatin binding,3.0
21280,83852,GO:0000278,SETDB2,mitotic cell cycle,3.0
21281,83852,GO:0001947,SETDB2,heart looping,3.0
21282,83852,GO:0003677,SETDB2,DNA binding,3.0
21283,83852,GO:0005515,SETDB2,protein binding,3.0
21284,83852,GO:0005634,SETDB2,nucleus,3.0
21286,83852,GO:0005654,SETDB2,nucleoplasm,3.0
21288,83852,GO:0005694,SETDB2,chromosome,3.0
21289,83852,GO:0005829,SETDB2,cytosol,3.0
21290,83852,GO:0007059,SETDB2,chromosome segregation,3.0
21291,83852,GO:0008270,SETDB2,zinc ion binding,3.0
21292,83852,GO:0010629,SETDB2,negative regulation of gene expression,3.0
21293,83852,GO:0045892,SETDB2,"negative regulation of transcription, DNA-templated",3.0
21294,83852,GO:0046974,SETDB2,histone methyltransferase activity (H3-K9 specific),3.0
21296,83852,GO:0051301,SETDB2,cell division,3.0
21297,83852,GO:0051567,SETDB2,histone H3-K9 methylation,3.0
21299,83852,GO:0070828,SETDB2,heterochromatin organization,3.0
21300,83852,GO:0070986,SETDB2,left/right axis specification,3.0
21301,83852,GO:0090309,SETDB2,positive regulation of DNA methylation-dependent heterochromatin assembly,3.0
21302,26470,GO:0005789,SEZ6L2,endoplasmic reticulum membrane,3.0
21303,26470,GO:0005886,SEZ6L2,plasma membrane,3.0
21304,26470,GO:0016021,SEZ6L2,integral component of membrane,3.0
21305,23451,GO:0000245,SF3B1,spliceosomal complex assembly,3.0
21306,23451,GO:0000375,SF3B1,"RNA splicing, via transesterification reactions",3.0
21307,23451,GO:0000398,SF3B1,"mRNA splicing, via spliceosome",3.0
21311,23451,GO:0003723,SF3B1,RNA binding,3.0
21313,23451,GO:0003729,SF3B1,mRNA binding,3.0
21314,23451,GO:0005515,SF3B1,protein binding,3.0
21315,23451,GO:0005634,SF3B1,nucleus,3.0
21316,23451,GO:0005654,SF3B1,nucleoplasm,3.0
21317,23451,GO:0005681,SF3B1,spliceosomal complex,3.0
21318,23451,GO:0005686,SF3B1,U2 snRNP,3.0
21320,23451,GO:0005689,SF3B1,U12-type spliceosomal complex,3.0
21322,23451,GO:0008380,SF3B1,RNA splicing,3.0
21323,23451,GO:0016607,SF3B1,nuclear speck,3.0
21324,23451,GO:0034693,SF3B1,U11/U12 snRNP,3.0
21325,23451,GO:0045815,SF3B1,"positive regulation of gene expression, epigenetic",3.0
21326,23451,GO:0071004,SF3B1,U2-type prespliceosome,3.0
21327,23451,GO:0071005,SF3B1,U2-type precatalytic spliceosome,3.0
21328,23451,GO:0071013,SF3B1,catalytic step 2 spliceosome,3.0
21330,23451,GO:1990935,SF3B1,splicing factor binding,3.0
21345,27352,GO:0005096,SGSM3,GTPase activator activity,3.0
21347,27352,GO:0005515,SGSM3,protein binding,3.0
21348,27352,GO:0005829,SGSM3,cytosol,3.0
21349,27352,GO:0005921,SGSM3,gap junction,3.0
21350,27352,GO:0006886,SGSM3,intracellular protein transport,3.0
21351,27352,GO:0007050,SGSM3,cell cycle arrest,3.0
21352,27352,GO:0031267,SGSM3,small GTPase binding,3.0
21355,27352,GO:0032483,SGSM3,regulation of Rab protein signal transduction,3.0
21356,27352,GO:0032486,SGSM3,Rap protein signal transduction,3.0
21357,27352,GO:0043547,SGSM3,positive regulation of GTPase activity,3.0
21358,27352,GO:0045732,SGSM3,positive regulation of protein catabolic process,3.0
21359,27352,GO:0048227,SGSM3,plasma membrane to endosome transport,3.0
21360,27352,GO:0090630,SGSM3,activation of GTPase activity,3.0
21361,27352,GO:1902017,SGSM3,regulation of cilium assembly,3.0
21362,344558,GO:0005515,SH3RF3,protein binding,3.0
21363,344558,GO:0006915,SH3RF3,apoptotic process,3.0
21364,344558,GO:0046330,SH3RF3,positive regulation of JNK cascade,3.0
21365,344558,GO:0046872,SH3RF3,metal ion binding,3.0
21366,344558,GO:0051865,SH3RF3,protein autoubiquitination,3.0
21367,344558,GO:0061630,SH3RF3,ubiquitin protein ligase activity,3.0
21534,9739,GO:0000785,SETD1A,chromatin,3.0
21535,9739,GO:0003723,SETD1A,RNA binding,3.0
21536,9739,GO:0005515,SETD1A,protein binding,3.0
21537,9739,GO:0005634,SETD1A,nucleus,3.0
21539,9739,GO:0005654,SETD1A,nucleoplasm,3.0
21540,9739,GO:0007420,SETD1A,brain development,3.0
21541,9739,GO:0008013,SETD1A,beta-catenin binding,3.0
21542,9739,GO:0008134,SETD1A,transcription factor binding,3.0
21543,9739,GO:0016607,SETD1A,nuclear speck,3.0
21544,9739,GO:0035097,SETD1A,histone methyltransferase complex,3.0
21545,9739,GO:0042800,SETD1A,histone methyltransferase activity (H3-K4 specific),3.0
21546,9739,GO:0044648,SETD1A,histone H3-K4 dimethylation,3.0
21547,9739,GO:0045652,SETD1A,regulation of megakaryocyte differentiation,3.0
21548,9739,GO:0048188,SETD1A,Set1C/COMPASS complex,3.0
21550,9739,GO:0080182,SETD1A,histone H3-K4 trimethylation,3.0
21551,9739,GO:0097692,SETD1A,histone H3-K4 monomethylation,3.0
21552,9739,GO:1902036,SETD1A,regulation of hematopoietic stem cell differentiation,3.0
21553,9739,GO:1902275,SETD1A,regulation of chromatin organization,3.0
21682,6505,GO:0005313,SLC1A1,L-glutamate transmembrane transporter activity,3.0
21683,6505,GO:0005314,SLC1A1,high-affinity glutamate transmembrane transporter activity,3.0
21684,6505,GO:0005515,SLC1A1,protein binding,3.0
21685,6505,GO:0005886,SLC1A1,plasma membrane,3.0
21687,6505,GO:0005887,SLC1A1,integral component of plasma membrane,3.0
21688,6505,GO:0006811,SLC1A1,ion transport,3.0
21689,6505,GO:0007268,SLC1A1,chemical synaptic transmission,3.0
21690,6505,GO:0010460,SLC1A1,positive regulation of heart rate,3.0
21691,6505,GO:0014047,SLC1A1,glutamate secretion,3.0
21692,6505,GO:0015108,SLC1A1,chloride transmembrane transporter activity,3.0
21693,6505,GO:0015183,SLC1A1,L-aspartate transmembrane transporter activity,3.0
21694,6505,GO:0015501,SLC1A1,glutamate:sodium symporter activity,3.0
21695,6505,GO:0015813,SLC1A1,L-glutamate transmembrane transport,3.0
21696,6505,GO:0016020,SLC1A1,membrane,3.0
21697,6505,GO:0016021,SLC1A1,integral component of membrane,3.0
21698,6505,GO:0016324,SLC1A1,apical plasma membrane,3.0
21699,6505,GO:0016595,SLC1A1,glutamate binding,3.0
21700,6505,GO:0030424,SLC1A1,axon,3.0
21701,6505,GO:0030425,SLC1A1,dendrite,3.0
21702,6505,GO:0031901,SLC1A1,early endosome membrane,3.0
21703,6505,GO:0031902,SLC1A1,late endosome membrane,3.0
21704,6505,GO:0032279,SLC1A1,asymmetric synapse,3.0
21705,6505,GO:0033229,SLC1A1,cysteine transmembrane transporter activity,3.0
21706,6505,GO:0035633,SLC1A1,maintenance of blood-brain barrier,3.0
21707,6505,GO:0036475,SLC1A1,neuron death in response to oxidative stress,3.0
21708,6505,GO:0042802,SLC1A1,identical protein binding,3.0
21709,6505,GO:0042883,SLC1A1,cysteine transport,3.0
21710,6505,GO:0043025,SLC1A1,neuronal cell body,3.0
21711,6505,GO:0043083,SLC1A1,synaptic cleft,3.0
21712,6505,GO:0043197,SLC1A1,dendritic spine,3.0
21713,6505,GO:0043198,SLC1A1,dendritic shaft,3.0
21714,6505,GO:0043204,SLC1A1,perikaryon,3.0
21715,6505,GO:0043679,SLC1A1,axon terminus,3.0
21716,6505,GO:0046872,SLC1A1,metal ion binding,3.0
21717,6505,GO:0048514,SLC1A1,blood vessel morphogenesis,3.0
21718,6505,GO:0051938,SLC1A1,L-glutamate import,3.0
21719,6505,GO:0055038,SLC1A1,recycling endosome membrane,3.0
21720,6505,GO:0070062,SLC1A1,extracellular exosome,3.0
21721,6505,GO:0070633,SLC1A1,transepithelial transport,3.0
21722,6505,GO:0070777,SLC1A1,D-aspartate transport,3.0
21723,6505,GO:0070778,SLC1A1,L-aspartate transmembrane transport,3.0
21725,6505,GO:0070779,SLC1A1,D-aspartate import across plasma membrane,3.0
21727,6505,GO:0071944,SLC1A1,cell periphery,3.0
21728,6505,GO:0097386,SLC1A1,glial cell projection,3.0
21729,6505,GO:0097440,SLC1A1,apical dendrite,3.0
21730,6505,GO:0098712,SLC1A1,L-glutamate import across plasma membrane,3.0
21732,6505,GO:0098793,SLC1A1,presynapse,3.0
21733,6505,GO:0099544,SLC1A1,perisynaptic space,3.0
21734,6505,GO:0140009,SLC1A1,L-aspartate import across plasma membrane,3.0
21735,6505,GO:0140010,SLC1A1,D-aspartate transmembrane transporter activity,3.0
21736,6505,GO:0150002,SLC1A1,distal dendrite,3.0
21737,6505,GO:0150104,SLC1A1,transport across blood-brain barrier,3.0
21739,6505,GO:1902476,SLC1A1,chloride transmembrane transport,3.0
21740,6505,GO:1903712,SLC1A1,cysteine transmembrane transport,3.0
21741,6505,GO:1990635,SLC1A1,proximal dendrite,3.0
21781,55356,GO:0003674,SLC22A15,molecular_function,3.0
21782,55356,GO:0005575,SLC22A15,cellular_component,3.0
21783,55356,GO:0006811,SLC22A15,ion transport,3.0
21784,55356,GO:0008150,SLC22A15,biological_process,3.0
21785,55356,GO:0016021,SLC22A15,integral component of membrane,3.0
21786,55356,GO:0022857,SLC22A15,transmembrane transporter activity,3.0
21787,55356,GO:0055085,SLC22A15,transmembrane transport,3.0
21788,114571,GO:0009914,SLC22A9,hormone transport,3.0
21789,114571,GO:0015301,SLC22A9,anion:anion antiporter activity,3.0
21790,114571,GO:0015347,SLC22A9,sodium-independent organic anion transmembrane transporter activity,3.0
21791,114571,GO:0015636,SLC22A9,short-chain fatty acid transmembrane transporter activity,3.0
21792,114571,GO:0015711,SLC22A9,organic anion transport,3.0
21793,114571,GO:0015913,SLC22A9,short-chain fatty acid import,3.0
21794,114571,GO:0016021,SLC22A9,integral component of membrane,3.0
21795,114571,GO:0016323,SLC22A9,basolateral plasma membrane,3.0
21796,114571,GO:0043252,SLC22A9,sodium-independent organic anion transport,3.0
21797,114571,GO:0098656,SLC22A9,anion transmembrane transport,3.0
21798,25769,GO:0001917,SLC24A2,photoreceptor inner segment,3.0
21799,25769,GO:0005262,SLC24A2,calcium channel activity,3.0
21800,25769,GO:0005886,SLC24A2,plasma membrane,3.0
21802,25769,GO:0005887,SLC24A2,integral component of plasma membrane,3.0
21803,25769,GO:0006811,SLC24A2,ion transport,3.0
21804,25769,GO:0006874,SLC24A2,cellular calcium ion homeostasis,3.0
21806,25769,GO:0007601,SLC24A2,visual perception,3.0
21807,25769,GO:0007612,SLC24A2,learning,3.0
21808,25769,GO:0007613,SLC24A2,memory,3.0
21809,25769,GO:0008273,SLC24A2,"calcium, potassium:sodium antiporter activity",3.0
21811,25769,GO:0015293,SLC24A2,symporter activity,3.0
21812,25769,GO:0034220,SLC24A2,ion transmembrane transport,3.0
21813,25769,GO:0035725,SLC24A2,sodium ion transmembrane transport,3.0
21814,25769,GO:0044214,SLC24A2,spanning component of plasma membrane,3.0
21815,25769,GO:0050896,SLC24A2,response to stimulus,3.0
21816,25769,GO:0060291,SLC24A2,long-term synaptic potentiation,3.0
21817,25769,GO:0060292,SLC24A2,long-term synaptic depression,3.0
21818,25769,GO:0065003,SLC24A2,protein-containing complex assembly,3.0
21819,25769,GO:0070588,SLC24A2,calcium ion transmembrane transport,3.0
21821,25769,GO:0071805,SLC24A2,potassium ion transmembrane transport,3.0
21822,25769,GO:0098656,SLC24A2,anion transmembrane transport,3.0
21823,25769,GO:0098703,SLC24A2,calcium ion import across plasma membrane,3.0
21824,8604,GO:0005313,SLC25A12,L-glutamate transmembrane transporter activity,3.0
21826,8604,GO:0005347,SLC25A12,ATP transmembrane transporter activity,3.0
21827,8604,GO:0005509,SLC25A12,calcium ion binding,3.0
21828,8604,GO:0005739,SLC25A12,mitochondrion,3.0
21830,8604,GO:0005743,SLC25A12,mitochondrial inner membrane,3.0
21831,8604,GO:0006094,SLC25A12,gluconeogenesis,3.0
21832,8604,GO:0006537,SLC25A12,glutamate biosynthetic process,3.0
21833,8604,GO:0006810,SLC25A12,transport,3.0
21834,8604,GO:0010907,SLC25A12,positive regulation of glucose metabolic process,3.0
21835,8604,GO:0015183,SLC25A12,L-aspartate transmembrane transporter activity,3.0
21837,8604,GO:0015810,SLC25A12,aspartate transmembrane transport,3.0
21839,8604,GO:0015813,SLC25A12,L-glutamate transmembrane transport,3.0
21841,8604,GO:0015867,SLC25A12,ATP transport,3.0
21842,8604,GO:0016021,SLC25A12,integral component of membrane,3.0
21843,8604,GO:0022857,SLC25A12,transmembrane transporter activity,3.0
21844,8604,GO:0031643,SLC25A12,positive regulation of myelination,3.0
21845,8604,GO:0042802,SLC25A12,identical protein binding,3.0
21846,8604,GO:0043490,SLC25A12,malate-aspartate shuttle,3.0
21848,8604,GO:0051592,SLC25A12,response to calcium ion,3.0
21849,8604,GO:0070778,SLC25A12,L-aspartate transmembrane transport,3.0
21850,8604,GO:1904024,SLC25A12,negative regulation of glucose catabolic process to lactate via pyruvate,3.0
21851,8604,GO:2001171,SLC25A12,positive regulation of ATP biosynthetic process,3.0
21852,9481,GO:0005739,SLC25A27,mitochondrion,3.0
21853,9481,GO:0005743,SLC25A27,mitochondrial inner membrane,3.0
21854,9481,GO:0008284,SLC25A27,positive regulation of cell population proliferation,3.0
21855,9481,GO:0009409,SLC25A27,response to cold,3.0
21856,9481,GO:0010917,SLC25A27,negative regulation of mitochondrial membrane potential,3.0
21857,9481,GO:0016021,SLC25A27,integral component of membrane,3.0
21858,9481,GO:0031966,SLC25A27,mitochondrial membrane,3.0
21859,9481,GO:0035356,SLC25A27,cellular triglyceride homeostasis,3.0
21860,9481,GO:0043025,SLC25A27,neuronal cell body,3.0
21861,9481,GO:0043066,SLC25A27,negative regulation of apoptotic process,3.0
21862,9481,GO:0045177,SLC25A27,apical part of cell,3.0
21863,9481,GO:0046324,SLC25A27,regulation of glucose import,3.0
21864,9481,GO:0048839,SLC25A27,inner ear development,3.0
21865,9481,GO:0051562,SLC25A27,negative regulation of mitochondrial calcium ion concentration,3.0
21866,9481,GO:0070997,SLC25A27,neuron death,3.0
21867,9481,GO:1902600,SLC25A27,proton transmembrane transport,3.0
21868,51629,GO:0005743,SLC25A39,mitochondrial inner membrane,3.0
21869,51629,GO:0006783,SLC25A39,heme biosynthetic process,3.0
21870,51629,GO:0016021,SLC25A39,integral component of membrane,3.0
21871,10999,GO:0000166,SLC27A4,nucleotide binding,3.0
21872,10999,GO:0001579,SLC27A4,medium-chain fatty acid transport,3.0
21873,10999,GO:0001676,SLC27A4,long-chain fatty acid metabolic process,3.0
21874,10999,GO:0004467,SLC27A4,long-chain fatty acid-CoA ligase activity,3.0
21876,10999,GO:0005324,SLC27A4,long-chain fatty acid transporter activity,3.0
21878,10999,GO:0005783,SLC27A4,endoplasmic reticulum,3.0
21880,10999,GO:0005789,SLC27A4,endoplasmic reticulum membrane,3.0
21882,10999,GO:0005886,SLC27A4,plasma membrane,3.0
21884,10999,GO:0005902,SLC27A4,microvillus,3.0
21885,10999,GO:0006631,SLC27A4,fatty acid metabolic process,3.0
21886,10999,GO:0007584,SLC27A4,response to nutrient,3.0
21887,10999,GO:0015908,SLC27A4,fatty acid transport,3.0
21888,10999,GO:0015909,SLC27A4,long-chain fatty acid transport,3.0
21890,10999,GO:0016020,SLC27A4,membrane,3.0
21891,10999,GO:0016021,SLC27A4,integral component of membrane,3.0
21892,10999,GO:0031526,SLC27A4,brush border membrane,3.0
21893,10999,GO:0031957,SLC27A4,very long-chain fatty acid-CoA ligase activity,3.0
21894,10999,GO:0042760,SLC27A4,very long-chain fatty acid catabolic process,3.0
21895,10999,GO:0043065,SLC27A4,positive regulation of apoptotic process,3.0
21896,10999,GO:0043588,SLC27A4,skin development,3.0
21897,10999,GO:0044381,SLC27A4,glucose import in response to insulin stimulus,3.0
21898,10999,GO:0044539,SLC27A4,long-chain fatty acid import into cell,3.0
21901,10999,GO:0046627,SLC27A4,negative regulation of insulin receptor signaling pathway,3.0
21902,10999,GO:0047676,SLC27A4,arachidonate-CoA ligase activity,3.0
21903,10999,GO:0062003,SLC27A4,"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity",3.0
21904,10999,GO:0090433,SLC27A4,palmitoyl-CoA ligase activity,3.0
21905,10999,GO:0090434,SLC27A4,oleoyl-CoA ligase activity,3.0
21907,10999,GO:0090630,SLC27A4,activation of GTPase activity,3.0
21908,10999,GO:0150104,SLC27A4,transport across blood-brain barrier,3.0
21909,10999,GO:1990379,SLC27A4,lipid transport across blood-brain barrier,3.0
21910,222962,GO:0001692,SLC29A4,histamine metabolic process,3.0
21911,222962,GO:0005326,SLC29A4,neurotransmitter transmembrane transporter activity,3.0
21914,222962,GO:0005337,SLC29A4,nucleoside transmembrane transporter activity,3.0
21915,222962,GO:0005342,SLC29A4,organic acid transmembrane transporter activity,3.0
21916,222962,GO:0005886,SLC29A4,plasma membrane,3.0
21919,222962,GO:0006836,SLC29A4,neurotransmitter transport,3.0
21921,222962,GO:0008324,SLC29A4,cation transmembrane transporter activity,3.0
21922,222962,GO:0008504,SLC29A4,monoamine transmembrane transporter activity,3.0
21926,222962,GO:0015101,SLC29A4,organic cation transmembrane transporter activity,3.0
21927,222962,GO:0015562,SLC29A4,efflux transmembrane transporter activity,3.0
21928,222962,GO:0015695,SLC29A4,organic cation transport,3.0
21929,222962,GO:0015844,SLC29A4,monoamine transport,3.0
21930,222962,GO:0016021,SLC29A4,integral component of membrane,3.0
21931,222962,GO:0016323,SLC29A4,basolateral plasma membrane,3.0
21932,222962,GO:0016324,SLC29A4,apical plasma membrane,3.0
21933,222962,GO:0019534,SLC29A4,toxin transmembrane transporter activity,3.0
21934,222962,GO:0042908,SLC29A4,xenobiotic transport,3.0
21937,222962,GO:0042910,SLC29A4,xenobiotic transmembrane transporter activity,3.0
21939,222962,GO:0051610,SLC29A4,serotonin uptake,3.0
21941,222962,GO:0051615,SLC29A4,histamine uptake,3.0
21943,222962,GO:0051620,SLC29A4,norepinephrine uptake,3.0
21945,222962,GO:0051625,SLC29A4,epinephrine uptake,3.0
21946,222962,GO:0090494,SLC29A4,dopamine uptake,3.0
21948,222962,GO:0098655,SLC29A4,cation transmembrane transport,3.0
21949,222962,GO:0098793,SLC29A4,presynapse,3.0
21950,222962,GO:0140115,SLC29A4,export across plasma membrane,3.0
21951,222962,GO:0150104,SLC29A4,transport across blood-brain barrier,3.0
21952,222962,GO:1901642,SLC29A4,nucleoside transmembrane transport,3.0
21953,222962,GO:1901998,SLC29A4,toxin transport,3.0
21954,222962,GO:1903825,SLC29A4,organic acid transmembrane transport,3.0
21976,57282,GO:0005452,SLC4A10,inorganic anion exchanger activity,3.0
21977,57282,GO:0005886,SLC4A10,plasma membrane,3.0
21979,57282,GO:0006821,SLC4A10,chloride transport,3.0
21980,57282,GO:0007601,SLC4A10,visual perception,3.0
21981,57282,GO:0008510,SLC4A10,sodium:bicarbonate symporter activity,3.0
21984,57282,GO:0009416,SLC4A10,response to light stimulus,3.0
21985,57282,GO:0009791,SLC4A10,post-embryonic development,3.0
21986,57282,GO:0015301,SLC4A10,anion:anion antiporter activity,3.0
21987,57282,GO:0015701,SLC4A10,bicarbonate transport,3.0
21990,57282,GO:0016021,SLC4A10,integral component of membrane,3.0
21991,57282,GO:0016323,SLC4A10,basolateral plasma membrane,3.0
21993,57282,GO:0016324,SLC4A10,apical plasma membrane,3.0
21994,57282,GO:0021860,SLC4A10,pyramidal neuron development,3.0
21995,57282,GO:0022857,SLC4A10,transmembrane transporter activity,3.0
21996,57282,GO:0030425,SLC4A10,dendrite,3.0
21997,57282,GO:0035264,SLC4A10,multicellular organism growth,3.0
21998,57282,GO:0035641,SLC4A10,locomotory exploration behavior,3.0
21999,57282,GO:0035725,SLC4A10,sodium ion transmembrane transport,3.0
22000,57282,GO:0036477,SLC4A10,somatodendritic compartment,3.0
22001,57282,GO:0043025,SLC4A10,neuronal cell body,3.0
22002,57282,GO:0043204,SLC4A10,perikaryon,3.0
22003,57282,GO:0043679,SLC4A10,axon terminus,3.0
22004,57282,GO:0045202,SLC4A10,synapse,3.0
22005,57282,GO:0048172,SLC4A10,regulation of short-term neuronal synaptic plasticity,3.0
22006,57282,GO:0048854,SLC4A10,brain morphogenesis,3.0
22007,57282,GO:0050801,SLC4A10,ion homeostasis,3.0
22008,57282,GO:0051453,SLC4A10,regulation of intracellular pH,3.0
22009,57282,GO:0055085,SLC4A10,transmembrane transport,3.0
22010,57282,GO:0097440,SLC4A10,apical dendrite,3.0
22011,57282,GO:0097441,SLC4A10,basal dendrite,3.0
22012,57282,GO:0097442,SLC4A10,CA3 pyramidal cell dendrite,3.0
22013,57282,GO:0098656,SLC4A10,anion transmembrane transport,3.0
22014,57282,GO:0098794,SLC4A10,postsynapse,3.0
22015,57282,GO:1902600,SLC4A10,proton transmembrane transport,3.0
22182,6532,GO:0001666,SLC6A4,response to hypoxia,3.0
22183,6532,GO:0005326,SLC6A4,neurotransmitter transmembrane transporter activity,3.0
22184,6532,GO:0005335,SLC6A4,serotonin:sodium symporter activity,3.0
22187,6532,GO:0005515,SLC6A4,protein binding,3.0
22188,6532,GO:0005886,SLC6A4,plasma membrane,3.0
22191,6532,GO:0005925,SLC6A4,focal adhesion,3.0
22192,6532,GO:0006836,SLC6A4,neurotransmitter transport,3.0
22193,6532,GO:0007584,SLC6A4,response to nutrient,3.0
22194,6532,GO:0007613,SLC6A4,memory,3.0
22195,6532,GO:0007623,SLC6A4,circadian rhythm,3.0
22196,6532,GO:0008504,SLC6A4,monoamine transmembrane transporter activity,3.0
22198,6532,GO:0009636,SLC6A4,response to toxic substance,3.0
22199,6532,GO:0010008,SLC6A4,endosome membrane,3.0
22200,6532,GO:0010628,SLC6A4,positive regulation of gene expression,3.0
22201,6532,GO:0012505,SLC6A4,endomembrane system,3.0
22202,6532,GO:0014064,SLC6A4,positive regulation of serotonin secretion,3.0
22203,6532,GO:0015844,SLC6A4,monoamine transport,3.0
22204,6532,GO:0017075,SLC6A4,syntaxin-1 binding,3.0
22205,6532,GO:0019811,SLC6A4,cocaine binding,3.0
22206,6532,GO:0021941,SLC6A4,negative regulation of cerebellar granule cell precursor proliferation,3.0
22207,6532,GO:0032227,SLC6A4,"negative regulation of synaptic transmission, dopaminergic",3.0
22208,6532,GO:0032355,SLC6A4,response to estradiol,3.0
22209,6532,GO:0035176,SLC6A4,social behavior,3.0
22210,6532,GO:0035725,SLC6A4,sodium ion transmembrane transport,3.0
22211,6532,GO:0042136,SLC6A4,neurotransmitter biosynthetic process,3.0
22212,6532,GO:0042310,SLC6A4,vasoconstriction,3.0
22213,6532,GO:0042493,SLC6A4,response to drug,3.0
22214,6532,GO:0042713,SLC6A4,sperm ejaculation,3.0
22215,6532,GO:0042802,SLC6A4,identical protein binding,3.0
22216,6532,GO:0043005,SLC6A4,neuron projection,3.0
22217,6532,GO:0045121,SLC6A4,membrane raft,3.0
22218,6532,GO:0045202,SLC6A4,synapse,3.0
22219,6532,GO:0045665,SLC6A4,negative regulation of neuron differentiation,3.0
22220,6532,GO:0045787,SLC6A4,positive regulation of cell cycle,3.0
22221,6532,GO:0046621,SLC6A4,negative regulation of organ growth,3.0
22222,6532,GO:0046872,SLC6A4,metal ion binding,3.0
22223,6532,GO:0048854,SLC6A4,brain morphogenesis,3.0
22224,6532,GO:0050998,SLC6A4,nitric-oxide synthase binding,3.0
22225,6532,GO:0051015,SLC6A4,actin filament binding,3.0
22226,6532,GO:0051378,SLC6A4,serotonin binding,3.0
22227,6532,GO:0051610,SLC6A4,serotonin uptake,3.0
22231,6532,GO:0071300,SLC6A4,cellular response to retinoic acid,3.0
22232,6532,GO:0071321,SLC6A4,cellular response to cGMP,3.0
22233,6532,GO:0090067,SLC6A4,regulation of thalamus size,3.0
22234,6532,GO:0099055,SLC6A4,integral component of postsynaptic membrane,3.0
22235,6532,GO:0099056,SLC6A4,integral component of presynaptic membrane,3.0
22236,6532,GO:0099154,SLC6A4,serotonergic synapse,3.0
22237,6535,GO:0003674,SLC6A8,molecular_function,3.0
22238,6535,GO:0005308,SLC6A8,creatine transmembrane transporter activity,3.0
22239,6535,GO:0005309,SLC6A8,creatine:sodium symporter activity,3.0
22240,6535,GO:0005886,SLC6A8,plasma membrane,3.0
22242,6535,GO:0005887,SLC6A8,integral component of plasma membrane,3.0
22243,6535,GO:0006600,SLC6A8,creatine metabolic process,3.0
22244,6535,GO:0006836,SLC6A8,neurotransmitter transport,3.0
22245,6535,GO:0006936,SLC6A8,muscle contraction,3.0
22246,6535,GO:0015881,SLC6A8,creatine transmembrane transport,3.0
22248,6535,GO:0016021,SLC6A8,integral component of membrane,3.0
22249,6535,GO:0035725,SLC6A8,sodium ion transmembrane transport,3.0
22250,6535,GO:0071705,SLC6A8,nitrogen compound transport,3.0
22321,9056,GO:0000821,SLC7A7,regulation of arginine metabolic process,3.0
22322,9056,GO:0003333,SLC7A7,amino acid transmembrane transport,3.0
22323,9056,GO:0005886,SLC7A7,plasma membrane,3.0
22324,9056,GO:0005887,SLC7A7,integral component of plasma membrane,3.0
22325,9056,GO:0006865,SLC7A7,amino acid transport,3.0
22326,9056,GO:0015174,SLC7A7,basic amino acid transmembrane transporter activity,3.0
22327,9056,GO:0015179,SLC7A7,L-amino acid transmembrane transporter activity,3.0
22328,9056,GO:0016323,SLC7A7,basolateral plasma membrane,3.0
22329,9056,GO:0050900,SLC7A7,leukocyte migration,3.0
22330,9056,GO:1902475,SLC7A7,L-alpha-amino acid transmembrane transport,3.0
22331,9056,GO:1990822,SLC7A7,basic amino acid transmembrane transport,3.0
22362,285195,GO:0005515,SLC9A9,protein binding,3.0
22363,285195,GO:0005886,SLC9A9,plasma membrane,3.0
22364,285195,GO:0006811,SLC9A9,ion transport,3.0
22365,285195,GO:0015385,SLC9A9,sodium:proton antiporter activity,3.0
22367,285195,GO:0015386,SLC9A9,potassium:proton antiporter activity,3.0
22368,285195,GO:0016021,SLC9A9,integral component of membrane,3.0
22369,285195,GO:0031902,SLC9A9,late endosome membrane,3.0
22370,285195,GO:0051453,SLC9A9,regulation of intracellular pH,3.0
22371,285195,GO:0055037,SLC9A9,recycling endosome,3.0
22373,285195,GO:0071805,SLC9A9,potassium ion transmembrane transport,3.0
22374,285195,GO:0098656,SLC9A9,anion transmembrane transport,3.0
22375,285195,GO:0098719,SLC9A9,sodium ion import across plasma membrane,3.0
22376,285195,GO:1902600,SLC9A9,proton transmembrane transport,3.0
22377,28234,GO:0005886,SLCO1B3,plasma membrane,3.0
22379,28234,GO:0005887,SLCO1B3,integral component of plasma membrane,3.0
22380,28234,GO:0008514,SLCO1B3,organic anion transmembrane transporter activity,3.0
22381,28234,GO:0015125,SLCO1B3,bile acid transmembrane transporter activity,3.0
22383,28234,GO:0015347,SLCO1B3,sodium-independent organic anion transmembrane transporter activity,3.0
22384,28234,GO:0015711,SLCO1B3,organic anion transport,3.0
22385,28234,GO:0015721,SLCO1B3,bile acid and bile salt transport,3.0
22387,28234,GO:0016323,SLCO1B3,basolateral plasma membrane,3.0
22388,28234,GO:0043252,SLCO1B3,sodium-independent organic anion transport,3.0
22390,28234,GO:0055085,SLCO1B3,transmembrane transport,3.0
22679,9126,GO:0000278,SMC3,mitotic cell cycle,3.0
22680,9126,GO:0000775,SMC3,"chromosome, centromeric region",3.0
22681,9126,GO:0000785,SMC3,chromatin,3.0
22682,9126,GO:0000800,SMC3,lateral element,3.0
22683,9126,GO:0003682,SMC3,chromatin binding,3.0
22684,9126,GO:0003777,SMC3,microtubule motor activity,3.0
22685,9126,GO:0005515,SMC3,protein binding,3.0
22686,9126,GO:0005524,SMC3,ATP binding,3.0
22687,9126,GO:0005654,SMC3,nucleoplasm,3.0
22689,9126,GO:0005694,SMC3,chromosome,3.0
22690,9126,GO:0005829,SMC3,cytosol,3.0
22691,9126,GO:0006275,SMC3,regulation of DNA replication,3.0
22692,9126,GO:0006281,SMC3,DNA repair,3.0
22693,9126,GO:0007062,SMC3,sister chromatid cohesion,3.0
22695,9126,GO:0008278,SMC3,cohesin complex,3.0
22697,9126,GO:0016363,SMC3,nuclear matrix,3.0
22698,9126,GO:0019827,SMC3,stem cell population maintenance,3.0
22699,9126,GO:0030893,SMC3,meiotic cohesin complex,3.0
22700,9126,GO:0034991,SMC3,nuclear meiotic cohesin complex,3.0
22701,9126,GO:0036033,SMC3,mediator complex binding,3.0
22702,9126,GO:0046982,SMC3,protein heterodimerization activity,3.0
22703,9126,GO:0048487,SMC3,beta-tubulin binding,3.0
22704,9126,GO:0051301,SMC3,cell division,3.0
22705,9126,GO:0051321,SMC3,meiotic cell cycle,3.0
22706,9126,GO:0070840,SMC3,dynein complex binding,3.0
22707,9126,GO:0090307,SMC3,mitotic spindle assembly,3.0
22708,9126,GO:0097431,SMC3,mitotic spindle pole,3.0
22709,23293,GO:0000184,SMG6,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.0
22712,23293,GO:0000781,SMG6,"chromosome, telomeric region",3.0
22713,23293,GO:0003723,SMG6,RNA binding,3.0
22714,23293,GO:0004521,SMG6,endoribonuclease activity,3.0
22717,23293,GO:0005515,SMG6,protein binding,3.0
22718,23293,GO:0005634,SMG6,nucleus,3.0
22719,23293,GO:0005697,SMG6,telomerase holoenzyme complex,3.0
22721,23293,GO:0005730,SMG6,nucleolus,3.0
22722,23293,GO:0005737,SMG6,cytoplasm,3.0
22723,23293,GO:0005829,SMG6,cytosol,3.0
22725,23293,GO:0006406,SMG6,mRNA export from nucleus,3.0
22726,23293,GO:0032204,SMG6,regulation of telomere maintenance,3.0
22727,23293,GO:0032210,SMG6,regulation of telomere maintenance via telomerase,3.0
22729,23293,GO:0035145,SMG6,exon-exon junction complex,3.0
22730,23293,GO:0035303,SMG6,regulation of dephosphorylation,3.0
22731,23293,GO:0042162,SMG6,telomeric DNA binding,3.0
22733,23293,GO:0043021,SMG6,ribonucleoprotein complex binding,3.0
22734,23293,GO:0046872,SMG6,metal ion binding,3.0
22735,23293,GO:0051972,SMG6,regulation of telomerase activity,3.0
22736,23293,GO:0070034,SMG6,telomerase RNA binding,3.0
22738,23293,GO:0070182,SMG6,DNA polymerase binding,3.0
22739,23293,GO:0090502,SMG6,"RNA phosphodiester bond hydrolysis, endonucleolytic",3.0
22740,23293,GO:1904354,SMG6,negative regulation of telomere capping,3.0
22741,57154,GO:0000209,SMURF1,protein polyubiquitination,3.0
22743,57154,GO:0004842,SMURF1,ubiquitin-protein transferase activity,3.0
22744,57154,GO:0005515,SMURF1,protein binding,3.0
22745,57154,GO:0005543,SMURF1,phospholipid binding,3.0
22746,57154,GO:0005654,SMURF1,nucleoplasm,3.0
22747,57154,GO:0005737,SMURF1,cytoplasm,3.0
22749,57154,GO:0005739,SMURF1,mitochondrion,3.0
22750,57154,GO:0005829,SMURF1,cytosol,3.0
22751,57154,GO:0005886,SMURF1,plasma membrane,3.0
22752,57154,GO:0006511,SMURF1,ubiquitin-dependent protein catabolic process,3.0
22753,57154,GO:0006611,SMURF1,protein export from nucleus,3.0
22754,57154,GO:0007179,SMURF1,transforming growth factor beta receptor signaling pathway,3.0
22755,57154,GO:0007398,SMURF1,ectoderm development,3.0
22756,57154,GO:0016567,SMURF1,protein ubiquitination,3.0
22758,57154,GO:0030154,SMURF1,cell differentiation,3.0
22759,57154,GO:0030279,SMURF1,negative regulation of ossification,3.0
22760,57154,GO:0030509,SMURF1,BMP signaling pathway,3.0
22762,57154,GO:0030512,SMURF1,negative regulation of transforming growth factor beta receptor signaling pathway,3.0
22763,57154,GO:0030514,SMURF1,negative regulation of BMP signaling pathway,3.0
22766,57154,GO:0030579,SMURF1,ubiquitin-dependent SMAD protein catabolic process,3.0
22768,57154,GO:0032801,SMURF1,receptor catabolic process,3.0
22769,57154,GO:0034394,SMURF1,protein localization to cell surface,3.0
22770,57154,GO:0043161,SMURF1,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
22772,57154,GO:0045732,SMURF1,positive regulation of protein catabolic process,3.0
22773,57154,GO:0048185,SMURF1,activin binding,3.0
22774,57154,GO:0060071,SMURF1,"Wnt signaling pathway, planar cell polarity pathway",3.0
22775,57154,GO:0061630,SMURF1,ubiquitin protein ligase activity,3.0
22778,57154,GO:0061734,SMURF1,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,3.0
22779,57154,GO:0061736,SMURF1,engulfment of target by autophagosome,3.0
22780,57154,GO:0061753,SMURF1,substrate localization to autophagosome,3.0
22781,57154,GO:0070062,SMURF1,extracellular exosome,3.0
22782,57154,GO:0070411,SMURF1,I-SMAD binding,3.0
22783,57154,GO:0070412,SMURF1,R-SMAD binding,3.0
22784,57154,GO:0071211,SMURF1,protein targeting to vacuole involved in autophagy,3.0
22785,57154,GO:0072659,SMURF1,protein localization to plasma membrane,3.0
22786,57154,GO:1903861,SMURF1,positive regulation of dendrite extension,3.0
22787,57154,GO:2000060,SMURF1,positive regulation of ubiquitin-dependent protein catabolic process,3.0
22788,6616,GO:0001504,SNAP25,neurotransmitter uptake,3.0
22789,6616,GO:0001917,SNAP25,photoreceptor inner segment,3.0
22790,6616,GO:0005249,SNAP25,voltage-gated potassium channel activity,3.0
22791,6616,GO:0005484,SNAP25,SNAP receptor activity,3.0
22792,6616,GO:0005515,SNAP25,protein binding,3.0
22793,6616,GO:0005737,SNAP25,cytoplasm,3.0
22795,6616,GO:0005802,SNAP25,trans-Golgi network,3.0
22796,6616,GO:0005829,SNAP25,cytosol,3.0
22797,6616,GO:0005856,SNAP25,cytoskeleton,3.0
22798,6616,GO:0005886,SNAP25,plasma membrane,3.0
22800,6616,GO:0006887,SNAP25,exocytosis,3.0
22801,6616,GO:0006906,SNAP25,vesicle fusion,3.0
22802,6616,GO:0007268,SNAP25,chemical synaptic transmission,3.0
22803,6616,GO:0007269,SNAP25,neurotransmitter secretion,3.0
22804,6616,GO:0007626,SNAP25,locomotory behavior,3.0
22805,6616,GO:0008021,SNAP25,synaptic vesicle,3.0
22806,6616,GO:0008076,SNAP25,voltage-gated potassium channel complex,3.0
22807,6616,GO:0008306,SNAP25,associative learning,3.0
22808,6616,GO:0010975,SNAP25,regulation of neuron projection development,3.0
22809,6616,GO:0014047,SNAP25,glutamate secretion,3.0
22810,6616,GO:0016020,SNAP25,membrane,3.0
22811,6616,GO:0016079,SNAP25,synaptic vesicle exocytosis,3.0
22812,6616,GO:0016081,SNAP25,synaptic vesicle docking,3.0
22813,6616,GO:0016082,SNAP25,synaptic vesicle priming,3.0
22814,6616,GO:0017075,SNAP25,syntaxin-1 binding,3.0
22816,6616,GO:0019905,SNAP25,syntaxin binding,3.0
22817,6616,GO:0030426,SNAP25,growth cone,3.0
22818,6616,GO:0031083,SNAP25,BLOC-1 complex,3.0
22819,6616,GO:0031201,SNAP25,SNARE complex,3.0
22823,6616,GO:0031234,SNAP25,extrinsic component of cytoplasmic side of plasma membrane,3.0
22824,6616,GO:0031629,SNAP25,synaptic vesicle fusion to presynaptic active zone membrane,3.0
22825,6616,GO:0031982,SNAP25,vesicle,3.0
22826,6616,GO:0035579,SNAP25,specific granule membrane,3.0
22827,6616,GO:0036477,SNAP25,somatodendritic compartment,3.0
22828,6616,GO:0042734,SNAP25,presynaptic membrane,3.0
22829,6616,GO:0043005,SNAP25,neuron projection,3.0
22830,6616,GO:0043312,SNAP25,neutrophil degranulation,3.0
22831,6616,GO:0048306,SNAP25,calcium-dependent protein binding,3.0
22832,6616,GO:0048471,SNAP25,perinuclear region of cytoplasm,3.0
22833,6616,GO:0050796,SNAP25,regulation of insulin secretion,3.0
22834,6616,GO:0060291,SNAP25,long-term synaptic potentiation,3.0
22835,6616,GO:0070032,SNAP25,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,3.0
22836,6616,GO:0070821,SNAP25,tertiary granule membrane,3.0
22837,6616,GO:0071805,SNAP25,potassium ion transmembrane transport,3.0
22838,6616,GO:0098794,SNAP25,postsynapse,3.0
22839,6616,GO:0098967,SNAP25,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,3.0
22840,6616,GO:0098978,SNAP25,glutamatergic synapse,3.0
22841,6616,GO:0099590,SNAP25,neurotransmitter receptor internalization,3.0
22842,27044,GO:0001649,SND1,osteoblast differentiation,3.0
22843,27044,GO:0003712,SND1,transcription coregulator activity,3.0
22844,27044,GO:0003723,SND1,RNA binding,3.0
22847,27044,GO:0004518,SND1,nuclease activity,3.0
22848,27044,GO:0004519,SND1,endonuclease activity,3.0
22849,27044,GO:0004521,SND1,endoribonuclease activity,3.0
22850,27044,GO:0005515,SND1,protein binding,3.0
22851,27044,GO:0005634,SND1,nucleus,3.0
22852,27044,GO:0005737,SND1,cytoplasm,3.0
22853,27044,GO:0005829,SND1,cytosol,3.0
22855,27044,GO:0006401,SND1,RNA catabolic process,3.0
22856,27044,GO:0010564,SND1,regulation of cell cycle process,3.0
22857,27044,GO:0010587,SND1,miRNA catabolic process,3.0
22858,27044,GO:0016020,SND1,membrane,3.0
22859,27044,GO:0016032,SND1,viral process,3.0
22860,27044,GO:0016442,SND1,RISC complex,3.0
22861,27044,GO:0031047,SND1,gene silencing by RNA,3.0
22862,27044,GO:0042470,SND1,melanosome,3.0
22863,27044,GO:0045296,SND1,cadherin binding,3.0
22864,27044,GO:0070062,SND1,extracellular exosome,3.0
22865,27044,GO:0090502,SND1,"RNA phosphodiester bond hydrolysis, endonucleolytic",3.0
22866,27044,GO:0097433,SND1,dense body,3.0
22867,27044,GO:1903506,SND1,regulation of nucleic acid-templated transcription,3.0
22868,27044,GO:1905172,SND1,RISC complex binding,3.0
22869,54221,GO:0003779,SNTG2,actin binding,3.0
22870,54221,GO:0005198,SNTG2,structural molecule activity,3.0
22871,54221,GO:0005515,SNTG2,protein binding,3.0
22872,54221,GO:0005622,SNTG2,intracellular anatomical structure,3.0
22873,54221,GO:0005737,SNTG2,cytoplasm,3.0
22874,54221,GO:0005856,SNTG2,cytoskeleton,3.0
22875,54221,GO:0007417,SNTG2,central nervous system development,3.0
22876,54221,GO:0016010,SNTG2,dystrophin-associated glycoprotein complex,3.0
22877,54221,GO:0016013,SNTG2,syntrophin complex,3.0
22878,54221,GO:0030165,SNTG2,PDZ domain binding,3.0
22879,54221,GO:0042383,SNTG2,sarcolemma,3.0
22880,54221,GO:0097109,SNTG2,neuroligin family protein binding,3.0
23048,6694,GO:0001501,SPP2,skeletal system development,3.0
23049,6694,GO:0002576,SPP2,platelet degranulation,3.0
23050,6694,GO:0004866,SPP2,endopeptidase inhibitor activity,3.0
23051,6694,GO:0005576,SPP2,extracellular region,3.0
23052,6694,GO:0005788,SPP2,endoplasmic reticulum lumen,3.0
23053,6694,GO:0010951,SPP2,negative regulation of endopeptidase activity,3.0
23054,6694,GO:0031089,SPP2,platelet dense granule lumen,3.0
23055,6694,GO:0043687,SPP2,post-translational protein modification,3.0
23056,6694,GO:0044267,SPP2,cellular protein metabolic process,3.0
23057,6694,GO:0046849,SPP2,bone remodeling,3.0
23058,6694,GO:0062023,SPP2,collagen-containing extracellular matrix,3.0
23081,9901,GO:0005096,SRGAP3,GTPase activator activity,3.0
23082,9901,GO:0005515,SRGAP3,protein binding,3.0
23083,9901,GO:0005737,SRGAP3,cytoplasm,3.0
23084,9901,GO:0005829,SRGAP3,cytosol,3.0
23085,9901,GO:0007165,SRGAP3,signal transduction,3.0
23086,9901,GO:0030336,SRGAP3,negative regulation of cell migration,3.0
23087,9901,GO:0031267,SRGAP3,small GTPase binding,3.0
23088,9901,GO:0043547,SRGAP3,positive regulation of GTPase activity,3.0
23089,9901,GO:0051056,SRGAP3,regulation of small GTPase mediated signal transduction,3.0
23103,6749,GO:0003677,SSRP1,DNA binding,3.0
23104,6749,GO:0003723,SSRP1,RNA binding,3.0
23105,6749,GO:0005515,SSRP1,protein binding,3.0
23106,6749,GO:0005654,SSRP1,nucleoplasm,3.0
23107,6749,GO:0005730,SSRP1,nucleolus,3.0
23108,6749,GO:0006260,SSRP1,DNA replication,3.0
23109,6749,GO:0006281,SSRP1,DNA repair,3.0
23110,6749,GO:0006366,SSRP1,transcription by RNA polymerase II,3.0
23111,6749,GO:0006368,SSRP1,transcription elongation from RNA polymerase II promoter,3.0
23112,6749,GO:0016032,SSRP1,viral process,3.0
23113,6749,GO:0031491,SSRP1,nucleosome binding,3.0
23114,6749,GO:0035101,SSRP1,FACT complex,3.0
23115,6749,GO:0042393,SSRP1,histone binding,3.0
23116,6749,GO:1901796,SSRP1,regulation of signal transduction by p53 class mediator,3.0
23117,6749,GO:1902275,SSRP1,regulation of chromatin organization,3.0
23119,7982,GO:0016021,ST7,integral component of membrane,3.0
23120,7982,GO:0030198,ST7,extracellular matrix organization,3.0
23121,7982,GO:0045595,ST7,regulation of cell differentiation,3.0
23159,6804,GO:0000149,STX1A,SNARE binding,3.0
23160,6804,GO:0001956,STX1A,positive regulation of neurotransmitter secretion,3.0
23161,6804,GO:0005484,STX1A,SNAP receptor activity,3.0
23162,6804,GO:0005515,STX1A,protein binding,3.0
23163,6804,GO:0005576,STX1A,extracellular region,3.0
23164,6804,GO:0005829,STX1A,cytosol,3.0
23165,6804,GO:0005886,STX1A,plasma membrane,3.0
23168,6804,GO:0006886,STX1A,intracellular protein transport,3.0
23169,6804,GO:0006887,STX1A,exocytosis,3.0
23170,6804,GO:0006906,STX1A,vesicle fusion,3.0
23171,6804,GO:0007269,STX1A,neurotransmitter secretion,3.0
23172,6804,GO:0008021,STX1A,synaptic vesicle,3.0
23173,6804,GO:0008076,STX1A,voltage-gated potassium channel complex,3.0
23174,6804,GO:0009629,STX1A,response to gravity,3.0
23175,6804,GO:0010701,STX1A,positive regulation of norepinephrine secretion,3.0
23176,6804,GO:0010807,STX1A,regulation of synaptic vesicle priming,3.0
23177,6804,GO:0012505,STX1A,endomembrane system,3.0
23178,6804,GO:0014047,STX1A,glutamate secretion,3.0
23179,6804,GO:0014069,STX1A,postsynaptic density,3.0
23180,6804,GO:0016021,STX1A,integral component of membrane,3.0
23181,6804,GO:0016079,STX1A,synaptic vesicle exocytosis,3.0
23182,6804,GO:0016081,STX1A,synaptic vesicle docking,3.0
23183,6804,GO:0016925,STX1A,protein sumoylation,3.0
23184,6804,GO:0017156,STX1A,calcium-ion regulated exocytosis,3.0
23185,6804,GO:0019221,STX1A,cytokine-mediated signaling pathway,3.0
23186,6804,GO:0019855,STX1A,calcium channel inhibitor activity,3.0
23187,6804,GO:0019869,STX1A,chloride channel inhibitor activity,3.0
23188,6804,GO:0019900,STX1A,kinase binding,3.0
23189,6804,GO:0019904,STX1A,protein domain specific binding,3.0
23190,6804,GO:0030073,STX1A,insulin secretion,3.0
23191,6804,GO:0030141,STX1A,secretory granule,3.0
23192,6804,GO:0030285,STX1A,integral component of synaptic vesicle membrane,3.0
23193,6804,GO:0030424,STX1A,axon,3.0
23194,6804,GO:0031201,STX1A,SNARE complex,3.0
23197,6804,GO:0031629,STX1A,synaptic vesicle fusion to presynaptic active zone membrane,3.0
23198,6804,GO:0031965,STX1A,nuclear membrane,3.0
23199,6804,GO:0032028,STX1A,myosin head/neck binding,3.0
23200,6804,GO:0032940,STX1A,secretion by cell,3.0
23201,6804,GO:0033605,STX1A,positive regulation of catecholamine secretion,3.0
23202,6804,GO:0035493,STX1A,SNARE complex assembly,3.0
23203,6804,GO:0042641,STX1A,actomyosin,3.0
23204,6804,GO:0042802,STX1A,identical protein binding,3.0
23205,6804,GO:0043005,STX1A,neuron projection,3.0
23206,6804,GO:0043008,STX1A,ATP-dependent protein binding,3.0
23207,6804,GO:0044325,STX1A,ion channel binding,3.0
23208,6804,GO:0044877,STX1A,protein-containing complex binding,3.0
23209,6804,GO:0045956,STX1A,positive regulation of calcium ion-dependent exocytosis,3.0
23210,6804,GO:0047485,STX1A,protein N-terminus binding,3.0
23211,6804,GO:0048278,STX1A,vesicle docking,3.0
23212,6804,GO:0048306,STX1A,calcium-dependent protein binding,3.0
23213,6804,GO:0048488,STX1A,synaptic vesicle endocytosis,3.0
23214,6804,GO:0048787,STX1A,presynaptic active zone membrane,3.0
23215,6804,GO:0050796,STX1A,regulation of insulin secretion,3.0
23216,6804,GO:0070032,STX1A,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,3.0
23217,6804,GO:0070033,STX1A,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,3.0
23218,6804,GO:0070044,STX1A,synaptobrevin 2-SNAP-25-syntaxin-1a complex,3.0
23219,6804,GO:0072657,STX1A,protein localization to membrane,3.0
23220,6804,GO:0098978,STX1A,glutamatergic synapse,3.0
23221,6804,GO:0099056,STX1A,integral component of presynaptic membrane,3.0
23222,6804,GO:2000463,STX1A,positive regulation of excitatory postsynaptic potential,3.0
23356,55359,GO:0004715,STYK1,non-membrane spanning protein tyrosine kinase activity,3.0
23357,55359,GO:0005102,STYK1,signaling receptor binding,3.0
23358,55359,GO:0005515,STYK1,protein binding,3.0
23359,55359,GO:0005524,STYK1,ATP binding,3.0
23360,55359,GO:0005886,STYK1,plasma membrane,3.0
23361,55359,GO:0007169,STYK1,transmembrane receptor protein tyrosine kinase signaling pathway,3.0
23362,55359,GO:0016021,STYK1,integral component of membrane,3.0
23363,55359,GO:0030154,STYK1,cell differentiation,3.0
23364,55359,GO:0031234,STYK1,extrinsic component of cytoplasmic side of plasma membrane,3.0
23365,55359,GO:0038083,STYK1,peptidyl-tyrosine autophosphorylation,3.0
23366,55359,GO:0042127,STYK1,regulation of cell population proliferation,3.0
23367,55359,GO:0045087,STYK1,innate immune response,3.0
23368,94056,GO:0005515,SYAP1,protein binding,3.0
23369,94056,GO:0005654,SYAP1,nucleoplasm,3.0
23370,94056,GO:0005794,SYAP1,Golgi apparatus,3.0
23371,94056,GO:0005829,SYAP1,cytosol,3.0
23372,94056,GO:0030154,SYAP1,cell differentiation,3.0
23373,94056,GO:0030424,SYAP1,axon,3.0
23374,94056,GO:0030425,SYAP1,dendrite,3.0
23375,94056,GO:0030426,SYAP1,growth cone,3.0
23376,94056,GO:0031234,SYAP1,extrinsic component of cytoplasmic side of plasma membrane,3.0
23377,94056,GO:0032869,SYAP1,cellular response to insulin stimulus,3.0
23378,94056,GO:0036120,SYAP1,cellular response to platelet-derived growth factor stimulus,3.0
23379,94056,GO:0038203,SYAP1,TORC2 signaling,3.0
23380,94056,GO:0042734,SYAP1,presynaptic membrane,3.0
23381,94056,GO:0043204,SYAP1,perikaryon,3.0
23382,94056,GO:0045211,SYAP1,postsynaptic membrane,3.0
23383,94056,GO:0045600,SYAP1,positive regulation of fat cell differentiation,3.0
23384,94056,GO:0048471,SYAP1,perinuclear region of cytoplasm,3.0
23385,94056,GO:0070062,SYAP1,extracellular exosome,3.0
23386,94056,GO:0071364,SYAP1,cellular response to epidermal growth factor stimulus,3.0
23387,94056,GO:0071902,SYAP1,positive regulation of protein serine/threonine kinase activity,3.0
23388,94056,GO:1990314,SYAP1,cellular response to insulin-like growth factor stimulus,3.0
23389,6853,GO:0000795,SYN1,synaptonemal complex,3.0
23390,6853,GO:0003779,SYN1,actin binding,3.0
23391,6853,GO:0005215,SYN1,transporter activity,3.0
23392,6853,GO:0005515,SYN1,protein binding,3.0
23393,6853,GO:0005524,SYN1,ATP binding,3.0
23394,6853,GO:0005794,SYN1,Golgi apparatus,3.0
23395,6853,GO:0005829,SYN1,cytosol,3.0
23396,6853,GO:0005856,SYN1,cytoskeleton,3.0
23397,6853,GO:0007268,SYN1,chemical synaptic transmission,3.0
23398,6853,GO:0007269,SYN1,neurotransmitter secretion,3.0
23399,6853,GO:0008021,SYN1,synaptic vesicle,3.0
23400,6853,GO:0014069,SYN1,postsynaptic density,3.0
23401,6853,GO:0019901,SYN1,protein kinase binding,3.0
23402,6853,GO:0030424,SYN1,axon,3.0
23403,6853,GO:0030425,SYN1,dendrite,3.0
23404,6853,GO:0030672,SYN1,synaptic vesicle membrane,3.0
23405,6853,GO:0042802,SYN1,identical protein binding,3.0
23406,6853,GO:0046928,SYN1,regulation of neurotransmitter secretion,3.0
23407,6853,GO:0048306,SYN1,calcium-dependent protein binding,3.0
23408,6853,GO:0048666,SYN1,neuron development,3.0
23409,6853,GO:0048786,SYN1,presynaptic active zone,3.0
23410,6853,GO:0050808,SYN1,synapse organization,3.0
23411,6853,GO:0097091,SYN1,synaptic vesicle clustering,3.0
23412,6853,GO:0098685,SYN1,Schaffer collateral - CA1 synapse,3.0
23413,6853,GO:0098850,SYN1,extrinsic component of synaptic vesicle membrane,3.0
23414,6853,GO:0098993,SYN1,anchored component of synaptic vesicle membrane,3.0
23415,6853,GO:2000300,SYN1,regulation of synaptic vesicle exocytosis,3.0
23416,6854,GO:0005524,SYN2,ATP binding,3.0
23417,6854,GO:0005886,SYN2,plasma membrane,3.0
23418,6854,GO:0007268,SYN2,chemical synaptic transmission,3.0
23419,6854,GO:0007269,SYN2,neurotransmitter secretion,3.0
23421,6854,GO:0014069,SYN2,postsynaptic density,3.0
23422,6854,GO:0017156,SYN2,calcium-ion regulated exocytosis,3.0
23423,6854,GO:0030672,SYN2,synaptic vesicle membrane,3.0
23425,6854,GO:0031201,SYN2,SNARE complex,3.0
23426,6854,GO:0042802,SYN2,identical protein binding,3.0
23427,6854,GO:0045202,SYN2,synapse,3.0
23428,6854,GO:0097091,SYN2,synaptic vesicle clustering,3.0
23429,6854,GO:0098978,SYN2,glutamatergic synapse,3.0
23430,10492,GO:0000398,SYNCRIP,"mRNA splicing, via spliceosome",3.0
23431,10492,GO:0001649,SYNCRIP,osteoblast differentiation,3.0
23432,10492,GO:0003723,SYNCRIP,RNA binding,3.0
23434,10492,GO:0003729,SYNCRIP,mRNA binding,3.0
23435,10492,GO:0005515,SYNCRIP,protein binding,3.0
23436,10492,GO:0005634,SYNCRIP,nucleus,3.0
23437,10492,GO:0005654,SYNCRIP,nucleoplasm,3.0
23438,10492,GO:0005783,SYNCRIP,endoplasmic reticulum,3.0
23439,10492,GO:0006396,SYNCRIP,RNA processing,3.0
23440,10492,GO:0008143,SYNCRIP,poly(A) binding,3.0
23441,10492,GO:0008380,SYNCRIP,RNA splicing,3.0
23442,10492,GO:0016020,SYNCRIP,membrane,3.0
23443,10492,GO:0016032,SYNCRIP,viral process,3.0
23444,10492,GO:0017148,SYNCRIP,negative regulation of translation,3.0
23446,10492,GO:0048027,SYNCRIP,mRNA 5'-UTR binding,3.0
23447,10492,GO:0070934,SYNCRIP,CRD-mediated mRNA stabilization,3.0
23449,10492,GO:0070937,SYNCRIP,CRD-mediated mRNA stability complex,3.0
23451,10492,GO:0071013,SYNCRIP,catalytic step 2 spliceosome,3.0
23452,10492,GO:0071204,SYNCRIP,histone pre-mRNA 3'end processing complex,3.0
23453,10492,GO:0071346,SYNCRIP,cellular response to interferon-gamma,3.0
23454,10492,GO:0097452,SYNCRIP,GAIT complex,3.0
23455,10492,GO:1990904,SYNCRIP,ribonucleoprotein complex,3.0
23457,23345,GO:0000932,SYNE1,P-body,3.0
23458,23345,GO:0003723,SYNE1,RNA binding,3.0
23459,23345,GO:0003779,SYNE1,actin binding,3.0
23460,23345,GO:0005515,SYNE1,protein binding,3.0
23461,23345,GO:0005521,SYNE1,lamin binding,3.0
23462,23345,GO:0005634,SYNE1,nucleus,3.0
23463,23345,GO:0005635,SYNE1,nuclear envelope,3.0
23464,23345,GO:0005640,SYNE1,nuclear outer membrane,3.0
23465,23345,GO:0005654,SYNE1,nucleoplasm,3.0
23466,23345,GO:0005730,SYNE1,nucleolus,3.0
23467,23345,GO:0005737,SYNE1,cytoplasm,3.0
23468,23345,GO:0005794,SYNE1,Golgi apparatus,3.0
23469,23345,GO:0005856,SYNE1,cytoskeleton,3.0
23470,23345,GO:0006997,SYNE1,nucleus organization,3.0
23471,23345,GO:0007010,SYNE1,cytoskeleton organization,3.0
23472,23345,GO:0007030,SYNE1,Golgi organization,3.0
23473,23345,GO:0007283,SYNE1,spermatogenesis,3.0
23474,23345,GO:0016021,SYNE1,integral component of membrane,3.0
23475,23345,GO:0019899,SYNE1,enzyme binding,3.0
23476,23345,GO:0030017,SYNE1,sarcomere,3.0
23477,23345,GO:0031965,SYNE1,nuclear membrane,3.0
23478,23345,GO:0034993,SYNE1,meiotic nuclear membrane microtubule tethering complex,3.0
23479,23345,GO:0042692,SYNE1,muscle cell differentiation,3.0
23480,23345,GO:0042803,SYNE1,protein homodimerization activity,3.0
23481,23345,GO:0045211,SYNE1,postsynaptic membrane,3.0
23482,23345,GO:0051015,SYNE1,actin filament binding,3.0
23483,23345,GO:0090292,SYNE1,nuclear matrix anchoring at nuclear membrane,3.0
23484,23345,GO:0140444,SYNE1,cytoskeleton-nuclear membrane anchor activity,3.0
23521,8867,GO:0003723,SYNJ1,RNA binding,3.0
23522,8867,GO:0004438,SYNJ1,phosphatidylinositol-3-phosphatase activity,3.0
23523,8867,GO:0004439,SYNJ1,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",3.0
23528,8867,GO:0005829,SYNJ1,cytosol,3.0
23529,8867,GO:0005874,SYNJ1,microtubule,3.0
23530,8867,GO:0006661,SYNJ1,phosphatidylinositol biosynthetic process,3.0
23531,8867,GO:0006836,SYNJ1,neurotransmitter transport,3.0
23532,8867,GO:0007420,SYNJ1,brain development,3.0
23533,8867,GO:0007612,SYNJ1,learning,3.0
23534,8867,GO:0012506,SYNJ1,vesicle membrane,3.0
23535,8867,GO:0016082,SYNJ1,synaptic vesicle priming,3.0
23536,8867,GO:0016191,SYNJ1,synaptic vesicle uncoating,3.0
23537,8867,GO:0017124,SYNJ1,SH3 domain binding,3.0
23538,8867,GO:0030117,SYNJ1,membrane coat,3.0
23539,8867,GO:0030132,SYNJ1,clathrin coat of coated pit,3.0
23540,8867,GO:0034595,SYNJ1,phosphatidylinositol phosphate 5-phosphatase activity,3.0
23541,8867,GO:0043195,SYNJ1,terminal bouton,3.0
23542,8867,GO:0043647,SYNJ1,inositol phosphate metabolic process,3.0
23543,8867,GO:0043812,SYNJ1,phosphatidylinositol-4-phosphate phosphatase activity,3.0
23544,8867,GO:0046488,SYNJ1,phosphatidylinositol metabolic process,3.0
23545,8867,GO:0046855,SYNJ1,inositol phosphate dephosphorylation,3.0
23547,8867,GO:0046856,SYNJ1,phosphatidylinositol dephosphorylation,3.0
23551,8867,GO:0048471,SYNJ1,perinuclear region of cytoplasm,3.0
23553,8867,GO:0048488,SYNJ1,synaptic vesicle endocytosis,3.0
23556,8867,GO:0048489,SYNJ1,synaptic vesicle transport,3.0
23557,8867,GO:0061024,SYNJ1,membrane organization,3.0
23558,8867,GO:0097060,SYNJ1,synaptic membrane,3.0
23559,8867,GO:0098793,SYNJ1,presynapse,3.0
23561,8867,GO:1904980,SYNJ1,positive regulation of endosome organization,3.0
23706,9013,GO:0001164,TAF1C,RNA polymerase I core promoter sequence-specific DNA binding,3.0
23708,9013,GO:0001181,TAF1C,RNA polymerase I general transcription initiation factor activity,3.0
23709,9013,GO:0001188,TAF1C,RNA polymerase I preinitiation complex assembly,3.0
23710,9013,GO:0001650,TAF1C,fibrillar center,3.0
23712,9013,GO:0005515,TAF1C,protein binding,3.0
23713,9013,GO:0005654,TAF1C,nucleoplasm,3.0
23715,9013,GO:0005730,TAF1C,nucleolus,3.0
23716,9013,GO:0006360,TAF1C,transcription by RNA polymerase I,3.0
23717,9013,GO:0006361,TAF1C,transcription initiation from RNA polymerase I promoter,3.0
23719,9013,GO:0006362,TAF1C,transcription elongation from RNA polymerase I promoter,3.0
23720,9013,GO:0006363,TAF1C,termination of RNA polymerase I transcription,3.0
23721,9013,GO:0006366,TAF1C,transcription by RNA polymerase II,3.0
23722,9013,GO:0045815,TAF1C,"positive regulation of gene expression, epigenetic",3.0
23880,9779,GO:0002092,TBC1D5,positive regulation of receptor internalization,3.0
23881,9779,GO:0005096,TBC1D5,GTPase activator activity,3.0
23882,9779,GO:0005515,TBC1D5,protein binding,3.0
23883,9779,GO:0005776,TBC1D5,autophagosome,3.0
23884,9779,GO:0005794,TBC1D5,Golgi apparatus,3.0
23885,9779,GO:0005829,TBC1D5,cytosol,3.0
23886,9779,GO:0006886,TBC1D5,intracellular protein transport,3.0
23887,9779,GO:0006914,TBC1D5,autophagy,3.0
23888,9779,GO:0010008,TBC1D5,endosome membrane,3.0
23889,9779,GO:0016236,TBC1D5,macroautophagy,3.0
23890,9779,GO:0030122,TBC1D5,AP-2 adaptor complex,3.0
23891,9779,GO:0030904,TBC1D5,retromer complex,3.0
23892,9779,GO:0031267,TBC1D5,small GTPase binding,3.0
23893,9779,GO:0035612,TBC1D5,AP-2 adaptor complex binding,3.0
23894,9779,GO:0042147,TBC1D5,"retrograde transport, endosome to Golgi",3.0
23895,9779,GO:0042594,TBC1D5,response to starvation,3.0
23896,9779,GO:0043231,TBC1D5,intracellular membrane-bounded organelle,3.0
23897,9779,GO:0044877,TBC1D5,protein-containing complex binding,3.0
23898,9779,GO:0090630,TBC1D5,activation of GTPase activity,3.0
23899,9779,GO:1902017,TBC1D5,regulation of cilium assembly,3.0
23900,9779,GO:1905394,TBC1D5,retromer complex binding,3.0
23901,9779,GO:1990316,TBC1D5,Atg1/ULK1 kinase complex,3.0
23967,6647,GO:0000187,SOD1,activation of MAPK activity,3.0
23968,6647,GO:0000303,SOD1,response to superoxide,3.0
23969,6647,GO:0001541,SOD1,ovarian follicle development,3.0
23970,6647,GO:0001819,SOD1,positive regulation of cytokine production,3.0
23971,6647,GO:0001890,SOD1,placenta development,3.0
23972,6647,GO:0001895,SOD1,retina homeostasis,3.0
23973,6647,GO:0001975,SOD1,response to amphetamine,3.0
23974,6647,GO:0002262,SOD1,myeloid cell homeostasis,3.0
23975,6647,GO:0002576,SOD1,platelet degranulation,3.0
23976,6647,GO:0004784,SOD1,superoxide dismutase activity,3.0
23978,6647,GO:0005507,SOD1,copper ion binding,3.0
23980,6647,GO:0005515,SOD1,protein binding,3.0
23981,6647,GO:0005576,SOD1,extracellular region,3.0
23982,6647,GO:0005615,SOD1,extracellular space,3.0
23984,6647,GO:0005634,SOD1,nucleus,3.0
23987,6647,GO:0005654,SOD1,nucleoplasm,3.0
23988,6647,GO:0005737,SOD1,cytoplasm,3.0
23989,6647,GO:0005739,SOD1,mitochondrion,3.0
23991,6647,GO:0005758,SOD1,mitochondrial intermembrane space,3.0
23992,6647,GO:0005759,SOD1,mitochondrial matrix,3.0
23993,6647,GO:0005764,SOD1,lysosome,3.0
23994,6647,GO:0005777,SOD1,peroxisome,3.0
23997,6647,GO:0005829,SOD1,cytosol,3.0
24000,6647,GO:0005886,SOD1,plasma membrane,3.0
24001,6647,GO:0006749,SOD1,glutathione metabolic process,3.0
24002,6647,GO:0006801,SOD1,superoxide metabolic process,3.0
24004,6647,GO:0006879,SOD1,cellular iron ion homeostasis,3.0
24005,6647,GO:0007283,SOD1,spermatogenesis,3.0
24006,6647,GO:0007566,SOD1,embryo implantation,3.0
24008,6647,GO:0007569,SOD1,cell aging,3.0
24009,6647,GO:0007605,SOD1,sensory perception of sound,3.0
24010,6647,GO:0007626,SOD1,locomotory behavior,3.0
24011,6647,GO:0008089,SOD1,anterograde axonal transport,3.0
24012,6647,GO:0008090,SOD1,retrograde axonal transport,3.0
24013,6647,GO:0008217,SOD1,regulation of blood pressure,3.0
24014,6647,GO:0008270,SOD1,zinc ion binding,3.0
24015,6647,GO:0009408,SOD1,response to heat,3.0
24016,6647,GO:0010033,SOD1,response to organic substance,3.0
24017,6647,GO:0019226,SOD1,transmission of nerve impulse,3.0
24018,6647,GO:0019430,SOD1,removal of superoxide radicals,3.0
24021,6647,GO:0030346,SOD1,protein phosphatase 2B binding,3.0
24022,6647,GO:0031045,SOD1,dense core granule,3.0
24023,6647,GO:0031267,SOD1,small GTPase binding,3.0
24024,6647,GO:0031410,SOD1,cytoplasmic vesicle,3.0
24025,6647,GO:0031667,SOD1,response to nutrient levels,3.0
24026,6647,GO:0032287,SOD1,peripheral nervous system myelin maintenance,3.0
24027,6647,GO:0032839,SOD1,dendrite cytoplasm,3.0
24028,6647,GO:0032930,SOD1,positive regulation of superoxide anion generation,3.0
24029,6647,GO:0032991,SOD1,protein-containing complex,3.0
24030,6647,GO:0033081,SOD1,regulation of T cell differentiation in thymus,3.0
24031,6647,GO:0034465,SOD1,response to carbon monoxide,3.0
24032,6647,GO:0034599,SOD1,cellular response to oxidative stress,3.0
24033,6647,GO:0035722,SOD1,interleukin-12-mediated signaling pathway,3.0
24034,6647,GO:0035865,SOD1,cellular response to potassium ion,3.0
24035,6647,GO:0040014,SOD1,regulation of multicellular organism growth,3.0
24036,6647,GO:0042493,SOD1,response to drug,3.0
24037,6647,GO:0042542,SOD1,response to hydrogen peroxide,3.0
24038,6647,GO:0042554,SOD1,superoxide anion generation,3.0
24039,6647,GO:0042802,SOD1,identical protein binding,3.0
24040,6647,GO:0043025,SOD1,neuronal cell body,3.0
24041,6647,GO:0043065,SOD1,positive regulation of apoptotic process,3.0
24042,6647,GO:0043085,SOD1,positive regulation of catalytic activity,3.0
24043,6647,GO:0043087,SOD1,regulation of GTPase activity,3.0
24044,6647,GO:0043524,SOD1,negative regulation of neuron apoptotic process,3.0
24045,6647,GO:0045471,SOD1,response to ethanol,3.0
24046,6647,GO:0045541,SOD1,negative regulation of cholesterol biosynthetic process,3.0
24047,6647,GO:0045859,SOD1,regulation of protein kinase activity,3.0
24048,6647,GO:0046620,SOD1,regulation of organ growth,3.0
24049,6647,GO:0046677,SOD1,response to antibiotic,3.0
24050,6647,GO:0046688,SOD1,response to copper ion,3.0
24051,6647,GO:0046716,SOD1,muscle cell cellular homeostasis,3.0
24052,6647,GO:0048538,SOD1,thymus development,3.0
24053,6647,GO:0048678,SOD1,response to axon injury,3.0
24054,6647,GO:0050665,SOD1,hydrogen peroxide biosynthetic process,3.0
24056,6647,GO:0050728,SOD1,negative regulation of inflammatory response,3.0
24057,6647,GO:0050766,SOD1,positive regulation of phagocytosis,3.0
24058,6647,GO:0051087,SOD1,chaperone binding,3.0
24059,6647,GO:0051881,SOD1,regulation of mitochondrial membrane potential,3.0
24060,6647,GO:0055114,SOD1,oxidation-reduction process,3.0
24061,6647,GO:0060047,SOD1,heart contraction,3.0
24062,6647,GO:0060052,SOD1,neurofilament cytoskeleton organization,3.0
24063,6647,GO:0060087,SOD1,relaxation of vascular associated smooth muscle,3.0
24064,6647,GO:0060088,SOD1,auditory receptor cell stereocilium organization,3.0
24065,6647,GO:0070062,SOD1,extracellular exosome,3.0
24066,6647,GO:0071276,SOD1,cellular response to cadmium ion,3.0
24067,6647,GO:0071318,SOD1,cellular response to ATP,3.0
24068,6647,GO:0072593,SOD1,reactive oxygen species metabolic process,3.0
24069,6647,GO:0097332,SOD1,response to antipsychotic drug,3.0
24070,6647,GO:1902177,SOD1,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,3.0
24071,6647,GO:1904115,SOD1,axon cytoplasm,3.0
24072,27347,GO:0000187,STK39,activation of MAPK activity,3.0
24073,27347,GO:0004674,STK39,protein serine/threonine kinase activity,3.0
24076,27347,GO:0005515,STK39,protein binding,3.0
24077,27347,GO:0005524,STK39,ATP binding,3.0
24078,27347,GO:0005654,STK39,nucleoplasm,3.0
24079,27347,GO:0005829,STK39,cytosol,3.0
24082,27347,GO:0005856,STK39,cytoskeleton,3.0
24083,27347,GO:0006468,STK39,protein phosphorylation,3.0
24084,27347,GO:0010820,STK39,positive regulation of T cell chemotaxis,3.0
24085,27347,GO:0016301,STK39,kinase activity,3.0
24086,27347,GO:0018105,STK39,peptidyl-serine phosphorylation,3.0
24088,27347,GO:0018107,STK39,peptidyl-threonine phosphorylation,3.0
24091,27347,GO:0019898,STK39,extrinsic component of membrane,3.0
24092,27347,GO:0019901,STK39,protein kinase binding,3.0
24093,27347,GO:0023014,STK39,signal transduction by protein phosphorylation,3.0
24094,27347,GO:0023016,STK39,signal transduction by trans-phosphorylation,3.0
24095,27347,GO:0032414,STK39,positive regulation of ion transmembrane transporter activity,3.0
24096,27347,GO:0035556,STK39,intracellular signal transduction,3.0
24097,27347,GO:0036438,STK39,maintenance of lens transparency,3.0
24098,27347,GO:0038146,STK39,chemokine (C-X-C motif) ligand 12 signaling pathway,3.0
24099,27347,GO:0043231,STK39,intracellular membrane-bounded organelle,3.0
24100,27347,GO:0043268,STK39,positive regulation of potassium ion transport,3.0
24101,27347,GO:0046777,STK39,protein autophosphorylation,3.0
24103,27347,GO:0071476,STK39,cellular hypotonic response,3.0
24104,27347,GO:0106310,STK39,protein serine kinase activity,3.0
24105,27347,GO:0106311,STK39,protein threonine kinase activity,3.0
24106,27347,GO:1901017,STK39,negative regulation of potassium ion transmembrane transporter activity,3.0
24107,27347,GO:1901380,STK39,negative regulation of potassium ion transmembrane transport,3.0
24108,27347,GO:1905408,STK39,negative regulation of creatine transmembrane transporter activity,3.0
24109,27347,GO:1990869,STK39,cellular response to chemokine,3.0
24110,27347,GO:2000650,STK39,negative regulation of sodium ion transmembrane transporter activity,3.0
24128,55638,GO:0000139,SYBU,Golgi membrane,3.0
24129,55638,GO:0005515,SYBU,protein binding,3.0
24130,55638,GO:0005874,SYBU,microtubule,3.0
24131,55638,GO:0005881,SYBU,cytoplasmic microtubule,3.0
24132,55638,GO:0008017,SYBU,microtubule binding,3.0
24133,55638,GO:0016021,SYBU,integral component of membrane,3.0
24134,55638,GO:0017075,SYBU,syntaxin-1 binding,3.0
24135,55638,GO:0019894,SYBU,kinesin binding,3.0
24136,55638,GO:0019896,SYBU,axonal transport of mitochondrion,3.0
24137,55638,GO:0031410,SYBU,cytoplasmic vesicle,3.0
24138,55638,GO:0031982,SYBU,vesicle,3.0
24139,55638,GO:0035774,SYBU,positive regulation of insulin secretion involved in cellular response to glucose stimulus,3.0
24140,55638,GO:0043231,SYBU,intracellular membrane-bounded organelle,3.0
24141,55638,GO:0060025,SYBU,regulation of synaptic activity,3.0
24142,55638,GO:0060074,SYBU,synapse maturation,3.0
24143,55638,GO:0097433,SYBU,dense body,3.0
24144,55638,GO:1904115,SYBU,axon cytoplasm,3.0
24145,55638,GO:1990048,SYBU,anterograde neuronal dense core vesicle transport,3.0
24146,93426,GO:0000795,SYCE1,synaptonemal complex,3.0
24147,93426,GO:0000801,SYCE1,central element,3.0
24148,93426,GO:0005515,SYCE1,protein binding,3.0
24149,93426,GO:0005654,SYCE1,nucleoplasm,3.0
24150,93426,GO:0005829,SYCE1,cytosol,3.0
24151,93426,GO:0007130,SYCE1,synaptonemal complex assembly,3.0
24152,93426,GO:0043231,SYCE1,intracellular membrane-bounded organelle,3.0
24153,93426,GO:0051301,SYCE1,cell division,3.0
24154,6855,GO:0005515,SYP,protein binding,3.0
24155,6855,GO:0006897,SYP,endocytosis,3.0
24156,6855,GO:0008021,SYP,synaptic vesicle,3.0
24157,6855,GO:0015485,SYP,cholesterol binding,3.0
24158,6855,GO:0016188,SYP,synaptic vesicle maturation,3.0
24159,6855,GO:0017075,SYP,syntaxin-1 binding,3.0
24160,6855,GO:0030285,SYP,integral component of synaptic vesicle membrane,3.0
24161,6855,GO:0030672,SYP,synaptic vesicle membrane,3.0
24162,6855,GO:0031594,SYP,neuromuscular junction,3.0
24163,6855,GO:0042169,SYP,SH2 domain binding,3.0
24164,6855,GO:0042734,SYP,presynaptic membrane,3.0
24165,6855,GO:0042802,SYP,identical protein binding,3.0
24166,6855,GO:0043005,SYP,neuron projection,3.0
24168,6855,GO:0043195,SYP,terminal bouton,3.0
24169,6855,GO:0043621,SYP,protein self-association,3.0
24170,6855,GO:0048168,SYP,regulation of neuronal synaptic plasticity,3.0
24171,6855,GO:0048169,SYP,regulation of long-term neuronal synaptic plasticity,3.0
24172,6855,GO:0048172,SYP,regulation of short-term neuronal synaptic plasticity,3.0
24173,6855,GO:0048471,SYP,perinuclear region of cytoplasm,3.0
24174,6855,GO:0048488,SYP,synaptic vesicle endocytosis,3.0
24175,6855,GO:0048499,SYP,synaptic vesicle membrane organization,3.0
24176,6855,GO:0048786,SYP,presynaptic active zone,3.0
24177,6855,GO:0060076,SYP,excitatory synapse,3.0
24178,6855,GO:0071310,SYP,cellular response to organic substance,3.0
24179,6855,GO:2000474,SYP,regulation of opioid receptor signaling pathway,3.0
24180,51760,GO:0000149,SYT17,SNARE binding,3.0
24181,51760,GO:0001786,SYT17,phosphatidylserine binding,3.0
24182,51760,GO:0005509,SYT17,calcium ion binding,3.0
24183,51760,GO:0005515,SYT17,protein binding,3.0
24184,51760,GO:0005544,SYT17,calcium-dependent phospholipid binding,3.0
24185,51760,GO:0005802,SYT17,trans-Golgi network,3.0
24186,51760,GO:0005886,SYT17,plasma membrane,3.0
24187,51760,GO:0014059,SYT17,regulation of dopamine secretion,3.0
24188,51760,GO:0016192,SYT17,vesicle-mediated transport,3.0
24189,51760,GO:0017156,SYT17,calcium-ion regulated exocytosis,3.0
24190,51760,GO:0017158,SYT17,regulation of calcium ion-dependent exocytosis,3.0
24191,51760,GO:0019905,SYT17,syntaxin binding,3.0
24192,51760,GO:0030276,SYT17,clathrin binding,3.0
24193,51760,GO:0070382,SYT17,exocytic vesicle,3.0
24194,51760,GO:0071277,SYT17,cellular response to calcium ion,3.0
24195,51760,GO:0098793,SYT17,presynapse,3.0
24196,51760,GO:1903861,SYT17,positive regulation of dendrite extension,3.0
24197,6907,GO:0000118,TBL1X,histone deacetylase complex,3.0
24199,6907,GO:0000122,TBL1X,negative regulation of transcription by RNA polymerase II,3.0
24200,6907,GO:0000976,TBL1X,transcription regulatory region sequence-specific DNA binding,3.0
24201,6907,GO:0003714,TBL1X,transcription corepressor activity,3.0
24204,6907,GO:0005515,TBL1X,protein binding,3.0
24205,6907,GO:0005634,TBL1X,nucleus,3.0
24206,6907,GO:0005654,TBL1X,nucleoplasm,3.0
24207,6907,GO:0006357,TBL1X,regulation of transcription by RNA polymerase II,3.0
24208,6907,GO:0006508,TBL1X,proteolysis,3.0
24209,6907,GO:0007605,TBL1X,sensory perception of sound,3.0
24210,6907,GO:0008013,TBL1X,beta-catenin binding,3.0
24211,6907,GO:0008022,TBL1X,protein C-terminus binding,3.0
24212,6907,GO:0008134,TBL1X,transcription factor binding,3.0
24213,6907,GO:0016575,TBL1X,histone deacetylation,3.0
24214,6907,GO:0017053,TBL1X,transcription repressor complex,3.0
24215,6907,GO:0019216,TBL1X,regulation of lipid metabolic process,3.0
24216,6907,GO:0019904,TBL1X,protein domain specific binding,3.0
24217,6907,GO:0042393,TBL1X,histone binding,3.0
24218,6907,GO:0043161,TBL1X,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
24219,6907,GO:0045893,TBL1X,"positive regulation of transcription, DNA-templated",3.0
24220,6907,GO:0045944,TBL1X,positive regulation of transcription by RNA polymerase II,3.0
24221,6907,GO:0050821,TBL1X,protein stabilization,3.0
24222,6907,GO:0072686,TBL1X,mitotic spindle,3.0
24223,6907,GO:0090263,TBL1X,positive regulation of canonical Wnt signaling pathway,3.0
24297,50945,GO:0000122,TBX22,negative regulation of transcription by RNA polymerase II,3.0
24298,50945,GO:0000785,TBX22,chromatin,3.0
24300,50945,GO:0000977,TBX22,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
24301,50945,GO:0000978,TBX22,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
24302,50945,GO:0000981,TBX22,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
24304,50945,GO:0001708,TBX22,cell fate specification,3.0
24305,50945,GO:0001947,TBX22,heart looping,3.0
24306,50945,GO:0003677,TBX22,DNA binding,3.0
24307,50945,GO:0003700,TBX22,DNA-binding transcription factor activity,3.0
24308,50945,GO:0005515,TBX22,protein binding,3.0
24309,50945,GO:0005634,TBX22,nucleus,3.0
24310,50945,GO:0006355,TBX22,"regulation of transcription, DNA-templated",3.0
24311,50945,GO:0006357,TBX22,regulation of transcription by RNA polymerase II,3.0
24312,50945,GO:0007275,TBX22,multicellular organism development,3.0
24313,50945,GO:0045892,TBX22,"negative regulation of transcription, DNA-templated",3.0
24410,7007,GO:0005201,TECTA,extracellular matrix structural constituent,3.0
24411,7007,GO:0005576,TECTA,extracellular region,3.0
24412,7007,GO:0005886,TECTA,plasma membrane,3.0
24413,7007,GO:0007160,TECTA,cell-matrix adhesion,3.0
24414,7007,GO:0007605,TECTA,sensory perception of sound,3.0
24415,7007,GO:0031225,TECTA,anchored component of membrane,3.0
24416,7007,GO:0062023,TECTA,collagen-containing extracellular matrix,3.0
24417,7007,GO:0070062,TECTA,extracellular exosome,3.0
24484,145645,GO:0000781,TERB2,"chromosome, telomeric region",3.0
24486,145645,GO:0005515,TERB2,protein binding,3.0
24487,145645,GO:0005637,TERB2,nuclear inner membrane,3.0
24489,145645,GO:0007129,TERB2,homologous chromosome pairing at meiosis,3.0
24491,145645,GO:0045141,TERB2,meiotic telomere clustering,3.0
24492,145645,GO:0070197,TERB2,meiotic attachment of telomere to nuclear envelope,3.0
24516,7057,GO:0000187,THBS1,activation of MAPK activity,3.0
24517,7057,GO:0001666,THBS1,response to hypoxia,3.0
24518,7057,GO:0001786,THBS1,phosphatidylserine binding,3.0
24519,7057,GO:0001937,THBS1,negative regulation of endothelial cell proliferation,3.0
24521,7057,GO:0001953,THBS1,negative regulation of cell-matrix adhesion,3.0
24522,7057,GO:0001968,THBS1,fibronectin binding,3.0
24523,7057,GO:0002040,THBS1,sprouting angiogenesis,3.0
24524,7057,GO:0002544,THBS1,chronic inflammatory response,3.0
24525,7057,GO:0002576,THBS1,platelet degranulation,3.0
24526,7057,GO:0002581,THBS1,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,3.0
24527,7057,GO:0002605,THBS1,negative regulation of dendritic cell antigen processing and presentation,3.0
24528,7057,GO:0005178,THBS1,integrin binding,3.0
24529,7057,GO:0005201,THBS1,extracellular matrix structural constituent,3.0
24532,7057,GO:0005509,THBS1,calcium ion binding,3.0
24533,7057,GO:0005515,THBS1,protein binding,3.0
24534,7057,GO:0005576,THBS1,extracellular region,3.0
24536,7057,GO:0005577,THBS1,fibrinogen complex,3.0
24537,7057,GO:0005615,THBS1,extracellular space,3.0
24539,7057,GO:0005783,THBS1,endoplasmic reticulum,3.0
24540,7057,GO:0005788,THBS1,endoplasmic reticulum lumen,3.0
24541,7057,GO:0006954,THBS1,inflammatory response,3.0
24542,7057,GO:0006955,THBS1,immune response,3.0
24543,7057,GO:0006986,THBS1,response to unfolded protein,3.0
24544,7057,GO:0007050,THBS1,cell cycle arrest,3.0
24545,7057,GO:0007155,THBS1,cell adhesion,3.0
24546,7057,GO:0008201,THBS1,heparin binding,3.0
24547,7057,GO:0008284,THBS1,positive regulation of cell population proliferation,3.0
24548,7057,GO:0009749,THBS1,response to glucose,3.0
24549,7057,GO:0009897,THBS1,external side of plasma membrane,3.0
24550,7057,GO:0009986,THBS1,cell surface,3.0
24551,7057,GO:0010595,THBS1,positive regulation of endothelial cell migration,3.0
24552,7057,GO:0010596,THBS1,negative regulation of endothelial cell migration,3.0
24553,7057,GO:0010748,THBS1,negative regulation of long-chain fatty acid import across plasma membrane,3.0
24554,7057,GO:0010751,THBS1,negative regulation of nitric oxide mediated signal transduction,3.0
24555,7057,GO:0010754,THBS1,negative regulation of cGMP-mediated signaling,3.0
24556,7057,GO:0010757,THBS1,negative regulation of plasminogen activation,3.0
24557,7057,GO:0010759,THBS1,positive regulation of macrophage chemotaxis,3.0
24558,7057,GO:0010763,THBS1,positive regulation of fibroblast migration,3.0
24559,7057,GO:0016477,THBS1,cell migration,3.0
24560,7057,GO:0016525,THBS1,negative regulation of angiogenesis,3.0
24563,7057,GO:0016529,THBS1,sarcoplasmic reticulum,3.0
24564,7057,GO:0017134,THBS1,fibroblast growth factor binding,3.0
24565,7057,GO:0018149,THBS1,peptide cross-linking,3.0
24566,7057,GO:0030141,THBS1,secretory granule,3.0
24567,7057,GO:0030169,THBS1,low-density lipoprotein particle binding,3.0
24568,7057,GO:0030194,THBS1,positive regulation of blood coagulation,3.0
24569,7057,GO:0030198,THBS1,extracellular matrix organization,3.0
24570,7057,GO:0030335,THBS1,positive regulation of cell migration,3.0
24572,7057,GO:0030511,THBS1,positive regulation of transforming growth factor beta receptor signaling pathway,3.0
24573,7057,GO:0031012,THBS1,extracellular matrix,3.0
24574,7057,GO:0031091,THBS1,platelet alpha granule,3.0
24575,7057,GO:0031093,THBS1,platelet alpha granule lumen,3.0
24576,7057,GO:0032026,THBS1,response to magnesium ion,3.0
24577,7057,GO:0032570,THBS1,response to progesterone,3.0
24578,7057,GO:0032695,THBS1,negative regulation of interleukin-12 production,3.0
24579,7057,GO:0032760,THBS1,positive regulation of tumor necrosis factor production,3.0
24580,7057,GO:0032914,THBS1,positive regulation of transforming growth factor beta1 production,3.0
24581,7057,GO:0034605,THBS1,cellular response to heat,3.0
24582,7057,GO:0034976,THBS1,response to endoplasmic reticulum stress,3.0
24583,7057,GO:0040037,THBS1,negative regulation of fibroblast growth factor receptor signaling pathway,3.0
24584,7057,GO:0042327,THBS1,positive regulation of phosphorylation,3.0
24585,7057,GO:0042493,THBS1,response to drug,3.0
24586,7057,GO:0042802,THBS1,identical protein binding,3.0
24587,7057,GO:0043032,THBS1,positive regulation of macrophage activation,3.0
24588,7057,GO:0043066,THBS1,negative regulation of apoptotic process,3.0
24589,7057,GO:0043154,THBS1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
24590,7057,GO:0043236,THBS1,laminin binding,3.0
24591,7057,GO:0043394,THBS1,proteoglycan binding,3.0
24592,7057,GO:0043536,THBS1,positive regulation of blood vessel endothelial cell migration,3.0
24593,7057,GO:0043537,THBS1,negative regulation of blood vessel endothelial cell migration,3.0
24594,7057,GO:0043652,THBS1,engulfment of apoptotic cell,3.0
24595,7057,GO:0045652,THBS1,regulation of megakaryocyte differentiation,3.0
24596,7057,GO:0045727,THBS1,positive regulation of translation,3.0
24597,7057,GO:0045766,THBS1,positive regulation of angiogenesis,3.0
24598,7057,GO:0048266,THBS1,behavioral response to pain,3.0
24599,7057,GO:0048661,THBS1,positive regulation of smooth muscle cell proliferation,3.0
24600,7057,GO:0050431,THBS1,transforming growth factor beta binding,3.0
24602,7057,GO:0050921,THBS1,positive regulation of chemotaxis,3.0
24603,7057,GO:0051592,THBS1,response to calcium ion,3.0
24604,7057,GO:0051895,THBS1,negative regulation of focal adhesion assembly,3.0
24605,7057,GO:0051897,THBS1,positive regulation of protein kinase B signaling,3.0
24606,7057,GO:0051918,THBS1,negative regulation of fibrinolysis,3.0
24607,7057,GO:0062023,THBS1,collagen-containing extracellular matrix,3.0
24612,7057,GO:0070051,THBS1,fibrinogen binding,3.0
24613,7057,GO:0070052,THBS1,collagen V binding,3.0
24614,7057,GO:0070062,THBS1,extracellular exosome,3.0
24615,7057,GO:0090051,THBS1,negative regulation of cell migration involved in sprouting angiogenesis,3.0
24616,7057,GO:1902043,THBS1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,3.0
24617,7057,GO:1903588,THBS1,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,3.0
24618,7057,GO:1903671,THBS1,negative regulation of sprouting angiogenesis,3.0
24619,7057,GO:2000353,THBS1,positive regulation of endothelial cell apoptotic process,3.0
24620,7057,GO:2000379,THBS1,positive regulation of reactive oxygen species metabolic process,3.0
24621,7057,GO:2001027,THBS1,negative regulation of endothelial cell chemotaxis,3.0
24622,7057,GO:2001237,THBS1,negative regulation of extrinsic apoptotic signaling pathway,3.0
24623,7067,GO:0000122,THRA,negative regulation of transcription by RNA polymerase II,3.0
24624,7067,GO:0000785,THRA,chromatin,3.0
24625,7067,GO:0000976,THRA,transcription regulatory region sequence-specific DNA binding,3.0
24626,7067,GO:0000978,THRA,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
24627,7067,GO:0000981,THRA,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
24628,7067,GO:0001502,THRA,cartilage condensation,3.0
24629,7067,GO:0001503,THRA,ossification,3.0
24630,7067,GO:0002154,THRA,thyroid hormone mediated signaling pathway,3.0
24631,7067,GO:0002155,THRA,regulation of thyroid hormone mediated signaling pathway,3.0
24632,7067,GO:0003700,THRA,DNA-binding transcription factor activity,3.0
24633,7067,GO:0004879,THRA,nuclear receptor activity,3.0
24635,7067,GO:0005515,THRA,protein binding,3.0
24636,7067,GO:0005634,THRA,nucleus,3.0
24637,7067,GO:0005654,THRA,nucleoplasm,3.0
24638,7067,GO:0005829,THRA,cytosol,3.0
24639,7067,GO:0006357,THRA,regulation of transcription by RNA polymerase II,3.0
24640,7067,GO:0006366,THRA,transcription by RNA polymerase II,3.0
24641,7067,GO:0006367,THRA,transcription initiation from RNA polymerase II promoter,3.0
24642,7067,GO:0007611,THRA,learning or memory,3.0
24643,7067,GO:0008016,THRA,regulation of heart contraction,3.0
24644,7067,GO:0008050,THRA,female courtship behavior,3.0
24645,7067,GO:0008134,THRA,transcription factor binding,3.0
24646,7067,GO:0008270,THRA,zinc ion binding,3.0
24647,7067,GO:0009409,THRA,response to cold,3.0
24648,7067,GO:0009755,THRA,hormone-mediated signaling pathway,3.0
24650,7067,GO:0017025,THRA,TBP-class protein binding,3.0
24651,7067,GO:0017055,THRA,negative regulation of RNA polymerase II transcription preinitiation complex assembly,3.0
24652,7067,GO:0019904,THRA,protein domain specific binding,3.0
24653,7067,GO:0030154,THRA,cell differentiation,3.0
24654,7067,GO:0030218,THRA,erythrocyte differentiation,3.0
24655,7067,GO:0030878,THRA,thyroid gland development,3.0
24656,7067,GO:0031490,THRA,chromatin DNA binding,3.0
24657,7067,GO:0033032,THRA,regulation of myeloid cell apoptotic process,3.0
24658,7067,GO:0044877,THRA,protein-containing complex binding,3.0
24659,7067,GO:0045892,THRA,"negative regulation of transcription, DNA-templated",3.0
24660,7067,GO:0045925,THRA,positive regulation of female receptivity,3.0
24661,7067,GO:0045944,THRA,positive regulation of transcription by RNA polymerase II,3.0
24662,7067,GO:0050994,THRA,regulation of lipid catabolic process,3.0
24663,7067,GO:0060509,THRA,type I pneumocyte differentiation,3.0
24664,7067,GO:0070324,THRA,thyroid hormone binding,3.0
24666,7067,GO:0120162,THRA,positive regulation of cold-induced thermogenesis,3.0
24667,7067,GO:2000143,THRA,"negative regulation of DNA-templated transcription, initiation",3.0
24694,116211,GO:0005515,TM4SF19,protein binding,3.0
24695,116211,GO:0016021,TM4SF19,integral component of membrane,3.0
24702,55116,GO:0005789,TMEM39B,endoplasmic reticulum membrane,3.0
24703,55116,GO:0016020,TMEM39B,membrane,3.0
24704,55116,GO:0016021,TMEM39B,integral component of membrane,3.0
24705,55116,GO:0045070,TMEM39B,positive regulation of viral genome replication,3.0
24706,55116,GO:1901097,TMEM39B,negative regulation of autophagosome maturation,3.0
24707,55116,GO:1902902,TMEM39B,negative regulation of autophagosome assembly,3.0
24736,8940,GO:0003677,TOP3B,DNA binding,3.0
24737,8940,GO:0003723,TOP3B,RNA binding,3.0
24738,8940,GO:0003916,TOP3B,DNA topoisomerase activity,3.0
24739,8940,GO:0003917,TOP3B,"DNA topoisomerase type I (single strand cut, ATP-independent) activity",3.0
24740,8940,GO:0005515,TOP3B,protein binding,3.0
24741,8940,GO:0005634,TOP3B,nucleus,3.0
24742,8940,GO:0006265,TOP3B,DNA topological change,3.0
24870,8295,GO:0000124,TRRAP,SAGA complex,3.0
24871,8295,GO:0000125,TRRAP,PCAF complex,3.0
24872,8295,GO:0000812,TRRAP,Swr1 complex,3.0
24873,8295,GO:0003712,TRRAP,transcription coregulator activity,3.0
24875,8295,GO:0005515,TRRAP,protein binding,3.0
24876,8295,GO:0005634,TRRAP,nucleus,3.0
24878,8295,GO:0005654,TRRAP,nucleoplasm,3.0
24880,8295,GO:0005794,TRRAP,Golgi apparatus,3.0
24881,8295,GO:0006281,TRRAP,DNA repair,3.0
24882,8295,GO:0006355,TRRAP,"regulation of transcription, DNA-templated",3.0
24883,8295,GO:0016301,TRRAP,kinase activity,3.0
24884,8295,GO:0016310,TRRAP,phosphorylation,3.0
24885,8295,GO:0016573,TRRAP,histone acetylation,3.0
24886,8295,GO:0016578,TRRAP,histone deubiquitination,3.0
24887,8295,GO:0016579,TRRAP,protein deubiquitination,3.0
24888,8295,GO:0030914,TRRAP,STAGA complex,3.0
24889,8295,GO:0033276,TRRAP,transcription factor TFTC complex,3.0
24890,8295,GO:0035267,TRRAP,NuA4 histone acetyltransferase complex,3.0
24892,8295,GO:0043967,TRRAP,histone H4 acetylation,3.0
24893,8295,GO:0043968,TRRAP,histone H2A acetylation,3.0
24894,8295,GO:1904837,TRRAP,beta-catenin-TCF complex assembly,3.0
25104,64216,GO:0000179,TFB2M,"rRNA (adenine-N6,N6-)-dimethyltransferase activity",3.0
25105,64216,GO:0003712,TFB2M,transcription coregulator activity,3.0
25106,64216,GO:0003723,TFB2M,RNA binding,3.0
25107,64216,GO:0005739,TFB2M,mitochondrion,3.0
25108,64216,GO:0005759,TFB2M,mitochondrial matrix,3.0
25111,64216,GO:0006355,TFB2M,"regulation of transcription, DNA-templated",3.0
25112,64216,GO:0006390,TFB2M,mitochondrial transcription,3.0
25113,64216,GO:0006391,TFB2M,transcription initiation from mitochondrial promoter,3.0
25116,64216,GO:0007005,TFB2M,mitochondrion organization,3.0
25117,64216,GO:0031167,TFB2M,rRNA methylation,3.0
25118,64216,GO:0034246,TFB2M,mitochondrial transcription factor activity,3.0
25120,64216,GO:0042645,TFB2M,mitochondrial nucleoid,3.0
25134,80194,GO:0005515,TMEM134,protein binding,3.0
25135,80194,GO:0016021,TMEM134,integral component of membrane,3.0
25136,80194,GO:0016032,TMEM134,viral process,3.0
25137,80194,GO:0048471,TMEM134,perinuclear region of cytoplasm,3.0
25138,51693,GO:0000139,TRAPPC2L,Golgi membrane,3.0
25139,51693,GO:0005515,TRAPPC2L,protein binding,3.0
25140,51693,GO:0005634,TRAPPC2L,nucleus,3.0
25141,51693,GO:0005737,TRAPPC2L,cytoplasm,3.0
25142,51693,GO:0005783,TRAPPC2L,endoplasmic reticulum,3.0
25143,51693,GO:0005829,TRAPPC2L,cytosol,3.0
25145,51693,GO:0006888,TRAPPC2L,endoplasmic reticulum to Golgi vesicle-mediated transport,3.0
25146,51693,GO:0030008,TRAPPC2L,TRAPP complex,3.0
25148,51693,GO:0043231,TRAPPC2L,intracellular membrane-bounded organelle,3.0
25149,51693,GO:0048208,TRAPPC2L,COPII vesicle coating,3.0
25150,51693,GO:0048471,TRAPPC2L,perinuclear region of cytoplasm,3.0
25173,22954,GO:0000209,TRIM32,protein polyubiquitination,3.0
25174,22954,GO:0001894,TRIM32,tissue homeostasis,3.0
25175,22954,GO:0003713,TRIM32,transcription coactivator activity,3.0
25176,22954,GO:0003723,TRIM32,RNA binding,3.0
25177,22954,GO:0004842,TRIM32,ubiquitin-protein transferase activity,3.0
25178,22954,GO:0005515,TRIM32,protein binding,3.0
25179,22954,GO:0005634,TRIM32,nucleus,3.0
25180,22954,GO:0005737,TRIM32,cytoplasm,3.0
25182,22954,GO:0005829,TRIM32,cytosol,3.0
25183,22954,GO:0005863,TRIM32,striated muscle myosin thick filament,3.0
25184,22954,GO:0006511,TRIM32,ubiquitin-dependent protein catabolic process,3.0
25185,22954,GO:0007014,TRIM32,actin ubiquitination,3.0
25186,22954,GO:0008270,TRIM32,zinc ion binding,3.0
25187,22954,GO:0009411,TRIM32,response to UV,3.0
25188,22954,GO:0016567,TRIM32,protein ubiquitination,3.0
25189,22954,GO:0017022,TRIM32,myosin binding,3.0
25190,22954,GO:0030307,TRIM32,positive regulation of cell growth,3.0
25191,22954,GO:0030335,TRIM32,positive regulation of cell migration,3.0
25192,22954,GO:0030957,TRIM32,Tat protein binding,3.0
25193,22954,GO:0031369,TRIM32,translation initiation factor binding,3.0
25194,22954,GO:0032479,TRIM32,regulation of type I interferon production,3.0
25195,22954,GO:0032897,TRIM32,negative regulation of viral transcription,3.0
25196,22954,GO:0034612,TRIM32,response to tumor necrosis factor,3.0
25197,22954,GO:0042802,TRIM32,identical protein binding,3.0
25198,22954,GO:0043123,TRIM32,positive regulation of I-kappaB kinase/NF-kappaB signaling,3.0
25199,22954,GO:0043130,TRIM32,ubiquitin binding,3.0
25200,22954,GO:0043621,TRIM32,protein self-association,3.0
25201,22954,GO:0045087,TRIM32,innate immune response,3.0
25203,22954,GO:0045444,TRIM32,fat cell differentiation,3.0
25204,22954,GO:0045666,TRIM32,positive regulation of neuron differentiation,3.0
25205,22954,GO:0045732,TRIM32,positive regulation of protein catabolic process,3.0
25206,22954,GO:0045787,TRIM32,positive regulation of cell cycle,3.0
25207,22954,GO:0045862,TRIM32,positive regulation of proteolysis,3.0
25208,22954,GO:0046716,TRIM32,muscle cell cellular homeostasis,3.0
25209,22954,GO:0048147,TRIM32,negative regulation of fibroblast proliferation,3.0
25210,22954,GO:0050769,TRIM32,positive regulation of neurogenesis,3.0
25211,22954,GO:0051091,TRIM32,positive regulation of DNA-binding transcription factor activity,3.0
25212,22954,GO:0051092,TRIM32,positive regulation of NF-kappaB transcription factor activity,3.0
25215,22954,GO:0051155,TRIM32,positive regulation of striated muscle cell differentiation,3.0
25216,22954,GO:0061564,TRIM32,axon development,3.0
25217,22954,GO:0061630,TRIM32,ubiquitin protein ligase activity,3.0
25219,22954,GO:0070936,TRIM32,protein K48-linked ubiquitination,3.0
25220,22954,GO:1902187,TRIM32,negative regulation of viral release from host cell,3.0
25221,22954,GO:1902230,TRIM32,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,3.0
25222,22954,GO:1903265,TRIM32,positive regulation of tumor necrosis factor-mediated signaling pathway,3.0
25223,22954,GO:1903508,TRIM32,positive regulation of nucleic acid-templated transcription,3.0
25224,22954,GO:1903883,TRIM32,positive regulation of interleukin-17-mediated signaling pathway,3.0
25225,22954,GO:1903886,TRIM32,positive regulation of chemokine (C-C motif) ligand 20 production,3.0
25226,22954,GO:2000147,TRIM32,positive regulation of cell motility,3.0
25246,26262,GO:0000151,TSPAN17,ubiquitin ligase complex,3.0
25247,26262,GO:0004842,TSPAN17,ubiquitin-protein transferase activity,3.0
25248,26262,GO:0005887,TSPAN17,integral component of plasma membrane,3.0
25249,26262,GO:0016567,TSPAN17,protein ubiquitination,3.0
25250,26262,GO:0019899,TSPAN17,enzyme binding,3.0
25251,26262,GO:0051604,TSPAN17,protein maturation,3.0
25252,26262,GO:0072594,TSPAN17,establishment of protein localization to organelle,3.0
25253,26262,GO:0072659,TSPAN17,protein localization to plasma membrane,3.0
25254,7106,GO:0003823,TSPAN4,antigen binding,3.0
25255,7106,GO:0005178,TSPAN4,integrin binding,3.0
25256,7106,GO:0005515,TSPAN4,protein binding,3.0
25257,7106,GO:0005886,TSPAN4,plasma membrane,3.0
25258,7106,GO:0005887,TSPAN4,integral component of plasma membrane,3.0
25259,7106,GO:0005925,TSPAN4,focal adhesion,3.0
25260,7106,GO:0031982,TSPAN4,vesicle,3.0
25261,7106,GO:0065003,TSPAN4,protein-containing complex assembly,3.0
25262,7102,GO:0005515,TSPAN7,protein binding,3.0
25263,7102,GO:0005887,TSPAN7,integral component of plasma membrane,3.0
25264,7102,GO:0016032,TSPAN7,viral process,3.0
25272,7273,GO:0000794,TTN,condensed nuclear chromosome,3.0
25273,7273,GO:0002020,TTN,protease binding,3.0
25274,7273,GO:0002576,TTN,platelet degranulation,3.0
25275,7273,GO:0003300,TTN,cardiac muscle hypertrophy,3.0
25276,7273,GO:0004674,TTN,protein serine/threonine kinase activity,3.0
25277,7273,GO:0004713,TTN,protein tyrosine kinase activity,3.0
25278,7273,GO:0005509,TTN,calcium ion binding,3.0
25279,7273,GO:0005515,TTN,protein binding,3.0
25280,7273,GO:0005516,TTN,calmodulin binding,3.0
25282,7273,GO:0005524,TTN,ATP binding,3.0
25283,7273,GO:0005576,TTN,extracellular region,3.0
25284,7273,GO:0005829,TTN,cytosol,3.0
25285,7273,GO:0006936,TTN,muscle contraction,3.0
25287,7273,GO:0006941,TTN,striated muscle contraction,3.0
25288,7273,GO:0007076,TTN,mitotic chromosome condensation,3.0
25289,7273,GO:0008307,TTN,structural constituent of muscle,3.0
25291,7273,GO:0010628,TTN,positive regulation of gene expression,3.0
25293,7273,GO:0010737,TTN,protein kinase A signaling,3.0
25294,7273,GO:0018108,TTN,peptidyl-tyrosine phosphorylation,3.0
25295,7273,GO:0019899,TTN,enzyme binding,3.0
25296,7273,GO:0019901,TTN,protein kinase binding,3.0
25297,7273,GO:0030018,TTN,Z disc,3.0
25298,7273,GO:0030049,TTN,muscle filament sliding,3.0
25299,7273,GO:0030240,TTN,skeletal muscle thin filament assembly,3.0
25300,7273,GO:0030241,TTN,skeletal muscle myosin thick filament assembly,3.0
25301,7273,GO:0031433,TTN,telethonin binding,3.0
25303,7273,GO:0031674,TTN,I band,3.0
25304,7273,GO:0035995,TTN,detection of muscle stretch,3.0
25306,7273,GO:0042802,TTN,identical protein binding,3.0
25307,7273,GO:0042805,TTN,actinin binding,3.0
25309,7273,GO:0043621,TTN,protein self-association,3.0
25310,7273,GO:0045214,TTN,sarcomere organization,3.0
25311,7273,GO:0045859,TTN,regulation of protein kinase activity,3.0
25312,7273,GO:0048739,TTN,cardiac muscle fiber development,3.0
25313,7273,GO:0048769,TTN,sarcomerogenesis,3.0
25314,7273,GO:0050714,TTN,positive regulation of protein secretion,3.0
25316,7273,GO:0050790,TTN,regulation of catalytic activity,3.0
25317,7273,GO:0051015,TTN,actin filament binding,3.0
25318,7273,GO:0051371,TTN,muscle alpha-actinin binding,3.0
25319,7273,GO:0051592,TTN,response to calcium ion,3.0
25320,7273,GO:0055003,TTN,cardiac myofibril assembly,3.0
25321,7273,GO:0055008,TTN,cardiac muscle tissue morphogenesis,3.0
25322,7273,GO:0060048,TTN,cardiac muscle contraction,3.0
25323,7273,GO:0070062,TTN,extracellular exosome,3.0
25324,7273,GO:0097493,TTN,structural molecule activity conferring elasticity,3.0
25326,7273,GO:0106310,TTN,protein serine kinase activity,3.0
25327,7273,GO:0106311,TTN,protein threonine kinase activity,3.0
25328,23371,GO:0001822,TNS2,kidney development,3.0
25329,23371,GO:0004725,TNS2,protein tyrosine phosphatase activity,3.0
25330,23371,GO:0005515,TNS2,protein binding,3.0
25331,23371,GO:0005886,TNS2,plasma membrane,3.0
25332,23371,GO:0005925,TNS2,focal adhesion,3.0
25334,23371,GO:0008285,TNS2,negative regulation of cell population proliferation,3.0
25335,23371,GO:0014850,TNS2,response to muscle activity,3.0
25336,23371,GO:0019725,TNS2,cellular homeostasis,3.0
25337,23371,GO:0019900,TNS2,kinase binding,3.0
25338,23371,GO:0032963,TNS2,collagen metabolic process,3.0
25339,23371,GO:0035264,TNS2,multicellular organism growth,3.0
25340,23371,GO:0035335,TNS2,peptidyl-tyrosine dephosphorylation,3.0
25341,23371,GO:0035556,TNS2,intracellular signal transduction,3.0
25342,23371,GO:0042802,TNS2,identical protein binding,3.0
25343,23371,GO:0046627,TNS2,negative regulation of insulin receptor signaling pathway,3.0
25344,23371,GO:0046872,TNS2,metal ion binding,3.0
25345,23371,GO:0048871,TNS2,multicellular organismal homeostasis,3.0
25346,9256,GO:0005515,TSPOAP1,protein binding,3.0
25347,9256,GO:0005737,TSPOAP1,cytoplasm,3.0
25348,9256,GO:0005739,TSPOAP1,mitochondrion,3.0
25350,9256,GO:0005829,TSPOAP1,cytosol,3.0
25351,9256,GO:0006700,TSPOAP1,C21-steroid hormone biosynthetic process,3.0
25352,9256,GO:0007269,TSPOAP1,neurotransmitter secretion,3.0
25353,9256,GO:0007274,TSPOAP1,neuromuscular synaptic transmission,3.0
25354,9256,GO:0008150,TSPOAP1,biological_process,3.0
25355,9256,GO:0014047,TSPOAP1,glutamate secretion,3.0
25356,9256,GO:0030156,TSPOAP1,benzodiazepine receptor binding,3.0
25358,9256,GO:0044305,TSPOAP1,calyx of Held,3.0
25359,9256,GO:0098978,TSPOAP1,glutamatergic synapse,3.0
25360,9256,GO:0099509,TSPOAP1,regulation of presynaptic cytosolic calcium ion concentration,3.0
25361,9256,GO:0099626,TSPOAP1,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,3.0
25362,114791,GO:0000278,TUBGCP5,mitotic cell cycle,3.0
25363,114791,GO:0000922,TUBGCP5,spindle pole,3.0
25364,114791,GO:0000923,TUBGCP5,equatorial microtubule organizing center,3.0
25365,114791,GO:0000930,TUBGCP5,gamma-tubulin complex,3.0
25366,114791,GO:0005515,TUBGCP5,protein binding,3.0
25367,114791,GO:0005813,TUBGCP5,centrosome,3.0
25369,114791,GO:0005829,TUBGCP5,cytosol,3.0
25371,114791,GO:0005874,TUBGCP5,microtubule,3.0
25372,114791,GO:0007020,TUBGCP5,microtubule nucleation,3.0
25373,114791,GO:0008017,TUBGCP5,microtubule binding,3.0
25374,114791,GO:0008274,TUBGCP5,gamma-tubulin ring complex,3.0
25376,114791,GO:0031122,TUBGCP5,cytoplasmic microtubule organization,3.0
25377,114791,GO:0043015,TUBGCP5,gamma-tubulin binding,3.0
25378,114791,GO:0051011,TUBGCP5,microtubule minus-end binding,3.0
25379,114791,GO:0051225,TUBGCP5,spindle assembly,3.0
25380,114791,GO:0051321,TUBGCP5,meiotic cell cycle,3.0
25381,114791,GO:0051415,TUBGCP5,microtubule nucleation by interphase microtubule organizing center,3.0
25451,51720,GO:0003677,UIMC1,DNA binding,3.0
25452,51720,GO:0005515,UIMC1,protein binding,3.0
25453,51720,GO:0005634,UIMC1,nucleus,3.0
25454,51720,GO:0005654,UIMC1,nucleoplasm,3.0
25456,51720,GO:0006302,UIMC1,double-strand break repair,3.0
25458,51720,GO:0006303,UIMC1,double-strand break repair via nonhomologous end joining,3.0
25459,51720,GO:0010212,UIMC1,response to ionizing radiation,3.0
25460,51720,GO:0016579,UIMC1,protein deubiquitination,3.0
25461,51720,GO:0016604,UIMC1,nuclear body,3.0
25462,51720,GO:0042393,UIMC1,histone binding,3.0
25464,51720,GO:0045739,UIMC1,positive regulation of DNA repair,3.0
25466,51720,GO:0045892,UIMC1,"negative regulation of transcription, DNA-templated",3.0
25467,51720,GO:0046872,UIMC1,metal ion binding,3.0
25468,51720,GO:0070530,UIMC1,K63-linked polyubiquitin modification-dependent protein binding,3.0
25470,51720,GO:0070531,UIMC1,BRCA1-A complex,3.0
25472,51720,GO:0070537,UIMC1,histone H2A K63-linked deubiquitination,3.0
25474,51720,GO:0072425,UIMC1,signal transduction involved in G2 DNA damage checkpoint,3.0
25475,23025,GO:0001956,UNC13A,positive regulation of neurotransmitter secretion,3.0
25476,23025,GO:0005509,UNC13A,calcium ion binding,3.0
25477,23025,GO:0005516,UNC13A,calmodulin binding,3.0
25479,23025,GO:0005543,UNC13A,phospholipid binding,3.0
25480,23025,GO:0005886,UNC13A,plasma membrane,3.0
25481,23025,GO:0007269,UNC13A,neurotransmitter secretion,3.0
25482,23025,GO:0007528,UNC13A,neuromuscular junction development,3.0
25483,23025,GO:0016081,UNC13A,synaptic vesicle docking,3.0
25484,23025,GO:0016082,UNC13A,synaptic vesicle priming,3.0
25485,23025,GO:0016188,UNC13A,synaptic vesicle maturation,3.0
25486,23025,GO:0017075,UNC13A,syntaxin-1 binding,3.0
25488,23025,GO:0019992,UNC13A,diacylglycerol binding,3.0
25489,23025,GO:0030672,UNC13A,synaptic vesicle membrane,3.0
25490,23025,GO:0031594,UNC13A,neuromuscular junction,3.0
25491,23025,GO:0031915,UNC13A,positive regulation of synaptic plasticity,3.0
25492,23025,GO:0035249,UNC13A,"synaptic transmission, glutamatergic",3.0
25493,23025,GO:0035556,UNC13A,intracellular signal transduction,3.0
25494,23025,GO:0042734,UNC13A,presynaptic membrane,3.0
25496,23025,GO:0043005,UNC13A,neuron projection,3.0
25497,23025,GO:0043195,UNC13A,terminal bouton,3.0
25498,23025,GO:0044305,UNC13A,calyx of Held,3.0
25499,23025,GO:0048172,UNC13A,regulation of short-term neuronal synaptic plasticity,3.0
25500,23025,GO:0048786,UNC13A,presynaptic active zone,3.0
25501,23025,GO:0050435,UNC13A,amyloid-beta metabolic process,3.0
25502,23025,GO:0051966,UNC13A,"regulation of synaptic transmission, glutamatergic",3.0
25503,23025,GO:0060384,UNC13A,innervation,3.0
25504,23025,GO:0061789,UNC13A,dense core granule priming,3.0
25505,23025,GO:0098831,UNC13A,presynaptic active zone cytoplasmic component,3.0
25506,23025,GO:0099011,UNC13A,neuronal dense core vesicle exocytosis,3.0
25507,23025,GO:0099525,UNC13A,presynaptic dense core vesicle exocytosis,3.0
25508,23025,GO:1900451,UNC13A,positive regulation of glutamate receptor signaling pathway,3.0
25509,23025,GO:1902991,UNC13A,regulation of amyloid precursor protein catabolic process,3.0
25510,23025,GO:1903861,UNC13A,positive regulation of dendrite extension,3.0
25516,285175,GO:0005261,UNC80,cation channel activity,3.0
25517,285175,GO:0005886,UNC80,plasma membrane,3.0
25518,285175,GO:0030424,UNC80,axon,3.0
25519,285175,GO:0034220,UNC80,ion transmembrane transport,3.0
25520,285175,GO:0034703,UNC80,cation channel complex,3.0
25521,285175,GO:0055080,UNC80,cation homeostasis,3.0
25522,285175,GO:0098655,UNC80,cation transmembrane transport,3.0
25523,26019,GO:0000184,UPF2,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.0
25526,26019,GO:0001889,UPF2,liver development,3.0
25527,26019,GO:0003723,UPF2,RNA binding,3.0
25528,26019,GO:0005515,UPF2,protein binding,3.0
25529,26019,GO:0005634,UPF2,nucleus,3.0
25530,26019,GO:0005737,UPF2,cytoplasm,3.0
25532,26019,GO:0005829,UPF2,cytosol,3.0
25534,26019,GO:0005844,UPF2,polysome,3.0
25535,26019,GO:0006406,UPF2,mRNA export from nucleus,3.0
25536,26019,GO:0031100,UPF2,animal organ regeneration,3.0
25537,26019,GO:0035145,UPF2,exon-exon junction complex,3.0
25539,26019,GO:0036464,UPF2,cytoplasmic ribonucleoprotein granule,3.0
25540,26019,GO:0042162,UPF2,telomeric DNA binding,3.0
25541,26019,GO:0048471,UPF2,perinuclear region of cytoplasm,3.0
25569,7399,GO:0001917,USH2A,photoreceptor inner segment,3.0
25570,7399,GO:0002141,USH2A,stereocilia ankle link,3.0
25571,7399,GO:0002142,USH2A,stereocilia ankle link complex,3.0
25572,7399,GO:0005515,USH2A,protein binding,3.0
25573,7399,GO:0005518,USH2A,collagen binding,3.0
25574,7399,GO:0005604,USH2A,basement membrane,3.0
25576,7399,GO:0005737,USH2A,cytoplasm,3.0
25577,7399,GO:0007601,USH2A,visual perception,3.0
25578,7399,GO:0007605,USH2A,sensory perception of sound,3.0
25579,7399,GO:0009887,USH2A,animal organ morphogenesis,3.0
25580,7399,GO:0009888,USH2A,tissue development,3.0
25581,7399,GO:0016021,USH2A,integral component of membrane,3.0
25582,7399,GO:0016324,USH2A,apical plasma membrane,3.0
25583,7399,GO:0016477,USH2A,cell migration,3.0
25584,7399,GO:0017022,USH2A,myosin binding,3.0
25585,7399,GO:0032391,USH2A,photoreceptor connecting cilium,3.0
25586,7399,GO:0032421,USH2A,stereocilium bundle,3.0
25587,7399,GO:0034446,USH2A,substrate adhesion-dependent cell spreading,3.0
25588,7399,GO:0035315,USH2A,hair cell differentiation,3.0
25589,7399,GO:0036064,USH2A,ciliary basal body,3.0
25590,7399,GO:0042802,USH2A,identical protein binding,3.0
25591,7399,GO:0043025,USH2A,neuronal cell body,3.0
25592,7399,GO:0043195,USH2A,terminal bouton,3.0
25593,7399,GO:0045184,USH2A,establishment of protein localization,3.0
25594,7399,GO:0045494,USH2A,photoreceptor cell maintenance,3.0
25595,7399,GO:0048496,USH2A,maintenance of animal organ identity,3.0
25596,7399,GO:0050896,USH2A,response to stimulus,3.0
25597,7399,GO:0050953,USH2A,sensory perception of light stimulus,3.0
25598,7399,GO:0060113,USH2A,inner ear receptor cell differentiation,3.0
25599,7399,GO:0060171,USH2A,stereocilium membrane,3.0
25600,7399,GO:1990075,USH2A,periciliary membrane compartment,3.0
25601,7399,GO:1990696,USH2A,USH2 complex,3.0
25734,8287,GO:0004197,USP9Y,cysteine-type endopeptidase activity,3.0
25735,8287,GO:0004843,USP9Y,thiol-dependent ubiquitin-specific protease activity,3.0
25736,8287,GO:0005634,USP9Y,nucleus,3.0
25737,8287,GO:0005737,USP9Y,cytoplasm,3.0
25738,8287,GO:0005829,USP9Y,cytosol,3.0
25739,8287,GO:0006511,USP9Y,ubiquitin-dependent protein catabolic process,3.0
25740,8287,GO:0007179,USP9Y,transforming growth factor beta receptor signaling pathway,3.0
25741,8287,GO:0007283,USP9Y,spermatogenesis,3.0
25742,8287,GO:0008234,USP9Y,cysteine-type peptidase activity,3.0
25743,8287,GO:0016477,USP9Y,cell migration,3.0
25744,8287,GO:0016579,USP9Y,protein deubiquitination,3.0
25746,8287,GO:0030509,USP9Y,BMP signaling pathway,3.0
25747,8287,GO:0070410,USP9Y,co-SMAD binding,3.0
25883,11326,GO:0001851,VSIG4,complement component C3b binding,3.0
25885,11326,GO:0005515,VSIG4,protein binding,3.0
25886,11326,GO:0006957,VSIG4,"complement activation, alternative pathway",3.0
25887,11326,GO:0016021,VSIG4,integral component of membrane,3.0
25888,11326,GO:0032703,VSIG4,negative regulation of interleukin-2 production,3.0
25889,11326,GO:0032991,VSIG4,protein-containing complex,3.0
25890,11326,GO:0042130,VSIG4,negative regulation of T cell proliferation,3.0
25891,11326,GO:0043031,VSIG4,negative regulation of macrophage activation,3.0
25892,11326,GO:0045957,VSIG4,"negative regulation of complement activation, alternative pathway",3.0
25962,6999,GO:0004833,TDO2,"tryptophan 2,3-dioxygenase activity",3.0
25964,6999,GO:0005515,TDO2,protein binding,3.0
25965,6999,GO:0005829,TDO2,cytosol,3.0
25966,6999,GO:0006569,TDO2,tryptophan catabolic process,3.0
25967,6999,GO:0016597,TDO2,amino acid binding,3.0
25968,6999,GO:0019441,TDO2,tryptophan catabolic process to kynurenine,3.0
25970,6999,GO:0019442,TDO2,tryptophan catabolic process to acetyl-CoA,3.0
25971,6999,GO:0019825,TDO2,oxygen binding,3.0
25972,6999,GO:0020037,TDO2,heme binding,3.0
25974,6999,GO:0042802,TDO2,identical protein binding,3.0
25975,6999,GO:0046872,TDO2,metal ion binding,3.0
25976,6999,GO:0051289,TDO2,protein homotetramerization,3.0
25977,6999,GO:0055114,TDO2,oxidation-reduction process,3.0
25978,6999,GO:1904842,TDO2,response to nitroglycerin,3.0
25979,7173,GO:0004447,TPO,iodide peroxidase activity,3.0
25980,7173,GO:0004601,TPO,peroxidase activity,3.0
25982,7173,GO:0005509,TPO,calcium ion binding,3.0
25983,7173,GO:0005615,TPO,extracellular space,3.0
25985,7173,GO:0005886,TPO,plasma membrane,3.0
25986,7173,GO:0005887,TPO,integral component of plasma membrane,3.0
25987,7173,GO:0006590,TPO,thyroid hormone generation,3.0
25989,7173,GO:0006979,TPO,response to oxidative stress,3.0
25990,7173,GO:0009986,TPO,cell surface,3.0
25991,7173,GO:0020037,TPO,heme binding,3.0
25992,7173,GO:0035162,TPO,embryonic hemopoiesis,3.0
25993,7173,GO:0042446,TPO,hormone biosynthetic process,3.0
25994,7173,GO:0042744,TPO,hydrogen peroxide catabolic process,3.0
25995,7173,GO:0055114,TPO,oxidation-reduction process,3.0
25996,7173,GO:0098869,TPO,cellular oxidant detoxification,3.0
25997,51592,GO:0000122,TRIM33,negative regulation of transcription by RNA polymerase II,3.0
25998,51592,GO:0000785,TRIM33,chromatin,3.0
25999,51592,GO:0003677,TRIM33,DNA binding,3.0
26000,51592,GO:0004842,TRIM33,ubiquitin-protein transferase activity,3.0
26001,51592,GO:0005515,TRIM33,protein binding,3.0
26002,51592,GO:0005634,TRIM33,nucleus,3.0
26003,51592,GO:0005654,TRIM33,nucleoplasm,3.0
26004,51592,GO:0008270,TRIM33,zinc ion binding,3.0
26005,51592,GO:0016567,TRIM33,protein ubiquitination,3.0
26007,51592,GO:0017015,TRIM33,regulation of transforming growth factor beta receptor signaling pathway,3.0
26008,51592,GO:0030514,TRIM33,negative regulation of BMP signaling pathway,3.0
26009,51592,GO:0045892,TRIM33,"negative regulation of transcription, DNA-templated",3.0
26010,51592,GO:0070410,TRIM33,co-SMAD binding,3.0
26011,51592,GO:0070412,TRIM33,R-SMAD binding,3.0
26012,7328,GO:0000209,UBE2H,protein polyubiquitination,3.0
26013,7328,GO:0004842,UBE2H,ubiquitin-protein transferase activity,3.0
26014,7328,GO:0005515,UBE2H,protein binding,3.0
26015,7328,GO:0005524,UBE2H,ATP binding,3.0
26016,7328,GO:0005634,UBE2H,nucleus,3.0
26017,7328,GO:0005829,UBE2H,cytosol,3.0
26018,7328,GO:0006511,UBE2H,ubiquitin-dependent protein catabolic process,3.0
26019,7328,GO:0016567,UBE2H,protein ubiquitination,3.0
26020,7328,GO:0043161,UBE2H,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
26021,7328,GO:0061631,UBE2H,ubiquitin conjugating enzyme activity,3.0
26022,7328,GO:0070936,UBE2H,protein K48-linked ubiquitination,3.0
26023,7328,GO:0070979,UBE2H,protein K11-linked ubiquitination,3.0
26024,137970,GO:0005042,UNC5D,netrin receptor activity,3.0
26025,137970,GO:0005886,UNC5D,plasma membrane,3.0
26026,137970,GO:0006915,UNC5D,apoptotic process,3.0
26027,137970,GO:0007411,UNC5D,axon guidance,3.0
26028,137970,GO:0009986,UNC5D,cell surface,3.0
26029,137970,GO:0016021,UNC5D,integral component of membrane,3.0
26030,137970,GO:0021859,UNC5D,pyramidal neuron differentiation,3.0
26031,137970,GO:0038007,UNC5D,netrin-activated signaling pathway,3.0
26032,137970,GO:0098742,UNC5D,cell-cell adhesion via plasma-membrane adhesion molecules,3.0
26033,137970,GO:2001222,UNC5D,regulation of neuron migration,3.0
26034,22846,GO:0001525,VASH1,angiogenesis,3.0
26035,22846,GO:0001937,VASH1,negative regulation of endothelial cell proliferation,3.0
26036,22846,GO:0003779,VASH1,actin binding,3.0
26037,22846,GO:0004181,VASH1,metallocarboxypeptidase activity,3.0
26039,22846,GO:0005515,VASH1,protein binding,3.0
26040,22846,GO:0005615,VASH1,extracellular space,3.0
26041,22846,GO:0005737,VASH1,cytoplasm,3.0
26043,22846,GO:0005783,VASH1,endoplasmic reticulum,3.0
26044,22846,GO:0006508,VASH1,proteolysis,3.0
26045,22846,GO:0007050,VASH1,cell cycle arrest,3.0
26046,22846,GO:0009611,VASH1,response to wounding,3.0
26047,22846,GO:0010596,VASH1,negative regulation of endothelial cell migration,3.0
26048,22846,GO:0016525,VASH1,negative regulation of angiogenesis,3.0
26050,22846,GO:0043537,VASH1,negative regulation of blood vessel endothelial cell migration,3.0
26051,22846,GO:0045177,VASH1,apical part of cell,3.0
26052,22846,GO:0045765,VASH1,regulation of angiogenesis,3.0
26053,22846,GO:0060716,VASH1,labyrinthine layer blood vessel development,3.0
26054,22846,GO:1901491,VASH1,negative regulation of lymphangiogenesis,3.0
26055,22846,GO:2000772,VASH1,regulation of cellular senescence,3.0
26056,7421,GO:0000122,VDR,negative regulation of transcription by RNA polymerase II,3.0
26058,7421,GO:0000785,VDR,chromatin,3.0
26059,7421,GO:0000902,VDR,cell morphogenesis,3.0
26060,7421,GO:0000978,VDR,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26061,7421,GO:0000981,VDR,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26062,7421,GO:0001501,VDR,skeletal system development,3.0
26063,7421,GO:0003677,VDR,DNA binding,3.0
26064,7421,GO:0003700,VDR,DNA-binding transcription factor activity,3.0
26065,7421,GO:0004879,VDR,nuclear receptor activity,3.0
26068,7421,GO:0005515,VDR,protein binding,3.0
26069,7421,GO:0005634,VDR,nucleus,3.0
26070,7421,GO:0005654,VDR,nucleoplasm,3.0
26072,7421,GO:0005829,VDR,cytosol,3.0
26073,7421,GO:0006367,VDR,transcription initiation from RNA polymerase II promoter,3.0
26074,7421,GO:0006816,VDR,calcium ion transport,3.0
26075,7421,GO:0006874,VDR,cellular calcium ion homeostasis,3.0
26076,7421,GO:0007275,VDR,multicellular organism development,3.0
26077,7421,GO:0007595,VDR,lactation,3.0
26078,7421,GO:0008270,VDR,zinc ion binding,3.0
26079,7421,GO:0008285,VDR,negative regulation of cell population proliferation,3.0
26080,7421,GO:0010628,VDR,positive regulation of gene expression,3.0
26081,7421,GO:0010629,VDR,negative regulation of gene expression,3.0
26082,7421,GO:0010839,VDR,negative regulation of keratinocyte proliferation,3.0
26083,7421,GO:0010980,VDR,positive regulation of vitamin D 24-hydroxylase activity,3.0
26084,7421,GO:0030154,VDR,cell differentiation,3.0
26085,7421,GO:0038183,VDR,bile acid signaling pathway,3.0
26086,7421,GO:0038186,VDR,lithocholic acid receptor activity,3.0
26087,7421,GO:0042359,VDR,vitamin D metabolic process,3.0
26088,7421,GO:0043235,VDR,receptor complex,3.0
26089,7421,GO:0045618,VDR,positive regulation of keratinocyte differentiation,3.0
26090,7421,GO:0045892,VDR,"negative regulation of transcription, DNA-templated",3.0
26091,7421,GO:0045944,VDR,positive regulation of transcription by RNA polymerase II,3.0
26093,7421,GO:0046697,VDR,decidualization,3.0
26094,7421,GO:0046965,VDR,retinoid X receptor binding,3.0
26096,7421,GO:0050892,VDR,intestinal absorption,3.0
26097,7421,GO:0060058,VDR,positive regulation of apoptotic process involved in mammary gland involution,3.0
26098,7421,GO:0060558,VDR,regulation of calcidiol 1-monooxygenase activity,3.0
26099,7421,GO:0060745,VDR,mammary gland branching involved in pregnancy,3.0
26100,7421,GO:0070561,VDR,vitamin D receptor signaling pathway,3.0
26102,7421,GO:0070644,VDR,vitamin D response element binding,3.0
26104,7421,GO:0090575,VDR,RNA polymerase II transcription regulator complex,3.0
26105,7421,GO:1902098,VDR,calcitriol binding,3.0
26107,7421,GO:1902121,VDR,lithocholic acid binding,3.0
26122,80737,GO:0003674,VWA7,molecular_function,3.0
26123,80737,GO:0005575,VWA7,cellular_component,3.0
26124,80737,GO:0005576,VWA7,extracellular region,3.0
26125,80737,GO:0008150,VWA7,biological_process,3.0
26136,65267,GO:0004672,WNK3,protein kinase activity,3.0
26137,65267,GO:0004674,WNK3,protein serine/threonine kinase activity,3.0
26140,65267,GO:0005515,WNK3,protein binding,3.0
26141,65267,GO:0005524,WNK3,ATP binding,3.0
26142,65267,GO:0005737,WNK3,cytoplasm,3.0
26144,65267,GO:0005829,WNK3,cytosol,3.0
26145,65267,GO:0005912,WNK3,adherens junction,3.0
26146,65267,GO:0005923,WNK3,bicellular tight junction,3.0
26147,65267,GO:0006468,WNK3,protein phosphorylation,3.0
26149,65267,GO:0006884,WNK3,cell volume homeostasis,3.0
26151,65267,GO:0007231,WNK3,osmosensory signaling pathway,3.0
26152,65267,GO:0010765,WNK3,positive regulation of sodium ion transport,3.0
26153,65267,GO:0010766,WNK3,negative regulation of sodium ion transport,3.0
26154,65267,GO:0010800,WNK3,positive regulation of peptidyl-threonine phosphorylation,3.0
26155,65267,GO:0018107,WNK3,peptidyl-threonine phosphorylation,3.0
26156,65267,GO:0019869,WNK3,chloride channel inhibitor activity,3.0
26158,65267,GO:0019870,WNK3,potassium channel inhibitor activity,3.0
26159,65267,GO:0032414,WNK3,positive regulation of ion transmembrane transporter activity,3.0
26160,65267,GO:0035556,WNK3,intracellular signal transduction,3.0
26162,65267,GO:0035633,WNK3,maintenance of blood-brain barrier,3.0
26163,65267,GO:0043066,WNK3,negative regulation of apoptotic process,3.0
26164,65267,GO:0046777,WNK3,protein autophosphorylation,3.0
26165,65267,GO:0050801,WNK3,ion homeostasis,3.0
26167,65267,GO:0051928,WNK3,positive regulation of calcium ion transport,3.0
26169,65267,GO:0072659,WNK3,protein localization to plasma membrane,3.0
26170,65267,GO:0090188,WNK3,negative regulation of pancreatic juice secretion,3.0
26171,65267,GO:0090279,WNK3,regulation of calcium ion import,3.0
26172,65267,GO:0106310,WNK3,protein serine kinase activity,3.0
26173,65267,GO:0106311,WNK3,protein threonine kinase activity,3.0
26174,65267,GO:1903078,WNK3,positive regulation of protein localization to plasma membrane,3.0
26175,65267,GO:1903288,WNK3,positive regulation of potassium ion import across plasma membrane,3.0
26176,65267,GO:1904062,WNK3,regulation of cation transmembrane transport,3.0
26178,65267,GO:2000651,WNK3,positive regulation of sodium ion transmembrane transporter activity,3.0
26181,7471,GO:0000578,WNT1,embryonic axis specification,3.0
26182,7471,GO:0001658,WNT1,branching involved in ureteric bud morphogenesis,3.0
26183,7471,GO:0001934,WNT1,positive regulation of protein phosphorylation,3.0
26184,7471,GO:0005109,WNT1,frizzled binding,3.0
26187,7471,GO:0005125,WNT1,cytokine activity,3.0
26189,7471,GO:0005576,WNT1,extracellular region,3.0
26190,7471,GO:0005615,WNT1,extracellular space,3.0
26191,7471,GO:0005737,WNT1,cytoplasm,3.0
26192,7471,GO:0005788,WNT1,endoplasmic reticulum lumen,3.0
26193,7471,GO:0005796,WNT1,Golgi lumen,3.0
26194,7471,GO:0005886,WNT1,plasma membrane,3.0
26195,7471,GO:0007267,WNT1,cell-cell signaling,3.0
26196,7471,GO:0007520,WNT1,myoblast fusion,3.0
26197,7471,GO:0008284,WNT1,positive regulation of cell population proliferation,3.0
26199,7471,GO:0009611,WNT1,response to wounding,3.0
26200,7471,GO:0009986,WNT1,cell surface,3.0
26201,7471,GO:0010592,WNT1,positive regulation of lamellipodium assembly,3.0
26202,7471,GO:0010812,WNT1,negative regulation of cell-substrate adhesion,3.0
26203,7471,GO:0016015,WNT1,morphogen activity,3.0
26204,7471,GO:0016055,WNT1,Wnt signaling pathway,3.0
26205,7471,GO:0019904,WNT1,protein domain specific binding,3.0
26206,7471,GO:0021527,WNT1,spinal cord association neuron differentiation,3.0
26207,7471,GO:0021536,WNT1,diencephalon development,3.0
26208,7471,GO:0021551,WNT1,central nervous system morphogenesis,3.0
26209,7471,GO:0021588,WNT1,cerebellum formation,3.0
26210,7471,GO:0021797,WNT1,forebrain anterior/posterior pattern specification,3.0
26211,7471,GO:0022004,WNT1,midbrain-hindbrain boundary maturation during brain development,3.0
26212,7471,GO:0022408,WNT1,negative regulation of cell-cell adhesion,3.0
26213,7471,GO:0030182,WNT1,neuron differentiation,3.0
26214,7471,GO:0030512,WNT1,negative regulation of transforming growth factor beta receptor signaling pathway,3.0
26215,7471,GO:0030514,WNT1,negative regulation of BMP signaling pathway,3.0
26216,7471,GO:0030579,WNT1,ubiquitin-dependent SMAD protein catabolic process,3.0
26217,7471,GO:0030666,WNT1,endocytic vesicle membrane,3.0
26218,7471,GO:0030901,WNT1,midbrain development,3.0
26219,7471,GO:0031100,WNT1,animal organ regeneration,3.0
26220,7471,GO:0033077,WNT1,T cell differentiation in thymus,3.0
26221,7471,GO:0033278,WNT1,cell proliferation in midbrain,3.0
26222,7471,GO:0036520,WNT1,astrocyte-dopaminergic neuron signaling,3.0
26223,7471,GO:0042472,WNT1,inner ear morphogenesis,3.0
26224,7471,GO:0042770,WNT1,signal transduction in response to DNA damage,3.0
26225,7471,GO:0043066,WNT1,negative regulation of apoptotic process,3.0
26226,7471,GO:0043568,WNT1,positive regulation of insulin-like growth factor receptor signaling pathway,3.0
26227,7471,GO:0045165,WNT1,cell fate commitment,3.0
26228,7471,GO:0045599,WNT1,negative regulation of fat cell differentiation,3.0
26229,7471,GO:0045747,WNT1,positive regulation of Notch signaling pathway,3.0
26230,7471,GO:0045893,WNT1,"positive regulation of transcription, DNA-templated",3.0
26233,7471,GO:0045944,WNT1,positive regulation of transcription by RNA polymerase II,3.0
26234,7471,GO:0048018,WNT1,receptor ligand activity,3.0
26237,7471,GO:0048146,WNT1,positive regulation of fibroblast proliferation,3.0
26238,7471,GO:0048664,WNT1,neuron fate determination,3.0
26239,7471,GO:0051091,WNT1,positive regulation of DNA-binding transcription factor activity,3.0
26240,7471,GO:0060061,WNT1,Spemann organizer formation,3.0
26241,7471,GO:0060070,WNT1,canonical Wnt signaling pathway,3.0
26246,7471,GO:0060071,WNT1,"Wnt signaling pathway, planar cell polarity pathway",3.0
26247,7471,GO:0060348,WNT1,bone development,3.0
26248,7471,GO:0061184,WNT1,positive regulation of dermatome development,3.0
26249,7471,GO:0070062,WNT1,extracellular exosome,3.0
26250,7471,GO:0070365,WNT1,hepatocyte differentiation,3.0
26251,7471,GO:0071375,WNT1,cellular response to peptide hormone stimulus,3.0
26252,7471,GO:0071425,WNT1,hematopoietic stem cell proliferation,3.0
26253,7471,GO:0090344,WNT1,negative regulation of cell aging,3.0
26254,7471,GO:1903204,WNT1,negative regulation of oxidative stress-induced neuron death,3.0
26255,7471,GO:1904886,WNT1,beta-catenin destruction complex disassembly,3.0
26256,7471,GO:1904953,WNT1,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,3.0
26258,7471,GO:1904954,WNT1,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,3.0
26259,7471,GO:1990403,WNT1,embryonic brain development,3.0
26260,7471,GO:2000059,WNT1,negative regulation of ubiquitin-dependent protein catabolic process,3.0
26287,11059,GO:0000151,WWP1,ubiquitin ligase complex,3.0
26288,11059,GO:0000209,WWP1,protein polyubiquitination,3.0
26289,11059,GO:0004842,WWP1,ubiquitin-protein transferase activity,3.0
26290,11059,GO:0005515,WWP1,protein binding,3.0
26291,11059,GO:0005634,WWP1,nucleus,3.0
26292,11059,GO:0005737,WWP1,cytoplasm,3.0
26293,11059,GO:0005829,WWP1,cytosol,3.0
26294,11059,GO:0005886,WWP1,plasma membrane,3.0
26295,11059,GO:0007165,WWP1,signal transduction,3.0
26296,11059,GO:0007417,WWP1,central nervous system development,3.0
26297,11059,GO:0016567,WWP1,protein ubiquitination,3.0
26299,11059,GO:0034220,WWP1,ion transmembrane transport,3.0
26300,11059,GO:0043161,WWP1,proteasome-mediated ubiquitin-dependent protein catabolic process,3.0
26301,11059,GO:0045732,WWP1,positive regulation of protein catabolic process,3.0
26302,11059,GO:0045892,WWP1,"negative regulation of transcription, DNA-templated",3.0
26303,11059,GO:0046718,WWP1,viral entry into host cell,3.0
26304,11059,GO:0061630,WWP1,ubiquitin protein ligase activity,3.0
26305,11059,GO:0070062,WWP1,extracellular exosome,3.0
26348,7514,GO:0000054,XPO1,ribosomal subunit export from nucleus,3.0
26349,7514,GO:0000055,XPO1,ribosomal large subunit export from nucleus,3.0
26351,7514,GO:0000056,XPO1,ribosomal small subunit export from nucleus,3.0
26353,7514,GO:0000122,XPO1,negative regulation of transcription by RNA polymerase II,3.0
26354,7514,GO:0000776,XPO1,kinetochore,3.0
26355,7514,GO:0003723,XPO1,RNA binding,3.0
26356,7514,GO:0005049,XPO1,nuclear export signal receptor activity,3.0
26359,7514,GO:0005515,XPO1,protein binding,3.0
26360,7514,GO:0005634,XPO1,nucleus,3.0
26361,7514,GO:0005635,XPO1,nuclear envelope,3.0
26362,7514,GO:0005642,XPO1,annulate lamellae,3.0
26363,7514,GO:0005654,XPO1,nucleoplasm,3.0
26365,7514,GO:0005730,XPO1,nucleolus,3.0
26366,7514,GO:0005737,XPO1,cytoplasm,3.0
26368,7514,GO:0005829,XPO1,cytosol,3.0
26370,7514,GO:0006611,XPO1,protein export from nucleus,3.0
26374,7514,GO:0006913,XPO1,nucleocytoplasmic transport,3.0
26375,7514,GO:0010824,XPO1,regulation of centrosome duplication,3.0
26376,7514,GO:0015030,XPO1,Cajal body,3.0
26377,7514,GO:0016020,XPO1,membrane,3.0
26378,7514,GO:0016032,XPO1,viral process,3.0
26379,7514,GO:0019904,XPO1,protein domain specific binding,3.0
26380,7514,GO:0031267,XPO1,small GTPase binding,3.0
26381,7514,GO:0031965,XPO1,nuclear membrane,3.0
26382,7514,GO:0032434,XPO1,regulation of proteasomal ubiquitin-dependent protein catabolic process,3.0
26383,7514,GO:0032991,XPO1,protein-containing complex,3.0
26384,7514,GO:0034504,XPO1,protein localization to nucleus,3.0
26385,7514,GO:0042254,XPO1,ribosome biogenesis,3.0
26386,7514,GO:0042493,XPO1,response to drug,3.0
26387,7514,GO:0043231,XPO1,intracellular membrane-bounded organelle,3.0
26388,7514,GO:0043488,XPO1,regulation of mRNA stability,3.0
26389,7514,GO:0043657,XPO1,host cell,3.0
26390,7514,GO:0046825,XPO1,regulation of protein export from nucleus,3.0
26391,7514,GO:0051028,XPO1,mRNA transport,3.0
26392,7514,GO:0075733,XPO1,intracellular transport of virus,3.0
26393,7514,GO:1990904,XPO1,ribonucleoprotein complex,3.0
26394,55689,GO:0000122,YEATS2,negative regulation of transcription by RNA polymerase II,3.0
26395,55689,GO:0005515,YEATS2,protein binding,3.0
26396,55689,GO:0005671,YEATS2,Ada2/Gcn5/Ada3 transcription activator complex,3.0
26397,55689,GO:0017025,YEATS2,TBP-class protein binding,3.0
26398,55689,GO:0042393,YEATS2,histone binding,3.0
26399,55689,GO:0043966,YEATS2,histone H3 acetylation,3.0
26400,55689,GO:0045892,YEATS2,"negative regulation of transcription, DNA-templated",3.0
26401,55689,GO:0072686,YEATS2,mitotic spindle,3.0
26402,55689,GO:0140030,YEATS2,modification-dependent protein binding,3.0
26403,64848,GO:0003723,YTHDC2,RNA binding,3.0
26405,64848,GO:0005515,YTHDC2,protein binding,3.0
26406,64848,GO:0005524,YTHDC2,ATP binding,3.0
26407,64848,GO:0005622,YTHDC2,intracellular anatomical structure,3.0
26408,64848,GO:0005634,YTHDC2,nucleus,3.0
26409,64848,GO:0005783,YTHDC2,endoplasmic reticulum,3.0
26411,64848,GO:0007286,YTHDC2,spermatid development,3.0
26412,64848,GO:0008186,YTHDC2,RNA-dependent ATPase activity,3.0
26413,64848,GO:0034458,YTHDC2,3'-5' RNA helicase activity,3.0
26414,64848,GO:0034612,YTHDC2,response to tumor necrosis factor,3.0
26415,64848,GO:0035770,YTHDC2,ribonucleoprotein granule,3.0
26416,64848,GO:0044829,YTHDC2,positive regulation by host of viral genome replication,3.0
26417,64848,GO:0048599,YTHDC2,oocyte development,3.0
26418,64848,GO:0051321,YTHDC2,meiotic cell cycle,3.0
26419,64848,GO:0051729,YTHDC2,"germline cell cycle switching, mitotic to meiotic cell cycle",3.0
26420,64848,GO:0070063,YTHDC2,RNA polymerase binding,3.0
26421,64848,GO:0070555,YTHDC2,response to interleukin-1,3.0
26422,64848,GO:1990247,YTHDC2,N6-methyladenosine-containing RNA binding,3.0
26423,7531,GO:0000086,YWHAE,G2/M transition of mitotic cell cycle,3.0
26424,7531,GO:0000165,YWHAE,MAPK cascade,3.0
26425,7531,GO:0001764,YWHAE,neuron migration,3.0
26426,7531,GO:0003064,YWHAE,regulation of heart rate by hormone,3.0
26427,7531,GO:0003723,YWHAE,RNA binding,3.0
26428,7531,GO:0005246,YWHAE,calcium channel regulator activity,3.0
26429,7531,GO:0005515,YWHAE,protein binding,3.0
26430,7531,GO:0005634,YWHAE,nucleus,3.0
26431,7531,GO:0005737,YWHAE,cytoplasm,3.0
26432,7531,GO:0005739,YWHAE,mitochondrion,3.0
26433,7531,GO:0005829,YWHAE,cytosol,3.0
26435,7531,GO:0005871,YWHAE,kinesin complex,3.0
26436,7531,GO:0005886,YWHAE,plasma membrane,3.0
26437,7531,GO:0005925,YWHAE,focal adhesion,3.0
26438,7531,GO:0006605,YWHAE,protein targeting,3.0
26439,7531,GO:0010389,YWHAE,regulation of G2/M transition of mitotic cell cycle,3.0
26440,7531,GO:0015459,YWHAE,potassium channel regulator activity,3.0
26441,7531,GO:0016020,YWHAE,membrane,3.0
26442,7531,GO:0016032,YWHAE,viral process,3.0
26443,7531,GO:0019899,YWHAE,enzyme binding,3.0
26444,7531,GO:0019903,YWHAE,protein phosphatase binding,3.0
26445,7531,GO:0019904,YWHAE,protein domain specific binding,3.0
26446,7531,GO:0021762,YWHAE,substantia nigra development,3.0
26447,7531,GO:0021766,YWHAE,hippocampus development,3.0
26448,7531,GO:0021987,YWHAE,cerebral cortex development,3.0
26449,7531,GO:0023026,YWHAE,MHC class II protein complex binding,3.0
26450,7531,GO:0031625,YWHAE,ubiquitin protein ligase binding,3.0
26451,7531,GO:0034504,YWHAE,protein localization to nucleus,3.0
26452,7531,GO:0034605,YWHAE,cellular response to heat,3.0
26453,7531,GO:0035329,YWHAE,hippo signaling,3.0
26454,7531,GO:0035556,YWHAE,intracellular signal transduction,3.0
26455,7531,GO:0042470,YWHAE,melanosome,3.0
26456,7531,GO:0042802,YWHAE,identical protein binding,3.0
26457,7531,GO:0042826,YWHAE,histone deacetylase binding,3.0
26458,7531,GO:0043154,YWHAE,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3.0
26459,7531,GO:0044325,YWHAE,ion channel binding,3.0
26460,7531,GO:0045296,YWHAE,cadherin binding,3.0
26461,7531,GO:0046827,YWHAE,positive regulation of protein export from nucleus,3.0
26462,7531,GO:0046982,YWHAE,protein heterodimerization activity,3.0
26463,7531,GO:0050815,YWHAE,phosphoserine residue binding,3.0
26464,7531,GO:0051219,YWHAE,phosphoprotein binding,3.0
26465,7531,GO:0051480,YWHAE,regulation of cytosolic calcium ion concentration,3.0
26466,7531,GO:0060306,YWHAE,regulation of membrane repolarization,3.0
26467,7531,GO:0061024,YWHAE,membrane organization,3.0
26468,7531,GO:0070062,YWHAE,extracellular exosome,3.0
26469,7531,GO:0086013,YWHAE,membrane repolarization during cardiac muscle cell action potential,3.0
26470,7531,GO:0086091,YWHAE,regulation of heart rate by cardiac conduction,3.0
26471,7531,GO:0090724,YWHAE,central region of growth cone,3.0
26472,7531,GO:0097110,YWHAE,scaffold protein binding,3.0
26473,7531,GO:0097711,YWHAE,ciliary basal body-plasma membrane docking,3.0
26474,7531,GO:0098978,YWHAE,glutamatergic synapse,3.0
26475,7531,GO:0099072,YWHAE,regulation of postsynaptic membrane neurotransmitter receptor levels,3.0
26476,7531,GO:1900034,YWHAE,regulation of cellular response to heat,3.0
26477,7531,GO:1900740,YWHAE,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,3.0
26478,7531,GO:1901016,YWHAE,regulation of potassium ion transmembrane transporter activity,3.0
26479,7531,GO:1901020,YWHAE,negative regulation of calcium ion transmembrane transporter activity,3.0
26480,7531,GO:1902309,YWHAE,negative regulation of peptidyl-serine dephosphorylation,3.0
26481,7531,GO:1905913,YWHAE,negative regulation of calcium ion export across plasma membrane,3.0
26495,2547,GO:0000723,XRCC6,telomere maintenance,3.0
26497,2547,GO:0000781,XRCC6,"chromosome, telomeric region",3.0
26499,2547,GO:0000783,XRCC6,nuclear telomere cap complex,3.0
26500,2547,GO:0000976,XRCC6,transcription regulatory region sequence-specific DNA binding,3.0
26501,2547,GO:0002218,XRCC6,activation of innate immune response,3.0
26502,2547,GO:0003677,XRCC6,DNA binding,3.0
26503,2547,GO:0003678,XRCC6,DNA helicase activity,3.0
26504,2547,GO:0003684,XRCC6,damaged DNA binding,3.0
26505,2547,GO:0003690,XRCC6,double-stranded DNA binding,3.0
26506,2547,GO:0003691,XRCC6,double-stranded telomeric DNA binding,3.0
26507,2547,GO:0003723,XRCC6,RNA binding,3.0
26508,2547,GO:0005515,XRCC6,protein binding,3.0
26509,2547,GO:0005524,XRCC6,ATP binding,3.0
26510,2547,GO:0005576,XRCC6,extracellular region,3.0
26511,2547,GO:0005634,XRCC6,nucleus,3.0
26512,2547,GO:0005654,XRCC6,nucleoplasm,3.0
26514,2547,GO:0005667,XRCC6,transcription regulator complex,3.0
26515,2547,GO:0005730,XRCC6,nucleolus,3.0
26516,2547,GO:0005829,XRCC6,cytosol,3.0
26517,2547,GO:0006266,XRCC6,DNA ligation,3.0
26518,2547,GO:0006303,XRCC6,double-strand break repair via nonhomologous end joining,3.0
26521,2547,GO:0006310,XRCC6,DNA recombination,3.0
26522,2547,GO:0007420,XRCC6,brain development,3.0
26523,2547,GO:0008022,XRCC6,protein C-terminus binding,3.0
26524,2547,GO:0008094,XRCC6,DNA-dependent ATPase activity,3.0
26525,2547,GO:0016020,XRCC6,membrane,3.0
26526,2547,GO:0030332,XRCC6,cyclin binding,3.0
26527,2547,GO:0032481,XRCC6,positive regulation of type I interferon production,3.0
26528,2547,GO:0032508,XRCC6,DNA duplex unwinding,3.0
26529,2547,GO:0032991,XRCC6,protein-containing complex,3.0
26530,2547,GO:0032993,XRCC6,protein-DNA complex,3.0
26531,2547,GO:0034774,XRCC6,secretory granule lumen,3.0
26532,2547,GO:0042162,XRCC6,telomeric DNA binding,3.0
26533,2547,GO:0043312,XRCC6,neutrophil degranulation,3.0
26534,2547,GO:0043564,XRCC6,Ku70:Ku80 complex,3.0
26536,2547,GO:0044877,XRCC6,protein-containing complex binding,3.0
26537,2547,GO:0045027,XRCC6,DNA end binding,3.0
26538,2547,GO:0045087,XRCC6,innate immune response,3.0
26539,2547,GO:0045621,XRCC6,positive regulation of lymphocyte differentiation,3.0
26540,2547,GO:0045860,XRCC6,positive regulation of protein kinase activity,3.0
26541,2547,GO:0045892,XRCC6,"negative regulation of transcription, DNA-templated",3.0
26542,2547,GO:0045893,XRCC6,"positive regulation of transcription, DNA-templated",3.0
26544,2547,GO:0045944,XRCC6,positive regulation of transcription by RNA polymerase II,3.0
26545,2547,GO:0048660,XRCC6,regulation of smooth muscle cell proliferation,3.0
26546,2547,GO:0051575,XRCC6,5'-deoxyribose-5-phosphate lyase activity,3.0
26547,2547,GO:0070419,XRCC6,nonhomologous end joining complex,3.0
26548,2547,GO:0071475,XRCC6,cellular hyperosmotic salinity response,3.0
26549,2547,GO:0071480,XRCC6,cellular response to gamma radiation,3.0
26551,2547,GO:0071481,XRCC6,cellular response to X-ray,3.0
26552,2547,GO:0075713,XRCC6,establishment of integrated proviral latency,3.0
26553,2547,GO:0097680,XRCC6,double-strand break repair via classical nonhomologous end joining,3.0
26554,2547,GO:1904813,XRCC6,ficolin-1-rich granule lumen,3.0
26555,7532,GO:0000086,YWHAG,G2/M transition of mitotic cell cycle,3.0
26556,7532,GO:0003723,YWHAG,RNA binding,3.0
26557,7532,GO:0005080,YWHAG,protein kinase C binding,3.0
26558,7532,GO:0005159,YWHAG,insulin-like growth factor receptor binding,3.0
26559,7532,GO:0005515,YWHAG,protein binding,3.0
26560,7532,GO:0005739,YWHAG,mitochondrion,3.0
26561,7532,GO:0005829,YWHAG,cytosol,3.0
26562,7532,GO:0005925,YWHAG,focal adhesion,3.0
26563,7532,GO:0006469,YWHAG,negative regulation of protein kinase activity,3.0
26564,7532,GO:0006605,YWHAG,protein targeting,3.0
26565,7532,GO:0008426,YWHAG,protein kinase C inhibitor activity,3.0
26566,7532,GO:0009966,YWHAG,regulation of signal transduction,3.0
26567,7532,GO:0010389,YWHAG,regulation of G2/M transition of mitotic cell cycle,3.0
26568,7532,GO:0016020,YWHAG,membrane,3.0
26569,7532,GO:0019904,YWHAG,protein domain specific binding,3.0
26570,7532,GO:0030971,YWHAG,receptor tyrosine kinase binding,3.0
26571,7532,GO:0032869,YWHAG,cellular response to insulin stimulus,3.0
26572,7532,GO:0042802,YWHAG,identical protein binding,3.0
26573,7532,GO:0045664,YWHAG,regulation of neuron differentiation,3.0
26574,7532,GO:0048167,YWHAG,regulation of synaptic plasticity,3.0
26575,7532,GO:0061024,YWHAG,membrane organization,3.0
26576,7532,GO:0070062,YWHAG,extracellular exosome,3.0
26577,7532,GO:0071901,YWHAG,negative regulation of protein serine/threonine kinase activity,3.0
26578,7532,GO:0097711,YWHAG,ciliary basal body-plasma membrane docking,3.0
26579,7532,GO:0098793,YWHAG,presynapse,3.0
26580,7532,GO:1900740,YWHAG,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,3.0
26626,7704,GO:0000122,ZBTB16,negative regulation of transcription by RNA polymerase II,3.0
26627,7704,GO:0000978,ZBTB16,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26629,7704,GO:0001227,ZBTB16,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
26631,7704,GO:0001228,ZBTB16,"DNA-binding transcription activator activity, RNA polymerase II-specific",3.0
26632,7704,GO:0001823,ZBTB16,mesonephros development,3.0
26633,7704,GO:0003677,ZBTB16,DNA binding,3.0
26635,7704,GO:0005515,ZBTB16,protein binding,3.0
26636,7704,GO:0005634,ZBTB16,nucleus,3.0
26638,7704,GO:0005829,ZBTB16,cytosol,3.0
26639,7704,GO:0005886,ZBTB16,plasma membrane,3.0
26640,7704,GO:0006357,ZBTB16,regulation of transcription by RNA polymerase II,3.0
26641,7704,GO:0006915,ZBTB16,apoptotic process,3.0
26642,7704,GO:0007417,ZBTB16,central nervous system development,3.0
26643,7704,GO:0008022,ZBTB16,protein C-terminus binding,3.0
26644,7704,GO:0008285,ZBTB16,negative regulation of cell population proliferation,3.0
26645,7704,GO:0009880,ZBTB16,embryonic pattern specification,3.0
26646,7704,GO:0009952,ZBTB16,anterior/posterior pattern specification,3.0
26647,7704,GO:0016567,ZBTB16,protein ubiquitination,3.0
26648,7704,GO:0016604,ZBTB16,nuclear body,3.0
26649,7704,GO:0016605,ZBTB16,PML body,3.0
26650,7704,GO:0016607,ZBTB16,nuclear speck,3.0
26651,7704,GO:0017053,ZBTB16,transcription repressor complex,3.0
26652,7704,GO:0019904,ZBTB16,protein domain specific binding,3.0
26653,7704,GO:0030097,ZBTB16,hemopoiesis,3.0
26655,7704,GO:0030099,ZBTB16,myeloid cell differentiation,3.0
26656,7704,GO:0032332,ZBTB16,positive regulation of chondrocyte differentiation,3.0
26657,7704,GO:0032991,ZBTB16,protein-containing complex,3.0
26658,7704,GO:0034504,ZBTB16,protein localization to nucleus,3.0
26659,7704,GO:0035116,ZBTB16,embryonic hindlimb morphogenesis,3.0
26660,7704,GO:0035136,ZBTB16,forelimb morphogenesis,3.0
26661,7704,GO:0042733,ZBTB16,embryonic digit morphogenesis,3.0
26662,7704,GO:0042802,ZBTB16,identical protein binding,3.0
26663,7704,GO:0042803,ZBTB16,protein homodimerization activity,3.0
26664,7704,GO:0043065,ZBTB16,positive regulation of apoptotic process,3.0
26665,7704,GO:0043687,ZBTB16,post-translational protein modification,3.0
26666,7704,GO:0045600,ZBTB16,positive regulation of fat cell differentiation,3.0
26667,7704,GO:0045638,ZBTB16,negative regulation of myeloid cell differentiation,3.0
26668,7704,GO:0045778,ZBTB16,positive regulation of ossification,3.0
26669,7704,GO:0045892,ZBTB16,"negative regulation of transcription, DNA-templated",3.0
26671,7704,GO:0045893,ZBTB16,"positive regulation of transcription, DNA-templated",3.0
26672,7704,GO:0045944,ZBTB16,positive regulation of transcription by RNA polymerase II,3.0
26673,7704,GO:0046872,ZBTB16,metal ion binding,3.0
26674,7704,GO:0048133,ZBTB16,male germ-line stem cell asymmetric division,3.0
26675,7704,GO:0051138,ZBTB16,positive regulation of NK T cell differentiation,3.0
26676,7704,GO:0051216,ZBTB16,cartilage development,3.0
26677,7704,GO:0061036,ZBTB16,positive regulation of cartilage development,3.0
26694,9877,GO:0000346,ZC3H11A,transcription export complex,3.0
26696,9877,GO:0003723,ZC3H11A,RNA binding,3.0
26697,9877,GO:0003729,ZC3H11A,mRNA binding,3.0
26698,9877,GO:0005515,ZC3H11A,protein binding,3.0
26699,9877,GO:0005654,ZC3H11A,nucleoplasm,3.0
26700,9877,GO:0006405,ZC3H11A,RNA export from nucleus,3.0
26701,9877,GO:0006406,ZC3H11A,mRNA export from nucleus,3.0
26702,9877,GO:0016973,ZC3H11A,poly(A)+ mRNA export from nucleus,3.0
26704,9877,GO:0031124,ZC3H11A,mRNA 3'-end processing,3.0
26705,9877,GO:0046872,ZC3H11A,metal ion binding,3.0
26714,23503,GO:0000281,ZFYVE26,mitotic cytokinesis,3.0
26715,23503,GO:0000724,ZFYVE26,double-strand break repair via homologous recombination,3.0
26716,23503,GO:0005515,ZFYVE26,protein binding,3.0
26717,23503,GO:0005765,ZFYVE26,lysosomal membrane,3.0
26718,23503,GO:0005813,ZFYVE26,centrosome,3.0
26720,23503,GO:0030496,ZFYVE26,midbody,3.0
26722,23503,GO:0032266,ZFYVE26,phosphatidylinositol-3-phosphate binding,3.0
26724,23503,GO:0032465,ZFYVE26,regulation of cytokinesis,3.0
26726,23503,GO:0046872,ZFYVE26,metal ion binding,3.0
26746,7566,GO:0000785,ZNF18,chromatin,3.0
26747,7566,GO:0000978,ZNF18,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26748,7566,GO:0000981,ZNF18,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26749,7566,GO:0005515,ZNF18,protein binding,3.0
26750,7566,GO:0006357,ZNF18,regulation of transcription by RNA polymerase II,3.0
26751,7566,GO:0046872,ZNF18,metal ion binding,3.0
26810,151126,GO:0002039,ZNF385B,p53 binding,3.0
26811,151126,GO:0003676,ZNF385B,nucleic acid binding,3.0
26812,151126,GO:0005634,ZNF385B,nucleus,3.0
26814,151126,GO:0008270,ZNF385B,zinc ion binding,3.0
26815,151126,GO:0072332,ZNF385B,intrinsic apoptotic signaling pathway by p53 class mediator,3.0
26824,340385,GO:0000977,ZNF517,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
26825,340385,GO:0000981,ZNF517,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26826,340385,GO:0005634,ZNF517,nucleus,3.0
26827,340385,GO:0006357,ZNF517,regulation of transcription by RNA polymerase II,3.0
26828,340385,GO:0046872,ZNF517,metal ion binding,3.0
26829,147694,GO:0000978,ZNF548,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26830,147694,GO:0000981,ZNF548,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26831,147694,GO:0005634,ZNF548,nucleus,3.0
26832,147694,GO:0006357,ZNF548,regulation of transcription by RNA polymerase II,3.0
26833,147694,GO:0046872,ZNF548,metal ion binding,3.0
26834,84527,GO:0000122,ZNF559,negative regulation of transcription by RNA polymerase II,3.0
26835,84527,GO:0000785,ZNF559,chromatin,3.0
26836,84527,GO:0000977,ZNF559,RNA polymerase II transcription regulatory region sequence-specific DNA binding,3.0
26837,84527,GO:0000981,ZNF559,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26838,84527,GO:0001227,ZNF559,"DNA-binding transcription repressor activity, RNA polymerase II-specific",3.0
26839,84527,GO:0005515,ZNF559,protein binding,3.0
26840,84527,GO:0006357,ZNF559,regulation of transcription by RNA polymerase II,3.0
26841,84527,GO:0046872,ZNF559,metal ion binding,3.0
26842,199777,GO:0000785,ZNF626,chromatin,3.0
26843,199777,GO:0000978,ZNF626,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26844,199777,GO:0000981,ZNF626,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26845,199777,GO:0006355,ZNF626,"regulation of transcription, DNA-templated",3.0
26846,199777,GO:0006357,ZNF626,regulation of transcription by RNA polymerase II,3.0
26847,199777,GO:0046872,ZNF626,metal ion binding,3.0
26848,349075,GO:0000785,ZNF713,chromatin,3.0
26849,349075,GO:0000978,ZNF713,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26850,349075,GO:0000981,ZNF713,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26851,349075,GO:0006355,ZNF713,"regulation of transcription, DNA-templated",3.0
26852,349075,GO:0006357,ZNF713,regulation of transcription by RNA polymerase II,3.0
26853,349075,GO:0046872,ZNF713,metal ion binding,3.0
26854,349075,GO:1990837,ZNF713,sequence-specific double-stranded DNA binding,3.0
26855,342132,GO:0000978,ZNF774,RNA polymerase II cis-regulatory region sequence-specific DNA binding,3.0
26856,342132,GO:0000981,ZNF774,"DNA-binding transcription factor activity, RNA polymerase II-specific",3.0
26857,342132,GO:0005515,ZNF774,protein binding,3.0
26858,342132,GO:0005634,ZNF774,nucleus,3.0
26859,342132,GO:0006357,ZNF774,regulation of transcription by RNA polymerase II,3.0
26860,342132,GO:0046872,ZNF774,metal ion binding,3.0
26878,152485,GO:0003677,ZNF827,DNA binding,3.0
26879,152485,GO:0005515,ZNF827,protein binding,3.0
26880,152485,GO:0005634,ZNF827,nucleus,3.0
26881,152485,GO:0010468,ZNF827,regulation of gene expression,3.0
26882,152485,GO:0045944,ZNF827,positive regulation of transcription by RNA polymerase II,3.0
26883,152485,GO:0046872,ZNF827,metal ion binding,3.0
26891,55055,GO:0000776,ZWILCH,kinetochore,3.0
26892,55055,GO:0000777,ZWILCH,condensed chromosome kinetochore,3.0
26893,55055,GO:0005515,ZWILCH,protein binding,3.0
26894,55055,GO:0005829,ZWILCH,cytosol,3.0
26895,55055,GO:0007093,ZWILCH,mitotic cell cycle checkpoint,3.0
26896,55055,GO:0051301,ZWILCH,cell division,3.0
26897,55055,GO:1990423,ZWILCH,RZZ complex,3.0
